test_order_name_SHORTNAME_sdist,test_order_name_LONG_COMMON_NAME_sdist,test_order_name_COMPONENT_sdist,test_result_name_SHORTNAME_sdist,test_result_name_LONG_COMMON_NAME_sdist,test_result_name_COMPONENT_sdist,test_order_name_SHORTNAME_tfidf,test_order_name_LONG_COMMON_NAME_tfidf,test_order_name_COMPONENT_tfidf,test_result_name_SHORTNAME_tfidf,test_result_name_LONG_COMMON_NAME_tfidf,test_result_name_COMPONENT_tfidf,label,assignment,test_order_name,test_result_name,COMPONENT,LONG_COMMON_NAME,SHORTNAME
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,URINALYSIS W MICRO W REFLEX CULTURE,NITRITES,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,CBC WITH DIFFERENTIAL,EOSINOPHILS,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.041428571428571426,0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,MANUAL DIFFERENTIAL,BLASTS %,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,IMMUNOGLOBULINS,IMMUNOGLOBULIN M,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.028999999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,MANUAL DIFFERENTIAL,EOSINOPHILS %,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.16625,0.44333333333333336,0.0,0.16625,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.015714285714285715,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,URINALYSIS COMPLETE,GLUCOSE QL,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,GLUCOSE,GLUCOSE FASTING,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE NEUTROPHILS,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,HAV AB TOTAL,HAV AB TOTAL,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,PROTEIN ELECTRO S,GAMMA GLOBULIN,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,HB S AG W REFLEX CONF,HB S AG,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.14285714285714285,0.36363636363636365,0.5714285714285714,0.14285714285714285,0.36363636363636365,0.5714285714285714,0.007859893039378507,0.033318761517623696,0.6583833712146145,0.007859893039378507,0.033318761517623696,0.6583833712146145,1,831008,HEPATITIS B CORE AB,HEPATITIS B CORE AB,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,CHEM SCREEN PANEL,EGFR NON AFR AMERICAN,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,CBC W AUTO DIFF ABS WBC MPV PLT,MCHC,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,HCV FIBROSURE,FIBROSIS SCORE,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,LYMPHOCYTE SUBSET PANEL 2,% CD4 HELPER CELLS,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.0,0.0,0.5,0.3333333333333333,0.0,0.0,0.0,0.0,0.1503314858492919,0.7071067811865476,0.0,1,304287,CBC W O DIFF WITH PLATELETS,MCV,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.030763983977592058,0.0,0.0,0.0,0.0,0,7773,CBC COMPLETE BLOOD COUNT W O DIFF,MCHC,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0,24729,COMPLETE BLOOD COUNT,MEAN PLATELET VOLUME,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.06666666666666667,0.05714285714285715,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,CMP CBC TSH,ABSOLUTE BLASTS,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,CBC WITH PLT MAN DIFF,BANDS ABSOLUTE,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,URINALYSIS CULTURE IF INDICATED,UROBILINOGEN,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.2,0.14285714285714285,0.0,0.0,0.0,0.0,0.009407312728814343,0.009963467485149535,0.0,0.0,0.0,0.0,0,7344,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE EOSINOPHILS,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,HEMOGLOBIN A1C,ESTIMATED AVG GLUCOSE,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,URINALYSIS SCREEN,PH,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,HEPATIC FUNCTION PANEL,INDIRECT BILI,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,CREATININE,LIPEMIA,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.14333333333333334,0.07692307692307693,0.3333333333333333,0.14333333333333334,0.15384615384615385,0.3333333333333333,0.0,0.05467558814705109,0.40824829046386313,0.0,0.10935117629410207,0.40824829046386313,1,204479,HIV 1 QUANT PCR,HIV 1 VIRAL COPY,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,PROTEIN ELECTRO S,GAMMA GLOBULIN,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,HEPATITIS PANEL ACUTE,HEPATITIS A IGM,Alpha-2-Macroglobulin,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,CMP14 EGFR,POTASSIUM,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,ANA SCR W RFL T P LUPUS 1,ANA PATTERN,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,CMP14 LP 5AC CBC D PLT RPR,HEMOGLOBIN A1C,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.24666666666666667,0.148,0.37,0.5333333333333333,0.2,0.0,0.0,0.0,0.0,0.015199507661834533,0.019538279191327113,0.0,1,93187,MICROALBUMIN CONC,ALB CREAT RATIO,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,SMN1 COPY NUMBER ANALYSIS,SPECIMEN TYPE,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,CBC INCLUDES DIFF PLT,ABSOLUTE BAND NEUTROPHILS,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.2,0.4,0.0,0.1,0.2,0.0,0.0,0.0,0.0,0.06813568816319682,0.09746345547029489,0,51938,HCV RNA QN GRAPH RFX NSA,HEPATITIS C QUANTITATION,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,PSA TOTAL REFLEX FREE,PROSTATE SPECIFIC AG SERUM,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,CBC,MONOCYTES ABSOLUTE,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,THYROID II PROFILE T3U T4 T7 TSH,T4 THYROXINE,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.5,0.5714285714285714,0.8,0.5,0.5714285714285714,0.8,0.07610104799408934,0.05391109450517806,0.06094209455758426,0.09320436823828604,0.03301366825316199,0.037319258880631256,1,128413,PSA TOTAL % FREE,% FREE PSA,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,UA M W RFLX CULTURE COMP,WBC,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,COMP METABOLIC PANEL 12,ALKALINE PHOSPHATASE,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,BILIRUBIN DIRECT,DIRECT BILIRUBIN,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,TSH ULTRASENSITIVE,TSH ULTRASENSITIVE,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.011764705882352941,0.025,0.0,0.039411764705882354,0.08375,0.0,0.0,0.0,0.0,0.01737113718052996,0.0,0,771477,COMP METABOLIC PROFILE FASTING CMP,BUN CREATININE RATIO CALC,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.022,0.03142857142857143,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,IRON BINDING CAPACITY,TIBC,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,RENAL PANEL 10,EGFR IF NONAFRICN AM,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,HEPATITIS B CORE IGM,HEPATITIS B CORE IGM,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.0,0.0,0.06666666666666667,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,COMPLETE BLOOD COUNT,BASOPHILS ABSOLUTE,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,URINALYSIS W MICRO,GLUCOSE,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,CMP WITH EGFR,ALKALINE PHOSPHATASE,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,PHOSPHATE AS PHOSPHORUS,ICTERUS,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,HIV 4TH GEN RFLX CONF,HIV 4TH GEN RFLX CONF,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,82644,LIVER FIBROSIS PNL HEPASCORE TM,METAVIR SCORE,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.0,0.0,0.0,0.06666666666666667,0.05,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,CBC W AUTO DIFF,BASOPHILS ABSOLUTE,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.16916093904956808,0.0,0.0,0.0,0.0,0,17426,PROTEIN ELECTRO SERUM,ALPHA 2 GLOBULIN,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc
0.375,0.0,0.0,0.0,0.0,0.0,0.01514201898468237,0.0,0.0,0.0,0.0,0.0,0,50484,IMMUNOGLOBULINS IGG A M SER,IMMUNOGLOBULIN A,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,REFLEX ANA PATTERN,PATTERN 1,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,UA MICROSCOPIC REFLEX CULTURE,BILIRUBIN,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.134,0.0,0.0,0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,UREA NITROGEN BUN,UREA NITROGEN BUN,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.011764705882352941,0.025,0.14333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,771477,BASIC METABOLIC PANEL,EGFR NON AFR AMERICAN,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.0834655896020069,0.34003516797720323,1.0,1,28233,CMP14 EGFR,POTASSIUM,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.07870803013413097,0.08411277379800186,0.09704900074164846,1,264788,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,LYMPHOCYTES,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,CBC H H RBC INDICES WBC PLT,PLATELET COUNT AUTO,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.057692307692307696,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,IMMUNOGLOBULINS,IMMUNOGLOBULIN M,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.08333333333333333,0.15,0.0,0.022222222222222223,0.04,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,HEPATIC FUNCTION PANEL AMA,BILIRUBIN DIRECT,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.017142857142857144,0.024,0.0,0.03142857142857143,0.044,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,CMP14 CBC D PLT,HEMATOLOGY COMMENTS,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.20545454545454545,0.0,0.0,0.0,0.0,0.0,0.12705867340885235,0.0,1,542183,LYMPHOCYTE SUBSET PANEL 2,HELPER SUPPRESSOR RATIO,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0125,0.027777777777777776,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,LIVER FIBROSIS PNL HEPASCORE TM,METAVIR SCORE,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.25,0.0,0.0,0.25,0.16666666666666666,1.0,0.0672790962344263,0.051758104169687846,0.0,0.0672790962344263,0.051758104169687846,0.7071067811865476,1,7534,DIFFERENTIAL MANUAL,ABSOLUTE NEUTROPHILS,Neutrophils,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,CBC W AUTO DIFF,BASOPHILS ABSOLUTE,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,LIPOPROTEIN ANALYSIS NMR,LDL P,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.01,0.0275,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,CMP14 LP CBC D PLT,NEUTROPHILS,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,COMPLEMENT COMPONENT C4C,COMPLEMENT COMPONENT C4C,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,LYMPHOCYTE SUBSET PANEL 2,% CD8 SUPPRESSOR T CELLS,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.0,0.0,0.0,0.0,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,MICROALBUMIN RANDOM URINE W CREATININE,MICROALBUMIN CREATININE RATIO RANDOM URINE,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.16625,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,HCV FIBROSURE,LIMITATIONS,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,CBC INCLUDES DIFF PLT,BAND NEUTROPHILS,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.0,0.0,0.0,0.0,0.08779161868611507,1.0,0.0,1,285395,MAYNAC CMP 4AC LIPID CBC T4 TSH PSA PROFILE,MCH,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,27771,CMP14 LP 6AC,PHOSPHORUS,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,DRUG ABUSE SCREEN 11 W ETOH NO CONF,OXYCODONE,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,DIFFERENTIAL MANUAL,NEUTROPHILS ABSOLUTE,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,LIVER FIBROSIS FIBROTEST,FIBROSIS STAGE,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,CBC W AUTO DIFF,MONOCYTES %,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,LIVER FIBROSIS FIBROTEST ACTITEST,NECROINFLAMMAT ACT GRADE,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.0,0.0,0.054000000000000006,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,FE ANA TIBC FER PTT PT A1A,MITOCHONDRIAL M2 ANTIBODY,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.31399999999999995,0.16714285714285712,0.38999999999999996,0.11600000000000002,0.04714285714285714,0.10999999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,ANA ANTI NUCLEAR AB WITH REFLEX TITER,ANTI NUCLEAR ANTIBODIES,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,T3 FREE,T3 FREE,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.066,0.12875,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,URINALYSIS WITH REFLEX MICROSCOP,PROTEIN TOTAL QUAL,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,IMMUNOGLOBULIN A,IMMUNOGLOBULIN A,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,HIV 1 RNA QN RT PCR,HIV 1 RNA QN PCR,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,NMR LIPOPROFILE,LDL P,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE LYMPHOCYTES,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,PAIN MANAGEMENT 8,CREATININE,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,COMP METABOLIC PANEL,CREATININE,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.155,0.2316666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,URINALYSIS WITH MICROSCOPIC,EPITHELIAL CELLS,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,QUESTASSURED TM 25OHD D2 D3,VITAMIN D 25 OH TOTAL,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,COMP METAB PANEL,ALBUMIN GLOBULIN RATIO,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,CMP14 LP 3AC,LDH,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,CBC WITH PLT DIFF,NRBC,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.18555555555555556,0.33399999999999996,0.0,0.0,0.0,0.0,0.055446852762574106,0.07759701258884111,0.0,0.0,0.0,0,139527,HEPATITIS BE AG,HBEAG INS,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.14285714285714285,0.2,0.0,0.11857142857142858,0.166,0.0,0.05557781728487099,0.14099568413003705,0.0,0.0,0.0,0,487967,LYMPHOCYTE SUBSET PANEL 1,% CD3 MATURE T CELLS,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.08833333333333333,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.06860647178857471,0.0793317966039091,1.0,1,251454,URINALYSIS,BACTERIA,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,HCV RNA PCR RFX NS5B,HCV NS5B RESISTANCE ASSAY PDF,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.041666666666666664,0.025,0.0,0.0,0.0,0.0,0.0,0.07462593631165992,0.0,0.0,0.0,0.0,0,17434,PROTEIN ELECTROPHORESIS SERUM,INTERPRETATION,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.0,0.09090909090909091,0.25,0.0,0.09090909090909091,0.25,0.0,0.03540360693747757,0.051861339431772846,0.0,0.04088056399127271,0.059884316562937245,0,322867,ACUTE HEPATITIS PANEL,HEPATITIS B SURF AG,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,HEPATITIS PANEL DIAGNOSTIC,HEP B CORE TOTAL AB,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0825,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,URINALYSIS W REFLEX MICRO,GLUCOSE,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,POL CMP WITH EGFR INV,GLUCOSE,Neutrophils,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,CBC WITH DIFFERENTIAL,NEUTROPHILS,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,CMP WITH ESTIMATED GFR CALCULATED,ALBUMIN,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,CBC WITH PLT DIFF,LYMPHOCYTES ABSOLUTE,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.0,0.08666666666666667,0.156,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,PROTEIN ELECTROPHORESIS SR W RFX,INTERPRETATION,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,URINALYSIS CULTURE IF INDICATED,UROBILINOGEN,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,CBC PLT DIFF,MONOS,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.125,0.0,0.316,0.375,1.0,0.0,0.06192203894113468,0.0,0.0,0.624939177332759,1.0,1,28688,IFE PE SERUM,ALPHA 2 GLOBULIN,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,PSA TOTAL % FREE,% FREE PSA,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,MANUAL DIFFERENTIAL,SEGMENTED NEUTROPHILS %,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,URINALYSIS W REFLEX MICRO,EPITHELIAL CELLS,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.09629383728860574,0.34003516797720323,1.0,1,17517,LITHOLINK CMP14 P,ALBUMIN,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.15356887434023136,0.0,0,7856,CBC W O DIFF WITH PLATELETS,PLATELET COUNT,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,DRUG ABUSE SCREEN III,COCAINE METABOLITE,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,NASH FIBROSURE,WEIGHT,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,URINE DRUG SCREEN 1,CREATININE,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,HEPATITIS B CORE AB,HEPATITIS B CORE AB,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,FE TIBC FER B12 HCT FOLRBC,IRON,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,LIPID PROFILE,FASTING NON FASTING,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,FIBROACT,NECROINFL SCORE,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,RPR REFLEX TP PA,RPR TITER,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.45,0.0,0.0,0.45,0.0,0.0,0.02574435456713875,0.0,0.0,0.04459053011835212,0.0,0.0,1,422543,ANA SCR IFA RFL TITR PATT,ANA SCREEN IFA,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.23399999999999999,0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.07583869961926504,0.0,0,28654,CMP14 HP5 LP 6AC CBC D PLT,MAGNESIUM SERUM,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,ASH FIBROSURE,APOLIPOPROTEIN A 1,Eosinophils,Eosinophils [#/volume] in Blood,Eosinophil # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,HDL CHOL DIRECT,HDL AS % CHOLESTEROL,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.25,0.2,0.25,0.0,0.0,0.0,0.0746172002260781,0.0,0.0,1,349993,SPECIAL A 2 PANEL #9633,POLYS,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,CBC PLT DIFF,MONOS,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,FIBROACT,ALT,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,HEPATITIS C RNA PCR QUANT,HCV PCR QUANT,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,CBC DIFF PLT,LYMPHOCYTES #,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,RPR REFLEX TITRE TPPA,RPR,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.028571428571428574,0.06666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,BMP,C02 BICARBONATE,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,CBC INC DIFF PLT,BASOPHILS,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,RHEUMATOID FACTOR QUANT,RHEUMATOID FACTOR QUANT,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,HEPATIC FUNCTION PANEL 6,ALT SGPT,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,LIVER FIBROSIS FIBROMETER,FIBROMETER PROTHROMBIN INDEX,Bacteria identified,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,POL CMP WITH EGFR INV,GLUCOSE,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,HEPATITIS B SURFACE AB QUANT,HEPATITIS B SURFACE AB,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,CBC W O DIFF WITH PLATELETS,PLATELET COUNT,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,HAV AB TOTAL,HAV AB TOTAL,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,CMP14 HP5 LP 6AC CBC D PLT,MAGNESIUM SERUM,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,CMP12 2AC,ALBUMIN SERUM,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,728592,HEPATITIS C VIRAL RNA NS3 DRUG RESI,BOCEPREVIR RESISTANCE,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.235,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.08089870281836808,1.0,1,7773,T B LYMPHOCYTE NK NYSDOH,PLATELETS,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,RPR SCREEN W TITER,RPR SCREEN,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,URINALYSIS CULTURE IF INDICATED,COLOR,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,AMY LIPASE,AMYLASE,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,DRUG ABUSE SCREEN 11 W ETOH W CONF,OXYCODONE,Protein pattern,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,LYMPHOCYTES,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,GLU RFX HA1C IF ABN,GLU RFX HA1C IF ABN,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0,0.0,0.0,0.03142857142857143,0.044,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,URINALYSIS,BACTERIA,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,LIPID PROFILE,FASTING NON FASTING,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.29333333333333333,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.917303309798122,0.1569574215481997,1,19752,CMP14 5AC,BILIRUBIN TOTAL,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,CBC WITH PLT DIFF,MEGAKARYOCYTE FRAGS,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,NASH FIBROSURE,AST SGOT P5P,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,RENAL PANEL 10,EGFR IF NONAFRICN AM,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,BILIRUBIN DIRECT,DIRECT BILIRUBIN,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,PROTHROMBIN TIME WITH INR,INR,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,CBC WITH PLT DIFF,VARIANT LYMPHOCYTES ABSOLUTE,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,ASH FIBROSURE,AST SGOT P5P,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,CEA,CEA CENTAUR,Leukocyte morphology finding,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,FERRITIN,FERRITIN,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.11,0.18333333333333335,0.0,0.22,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.08318397885080242,1.0,1,57703,UA MICROSCOPIC REFLEX CULTURE,BILIRUBIN,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,ASH FIBROSURE,WEIGHT,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,HEPATITIS BE ANTIGEN,HEP BE ANTIGEN,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,HIV 1 RNA QN RT PCR,HIV 1 RNA QN PCR,Body weight,Body weight Measured,Weight Measured
0.0,0.0,0.0,0.0,0.017857142857142856,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,DRUG ABUSE SCREEN II,COCAINE METABOLITE,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,BMP8 EGFR,POTASSIUM,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,RPR,RPR QUANT,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,DIFFERENTIAL MANUAL,NEUTROPHILS ABSOLUTE,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,PROTEIN TOTAL URINE,PROTEIN CR RATIO,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,CHEM SCREEN PANEL,EGFR NON AFR AMERICAN,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BARBITURATES,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,IMMUNODEF PROFILE #1,ABSOLUTE CD3,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,CBC WITH AUTO DIFF,PLATELET COUNT,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,DACLATASVIR RESISTANCE,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.05888888888888889,0.0,0.0,0.05888888888888889,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,CERULOPLASMIN,CERULOPLASMIN,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,TSH RFLX FT4,TSH RFLX FT4,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.13833333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,HEPATIC FUNCTION PANEL W O TP,BILIRUBIN DIRECT,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.049239293855151356,0.0,0.0,0.0,0.0,1,143149,DRUG ABUSE SCREEN CLINICAL 9,COCAINE,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,CMP14 CBC D PLT ESR WES ANA,LYMPHS ABSOLUTE,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,CBCI COMPLETE BLOOD COUNT W DIFF,MCV,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,CBC,MONOCYTES ABSOLUTE,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.11142857142857143,0.26,0.0,0.14285714285714285,0.3333333333333333,0.0,0.08312548434166944,0.0,0.0,0.024709442127028525,0.026937046735900805,0,18341,PROTEIN ELECTRO SERUM,ALPHA 2 GLOBULIN,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,LITHOLINK CMP14 P,ALBUMIN,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D3,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,DIFFERENTIAL MANUAL,PLATELET ESTIMATION,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,LIVER FIBROSIS PANEL,HAPTOGLOBIN,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,URINALYSIS,BILIRUBIN,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,CBC DIFF PLT,LYMPHOCYTES #,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,HCV RNA PCR QN RFX NSA,HCV GENOSURE R NSA PDF,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,LIPID PANEL STANDARD,CHOLESTEROL HDL RATIO,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,HEMATOPATH CONSULTATION SMEAR,WBC,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.015059977897765364,0.0990849048789324,0.17162008951344032,0,23366,PROTEIN ELECTRO S,ALPHA 2 GLOBULIN,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.25,0.42857142857142855,0.75,0.25,0.42857142857142855,0.75,0.031780094498001676,0.0,0.0,0.034326425302074526,0.0,0.0,0,223271,HCV GT3 NS5A DRUG RESIST ASSAY,HCV NS5A DRUG RESIST ASSAY,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,BAND NEUTROPHILS,Basophils,Basophils [#/volume] in Blood,Basophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,CMP14 HP4 DBILI CBC D PLT R,LYMPHS,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,HEPATITIS PANEL ACUTE,HEPATITIS A IGM,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,COMP METABOLIC PANEL,GLOBULIN,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,CRP,C REACTIVE PROTEIN ULTRA,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,CMP14 LP 3AC,LDH,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,CBC WITH AUTO DIFF,MONOCYTES #,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,COMP METABOLIC PROFILE FASTING CMP,BUN CREATININE RATIO CALC,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,CMP14 CBC D PLT,HEMATOLOGY COMMENTS,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,HIV AG AB 4TH GEN RFL,RACE NR,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,DIFFERENTIAL MANUAL,NEUTROPHILS ABSOLUTE,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,COMPREHENSIVE METABOLIC PANEL W O ALT,BUN CREATININE RATIO,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0375,0.1875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,HEPATIC FUNCTION PANEL,INDIRECT BILI,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.1075,0.172,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,PSA FREE TOTAL,FREE PSA,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.25,0.16666666666666666,0.5,0.0,0.16666666666666666,0.5,0.02611679408414369,0.143972626009104,0.3162277660168379,0.0,0.3219325786555107,0.7071067811865476,1,25023,IRON TOTAL BINDING CAPACITY,% SATURATION,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.19999999999999998,0.0,0.0,0.19999999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,23457,GLU RFX HA1C IF ABN,GLU RFX HA1C IF ABN,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,HNK1 CD57 PANEL,LYMPHS ABSOLUTE,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,LIVER FIBROSIS PANEL,ALT,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,HCV RNA PCR QN RFX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,CMP12 LP TP TSH 6AC CBC D PLT,LDH,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,URINALYSIS,PH,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,CBC WITH DIFF PLATELET,WBC,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,URINALYSIS WITH MICROSCOPIC,EPITHELIAL CELLS,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,CREATININE,EGFR IF NONAFRICN AM,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.3,0.18,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,CMP WITH EGFR,ALKALINE PHOSPHATASE,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0225,0.045,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,MICROALBUMIN CREATININE RATIO,MICROALBUMIN RAN 24HR,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,CBCI COMPLETE BLOOD COUNT W DIFF,PLT MORPHOLOGY,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,PSA TOTAL % FREE,PSA FREE,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,EGFR,EGFR,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,HEPATIC FUNCTION PANEL,INDIRECT BILI,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CBC WITH PLT DIFF,MYELOCYTES,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,ANA TITER PATTERN,ANA PATTERN,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,PROTEIN ELECTROPHORESIS,ALPHA 1 GLOBULINS,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,T4 THYROXINE,T4 THYROXINE,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,CMP14 3AC CBC D PLT RPR MG,EOS,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,HEPATIC FUNCTION PANEL,TOTAL PROTEIN,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,ANA ANTI NUCLEAR AB WITH REFLEX TITER,ANTI NUCLEAR ANTIBODIES,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,PSA TOTAL % FREE SERIAL,% FREE PSA,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,BILIRUBIN PANEL,BILIRUBIN INDIRECT,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,CMP14 LP 1AC CBC D PLT TSH,LYMPHS,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.0,0.0,0.0,0.0,0.01636363636363636,0.045,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,GENERAL HEALTH PANEL,CALC GLOBULIN,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,CBC PLATELET HEM REVIEW,EOS ABSOLUTE VALUE,Monocytes,Monocytes [#/volume] in Blood,Monocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,HEPATITIS C RNA PCR QUANTITATIVE,HCV VIRAL LOG,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,METHADONE,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,SMOOTH MUSCLE AB RFX TITER,F ACTIN IGG,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.0877518356997824,0.5773502691896257,1.0,1,23366,COMPREHENSIVE METABOLIC PANEL AMA,GLOBULIN,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,CMP12 LP 6AC,CHOLESTEROL TOTAL,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH TOTAL,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,CBC W AUTO DIFF,MCHC,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,CMP14 5AC,EGFR IF NONAFRICN AM,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,LIPID PANEL,HDL AS % CHOLESTEROL,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,PROTEIN 24 HOUR URINE,PROTEIN URINE CONC,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,HEPATITIS B CORE IGM ANTIBODY,HEP B CORE IGM ANTIBODY,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,LIPID PROFILE WITH CALC NON HDL CHOLESTEROL,RISK RATIO LDL HDL,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,VITAMIN B 12 FOLIC ACID,VITAMIN B 12,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,PROTEIN TOTAL URINE,PROTEIN CR RATIO,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,URINALYSIS,BACTERIA,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.038571428571428576,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,FE ANA TIBC FER PTT PT A1A,MITOCHONDRIAL M2 ANTIBODY,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,FASTING,FASTING STATUS,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,HEPATITIS PANEL AMA,HEPATITIS C ANTIBODY,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,HIV 1 QUANT PCR,HIV 1 VIRAL COPY,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,CBC PLATELET HEM REVIEW,NEUTROPHILS ABSOLUTE,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,ANA TITER PATTERN,ANTI NUCLEAR AB TITER,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,T B LYMPHOCYTE NK NYSDOH,PLATELETS,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,URINALYSIS,BILIRUBIN,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,URINALYSIS ROUTINE W RFX,BILIRUBIN,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,PHOSPHATE AS PHOSPHORUS,ICTERUS,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.06,0.06,0.12,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,COMPREHENSIVE METABOLIC PANEL E GFR,CARBON DIOXIDE,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,IRON TOTAL IRON BIND CAPACITY,TIBC,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,TRANSFERRIN,TRANSFERRIN,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.03666666666666667,0.0,0.0,0.03666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,HEPATITIS B SURFACE ANTIBODY,HEPATITIS B SURFACE ANTIBODY,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,EGFR,EGFR,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,RPR REFLEX PER CDC,RPR,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,CBC W AUTO DIFF,HGB,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,HEPATITIS C VIRAL RNA NS3 GENOTYPE,BOCEPREVIR RESISTANCE,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.31,0.386,0.5514285714285714,0.31,0.386,0.5514285714285714,0.021966949517961187,0.0,0.0,0.021966949517961187,0.0,0.0,1,736553,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B DRUG RESISTANCE ASSAY,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,URINALYSIS W MICRO,GLUCOSE,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,URINALYSIS SCREEN,PH,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.15,0.14285714285714285,0.0,0.15,0.14285714285714285,0.0,0.0,0.0162206600257484,0.0,0.0,0.0162206600257484,0.0,0,139519,CREATININE SERUM,CREATININE SERUM,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0.0,0.0,0.0,0,29868,IFE PE SERUM,ALPHA 2 GLOBULIN,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,ALPHA 1 ANTITRYPSIN QN,ALPHA 1 ANTITRYPSIN QN,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,MAGNESIUM SERUM,MAGNESIUM SERUM,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.7071067811865476,0.7071067811865476,0.7071067811865476,1,326249,LYMPHOCYTE SUBSET PANEL 4,RACE NR,Race,Race,Race
0.0,0.10714285714285714,0.15,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,HEPATIC FUNCTION PROFILE,BILIRUBIN INDIRECT,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,CBC WITH DIFFERENTIAL,MYELOCYTES,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.0,0.0,0.3333333333333333,0.16666666666666666,0.5,0.0,0.0,0.0,0.06486415033444226,0.07799978756310755,0.0,1,205088,OBSTETRIC PANEL,RPR RESULT,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,FIBROACT COMPLETE,APOLIPOPROTEIN A1,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,IMMUNODEF PROFILE #1,ABSOLUTE CD3,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,URINALYSIS,BILIRUBIN,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,ANA TITER PATTERN,ANA TITER,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,CBC INCLUDES DIFF PLT,INTERNAL WBC,Prothrombin.activity actual/Normal,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,CMP14 LP CBC D PLT TSH UA M,AST SGOT,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,URINALYSIS,BACTERIA,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.0,0.10444444444444444,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,CBC WITH DIFFERENTIAL PLATELETS,MCH,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BENZODIAZEPINES,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,HCV FIBROSURE,COMMENT,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,HEMOGLOBINOPATHY EVAL,MCH,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.534,0.534,0.5,0.36,0.0,0.0,0.016107508969110285,0.3644215793074378,0.9679688834828893,0.027385328599057512,0.0,0.0,1,345355,MICROALBUMIN CREATININE RANDOM RATIO,CALC MICROALB CREAT RND,Microalbumin/Creatinine ratio panel,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur
0.25,0.0,0.0,0.25,0.2,0.0,0.04221452135443238,0.06312481184311647,0.0,0.051702018527091775,0.07731178956241591,0.0,1,50484,ANA TITER PATTERN,ANA TITER,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BARBITURATES,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,PROTEIN ELEC INTERP SERUM,P E INTERPRETATION S,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.125,0.0,0.0,0.125,0.0,0.0,0.06547241049372987,0.0,0.0,0.05345799931322692,0.0,0,139550,IMMUNOFIXATION SERUM,IGG SERUM NR,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,COMP METABOLIC PANEL,GLUCOSE NON FASTING,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,CBC WITH MANUAL DIFFERENTIAL,NEUTROPHILS,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.049999999999999996,0.0875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,LIPID PROFILE WITH CALC NON HDL CHOLESTEROL,RISK RATIO LDL HDL,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.0,0.0,0.0,0.6666666666666666,0.5,1.0,0.0,0.0,0.0,0.1625018229625479,0.15505905338492743,1.0,1,264747,CBC DIFF PLT,LYMPHOCYTES #,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,ANION GAP,ANION GAP,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,ALPHA 1 ANTITRYPSIN PHENOTYPE,ALPHA 1 ANTITRYPSIN,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,APTT,PARTIAL THROMBOPLASTIN,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.5,0.42857142857142855,1.0,0.0,0.0,0.0,0.4335293647738059,0.013881484946973388,0.01569188635480001,0.0,0.0,0.0,1,128413,PSA FREE TOTAL,INTERNAL %,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.005927177993249377,0.0,0,45484,BASIC METABOLIC PANEL,UREA NITROGEN BLOOD BUN,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,IRON TIBC SERUM,IRON BINDING CAPACITY,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,TRANSFERRIN SATURATION,TRANSFERRIN,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,CREATININE,EGFR IF AFRICN AM,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,HCV RNA NS5A GENOTYPE,LEDIPASVIR RESISTANCE,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0775,0.31,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,CMP14 3AC CBC D PLT RPR MG,EOS,pH,pH of Urine by Test strip,pH Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,ALPHA FETOPROTEIN TUMOR MARKER,ALPHA FETOPROTEIN TUMOR,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,LIPOPROTEIN ANALYSIS NMR,LDL P,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,NEG HIV 4TH GEN,NEG HIV 2 ANTIBODY,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,URINALYSIS WITH MICROSCOPIC,PH,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.0,0.20750000000000002,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,HCV FIBROSURE LABCORP,RESULT,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,CD4 CD8 ENUMERATION,ABSOLUTE LYMPHOCYTES,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.02643030941392499,0.036735579740092894,0.04768073139968454,0,172841,HIV ANTIGEN ANTIBODY FOURTH GENERATION W RFL,HIV AG AB 4TH GEN,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,IMMUNOGLOBULINS,IMMUNOGLOBULIN A,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.0,0.0,0.25,0.2,1.0,0.0,0.0,0.0,0.07962607175736813,0.12353958214165095,1.0,1,195586,DRUG ABUSE PANEL 10 WITH OXYCODONE,METHAQUALONE,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,CMP12 LP TP TSH 6AC CBC D PLT,EOS ABSOLUTE,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,CBC W AUTO DIFF ABS WBC MPV PLT,EOSINOPHILS,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,COMP METABOLIC PANEL W GFR,CHLORIDE,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,CBC INCLUDES DIFF PLT,BASOPHILS ABSOLUTE,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,HEP B CORE TOTAL AB,HEP B CORE TOTAL AB,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,DIRECT LDL,DIRECT LDL,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,RPR,RPR QUANT,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,IRON TIBC,UIBC,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,CBC WITH AUTO DIFF,EOSINOPHILS ABSOLUTE,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,PTH INTACT MOLECULE,PTH,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,COMP METABOLIC PANEL,RATIO,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,URINALYSIS COMPLETE,GLUCOSE QL,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,IFE PE SERUM,ALPHA 2 GLOBULIN,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,CBC,MO%,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,PROTEIN ELECTRO S,BETA GLOBULIN,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.31666666666666665,0.2375,0.95,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD3 CELLS,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.19999999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,NEG HIV 4TH GEN,NEG HIV 1 ANTIBODY,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,TRIIODOTHYRONINE T3 FREE,TRIIODOTHYRONINE T3 FREE,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,UA W MICRO HOLD SPEC 24 HR,APPEARANCE,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,COMPLETE BLOOD COUNT,BASOPHILS %,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,CMP WITH ESTIMATED GFR CALCULATED,CARBON DIOXIDE,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,IMMUNE COMPETENCE PANEL,CD4 CD8 RATIO,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,HCV RNA PCR RFX NS5B,HCV NS5B RESISTANCE ASSAY PDF,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.013636363636363636,0.0375,0.0,0.015454545454545455,0.0425,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,CMP12 LP 6AC,CHOLESTEROL TOTAL,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.215,0.16666666666666666,0.5,0.0,0.0,0.0,0.0,0.0,0.0,1,203943,ALKALINE PHOSPHATASE,LIPEMIA,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,LIVER FIBRO HEPSCORE R,AGE,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,CMP14 HP4 DBILI CBC D PLT R,EOS ABSOLUTE,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,CBC W DIFF PLT,PLATELET SUFFICIENCY,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,HEMOGLOBIN A1C WITH EAG,ESTIMATED AVERAGE GLUCOSE,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,IFE PE SERUM,ALPHA 1 GLOBULIN,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,THYROID PROFILE T4 T3UP FTI TSH,T 4,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,CBC WITH PLT DIFF,OTHERS,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,CMP13 LP TP TSH 2AC CBC D P,HDL CHOLESTEROL,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,CMP12 LP TP TSH 6AC CBC D PLT,HEMOGLOBIN,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,IMMUNOGLOBULINS,IMMUNOGLOBULIN G,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,TSH ULTRASENSITIVE,TSH ULTRASENSITIVE,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,UA MICROSCOPIC REFLEX CULTURE,BILIRUBIN,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,CRP,C REACTIVE PROTEIN ULTRA,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,COMPLETE BLOOD COUNT,RED CELL DIST WIDTH,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.04833333333333333,0.0,0.0,0.0,0.02,0.03333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,CBC WITH DIFFERENTIAL,BASOPHILS,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,HEPATITIS C ANTIBODY,HEPATITIS C ANTIBODY,pH,pH of Urine by Test strip,pH Ur Strip
0.1925,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,URINALYSIS CULTURE IF INDICATED,LEUKOCYTE ESTERASE,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,TRANSFERRIN SATURATION,TRANSFERRIN,Ceruloplasmin,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,UA MICROSCOPIC REFLEX CULTURE,RED BLOOD CELLS,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,COMPLEMENT COMPONENT C3C,COMPLEMENT COMPONENT C3C,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,HEPATIC FUNCTION PANEL W O TP,BILIRUBIN DIRECT,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.0,0.12166666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,ACUTE HEPATITIS PANEL,HEPATITIS A IGM,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,CBC WITH PLT DIFF,PLATELET MORPHOLOGY,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,LIPID PANEL WITH LDL HDL RATIO,HDL CHOLESTEROL,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,CMP13 LP TP TSH 2AC CBC D P,HDL CHOLESTEROL,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,HCV FIBROSURE,FIBROSIS SCORE,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,URINALYSIS W REFLEX MICRO,RED BLOOD CELLS,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,THYROID II PROFILE T3U T4 T7 TSH,T4 THYROXINE,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,CMP12 LP TP TSH 6AC CBC D PLT,LDH,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,PSA TOTAL % FREE,% FREE PSA,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.7666666666666666,0.386,0.465,0.4666666666666666,0.454,0.635,0.010152652931362582,0.03360193723570992,0.017176466887497077,0.0,0.9783777508095268,0.9781387946600695,1,28902,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN CREATININE RATIO,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.057549248626998395,0.1125015497193188,0,303925,CBC WITH PLT DIFF,NUCLEATED RBCS,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,ALBUMIN CREATININE RATIO URINE RANDOM,CALC ALBUMIN CREAT RND,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.06666666666666667,0.25,0.0,0.06666666666666667,0.25,0.0,0.05117681691383591,0.14539805437566944,0.0,0.0626785440493669,0.17807552140691663,0,381806,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.054432052556039556,0.0,0.0,0.0,0.0,0,295410,CMP WITH EGFR,ANION GAP,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06691275831255872,0.06348916544989514,0.09169555407390673,1,59055,CBC INC DIFF PLT,MONOCYTES,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,NGI HCV SUPERQUANT,HEPATITIS C QUANTITATION,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.2,0.63625,0.8483333333333333,0.0,0.0,0.0,0.03628551739281716,0.1524643612967882,0.11313616447240271,0,519132,CMP14 HP4 1AC PT AFP,HEP A AB IGM,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,HDL CHOL DIRECT,HDL AS % CHOLESTEROL,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.03333333333333333,0.125,0.0,0.03333333333333333,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE CD4,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.044,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,CBC WITH DIFF PLATELET,WBC,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,URINALYSIS WITH MICROSCOPIC,GLUCOSE,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,FERRITIN SERUM,FERRITIN SERUM,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,IRON TOTAL,HEMOLYSIS,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,CMP14 HP4 DBILI CBC D PLT R,EOS ABSOLUTE,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,CBC WITH PLT DIFF,NO CELLS DIFF,Color,Color of Urine,Color Ur
0.0,0.1,0.2,0.0,0.1,0.2,0.0,0.04309279290773527,0.06164130158330583,0.0,0.04309279290773527,0.06164130158330583,0,51938,HEPATITIS C VIRAL RNA QUALITATIVE TMA,HEPATITIS C VIRAL RNA QUALITATIVE TMA,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,THYROID PROFILE T4 T3UP FTI TSH,T 4,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,BMP8 CBC D PLT,CREATININE,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.11,0.0,0.0,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,HEP B SURFACE AG W REFLEX,HEP B SURFACE AG W REFLEX,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,DRUG ABUSE PANEL 10 WITH OXYCODONE,PHENCYCLIDINE,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,DRUG ABUSE PANEL 10 WITH OXYCODONE,METHAQUALONE,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,ASH FIBROSURE,WEIGHT,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D3,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,COMPLEMENT C3 SERUM,COMPLEMENT C3 SERUM,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD8 CELLS,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.022679367039845966,0.0,0.0,0.0,0.0,0,339143,PROTEIN ELECTROPHORESIS SERUM,BETA,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,HCV QUANT GT1A NS5A PROFILE,HCV LOG10,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,NGI HCV ULTRAQUAL RFX SUPER QT,COPIES ML,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,LIPID PANEL,HDL AS % CHOLESTEROL,Sex,Sex,Sex
0.0,0.14285714285714285,0.3333333333333333,0.0,0.14285714285714285,0.3333333333333333,0.0,0.4596659728295528,0.8660254037844386,0.0,0.4596659728295528,0.8660254037844386,1,18259,ALPHA 1 ANTITRYPSIN QN,ALPHA 1 ANTITRYPSIN QN,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.05500000000000001,0.07857142857142858,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,EOSINOPHILS #,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,LIPOPROT LDL DIRECT,LIPOPROT LDL DIRECT,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,LYMPHOCYTE SUBSET PANEL 3,CD4 CD8 RATIO,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,TSH FT4,TSH,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,COMPLETE BLOOD COUNT,BASOPHILS ABSOLUTE,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,NGI HCV QUANTASURE,HEPATITIS C QUANTITATION,Bacteria identified,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,COMPREHENSIVE METABOLIC PANEL,OSMOLALITY,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE MONOS,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,SMOOTH MUSCLE AB F ACTIN REFLEX IFA TITER,F ACTIN IGG,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.06666666666666667,0.0,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,CMP14 CBC D PLT RPR UA TSH,NEUTROPHILS ABSOLUTE,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,HEMOGLOBIN A1C,ESTIMATED AVG GLUCOSE,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,ACCUTYPE R IL28B,ACCUTYPE R IL28B,Prothrombin.activity actual/Normal,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,CD4 CD8 LYMPHOCYTE ENUMERATION,PERCENT CD4,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,CULTURE ROUTINE,CULTURE ROUTINE,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.03571428571428571,0.05,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,AUTOMATED BLD CNT,HEMOGLOBIN,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,OMBITASVIR RESISTANCE,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,CMP14,EGFR IF AFRICN AM,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,BASIC METABOLIC PANEL,ANION GAP,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.06538932921065,0.24044117311858715,0.7071067811865476,0.09247447620418048,0.34003516797720323,1.0,1,30346,TRANSFERRIN SATURATION,TRANSFERRIN,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,HEPATITIS C AB REFLEX HCV RNA QUANT,HEPATITIS C ANTIBODY,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,CBC INCLUDES DIFF PLT,BASOPHILS %,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,IMMUNODEF PROFILE #1,ABSOLUTE CD3,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,FASTING,FASTING STATUS,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,HCV RNA PCR QN GRAPH RFX NS5A,HCV NS5A RESIST ASSAY INTERP,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.1416666666666667,0.42500000000000004,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,NGI HCV SUPERQUANT,INTERNATIONAL UNITS,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.072,0.05142857142857143,0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,COMPREHENSIVE METABOLIC PANEL WITH GFR,CREATININE,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA TITER,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,CBC INC DIFF PLT,ABSOLUTE MONOCYTES,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,HEPATITIS PANEL AMA,HEPATITIS C ANTIBODY,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.3625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,T B LYMPHOCYTE NK NYSDOH,PLATELETS,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,BASIC METABOLIC PANEL 7,EGFR IF AFRICN AM,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,CBC DIFF PLT,MCHC,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,UA MICROSCOPIC REFLEX CULTURE,RED BLOOD CELLS,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,NGI HCV ULTRAQUAL RFX SUPER QT,COPIES ML,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.125,0.125,0.0,0.0,0.05,0.08,0.0,0.0666872623744319,0.0,0.0,0.0,0.0,0,109009,PROTEIN ELECTROPHORESIS SERUM,BETA,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B DRUG RESISTANCE ASSAY,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,BASIC METABOLIC PANEL,ANION GAP,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,CBC WITH DIFFERENTIAL,ABS NEUTROPHILS,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,RHEUMATOID FACTOR RF,RHEUMATOID FACTOR RF,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.2866666666666667,0.0,0.0,0.2866666666666667,0.3333333333333333,1.0,0.0,0.06051098295968049,0.06634109142172151,0.0,0.042056338045787456,0.046108379515458875,1,20859,LIPID PANEL WITH LDL HDL RATIO,HDL CHOLESTEROL,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.0,0.05,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,CBC,MO#,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,CBC INCLUDES DIFF PLT,INTERNAL WBC,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,VIT B 12 FOLATE PANEL,VITAMIN B 12,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,LYMPHOCYTE SUBSET PANEL 4,ABS CD4 COUNT,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,LIPID PANEL STANDARD,CHOLESTEROL HDL RATIO,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,URINALYSIS COMP W RFL CULTURE,PROTEIN,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,URINALYSIS C,BILIRUBIN,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,CREATININE,ICTERUS,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.0,0.0,0.25,0.3233333333333333,0.94,0.0,0.0,0.0,0.06713496212611103,0.05720402135206337,0.0,1,7773,CBC INC DIFF PLT,PLATELET COUNT,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,COMPREHENSIVE METABOLIC PANEL W O ALT,BUN CREATININE RATIO,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.11,0.1325,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,URINALYSIS WITH MICROSCOPIC,GLUCOSE,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,URINALYSIS CULTURE IF INDICATED,COLOR,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,RPR REFLEX PER CDC,RPR,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,AFP TUMOR MARKER SIEMENS CLIA,AFP TUMOR MARKER SIEMENS CLIA,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,CMP WITH EGFR,ALKALINE PHOSPHATASE,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc
0.0,0.125,0.16666666666666666,0.0,0.1525,0.20333333333333334,0.0,0.0762321806483941,0.056568082236201356,0.0,0.09336497228411789,0.06928146860324524,0,519132,HEPATITIS PANEL AMA,HEPATITIS C ANTIBODY,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,PE INTERP RFX IFE S,BETA GLOBULIN,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,CMP14 LP 6AC,PHOSPHORUS,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,UA W RFLX MICROSCOPIC,COLOR,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,PTT,PTT,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.3333333333333333,0.0,0.0,0.3333333333333333,0.0,0.0,0.029385511327157166,0.0,0.0,0.029023776041771865,0,149799,HEPATITIS B SURFACE AB IMMUN,HEPATITIS B SURFACE AB IMMUNITY QN,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,HCV FIBROSURE,INTERPRETATION,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0825,0.10600000000000001,0.0,0.25,0.2,1.0,0.0,0.0,0.0,0.0763206923693498,0.09762443806815091,1.0,1,58024,URINALYSIS,NITRITE,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,HIV 1 HIV 2 AB SCREEN,HIV 1 HIV 2 AB SCREEN,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,CMP,BUN,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,LDL CHOLESTEROL DIRECT,LDL CHOL DIRECT,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,LDL CHOLESTEROL DIRECT,LDL CHOL DIRECT,Sex,Sex,Sex
0.0,0.14285714285714285,0.25,0.392,0.09571428571428572,0.1675,0.0,0.021677644767150728,0.021863366293155218,0.03321870600293453,0.043355289534301455,0.043726732586310324,1,142513,ANA AMA ASMA LKM AB,MITOCHONDRIAL M2 ANTIBODY,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,BASIC METABOLIC PANEL 8,EGFR IF AFRICN AM,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,FIBROACT COMPLETE,APOLIPOPROTEIN A1,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,VIT B 12 FOLATE PANEL,VITAMIN B 12,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,MICROALBUMIN CONC,ALB CREAT RATIO,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,URINALYSIS WITH MICROSCOPIC,EPITHELIAL CELLS,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,CHEM PROFILE 29,ALK PHOS,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,NEG HIV 4TH GEN,NEG HIV 2 ANTIBODY,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,CMP14 LP 6AC,PHOSPHORUS,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,COMPREHENSIVE METABOLIC PANEL,CARBON DIOXIDE,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.025,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,CBC W AUTO DIFF,MCV,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.10444444444444444,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE MONOS,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,HCV RNA PCR QN RFX GENO,PLEASE NOTE,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.14333333333333334,0.0,0.0,0.14333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,339143,EGFR,EGFR,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,COMP METAB PANEL,ALBUMIN GLOBULIN RATIO,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.07142857142857142,0.0,0.0,0.0,0.03272727272727272,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,CBC DIFF PLT,MONOCYTES %,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.142,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,1,7369,CMP14 LP 1AC CBC D PLT TSH,LYMPHS,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,PROTEIN ELECTRO S,BETA GLOBULIN,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,BASIC METABOLIC PANEL,BUN CREATININE RATIO,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.0,0.0,0.25,0.2,0.0,0.0,0.0,0.0,0.06650223739152306,0.21717918485032472,0.0,1,7856,CBC,MCH,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,RPR REFLEX T PALLIDUM PA,RPR,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,HCV RNA PCR RFX NS5B,HCV NS5B RESISTANCE ASSAY PDF,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.16666666666666666,0.25,0.0,0.3333333333333333,0.5,0.0,0.07184578234577044,0.07240860968350848,0.0,0.08799275345909874,0.08868207335447242,1,161281,HEPATITIS PANEL ACUTE,HEPATITIS C ANTIBODY,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.025,0.03333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,CBC WITH AUTO DIFF,NRBC,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.07858063232628809,0.0,0,28621,AFP WITH AFP L3%,AFP SERUM,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,HIV 4TH GEN RFLX CONF,HIV 4TH GEN RFLX CONF,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.07870803013413097,0.08752895424186691,0.10240603634159506,1,265116,CBC WITH MANUAL DIFFERENTIAL,NEUTROPHILS,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,PROTEIN ELECTRO S,M SPIKE,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.046706887849276346,0.0,0,7310,URINALYSIS WITH MICROSCOPIC,RED BLOOD CELLS,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,LIVER FIBROSIS FIBROTEST ACTITEST,BILIRUBIN,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.09247447620418048,0.34003516797720323,1.0,0.09247447620418048,0.34003516797720323,1.0,1,191239,MAGNESIUM,MAGNESIUM,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.014784753707515419,0.0,0.0,0.0,0.0,0,302398,IRON TIBC SERUM,IRON BINDING CAPACITY,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.16039782244384237,0.0,1,59022,ANTIPHOSPHOLIPID SYNDROME,PT,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,CBC W AUTO DIFF,MCHC,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,CMP14 LP 2AC CBC D PLT MG T,WBC,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,DRUG ABUSE PANEL 10 WITH OXYCODONE,PHENCYCLIDINE,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,PROTEIN ELECTRO S,M SPIKE,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,ESR WES CRP,C REACTIVE PROTEIN QUANT,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.1375,0.0,0.0,0.725,0.9666666666666667,0.9666666666666667,0.0,0.0,0.0,0.4224956153898245,0.022046838418816495,0.022046838418816495,1,487926,LIVER FIBROTEST ACTITEST,NECROINFLAMMAT ACT SCORE,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,CMP14 HP4 DBILI CBC D PLT R,C REACTIVE PROTEIN QUANT,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,C REACTIVE PROTEIN,C REACTIVE PROTEIN,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.6666666666666666,0.5,1.0,0.0,0.0,0.0,0.1503314858492919,0.15505905338492743,1.0,1,264846,CBC WITH AUTO DIFF,MONOCYTES #,Monocytes,Monocytes [#/volume] in Blood,Monocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,URINALYSIS C,BILIRUBIN,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,HB S AG W REFLEX CONF,HB S AG,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.02631578947368421,0.05555555555555555,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,CBC,MO#,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,ACCUTYPE R IL28B NY,IL28B GENOTYPE,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,CMP14 LP 5AC CBC D PLT RPR,WBC,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,PSA FREE TOTAL,FREE PSA,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.07142857142857142,0.25,0.0,0.08214285714285714,0.2875,0.0,0.04549601264246461,0.17807552140691663,0.0,0.0,0.0,0,296095,HEPATITIS PANEL 4,HEP B CORE AB IGM,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,CMP,ALT SGPT,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,DIRECT LDL,DIRECT LDL,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,CBC W AUTO DIFF,ABS NEUTROPHILS,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,IMMUNOFIXATION SERUM,IMMUNOGLOBULIN M,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.165,0.265,0.0,0.7849999999999999,1.0,1.0,0.0,0.0,0.0,0.08679392382276507,0.8164965809277261,0.5773502691896257,1,57786,URINALYSIS W MICROSCOPIC,URINALYSIS URINE COLOR,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,COMP METAB PANEL,GLUCOSE FASTING,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,URINALYSIS W REFLEX MICRO,OCCULT BLOOD,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,CBC WITH PLT DIFF,BANDS ABSOLUTE,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.0,0.0,0.0,0.2075,0.16599999999999998,0.27666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,LYMPHOCYTE SUBSET PANEL 4,ABS CD4 COUNT,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,DIFFERENTIAL MANUAL,ABSOLUTE EOSINOPHILS,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,LIVER FIBROSIS FIBROTEST,FIBROSIS STAGE,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,LIPID PANEL W CHOL HDL RATIO,VLDL CHOLESTEROL CAL,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,IMMUNOFIXATION SERUM,IMMUNOGLOBULIN M,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.1075,0.172,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,CBC INCLUDES DIFFERENTIAL PLATELETS,RBC,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,ANA SCR W RFL T P LUPUS 1,ANA PATTERN,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,LIVER FIBROSIS PANEL,ALT,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,DIFFERENTIAL MANUAL,ABSOLUTE LYMPHOCYTES,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,CBC W O DIFF WITH PLATELETS,MCV,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,FREE T3,FREE T3,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,CMP14 LP 5AC CBC D PLT RPR,WBC,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,DRUG ABUSE SCREEN III,METHADONE,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,IMMUNOGLOBULINS,IMMUNOGLOBULIN A,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,URINE DRUG SCREEN,OPIATES,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,CBC WITH DIFFERENTIAL,NEUTROPHILS,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,DRUG ABUSE SCREEN I,AMPHETAMINES,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,MICROALBUMIN RANDOM,MICROALBUMIN RANDOM,Monocytes,Monocytes [#/volume] in Blood,Monocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0.0,0.0,0.0,0,23457,PE FLC SERUM,ALBUMIN,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,UA MICROSCOPIC REFLEX CULTURE,RED BLOOD CELLS,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,1.0,0.0,0.0,0.0,0.060037523066651444,0.45528141890436646,0.7071067811865476,1,17988,CMP14 LP 7AC CBC D PLT T B,AMYLASE SERUM,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,HCV FIBROSURE,FIBROSIS SCORE,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,CBC WITH DIFFERENTIAL,EOSINOPHILS,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.044274927162410105,0.0,0,7880,BASIC METABOLIC PANEL,BUN CREATININE RATIO,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,HCV FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D3,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,TRIIODOTHYRONINE T3 FREE,TRIIODOTHYRONINE T3 FREE,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.16625,0.22166666666666668,0.0,0.1525,0.20333333333333334,0.0,0.06601900502739377,0.048989396259917606,0.0,0.09336497228411789,0.06928146860324524,0,519132,ACUTE HEPATITIS PANEL,HEPATITIS C ANTIBODY,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,HCV FIBROSURE RESULTS,FIBROSIS STAGE,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,MITOCHONDRIAL AB W RFX TITER,MITOCHONDRIAL AB SCN,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,CMP12 2AC,ALBUMIN SERUM,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,DRUG ABUSE SCREEN 11 W ETOH W CONF,METHADONE,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD3 CELLS,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,PLATELET ESTIMATION,PLATELET ESTIMATION,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0075,0.015,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,CMP14 LP 5AC CBC D PLT RPR,HEMOGLOBIN A1C,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,SED RATE MODIFIED WESTERGREN MANUAL,SED RATE MODIFIED WESTERGREN MANUAL,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,CBC W DIFF PLT,MPV,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.16625,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,HCV FIBROSURE,COMMENT,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,URINALYSIS WITH REFLEX MICROSCOP,PROTEIN TOTAL QUAL,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,CBC,HEMOGLOBIN,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.06713496212611103,0.05720402135206337,0.7071067811865476,1,7518,DIFFERENTIAL MANUAL,NEUTROPHILS ABSOLUTE,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,CBC WITH PLT DIFF,PROMYELOCYTES,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,CREATININE,EGFR IF AFRICN AM,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.008140888226429221,0.0,0.0,0.008140888226429221,0.0,0,305227,TESTOSTERONE SERUM,TESTOSTERONE SERUM,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.17692551543363566,0.0,0,19687,IGG SUBCLASSES,IMMUNOGLOBULIN G QN SERUM,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,CMP14 4AC,EGFR IF NONAFRICN AM,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,HIV AB EIA WITH REFLEXES,HIV AB,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.2,0.0,0.0,0.2,0.0,0.0,0.24044117311858715,0.0,0.0,0.24044117311858715,0.0,0,21600,MAGNESIUM SERUM,MAGNESIUM SERUM,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.018125,0.03625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,SMOOTH MUSCLE AB F ACTIN REFLEX IFA TITER,F ACTIN IGG,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,COMPLETE BLOOD COUNT,RED CELL DIST WIDTH,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.04,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,ALPHA 1 ANTITRYPSIN PHENOTYPE,ALPHA 1 ANTITRYPSIN,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,LIPID PROFILE,NON HDL CHOLESTEROL,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,CBC WITH DIFFERENTIAL,IMMATURE GRANS,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,ASH FIBROSURE,APOLIPOPROTEIN A 1,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,CREATININE,LIPEMIA,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,SMOOTH MUSCLE AB RFX TITER,F ACTIN IGG,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.31,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.05153731836902975,0.0,0.0,1,7732,CBC WITH PLT DIFF,NRBC,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,COMP METABOLIC PANEL,GLOBULIN,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.19,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,HCV FIBROSURE RESULTS,NECROINFLAMMAT ACT GRADE,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.25,0.14285714285714285,0.0,0.5,0.40857142857142853,0.0,0.06846967404361237,0.13206830547789195,0.0,0.47783666597772956,0.03710163638517516,0.0,1,21329,B12,VIT B12 SERUM,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,DRUG ABUSE SCREEN II,BENZODIAZEPINES,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,REFERRED CBC,MCH,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,COMP METAB PANEL,GLUCOSE FASTING,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,HP5,HEP C VIRUS AB,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.4325,0.16666666666666666,0.0,0.0,0.0,0.0,0.04524395250155222,0.2276407094521833,0.0,1,19711,HEPATIC FUNCTION PANEL,INDIRECT BILI,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,UA MICROSCOPIC REFLEX CULTURE,KETONES,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,HEMOGLOBIN A1C EAG,HEMOGLOBIN A1C,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,PSA FREE TOTAL,PSA FREE,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.11,0.1325,0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.08466774310592073,0.09762443806815091,1.0,1,58032,URINALYSIS,PH,pH,pH of Urine by Test strip,pH Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,URINE DRUG SCREEN,OPIATES,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.03333333333333333,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,CBC DIFF PLT,MCH,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,DIFFERENTIAL MANUAL,ABSOLUTE LYMPHOCYTES,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,URINALYSIS COMPLETE,GLUCOSE QL,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,CYSTIC FIBROSIS SCREEN,ETHNICITY,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,DIFFERENTIAL MANUAL,ABSOLUTE LYMPHOCYTES,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,LP LDL DIRECT,HDL CHOLESTEROL,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,COMPREHENSIVE METABOLIC PANEL WITH GFR,ANION GAP,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,CBC WITH AUTO DIFF,EOSINOPHILS #,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.04833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,CBC WITH MANUAL DIFFERENTIAL,MCHC,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.05714285714285715,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,HEMOGLOBIN A1C WITH EAG,ESTIMATED AVERAGE GLUCOSE,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,URINALYSIS WITH MICROSCOPIC,PH,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.195,0.14285714285714285,0.3333333333333333,0.0,0.0,0.0,0.0,0.0762496717190787,0.08190888212768821,1,18358,HCV FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Alpha-2-Macroglobulin,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.028333333333333335,0.0425,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,LIPID PANEL STANDARD,CHOLESTEROL HDL RATIO,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,AMY LIPASE,AMYLASE,Ceruloplasmin,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,URINALYSIS W MICRO,GLUCOSE,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,CMP13 LP 2AC CBC D PLT,ALT SGPT,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.06,0.07666666666666666,0.13799999999999998,0.0,0.024444444444444446,0.044,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,BASIC METABOLIC PANEL,BUN CREATININE RATIO,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,URINALYSIS SCREEN,PH,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,CBC WITH PLT DIFF,RBC MORPHOLOGY,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,FIBROSIS SCORE,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.124,0.1985714285714286,0.0,0.2,0.14285714285714285,0.5,0.0,0.0,0.0,0.03285364306619687,0.04098035251271415,0.09061940958216264,0,204537,UA MICROSCOPIC REFLEX CULTURE,RED BLOOD CELLS,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,SPECIAL PROFILE 3619,LEUKOCYTE ESTERASE,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,HEPATITIS C VIRAL RNA QUAL TMA,HEPATITIS C VIRAL RNA QUAL TMA,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,ALPHA 1 ANTITRYPSIN PHENOTYPE,ALPHA 1 ANTITRYPSIN,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.09499999999999999,0.08142857142857142,0.1425,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,PHENCYCLIDINE,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,AST CBC D PLT,EOS,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,URINALYSIS W REFLEX MICRO,UROBILINOGEN,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,CREATININE,ICTERUS,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,COMPLEMENT COMPONENT C3C,COMPLEMENT COMPONENT C3C,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,LIVER FIBROSIS PANEL,ALT,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,HIV 4TH GEN RFLX CONF,HIV 4TH GEN RFLX CONF,Hemoglobin,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,HEPATIC FUNCTION PANEL,INDIRECT BILI,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,COMPLETE BLOOD COUNT,BASOPHILS ABSOLUTE,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,MAGNESIUM,HEMOLYSIS,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,PROTEIN ELECTROPHORESIS SERUM,BETA,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,URINALYSIS,BILIRUBIN,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,TSH,TSH,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,CMP WITH EGFR,EGFR NON AFRICAN AM,Erythrocytes,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,GORBYMI CMP 4AC CORONARY RISK CBC TSH PROFILE,CALCIUM,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.5566666666666666,0.4,0.3333333333333333,0.0,0.0,0.0,0.05352091133427317,0.04991270465467579,0.05003751769211573,1,67421,CBC WITH PLT DIFF,RBC MORPHOLOGY,Erythrocyte morphology finding,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld
0.0,0.011764705882352941,0.025,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,COMP METABOLIC PANEL,GLUCOSE NON FASTING,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.08597114196594469,0.0,0.0,1,7187,CBC W AUTO DIFF,HGB,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.14666666666666667,0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,FIBROACT COMPLETE,APOLIPOPROTEIN A1,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,ACTIVATED PTT,ACTIVATED PTT PATIENT,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,CMP14 HP5 LP 6AC CBC D PLT,MAGNESIUM SERUM,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0294073427013698,0.0,0.0,0,139501,NEG HIV 4TH GEN,NEG HIV 1 RNA QL TMA,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.09090909090909091,0.0,0.0,0.0,0.0,0.0,0.02495699463174772,0.0,0.0,0.0,0.0,0,611517,IFE PE SERUM,ALPHA 2 GLOBULIN,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.1142857142857143,0.16,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,NASH FIBROSURE,APOLIPOPROTEIN A 1,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.3333333333333333,0.4,1.0,0.3333333333333333,0.4,1.0,0.06696411491014109,0.4808823462371743,0.7071067811865476,0.06696411491014109,0.4808823462371743,0.7071067811865476,1,22764,FERRITIN SERUM,FERRITIN SERUM,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.21666666666666667,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.09338639438323382,0.0,1,17590,COMPREHENSIVE METABOLIC PANEL E GFR,CALCULATED A G RATIO,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,CBC WITH ABSOLUTE NEUTROPHIL COUNT,NEUTROPHILS,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,CBC DIFF PLT,MCHC,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,DRUG ABUSE SCREEN II,METHAQUALONE,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,HEP B SURFACE AG W REFLEX,HEP B SURFACE AG W REFLEX,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.09428571428571428,0.08,0.0,0.0,0.0,0.0,0.022748006321232306,0.0,0.0,0.0,0.0,0,296095,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,ALT,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,UA M W RFLX CULTURE COMP,WBC,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,BASIC METABOLIC PANEL,EGFR NON AFR AMERICAN,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,METHADONE,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,CMP,ALBUMIN,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,CMP14 LP CBC D PLT UA MG TS,VLDL CHOLESTEROL CAL,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,COMP METABOLIC PANEL 14,EGFR IF AFRICN AM,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,CBC WITH ABSOLUTE NEUTROPHIL COUNT,NEUTROPHILS,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,CMP12 LP TP TSH 6AC CBC D PLT,BILIRUBIN TOTAL,pH,pH of Urine by Test strip,pH Ur Strip
0.39666666666666667,0.1,0.2,0.39666666666666667,0.2,0.2,0.025474992674050623,0.03132695058051882,0.06720098415971731,0.029415987755933792,0.07234649340221055,0.07759701258884111,1,79053,HB S AG W REFLEX CONF,HB S AG NEUTRALIZATION,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,UA W RFLX MICROSCOPIC,COLOR,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,DRUG ABUSE SCREEN CLINICAL 9,COCAINE,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,IRON TOTAL,HEMOLYSIS,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.08030844563447248,0.0,0,303503,URINALYSIS WITH MICROSCOPIC,RED BLOOD CELLS,Hemoglobin,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,BASIC METABOLIC PANEL,ANION GAP,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.08719609088829028,0.0,0.0,0,7872,PATHOLOGIST SMEAR REVIEW,RBC,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.3333333333333333,0.16666666666666666,1.0,0.0,0.0,0.0,0.042798044679898894,0.06872782032043556,0.5773502691896257,1,747741,COMP METABOLIC PANEL,GLUCOSE NON FASTING,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,CBC W DIFF PLATELET,MCH,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,RPR,RPR RESULT,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.1569574215481997,0.0,0.0,1,303842,CBC DIFF PLT,RDW,Erythrocyte distribution width,Erythrocyte distribution width [Entitic volume],RDW RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,TESTOSTERONE,TESTOSTERONE,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,ALPHA 1 ANTITRYPSIN PHENOTYPE,ALPHA 1 ANTITRYPSIN,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,CBC W DIFF PLATELET,MCH,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.2,0.0,0.0,0.2,0.0,0.0,0.24044117311858715,0.0,0.0,0.24044117311858715,0.0,0,45427,FERRITIN SERUM,FERRITIN SERUM,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,T B LYMPHOCYTE NK NYSDOH,PLATELETS,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,FREE T4 THYROXINE,FREE T4,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,HCV QUANT GT1A NS5A PROFILE,HCV NS5A RESISTANCE ASSAY PDF,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,C4 C3,COMPLEMENT C3 SERUM,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.0,0.0,0.0,0.05,0.0,0.0,0.024414913142778216,0.0,0.0,0.024414913142778216,0.0,0,347047,FOLATE SERUM,FOLATE SERUM,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.4,0.25,0.6666666666666666,0.0,0.0,0.0,0.43159805011496677,0.036870751523516376,0.02890669461985995,1,141358,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD8 CELLS,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,FSRC NEW PATIENT PANEL,D BILIRUBIN,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.0,0.3333333333333333,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.025569947555028505,0.0,0.04731446515070681,0.0448936194214955,0.0648385480903172,0,7062,COMPLETE BLOOD COUNT,BASOPHILS ABSOLUTE,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,IFE PE SERUM,ALPHA 1 GLOBULIN,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,URINALYSIS W REFLEX MICRO,BACTERIA,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,CBC WITH DIFFERENTIAL,NUCLEATED RBCS,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.0,0.0,0.25,0.09090909090909091,1.0,0.0,0.0,0.0,0.008266925420703064,0.0060717988629857,0.140463816246154,0,611517,COMP METAB PANEL,ALBUMIN GLOBULIN RATIO,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.3333333333333333,0.375,0.75,0.0,0.1,0.0,0.31324120943733813,0.38519704454404224,0.8263051464980926,0.0,0.06265390116103764,0.0,1,79053,HEP B SURFACE AG W REFLEX CONFIRM,NEUTRALIZATION,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,CMP14 LP 3AC,LDH,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,HIV 1 QUANT PCR,HIV 1 VIRAL LOG,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,CBC WITH DIFFERENTIAL,NO CELLS DIFF,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,URINALYSIS W MICRO,GLUCOSE,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,HEPATIC FUNCTION PANEL 6,ALT SGPT,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.047142857142857146,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,RDW,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,C REACTIVE PROTEIN,C REACTIVE PROTEIN,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,LITHOLINK CMP14 P,ALBUMIN,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.31,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,TESTOSTERONE FREE TOTAL LC MS,FREE TESTOSTERONE DIRECT,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,URINALYSIS COMP W RFL CULTURE,PROTEIN,Erythrocyte distribution width,Erythrocyte distribution width [Entitic volume],RDW RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,HBSAB AG,HEP B SURFACE AB QUAL,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,COMPLETE BLOOD COUNT,BASOPHILS ABSOLUTE,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,CMP14 LP 6AC,PHOSPHORUS,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.4175,0.08571428571428572,0.0,0.6675,0.3242857142857143,0.0,0.027952627376922723,0.0,0.0,0.061241138223508074,0.059062741744354885,0.0,1,19901,VITAMIN D 25 OH LCMSMS W REFLEX,VITAMIN D 25 OH D3,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.07714285714285715,0.16,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,CMP14 HP4 1AC PT AFP,HEP A AB IGM,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,DRUG ABUSE SCREEN W ETOH NO GCMS,AMPHETAMINES,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH TOTAL,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,THYROID PROFILE T4 T3UP FTI TSH,T 4,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.036,0.12363636363636363,0.05142857142857143,0.036,0.12363636363636363,0.05142857142857143,0.0,0.036065072854330915,0.0,0.0,0.036065072854330915,0.0,0,568881,MAGNESIUM SERUM,MAGNESIUM SERUM,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,FE CBC D PLT TIBC FER B12 F,FERRITIN SERUM,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,HIV 1 QUANT PCR,HIV 1 VIRAL COPY,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,PROTEIN ELECTROPHORESIS,GAMMA GLOBULINS,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,LYMPHOCYTE SUBSET PANEL 4,COMMENTS,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,LIPID PANEL AMA,NON HDL CHOLESTEROL,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,SED RATE MODIFIED WESTERGREN MANUAL,SED RATE MODIFIED WESTERGREN MANUAL,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,PHOSPHATE AS PHOSPHORUS,ICTERUS,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,LEDIPASVIR RESISTANCE,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,URINALYSIS,PH,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,HIV AG AB 4TH GEN RFL,HIV AG AB 4TH GEN,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.1925,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,URINALYSIS CULTURE IF INDICATED,OCCULT BLOOD,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.02146570986203966,0.0,0.0,0.0,0.0,0,304519,CBCI COMPLETE BLOOD COUNT W DIFF,PLT MORPHOLOGY,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,LIVER FIBROTEST ACTITEST,HAPTOGLOBIN,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,HEMOGLOBIN A1C,HEMOGLOBIN A1C,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,HEPATIC FUNCTION PANEL,INDIRECT BILI,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,LYMPHOCYTE SUBSET PANEL 4,% CD8 SUPPRESSOR T CELLS,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,CBC,MONOCYTES ABSOLUTE,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,ANTIPHOSPHOLIPID SYNDROME,PT,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0625,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,CMP,BUN,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.18999999999999997,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,148692,HEMATOPATH CONSULTATION SMEAR,WBC,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,CBC WITH AUTO DIFF,HEMATOCRIT,Monocytes,Monocytes [#/volume] in Blood,Monocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,PROTEIN ELECTROPHORESIS,ALPHA 1 GLOBULINS,Basophils,Basophils [#/volume] in Blood,Basophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,COMPLETE BLOOD COUNT,BASOPHILS ABSOLUTE,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.15666666666666665,0.94,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,CBC WITH PLT DIFF,OTHERS,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,PT PROTIME,INR,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.10333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,CD4 CD8 ENUMERATION,ABSOLUTE LYMPHOCYTES,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,BASIC METABOLIC PANEL AMA,GLUCOSE,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,LIPID CASCADE W RFLX APOLIB,LDL HDL RATIO,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,FREE T3,FREE T3,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,LYMPHOCYTE SUBSET PANEL 2,% CD4 HELPER CELLS,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.010714285714285714,0.0375,0.0,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.06292624359840293,0.0,0,110114,CMP12 LP 6AC,PHOSPHORUS SERUM,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.088,0.12875,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,UA MICROSCOPIC REFLEX CULTURE,BILIRUBIN,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,URIC ACID,URIC ACID,Basophils,Basophils [#/volume] in Blood,Basophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,URINALYSIS W MICROSCOPIC,URINALYSIS URINE COLOR,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,VITAMIN D 25 OH TOTAL,VITAMIN D 25 OH TOTAL,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,SMN1 COPY NUMBER ANALYSIS,SPECIMEN TYPE,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,PAIN MANAGEMENT 8,CREATININE,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,HEMOGLOBIN A1C,HEMOGLOBIN A1C,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,DIFFERENTIAL MANUAL,ABSOLUTE LYMPHOCYTES,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,CD4 CD8 LYMPHOCYTE ENUMERATION,PERCENT CD4,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.3333333333333333,0.36363636363636365,0.75,0.5,0.45454545454545453,1.0,0.058932068039107444,0.04521753067807699,0.0,0.32919781270269133,0.03140282649351023,0.04372412516808821,1,112599,HCV ANTIBODY REFLEX NAA,HCV RNA NAA QUALITATIVE,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.25,0.2573333333333333,0.965,0.25,0.2573333333333333,0.965,0.22848423004998408,0.011147902332567239,0.04372412516808821,0.22848423004998408,0.011147902332567239,0.04372412516808821,1,426171,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,ASH FIBROSURE,HAPTOGLOBIN,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.155,0.21833333333333335,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.06860647178857471,0.0793317966039091,1.0,1,251454,URINALYSIS W MICROSCOPIC,BACTERIA,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,PROTEIN ELECTRO S,ALPHA 2 GLOBULIN,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,CBC W O DIFF WITH PLATELETS,MCV,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,MAGNESIUM,HEMOLYSIS,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,CRP,C REACTIVE PROTEIN ULTRA,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.25,0.2,0.0,0.0,0.0,0.0,0.06650223739152306,0.21717918485032472,0.0,1,7856,CBC W DIFF PLATELET,MCH,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.02428571428571429,0.0425,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,LIPID PANEL WITH LDL HDL RATIO,HDL CHOLESTEROL,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,URINALYSIS CULTURE IF INDICATED,COLOR,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,TRIGLYCERIDES REFL,TRIGLYCERIDES,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.2375,0.15833333333333333,0.95,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,LYMPHOCYTE SUBSET PANEL 4,% CD4 HELPER CELLS,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,MORPHOLOGICAL REVIEW,PATH REVIEW PERIPHERAL SMEAR,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,CBC DIFF PLT,MONOCYTES %,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,FERRITIN,FERRITIN SERUM,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,PSA TOTAL % FREE,PSA FREE,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.2,0.125,0.3333333333333333,0.2,0.125,0.3333333333333333,0.03326797734982634,0.049549723851913474,0.04806998066173307,0.052601290786171706,0.07834499240220905,0.07600531298566238,1,244673,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE CD4,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,URINALYSIS W REFLEX MICRO,BACTERIA,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,LIPID PANEL,LDL CALC,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,COMPLEMENT COMPONENT C3C,COMPLEMENT COMPONENT C3C,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.5,0.16666666666666666,0.5,0.25,0.31,0.9299999999999999,0.13418198861418107,0.05660928660351461,0.05881293452243719,0.044727329538060356,0.05660928660351461,0.05881293452243719,1,27318,PTH INTACT,PARATHYROID HORMONE INTACT,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.02948276095739455,0.0,0.0,0.0,0.0,0,264994,CBC COMPLETE BLOOD COUNT W O DIFF,MCV,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,HEMOGLOBINOPATHY EVAL,MCH,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.08399999999999999,0.06799999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,CBC WITH PLT DIFF,RBC MORPHOLOGY,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.05263157894736842,0.0,0.12285714285714286,0.0,0.0,0.0,0.03350578343083632,0.0,0.0,0.0,0.0,1,486431,CREATININE,EGFR IF AFRICN AM,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,HEPATITIS C VIRAL RNA NS3 GENOTYPE,TELAPREVIR RESISTANCE,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,STOOL CULTURE,RESULT 1,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,COMP METABOLIC PANEL,RATIO,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,CEA CARCINOEMBRYONIC ANTIGEN,CEA CENTAUR,Eosinophils,Eosinophils [#/volume] in Blood,Eosinophil # Bld
0.3333333333333333,0.2,0.5,0.3333333333333333,0.2,0.5,0.08544834831866432,0.11098565713428754,0.0,0.06042110653731758,0.07847871077409985,0.0,1,311472,RPR,RPR QUANT,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,REFERRED CBC,MCH,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,CBC WITH PLT DIFF,MYELOCYTES,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,MORPHOLOGICAL REVIEW,MORPHOLOGICAL REVIEW,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,LP LDLDIR,TRIGLYCERIDES,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,HEPATITIS C ANTIBODY,HEPATITIS C ANTIBODY,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,IFE PE SERUM,M SPIKE,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,ANION GAP,ANION GAP,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,HCV FIBROSURE,INTERPRETATION,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,UREA NITROGEN BUN,UREA NITROGEN BUN,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.266,0.19,0.44333333333333336,0.266,0.19,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,HEPATITIS C AB,HEPATITIS C AB,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.0834655896020069,0.34003516797720323,1.0,1,29512,COMP METABOLIC PANEL W GFR,SODIUM,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,CBC WITH MANUAL DIFFERENTIAL,NEUTROPHILS,Reference lab test method,Reference lab test method,Ref lab test method
0.11,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.07163871665340582,0.09716253076254433,1.0,1,57976,UROGRAM,KETONES,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,CBC COMPLETE BLOOD COUNT W O DIFF,MCV,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,CBC W AUTO DIFF WITH PLATELETS,COMMENTS,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,HP4 RPR,HEP C VIRUS AB,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,DACLATASVIR RESISTANCE,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,HEPATITIS B CORE AB TOTAL,HEPATITIS B CORE AB TOTAL,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,HEPATIC FUNCTION PANEL AMA,BILIRUBIN DIRECT,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,ESR WES CRP,C REACTIVE PROTEIN QUANT,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,DIFFERENTIAL MANUAL,NEUTROPHILS,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,FREE T4 THYROXINE,FREE T4,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,HEPATITIS B CORE IGM,HEPATITIS B CORE IGM,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,URINALYSIS,BACTERIA,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,CD4 CD8 ENUMERATION,ABSOLUTE LYMPHOCYTES,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,PSA FREE TOTAL,FREE PSA,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD8 CELLS,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,STOOL CULTURE,RESULT 1,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,CRYOGLOBULINS REFLEX IFE QUANT,IGM CRYOPRECIPITATE,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,CMP12 LP TP TSH 6AC CBC D PLT,HEMOGLOBIN,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,CBC W DIFF PLATELET,HCT,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS B SURFACE AB,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,MORPHOLOGICAL REVIEW,MORPHOLOGICAL REVIEW,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,ANA SCR IFA RFL TITR PATT,ANA SCREEN IFA,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,URINALYSIS COMPLETE,APPEARANCE,Hemoglobin,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,PROTEIN ELECTROPHORESIS SR W RFX,INTERPRETATION,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,CMP14 CBC D PLT RPR UA TSH,NEUTROPHILS ABSOLUTE,Eosinophils,Eosinophils [#/volume] in Blood,Eosinophil # Bld
0.2,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.048918155723576384,0.039328530307136456,0.0,0.0691807192705608,0.0556189409485538,0.10240603634159506,1,237610,DIFFERENTIAL MANUAL,NEUTROPHILS,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,CBC W AUTO DIFF,HCT,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,HEPATITIS B CORE IGM,HEPATITIS B CORE IGM,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,COMP METABOLIC PANEL W GFR,SODIUM,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.045,0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,BASIC METABOLIC PANEL,BUN CREATININE RATIO,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,LYMPHOCYTE SUBSET PANEL 4,% CD8 SUPPRESSOR T CELLS,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,HCV RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,CBC WITH AUTO DIFF,BASOPHILS %,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,COMPREHENSIVE METABOLIC PANEL E GFR,CALC GLOBULIN,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.061769791070825475,0.0,0.0,0.12353958214165095,1.0,1,196592,DRUG SCREEN AUSTIN 20,PHENCYCLIDINE,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.25,0.16699999999999998,0.5,0.0,0.0,0.0,0.049020432311290385,0.0,0.0,1,302398,ASH FIBROSURE,AST SGOT P5P,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,URINE DRUG SCREEN,OPIATES,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,CBC WITH AUTO DIFF,HEMATOCRIT,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,REFERRED CBC,MCH,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,AFP TUMOR MARKER,AFP TUMOR MARKER,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.3333333333333333,0.25,0.0,0.0,0.0,0.0,0.03219424954825956,0.0,0.0,0.0,0.0,0.0,0,183145,AUTOMATED BLD CNT,HEMOGLOBIN,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,HEPATITIS PANEL 4,HEP B CORE AB IGM,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,LIPID PANEL WITH LDL HDL RATIO,LDL HDL RATIO,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,LYMPHOCYTE SUBSET PANEL 2,% CD3 MATURE T CELL,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,HEP B CORE AB QUAL,HEPATITIS B CORE AB QL,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,DRGABU2,METHAQUALONE,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,TSH W REFLEX FT4,TSH 3RD GENERATION W REFLEX FT4,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,CBC WITH DIFFERENTIAL,MONOCYTES,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,CBC INCLUDES DIFF PLT,ABSOLUTE BAND NEUTROPHILS,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,ACUTE HEPATITIS PANEL,HEPATITIS C ANTIBODY,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,VITAMIN B12 FOLATE,FOLATE SERUM,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,FREE T4 THYROXINE,FREE T4,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,URINALYSIS,NITRITE,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD3 CELLS,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,DRUG ABUSE SCREEN II,COCAINE METABOLITE,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.072,0.09857142857142856,0.13799999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,BASIC METABOLIC PANEL,ANION GAP,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,URINALYSIS WITH REFLEX MICROSCOP,PROTEIN TOTAL QUAL,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,CMP WITH ESTIMATED GFR CALCULATED,FASTING NON FASTING,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D2,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,LIPID PROFILE WITH CALC NON HDL CHOLESTEROL,RISK RATIO LDL HDL,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,APTT,PARTIAL THROMBOPLASTIN,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,CMP12 LP TP TSH 6AC CBC D PLT,HEMOGLOBIN,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,URINALYSIS WITH MICROSCOPIC,PROTEIN,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,HDL CHOL DIRECT,HDL AS % CHOLESTEROL,pH,pH of Urine by Test strip,pH Ur Strip
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.08312548434166944,0.0,0.0,0.0,0.0,0,18341,IFE PE SERUM,M SPIKE,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.028333333333333335,0.01888888888888889,0.028333333333333335,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,CD4 CD8 LYMPHOCYTE ENUMERATION,PERCENT CD4,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,CBC PLATELET HEM REVIEW,EOS ABSOLUTE VALUE,Color,Color of Urine,Color Ur
0.3333333333333333,0.3333333333333333,1.0,0.3333333333333333,0.3333333333333333,1.0,0.04623723810209024,0.4596659728295527,0.8660254037844386,0.04623723810209024,0.4596659728295527,0.8660254037844386,1,30940,UREA NITROGEN BUN,UREA NITROGEN BUN,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,HBC AB TOTAL,HBC AB TOTAL,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,TSH RFLX FT4,TSH RFLX FT4,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,DIFFERENTIAL MANUAL,ABSOLUTE EOSINOPHILS,Prothrombin.activity actual/Normal,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP
0.0,0.08142857142857142,0.1425,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,DRUG ABUSE SCREEN III,AMPHETAMINES,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,BASIC METABOLIC PANEL,BUN CREATININE RATIO,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.1875,0.2,0.0,0.0,0.0,0.0,0.0,0.09553982688249574,0.0,0,473835,CMP14 HP5 LP 6AC CBC D PLT,MAGNESIUM SERUM,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,URINE MICROALBUMIN CREAT RATIO,UR MICROALBUMI,Neutrophils,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,CBC WITH PLT DIFF,MEGAKARYOCYTE FRAGS,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,RHEUMATOID FACTOR RF,RHEUMATOID FACTOR RF,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,CREATININE,EGFR IF NONAFRICN AM,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.2857142857142857,0.2857142857142857,1.0,0.14285714285714285,0.21428571428571427,0.75,0.23545370673552535,0.010697710099832114,0.04187180795069423,0.018545418747212716,0.0,0.0,0,296095,HCV RNA PCR QN GRAPH RFX NS5A,HCV NS5A RESIST ASSAY INTERP,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.2,0.0,0.25,0.2,0.0,0.0,0.04035350753708156,0.0,0.06725870151848445,0.21223170681007852,0.0,1,7864,CBC COMPLETE BLOOD COUNT W O DIFF,MCHC,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,COMP METABOLIC PANEL W GFR,GLOBULIN,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,MCCARJUH MCCARTHY PROFILE 1,MITOCHONDRIAL M2 AB,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,HIV 1 HIV 2 AG AB COMBO W REFLEXES,HIV INTERPRETATION,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,HCV FIBROSURE,ALPHA 2 MACROGLOBULINS QN,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,PSA TOTAL % FREE,% FREE PSA,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.2,0.14285714285714285,0.0,0.27999999999999997,0.0,0.0,0.03776245386391519,0.10966144007006884,0.09102369686139644,0.0,0.0,0.0,1,333583,PROTEIN ELEC INTERP SERUM,M SPIKE,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,CBC WITH PLT DIFF,NRBC,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,TESTOSTERONE FREE LC MS MS,TESTOSTERONE FREE LC MS MS,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,HCV FIBROSURE,GGT,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE NEUTROPHILS,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,PROTHROMBIN PTT,CONTROL,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.06113610877573539,0.0,0.0,0.0,0.0,0,17830,CBC WITH ABSOLUTE WHITE BLOOD CELLS,WBC,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,HCV FIBROSURE RESULTS,FIBROSIS SCORE,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,HCV QUANT GT1A NS5A PROFILE,HCV NS5A RESISTANCE ASSAY PDF,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,HCV QUANT GT1A NS5A PROFILE,HCV LOG10,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,LYMPHOCYTE SUBSET PANEL 2,% CD8 SUPPRESSOR T CELLS,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,LIVER FIBROSIS PANEL,HAPTOGLOBIN,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.16666666666666666,0.26,0.715,0.16666666666666666,0.26,0.715,0.026355222038017434,0.08088757789668977,0.22524969726717137,0.026355222038017434,0.08088757789668977,0.22524969726717137,1,112599,HEPATITIS C VIRAL RNA QUAL TMA,HEPATITIS C VIRAL RNA QUAL TMA,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,HEP A AB IGM,HEPATITIS A AB IGM,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,TESTOSTERONE FREE LC MS MS,TESTOSTERONE FREE LC MS MS,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,FASTING,FASTING STATUS,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,URINALYSIS COMPLETE,BILIRUBIN,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,DACLATASVIR RESISTANCE,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,TSH RFLX FT4,TSH RFLX FT4,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,COMPREHENSIVE METABOLIC PANEL AMA,CHLORIDE,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.0769832768017027,0.08055537486383768,0.09169555407390673,1,301804,CBC,% BASOPHILS,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,URINALYSIS,LEUKOCYTE ESTERASE,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.16,0.0,0.25,0.2,1.0,0.0,0.061769791070825475,0.0,0.08356777192520215,0.12353958214165095,1.0,1,192955,DRUG ABUSE SCREEN II,OPIATES,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.009523809523809525,0.02,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,COMPREHENSIVE METABOLIC PANEL AMA,GLOBULIN,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,IRON TOTAL,HEMOLYSIS,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,AST CBC D PLT,EOS,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.09090909090909091,0.0,0.0,0.030000000000000002,0.0825,0.0,0.04088056399127271,0.0,0.0,0.0,0.0,0,322867,URINALYSIS WITH MICROSCOPIC,RED BLOOD CELLS,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,CD4 CD8 ENUMERATION,ABSOLUTE LYMPHOCYTES,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,RPR,RPR RESULT,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,LIVER FIBROSIS,NECROINFLAM ACT GRADE,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,HEMOGRAM W AUTOMATED DIFF,WBC,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,B12,VIT B12 SERUM,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,LIPOPROT LDL DIRECT,LIPOPROT LDL DIRECT,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.03968462988854371,0.0,0,192526,UA MICROSCOPIC REFLEX CULTURE,WHITE BLOOD CELLS,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.1,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.030526286249592305,0.0,0,7096,UA MICROSCOPIC REFLEX CULTURE,WHITE BLOOD CELLS,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,COMPLEMENT COMPONENT C4C,COMPLEMENT COMPONENT C4C,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,HEPATITIS BS AB QL,HEPATITIS B SURF AB QL,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,COMPLEMENT COMPONENT C4C,COMPLEMENT COMPONENT C4C,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,AFP TUMOR MARKER SIEMENS CLIA,AFP TUMOR MARKER SIEMENS CLIA,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,HEPATITIS B CORE AB,HEPATITIS B CORE AB,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,CEA,CEA SIEMENS IMMULITE 2000,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.008571428571428572,0.012,0.0,0.02428571428571429,0.034,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,CMP13 LP TP TSH 2AC CBC D P,CHOLESTEROL TOTAL,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,RPR HBSAG HCVAB HSV1 HSV2 I,HEP C VIRUS AB,Eosinophils,Eosinophils [#/volume] in Blood,Eosinophil # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,FE TIBC FER B12 HCT FOLRBC,IRON,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.0,0.0,0.0,0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.08522930735490397,0.0,0,139543,FE CBC D PLT TIBC FER B12 F,FERRITIN SERUM,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,UROGRAM,KETONES,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,LIPID PANEL AMA,NON HDL CHOLESTEROL,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,ALT,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE NEUTROPHILS,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,IRON BINDING CAPACITY,TIBC,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,HCV FIBROSURE RESULTS,NECROINFLAMMAT ACT GRADE,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.3333333333333333,0.25,0.74,0.3333333333333333,0.25,0.74,0.06192371508395944,0.40824829046386313,0.0,0.06192371508395944,0.40824829046386313,0.0,1,149575,MICROALBUMIN RANDOM,MICROALBUMIN RANDOM,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,CBC W DIFF PLATELET,HCT,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,PROTEIN ELEC INTERP SERUM,M SPIKE,Erythrocyte distribution width,Erythrocyte distribution width [Entitic volume],RDW RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,ACUTE HEPATITIS PANEL,HEPATITIS B SURF AG,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.2544444444444445,0.38166666666666665,0.0,0.0,0.0,0.0,0.025425559932405584,0.04202185668774028,0.0,0.0,0.0,0,481598,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,VELPATASVIR RESISTANCE,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.0,0.0,0.0,0.19999999999999998,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.03622836077219149,0.18114949547659975,0.22056758755212558,1,241109,RPR,TREPONEMA PALLIDUM ANTIBODIES,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.125,0.2857142857142857,0.0,0.0,0.0,0.0,0.0,0.039128970186175116,0.0,0.0,0.07825794037235023,0.0,0,427682,PROTEIN ELEC INTERP SERUM,P E INTERPRETATION S,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,CBC WITH AUTO DIFF,EOSINOPHILS #,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,HEPATITIS C AB REFLEX HCV RNA QUANT,HEPATITIS C ANTIBODY,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,TESTOSTERONE,TESTOSTERONE,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,IRON TIBC,UIBC,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,ACTIVATED PTT,ACTIVATED PTT PATIENT,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.2,0.375,0.75,0.0,0.0,0.0,0.009770769191754458,0.0,0.0,0.0,0.0,0.0,0,139550,HCV FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,MANUAL DIFFERENTIAL,EOSINOPHILS %,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,COMP METABOLIC PANEL 14,EGFR IF AFRICN AM,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.0,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,URINALYSIS COMPLETE,BILIRUBIN,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,COMPLETE BLOOD COUNT,BASOPHILS ABSOLUTE,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,AFP TUMOR MARKER SIEMENS IMMULITE,AFP TUMOR MARKER,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1858678609476695,0.0,0.0,0.0,0.0,0,17988,PROTEIN ELECTROPHORESIS SERUM,INTERPRETATION,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.2,0.16666666666666666,0.0,0.0,0.0,0.0,0.028242910375266828,0.0,0.0,0.0,0.0,0.0,0,237610,AUTOMATED BLD CNT,HEMOGLOBIN,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,BMP8 CBC D PLT,CREATININE,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.266,0.0,0.0,0.27999999999999997,0.0,0.0,0.05340417440283707,0.0775423479082279,0.12872694659872408,0.0,0.0,0.0,1,333583,PROTEIN ELECTRO S,M SPIKE,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,CMP14 LP 7AC CBC D PLT T B,AMYLASE SERUM,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.05504399149282735,0.0,0,339358,COMPLETE BLOOD COUNT,MEAN PLATELET VOLUME,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.03777777777777777,0.0,0.0,0.03777777777777777,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,HCV RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,HCV FIBROSURE RESULTS,FIBROSIS STAGE,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,COMPREHENSIVE METABOLIC PANEL E GFR,ALBUMIN,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.0,0.0,0.0,0.0625,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,OBSTETRIC PANEL,RPR RESULT,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,HCV QUANT GT1A NS5A PROFILE,HCV NS5A RESISTANCE ASSAY PDF,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,CMP14 2AC MG,EGFR IF NONAFRICN AM,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,ANA SCR W RFL T P LUPUS 1,ANA PATTERN,Ceruloplasmin,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,HCV RNA GENOTYPE LIPA R,HCV RNA GENOTYPE LIPA,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.14285714285714285,0.09090909090909091,0.5,0.0,0.0,0.0,0.061685809626148336,0.0,0.0,1,17442,CMP,ALT SGPT,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,MPV,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,HEPATITIS PANEL 4,HEP B CORE AB IGM,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,PROTEIN ELECTROPHORESIS,ALPHA 1 GLOBULINS,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,DIFFERENTIAL MANUAL,ABSOLUTE NEUTROPHILS,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,DRUG ABUSE PANEL 10 WITH OXYCODONE,METHAQUALONE,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.004666666666666667,0.0175,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,CMP12 LP TP TSH 6AC CBC D PLT,BILIRUBIN TOTAL,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,VAP CHOLESTEROL PROFILE,TRIGLYCERIDES,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,UA W MICRO HOLD SPEC 24 HR,SPECIFIC GRAVITY,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,FOLATE,FOLATE,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,GLUCOSE,GLUCOSE FASTING,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,COMPREHENSIVE METABOLIC PANEL E GFR,CHLORIDE,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN RT PCR LOG COPIES ML,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,TRANSFERRIN,TRANSFERRIN,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,CBC INCLUDES DIFF PLT,BAND NEUTROPHILS,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,HEPATITIS BE ANTIGEN,HEP BE ANTIGEN,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D2,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,CBC WITH PLT DIFF,RDW,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.1063004130698838,0.10964330813284906,0.7071067811865476,1,264440,CBC W AUTO DIFF,ABS BASOPHILS,Basophils,Basophils [#/volume] in Blood,Basophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,HEPATITIS C RNA PCR QUANT,HCV PCR QUANT,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,DRUG ABUSE SCREEN W ETOH NO GCMS,BARBITURATES,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,PROTEIN ELECTROPHORESIS SERUM,INTERPRETATION,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.3333333333333333,0.4444444444444444,0.8,0.3333333333333333,0.4444444444444444,0.8,0.36763357933547924,0.6120420156055605,0.8565433315613047,0.36763357933547924,0.6120420156055605,0.8565433315613047,1,139527,HEPATITIS B CORE AB TOTAL,HEPATITIS B CORE AB TOTAL,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,HEPATITIS A DIAGNOSTIC PANEL,HAV AB TOTAL,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,TRIIODOTHYRONINE T3 FREE,TRIIODOTHYRONINE T3 FREE,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,COMP METABOLIC PANEL W GFR,CHLORIDE,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.45,0.32,0.96,0.45,0.32,0.96,0.008516468395054266,0.913744925535582,0.9900858126069512,0.008516468395054266,0.913744925535582,0.9900858126069512,1,115725,RHEUMATOID FACTOR QUANT,RHEUMATOID FACTOR QUANT,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,COMP METABOLIC PANEL W GFR,SODIUM,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,PHENCYCLIDINE,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,PROTEIN ELECTRO S,M SPIKE,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,CMP12 LP TP TSH 6AC CBC D PLT,HEMOGLOBIN,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.026000000000000002,0.07142857142857142,0.049999999999999996,0.10600000000000001,0.12571428571428572,0.043333333333333335,0.0,0.24044117311858715,0.0,0.0,0.0,0.0,0,18697,IMMUNOFIXATION SERUM,IMMUNOGLOBULIN M,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,LYMPHOCYTE SUBSET PANEL 2,COMMENT S,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,NASH FIBROSURE,ALT SGPT P5P,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.11,0.0,0.0,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,HEPATITIS B SURFACE AB IMMUN,HEPATITIS B SURFACE AB IMMUNITY QN,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,CMP14 LP CBC D PLT UA MG TS,VLDL CHOLESTEROL CAL,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.3333333333333333,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.025569947555028505,0.0,0.06691275831255872,0.06348916544989514,0.09169555407390673,1,7062,COMPLETE BLOOD COUNT,BASOPHILS %,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,IFE PE SERUM,ALPHA 1 GLOBULIN,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,PROTEIN CREATININE RATIO URINE,PROTEIN UR MG DL,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,BASIC METABOLIC PANEL,EGFR NON AFR AMERICAN,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6334913618927072,0.31420258272955537,0.0,0.6334913618927072,0.31420258272955537,1,45377,SEDIMENTATION RATE WESTERGREN,SEDIMENTATION RATE WESTERGREN,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.1325,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,HEPATITIS PANEL 4,HEP B CORE AB IGM,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,CD4 T4 ENUMERATION,ABSOLUTE LYMPHOCYTES,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,PROTIME PTT,PROTHROMBIN TIME PT,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,QUESTASSURED TM 25OHD D2 D3,VITAMIN D 25 OH TOTAL,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,URINALYSIS SCREEN,PH,Service comment,Service comment,Service Cmnt XXX-Imp
0.3333333333333333,0.0,0.0,0.3333333333333333,0.3333333333333333,0.5,0.05339016372965322,0.1858678609476695,0.40824829046386313,0.05339016372965322,0.5576035828430085,0.8164965809277261,1,44859,C4 C3,COMPLEMENT C3 SERUM,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.05714285714285715,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,CD4 T4 ENUMERATION,ABSOLUTE LYMPHOCYTES,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,HCV ANTIBODY REFLEX NAA,HCV RNA NAA QUALITATIVE,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,VELPATASVIR RESISTANCE,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,CBC WITH AUTO DIFF,BASOPHILS ABSOLUTE,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,IMMUNOGLOBULINS,IMMUNOGLOBULIN G,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,TSH FREE T4 PROFILE,TSH THIRD GENERATION,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,IFE PE SERUM,GLOBULIN TOTAL,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.1,0.03222222222222222,0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,ANEMIA PROFILE B,UIBC,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,HEPATITIS C VIRAL RNA NS3 DRUG RESI,BOCEPREVIR RESISTANCE,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.3333333333333333,0.0,0.0,0.0,0.25,0.0,0.06407759902266841,0.0,0.0,0.0,0.021568451983879244,0.0,0,264648,CBC RBC H H INDICES WBC PLT,RED BLOOD CELL COUNT,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,MAGNESIUM,MAGNESIUM,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,CBC WITH AUTO DIFF,MONOCYTES #,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.0,0.0,0.08,0.05714285714285715,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD8 CELLS,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0725,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,QUESTASSURED TM 25OHD D2 D3,VITAMIN D 25 OH TOTAL,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,THYROID II PROFILE T3U T4 T7 TSH,T4 THYROXINE,Neutrophils,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual
0.45,0.3333333333333333,1.0,0.45,0.3333333333333333,1.0,0.008516468395054266,0.913744925535582,0.9900858126069512,0.008516468395054266,0.913744925535582,0.9900858126069512,1,115725,RHEUMATOID FACTOR RF,RHEUMATOID FACTOR RF,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.3333333333333333,0.4,0.6666666666666666,0.3333333333333333,0.4,0.6666666666666666,0.3633686386387077,0.6165194983348576,0.061963579130171476,0.3633686386387077,0.6165194983348576,0.061963579130171476,1,241133,HEPATITIS B CORE IGM,HEPATITIS B CORE IGM,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,OBSTETRIC PANEL,RPR RESULT,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,NGI HCV SUPERQUANT,HEPATITIS C QUANTITATION,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.25,0.16666666666666666,0.0,0.25,0.16666666666666666,1.0,0.06812389033458222,0.051758104169687846,0.0,0.06812389033458222,0.051758104169687846,0.7071067811865476,1,7328,DIFFERENTIAL MANUAL,ABSOLUTE LYMPHOCYTES,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,CMP14 3AC CBC D PLT RPR MG,EOS,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,HEMOGLOBINOPATHY INDICES,HEMATOCRIT,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,BILIRUBIN PANEL,BILIRUBIN INDIRECT,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,GORBYMI CMP 4AC CORONARY RISK CBC TSH PROFILE,CALCIUM,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,FIBROSIS SCORE,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,IRON IBC W RFX FERRITIN,%TRANSFERRIN SATURATION,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,772020,PROTEIN ELECTRO S,PLEASE NOTE,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.01,0.022222222222222223,0.1075,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,882936,COMP METABOLIC PANEL 14,EGFR IF AFRICN AM,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,HIV AB EIA WITH REFLEXES,HIV AB,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.25,0.26666666666666666,1.0,0.25,0.26666666666666666,0.965,0.22848423004998408,0.011147902332567239,0.04372412516808821,0.22848423004998408,0.011147902332567239,0.04372412516808821,1,426171,HCV RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,CBC,HCT,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.0725,0.0,0.0,0.0,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,MANUAL DIFFERENTIAL,EOSINOPHILS ABSOLUTE,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,HEPATITIS C VIRAL RNA NS3 DRUG RESI,BOCEPREVIR RESISTANCE,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,CBC,MO%,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,TSH ULTRASENSITIVE,TSH ULTRASENSITIVE,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,LIPID PANEL,NON HDL CHOLESTEROL,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.16666666666666666,0.0,0.0,0.16666666666666666,0.0,0.0,0.06872782032043556,0.0,0.0,0.06872782032043556,0.0,0,747741,COMPLEMENT C4 SERUM,COMPLEMENT C4 SERUM,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,CBC WITH PLT DIFF,VARIANT LYMPHOCYTES ABSOLUTE,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,CEA CARCINOEMBRYONIC ANTIGEN,CEA CENTAUR,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,CMP12 LP TP TSH 6AC CBC D PLT,EOS ABSOLUTE,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,LP WITHOUT VLDL CHOL HDL,LDL CHOLESTEROL CALC,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,VITAMIN D 25 OH LCMSMS W REFLEX,VITAMIN D 25 OH D3,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.386,0.24181818181818182,0.38,0.386,0.24181818181818182,0.38,0.05021212994557489,0.057832776964263255,0.0622918052531054,0.05423529901533852,0.062466538562374274,0.06728283958018277,1,568881,HIV AG AB 4TH GEN RFL,HIV AG AB 4TH GEN,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,NGI HCV ULTRAQUAL RFX SUPER QT,COPIES ML,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,HCV RNA NS5A GENOTYPE,VELPATASVIR RESISTANCE,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,BMP8 EGFR,POTASSIUM,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,CBC WITH PLT DIFF,WBC MORPHOLOGY,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,IRON TIBC,TRANSFERRIN SAT %,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.14285714285714285,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,7765,CBC W DIFF PLT,MPV,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,HCV ANTIBODY REFLEX NAA,HCV RNA NAA QUALITATIVE,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,HAV AB TOTAL,HAV AB TOTAL,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,LITHOLINK CMP14 P,ALBUMIN,Basophils,Basophils [#/volume] in Blood,Basophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,HIV AB 1 HIV 2 EIA W REFL 1 WB,HIV EIA AB SCREEN,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,HIV 1 HIV 2 AB RFLX,HIV 1 WESTERN BLOT RESULT,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.06666666666666667,0.05,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,CBC WITH ABSOLUTE NEUTROPHIL COUNT,NEUTROPHILS,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,COMPREHENSIVE METABOLIC PANEL REFL,UREA NITROGEN BUN,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,DRUG ABUSE SCREEN II,METHAQUALONE,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,PAIN MANAGEMENT 8,CREATININE,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,CMP,BUN BLOOD UREA NITROGEN,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,COMPREHENSIVE METABOLIC PANEL E GFR,ALBUMIN,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,GORBYMI CMP 4AC CORONARY RISK CBC TSH PROFILE,CALCIUM,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,CBC DIFF PLT,MCHC,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,CBC WITH PLT DIFF,RDW,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.1925,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,204081,URINALYSIS CULTURE IF INDICATED,OCCULT BLOOD,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,CHEM SCREEN PANEL HDL,URIC ACID,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,HCV FIBROSURE RESULTS,NECROINFLAMMAT ACT GRADE,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,LIPID PANEL,LDL CALC,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,TRANSFERRIN,TRANSFERRIN,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,COMPREHENSIVE METABOLIC PANEL E GFR,CALCULATED A G RATIO,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,COMP METAB PANEL,EGFR NON AFR AMERICAN,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,DIFFERENTIAL MANUAL,ABSOLUTE LYMPHOCYTES,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,CMP14 HP4 DBILI CBC D PLT R,LYMPHS,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.24666666666666667,0.4,1.0,0.24666666666666667,0.4,1.0,0.0,0.10223598408605306,0.1503314858492919,0.0,0.10223598408605306,0.1503314858492919,1,29868,TESTOSTERONE SERUM,TESTOSTERONE SERUM,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,URINALYSIS REFLEX,GLUCOSE QL,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,IRON TOTAL IRON BIND CAPACITY,TIBC,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,ACCUTYPE R IL28B NY,IL28B GENOTYPE,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,HEPATITIS PANEL DIAGNOSTIC,HEP B CORE TOTAL AB,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,LIPID PANEL,CALC LDL CHOL,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD3 CELLS,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE LYMPHOCYTES,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,MCCARJUH MCCARTHY PROFILE 1,MITOCHONDRIAL M2 AB,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,FIBROMETER VIRUS,GAMMA GLUTAMYL TRANSFERASE FM,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,CBC W DIFF PLATELET,MCH,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,CBC WITH MANUAL DIFFERENTIAL,NEUTROPHILS,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,CMP14 LP 5AC CBC D PLT RPR,WBC,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,AUTOMATED BLD CNT,HEMOGLOBIN,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,COMPLEMENT C3 SERUM,COMPLEMENT C3 SERUM,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,CMP13 LP 2AC CBC D PLT,EGFR IF AFRICN AM,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,ARTHRITIS PROFILE,SEDIMENTATION RATE,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,URINE DRUG SCREEN,OPIATES,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0825,0.10600000000000001,0.0,0.0725,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,URINALYSIS W REFLEX MICRO,UROBILINOGEN,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,IRON TOTAL BINDING CAPACITY,% SATURATION,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,SMOOTH MUSCLE AB RFX TITER,F ACTIN IGG,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN RT PCR LOG COPIES ML,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.165,0.265,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,URINALYSIS REFLEX,GLUCOSE,Appearance,Appearance of Urine,Appearance Ur
0.0,0.03333333333333333,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,CBC W AUTO DIFF,HCT,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,LYMPHOCYTE SUBSET PANEL 4,% CD8 SUPPRESSOR T CELLS,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,HCV RNA QN GRAPH RFX NSA,HEPATITIS C QUANTITATION,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,COMPREHENSIVE METABOLIC PANEL W EGF,AST,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,TESTOSTERONE FREE TOTAL LC MS,TESTOSTERONE TOTAL LC MS,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.25,0.16666666666666666,0.0,0.0,0.0,0.0,0.013668034462936185,0.010384485502120788,0.0,0.0,0.0,0.0,0,7328,MANUAL DIFFERENTIAL,EOSINOPHILS ABSOLUTE,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,ANA SCREEN IFA,ANA SCREEN IFA,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,LEUKEMIA LYMPHOMA EVALUATION,SPECIMEN TYPE,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,CBC WITH PLT DIFF,PROMYELOCYTES,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,NASH FIBROSURE,WEIGHT,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,CREATINE KINASE TOTAL,CREATINE KINASE TOTAL,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,CMP14 3AC CBC D PLT RPR MG,EOS,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,GLU RFX HA1C IF ABN,GLU RFX HA1C IF ABN,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,CBC WITH DIFFERENTIAL,MONOCYTES,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.05142857142857143,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,UA MICROSCOPIC REFLEX CULTURE,KETONES,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.06666666666666667,0.1,0.0,0.0,0.0,0.0,0.0,0.04972639190343808,0.0,0.0,0.0,0.0,0,302398,CBC WITH AUTO DIFF,BASOPHILS ABSOLUTE,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,CBC INCLUDES DIFF PLT,INTERNAL WBC,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.14285714285714285,0.3333333333333333,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,CBC W DIFF PLT,RBC,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,RPR SCREEN W TITER,RPR SCREEN,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.047142857142857146,0.030000000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,COMP METAB PANEL,GLUCOSE FASTING,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,HEPATITIS C VIRAL RNA NS3 GENOTYPE,BOCEPREVIR RESISTANCE,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,HEPATITIS C VIRAL RNA QUAL TMA,HEPATITIS C VIRAL RNA QUAL TMA,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,CMP14 CBC D PLT ESR WES ANA,NEUTROPHILS,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,IRON BINDING CAPACITY,TIBC,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.08,0.05714285714285715,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCV,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,HCV RNA GENOTYPE LIPA R,HCV RNA GENOTYPE LIPA,Erythrocyte distribution width,Erythrocyte distribution width [Entitic volume],RDW RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,DIFFERENTIAL MANUAL,NEUTROPHILS,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,URINALYSIS W MICRO,GLUCOSE,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,CBC WITH PLT DIFF,MYELOCYTES,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,HEP B SURFACE AG W REFLEX,HEP B SURFACE AG W REFLEX,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.2,0.16666666666666666,0.3333333333333333,0.346,0.16666666666666666,0.3333333333333333,0.06846967404361237,0.3219325786555107,1.0,0.04841537082187086,0.45528141890436646,0.7071067811865476,1,15586,GLUCOSE,GLUCOSE FASTING,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,VELPATASVIR RESISTANCE,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,URINALYSIS W REFLEX MICRO,WHITE BLOOD CELLS,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.14285714285714285,0.2,0.0,0.0,0.0,0.0,0.05557781728487099,0.14099568413003705,0.0,0.0,0.0,0,487967,DRUG PANEL 8 SCREEN,OPIATES,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,BASIC METABOLIC PANEL,BUN,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,HEPATITIS C VIRAL RNA QUALITATIVE TMA,HEPATITIS C VIRAL RNA QUALITATIVE TMA,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,HCV FIBROSURE,COMMENT,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.3333333333333333,0.0,0.0,0.0,0.03142857142857143,0.07333333333333333,0.05467597086898157,0.0,0.0,0.0,0.9131129509166843,0.9888882125258499,1,19885,ESR WES CRP,C REACTIVE PROTEIN QUANT,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD8 CELLS,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.365,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.16039782244384237,0.0,1,59022,PROTIME INR F,PT,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,PROTHROMBIN TIME WITH INR,INR,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,AST CBC D PLT,EOS,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1216962121474966,1.0,1,45443,HEMOGLOBINOPATHY INDICES,HEMATOCRIT,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,CBC,HEMOGLOBIN,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,HIV 1 RNA QN RT PCR,HIV 1 RNA QN PCR,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.3333333333333333,0.4,1.0,0.0,0.0,0.0,0.06696411491014109,0.4808823462371743,0.7071067811865476,1,178616,COMPREHENSIVE METABOLIC PANEL,CALCIUM SERUM,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,DRUG ABUSE SCREEN III,COCAINE METABOLITE,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,COMPREHENSIVE METABOLIC PANEL AMA,CHLORIDE,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,LEUKEMIA LYMPHOMA EVALUATION,SPECIMEN TYPE,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,AUTOMATED BLD CNT,HEMOGLOBIN,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,GLU RFX HA1C IF ABN,GLU RFX HA1C IF ABN,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.03666666666666667,0.055,0.0,0.05555555555555555,0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,BASIC METABOLIC PANEL,BUN,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,CBC WITH PLT DIFF,NUCLEATED RBCS,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.16666666666666666,0.21428571428571427,0.75,0.0,0.14285714285714285,0.5,0.04036164461486136,0.0,0.0,0.0,0.06317690320497038,0.17807552140691663,1,204164,NGI HCV SUPERQUANT,HEPATITIS C QUANTITATION,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,ALBUMIN CREATININE RATIO URINE RANDOM,CALC ALBUMIN CREAT RND,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,LYMPHOCYTE SUBSET PANEL 2,% CD4 HELPER CELLS,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD3 CELLS,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,HIV 1 RNA QN RT PCR,HIV 1 RNA QN PCR,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,RPR REFLEX PER CDC,RPR,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.03571428571428571,0.125,0.0,0.09714285714285713,0.09,0.0,0.0,0.0,0.0,0.05137906274872117,0.0,0,110114,C4 C3,COMPLEMENT C3 SERUM,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.07142857142857142,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,ASH FIBROSURE,HAPTOGLOBIN,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,CBC WITH DIFFERENTIAL,MONOCYTES,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,ALBUMIN CREATININE RATIO RANDOM URINE,CALC ALBUMIN CREAT RND,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.2225,0.89,0.22333333333333336,0.25,1.0,0.0,0.0,0.0,0.0,0.5773502691896257,1.0,1,21618,DRG TOX CRT REFL SPEC GR,CREATININE,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,CBC W DIFF PLT,BLAST CELLS ABSOLUTE,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,LIPID PROFILE WITH CALCULATIONS NON HDL CHOLESTEROL,RISK RATIO CHOL HDL,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,NASH FIBROSURE,AST SGOT P5P,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,CMP12 LP TP TSH 6AC CBC D PLT,EOS ABSOLUTE,Reference lab test method,Reference lab test method,Ref lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,PROTEIN TOTAL URINE,PROTEIN CR RATIO,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,FIBROACT COMPLETE,WEIGHT LBS,Monocytes,Monocytes [#/volume] in Blood,Monocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,PTT,PTT,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.25,0.16666666666666666,0.0,0.25,0.16666666666666666,1.0,0.05393370274893572,0.0,0.0,0.06605502583691747,0.05720402135206337,0.7071067811865476,1,7047,CBC W AUTO DIFF,BASOPHILS ABSOLUTE,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.07333333333333333,0.07125,0.1425,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,HCV FIBROSURE LABCORP,RESULT,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.134,0.09571428571428572,0.22333333333333336,0.134,0.09571428571428572,0.22333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,HAV AB TOTAL,HAV AB TOTAL,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.3333333333333333,0.14285714285714285,0.5,0.0,0.0,0.0,0.084905879372146,0.0,0.0,1,19208,COMPREHENSIVE METABOLIC PANEL W EGF,AST,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.11,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,UA MICROSCOPIC REFLEX CULTURE,SPECIFIC GRAVITY,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,URINALYSIS W REFLEX MICRO,RED BLOOD CELLS,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.025,0.0,0.0,0.025,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,CARDIO CRP R,CARDIO CRP R,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.14285714285714285,0.3409090909090909,0.5357142857142857,0.14285714285714285,0.3409090909090909,0.5357142857142857,0.025344837556394273,0.07162596183040726,0.10208830230491539,0.025344837556394273,0.07162596183040726,0.10208830230491539,1,831008,HEP B CORE TOTAL AB,HEP B CORE TOTAL AB,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,ACTIVATED PTT,ACTIVATED PTT PATIENT,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,LIVER FIBROSIS FIBROMETER,FIBROMETER PROTHROMBIN INDEX,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,MORPHOLOGICAL REVIEW,PATH REVIEW PERIPHERAL SMEAR,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,TESTOSTERONE SERUM,TESTOSTERONE SERUM,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.265,0.0,0.5,0.5,1.0,0.0,0.0,0.0,0.14187034543632637,0.7071067811865476,1.0,1,57679,UA W MICRO HOLD SPEC 24 HR,APPEARANCE,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,CMP14 LP 3AC,LDH,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,URINALYSIS WITH MICROSCOPIC,PH,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,HEPATIC FUNCTION PANEL,ALT,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.025,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,CBC WITH PLT DIFF,WBC MORPHOLOGY,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.5,0.4,1.0,0.0,0.0,0.0,0.5980553435796393,0.7141611687807009,0.042181184586030485,1,81224,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD3 CELLS,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,LIVER FIBROTEST ACTITEST,FIBROSIS STAGE,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,ASH FIBROSURE,HEIGHT,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.0,0.11857142857142858,0.20750000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,LYMPHOCYTE SUBSET PANEL 4,% CD4 HELPER CELLS,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.02428571428571429,0.034,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,LIPID PROFILE,NON HDL CHOLESTEROL,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,X HEPATITIS COMPLEX PROFILE,ANTI HBC TOTAL,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,PROTEIN ELECTROPHORESIS SR W RFX,INTERPRETATION,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.16666666666666666,0.25,0.0,0.3333333333333333,0.5,0.0,0.06222027266620478,0.0627076954386303,0.0,0.08799275345909874,0.08868207335447242,1,161281,ACUTE HEPATITIS PANEL,HEPATITIS C ANTIBODY,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,CBC W AUTO DIFF,ABS BASOPHILS,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,HCV QUANT GT1A NS5A PROFILE,HCV NS5A RESISTANCE ASSAY PDF,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.24333333333333332,0.335,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,823781,HEPATITIS C GENO TYPE 1 NS5A RESIST,OMBITASVIR RESISTANCE,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,LYMPHOCYTE SUBSET PANEL 4,% CD4 HELPER CELLS,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.2,0.4,0.3333333333333333,0.2,0.4,0.3333333333333333,0.007806566737586396,0.37372692636381444,0.46844093359181893,0.007806566737586396,0.37372692636381444,0.46844093359181893,1,178566,HEMOGLOBIN A1C,HEMOGLOBIN A1C,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,PTT,PTT,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,CMP14 HP4 DBILI CBC D PLT R,LYMPHS,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.5,0.5,1.0,0.0,0.0,0.0,0.12460215794786256,0.16901735079974012,1.0,1,330373,COMPREHENSIVE METABOLIC PANEL WITH GFR,ANION GAP,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,ACUTE HEPATITIS PANEL,HEPATITIS B SURFACE ANTIGEN,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.03333333333333333,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,CBC W AUTO DIFF ABS WBC MPV PLT,LYMPHOCYTES,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,CBC W DIFF PLT,BLAST CELLS ABSOLUTE,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,ACCUTYPE R IL28B,IL28B GENOTYPE,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,HDL CHOL DIRECT,HDL AS % CHOLESTEROL,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,THYROXINE T4 FREE,T 4 FREE,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.11,0.132,0.33,0.11,0.066,0.165,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,MITOCHONDRIAL AB W RFX TITER,MITOCHONDRIAL AB SCN,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,LYMPHOCYTE SUBSET PANEL 2,% CD4 HELPER CELLS,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,ANA SCR IFA RFL TITR PATT,ANA SCREEN IFA,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,CBC,MCH,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,HIV ANTIGEN ANTIBODY FOURTH GENERATION W RFL,HIV AG AB 4TH GEN,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,HEPATITIS PANEL AMA,HEPATITIS C ANTIBODY,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,URINALYSIS C,BILIRUBIN,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,CBC W AUTO DIFF,HGB,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,CBC INCLUDES DIFF PLT,BLASTS,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.3333333333333333,0.16666666666666666,1.0,0.3333333333333333,0.31666666666666665,1.0,0.03495206666531736,0.12167907743603168,0.0,0.06538932921065,0.45528141890436646,0.7071067811865476,1,30262,THYROID II PROFILE T3U T4 T7 TSH,T4 THYROXINE,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,MANUAL DIFFERENTIAL,TOTAL NEUTROPHILS %,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.2,0.16666666666666666,0.0,0.0,0.0,0.0,0.04691901659578246,0.03738691252681969,0.0,0.0,0.0,0.0,0,7492,DIFFERENTIAL MANUAL,ABSOLUTE BAND NEUTROPHILS,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,TRANSFERRIN CARBOHYDRATE DEFICIENT ALCOHOL USE,TRANSFERRIN,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.2,0.16666666666666666,0.0,0.0,0.0,0.0,0.03401801828400064,0.0,0.0,0.0,0.0,0.0,0,7369,CBC WITH AUTO DIFF,MCV,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,FE ANA TIBC FER PTT PT A1A,MITOCHONDRIAL M2 ANTIBODY,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,DRUG ABUSE SCREEN II,BENZODIAZEPINES,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,HCV RNA QN GRAPH RFX NSA,HEPATITIS C QUANTITATION,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,COMPREHENSIVE METABOLIC PANEL E GFR,CALCULATED A G RATIO,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.0,0.0,0.11000000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,HEMOGLOBIN A1C,MEAN GLUCOSE EST,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,LIPID PANEL WITH LDL HDL RATIO,LDL HDL RATIO,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,SED RATE MODIFIED WESTERGREN MANUAL,SED RATE MODIFIED WESTERGREN MANUAL,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,PROTEIN ELECTROPHORESIS,ALPHA 1 GLOBULINS,Bacteria identified,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult
0.0,0.0,0.0,0.12166666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,COMPREHENSIVE METABOLIC PANEL,CALCIUM,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,CMP,BUN BLOOD UREA NITROGEN,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0825,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,URINALYSIS ROUTINE W RFX,BILIRUBIN,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,BAND NEUTROPHILS,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,CBC WITH PLT DIFF,BANDS,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,CBCI COMPLETE BLOOD COUNT W DIFF,LYMPHOCYTES,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,PT PROTIME,INR,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.11399999999999999,0.285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,DRUG ABUSE PANEL 10 WITH OXYCODONE,PHENCYCLIDINE,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,LYMPHOCYTE SUBSET PANEL 2,HELPER SUPPRESSOR RATIO,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,ASH FIBROSURE,HEIGHT,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.0,0.0,0.27,0.25,0.4,0.0,0.0,0.0,0.03937969291800214,0.06185427189076809,0.13271332481154674,1,7641,CBC INCLUDES DIFF PLT,BAND NEUTROPHILS,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,URINALYSIS ROUTINE W RFX,BILIRUBIN,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,HEPATIC FUNCTION PANEL,ALBUMIN,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,LIVER FIBRO HEPSCORE R,AGE,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,CBC WITH PLT DIFF,LYMPHOCYTES ABSOLUTE,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,CREATININE,EGFR IF NONAFRICN AM,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,IFE PE SERUM,ALPHA 1 GLOBULIN,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,ANA AMA ASMA LKM AB,MITOCHONDRIAL M2 ANTIBODY,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,URINALYSIS WITH MICROSCOPIC,UROBILINOGEN,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.0834655896020069,0.34003516797720323,1.0,1,20750,COMPREHENSIVE METABOLIC PANEL E GFR,CHLORIDE,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.2,0.375,0.75,0.2,0.375,0.75,0.04869923401997367,0.13094482098745974,0.17736414670894485,0.04869923401997367,0.13094482098745974,0.17736414670894485,1,139550,HEPATITIS C AB,HEPATITIS C AB,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,ASH FIBROSURE,WEIGHT,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.07142857142857142,0.1,0.088,0.10428571428571429,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,CBC WITH PLT DIFF,NO CELLS DIFF,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,HEPATITIS C RNA PCR QUANT,HCV PCR QUANT,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.04857142857142858,0.0,0.0,0.04857142857142858,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,CMP12 LP TP TSH 6AC CBC D PLT,BILIRUBIN TOTAL,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.023809523809523808,0.05,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,CBC WITH PLT MAN DIFF,BANDS ABSOLUTE,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,HCV RNA QN REAL TIME PCR W RFX QL T,HCV RNA PCR QN,Sex,Sex,Sex
0.43333333333333335,0.2857142857142857,1.0,0.43333333333333335,0.2857142857142857,1.0,0.0,0.43337723529131744,0.10031748330730439,0.0,0.43337723529131744,0.10031748330730439,1,30510,T3 FREE,T3 FREE,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,CBC WITH AUTO DIFF,NRBC,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,IRON BINDING CAPACITY % SATURATION,IRON SERUM,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,PE INTERP RFX IFE S,BETA GLOBULIN,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,MICROALBUMIN RANDOM,MICROALBUMIN CR RATIO,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,T B LYMPHOCYTE NK NYSDOH,PLATELETS,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,LIVER FIBRO HEPSCORE R,AGE,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,CBC INC DIFF PLT,MONOCYTES,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,MPV,Bacteria identified,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,ALBUMIN CREATININE RATIO RANDOM URINE,CALC ALBUMIN CREAT RND,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,PROTEIN ELECTRO S,BETA GLOBULIN,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,CBC WITH PLT DIFF,MYELOCYTES,Globulin,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,LIVER FIBROSIS,NECROINFLAM ACT GRADE,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,DRG TOX CRT REFL SPEC GR,CREATININE,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,CMP13 LP TP TSH 2AC CBC D P,HDL CHOLESTEROL,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,NMR LIPOPROFILE,LDL P,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,COMP METABOLIC PROFILE FASTING CMP,BUN CREATININE RATIO CALC,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,CBC WITH PLT DIFF,RDW,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,CBC WITH AUTO DIFF,WBC,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Prothrombin.activity actual/Normal,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,PROSTATE SPECIFIC ANTIGEN PSA,PSA,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,HCV RNA PCR QN RFX NSA,HCV GENOSURE R NSA PDF,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.06200000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,HCV RNA NS5A GENOTYPE,VELPATASVIR RESISTANCE,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.2866666666666667,0.2285714285714286,0.5333333333333333,0.5733333333333334,0.14285714285714285,0.0,0.0,0.019502101456765675,0.019832981037157915,0.0,0.0986582980974181,0.06688811321734245,1,110544,LIPID PROFILE WITH CALC NON HDL CHOLESTEROL,RISK RATIO LDL HDL,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,UA M W RFLX CULTURE COMP,WBC,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,PROTEIN ELECTRO S,ALPHA 2 GLOBULIN,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,COMP METABOLIC PANEL,ALKALINE PHOSPHATASE,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,CBC INC DIFF PLT,MONOCYTES,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,ESR WES CRP,C REACTIVE PROTEIN QUANT,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,HEPATIC FUNCTION PROFILE,BILIRUBIN INDIRECT,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,IMMUNOGLOBULINS,IMMUNOGLOBULIN A,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,PROTEIN ELECTRO SERUM,ALPHA 2 GLOBULIN,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.2,0.16666666666666666,0.3333333333333333,0.2,0.16666666666666666,0.3333333333333333,0.0337496424497612,0.04347805014776318,0.043852684749311255,0.0337496424497612,0.04347805014776318,0.043852684749311255,0,497818,HBC AB TOTAL,HBC AB TOTAL,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,HCV GT3 NS5A DRUG RESIST ASSAY,HCV NS5A DRUG RESIST ASSAY,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.16666666666666666,0.0,0.0,0.16666666666666666,0.0,0.0,0.042736666130574696,0.0,0.0,0.042736666130574696,0.0,0,128512,COMPLEMENT C4 SERUM,COMPLEMENT C4 SERUM,Protein pattern,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,URINALYSIS WITH MICROSCOPIC,APPEARANCE,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,DRUG ABUSE SCREEN II,BENZODIAZEPINES,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.25,0.16699999999999998,0.5,0.0,0.0,0.0,0.050366252651508736,0.0,0.0,1,17434,NASH FIBROSURE,ALT SGPT P5P,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,CMP13 LP 2AC CBC D PLT,ALT SGPT,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,HEMOGLOBIN A1C WITH EAG,ESTIMATED AVERAGE GLUCOSE,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,CBC INC DIFF PLT,PLATELET COUNT,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.46,0.46,0.46,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,PAIN MANAGEMENT 8,CREATININE,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,CMP12 LP TP TSH 6AC CBC D PLT,LDH,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,LIVER FIBROSIS PNL HEPASCORE TM,METAVIR SCORE,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.0,0.0,0.0,0.0,0.08287539106540942,0.7071067811865476,0.0,1,285403,CBC W AUTO DIFF ABS WBC MPV PLT,MCHC,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.04357905440832277,0.0,0,64634,SMN1 COPY NUMBER ANALYSIS,SPECIMEN TYPE,Bacteria identified,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,LIVER FIBROSIS,NECROINFLAM ACT SCORE,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,CMP WITH EGFR,EGFR NON AFRICAN AM,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,DRUG ABUSE SCREEN II,OPIATES,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.021294371112735133,0.0,0.0,0.0,0.0,0,7492,COMPLETE BLOOD COUNT,MEAN PLATELET VOLUME,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,LIVER FIBROSIS FIBROTEST ACTITEST,BILIRUBIN,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,THYROID II PROFILE T3U T4 T7 TSH,T4 THYROXINE,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,APTT,PARTIAL THROMBOPLASTIN,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.015714285714285715,0.055,0.0,0.015714285714285715,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,CREATINE KINASE TOTAL,CREATINE KINASE TOTAL,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,HEPATITIS C RNA PCR QUANTITATIVE,HCV VIRAL LOG,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE LYMPHOCYTES,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,HCV RNA NS5A GENOTYPE,DACLATASVIR RESISTANCE,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,FIBROSIS SCORE,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.07857142857142858,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,LIVER FIBROSIS,NECROINFLAM ACT GRADE,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.25,0.16666666666666666,0.0,0.0,0.0,0.0,0.0672790962344263,0.051758104169687846,0.0,0.0,0.0,0.0,0,7120,DIFFERENTIAL MANUAL,NEUTROPHILS ABSOLUTE,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,CMP14 LP 3AC CBC D PLT,LYMPHS,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,HCV RNA QN GRAPH RFX NSA,HEPATITIS C QUANTITATION,Basophils,Basophils [#/volume] in Blood,Basophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,ANION GAP,ANION GAP,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,MANUAL DIFFERENTIAL,LYMPHOCYTES ABSOLUTE,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,THYROID PROFILE T4 T3UP FTI TSH,T 4,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,MICROALBUMIN CONC,ALB CREAT RATIO,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.05,0.0,0.0,0.146,0.08666666666666667,0.0,0.0,0.0,0.0,0.0,0.2276407094521833,0.0,0,15586,LIPID PROFILE,FASTING NON FASTING,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,THYROXINE T4 FREE,T 4 FREE,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,CBC,MO%,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,CREATININE,LIPEMIA,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,FOLATE SERUM,FOLATE SERUM,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,HIV AG AB 4TH GEN RFL,HIV AG AB 4TH GEN,Protein pattern,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp
0.0,0.011764705882352941,0.025,0.14333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,771477,COMP METAB PANEL,EGFR NON AFR AMERICAN,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.11399999999999999,0.08142857142857142,0.11399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,DRUG ABUSE SCREEN W ETOH NO GCMS,AMPHETAMINES,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.5675,0.23857142857142857,0.0,0.6675,0.3242857142857143,0.0,0.018299290118234723,0.07059347867858168,0.0,0.061241138223508074,0.059062741744354885,0.0,1,19901,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D3,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,HAV AB TOTAL,HAV AB TOTAL,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,AFP TUMOR MARKER SIEMENS CLIA,AFP TUMOR MARKER SIEMENS CLIA,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,CMP14 LP 3AC,LDH,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,CMP14 CBC D PLT ESR WES ANA,NEUTROPHILS,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.11,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,UA M W RFLX CULTURE COMP,WBC,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,FIBROACT COMPLETE,WEIGHT LBS,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,CBC DIFF PLT,LYMPHOCYTES #,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,ANTI SMOOTH MUSCLE MITOCHOND,MITOCHONDRIAL M2 ANTIBODY,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,BMP WITH ESTIMATED GFR CALCULATED,CARBON DIOXIDE,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,COMP METABOLIC PANEL W GFR,SODIUM,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.04,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,NGI HCV ULTRAQUAL RFX SUPER QT,COPIES ML,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0953620011163746,0.0,0,28746,CMP12 2AC,ALBUMIN SERUM,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,HEPATITIS B CORE AB,HEPATITIS B CORE AB,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,CBC DIFF PLT,MCHC,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,CMP14 2AC MG,EGFR IF NONAFRICN AM,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,TSH,TSH,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,HCV RNA GENOTPE 1 NS5A DRUG RE,OMBITASVIR RESISTANCE,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.1425,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.01110152662244912,0.0,0.0,0.0,0.0,0,57976,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN CREATININE RATIO,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,HEPATITIS C VIRAL RNA NS3 DRUG RESI,BOCEPREVIR RESISTANCE,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,RHEUMATOID FACTOR QUANT,RHEUMATOID FACTOR QUANT,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,URINALYSIS,BACTERIA,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.034111472287449485,0.0,0,24984,FE ANA TIBC FER A1A AMA ASM,ALPHA 1 ANTITRYPSIN SERUM,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,DRUG ABUSE SCREEN II,BENZODIAZEPINES,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,ASH FIBROSURE,COMMENT,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,TSH FT4,FREE T4,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,IMMUNOGLOBULINS,IMMUNOGLOBULIN G,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,HEPATITIS A TOTAL AB REFLEX IGM,HEPATITIS A TOTAL AB,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.19999999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,CMP WITH ESTIMATED GFR CALCULATED,FASTING NON FASTING,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.17500000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,LIVER FIBROSIS FIBROTEST ACTITEST,NECROINFLAMMAT ACT GRADE,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.025,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,CBC WITH DIFFERENTIAL,BASOPHILS,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,PROTEIN ELECTRO S,PLEASE NOTE,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,PTT,PTT,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CMP14 HP5 LP 6AC CBC D PLT,MAGNESIUM SERUM,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,SPECIAL PROFILE 3619,LEUKOCYTE ESTERASE,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,HB S AG W REFLEX CONF,HB S AG NEUTRALIZATION,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,COMP METABOLIC PANEL,CREATININE,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,UA MICROSCOPIC REFLEX CULTURE,OCCULT BLOOD,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.19,0.15833333333333333,0.31666666666666665,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME NR,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,PROTEIN ELECTRO S,GAMMA GLOBULIN,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,COMPREHENSIVE METABOLIC PANEL E GFR,CALCULATED A G RATIO,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,FIBROACT,NECROINFL SCORE,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,HCV FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.25,0.20000000000000004,0.0,0.25,0.16666666666666666,1.0,0.03960996495528413,0.0,0.0,0.06860647178857471,0.0793317966039091,1.0,1,251454,URINALYSIS W REFLEX MICRO,BACTERIA,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,CBC WITH PLT DIFF,PLATELET MORPHOLOGY,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,URIC ACID,URIC ACID,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,BMP,C02 BICARBONATE,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,MITOCHONDRIAL ANTIBODY W REFL TITER,MITOCHONDRIAL AB SCREEN,Globulin,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,C REACTIVE PROTEIN CARDIAC,C REACTIVE PROTEIN CARDIAC,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,A FETOPROTEIN TUMOR MARKER,A FETOPROTEIN TUMOR MARKER,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,COMPREHENSIVE METABOLIC PANEL E GFR,SODIUM,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,NASH FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.06,0.045,0.072,0.125,0.125,0.0,0.0,0.0,0.0,0.0,0.05515090694457048,0.0,0,134999,COMPREHENSIVE METABOLIC PANEL,CALCIUM SERUM,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,BMP,C02 BICARBONATE,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,COMPLETE BLOOD COUNT,RED CELL DIST WIDTH,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,URINALYSIS RX ALB CREA,KETONES,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,URINALYSIS WITH MICROSCOPIC,APPEARANCE,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,HEPATITIS B SURFACE AB IMMUN,HEPATITIS B SURFACE AB IMMUNITY QN,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,COMPREHENSIVE METABOLIC PANEL,CALCIUM SERUM,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.25,0.3,1.0,0.0,0.022,0.07333333333333333,0.06380059491394674,0.0,0.0,0.0,0.35622065033847605,0.9888882125258499,1,305227,CRP,C REACTIVE PROTEIN ULTRA,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.2,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,LD,LD,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.19999999999999998,0.16666666666666666,1.0,0.3333333333333333,0.16666666666666666,1.0,0.0,0.0,0.0,0.084905879372146,0.3219325786555107,1.0,1,17988,AMY LIPASE,AMYLASE,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,CBC WITH DIFFERENTIAL PLATELETS,POLYS,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.025,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,CBC INCLUDES DIFF PLT,ABSOLUTE BAND NEUTROPHILS,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,PROTEIN ELEC INTERP SERUM,P E INTERPRETATION S,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,CBC INC DIFF PLT,BASOPHILS,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,CMP WITH EGFR,ALKALINE PHOSPHATASE,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.16,0.0,0.3225,0.2,1.0,0.0,0.05043482321394899,0.0,0.08103461702415493,0.12353958214165095,1.0,1,192708,DRUG ABUSE SCREEN W ETOH NO GCMS,BARBITURATES,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,LIVER FIBROSIS,NECROINFLAM ACT GRADE,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,COMPREHENSIVE METABOLIC PANEL W EGF,AST,Hemoglobin,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,TRIGLYCERIDES REFL,TRIGLYCERIDES,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE CD4,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,COMP METAB PANEL,ALT,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,CBC WITH PLT DIFF,BLASTS,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.31,0.10615384615384614,0.45999999999999996,0.31,0.22,0.9533333333333333,0.028275241940297513,0.08470305693504976,0.6324555320336758,0.03161268152937924,0.09470089660440306,0.7071067811865476,1,204479,HIV 1 RNA QN RT PCR,HIV 1 RNA QN PCR,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,LIVER FIBROTEST ACTITEST,HAPTOGLOBIN,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,CUSTOM HEPATITIS PANEL,HEPATITIS C ANTIBODY,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,DRUG ABUSE SCREEN 11 W ETOH NO CONF,OXYCODONE,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,LIVER FIBROSIS,NECROINFLAM ACT SCORE,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,COMPREHENSIVE METABOLIC PANEL WITH GFR,CREATININE,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,HEPATITIS PANEL ACUTE,HEPATITIS A IGM,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,NEG HIV 4TH GEN,HIV 1 AB WESTERN BLOT,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.66,0.514,0.7849999999999999,0.66,0.548,0.37,0.0,0.03869667864135018,0.019733925021995558,0.0,0.04216763877231289,0.014335993873441866,1,93187,MICROALBUMIN RANDOM URINE W CREATININE,MICROALBUMIN CREATININE RATIO RANDOM URINE,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,GENERAL HEALTH PANEL,CALC GLOBULIN,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE CD4,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,COMP METAB PANEL,EGFR NON AFR AMERICAN,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,IRON TIBC,TRANSFERRIN SAT %,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,CBC WITH ABSOLUTE NEUTROPHIL COUNT,PLATELET COUNT,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,DRUG ABUSE SCREEN CLINICAL 9,COCAINE,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.16666666666666666,0.4,0.6666666666666666,0.16666666666666666,0.4,0.6666666666666666,0.008951816126908763,0.044469508326277385,0.8590550279997562,0.008951816126908763,0.044469508326277385,0.8590550279997562,0,241133,HEPATITIS B CORE AB,HEPATITIS B CORE AB,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.1325,0.0,0.0,0.1325,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,MITOCHONDRIAL AB W RFX TITER,MITOCHONDRIAL AB SCN,Neutrophils,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,PSA TOTAL % FREE,PSA FREE,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,BMP WITH ESTIMATED GFR CALCULATED,CARBON DIOXIDE,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,CBC PLT DIFF,POLYS,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,IRON PANEL,IRON,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,BUN CREATININE,EGFR AFRICAN AMERICAN,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,CBC WITH MANUAL DIFFERENTIAL,EOSINOPHILS,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.04,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,COMP METABOLIC PANEL,SODIUM,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,URINALYSIS W REFLEX MICRO,GLUCOSE,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.3333333333333333,0.2,0.5,0.0,0.0,0.0,0.07306851338365716,0.0772290548600788,0.10486728028628622,1,772020,ASH FIBROSURE,COMMENT,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.14285714285714285,0.3333333333333333,0.3333333333333333,0.14285714285714285,0.3333333333333333,0.0,0.043196238761996186,0.044151771767438786,0.0834655896020069,0.0,0.0,1,544346,LIPOPROTEIN ANALYSIS NMR,LDL P,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,DRUG ABUSE SCREEN W ETOH NO GCMS,BARBITURATES,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,HEPASCORE R,AGE,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,AMY LIPASE,AMYLASE,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,ASH FIBROSURE,HAPTOGLOBIN,Race,Race,Race
0.2,0.16666666666666666,0.0,0.0,0.0,0.0,0.009814692540447978,0.007699380476897,0.0,0.0,0.0,0.0,0,7146,MANUAL DIFFERENTIAL,SEGMENTED NEUTROPHILS %,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,ALPHA 1 ANTITRYPSIN QN,ALPHA 1 ANTITRYPSIN QN,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.3333333333333333,0.42857142857142855,1.0,0.3333333333333333,0.0,0.0,0.050078247894864814,0.0,0.0,0.07082133735279972,0.0,0.0,1,28571,PSA TOTAL REFLEX FREE,PSA TOTAL,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,CMP14 CBC D PLT ESR WES ANA,LYMPHS ABSOLUTE,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,HEMATOPATH CONSULTATION SMEAR,WBC,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,UA W MICRO HOLD SPEC 24 HR,APPEARANCE,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,COMPREHENSIVE METABOLIC PANEL WITH GFR,CREATININE,Ceruloplasmin,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,COMPREHENSIVE METABOLIC PANEL,CARBON DIOXIDE,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,LYMPHOCYTE SUBSET PANEL 2,COMMENT S,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,CMP12 LP 6AC,CHOLESTEROL TOTAL,Globulin,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,UROGRAM,KETONES,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,ESR WES CRP,C REACTIVE PROTEIN QUANT,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.04273763542324893,0.0,0.0,0.0,0.0,0,7864,COMPLETE BLOOD COUNT,RED CELL DIST WIDTH,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,CBC INCLUDES DIFF PLT,ABSOLUTE BLASTS,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.066,0.06285714285714286,0.0,0.176,0.14285714285714285,1.0,0.0,0.0,0.0,0.0,0.07582142074137055,1.0,1,505511,URINALYSIS C,BILIRUBIN,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,RPR SCREEN W TITER,RPR SCREEN,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,CBC,HCT,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,HEP C RNA GENOT 3 NS5A,VELPATASVIR RESISTANCE,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,LIVER FIBROSIS FIBROTEST,FIBROSIS STAGE,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,MANUAL DIFFERENTIAL,BLASTS %,Color,Color of Urine,Color Ur
0.0,0.11142857142857143,0.26,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,PROTEIN ELECTROPHORESIS SR W RFX,INTERPRETATION,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.18999999999999997,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,30841,URIC A ESR WES ANA RA QN CC,URIC ACID,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,URINALYSIS CULTURE IF INDICATED,COLOR,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,OBSTETRIC PANEL,RPR RESULT,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,LIPID PNL W REFL TRIG>400,CHOLESTEROL HDL RATIO,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,HIV AG AB 4TH GEN RFL,HIV AG AB 4TH GEN,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,1.0,0.0,0.0,0.0,0.009230477088992273,0.09176448258921266,0.17288722199339546,1,30940,BASIC METABOLIC PANEL,UREA NITROGEN BLOOD BUN,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,TSH FT4,TSH,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,CBC W DIFF PLATELET,MCH,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,LIPID PANEL AMA,CHOLESTEROL HDL RATIO,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,HEP B SURFACE AG W REFLEX,HEP B SURFACE AG W REFLEX,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,TSH ULTRASENSITIVE,TSH ULTRASENSITIVE,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,CPK,CPK,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,CBC COMPLETE BLOOD COUNT W O DIFF,MCHC,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,METHADONE,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,PROTEIN ELECTRO S,BETA GLOBULIN,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,UA MICROSCOPIC REFLEX CULTURE,SPECIFIC GRAVITY,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,LIPID PNL W REFL TRIG>400,CHOLESTEROL HDL RATIO,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,TESTOSTERONE,TESTOSTERONE,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,ALT,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,BILIRUBIN DIRECT,DIRECT BILIRUBIN,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,ACUTE HEPATITIS PANEL,HEPATITIS A AB IGM,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,IMMUNOFIXATION SERUM,IGG SERUM NR,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,VITAMIN D 25 OH TOTAL,VITAMIN D 25 OH TOTAL,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0.0,0.0,0.0,0,22764,IFE PE SERUM,ALPHA 1 GLOBULIN,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,CMP14 LP TP TSH 4AC CBC D P,HEMATOCRIT,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.31,0.25,0.0,0.3333333333333333,0.25,1.0,0.0,0.0840117798597445,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,728600,HEPATITIS C VIRAL RNA NS3 GENOTYPE,TELAPREVIR RESISTANCE,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,RPR SCREEN W TITER,RPR SCREEN,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.25,0.16666666666666666,0.0,0.0,0.0,0.0,0.047471586974075164,0.0,0.0,0.0,0.0,0.0,0,7773,CBC WITH AUTO DIFF,NRBC,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,CBC WITH PLT DIFF,RBC MORPHOLOGY,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,CBC WITH AUTO DIFF,HEMATOCRIT,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.2375,0.15833333333333333,0.95,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,LYMPHOCYTE SUBSET PANEL 2,CD4 ABSOLUTE,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,DRUG ABUSE SCREEN III,METHADONE,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,DRGABU2,METHAQUALONE,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,CEA,CEA SIEMENS IMMULITE 2000,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,MAGNESIUM,MAGNESIUM,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,HEPATIC FUNCTION PANEL 6,ALT SGPT,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.125,0.0,0.316,0.125,1.0,0.0,0.06192203894113468,0.0,0.0,0.624939177332759,1.0,1,28654,IFE PE SERUM,ALPHA 1 GLOBULIN,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.047142857142857146,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,CBC H H RBC INDICES WBC PLT,PLATELET COUNT AUTO,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.0,0.037222222222222226,0.08375,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,LIPID PROFILE WITH CALCULATIONS NON HDL CHOLESTEROL,RISK RATIO CHOL HDL,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.04125,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,AUTOIMMUNE HEPATITIS DIAG PNL,MITOCHONDRIAL AB SCREEN,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,HP5,HEP C VIRUS AB,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.017,0.02428571428571429,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,LIPID PROFILE,CHOLESTEROL,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,URINE PROTEIN TOTAL RANDOM W O CREATININE,PROTEIN TOTAL RANDOM UR,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,CBCI COMPLETE BLOOD COUNT W DIFF,ABS NEUTROPHILS,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.044,0.10285714285714286,0.24,0.044,0.03142857142857143,0.07333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE EOSINOPHILS,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.1503314858492919,0,19687,CMP WITH ESTIMATED GFR CALCULATED,ALBUMIN,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.33399999999999996,0.2857142857142857,1.0,0.0,0.0,0.0,0.04215892569416535,0.1907240022327492,1.0,1,28746,PROTEIN ELECTRO S,GAMMA GLOBULIN,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.04,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,COMPREHENSIVE METABOLIC PANEL,GLUCOSE,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,PTT,PTT,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.009333333333333334,0.035,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,HEMATOPATH CONSULTATION SMEAR,WBC,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,ANA TITER PATTERN,ANTI NUCLEAR AB TITER,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,LIVER FIBROTEST ACTITEST,FIBROSIS STAGE,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,NEG HIV 4TH GEN,HIV 1 AB WESTERN BLOT,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,LYMPHOCYTE SUBSET PANEL 2,% CD3 MATURE T CELL,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.25,0.0,0.0,0.45,0.0,0.0,0.0473621793366501,0.0,0.0,0.041016850484133394,0.0,0.0,1,473835,ANA SCREEN QUAL,ANA ANTIBODY SCREEN EIA,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,HEPATITIS B SURFACE AB IMMUN,HEPATITIS B SURFACE AB IMMUNITY QN,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.22,0.0,0.0,0.21000000000000002,0.2,0.5,0.0,0.0,0.0,0.0,0.38075107277079945,1.0,1,58115,UROGRAM,SPECIFIC GRAVITY,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,CMP12 LP TP TSH 6AC CBC D PLT,HEMOGLOBIN,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,RPR,RPR QUANT,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,FE CBC D PLT TIBC FER B12 F,FERRITIN SERUM,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,BMP8 EGFR,POTASSIUM,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,URINALYSIS W REFLEX MICRO,RED BLOOD CELLS,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.13333333333333333,0.06666666666666667,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,CBC W AUTO DIFF,ABS NEUTROPHILS,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.25,0.1111111111111111,0.2,0.0,0.1111111111111111,0.0,0.04654668454414035,0.06741484628176253,0.050413051417317334,0.0,0.05504399149282735,0.0,0,339358,IGG SUBCLASSES,IMMUNOGLOBULIN G QN SERUM,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,HEPATIC FUNCTION PANEL 6,ALT SGPT,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,LDL CHOLESTEROL DIRECT,LDL CHOL DIRECT,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.29333333333333333,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.917303309798122,0.1569574215481997,1,19752,CMP12 LP TP TSH 6AC CBC D PLT,BILIRUBIN TOTAL,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,COMPLETE BLOOD COUNT,MEAN PLATELET VOLUME,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,FSRC NEW PATIENT PANEL,D BILIRUBIN,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,URINALYSIS W REFLEX MICRO,GLUCOSE,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,ANA TITER PATTERN,ANTI NUCLEAR AB TITER,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D2,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,ANTIPHOSPHOLIPID SYNDROME,PT,Appearance,Appearance of Urine,Appearance Ur
0.0,0.125,0.2,0.0,0.25,0.4,0.0,0.057752863325096104,0.06891707028091865,0.0,0.0,0.0,0,109009,HEPATITIS C RNA PCR QUANT,HCV PCR QUANT,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,VAP CHOLESTEROL PROFILE,TRIGLYCERIDES,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.045454545454545456,0.125,0.0,0.030000000000000002,0.0825,0.0,0.052212707018155835,0.0,0.0,0.0,0.0,0,112599,CBC WITH DIFFERENTIAL,NO CELLS DIFF,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,LIPID PANEL WITH LDL HDL RATIO,HDL CHOLESTEROL,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,HEPATITIS BE AG,HB E AG,Alpha-2-Macroglobulin,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,HEPATITIS A DIAGNOSTIC PANEL,HAV AB TOTAL,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.046706887849276346,0.0,0,7310,CBC INCLUDES DIFF PLATELETS,MEAN PLATELET VOLUME,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,CBC WITH PLT DIFF,PLATELET MORPHOLOGY,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,RPR REFLEX PER CDC,RPR,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,RPR REFLEX TP PA,RPR TITER,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,LIPID PANEL WITH LDL HDL RATIO,LDL HDL RATIO,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,ASH FIBROSURE,WEIGHT,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,LP LDLDIR,TRIGLYCERIDES,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.061769791070825475,0.0,0.0,0.0,0.0,0,192708,DRUG ABUSE SCREEN CLINICAL 9,COCAINE,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,CREATINE KINASE TOTAL,LIPEMIA,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,HP5,HEP C VIRUS AB,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,FE TIBC FER B12 HCT FOLRBC,IRON,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,TRANSFERRIN CARBOHYDRATE DEFICIENT ALCOHOL USE,TRANSFERRIN,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,LIPID PNL W REFL TRIG>400,CHOLESTEROL HDL RATIO,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.06200000000000001,0.0,0.0,0.06200000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,HEPATITIS C RNA PCR QUANT,HCV PCR QUANT,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,HCV RNA PCR QN RFX GENO,PLEASE NOTE,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,SEDIMENTATION RATE WESTERGREN,SEDIMENTATION RATE WESTERGREN,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,CBC COMPLETE BLOOD COUNT W O DIFF,MCV,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,LIVER FIBROSIS,NECROINFLAM ACT GRADE,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,THYROID II PROFILE T3U T4 T7 TSH,T4 THYROXINE,Alpha-2-Macroglobulin,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,LIPID PANEL WITH LDL HDL RATIO,LDL HDL RATIO,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,HELPER T LYMPH CD4,HEMATOLOGY COMMENTS,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,SEDIMENTATION RATE WESTERGREN,SEDIMENTATION RATE WESTERGREN,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,ALPHA FETOPROTEIN TUMOR MARKER,ALPHA FETOPROTEIN TUMOR,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,URINALYSIS,BILIRUBIN,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,CULTURE ROUTINE,CULTURE ROUTINE,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,DRUG ABUSE SCREEN W ETOH NO GCMS,BARBITURATES,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,CBC W O DIFF WITH PLATELETS,MCV,Body weight,Body weight Measured,Weight Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD IU ML,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,CMP14 LP 2AC CBC D PLT MG T,WBC,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.172,0.14285714285714285,0.3333333333333333,0.252,0.2857142857142857,0.6666666666666666,0.0,0.037677447047597123,0.07267302452237867,0.0,0.048641374980985086,0.09382047123123194,1,52217,NEG HIV 4TH GEN,NEG HIV 1 ANTIBODY,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.0,0.04833333333333333,0.09666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,UA MICROSCOPIC REFLEX CULTURE,BILIRUBIN,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.03302675712634284,0.0,0.0,0.0,0.0,0,7773,CBC WITH ABSOLUTE NEUTROPHIL COUNT,NEUTROPHILS,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.2,1.0,0.0,0.0,0.0,0.0,0.13909830811578938,1.0,1,303503,CBC,HEMOGLOBIN,Hemoglobin,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,HEPATITIS C RNA PCR QUANT,HCV PCR QUANT,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,TSH RFLX FT4,TSH RFLX FT4,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,MORPHOLOGICAL REVIEW,PATH REVIEW PERIPHERAL SMEAR,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,CBC WITH DIFFERENTIAL,NO CELLS DIFF,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06800077147700478,0.05369526777702294,0.09169555407390673,1,7831,CBC WITH PLT DIFF,PROMYELOCYTES,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,PLATELET ESTIMATION,PLATELET ESTIMATION,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,ASH FIBROSURE,COMMENT,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,HEPATIC FUNCTION PANEL 6,ALT SGPT,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,CMP,ALBUMIN,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B RESIST ASSAY INTERP,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,CMP13 LP 2AC CBC D PLT,ALT SGPT,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,AFP TUMOR MARKER,AFP TUMOR MARKER,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,MANUAL DIFFERENTIAL,EOSINOPHILS ABSOLUTE,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD8 CELLS,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,CBCI COMPLETE BLOOD COUNT W DIFF,LYMPHOCYTES,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,MICROALBUMIN CREATININE RANDOM RATIO,CALC MICROALB CREAT RND,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,UA MICROSCOPIC REFLEX CULTURE,RED BLOOD CELLS,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,CMP14 4AC,EGFR IF AFRICN AM,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,PROTEIN ELECTRO S,ALPHA 2 GLOBULIN,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,HEPASCORE R,AGE,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,CBC DIFF AMBIGUOUS DEFAULT,NEUTROPHILS,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,ANION GAP,ANION GAP,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,HCV RNA PCR QN RFX NSA,HCV GENOSURE R NSA PDF,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,CBCI COMPLETE BLOOD COUNT W DIFF,MCHC,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,LIVER FIBROSIS FIBROTEST ACTITEST,NECROINFLAMMAT ACT GRADE,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,HEPASCORE R,AGE,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,GLUCOSE,GLUCOSE FASTING,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.09499999999999999,0.07125,0.11399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,DRUG ABUSE SCREEN 11 W ETOH NO CONF,OXYCODONE,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,CMP14,EGFR IF AFRICN AM,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,AFP TUMOR MARKER,AFP TUMOR MARKER,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,HEMOGLOBINOPATHY EVAL,MCH,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,DRUG ABUSE SCREEN III,AMPHETAMINES,Basophils,Basophils [#/volume] in Blood,Basophils # Bld
0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0618006251322335,0.0,0.0,1,7880,CBC WITH PLT DIFF,RDW,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,LYMPHOCYTE SUBSET PANEL 2,% CD4 HELPER CELLS,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,PTH INTACT WITHOUT CALCIUM,PTH INTACT,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.04,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,COMP METAB PANEL,GLUCOSE FASTING,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,THYROID PROFILE T4 T3UP FTI TSH,T 4,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,URINALYSIS W MICROSCOPIC,BACTERIA,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,RDW,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,RDW,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,CBC WITH PLT DIFF,MPV,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,TRANSFERRIN CARBOHYDRATE DEFICIENT ALCOHOL USE,TRANSFERRIN,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,CBCI COMPLETE BLOOD COUNT W DIFF,PLT MORPHOLOGY,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,PSA TOTAL % FREE,% FREE PSA,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.14666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D2,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,CBC WITH AUTO DIFF,MCV,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,CMP14 4AC,EGFR IF AFRICN AM,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,URINALYSIS CULTURE IF INDICATED,LEUKOCYTE ESTERASE,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,CBC INCLUDES DIFF PLT,INTERNAL WBC,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.16666666666666666,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,MAYNAC CMP 4AC LIPID CBC T4 TSH PSA PROFILE,MCH,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,SMOOTH MUSCLE AB F ACTIN REFLEX IFA TITER,F ACTIN IGG,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,TRIGLYCERIDES REFL,TRIGLYCERIDES,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,COMPLEMENT C3 SERUM,COMPLEMENT C3 SERUM,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,CBC,HCT,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.155,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,PROTEIN ELECTRO S,M SPIKE,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,FE CBC D PLT TIBC FER B12 F,FERRITIN SERUM,Microalbumin/Creatinine ratio panel,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,BMP WITH ESTIMATED GFR CALCULATED,CARBON DIOXIDE,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,LIPID PANEL AMA,NON HDL CHOLESTEROL,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.2,0.0,0.3333333333333333,0.2,0.0,0.0,0.04035350753708156,0.0,0.08719609088829028,0.21223170681007852,0.0,1,7872,CBC COMPLETE BLOOD COUNT W O DIFF,MCV,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.16666666666666666,0.2727272727272727,0.75,0.0,0.0,0.0,0.00827782317605108,0.0,0.0,0.0,0.0,0.0,0,112599,HCV FIBROSURE RESULTS,FIBROSIS STAGE,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.05,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,CHEM PROFILE 29,ALK PHOS,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD8 CELLS,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.05137906274872117,0.0,0.0,0.0,0.0,0,110114,PROTEIN ELECTRO SERUM,ALPHA 2 GLOBULIN,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,HEMOGLOBIN A1C EAG,HEMOGLOBIN A1C,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,CBC WITH MANUAL DIFFERENTIAL,MCHC,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,AMY LIPASE,AMYLASE,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,TESTOSTERONE FREE LC MS MS,TESTOSTERONE FREE LC MS MS,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,COMPLEMENT COMPONENT C3C,COMPLEMENT COMPONENT C3C,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.0,0.1111111111111111,0.0,0.0,0.08522930735490397,0.0,0.0,0.06958943805011741,0.0,0,139543,IMMUNOFIXATION SERUM,IGG SERUM NR,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,TESTOSTERONE FREE TOTAL LC MS,FREE TESTOSTERONE DIRECT,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.25,0.0,0.0,0.0,0.3333333333333333,0.0,0.038136886948272,0.0,0.0,0.0,0.020902601012917743,0.0,1,7898,CBC RBC H H INDICES WBC PLT,RED BLOOD CELL COUNT,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CARBON DIOXIDE,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,FSRC NEW PATIENT PANEL,D BILIRUBIN,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.09499999999999999,0.0,0.0,0.16666666666666666,0.14285714285714285,0.25,0.0,0.0,0.0,0.01096176659131598,0.012393982834815409,0.025735980206497144,0,427682,HBSAB AG,HEP B SURFACE AB QUAL,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,AFP TUMOR MARKER,AFP TUMOR MARKER,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,DRUG ABUSE SCREEN I,AMPHETAMINES,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.0,0.028571428571428574,0.1,0.0,0.012857142857142857,0.045,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,COMP METABOLIC PANEL,CREATININE,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,CD4 CD8 ENUMERATION,ABSOLUTE LYMPHOCYTES,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,DRUG PANEL 8 SCREEN,OPIATES,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,CBC WITH PLT DIFF,OTHERS,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,UA W MICRO HOLD SPEC 24 HR,APPEARANCE,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,TRANSFERRIN CARBOHYDRATE DEFICIENT ALCOHOL USE,TRANSFERRIN,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,CBC DIFF AMBIGUOUS DEFAULT,NEUTROPHILS,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,MAYNAC CMP 4AC LIPID CBC T4 TSH PSA PROFILE,MCH,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.0,0.05700000000000001,0.25,0.0,0.05700000000000001,0.25,0.0,0.024414913142778216,0.17807552140691663,0.0,0.024414913142778216,0.17807552140691663,0,347047,HEPATITIS A IGM,HEPATITIS A IGM,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.06290250689706056,0.0,0.0,1,58214,CMP14 LP 2AC CBC D PLT MG T,WBC,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.1925,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,URINALYSIS CULTURE IF INDICATED,WHITE BLOOD CELLS,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,URINE PROTEIN TOTAL RANDOM W O CREATININE,PROTEIN TOTAL RANDOM UR,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.2,0.14285714285714285,0.5,0.0,0.0,0.0,0.008459434108369801,0.010551968045691806,0.02333345263278952,0,204537,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD3 CELLS,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,LITHOLINK CMP14 P,ALBUMIN,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.3333333333333333,0.14285714285714285,0.3333333333333333,0.3333333333333333,0.14285714285714285,0.3333333333333333,0.03775254682189788,0.0,0.0,0.04623723810209024,0.0,0.0,1,18341,AFP TUMOR MARKER SIEMENS IMMULITE,AFP TUMOR MARKER,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,QUESTASSURED TM 25OHD D2 D3,VITAMIN D 25 OH TOTAL,Body weight,Body weight Measured,Weight Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,CBC W AUTO DIFF,MCHC,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,LIPID PROFILE,CHOLESTEROL,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,CBC W AUTO DIFF,MCV,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,HEPASCORE R,AGE,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,LYMPHOCYTE SUBSET PANEL 3,% CD3 MATURE T CELLS,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,COMPREHENSIVE METABOLIC PANEL E GFR,CHLORIDE,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,HEMOGLOBINOPATHY EVAL,MCH,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,FIBROACT COMPLETE,HEIGHT INCHES,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,CBCI COMPLETE BLOOD COUNT W DIFF,ABS NEUTROPHILS,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCV,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,COMP METABOLIC PANEL,SODIUM,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,CMP WITH ESTIMATED GFR CALCULATED,ALBUMIN,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,LP LDLDIR,TRIGLYCERIDES,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,CMP,BUN,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.2375,0.2375,0.31666666666666665,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.07870803013413097,0.08752895424186691,0.10240603634159506,1,265116,CBC WITH ABSOLUTE NEUTROPHIL COUNT,NEUTROPHILS,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,CREATININE SERUM,CREATININE SERUM,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,BASIC METABOLIC PANEL,BUN,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,VITAMIN D 25 OH LCMSMS W REFLEX,VITAMIN D 25 OH D3,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,CBC WITH PLT DIFF,PROMYELOCYTES,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,NASH FIBROSURE,WEIGHT,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,CBC W AUTO DIFF WITH PLATELETS,COMMENTS,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,HEPATIC FUNCTION PANEL,ALT,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,CBC W AUTO DIFF,MONOCYTES %,Body weight,Body weight Measured,Weight Measured
0.1925,0.10600000000000001,0.0,0.1825,0.2,1.0,0.0,0.0,0.0,0.0,0.09762443806815091,1.0,1,204545,URINALYSIS COMP W RFL CULTURE,PROTEIN,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,ANTIPHOSPHOLIPID SYNDROME,PT,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.0,0.01,0.0225,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,CBC WITH PLT DIFF,PLATELET MORPHOLOGY,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.31,0.25,0.0,0.3333333333333333,0.25,1.0,0.0,0.032615729323927534,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,823773,HCV RNA NS5A GENOTYPE,LEDIPASVIR RESISTANCE,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,HEPATITIS C RNA PCR QUANTITATIVE,HCV VIRAL LOG,Eosinophils,Eosinophils [#/volume] in Blood,Eosinophil # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,MICROALBUMIN CREATININE RATIO,MICROALBUMIN RAN 24HR,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.12166666666666666,0.133,0.0,0.0,0.0,0.0,0.0,0.04447663702875304,0.0,0.0,0.0,0.0,0,302398,COMPREHENSIVE METABOLIC PANEL WITH GFR,CREATININE,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.3133333333333333,0.25,1.0,0.3333333333333333,0.235,0.94,0.0,0.07752952669246371,0.5,0.11098565713428754,0.0,0.0,1,265157,CBC W O DIFF WITH PLATELETS,PLATELET COUNT,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,CMP WITH EGFR,ALKALINE PHOSPHATASE,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,URINALYSIS WITH MICROSCOPIC,EPITHELIAL CELLS,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,MAYNAC CMP 4AC LIPID CBC T4 TSH PSA PROFILE,MCH,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,ANA TITER PATTERN,ANTI NUCLEAR AB TITER,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,LYMPHOCYTE SUBSET PANEL 5,ANALYZED DATE TIME NR,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,LIPID PANEL,LDL CALC,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,CBC W AUTO DIFF,HCT,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,URINALYSIS W MICROSCOPIC,BACTERIA,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,COMPREHENSIVE METABOLIC PANEL E GFR,CALC GLOBULIN,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,MICROALBUMIN CREATININE RATIO,MICROALBUMIN RAN 24HR,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,CBC WITH DIFFERENTIAL PLATELETS,MCH,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,CREATININE,EGFR IF AFRICN AM,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,CBC,HCT,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,CMP14 HP4 1AC PT AFP,HEP A AB IGM,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,CBC WITH PLT DIFF,NO CELLS DIFF,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,AFP TUMOR MARKER,AFP TUMOR MARKER,Erythrocyte morphology finding,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,COMP METABOLIC PANEL,GLUCOSE NON FASTING,Globulin,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,PROTIME INR F,PT,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.10714285714285714,0.125,0.0,0.023571428571428573,0.0825,0.0,0.051583725460460195,0.0,0.0,0.0,0.0,0,204164,CBC WITH DIFFERENTIAL,NUCLEATED RBCS,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,HIV AG AB 4TH GEN RFL,RACE NR,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.20750000000000002,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,204081,URINALYSIS W REFLEX MICRO,OCCULT BLOOD,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,AUTOIMMUNE HEPATITIS DIAG PNL,MITOCHONDRIAL AB SCREEN,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.14333333333333334,0.2866666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,IRON BINDING CAPACITY % SATURATION,IRON SERUM,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.20714285714285716,0.45,0.0,0.0,0.0,0.0,0.0,0.0,1,67686,CHEM PROFILE 29,ALK PHOS,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.06738029520353905,0.0,0.0,0.0,0.0,0,205674,IFE PE FLC SERUM,ALBUMIN,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,CBC WITH PLT DIFF,BANDS,Eosinophils,Eosinophils [#/volume] in Blood,Eosinophil # Bld
0.3333333333333333,0.25,0.74,0.26666666666666666,0.0,0.0,0.012877229495112386,0.08489650403181737,0.0,0.0,0.0,0.0,0,149575,MICROALBUMIN CREATININE RANDOM RATIO,CALC MICROALB CREAT RND,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,DRUG ABUSE SCREEN II,METHAQUALONE,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.14285714285714285,0.25,0.0,0.14285714285714285,0.25,0.0,0.0612785819463697,0.0627076954386303,0.0,0.07075841156459017,0.07240860968350848,0,223271,ACUTE HEPATITIS PANEL,HEPATITIS B SURFACE ANTIGEN,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,DIFFERENTIAL MANUAL,EOSINOPHILS,Bacteria identified,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,LYMPHOCYTE SUBSET PANEL 3,% CD8 SUPPRESSOR T CELLS,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,URINALYSIS W MICROSCOPIC,URINALYSIS URINE COLOR,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.25,0.3333333333333333,0.0,0.29125,0.38833333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,HCV RNA PCR QN RFX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.26666666666666666,0.48,0.0,0.26666666666666666,0.48,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,HCV QUANT GT1A NS5A PROFILE,HCV LOG10,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,NASH FIBROSURE,APOLIPOPROTEIN A 1,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CBC W O DIFF WITH PLATELETS,RBC,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,HIV 1 QUANT PCR,HIV 1 VIRAL LOG,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,LIVER FIBROSIS FIBROTEST ACTITEST,BILIRUBIN,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.15,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.04612090043126471,0.0,0,632117,CMP12 LP 6AC,PHOSPHORUS SERUM,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,ASH FIBROSURE,AST SGOT P5P,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,CBC WITH DIFFERENTIAL,NO CELLS DIFF,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,NGI HCV QUANTASURE,HEPATITIS C QUANTITATION,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,NGI HCV QUANTASURE,HEPATITIS C QUANTITATION,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,CBC WITH DIFFERENTIAL,MONOCYTES,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,CMP CBC TSH,ABSOLUTE BLASTS,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,CBC DIFF PLT,MONOCYTES %,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,IMMUNOGLOBULINS,IMMUNOGLOBULIN G,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D2,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,URINALYSIS W MICROSCOPIC,BACTERIA,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,SEDIMENTATION RATE WESTERGREN,SEDIMENTATION RATE WESTERGREN,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,SMOOTH MUSCLE AB F ACTIN REFLEX IFA TITER,F ACTIN IGG,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,DRUG ABUSE SCREEN I,AMPHETAMINES,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,URINALYSIS COMPLETE,BILIRUBIN,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,COMP METAB PANEL,EGFR NON AFR AMERICAN,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,CBC,HEMOGLOBIN,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,LIPID PANEL,CALC LDL CHOL,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.16666666666666666,0.0,0.0,0.16666666666666666,0.0,0.0,0.04839660289257697,0.0,0.0,0.04839660289257697,0.0,0,15586,CREATININE SERUM,CREATININE SERUM,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,PTT,PTT,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,RPR,RPR RESULT,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.3333333333333333,0.2,0.5,0.3333333333333333,0.4,0.5,0.04272417415933216,0.05549282856714377,0.0,0.06042110653731758,0.1569574215481997,0.0,1,311472,RPR REFLEX TP PA,RPR TITER,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,LYMPHOCYTE SUBSET PANEL 4,COMMENTS,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,TSH FREE T4 PROFILE,TSH THIRD GENERATION,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.1475,0.0,0.0,0.29,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,MICROALBUMIN RANDOM,MICROALBUMIN CR RATIO,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.2866666666666667,0.2,0.0,0.0,0.2,1.0,0.0,0.0,0.0,0.0,0.13909830811578938,1.0,1,303503,AUTOMATED BLD CNT,HEMOGLOBIN,Hemoglobin,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc
0.044,0.03142857142857143,0.07333333333333333,0.134,0.09571428571428572,0.22333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,MITOCHONDRIAL ANTIBODY W REFL TITER,MITOCHONDRIAL AB SCREEN,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,CBC WITH DIFF PLATELET,WBC,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,CBC WITH DIFFERENTIAL,MYELOCYTES,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,METHADONE,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,MICROALBUMIN CONC,ALB CREAT RATIO,Leukocyte morphology finding,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0,19638,FE CBC D PLT TIBC FER B12 F,FERRITIN SERUM,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,PROTEIN ELECTRO S,M SPIKE,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,FIBROACT,ALT,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,HIV ANTIGEN ANTIBODY FOURTH GENERATION W RFL,HIV AG AB 4TH GEN,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.2,0.14285714285714285,0.25,0.2,0.14285714285714285,0.25,0.01080432276734078,0.010461916354288947,0.011796976054046393,0.01080432276734078,0.010461916354288947,0.011796976054046393,0,632117,HIV 1 HIV 2 AB SCREEN,HIV 1 HIV 2 AB SCREEN,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,GLUCOSE,GLUCOSE FASTING,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.17666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,LIVER FIBROSIS PANEL,HAPTOGLOBIN,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,LIVER FIBROTEST ACTITEST,HAPTOGLOBIN,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.08708612196151422,0.0,0,264531,UA MICROSCOPIC REFLEX CULTURE,OCCULT BLOOD,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.5733333333333334,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.11392078992866939,0.07723574034323777,1,110544,LIPID CASCADE W RFLX APOLIB,LDL HDL RATIO,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,RPR,RPR QUANT,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.0,0.0,0.5,0.3333333333333333,0.0,0.0,0.0,0.0,0.1503314858492919,0.7071067811865476,0.0,1,304287,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCV,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,IRON TIBC,TRANSFERRIN SAT %,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.24333333333333332,0.2,1.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.7071067811865476,1,28852,HEPATIC FUNCTION PANEL A,TOTAL PROTEIN,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.0,0.0125,0.025,0.0,0.0625,0.0,0.0,0.0,0.0,0.0,0.027776438468458897,0.0,0,339143,COMPREHENSIVE METABOLIC PANEL,CALCIUM SERUM,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,HEPATITIS C VIRAL RNA NS3 GENOTYPE,TELAPREVIR RESISTANCE,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,CMP14 4AC,EGFR IF NONAFRICN AM,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,DRUG ABUSE SCREEN II,METHAQUALONE,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,CD4 T4 ENUMERATION,ABSOLUTE LYMPHOCYTES,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.385,0.265,0.0,0.5,0.5,1.0,0.0,0.0,0.0,0.1503314858492919,0.7071067811865476,1.0,1,57786,URINALYSIS CULTURE IF INDICATED,COLOR,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,CMP14 HP4 DBILI CBC D PLT R,LYMPHS,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,HEPATITIS B SURF AG,HEPATITIS B SURF AG,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.15666666666666665,0.20333333333333334,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,CRYOGLOBULINS REFLEX IFE QUANT,IGM CRYOPRECIPITATE,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.0834655896020069,0.34003516797720323,1.0,1,29512,COMPREHENSIVE METABOLIC PANEL E GFR,SODIUM,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,CBC W O DIFF WITH PLATELETS,RBC,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0,191239,IGG SUBCLASSES,IMMUNOGLOBULIN G QN SERUM,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.12,0.12,0.0,0.12,0.12,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,GGT,GGT,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.5,0.5,0.9,0.0,0.0,0.0,0.08506391669557933,0.14687247901289302,0.5773502691896257,1,81240,LYMPHOCYTE SUBSET PANEL 1,% CD3 MATURE T CELLS,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.0,0.0,0.46499999999999997,0.4,0.6666666666666666,0.0,0.0,0.0,0.034103916281504665,0.16901735079974012,1.0,1,104661,CMP WITH EGFR,ANION GAP,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,ANA TITER PATTERN,ANA PATTERN,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,CBC WITH PLT DIFF,MPV,Monocytes,Monocytes [#/volume] in Blood,Monocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,CMP13 LP 2AC CBC D PLT,EGFR IF AFRICN AM,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,COMPREHENSIVE METABOLIC PANEL E GFR,CHLORIDE,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.2857142857142857,0.2757142857142857,0.965,0.2857142857142857,0.2757142857142857,0.965,0.2458696638252934,0.011170953400621464,0.04372412516808821,0.2458696638252934,0.011170953400621464,0.04372412516808821,1,296095,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0825,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,URINALYSIS,BACTERIA,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,CMP14 HP4 1AC PT AFP,HEP A AB IGM,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,CBC WITH AUTO DIFF,BASOPHILS %,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.5,0.5714285714285714,0.6,0.0,0.03571428571428571,0.05,0.4543382861631333,0.013656950654702071,0.034646396615759856,0.0,0.0,0.0,1,487967,HCV FIBROSURE,COMMENT,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,CBC W AUTO DIFF ABS WBC MPV PLT,EOSINOPHILS,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,LIVER FIBRO HEPSCORE R,AGE,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,HCV RNA NS5A GENOTYPE,VELPATASVIR RESISTANCE,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.02984688727689122,0.0,0,7708,CMP,BUN BLOOD UREA NITROGEN,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.182,0.14285714285714285,0.2,0.0,0.0,0.0,0.0,0.029699923646854032,0.04007989868886952,0.0,0.0,0.0,0,728626,SPECIAL A 2 PANEL #9633,POLYS,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,CBCI COMPLETE BLOOD COUNT W DIFF,LYMPHOCYTES,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.0,0.0,0.0,0.023571428571428573,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,PROTEIN 24 HOUR URINE,PROTEIN URINE CONC,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.16,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,HEPATITIS ABC PANEL,HEPATITIS A ANTIBODY TOTAL,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,ANA TITER PATTERN,ANA PATTERN,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.12166666666666666,0.0,0.0,0.12166666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,HEPATITIS A IGM,HEPATITIS A IGM,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,IRON PANEL,IRON,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,COMP METABOLIC PANEL W GFR,GLOBULIN,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.2,0.16666666666666666,0.0,0.0,0.0,0.0,0.009647292939379382,0.0076177661878222835,0.0,0.0,0.0,0.0,0,7831,MANUAL DIFFERENTIAL,TOTAL NEUTROPHILS %,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,URINALYSIS REFLEX,GLUCOSE QL,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,MAGNESIUM,MAGNESIUM,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,CBC W AUTO DIFF ABS WBC MPV PLT,NEUTROPHILS,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.04786359231046444,0.03458598148635306,0.0,0.0,0.0,0.0,0,59014,PT PROTIME,INR,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.0,0.0,0.1775,0.25,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,1,264853,CBC PLT DIFF,MONOS,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,LYMPHOCYTE SUBSET PANEL 4,% CD4 HELPER CELLS,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,HP4 RPR,HEP C VIRUS AB,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,UA MICROSCOPIC REFLEX CULTURE,BILIRUBIN,Specimen source,Specimen source identified,Specimen source XXX
0.372,0.39285714285714285,0.9166666666666666,0.172,0.3671428571428571,0.6666666666666666,0.009586772624209705,0.5117389382516007,0.9870524497488843,0.0,0.037677447047597123,0.07267302452237867,1,52217,HIV 1 HIV 2 AB RFLX,HIV 1 WESTERN BLOT RESULT,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,ANA SCREEN QUAL,ANA ANTIBODY SCREEN EIA,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE NEUTROPHILS,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,MANUAL DIFFERENTIAL,BLASTS %,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.092,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,1,7138,AST CBC D PLT,EOS,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,HEPATITIS A IGM,HEPATITIS A IGM,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.11399999999999999,0.12857142857142856,0.22499999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,DRUG ABUSE SCREEN 11 W ETOH NO CONF,OXYCODONE,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,CBC INCLUDES DIFFERENTIAL PLATELETS,RBC,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,NGI HCV ULTRAQUAL RFX SUPER QT,COPIES ML,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.0,0.0,0.0,0.3333333333333333,0.25,0.0,0.0,0.0,0.0,0.1503314858492919,0.0,0.0,1,264531,PATHOLOGIST SMEAR REVIEW,RBC,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,CBC WITH DIFFERENTIAL,EOSINOPHILS,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.47250000000000003,0.47250000000000003,0.845,0.0,0.0,0.0,0.04253195834778967,0.048957493004297636,0.0,1,81240,LYMPHOCYTE SUBSET PANEL 2,% CD3 MATURE T CELL,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,DIFFERENTIAL MANUAL,ABSOLUTE BAND NEUTROPHILS,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,TRIIODOTHYRONINE T3 FREE,TRIIODOTHYRONINE T3 FREE,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,CBC W AUTO DIFF WITH PLATELETS,COMMENTS,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,UA W MICRO HOLD SPEC 24 HR,SPECIFIC GRAVITY,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,CBC PLT DIFF,MONOS,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,C REACTIVE PROTEIN,C REACTIVE PROTEIN,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,URINALYSIS,BILIRUBIN,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,FIBROACT COMPLETE,HEIGHT INCHES,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,NASH FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,LIPID PANEL WITH LDL HDL RATIO,LDL HDL RATIO,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,CPK,CPK,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,HP4 RPR,HEP C VIRUS AB,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,RPR REFLEX TITRE TPPA,RPR,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,UROGRAM,KETONES,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.06437040281437945,0.0,0.0,1,45443,CBC W DIFF PLATELET,HCT,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,AFP WITH AFP L3%,AFP SERUM,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,ANTIPHOSPHOLIPID SYNDROME,PT,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,HEPATITIS A IGM,HEPATITIS A IGM,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,HEP B CORE TOTAL AB,HEP B CORE TOTAL AB,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,URINALYSIS W REFLEX MICRO,GLUCOSE,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,DRUG ABUSE SCREEN II,BENZODIAZEPINES,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,AMY LIPASE,AMYLASE,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,CBC W AUTO DIFF,MEAN PLATELET VOLUME,Color,Color of Urine,Color Ur
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.17692551543363566,0.0,0.0,0.0,0.0,0,30940,IFE PE SERUM,ALPHA 2 GLOBULIN,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,CBC PLT DIFF,MONOS,Neutrophils,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,REFLEX ANA PATTERN,PATTERN 1,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,CMP14 CBC D PLT,HEMATOLOGY COMMENTS,Globulin,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc
0.0,0.156,0.78,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,LP LDLDIR,TRIGLYCERIDES,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,MORPHOLOGICAL REVIEW,PATH REVIEW PERIPHERAL SMEAR,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,CBC WITH PLT DIFF,BANDS,Color,Color of Urine,Color Ur
0.0,0.1742857142857143,0.4066666666666667,0.0,0.1742857142857143,1.0,0.0,0.9233732785472102,1.0,0.0,0.9233732785472102,1.0,1,19885,C REACTIVE PROTEIN,C REACTIVE PROTEIN,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,TESTOSTERONE FREE TOTAL,FREE TESTOSTERONE DIRECT,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.2,0.16666666666666666,0.0,0.0,0.0,0.0,0.009413595328285118,0.0075011219466417645,0.0,0.0,0.0,0.0,0,7096,MANUAL DIFFERENTIAL,LYMPHOCYTES ABSOLUTE,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0825,0.08833333333333333,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.07163871665340582,0.09716253076254433,1.0,1,57976,URINALYSIS RX ALB CREA,KETONES,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.14285714285714285,0.5,0.0,0.0,0.0,0.0,0.5074828171487041,1.0,1,67686,COMP METABOLIC PANEL 12,ALKALINE PHOSPHATASE,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,CBC INCLUDES DIFF PLT,BASOPHILS %,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.06,0.05142857142857143,0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,COMPREHENSIVE METABOLIC PANEL REFL,UREA NITROGEN BUN,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,LP LDLDIR,TRIGLYCERIDES,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.0335,0.07444444444444445,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,LYMPHOCYTE SUBSET PANEL 2,HELPER SUPPRESSOR RATIO,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,LYMPHOCYTE SUBSET PANEL 2,% CD4 HELPER CELLS,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,LP NON HDL CHOLESTEROL,VLDL CHOLESTEROL CAL,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH TOTAL,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.047619047619047616,0.0,0.0,0.0,0.0,0.0,0.006079174216221173,0.0,0.0,0.0,0.0,0,882944,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,EOSINOPHILS #,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.0,0.03777777777777777,0.0,0.0,0.03777777777777777,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,HEPATITIS C RNA PCR QUANT,HCV PCR QUANT,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.09815496092726139,0.0,0,29918,FERRITIN,FERRITIN SERUM,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,HCV FIBROSURE,GGT,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.046706887849276346,0.0,0,7112,LYMPHOCYTE SUBSET PANEL 4,ABS CD4 COUNT,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,CBC WITH AUTO DIFF,MCV,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,REFERRED CBC,MCH,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.08581504994646605,0.11153417675642818,1.0,1,181826,BASIC METABOLIC PANEL,OSMOLALITY,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,URINALYSIS WITH MICROSCOPIC,EPITHELIAL CELLS,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,ARTHRITIS PROFILE,ANTI NUCLEAR ANTIBODIES,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,PROTEIN ELECTROPHORESIS,ALPHA 1 GLOBULINS,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,COMPLEMENT COMPONENT C3C,COMPLEMENT COMPONENT C3C,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,MAYNAC CMP 4AC LIPID CBC T4 TSH PSA PROFILE,MCH,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,CMP14 LP CBC D PLT,NEUTROPHILS,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,CBC WITH DIFFERENTIAL,MONOCYTES,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.25,0.205,0.0,0.25,0.205,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,LIVER FIBROTEST ACTITEST,FIBROSIS STAGE,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,LIVER FIBROSIS FIBROMETER,ALPHA 2 MACROGLOBULIN FM,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.054285714285714284,0.19,0.46499999999999997,0.25142857142857145,0.5,0.0,0.0,0.0,0.008912499759331616,0.025541167468744463,0.04409367683763299,1,134577,LP WITHOUT VLDL CHOL HDL,LDL CHOLESTEROL CALC,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,HCV RNA NS5A GENOTYPE,DACLATASVIR RESISTANCE,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,METHADONE,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.3333333333333333,0.2,1.0,0.3333333333333333,0.3285,1.0,0.2539585678404015,0.005994763961878147,0.04372412516808821,0.16069190982168602,0.19983987779463963,0.02766637581197129,1,347047,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD IU ML,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,URINALYSIS CULTURE IF INDICATED,NITRITE,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE LYMPHOCYTES,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,TRANSFERRIN SATURATION,TRANSFERRIN,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,CBC,HEMOGLOBIN,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,HIV 1 RNA QN RT PCR,HIV 1 RNA QN PCR,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME NR,Hemoglobin,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,CBC W DIFF PLT,RBC,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,HCV RNA PCR QN RFX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,THYROID II PROFILE T3U T4 T7 TSH,T4 THYROXINE,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,PAIN MANAGEMENT 8,CREATININE,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,HEPASCORE R,AGE,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.21166666666666667,0.1111111111111111,0.16666666666666666,0.21166666666666667,0.1111111111111111,0.16666666666666666,0.007914915047499527,0.007985828727564592,0.013198503836875264,0.007914915047499527,0.007985828727564592,0.013198503836875264,0,481598,MITOCHONDRIAL M2 AB,MITOCHONDRIAL M2 AB,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.11,0.0,0.0,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,HEPATITIS B SURFACE ANTIBODY,HEPATITIS B SURFACE ANTIBODY,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,URINALYSIS SCREEN,PH,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,HCV RNA GENOTYPE LIPA R,HCV RNA GENOTYPE LIPA,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.235,0.15666666666666665,1.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0,93179,CBC WITH DIFFERENTIAL PLATELETS,POLYS,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.5,0.5,0.9,0.0,0.0,0.0,0.08506391669557933,0.14687247901289302,0.5773502691896257,1,81240,LYMPHOCYTE SUBSET PANEL 3,% CD3 MATURE T CELLS,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.01939736162617678,0.0,0.0,0.0,0.0,0,7302,CBCI COMPLETE BLOOD COUNT W DIFF,PLT MORPHOLOGY,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,URIC ACID,URIC ACID,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,CBC WITH PLT DIFF,BANDS,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0111888279149569,0.0,0,181826,FE ANA TIBC FER A1A AMA ASM,ALPHA 1 ANTITRYPSIN SERUM,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,PSA FREE TOTAL,FREE PSA,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,CBC W O DIFF WITH PLATELETS,MCV,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.2290909090909091,0.63,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,HEP C RNA GENOT 3 NS5A,VELPATASVIR RESISTANCE,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.385,0.265,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,URINALYSIS W MICRO W REFLEX CULTURE,NITRITES,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,HCV RNA PCR QN RFX GENO,PLEASE NOTE,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0.0,0.0,0.0,0,25718,IFE PE SERUM,M SPIKE,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,CBC INCLUDES DIFFERENTIAL PLATELETS,RBC,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,URINALYSIS WITH MICROSCOPIC,UROBILINOGEN,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,HEPATITIS C VIRAL RNA NS3 GENOTYPE,BOCEPREVIR RESISTANCE,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1216962121474966,1.0,1,45443,CMP14 LP TP TSH 4AC CBC D P,HEMATOCRIT,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.1425,0.09499999999999999,0.1425,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,DRUG ABUSE SCREEN II,OPIATES,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D2,Ceruloplasmin,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,HEMOGLOBINOPATHY INDICES,HEMATOCRIT,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,DRUG SCREEN AUSTIN 20,PHENCYCLIDINE,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,WBC,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,URINALYSIS CULTURE IF INDICATED,COLOR,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,HCV FIBROSURE,COMMENT,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,CBC INCLUDES DIFF PLT,BLASTS,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,CBC WITH AUTO DIFF,BASOPHILS ABSOLUTE,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,EGFR,EGFR,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,METHADONE,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,PROTHROMBIN TIME,INR,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,CMP14 4AC,EGFR IF AFRICN AM,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,UA W MICRO HOLD SPEC 24 HR,SPECIFIC GRAVITY,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,ASH FIBROSURE,HAPTOGLOBIN,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,IRON TOTAL,HEMOLYSIS,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,NASH FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,HBC AB TOTAL,HBC AB TOTAL,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,HCV RNA GENOTPE 1 NS5A DRUG RE,OMBITASVIR RESISTANCE,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,PROTEIN ELECTRO S,BETA GLOBULIN,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,LP NON HDL CHOLESTEROL,VLDL CHOLESTEROL CAL,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,DIFFERENTIAL MANUAL,PLATELET ESTIMATION,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,CMP12 2AC,ALBUMIN SERUM,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,CBC WITH DIFFERENTIAL PLATELETS,MCH,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,LIVER FIBROSIS FIBROMETER,FIBROMETER PROTHROMBIN INDEX,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,FERRITIN,FERRITIN SERUM,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.0,0.0,0.0,0.0,0.08779161868611507,1.0,0.0,1,285395,REFERRED CBC,MCH,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,CMP12 LP TP TSH 6AC CBC D PLT,HEMOGLOBIN,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,HEPATIC FUNCTION PANEL,ALBUMIN,Basophils,Basophils [#/volume] in Blood,Basophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD IU ML,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,HEPATITIS BE ANTIGEN,HEP BE ANTIGEN,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.0,0.0,0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.061769791070825475,0.0,0,193433,HIV AB 1 HIV 2 EIA W REFL 1 WB,HIV EIA AB SCREEN,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,CBC H H RBC INDICES WBC PLT,PLATELET COUNT AUTO,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.08952338621207645,0.0,0,264499,URINALYSIS CULTURE IF INDICATED,WHITE BLOOD CELLS,Eosinophils,Eosinophils [#/volume] in Blood,Eosinophil # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,ACCUTYPE R IL28B,IL28B GENOTYPE,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.375,0.0,0.0,0.375,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,ACCUTYPE R IL28B,ACCUTYPE R IL28B,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,CBC RBC H H INDICES WBC PLT,RED BLOOD CELL COUNT,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,CBC WITH AUTO DIFF,EOSINOPHILS ABSOLUTE,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,CBC WITH DIFFERENTIAL,MONOCYTES,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,PTH INTACT,PARATHYROID HORMONE INTACT,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,URINALYSIS WITH MICROSCOPIC,APPEARANCE,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,ACUTE HEPATITIS PANEL,HEPATITIS A IGM,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,DRUG ABUSE PANEL 10 WITH OXYCODONE,METHAQUALONE,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,CBC DIFF PLT,MONOCYTES %,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.16666666666666666,0.3655555555555556,0.5483333333333333,0.0,0.0,0.0,0.009501051983062836,0.0,0.0,0.0,0.0,0.0,0,481598,HCV RNA GENOTPE 1 NS5A DRUG RE,OMBITASVIR RESISTANCE,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,BMP WITH ESTIMATED GFR CALCULATED,CARBON DIOXIDE,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CBC WITH PLT DIFF,MEGAKARYOCYTE FRAGS,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,LYMPHOCYTE SUBSET PANEL 4,% CD4 HELPER CELLS,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,PROTEIN ELECTROPHORESIS SR W RFX,INTERPRETATION,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.0,0.0,0.16999999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,486423,CMP14 5AC,EGFR IF NONAFRICN AM,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.06070256115709882,0.0,0.0,0.06070256115709882,0.0,0,81232,T4 THYROXINE,T4 THYROXINE,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,CBC WITH ABSOLUTE NEUTROPHIL COUNT,NEUTROPHILS,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.025,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,CBC W DIFF PLATELET,HCT,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,CMP,ALBUMIN,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,COMPREHENSIVE METABOLIC PANEL AMA,GLOBULIN,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.042727272727272725,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,CBC WITH AUTO DIFF,BASOPHILS %,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,HEP B CORE TOTAL AB,HEP B CORE TOTAL AB,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,HEP B SURFACE AB IMMUNITY QN,HEP B SURFACE AB IMMUNITY QN,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,HEPATITIS C RNA PCR QUANT,HCV PCR QUANT,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.2,0.36363636363636365,1.0,0.2,0.36363636363636365,1.0,0.009954249465735754,0.012293609461087485,0.018008420843363293,0.009954249465735754,0.012293609461087485,0.018008420843363293,1,322867,HCV RNA GENOTYPE LIPA R,HCV RNA GENOTYPE LIPA,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,CBC INCLUDES DIFF PLT,BLASTS,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.07142857142857142,0.25,0.0,0.07142857142857142,0.25,0.0,0.037147338768416915,0.14539805437566944,0.0,0.037147338768416915,0.14539805437566944,0,296095,HEPATITIS B SURF AG,HEPATITIS B SURF AG,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.09571428571428572,0.09333333333333332,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,HCV RNA GENOTPE 1 NS5A DRUG RE,OMBITASVIR RESISTANCE,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06803603656800117,0.06673966886790239,0.10240603634159506,1,7708,CMP14 CBC D PLT ESR WES ANA,NEUTROPHILS,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.07142857142857142,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE NEUTROPHILS,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,CBC DIFF PLT,RDW,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0725,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.03720100626985978,0.0,0,57703,QUESTASSURED TM 25OHD D2 D3,VITAMIN D 25 OH TOTAL,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,HEPATIC FUNCTION PROFILE,BILIRUBIN INDIRECT,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,RHEUMATOID FACTOR RF,RHEUMATOID FACTOR RF,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,LYMPHOCYTE SUBSET PANEL 4,RACE NR,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.0,0.15,0.0,0.0,0.0,0.0,0.0,0.0,0.04612090043126471,0.0,0,632117,VITAMIN B12 FOLATE,FOLATE SERUM,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.066,0.165,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,IRON IBC W RFX FERRITIN,%TRANSFERRIN SATURATION,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.05888888888888889,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.06290250689706056,0.0,0.0,1,58214,UA M W RFLX CULTURE COMP,WBC,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,PROTEIN TOTAL URINE,PROTEIN CR RATIO,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.04540213241165436,0.0,0.0,0.04540213241165436,0.0,0,426171,FOLATE SERUM,FOLATE SERUM,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,NEG HIV 4TH GEN,NEG HIV 1 RNA QL TMA,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,ANA ANTI NUCLEAR AB WITH REFLEX TITER,ANTI NUCLEAR ANTIBODIES,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,HEPATITIS B SURFACE AB IMMUN,HEPATITIS B SURFACE AB IMMUNITY QN,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,30841,URIC ACID,URIC ACID,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,CMP14 LP 1AC CBC D PLT TSH,LYMPHS,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,HCV RNA PCR QN RFX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.18666666666666668,0.2,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,25718,VAP CHOLESTEROL PROFILE,TRIGLYCERIDES,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.03288659407583738,0.0,0.0,0.0,0.0,0,301804,CBC WITH ABSOLUTE WHITE BLOOD CELLS,RDW,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,THYROXINE T4 FREE,T 4 FREE,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,CBC WITH PLT DIFF,OTHERS,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.055,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,PROTEIN ELECTROPHORESIS,GAMMA GLOBULINS,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,HEPATITIS B SURFACE AB QUANT,HEPATITIS B SURFACE AB,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,PROTEIN ELECTROPHORESIS,ALPHA 1 GLOBULINS,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.0,0.0,0.5,0.352,1.0,0.0,0.0,0.0,0.09322033388114626,0.0983573569202505,0.7071067811865476,1,108340,GENERAL HEALTH PANEL,CALC GLOBULIN,Globulin,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,ASH FIBROSURE,COMMENT,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,RPR REFLEX T PALLIDUM PA,RPR,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,CMP14 HP4 DBILI CBC D PLT R,EOS ABSOLUTE,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,LYMPHOCYTE SUBSET PANEL 4,RACE NR,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,AFP TUMOR MARKER SIEMENS IMMULITE,AFP TUMOR MARKER,Erythrocytes,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,LYMPHOCYTE SUBSET PANEL 5,ANALYZED DATE TIME NR,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,LIVER FIBROSIS PANEL,ALT,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.4,0.18181818181818182,0.25,0.0,0.0,0.0,0.04802835732051414,0.11003603894321656,0.12851200387967032,1,542183,IMMUNE COMPETENCE PANEL,CD4 CD8 RATIO,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.124,0.2,0.25,0.0,0.0,0.0,0.0,0.06906520772851166,0.16798781955203945,1,265058,CBC WITH DIFFERENTIAL,NEUTROPHILS,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.05714285714285715,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,HIV 1 HIV 2 AB RFLX,HIV 1 WESTERN BLOT RESULT,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,PSA TOTAL % FREE,PSA FREE,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.5,0.42857142857142855,0.6,0.0,0.0,0.0,0.4543382861631333,0.013656950654702071,0.034646396615759856,0.0,0.0,0.0,1,487967,HCV FIBROSURE,LIMITATIONS,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,LIPID PNL W REFL TRIG>400,CHOLESTEROL HDL RATIO,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,IMMUNE COMPETENCE PANEL,CD4 CD8 RATIO,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,LYMPHOCYTE SUBSET PANEL 4,COMMENTS,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.0,0.0,0.65,0.5,1.0,0.0,0.0,0.0,0.0,0.15505905338492743,1.0,1,264499,CBC WITH AUTO DIFF,EOSINOPHILS #,Eosinophils,Eosinophils [#/volume] in Blood,Eosinophil # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,LYMPHOCYTE SUBSET PANEL 1,% CD3 MATURE T CELLS,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,CBC W AUTO DIFF,BASOPHILS ABSOLUTE,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,HCV RNA GENOTYPE LIPA R,HCV RNA GENOTYPE LIPA,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,HEPATIC FUNCTION PANEL W O TP,BILIRUBIN DIRECT,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,DIFFERENTIAL MANUAL,ABSOLUTE NEUTROPHILS,Protein pattern,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp
0.2,0.4,0.6666666666666666,0.2,0.4,0.6666666666666666,0.007719821827095519,0.36957415218469236,0.4632357174935542,0.007806566737586396,0.37372692636381444,0.46844093359181893,1,178566,HEMOGLOBIN A1C EAG,HEMOGLOBIN A1C,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,LIVER FIBROTEST ACTITEST,NECROINFLAMMAT ACT SCORE,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,RHEUMATOID FACTOR QUANT,RHEUMATOID FACTOR QUANT,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,URINALYSIS WITH MICROSCOPIC,APPEARANCE,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,HEPATITIS B SURFACE ANTIBODY,HEPATITIS B SURFACE AB QUAL,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.2,0.25,0.0,0.0,0.0,0.0,0.027385328599057512,0.07274033002715963,0.0,0.0,0.0,0,345355,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Microalbumin/Creatinine ratio panel,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,HIV 1 QUANT PCR,HIV 1 VIRAL LOG,Globulin,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,DRUG ABUSE SCREEN 11 W ETOH W CONF,METHADONE,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,DRUG ABUSE SCREEN 9 NO THC W CONF,OXYCODONE,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,CBC INCLUDES DIFF PLT,ABSOLUTE BAND NEUTROPHILS,Reference lab test method,Reference lab test method,Ref lab test method
0.0,0.18555555555555556,0.33399999999999996,0.0,0.0,0.0,0.0,0.019194216590067148,0.019959992495042767,0.0,0.0,0.0,0,139501,HIV 1 HIV 2 AB RFLX,HIV 1 WESTERN BLOT RESULT,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.4175,0.18142857142857144,0.0,0.6675,0.3242857142857143,0.0,0.019765492370202753,0.0,0.0,0.061241138223508074,0.058554296133023875,0.0,1,22368,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D2,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.06968261318695779,0.24044117311858715,0.7071067811865476,1,24729,CRYOGLOBULINS REFLEX IFE QUANT,IGM CRYOPRECIPITATE,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,RENAL PANEL 10,EGFR IF NONAFRICN AM,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,URINALYSIS WITH REFLEX MICROSCOP,PROTEIN TOTAL QUAL,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,DIFFERENTIAL MANUAL,NEUTROPHILS ABSOLUTE,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,URINALYSIS CULTURE IF INDICATED,OCCULT BLOOD,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,HEPATIC FUNCTION PANEL W O TP,BILIRUBIN DIRECT,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,URINALYSIS REFLEX,GLUCOSE,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,MANUAL DIFFERENTIAL,BLASTS %,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,MICROALBUMIN RANDOM,MICROALBUMIN CR RATIO,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.18666666666666668,0.2,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,25718,LP LDLDIR,TRIGLYCERIDES,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.316,0.125,0.3333333333333333,0.0,0.0,0.0,0.0,0.624939177332759,1.0,1,28688,PROTEIN ELECTRO S,ALPHA 2 GLOBULIN,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.04833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,NASH FIBROSURE,WEIGHT,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,DIFFERENTIAL MANUAL,ABSOLUTE EOSINOPHILS,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.019633410894271397,0.0,0.0,0.0,0.0,0,20396,IRON TIBC SERUM,IRON BINDING CAPACITY,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,ANA SCREEN IFA,ANA SCREEN IFA,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,SPECIAL PROFILE 3619,LEUKOCYTE ESTERASE,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,CBCM COMPLETE BLOOD CNT W MAN DIFF,EOSINOPHILS,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,FOLATE,FOLATE,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.4375,0.2857142857142857,1.0,0.0,0.0,0.0,0.0,0.10343053687972403,0.17358784764553015,1,134585,CMP14 LP CBC D PLT UA MG TS,VLDL CHOLESTEROL CAL,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,IRON IBC W RFX FERRITIN,%TRANSFERRIN SATURATION,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,HCV RNA PCR QN RFX NSA,HCV GENOSURE R NSA PDF,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06803603656800117,0.06673966886790239,0.10240603634159506,1,7708,CMP14 LP CBC D PLT,NEUTROPHILS,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,HEPATITIS B SURFACE ANTIBODY,HEPATITIS B SURFACE ANTIBODY,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.09338639438323382,0.0,0.0,0.09338639438323382,0.0,0,21329,C4 SERUM,C4 SERUM,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,NEG HIV 4TH GEN,NEG HIV 2 ANTIBODY,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,LIPID PANEL AMA,CHOLESTEROL HDL RATIO,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,HEMOGLOBINOPATHY INDICES,HEMATOCRIT,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,CMP14 LP CBC D PLT,NEUTROPHILS,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,HEMOGLOBIN A1C EAG,HEMOGLOBIN A1C,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,COMPLETE BLOOD COUNT,NEUTROPHILS ABSOLUTE,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,CBC WITH PLT DIFF,BANDS ABSOLUTE,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.24666666666666667,0.148,0.37,0.4366666666666667,0.348,0.37,0.0,0.0,0.0,0.0,0.08030844563447248,0.0,1,93187,MICROALBUMIN RANDOM,MICROALBUMIN CR RATIO,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,CBC WITH PLT DIFF,BANDS ABSOLUTE,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,LYMPHOCYTE SUBSET PANEL 3,% CD8 SUPPRESSOR T CELLS,Ceruloplasmin,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,ALPHA 1 ANTITRYPSIN PHENOTYPE,ALPHA 1 ANTITRYPSIN,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.27999999999999997,0.09090909090909091,0.2,0.2,0.09090909090909091,0.2,0.02475914086502795,0.018524468044861964,0.02925507076854461,0.04288408992998327,0.032085319836887005,0.0506712689501424,1,602797,ACCUTYPE R IL28B NY,IL28B GENOTYPE,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,CBC WITH AUTO DIFF,NRBC,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,CYSTIC FIBROSIS SCREEN,ETHNICITY,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,LYMPHOCYTE SUBSET PANEL 2,HELPER SUPPRESSOR RATIO,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,ACCUTYPE R IL28B NY,IL28B GENOTYPE,Reference lab test method,Reference lab test method,Ref lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B DRUG RESISTANCE ASSAY,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,HEPATITIS PANEL ACUTE,HEPATITIS C ANTIBODY,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.047142857142857146,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,URINALYSIS CULTURE IF INDICATED,OCCULT BLOOD,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,FIBROACT,ALT,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,ANTI SMOOTH MUSCLE MITOCHOND,MITOCHONDRIAL M2 ANTIBODY,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,FE ANA TIBC FER PTT PT A1A,MITOCHONDRIAL M2 ANTIBODY,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CHEM PROFILE 29,ALK PHOS,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,GENERAL HEALTH PANEL,CALC GLOBULIN,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,VITAMIN D 25 OH TOTAL,VITAMIN D 25 OH TOTAL,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,HEPATITIS ABC PANEL,HEPATITIS A ANTIBODY TOTAL,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,RHEUMATOID FACTOR RF,RHEUMATOID FACTOR RF,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.5,0.0,0.0,0.0,0.08432989233649546,0.08432989233649546,0.1503314858492919,1,31377,ASH FIBROSURE,HEIGHT,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,URINALYSIS ROUTINE W RFX,BILIRUBIN,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS A TOTAL AB,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,ANA ANTI NUCLEAR AB WITH REFLEX TITER,ANTI NUCLEAR ANTIBODIES,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,HCV FIBROSURE RESULTS,FIBROSIS SCORE,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,TSH W REFLEX FT4,TSH 3RD GENERATION W REFLEX FT4,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,URINALYSIS,BILIRUBIN,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,CREATININE,LIPEMIA,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,LIPID PROFILE,NON HDL CHOLESTEROL,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,LIVER FIBROSIS PNL HEPASCORE TM,METAVIR SCORE,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,HCV RNA GENOTPE 1 NS5A DRUG RE,OMBITASVIR RESISTANCE,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,UA MICROSCOPIC REFLEX CULTURE,WHITE BLOOD CELLS,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,LIPID PANEL,LDL CALC,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.15,0.14285714285714285,0.0,0.15,0.14285714285714285,0.0,0.0,0.043355289534301455,0.0,0.0,0.043355289534301455,0.0,0,142513,COMPLEMENT C3 SERUM,COMPLEMENT C3 SERUM,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,CMP12 LP TP TSH 6AC CBC D PLT,EOS ABSOLUTE,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,CBC W AUTO DIFF WITH PLATELETS,COMMENTS,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.26666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,CMP14 LP 5AC CBC D PLT RPR,WBC,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,CBC WITH PLT DIFF,BANDS,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,URINALYSIS C,BILIRUBIN,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,CBC DIFF PLT,RDW,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.04833333333333333,0.0,0.0,0.295,0.024444444444444446,0.03666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,LYMPHOCYTE SUBSET PANEL 2,COMMENT S,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,CMP14 HP4 DBILI CBC D PLT R,C REACTIVE PROTEIN QUANT,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,CERULOPLASMIN,CERULOPLASMIN,Leukocyte morphology finding,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,DRUG ABUSE SCREEN 11 W ETOH W CONF,OXYCODONE,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,BUN CREATININE RATIO,ICTERUS,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,MANUAL DIFFERENTIAL,LYMPHOCYTES ABSOLUTE,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,PROSTATE SPECIFIC ANTIGEN PSA,PSA,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,COMPREHENSIVE METABOLIC PANEL,OSMOLALITY,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D3,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,CBC,% BASOPHILS,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,CMP WITH ESTIMATED GFR CALCULATED,CARBON DIOXIDE,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,LIVER FIBROSIS PANEL,HAPTOGLOBIN,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,NASH FIBROSURE,APOLIPOPROTEIN A 1,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.08333333333333333,0.022,0.0,0.08333333333333333,0.022,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,PSA FREE TOTAL,PSA FREE,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.072,0.095,0.19,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,COMP METABOLIC PANEL,GLUCOSE NON FASTING,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,CMP14 3AC CBC D PLT RPR MG,EOS,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,CBC WITH PLT DIFF,RBC MORPHOLOGY,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,DIRECT LDL,DIRECT LDL,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,HCV AB W RFL RNA RFL GENO,HEPATITIS C AB,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,DRUG ABUSE SCREEN I,AMPHETAMINES,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,CBC W O DIFF WITH PLATELETS,RBC,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.045454545454545456,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,CBC W AUTO DIFF,HCT,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D2,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,CMP12 LP TP TSH 6AC CBC D PLT,POTASSIUM,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,CBC W AUTO DIFF,HCT,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,UREA NITROGEN BUN,HEMOLYSIS,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,C REACTIVE PROTEIN CARDIAC,C REACTIVE PROTEIN CARDIAC,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,LIVER FIBROSIS FIBROTEST ACTITEST,NECROINFLAMMAT ACT GRADE,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,HCV FIBROSURE,COMMENT,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,COMP METABOLIC PANEL,ANION GAP,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,COMPREHENSIVE METABOLIC PANEL AMA,CHLORIDE,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.009761890689840791,0.0,0.0,0.0,0.0,0,273532,CBCI COMPLETE BLOOD COUNT W DIFF,ABS NEUTROPHILS,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,C REACTIVE PROTEIN CARDIAC,C REACTIVE PROTEIN CARDIAC,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,CBC WITH PLT DIFF,EOSINOPHILS ABSOLUTE,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,BUN CREAT RATIO W EGFR,NON AFRICAN AMERICAN EGFR,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,CBC WITH DIFFERENTIAL,IMMATURE GRANS,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,FSRC NEW PATIENT PANEL,D BILIRUBIN,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,HEP A AB IGM,HEPATITIS A AB IGM,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,HCV FIBROSURE,LIMITATIONS,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.11,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,URINALYSIS WITH MICROSCOPIC,PH,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,HEPATITIS B SURFACE AB,HEPATITIS B SURFACE AB,Protein pattern,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,CBC WITH AUTO DIFF,PLATELET COUNT,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,RPR RFX QN RPR CONFIRM TP,TREPONEMA PALLIDUM ANTIBODIES,Bacteria identified,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult
0.125,0.10375,0.0,0.0,0.0,0.0,0.0,0.0666872623744319,0.0,0.0,0.0,0.0,0,109009,PROTEIN ELECTROPHORESIS SERUM,INTERPRETATION,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,HEP C RNA GENOT 3 NS5A,VELPATASVIR RESISTANCE,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.0,0.16666666666666666,0.94,0.25,0.16666666666666666,0.94,0.0,0.0,0.0,0.05026217761451124,0.056942591518096664,0.0,1,93179,CBC W DIFF PLT,PLATELET SUFFICIENCY,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.1111111111111111,0.16666666666666666,0.0,0.0,0.0,0.0,0.08522930735490397,0.17807552140691663,0.0,0.0,0.0,0,139543,FIBROMETER VIRUS,GAMMA GLUTAMYL TRANSFERASE FM,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,CBC WITH DIFFERENTIAL,BASOPHILS,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.08,0.06666666666666667,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,CBC W AUTO DIFF,BASOPHILS ABSOLUTE,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,URINALYSIS REFLEX,GLUCOSE QL,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,LIPID PANEL STANDARD,CHOLESTEROL HDL RATIO,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,HEPATITIS C VIRAL RNA QUALITATIVE TMA,HEPATITIS C VIRAL RNA QUALITATIVE TMA,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,COMPREHENSIVE METABOLIC PANEL E GFR,CHLORIDE,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.0,0.0,0.3,0.2,1.0,0.0,0.0,0.0,0.0,0.34003516797720323,1.0,1,45427,ASH FIBROSURE,HAPTOGLOBIN,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.008095238095238096,0.017,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,URINALYSIS WITH MICROSCOPIC,UROBILINOGEN,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,URINALYSIS WITH MICROSCOPIC,UROBILINOGEN,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,HCV GT3 NS5A DRUG RESIST ASSAY,HCV NS5A DRUG RESIST ASSAY,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D3,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,LYMPHOCYTE SUBSET PANEL 2,% CD3 MATURE T CELL,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,CBC WITH PLT DIFF,LYMPHOCYTES ABSOLUTE,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE CD4,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,CMP WITH EGFR,ALKALINE PHOSPHATASE,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,DRUG SCREEN AUSTIN 20,PHENCYCLIDINE,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,SED RATE MODIFIED WESTERGREN MANUAL,SED RATE MODIFIED WESTERGREN MANUAL,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,CMP13 LP 2AC CBC D PLT,ALT SGPT,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,FREE T4 THYROXINE,FREE T4,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,NASH FIBROSURE,ALT SGPT P5P,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,COMPLETE BLOOD COUNT,RED CELL DIST WIDTH,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,HCV FIBROSURE,FIBROSIS SCORE,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,HEPATIC FUNCTION PANEL W O TP,BILIRUBIN DIRECT,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,COMP METABOLIC PANEL W GFR,ANION GAP,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,CMP,BUN,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,CEA,CEA CENTAUR,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,CBC W O DIFF WITH PLATELETS,RBC,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.029411764705882353,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,HEMOGLOBINOPATHY EVAL,MCH,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,COMP METABOLIC PANEL W GFR,GLOBULIN,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,COMPREHENSIVE METABOLIC PANEL,CALCIUM,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,CMP12 LP TP TSH 6AC CBC D PLT,BILIRUBIN TOTAL,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,GLUCOSE,GLUCOSE FASTING,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.07257572557143144,0.13610564768002043,1.0,1,28621,PE INTERP RFX IFE S,ALBUMIN,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,HIV AG AB 4TH GEN RFL,HIV AG AB 4TH GEN,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,PROTHROMBIN TIME PT,PROTHROMBIN TIME PT,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,LIVER FIBROSIS,NECROINFLAM ACT SCORE,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,T4 THYROXINE,T4 THYROXINE,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.33333333333333337,0.0,0,149575,CBC INCLUDES DIFF PLATELETS,MEAN PLATELET VOLUME,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.2,0.0,0.0,0.2,0.0,0.0,0.24044117311858715,0.0,0.0,0.24044117311858715,0.0,0,24588,MAGNESIUM SERUM,MAGNESIUM SERUM,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,PT PROTIME,INR,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,PSA TOTAL REFLEX FREE,PSA TOTAL,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,BUN CREAT RATIO W EGFR,NON AFRICAN AMERICAN EGFR,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,HB S AG W REFLEX CONF,HFLAG NR,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.16666666666666666,0.0125,0.025,0.0,0.0,0.0,0.023003531473262395,0.0,0.0,0.0,0.0,0.0,0,339143,COMP METABOLIC PANEL W GFR,PROTEIN TOTAL,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.05,0.0,0.0,0.0,0.0,0.0,0.019934693104725842,0.0,0.0,0.0,0.0,0,347047,IFE PE SERUM,GAMMA GLOBULIN,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,CBC WITH MANUAL DIFFERENTIAL,NEUTROPHILS,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.05928571428571429,0.20750000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,LYMPHOCYTE SUBSET PANEL 4,% CD4 HELPER CELLS,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,LIPID PANEL WITH LDL HDL RATIO,HDL CHOLESTEROL,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.006,0.03,0.0,0.006,0.03,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,CEA,CEA SIEMENS IMMULITE 2000,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.215,0.16666666666666666,0.5,0.0,0.0,0.0,0.0,0.0,0.0,1,203943,CREATINE KINASE TOTAL,LIPEMIA,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,CMP14 EGFR,POTASSIUM,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.16666666666666666,0.29666666666666663,0.445,0.4666666666666666,0.2222222222222222,0.3333333333333333,0.038211926035394805,0.13917887610023483,0.290796108751339,0.046799860437844454,0.08522930735490397,0.17807552140691663,1,139543,HEPATITIS BE AG,HB E AG,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.17,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,LYMPHOCYTE SUBSET PANEL 2,COMMENT S,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,DRUG ABUSE SCREEN II,METHAQUALONE,Neutrophils,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,RPR,RPR QUANT,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,LIVER FIBROSIS FIBROTEST ACTITEST,BILIRUBIN,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,PSA TOTAL % FREE,PSA FREE,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.0,0.0,0.3333333333333333,0.14285714285714285,0.5,0.0,0.0,0.0,0.060037523066651444,0.0,0.0,1,19208,CMP14 LP CBC D PLT TSH UA M,AST SGOT,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,CBC WITH MANUAL DIFFERENTIAL,MCHC,Body weight,Body weight Measured,Weight Measured
0.0,0.03333333333333333,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,CBC PLT DIFF,POLYS,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,GGT,GGT,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.2775,0.37000000000000005,0.0,0.25,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,HCV ANTIBODY REFLEX NAA,HCV RNA NAA QUALITATIVE,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,HIV AB EIA WITH REFLEXES,HIV AB,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.11999999999999998,0.08,0.0,0.026363636363636363,0.0725,0.0,0.03197362257097902,0.0,0.0,0.0,0.0,0,112599,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CARBON DIOXIDE,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,HEPATITIS B SURF AG,HEPATITIS B SURF AG,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESIST ASSAY INTERP,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,AFP TUMOR MARKER,AFP TUMOR MARKER,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,CLR CBC W DIFF PLT,ABSOLUTE EOSINOPHILS,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,RPR REFLEX T PALLIDUM PA,RPR,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.021052631578947368,0.044444444444444446,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,TRICHOMONAS MALE,SOURCE,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,CMP14 5AC,BILIRUBIN TOTAL,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.13333333333333333,0.05,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,CBC W AUTO DIFF,ABS NEUTROPHILS,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,FERRITIN,FERRITIN SERUM,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0415,0.20750000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD3 CELLS,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,CRYOGLOBULINS REFLEX IFE QUANT,IGM CRYOPRECIPITATE,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BENZODIAZEPINES,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,AFP TUMOR MARKER SIEMENS IMMULITE,AFP TUMOR MARKER,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,COMP METABOLIC PANEL 12,ALKALINE PHOSPHATASE,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.2,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,LD,LD,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.05563255642440801,0.0,0.0,0.0,0.0,0,51938,IFE PE SERUM,ALPHA 2 GLOBULIN,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,PROTEIN TOTAL URINE,PROTEIN CR RATIO,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,HEPATIC FUNCTION PANEL AMA,BILIRUBIN DIRECT,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.12285714285714286,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,622381,CMP13 LP 2AC CBC D PLT,EGFR IF AFRICN AM,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.11,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,UA MICROSCOPIC REFLEX CULTURE,KETONES,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,LIVER FIBROTEST ACTITEST,HAPTOGLOBIN,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.10480809690210113,0.0,0.0,0.10480809690210113,0.0,0,20859,FOLATE SERUM,FOLATE SERUM,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.16666666666666666,0.21428571428571427,0.75,0.16666666666666666,0.21428571428571427,0.75,0.031263995483780005,0.0,0.0,0.031263995483780005,0.0,0.0,0,204164,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B DRUG RESISTANCE ASSAY,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,HEPATITIS BE AG,HBEAG INS,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,CRP,C REACTIVE PROTEIN ULTRA,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,URINALYSIS COMPLETE,GLUCOSE QL,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,CBC W AUTO DIFF,HGB,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,FIBROACT,ALT,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,DRUG ABUSE SCREEN CLINICAL 9,COCAINE,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,LIVER FIBROSIS,NECROINFLAM ACT GRADE,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,LIVER FIBROSIS,NECROINFLAM ACT GRADE,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD3 CELLS,Prothrombin.activity actual/Normal,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,HEP B SURFACE AB IMMUNITY QN,HEP B SURFACE AB IMMUNITY QN,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,RPR RFX QN RPR CONFIRM TP,TREPONEMA PALLIDUM ANTIBODIES,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,CBC,HEMOGLOBIN,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,CBC,HCT,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.12,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,PROFILE 104 LIVER,AST SGOT,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,LIPID PANEL W CHOL HDL RATIO,VLDL CHOLESTEROL CAL,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,ANA ANTI NUCLEAR AB WITH REFLEX TITER,ANTI NUCLEAR ANTIBODIES,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,CMP12 LP TP TSH 6AC CBC D PLT,LDH,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,GLUCOSE,GLUCOSE FASTING,Reference lab test method,Reference lab test method,Ref lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,LIVER FIBROSIS PANEL,HAPTOGLOBIN,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,LIVER FIBROTEST ACTITEST,NECROINFLAMMAT ACT SCORE,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,IRON TIBC SERUM,IRON BINDING CAPACITY,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,CBC WITH PLT DIFF,PROMYELOCYTES,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.0,0.0,0.0,0.015,0.03,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BARBITURATES,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD3 CELLS,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.017142857142857144,0.024,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,CBC PLATELET HEM REVIEW,NEUTROPHILS ABSOLUTE,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,BUN CREATININE RATIO,ICTERUS,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,CPK,CPK,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,THYROID PROFILE T4 T3UP FTI TSH,T 4,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0825,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,URINALYSIS,BILIRUBIN,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,LIVER FIBROTEST ACTITEST,NECROINFLAMMAT ACT SCORE,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,LIPID PANEL,HDL AS % CHOLESTEROL,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,HEPATITIS PANEL ACUTE,HEPATITIS C ANTIBODY,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.0,0.0,0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.1569574215481997,0.0,0.0,1,264648,CBC WITH AUTO DIFF,WBC,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.36,0.5242857142857142,0.9175,0.0,0.11857142857142856,0.2075,0.007003812612930815,0.6069574118776362,0.6844120915582587,0.0,0.04612090043126471,0.0520064526950299,1,632117,SMOOTH MUSCLE AB F ACTIN REFLEX IFA TITER,F ACTIN IGG,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.07142857142857142,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,CBC WITH DIFFERENTIAL,IMMATURE GRANS,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,ANEMIA PROFILE B,UIBC,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,UA W MICRO HOLD SPEC 24 HR,SPECIFIC GRAVITY,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.16,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,CBC W AUTO DIFF ABS WBC MPV PLT,NEUTROPHILS,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,IMMUNOGLOBULIN A,IMMUNOGLOBULIN A,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,URINALYSIS WITH MICROSCOPIC,PROTEIN,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.09338639438323382,0.0,0,18358,FERRITIN,FERRITIN SERUM,Alpha-2-Macroglobulin,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc
0.055,0.033,0.0,0.0,0.059,0.185,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,ACUTE HEPATITIS PANEL,HEPATITIS A AB IGM,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,HEMOGLOBIN A1C,ESTIMATED AVG GLUCOSE,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,CMP14 LP CBC D PLT,NEUTROPHILS,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,MANUAL DIFFERENTIAL,EOSINOPHILS ABSOLUTE,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,1.0,1,205708,CBC WITH AUTO DIFF,HEMATOCRIT,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,COMP METABOLIC PANEL W GFR,GLOBULIN,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,CBC WITH AUTO DIFF,BASOPHILS %,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,FIBROACT,NECROINFL SCORE,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,NGI HCV SUPERQUANT,INTERNATIONAL UNITS,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,COMPREHENSIVE METABOLIC PANEL W O ALT,BUN CREATININE RATIO,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.3333333333333333,0.0,0.25,0.16666666666666666,1.0,0.0,0.03258155267402285,0.0,0.06605502583691747,0.05720402135206337,0.7071067811865476,1,7047,COMPLETE BLOOD COUNT,BASOPHILS ABSOLUTE,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,C REACTIVE PROTEIN CARDIAC,C REACTIVE PROTEIN CARDIAC,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,COMPREHENSIVE METABOLIC PANEL,CALCIUM,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,PROTEIN ELECTRO S,ALPHA 2 GLOBULIN,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.1,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,HIV ANTIBODY 1 WESTERN BLOT,HIV WB INTERP,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.1675,0.11166666666666668,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,CBC WITH PLT MAN DIFF,BANDS ABSOLUTE,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,COMP METABOLIC PANEL,SODIUM,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.027777777777777776,0.05,0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.06790824855576716,0.0,0,139527,IRON BINDING CAPACITY % SATURATION,IRON SERUM,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,CBC W O DIFF WITH PLATELETS,PLATELET COUNT,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.186,0.16909090909090907,0.2657142857142857,0.186,0.16909090909090907,0.2657142857142857,0.018078433005112804,0.02082217952079146,0.022427613193394258,0.018078433005112804,0.02082217952079146,0.022427613193394258,1,568881,HIV 4TH GEN RFLX CONF,HIV 4TH GEN RFLX CONF,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,SMOOTH MUSCLE AB RFX TITER,F ACTIN IGG,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,HEPATITIS B SURFACE ANTIBODY,HEPATITIS B SURFACE AB QUAL,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,CBC DIFF PLT,MCH,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,CBC WITH AUTO DIFF,MONOCYTES #,Ceruloplasmin,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,CBC INCLUDES DIFF PLT,BASOPHILS %,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.12285714285714286,0.0,0.0,0.12285714285714286,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,CMP WITH EGFR,EGFR NON AFRICAN AM,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,IRON TOTAL,HEMOLYSIS,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,CMP12 LP TP TSH 6AC CBC D PLT,EOS ABSOLUTE,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,COMP METABOLIC PROFILE FASTING CMP,BUN CREATININE RATIO CALC,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,DRG TOX CRT REFL SPEC GR,CREATININE,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,WBC,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,CBC INC DIFF PLT,PLATELET COUNT,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,URIC A ESR WES ANA RA QN CC,URIC ACID,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0125,0.0625,0.0,0.0165,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,UA MICROSCOPIC REFLEX CULTURE,RED BLOOD CELLS,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,ASH FIBROSURE,APOLIPOPROTEIN A 1,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.2,0.3333333333333333,0.4466666666666667,0.4,0.6666666666666666,0.0,0.0,0.0,0.0,0.5319935785070767,0.5335152913507774,1,111252,CBC WITH PLT DIFF,PLATELET MORPHOLOGY,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.0,0.0,0.0,0.06999999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,HCV FIBROSURE,INTERPRETATION,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,LIPID PROFILE,FASTING NON FASTING,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,MICROALBUMIN RANDOM URINE W CREATININE,MICROALBUMIN CREATININE RATIO RANDOM URINE,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,DRUG ABUSE SCREEN I,AMPHETAMINES,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,CEA CARCINOEMBRYONIC ANTIGEN,CEA CENTAUR,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,STOOL CULTURE,RESULT 2,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,VITAMIN B 12 FOLIC ACID,VITAMIN B 12,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,CREATINE KINASE TOTAL,CREATINE KINASE TOTAL,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.09571428571428572,0.134,0.0,0.09571428571428572,0.134,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,PSA TOTAL % FREE,PSA FREE,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,NASH FIBROSURE,AST SGOT P5P,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,LIVER FIBROSIS PNL HEPASCORE TM,METAVIR SCORE,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,PLATELET ESTIMATION,PLATELET ESTIMATION,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,CBC,MO#,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,COMP METAB PANEL,EGFR NON AFR AMERICAN,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,BAND NEUTROPHILS,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,HB S AG W REFLEX CONF,HB S AG,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.047142857142857146,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,PATHOLOGIST SMEAR REVIEW,RBC,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.05043482321394899,0.0,0.0,0.12353958214165095,1.0,1,196592,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,PHENCYCLIDINE,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.2866666666666667,0.3333333333333333,1.0,0.0,0.0,0.0,0.0,0.042056338045787456,0.046108379515458875,1,20859,LP LDL DIRECT,HDL CHOLESTEROL,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.25,0.16666666666666666,1.0,0.25,0.16666666666666666,1.0,0.06539244069491312,0.1347605904070781,1.0,0.06539244069491312,0.1347605904070781,1.0,1,205674,FERRITIN,FERRITIN,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.07571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,HGB A1C WITH EAG ESTIMATION,HEMOGLOBIN A1C,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA TITER,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.11,0.1325,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,URINALYSIS,BILIRUBIN,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.3333333333333333,0.16666666666666666,0.5,0.3333333333333333,0.16666666666666666,0.5,0.09173176111477566,0.11030835743396694,0.0,0.06486415033444226,0.07799978756310755,0.0,1,205088,RPR,RPR RESULT,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.0,0.0,0.3333333333333333,0.14285714285714285,0.5,0.0,0.0,0.0,0.060037523066651444,0.0,0.0,1,19208,PROFILE 104 LIVER,AST SGOT,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,LIVER FIBROSIS PNL HEPASCORE TM,METAVIR SCORE,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.3333333333333333,0.3333333333333333,1.0,0.3333333333333333,0.16666666666666666,1.0,0.060037523066651444,0.45528141890436646,0.7071067811865476,0.060037523066651444,0.45528141890436646,0.7071067811865476,1,17988,AMYLASE SERUM,AMYLASE SERUM,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,URINALYSIS W REFLEX MICRO,WHITE BLOOD CELLS,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.031811089746947796,0.0,0.0,0.0,0.0,0,115790,IFE PE SERUM,ALPHA 1 GLOBULIN,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.1569574215481997,0.0,0.0,1,303842,CBC WITH ABSOLUTE WHITE BLOOD CELLS,RDW,Erythrocyte distribution width,Erythrocyte distribution width [Entitic volume],RDW RBC
0.11,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,UA MICROSCOPIC REFLEX CULTURE,WHITE BLOOD CELLS,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.22333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.0983573569202505,0.10031748330730439,0.0,0.0,0.0,0,93187,BUN CREATININE,EGFR AFRICAN AMERICAN,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CARBON DIOXIDE,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,CYCLIC CITRULLINATED PEPTIDE CCP AB IGG,CYCLIC CITRULLINATED PEPTIDE CCP AB IGG,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.25666666666666665,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,URINALYSIS CULTURE IF INDICATED,OCCULT BLOOD,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.009561032825784799,0.0,0,192526,CBC RBC H H INDICES WBC PLT,RED BLOOD CELL COUNT,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,HIV AG AB 4TH GEN RFL,HIV AG AB 4TH GEN,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,TESTOSTERONE FREE TOTAL LC MS,TESTOSTERONE TOTAL LC MS,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,19638,COMPREHENSIVE METABOLIC PANEL,CARBON DIOXIDE,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.008976764595382658,0.0,0.0,0.0,0.0,0,110544,ALBUMIN CREATININE RATIO URINE RANDOM,CALC ALBUMIN CREAT RND,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,LYMPHOCYTE SUBSET PANEL 2,HELPER SUPPRESSOR RATIO,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,FIBROACT COMPLETE,HEIGHT INCHES,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.31,0.25,0.0,0.3333333333333333,0.25,1.0,0.0,0.0840117798597445,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,823781,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,OMBITASVIR RESISTANCE,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,PROTEIN CREATININE RATIO URINE,PROTEIN UR MG DL,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,DRUG ABUSE SCREEN II,BENZODIAZEPINES,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,IFE PE SERUM,GLOBULIN TOTAL,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,BUN CREATININE RATIO,ICTERUS,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.11200000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,LIPID PROFILE WITH CALC NON HDL CHOLESTEROL,RISK RATIO LDL HDL,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,AST CBC D PLT,EOS,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,URINALYSIS CULTURE IF INDICATED,OCCULT BLOOD,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.1142857142857143,0.16,0.0,0.06285714285714286,0.088,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,HEMOGLOBIN A1C WITH EAG,ESTIMATED AVERAGE GLUCOSE,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,CD4 CD8 LYMPHOCYTE ENUMERATION,PERCENT CD4,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.02428571428571429,0.034,0.0,0.08142857142857143,0.11400000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,LP NON HDL CHOLESTEROL,VLDL CHOLESTEROL CAL,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,HIV 1 HIV 2 AB SCREEN,HIV 1 HIV 2 AB SCREEN,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,IFE PE SERUM,GLOBULIN TOTAL,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.2,0.5,0.0,0.2,0.5,0.0,0.010871512957143614,0.017347737025014798,0.0,0.010871512957143614,0.017347737025014798,0,422543,CYCLIC CITRULLINATED PEPTIDE CCP AB IGG,CYCLIC CITRULLINATED PEPTIDE CCP AB IGG,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.011337917407329035,0.0,0.0,0.0,0.0,0,108860,IRON TIBC SERUM,IRON BINDING CAPACITY,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,PSA TOTAL % FREE SERIAL,% FREE PSA,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.0,0.0,0.0,0.0,0.08779161868611507,1.0,0.0,0,285395,CBC W DIFF PLATELET,MCH,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,CMP14 5AC,EGFR IF NONAFRICN AM,Hemoglobin,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,ANTIPHOSPHOLIPID SYNDROME,PT,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.0,0.0,0.0,0.0335,0.07444444444444445,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,LIPID PANEL STANDARD,CHOLESTEROL HDL RATIO,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,URINALYSIS COMPLETE,BILIRUBIN,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,DRUG ABUSE SCREEN 8 W CONFIRMATION,BARBITURATES,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,CREATINE KINASE TOTAL,CREATINE KINASE TOTAL,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,HEP A AB IGM,HEPATITIS A AB IGM,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A DRUG RESISTANCE ASSAY,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,COMP METABOLIC PANEL W GFR,ANION GAP,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,CBC,HCT,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.11,0.0,0.0,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,HEPATITIS B SURFACE AB IMMUN,HEPATITIS B SURFACE AB IMMUNITY QN,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,CMP14 LP 5AC CBC D PLT RPR,WBC,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D3,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,CBC INCLUDES DIFF PLT,BASOPHILS ABSOLUTE,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.25,0.3333333333333333,0.0,0.25,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,HCV RNA PCR QN RFX NSA,HCV GENOSURE R NSA PDF,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,IMMUNOGLOBULINS,IMMUNOGLOBULIN G,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,HEPATIC FUNCTION PANEL A,TOTAL PROTEIN,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.39666666666666667,0.1111111111111111,0.2,0.39666666666666667,0.1111111111111111,0.2,0.029399247153846342,0.04801838305228456,0.06720098415971731,0.04157681404852809,0.06790824855576716,0.09503654320349175,1,51961,HB S AG W REFLEX CONF,HB S AG,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,LIPOPROT LDL DIRECT,LIPOPROT LDL DIRECT,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.01470053887553957,0.0,0.0,0.0,0.0,0,303644,COMPLETE BLOOD COUNT,NEUTROPHILS ABSOLUTE,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,CREATININE,EGFR IF NONAFRICN AM,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.265,0.0,0.5,0.5,1.0,0.0,0.0,0.0,0.1503314858492919,0.7071067811865476,1.0,1,57786,UA W RFLX MICROSCOPIC,COLOR,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,CBC,MCH,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,NASH FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,COMPREHENSIVE METABOLIC PANEL E GFR,SODIUM,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.16,0.0,0.1675,0.192,0.96,0.0,0.05043482321394899,0.0,0.0,0.0,0.0,1,193433,DRUG ABUSE SCREEN W ETOH NO GCMS,AMPHETAMINES,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,PROTEIN ELEC INTERP SERUM,M SPIKE,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,PROTEIN ELECTRO S,PLEASE NOTE,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.3333333333333333,0.0,0.0,0.3333333333333333,0.0,0.0,0.02142196630047022,0.0,0.0,0.1569574215481997,0.0,0.0,1,264648,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,WBC,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,CBC INCLUDES DIFF PLT,BAND NEUTROPHILS,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,ACCUTYPE R IL28B,IL28B GENOTYPE,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,OBSTETRIC PANEL,RPR RESULT,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.14285714285714285,0.0,0.0,0.14285714285714285,0.0,0.0,0.16916093904956808,0.0,0.0,0.16916093904956808,0.0,0,25320,COMPLEMENT C4 SERUM,COMPLEMENT C4 SERUM,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,VITAMIN B 12 FOLIC ACID,VITAMIN B 12,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,LYMPHOCYTE SUBSET PANEL 4,COMMENTS,Eosinophils,Eosinophils [#/volume] in Blood,Eosinophil # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,LP WITHOUT VLDL CHOL HDL,LDL CHOLESTEROL CALC,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,FREE T3,FREE T3,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,NGI HCV SUPERQUANT,HEPATITIS C QUANTITATION,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,HCV FIBROSURE,INTERPRETATION,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA TITER,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,URIC ACID,URIC ACID,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.022706337559657674,0.0,0.0,0.0,0.0,0,237610,CBC WITH ABSOLUTE WHITE BLOOD CELLS,RDW,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE CD4,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,COMPREHENSIVE METABOLIC PANEL WITH GFR,CREATININE,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,T3 FREE,T3 FREE,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.25,0.16666666666666666,0.94,0.25,0.16666666666666666,0.94,0.05026217761451124,0.056942591518096664,0.0,0.05026217761451124,0.056942591518096664,0.0,1,93179,PLATELET ESTIMATION,PLATELET ESTIMATION,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,PROTHROMBIN TIME,INR,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,DIFFERENTIAL MANUAL,NEUTROPHILS ABSOLUTE,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,CBC COMPLETE BLOOD COUNT W O DIFF,MCHC,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,CBC WITH DIFFERENTIAL,MONOCYTES,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,CBC WITH AUTO DIFF,PLATELET COUNT,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,CMP14 HP4 DBILI CBC D PLT R,EOS ABSOLUTE,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,PROTEIN ELECTRO S,ALPHA 2 GLOBULIN,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,PROTEIN ELECTRO S,ALPHA 1 GLOBULIN,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,URINE MICROALBUMIN CREAT RATIO,UR MICROALBUMI,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,CBC,MONOCYTES ABSOLUTE,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,UA M W RFLX CULTURE COMP,WBC,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,PROTEIN ELEC INTERP SERUM,P E INTERPRETATION S,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D3,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,CBC WITH AUTO DIFF,WBC,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.0,0.0,0.0,0.092,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,1,7138,CMP14 3AC CBC D PLT RPR MG,EOS,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,URINALYSIS CULTURE IF INDICATED,UROBILINOGEN,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.27,0.0,0.0,0.2783333333333333,0.5,0.6666666666666666,0.006570998517002713,0.0,0.0,0.03275101358391164,1.0,0.1986458339579933,1,487959,HCV FIBROSURE,FIBROSIS SCORE,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.186,0.16909090909090907,0.2657142857142857,0.386,0.24181818181818182,0.38,0.018078433005112804,0.02082217952079146,0.022427613193394258,0.05423529901533852,0.062466538562374274,0.06728283958018277,1,568881,HIV ANTIGEN ANTIBODY FOURTH GENERATION W RFL,HIV AG AB 4TH GEN,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,UREA NITROGEN BUN,UREA NITROGEN BUN,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,CMP CBC TSH,ABSOLUTE BLASTS,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,CBC WITH AUTO DIFF,EOSINOPHILS ABSOLUTE,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.06999999999999999,0.06999999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,UA MICROSCOPIC REFLEX CULTURE,OCCULT BLOOD,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.125,0.2,0.75,0.0,0.0,0.0,0.0059890119329250036,0.0,0.0,0.0,0.0,0.0,0,426171,HCV FIBROSURE,GGT,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,EP LP 11AC CBC D PLT TSH FER,CALCIUM,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.27,0.25,0.4,0.0,0.0,0.0,0.03937969291800214,0.06185427189076809,0.13271332481154674,1,7641,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,BAND NEUTROPHILS,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,CBC INCLUDES DIFF PLT,BAND NEUTROPHILS,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.07142857142857142,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,CBC INC DIFF PLT,MONOCYTES,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,LP NON HDL CHOLESTEROL,VLDL CHOLESTEROL CAL,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,PROTIME PTT,PTT,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.021862468942030144,0.0,0.0,0.0,0.0,0,81224,COMPLETE BLOOD COUNT,BASOPHILS %,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,LIPID PANEL STANDARD,CHOLESTEROL HDL RATIO,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,PROTIME PTT,PTT,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD8 CELLS,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.11399999999999999,0.13249999999999998,0.1875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,DRUG ABUSE SCREEN 9 NO THC W CONF,OXYCODONE,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,CHEM PROFILE 29,ALK PHOS,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,HCV RNA NS5A GENOTYPE,DACLATASVIR RESISTANCE,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.2,0.375,0.75,0.2,0.375,0.75,0.03080009996173494,0.0,0.0,0.03080009996173494,0.0,0.0,0,139550,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B DRUG RESISTANCE ASSAY,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.044444444444444446,0.08,0.0,0.044444444444444446,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE MONOCYTES,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,CMP12 LP 6AC,CHOLESTEROL TOTAL,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,HEPATIC FUNCTION PANEL A,TOTAL PROTEIN,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,MITOCHONDRIAL AB W RFX TITER,MITOCHONDRIAL AB SCN,Erythrocytes,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,EGFR,EGFR,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.02341720037657824,0.0,0.0,0.0,0.0,0,264531,CBCI COMPLETE BLOOD COUNT W DIFF,MCV,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,URINALYSIS COMP W RFL CULTURE,PROTEIN,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,LDL CHOLESTEROL DIRECT,LDL CHOL DIRECT,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,ALBUMIN CREATININE RATIO RANDOM URINE,CALC ALBUMIN CREAT RND,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,DRUG ABUSE SCREEN 8 W CONFIRMATION,BARBITURATES,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE LYMPHOCYTES,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.1,0.0,0.2,0.125,0.5,0.0,0.02509091837088262,0.0,0.05623518965539054,0.07096783410499707,0.7071067811865476,1,196444,DRUG ABUSE SCREEN 11 W ETOH NO CONF,OXYCODONE,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,VITAMIN B12 FOLATE,FOLATE SERUM,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.4766666666666666,0.25,0.5,0.4766666666666666,0.25,0.5,0.010626391791545897,0.6369705461296918,0.9870524497488843,0.010626391791545897,0.6369705461296918,0.9870524497488843,1,312017,HIV 1 HIV 2 AB SCREEN,HIV 1 HIV 2 AB SCREEN,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,CBC W AUTO DIFF ABS WBC MPV PLT,NEUTROPHILS,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.2222222222222222,0.4,0.0,0.2222222222222222,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,HCV ANTIBODY REFLEX NAA,HCV RNA NAA QUALITATIVE,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,PROTIME PTT,PTT,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,CBC WITH PLT MAN DIFF,BANDS ABSOLUTE,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,TRANSFERRIN SATURATION,TRANSFERRIN,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,CREATINE KINASE TOTAL,LIPEMIA,Neutrophils,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,NEG HIV 4TH GEN,NEG HIV 1 RNA QL TMA,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,LYMPHOCYTE SUBSET PANEL 2,% CD3 MATURE T CELL,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCV,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.09247447620418048,0.34003516797720323,1.0,0.09247447620418048,0.34003516797720323,1.0,1,30346,TRANSFERRIN,TRANSFERRIN,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,NASH FIBROSURE,HEIGHT,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,CBC WITH PLT DIFF,WBC MORPHOLOGY,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,BASIC METABOLIC PANEL,EGFR NON AFR AMERICAN,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,TRIIODOTHYRONINE T3 FREE,TRIIODOTHYRONINE T3 FREE,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,PATHOLOGIST SMEAR REVIEW,RBC,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.014350566291898903,0.0,0.0,0.0,0.0,0,111252,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,RDW,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,DRGABU2,METHAQUALONE,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,CMP14 LP TP TSH 4AC CBC D P,HEMATOCRIT,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,URINALYSIS REFLEX,GLUCOSE QL,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,CMP14 LP 3AC CBC D PLT,LYMPHS,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,MICROALBUMIN RANDOM,MICROALBUMIN CR RATIO,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,CMP14 HP4 DBILI CBC D PLT R,C REACTIVE PROTEIN QUANT,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,PROTHROMBIN TIME,PT POP MEAN,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.435,0.3333333333333333,1.0,0.435,0.3333333333333333,1.0,0.010606315746132022,0.8842696816801202,0.957651366164057,0.010348362482358597,0.03899614814102015,0.04223226840869254,1,29918,TESTOSTERONE FREE TOTAL LC MS,FREE TESTOSTERONE DIRECT,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,HCV RNA NS5A GENOTYPE,LEDIPASVIR RESISTANCE,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,DRUG ABUSE SCREEN II,COCAINE METABOLITE,Bacteria identified,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,CUSTOM HEPATITIS PANEL,HEPATITIS C ANTIBODY,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.06666666666666667,0.25,0.0,0.06666666666666667,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,HAV AB TOTAL,HAV AB TOTAL,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,FOLATE,FOLATE,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN CREATININE RATIO,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.2,0.375,0.75,0.0,0.25,0.5,0.03976275807110774,0.0,0.0,0.0,0.06547241049372987,0.08868207335447242,0,139550,NGI HCV SUPERQUANT,HEPATITIS C QUANTITATION,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,CBC INC DIFF PLT,MONOCYTES,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,URINALYSIS W REFLEX MICRO,WHITE BLOOD CELLS,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,POL CMP WITH EGFR INV,GLUCOSE,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,CBC PLT DIFF,POLYS,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,NEG HIV 4TH GEN,NEG HIV 2 ANTIBODY,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,EGFR,EGFR,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,CMP WITH EGFR,EGFR NON AFRICAN AM,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,BASIC METABOLIC PANEL 8,EGFR IF AFRICN AM,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,URINALYSIS W REFLEX MICRO,RED BLOOD CELLS,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,IMMUNOGLOBULINS IGG A M SER,IMMUNOGLOBULIN A,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE CD4,Monocytes,Monocytes [#/volume] in Blood,Monocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,SMN1 COPY NUMBER ANALYSIS,SPECIMEN TYPE,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,HCV GT3 NS5A DRUG RESIST ASSAY,HCV NS5A DRUG RESIST ASSAY,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,MITOCHONDRIAL AB W RFX TITER,MITOCHONDRIAL AB SCN,Sex,Sex,Sex
0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.02106673651623614,0.0,0.0,0.0,0.0,0,244673,CBCI COMPLETE BLOOD COUNT W DIFF,DIFFERENTIAL NEUTROPHILS,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,CMP CBC TSH,ABSOLUTE BLASTS,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,PROTEIN ELECTRO S,BETA GLOBULIN,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.0,0.0,0.25,0.09090909090909091,1.0,0.0,0.0,0.0,0.058854483963441506,0.04322678270641078,1.0,1,611517,COMPREHENSIVE METABOLIC PANEL E GFR,ALBUMIN,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,LIVER FIBROSIS FIBROMETER,ALPHA 2 MACROGLOBULIN FM,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.006,0.0225,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,CMP13 LP 2AC CBC D PLT,ALT SGPT,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,HCV GENOSURE R NSA,HCV GENOSURE R NSA,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,OMBITASVIR RESISTANCE,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CBC W AUTO DIFF ABS WBC MPV PLT,NEUTROPHILS,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.5,0.0,0.0,0.0,0.07776291418096726,0.1106775195057691,0.14187034543632637,1,312082,TRICHOMONAS MALE,SOURCE,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,FIBROSIS SCORE,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN RT PCR LOG COPIES ML,Color,Color of Urine,Color Ur
0.3333333333333333,0.351,0.608,0.3333333333333333,0.351,0.608,0.31830503283138056,0.5707899377594806,0.8164760814988351,0.31830503283138056,0.5707899377594806,0.8164760814988351,1,51938,HEP B SURFACE AB IMMUNITY QN,HEP B SURFACE AB IMMUNITY QN,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,COMP METABOLIC PANEL,ANION GAP,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,RENAL PANEL 10,EGFR IF AFRICN AM,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,DIFFERENTIAL MANUAL,ABSOLUTE LYMPHOCYTES,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,ACUTE HEPATITIS PANEL,HEPATITIS A AB IGM,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,RPR REFLEX PER CDC,RPR,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,CBC WITH DIFFERENTIAL,NEUTROPHILS,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,MANUAL DIFFERENTIAL,LYMPHOCYTES ABSOLUTE,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,FOLATE,FOLATE,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,CBC WITH AUTO DIFF,MONOCYTES #,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,CBC INCLUDES DIFF PLT,ABSOLUTE BAND NEUTROPHILS,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.11399999999999999,0.08142857142857142,0.11399999999999999,0.0,0.02142857142857143,0.03,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BARBITURATES,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,Leukocyte morphology finding,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,CMP14 5AC,BILIRUBIN TOTAL,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,LDL CHOLESTEROL DIRECT,LDL CHOL DIRECT,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,MICROALBUMIN CREATININE RANDOM RATIO,CALC MICROALB CREAT RND,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.09,0.12666666666666668,0.19,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,COMP METABOLIC PANEL W GFR,GLOBULIN,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.0,0.0,0.0,0.0,0.06899999999999999,0.07444444444444445,0.0,0.0,0.0,0.0,0.00492133809918216,0.0,0,882936,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN CREATININE RATIO,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,CMP14 LP CBC D PLT UA MG TS,VLDL CHOLESTEROL CAL,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,UA MICROSCOPIC REFLEX CULTURE,SPECIFIC GRAVITY,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.044444444444444446,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,DIFFERENTIAL MANUAL,NEUTROPHILS ABSOLUTE,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,FOLATE,FOLATE,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,BASIC METABOLIC PANEL,BUN,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,URINE DRUG SCREEN 1,CREATININE,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,TSH ULTRASENSITIVE,TSH ULTRASENSITIVE,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,HEPATITIS PANEL AMA,HEPATITIS C ANTIBODY,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,CBC W AUTO DIFF,MCHC,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,HCV GENOSURE R NSA,HCV GENOSURE R NSA,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.2,0.42857142857142855,0.6,0.33399999999999996,0.6828571428571429,0.9560000000000001,0.008234817298221175,0.0,0.0,0.021528614002227053,0.023005461933579552,0.031045756027934357,1,728626,HCV RNA PCR RFX NS5B,HCV NS5B RESISTANCE ASSAY PDF,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,HEPATITIS B SURF AG,HEPATITIS B SURF AG,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,T B LYMPHOCYTE NK NYSDOH,PLATELETS,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,CBC,% BASOPHILS,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.396,0.1142857142857143,0.26666666666666666,0.0,0.0,0.0,0.0,0.34003516797720323,1.0,1,18697,NASH FIBROSURE,APOLIPOPROTEIN A 1,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,COMPREHENSIVE METABOLIC PANEL,CALCIUM SERUM,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,LYMPHOCYTE SUBSET PANEL 5,ANALYZED DATE TIME NR,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,CMP14 HP4 DBILI CBC D PLT R,LYMPHS,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,COMP METAB PANEL,GLUCOSE FASTING,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.11399999999999999,0.285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BARBITURATES,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,LIVER FIBROSIS PANEL,HAPTOGLOBIN,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.0778704158893051,0.14740142971618808,1.0,0,382507,EP LP 11AC CBC D PLT TSH FER,CALCIUM,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE MONOS,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,UROGRAM,KETONES,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,HEPATITIS C AB REFLEX HCV RNA QUANT,HEPATITIS C ANTIBODY,Bacteria identified,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,FIBROACT COMPLETE,APOLIPOPROTEIN A1,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.2,0.42857142857142855,0.6,0.33399999999999996,0.6828571428571429,0.9560000000000001,0.008116914535954867,0.0,0.0,0.019652845868068813,0.021001017411413248,0.02834076815216946,1,728626,HCV RNA PCR QN RFX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,LIVER FIBROSIS FIBROTEST ACTITEST,BILIRUBIN,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,HCV RNA GENOTYPE LIPA R,HCV RNA GENOTYPE LIPA,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,HIV AB EIA WITH REFLEXES,HIV AB,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN CREATININE RATIO,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,VAP CHOLESTEROL PROFILE,TRIGLYCERIDES,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,CBC W AUTO DIFF,MEAN PLATELET VOLUME,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,MICROALBUMIN RANDOM URINE W CREATININE,MICROALBUMIN CREATININE RATIO RANDOM URINE,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,MAGNESIUM SERUM,MAGNESIUM SERUM,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BARBITURATES,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,EP LP 11AC CBC D PLT TSH FER,CALCIUM,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,PROTHROMBIN TIME,PT POP MEAN,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,LIPOPROT LDL DIRECT,LIPOPROT LDL DIRECT,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,HEPATITIS A DIAGNOSTIC PANEL,HAV AB TOTAL,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,CD4 T4 ENUMERATION,ABSOLUTE LYMPHOCYTES,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,URINALYSIS W MICROSCOPIC,URINALYSIS URINE COLOR,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,UA MICROSCOPIC REFLEX CULTURE,KETONES,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,CMP14 LP CBC D PLT TSH UA M,AST SGOT,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,VELPATASVIR RESISTANCE,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,HCV RNA QN GRAPH RFX NSA,HEPATITIS C QUANTITATION,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.5,0.5,1.0,0.5,0.375,1.0,0.48462344379507305,0.011337917407329035,0.011598869223880981,0.4900689862175951,0.011465317579597123,0.011729201619518514,1,108860,PSA FREE TOTAL,PSA FREE,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,CMP14 HP4 1AC PT AFP,HEP A AB IGM,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.134,0.08375,0.0,0.178,0.11125,0.2966666666666667,0.0,0.0,0.0,0.0,0.0,0.0,1,7633,CBC WITH PLT MAN DIFF,BANDS ABSOLUTE,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,TRANSFERRIN CARBOHYDRATE DEFICIENT ALCOHOL USE,TRANSFERRIN,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.0,0.08833333333333333,0.0,0.0,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,CERULOPLASMIN,CERULOPLASMIN,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,CBC WITH PLT DIFF,RDW,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.16999999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,486423,CMP14 2AC MG,EGFR IF NONAFRICN AM,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,LIVER FIBROSIS PNL HEPASCORE TM,METAVIR SCORE,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,ANA AMA ASMA LKM AB,MITOCHONDRIAL M2 ANTIBODY,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.044444444444444446,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,CD4 T4 ENUMERATION,ABSOLUTE LYMPHOCYTES,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,IRON TOTAL,HEMOLYSIS,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,CBC W O DIFF WITH PLATELETS,RBC,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,CMP12 LP TP TSH 6AC CBC D PLT,LDH,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE NEUTROPHILS,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,FERRITIN,FERRITIN,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,COMPREHENSIVE METABOLIC PANEL E GFR,CARBON DIOXIDE,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,RHEUMATOID FACTOR QUANT,RHEUMATOID FACTOR QUANT,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,TESTOSTERONE FREE TOTAL LC MS,FREE TESTOSTERONE DIRECT,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,LYMPHOCYTES,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,CERULOPLASMIN,CERULOPLASMIN,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.07142857142857142,0.1,0.0,0.047142857142857146,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,CBC INC DIFF PLT,PLATELET COUNT,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,LIPID PANEL W CHOL HDL RATIO,VLDL CHOLESTEROL CAL,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.04833333333333333,0.0,0.0,0.06666666666666667,0.04,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,DIFFERENTIAL MANUAL,ABSOLUTE NEUTROPHILS,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.16625,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,HCV FIBROSURE LABCORP,RESULT,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,HIV ANTIBODY 1 WESTERN BLOT,HIV WB INTERP,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,1.0,0.0,0.0,0.0,0.04623723810209024,0.4596659728295527,0.8660254037844386,1,30940,COMPREHENSIVE METABOLIC PANEL REFL,UREA NITROGEN BUN,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,HEPATITIS C GENO TYPE 1 NS5A RESIST,OMBITASVIR RESISTANCE,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,CMP,BUN BLOOD UREA NITROGEN,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,HIV AB 1 HIV 2 EIA W REFL 1 WB,HIV EIA AB SCREEN,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.06666666666666667,0.0,0.0,0.06666666666666667,0.0,0.0,0.04540213241165436,0.0,0.0,0.04540213241165436,0.0,0,426171,FERRITIN SERUM,FERRITIN SERUM,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,CMP,ALBUMIN,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.1325,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,ACUTE HEPATITIS PANEL,HEPATITIS B SURF AG,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,THYROID PROFILE T4 T3UP FTI TSH,T 4,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,CRP,C REACTIVE PROTEIN ULTRA,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.25,0.2,0.0,0.0,0.548,0.87,0.04221452135443238,0.06312481184311647,0.0,0.0,0.6143530535007152,0.9567642781036875,1,50484,ANA TITER PATTERN,ANTI NUCLEAR AB TITER,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,FE ANA TIBC FER A1A AMA ASM,ALPHA 1 ANTITRYPSIN SERUM,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,HEPATITIS B SURFACE AB IMMUN,HEPATITIS B SURFACE AB IMMUNITY QN,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,COMPREHENSIVE METABOLIC PANEL E GFR,SODIUM,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,ANTI SMOOTH MUSCLE MITOCHOND,MITOCHONDRIAL M2 ANTIBODY,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,MICROALBUMIN CONC,ALB CREAT RATIO,Reference lab test method,Reference lab test method,Ref lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,DRUG ABUSE SCREEN III,AMPHETAMINES,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.075,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,MAYNAC CMP 4AC LIPID CBC T4 TSH PSA PROFILE,MCH,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,LIVER FIBROSIS FIBROMETER,ALPHA 2 MACROGLOBULIN FM,Race,Race,Race
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.0834655896020069,0.34003516797720323,1.0,1,20750,COMP METABOLIC PANEL W GFR,CHLORIDE,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.5,0.4444444444444444,0.8,0.5,0.1111111111111111,0.2,0.07601041756762406,0.05504399149282735,0.04116208411637334,0.4593936218462633,0.013391678360790693,0.01001434264116019,1,339358,CCP ANTIBODY IGG,ANTI CCP IGG,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,COMPREHENSIVE METABOLIC PANEL E GFR,CALC GLOBULIN,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,TESTOSTERONE FREE LC MS MS,TESTOSTERONE FREE LC MS MS,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,CHEM SCREEN PANEL HDL,URIC ACID,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,HEPATIC FUNCTION PROFILE,BILIRUBIN INDIRECT,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,EGFR,EGFR,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.0,0.2,0.0,0.155,0.2,0.5,0.0,0.02146570986203966,0.0,0.0,0.07982873259716383,0.5,0,304519,CBCI COMPLETE BLOOD COUNT W DIFF,DIFFERENTIAL NEUTROPHILS,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,LIPID PANEL STANDARD,CHOLESTEROL HDL RATIO,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.04,0.072,0.0,0.024444444444444446,0.044,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,BASIC METABOLIC PANEL,EGFR NON AFR AMERICAN,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,CMP13 LP 2AC CBC D PLT,EGFR IF AFRICN AM,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,CBC WITH AUTO DIFF,RDW,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.07142857142857142,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,RPR RFX QN RPR CONFIRM TP,TREPONEMA PALLIDUM ANTIBODIES,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,ANA TITER PATTERN,ANTI NUCLEAR AB TITER,Body height,Body height Measured,Body height Measured
0.0,0.0,0.06200000000000001,0.0,0.0,0.06200000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,CARDIO CRP R,CARDIO CRP R,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,ACTIVATED PTT,ACTIVATED PTT PATIENT,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.25,0.4,0.5,0.0,0.0,0.0,0.05249083695705592,0.1253627038833952,0.08190888212768821,0,81224,URINALYSIS W REFLEX MICRO,RED BLOOD CELLS,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,URINALYSIS W REFLEX MICRO,BACTERIA,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,HCV RNA PCR QN RFX NSA,HCV GENOSURE R NSA PDF,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,CBC W DIFF PLATELET,MCH,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE MONOCYTES,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,SPECIAL PROFILE 3619,LEUKOCYTE ESTERASE,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,NASH FIBROSURE,WEIGHT,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.011764705882352941,0.025,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,COMP METABOLIC PANEL,GLOBULIN,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,DIFFERENTIAL MANUAL,ABSOLUTE EOSINOPHILS,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,CBC WITH DIFFERENTIAL PLATELETS,POLYS,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,LIVER FIBROSIS FIBROMETER,ALPHA 2 MACROGLOBULIN FM,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.0,0.028999999999999998,0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,CMP CBC TSH,ABSOLUTE BLASTS,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt
0.31,0.20428571428571426,0.9533333333333333,0.31,0.20428571428571426,0.9533333333333333,0.021033838986238895,0.07126828601996171,0.5345224838248488,0.027825153537281433,0.09427908058731993,0.7071067811865476,1,295410,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,LIPID PROFILE,NON HDL CHOLESTEROL,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,HEPATITIS B CORE AB TOTAL,HEPATITIS B CORE AB TOTAL,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.07761546026945332,0.0,0.0,0.0,0.0,0,30841,IFE PE SERUM,ALPHA 2 GLOBULIN,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.049239293855151356,0.0,0.0,0.0,0.0,1,143149,DRUG ABUSE SCREEN II,COCAINE METABOLITE,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,COMP METABOLIC PANEL 14,EGFR IF AFRICN AM,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,HIV 4TH GEN RFLX CONF,HIV 4TH GEN RFLX CONF,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,CYSTIC FIBROSIS SCREEN,ETHNICITY,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,CBC INCLUDES DIFF PLT,BASOPHILS ABSOLUTE,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,OBSTETRIC PANEL,RPR RESULT,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.16666666666666666,0.08888888888888889,0.13333333333333333,0.0,0.0,0.0,0.02501557764389295,0.04555698106201478,0.09518537001083005,0.0,0.0,0.0,0,139543,HIV AG AB 4TH GEN RFL,RACE NR,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,T B LYMPHOCYTE NK NYSDOH,PLATELETS,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,CBC W AUTO DIFF,ABS NEUTROPHILS,Leukocyte morphology finding,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,HEPATITIS C AB REFLEX HCV RNA QUANT,HEPATITIS C ANTIBODY,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.07142857142857142,0.02,0.0,0.07142857142857142,0.02,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,PSA TOTAL % FREE SERIAL,% FREE PSA,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,HCV QUANT GT1A NS5A PROFILE,HCV LOG10,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,LP WITHOUT VLDL CHOL HDL,LDL CHOLESTEROL CALC,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,HCV FIBROSURE,GGT,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,CBCI COMPLETE BLOOD COUNT W DIFF,PLT MORPHOLOGY,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.08,0.0,0.0,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,SED RATE MODIFIED WESTERGREN MANUAL,SED RATE MODIFIED WESTERGREN MANUAL,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,PROTHROMBIN TIME INR,PROTHROMBIN TIME,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.62,0.5,0.0,0.285,0.5,0.0,0.0,0.05472672512384891,0.0,0.0,0.11341838793759673,0.0,0,57679,PROTEIN 24 HOUR URINE,PROTEIN URINE CONC,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,LIPOPROTEIN ANALYSIS NMR,LDL P,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,CBC PLATELET HEM REVIEW,NEUTROPHILS,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,IFE PE FLC SERUM,ALBUMIN,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,19638,COMPREHENSIVE METABOLIC PANEL E GFR,CARBON DIOXIDE,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,NMR LIPOPROFILE,LDL P,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.2857142857142857,0.0,0.0,0.0,0.0,0.0,0.017537266502456905,0.0,0.0,0.0,0.0,0.0,0,115790,CMP12 LP TP TSH 6AC CBC D PLT,BILIRUBIN TOTAL,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,URINALYSIS REFLEX,GLUCOSE QL,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,RPR REFLEX T PALLIDUM PA,RPR,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,URINALYSIS REFLEX,GLUCOSE,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,CMP14 LP CBC D PLT TSH UA M,AST SGOT,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,COMPLEMENT COMPONENT C3C,COMPLEMENT COMPONENT C3C,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,ALPHA 1 ANTITRYPSIN PHENOTYPE,A 1 ANTITRYPSIN PHENOTYPE,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,AMY LIPASE,AMYLASE,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,COMP METAB PANEL,EGFR NON AFR AMERICAN,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,ACUTE HEPATITIS PANEL,HEPATITIS B SURF AG,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,IFE PE SERUM,M SPIKE,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,HB S AG W REFLEX CONF,HB S AG,Globulin,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.046706887849276346,0.0,0,7112,URINALYSIS CULTURE IF INDICATED,WHITE BLOOD CELLS,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,TESTOSTERONE FREE TOTAL,FREE TESTOSTERONE DIRECT,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,CBC INC DIFF PLT,ABSOLUTE MONOCYTES,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.2544444444444445,0.38166666666666665,0.0,0.2544444444444445,0.38166666666666665,0.0,0.04020134008575915,0.06644238932121915,0.0,0.04020134008575915,0.06644238932121915,0,481598,HEPATITIS C ANTIBODY,HEPATITIS C ANTIBODY,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,CBC PLATELET HEM REVIEW,NEUTROPHILS ABSOLUTE,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,CBC WITH PLT DIFF,MPV,Leukocyte morphology finding,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,HCV QUANT GT1A NS5A PROFILE,HCV NS5A RESISTANCE ASSAY PDF,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.06333333333333332,0.11399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,DRUG ABUSE PANEL 10 WITH OXYCODONE,METHAQUALONE,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,URINALYSIS CULTURE IF INDICATED,COLOR,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,DRUG ABUSE PANEL 10 WITH OXYCODONE,PHENCYCLIDINE,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06691275831255872,0.06348916544989514,0.09169555407390673,1,7062,CBC INC DIFF PLT,BASOPHILS,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,COMP METABOLIC PANEL 14,EGFR IF AFRICN AM,Alpha-2-Macroglobulin,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,DRUG ABUSE SCREEN 11 W ETOH W CONF,OXYCODONE,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.22,0.16666666666666666,0.3333333333333333,0.47,0.16666666666666666,0.3333333333333333,0.0,0.2276407094521833,0.5,0.04524395250155222,0.45528141890436646,0.5,1,19711,BILIRUBIN PANEL,BILIRUBIN INDIRECT,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,PROTHROMBIN TIME PT,PROTHROMBIN TIME PT,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,CULTURE ROUTINE,CULTURE ROUTINE,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,HP4 RPR,HEP C VIRUS AB,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.06900104452272493,0.0,0,330373,CMP12 7AC MG,PHOSPHORUS SERUM,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,CBC WITH AUTO DIFF,WBC,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.0,0.14285714285714285,0.3333333333333333,0.0,0.14285714285714285,0.3333333333333333,0.0,0.4596659728295528,0.8660254037844386,0.0,0.530776546300907,1.0,1,18259,ALPHA 1 ANTITRYPSIN PHENOTYPE,ALPHA 1 ANTITRYPSIN,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,CBC WITH AUTO DIFF,BASOPHILS %,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,UA W RFLX MICROSCOPIC,COLOR,Prothrombin.activity actual/Normal,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,IMMUNOFIXATION SERUM,IGG SERUM NR,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,COMPREHENSIVE METABOLIC PANEL,OSMOLALITY,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,HB S AG W REFLEX CONF,HB S AG,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.06666666666666667,0.1,0.0,0.0,0.0,0.0,0.0,0.013833713964941818,0.0,0.0,0.0,0.0,0,302398,CBC WITH MANUAL DIFFERENTIAL,NEUTROPHILS,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,CMP14 3AC CBC D PLT RPR MG,EOS,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,URINALYSIS COMPLETE,BILIRUBIN,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,CBC WITH PLT DIFF,RDW,Protein pattern,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,LYMPHOCYTE SUBSET PANEL 4,COMMENTS,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,LIVER FIBROSIS FIBROTEST ACTITEST,NECROINFLAMMAT ACT GRADE,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,HCV RNA NS5A GENOTYPE,LEDIPASVIR RESISTANCE,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,TSH W REFLEX FT4,TSH 3RD GENERATION W REFLEX FT4,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,SED RATE MODIFIED WESTERGREN MANUAL,SED RATE MODIFIED WESTERGREN MANUAL,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,HEPATITIS A IGM,HEPATITIS A IGM,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,CBC,MCH,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,C REACTIVE PROTEIN,C REACTIVE PROTEIN,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.026363636363636363,0.041428571428571426,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,CBC W DIFF PLT,BLAST CELLS ABSOLUTE,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,HCV FIBROSURE,LIMITATIONS,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,URINALYSIS W MICROSCOPIC,URINALYSIS URINE COLOR,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,THYROID PROFILE T4 T3UP FTI TSH,T 4,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,CBC PLATELET HEM REVIEW,EOS ABSOLUTE VALUE,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,BASIC METABOLIC PANEL,UREA NITROGEN BLOOD BUN,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,CBC COMPLETE BLOOD COUNT W O DIFF,MCV,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,BASIC METABOLIC PANEL,OSMOLALITY,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,CMP14 EGFR,POTASSIUM,Alpha-2-Macroglobulin,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,COMPLETE BLOOD COUNT,BASOPHILS %,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,HEPATITIS B SURF AG,HEPATITIS B SURF AG,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,COMP METABOLIC PANEL,SODIUM,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,CBCI COMPLETE BLOOD COUNT W DIFF,MCV,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,HNK1 CD57 PANEL,LYMPHS ABSOLUTE,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.5566666666666666,0.14285714285714285,0.3333333333333333,0.0,0.0,0.0,0.041620163040118285,0.0966660720824497,0.050158741653652195,1,30973,BASIC METABOLIC PANEL,BUN CREATININE RATIO,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,HP5,HEP C VIRUS AB,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,BASIC METABOLIC PANEL,BUN,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,HCV FIBROSURE LABCORP,RESULT,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,CMP14 5AC,BILIRUBIN TOTAL,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.2857142857142857,0.0,0.0,0.0,0.0,0.0,0.01894241279354958,0.0,0.0,0.0,0.0,0.0,0,115790,CMP13 LP TP TSH 2AC CBC D P,CHOLESTEROL TOTAL,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,PROTEIN ELECTRO S,ALPHA 1 GLOBULIN,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,FIBROSIS SCORE,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,HEPATITIS C AB,HEPATITIS C AB,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.06200000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,NGI HCV ULTRAQUAL RFX SUPER QT,COPIES ML,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,ASH FIBROSURE,AST SGOT P5P,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.0,0.0,0.0,0.11399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,BASIC METABOLIC PANEL 7,EGFR IF AFRICN AM,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,HNK1 CD57 PANEL,LYMPHS ABSOLUTE,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,HB S AG W REFLEX CONF,HB S AG NEUTRALIZATION,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.25,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.00996262543708748,0,285395,HGB A1C WITH EAG ESTIMATION,HEMOGLOBIN A1C,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,IRON TIBC,UIBC,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,DRUG SCREEN AUSTIN 20,PHENCYCLIDINE,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,HCV RNA NS5A GENOTYPE,DACLATASVIR RESISTANCE,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.2866666666666667,0.172,0.0,0.2866666666666667,0.172,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,121855,PTT,PTT,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,CBC W AUTO DIFF,ABS BASOPHILS,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,LIPOPROT LDL DIRECT,LIPOPROT LDL DIRECT,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,FIBROMETER VIRUS,GAMMA GLUTAMYL TRANSFERASE FM,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,HEP A AB IGM,HEPATITIS A AB IGM,Microalbumin/Creatinine ratio panel,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur
0.0,0.0,0.0,0.0,0.16666666666666666,0.5,0.0,0.0,0.0,0.0,0.25937854254408554,1.0,1,17830,COMP METABOLIC PANEL,ALKALINE PHOSPHATASE,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,COMPREHENSIVE METABOLIC PANEL AMA,GLOBULIN,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.14285714285714285,0.2757142857142857,0.715,0.2857142857142857,0.2857142857142857,0.965,0.020315488372455226,0.08632261464360236,0.22524969726717137,0.2458696638252934,0.011170953400621464,0.04372412516808821,1,296095,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,PHENCYCLIDINE,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,TESTOSTERONE,TESTOSTERONE,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,OBSTETRIC PANEL INCLUDING HIV,HEMOGLOBIN,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,STOOL CULTURE,RESULT 2,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0,0.06200000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,HCV FIBROSURE,INTERPRETATION,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,T B LYMPHOCYTE NK NYSDOH,PLATELETS,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.14285714285714285,0.25,0.0,0.10714285714285714,0.1875,0.0,0.07075841156459017,0.07240860968350848,0.0,0.0,0.0,0,223271,HEPATITIS BE ANTIGEN,HEP BE ANTIGEN,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,PROTEIN TOTAL URINE,PROTEIN CR RATIO,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.4,0.25,0.6666666666666666,0.0,0.0,0.0,0.43159805011496677,0.036870751523516376,0.02890669461985995,1,141358,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD8 CELLS,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,HEPATITIS B CORE AB TOTAL,HEPATITIS B CORE AB TOTAL,Protein pattern,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp
0.14666666666666667,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,DRUG ABUSE SCREEN 9 NO THC W CONF,OXYCODONE,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B DRUG RESISTANCE ASSAY,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,ACCUTYPE R IL28B NY,IL28B GENOTYPE,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,HIV AB 1 HIV 2 EIA W REFL 1 WB,HIV EIA AB SCREEN,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME NR,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.07857142857142858,0.11000000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,COMPLETE BLOOD COUNT,BASOPHILS %,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Prothrombin.activity actual/Normal,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,CMP14 LP CBC D PLT,NEUTROPHILS,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D2,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,COMP METABOLIC PANEL W GFR,PROTEIN TOTAL,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,MICROALBUMIN RANDOM,MICROALBUMIN RANDOM,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,TESTOSTERONE FREE TOTAL LC MS,FREE TESTOSTERONE DIRECT,Neutrophils,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,CBC,MCH,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,PROFILE 104 LIVER,AST SGOT,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,HEMOGLOBIN A1C EAG,HEMOGLOBIN A1C,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,CHEM SCREEN PANEL,EGFR NON AFR AMERICAN,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,PROTEIN 24 HOUR URINE,PROTEIN URINE CONC,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,PROTHROMBIN TIME INR,PROTHROMBIN TIME,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,TRANSFERRIN SATURATION,TRANSFERRIN,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,LIVER FIBROSIS,NECROINFLAM ACT GRADE,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,ANEMIA PROFILE B,UIBC,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,CBC WITH PLT DIFF,OTHERS,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,DIFFERENTIAL MANUAL,ABSOLUTE LYMPHOCYTES,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE LYMPHOCYTES,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,PROTIME PTT,PROTHROMBIN TIME PT,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,CBC,MONOCYTES ABSOLUTE,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,FE CBC D PLT TIBC FER B12 F,FERRITIN SERUM,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN RT PCR LOG COPIES ML,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.058823529411764705,0.0,0.0,0.0,0.0,0.0,0.022426041668292318,0.0,0.0,0.0,0.0,0,771477,IFE PE SERUM,GAMMA GLOBULIN,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.3333333333333333,0.3283333333333333,0.985,0.3333333333333333,0.16666666666666666,0.5,0.03775254682189788,0.05391665993580863,0.057918325991897945,0.06538932921065,0.0,0.0,1,20396,CEA CARCINOEMBRYONIC ANTIGEN,CEA CENTAUR,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,LIPID PANEL,NON HDL CHOLESTEROL,Body height,Body height Measured,Body height Measured
0.24666666666666667,0.2,1.0,0.24666666666666667,0.2,1.0,0.0,0.0489532149155677,0.14396515280104705,0.0,0.04684727929085075,0.13777186509717598,1,29868,TESTOSTERONE FREE TOTAL LC MS,TESTOSTERONE TOTAL LC MS,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,MANUAL DIFFERENTIAL,LYMPHOCYTES ABSOLUTE,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,CBC WITH PLT DIFF,MYELOCYTES,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,CBC WITH DIFFERENTIAL,NEUTROPHILS,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.01,0.02,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,DRUG ABUSE SCREEN 11 W ETOH W CONF,METHADONE,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.0,0.0,0.0,0.0,0.124,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,CMP14 CBC D PLT ESR WES ANA,LYMPHS ABSOLUTE,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,CMP12 LP 6AC,PHOSPHORUS SERUM,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,BMP8 CBC D PLT,CREATININE,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,BUN CREATININE RATIO,ICTERUS,Globulin,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc
0.0,0.0,0.0,0.0,0.06625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,LYMPHOCYTE SUBSET PANEL 2,HELPER SUPPRESSOR RATIO,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,DIRECT LDL,DIRECT LDL,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.25,0.16666666666666666,0.0,0.2375,0.16666666666666666,1.0,0.012985917004718295,0.009990122975599758,0.0,0.0,0.051758104169687846,0.7071067811865476,0,7120,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE EOSINOPHILS,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,UA W MICRO HOLD SPEC 24 HR,SPECIFIC GRAVITY,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.030763983977592058,0.0,0.0,0.0,0.0,0,7427,CBCI COMPLETE BLOOD COUNT W DIFF,MCV,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0225,0.03,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,URINALYSIS COMPLETE,APPEARANCE,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,PROTHROMBIN TIME PT,PT CONTROL,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.08333333333333333,0.022,0.0,0.08333333333333333,0.022,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,PSA TOTAL REFLEX FREE,PSA TOTAL,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE EOSINOPHILS,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0775,0.10333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,CLR CBC W DIFF PLT,ABSOLUTE EOSINOPHILS,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,PSA TOTAL REFLEX FREE,PSA TOTAL,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.08857142857142856,0.0,0.0,0.08857142857142856,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,HEPATITIS C VIRAL RNA QUAL TMA,HEPATITIS C VIRAL RNA QUAL TMA,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,UROGRAM,SPECIFIC GRAVITY,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.14285714285714285,0.2,0.146,0.42857142857142855,0.6,0.0,0.06827160107039187,0.06891707028091865,0.0,0.07883325451199508,0.0795785781568974,0,223222,ACUTE HEPATITIS PANEL,HEPATITIS B SURF AG,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.3333333333333333,0.14285714285714285,0.5,0.0,0.0,0.0,0.061685809626148336,0.0,0.0,1,17426,HEPATIC FUNCTION PANEL 6,ALT SGPT,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,HCV RNA QN REAL TIME PCR W RFX QL T,HCV RNA PCR QN,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.2,0.16666666666666666,0.0,0.0,0.0,0.0,0.03401801828400064,0.0,0.0,0.0,0.0,0.0,0,7138,CBC WITH AUTO DIFF,HEMATOCRIT,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,TSH FT4,FREE T4,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,PROTEIN ELECTRO S,ALPHA 1 GLOBULIN,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,CBC DIFF PLT,LYMPHOCYTES #,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,BMP WITH ESTIMATED GFR CALCULATED,CARBON DIOXIDE,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,HIV AG AB 4TH GEN RFL,RACE NR,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,7765,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,MPV,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.045454545454545456,0.125,0.0,0.0,0.0,0.0,0.03540360693747757,0.0,0.0,0.0,0.0,0,322867,CBC WITH AUTO DIFF,RDW,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,LYMPHOCYTE SUBSET PANEL 2,% CD8 SUPPRESSOR T CELLS,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,BUN CREATININE,EGFR AFRICAN AMERICAN,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,IRON BINDING CAPACITY % SATURATION,IRON SERUM,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,LIVER FIBROSIS FIBROMETER,ALPHA 2 MACROGLOBULIN FM,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.08833333333333333,0.0,0.0,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,CERULOPLASMIN,CERULOPLASMIN,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,BASIC METABOLIC PANEL,OSMOLALITY,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,CMP14 LP 5AC CBC D PLT RPR,HEMOGLOBIN A1C,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,LYMPHOCYTE SUBSET PANEL 3,CD4 CD8 RATIO,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.39000000000000007,0.0,0.0,0.3333333333333333,0.4,1.0,0.0,0.0,0.0,0.06696411491014109,0.4808823462371743,0.7071067811865476,1,22764,FE CBC D PLT TIBC FER B12 F,FERRITIN SERUM,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,BASIC METABOLIC PANEL,ANION GAP,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,RPR REFLEX TP PA,RPR TITER,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,COMP METABOLIC PANEL 12,ALKALINE PHOSPHATASE,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,ACCUTYPE R IL28B NY,IL28B GENOTYPE,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,BILIRUBIN PANEL,BILIRUBIN INDIRECT,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE NEUTROPHILS,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,URINALYSIS WITH MICROSCOPIC,PROTEIN,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,CBC WITH AUTO DIFF,BASOPHILS ABSOLUTE,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,COMP METABOLIC PANEL W GFR,PROTEIN TOTAL,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,UROGRAM,SPECIFIC GRAVITY,Body weight,Body weight Measured,Weight Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,CBC PLATELET HEM REVIEW,LYMPHS ABSOLUTE,Reference lab test method,Reference lab test method,Ref lab test method
0.0,0.08333333333333333,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,MICROALBUMIN CREATININE RANDOM RATIO,CALC MICROALB CREAT RND,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,HCV FIBROSURE LABCORP,RESULT,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,UA MICROSCOPIC REFLEX CULTURE,KETONES,Eosinophils,Eosinophils [#/volume] in Blood,Eosinophil # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,ALKALINE PHOSPHATASE,LIPEMIA,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,HCV FIBROSURE,GGT,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,ARTHRITIS PROFILE,ANTI NUCLEAR ANTIBODIES,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,DRUG ABUSE SCREEN 11 W ETOH W CONF,OXYCODONE,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,HB S AG W REFLEX CONF,HB S AG,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,HEPATITIS B CORE AB,HEPATITIS B CORE AB,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual
0.2375,0.15833333333333333,0.95,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.06797427042040116,0.05720402135206337,0.7071067811865476,1,7310,LYMPHOCYTE SUBSET PANEL 4,LYMPHOCYTES ABSOLUTE,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,HIV AB EIA WITH REFLEXES,HIV AB,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,SEDIMENTATION RATE WESTERGREN,SEDIMENTATION RATE WESTERGREN,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,CBC W AUTO DIFF,ABS BASOPHILS,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,HEPATITIS C VIRAL RNA NS3 GENOTYPE,TELAPREVIR RESISTANCE,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.366,0.26,0.40857142857142853,0.286,0.26,0.40857142857142853,0.26231496846822855,0.30212626077113414,0.325420828562908,0.2725073196367942,0.31386549534477215,0.3380651827209913,0,568881,HIV AB EIA WITH REFLEXES,HIV AB,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,FERRITIN,FERRITIN SERUM,Monocytes,Monocytes [#/volume] in Blood,Monocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.08135057852153249,0.08581004475672016,0.0,0.0,0.0,0,28571,HBSAB AG,HEP B SURFACE AB QUAL,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.07559327125736637,0.0,0.0,0.0,0.0,0,30247,IFE PE SERUM,ALPHA 1 GLOBULIN,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.072,0.05142857142857143,0.12,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CARBON DIOXIDE,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,URINALYSIS WITH REFLEX MICROSCOP,PROTEIN TOTAL QUAL,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.1425,0.2,0.0,0.25,0.2,0.0,0.0,0.022973787932824563,0.0,0.015070377317401573,0.0,0.0,0,195586,URINE PROTEIN TOTAL RANDOM W O CREATININE,PROTEIN TOTAL RANDOM UR,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE LYMPHOCYTES,Globulin,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc
0.0,0.09142857142857143,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD IU ML,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,ACTIVATED PTT,ACTIVATED PTT PATIENT,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,PE FLC SERUM,ALBUMIN,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,COMP METABOLIC PROFILE FASTING CMP,BUN CREATININE RATIO CALC,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,LYMPHOCYTE SUBSET PANEL 2,% CD8 SUPPRESSOR T CELLS,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,HCV RNA GENOTYPE LIPA R,HCV RNA GENOTYPE LIPA,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,BASIC METABOLIC PANEL,OSMOLALITY,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,PTH INTACT,PARATHYROID HORMONE INTACT,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.11,0.10600000000000001,0.0,0.21000000000000002,0.2,0.5,0.0,0.0,0.0,0.0,0.38075107277079945,1.0,1,58115,UA MICROSCOPIC REFLEX CULTURE,SPECIFIC GRAVITY,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.017142857142857144,0.04,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,CBC PLATELET HEM REVIEW,NEUTROPHILS ABSOLUTE,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,HEMOGRAM W AUTOMATED DIFF,WBC,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.16666666666666666,0.0125,0.025,0.0,0.0,0.0,0.023003531473262395,0.0,0.0,0.0,0.0,0.0,0,339143,COMP METABOLIC PANEL W GFR,ANION GAP,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,STOOL CULTURE,RESULT 1,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.14666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,PHOSPHATE AS PHOSPHORUS,ICTERUS,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,ACUTE HEPATITIS PANEL,HEPATITIS B SURF AG,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,FIBROACT,NECROINFL SCORE,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.0,0.135,0.27,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,COMPREHENSIVE METABOLIC PANEL E GFR,CALCULATED A G RATIO,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE EOSINOPHILS,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0775,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,MAYNAC CMP 4AC LIPID CBC T4 TSH PSA PROFILE,MCH,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,LIVER FIBROSIS,NECROINFLAM ACT SCORE,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,HEPATITIS C ANTIBODY,HEPATITIS C ANTIBODY,Reference lab test method,Reference lab test method,Ref lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,RPR HBSAG HCVAB HSV1 HSV2 I,HEP C VIRUS AB,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,CBC WITH AUTO DIFF,HEMATOCRIT,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,ANA SCREEN IFA,ANA SCREEN IFA,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0555512416863837,0.0,0.0,0.0,0.0,0,23242,PROTEIN ELECTROPHORESIS SERUM,BETA,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.14833333333333334,0.11125,0.178,0.0,0.0,0.0,0.0,0.0,0.0,1,7641,CBC WITH PLT DIFF,BANDS,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,DRG TOX CRT REFL SPEC GR,CREATININE,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,ACCUTYPE R IL28B NY,IL28B GENOTYPE,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,PSA FREE TOTAL,PSA FREE,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,COMP METABOLIC PANEL W GFR,PROTEIN TOTAL,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,PROTEIN ELECTRO S,GAMMA GLOBULIN,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,HEMATOPATH CONSULTATION SMEAR,WBC,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,MICROALBUMIN RANDOM,MICROALBUMIN CR RATIO,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,HEPATITIS BE AG,HB E AG,Basophils,Basophils [#/volume] in Blood,Basophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,URINALYSIS W REFLEX MICRO,UROBILINOGEN,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,HCV RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,HIV 1 HIV 2 AB RFLX,HIV 1 WESTERN BLOT RESULT,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.14777777777777779,0.266,0.2,0.4077777777777778,0.734,0.0,0.06908938005713361,0.07184578234577044,0.04649709143472869,0.1692337277851974,0.17598550691819748,1,139501,HEPATITIS PANEL ACUTE,HEPATITIS A IGM,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,ASH FIBROSURE,WEIGHT,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,CMP14 LP CBC D PLT TSH UA M,AST SGOT,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,HEPATITIS A TOTAL AB REFLEX IGM,HEPATITIS A TOTAL AB,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,CMP13 LP 2AC CBC D PLT,ALT SGPT,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,MCCARJUH MCCARTHY PROFILE 1,MITOCHONDRIAL M2 AB,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,ANA TITER PATTERN,ANA TITER,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,RENAL PANEL 10,EGFR IF AFRICN AM,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,LIPID PANEL W CHOL HDL RATIO,VLDL CHOLESTEROL CAL,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,CREATININE,ICTERUS,Erythrocytes,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro
0.0,0.0,0.0,0.2,0.14285714285714285,0.3333333333333333,0.0,0.0,0.0,0.03696139574387214,0.09912686727665487,0.06205807818513498,0,81232,CBC WITH DIFFERENTIAL,NO CELLS DIFF,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,HCV QUANT GT1A NS5A PROFILE,HCV NS5A RESISTANCE ASSAY PDF,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD3 CELLS,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,CREATINE KINASE CK,CREATINE KINASE CK,Basophils,Basophils [#/volume] in Blood,Basophils # Bld
0.325,0.0,0.0,0.45,0.0,0.0,0.0,0.0,0.0,0.04459053011835212,0.0,0.0,1,422543,ANACHOICE SCR W REFL TITER IFA,ANA SCREEN IFA,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,CBC W AUTO DIFF,HGB,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,CBC WITH PLT DIFF,NRBC,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.07647311194538908,0.0,0.0,1,205708,CBC,HCT,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,CLR CBC W DIFF PLT,ABSOLUTE EOSINOPHILS,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,PSA TOTAL % FREE SERIAL,% FREE PSA,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.055,0.1311111111111111,0.03,0.055,0.1311111111111111,0.03,0.0,0.008546838114158128,0.0,0.0,0.008546838114158128,0.0,0,481598,CREATININE SERUM,CREATININE SERUM,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,HCV FIBROSURE RESULTS,FIBROSIS SCORE,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BENZODIAZEPINES,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,URINALYSIS W REFLEX MICRO,RED BLOOD CELLS,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD3 CELLS,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.25,0.16666666666666666,0.5,0.25,0.16666666666666666,0.5,0.03683639943337358,0.06940603847876714,0.07516574292464595,0.05209453566766953,0.09815496092726139,0.1063004130698838,0,29918,PSA TOTAL % FREE SERIAL,% FREE PSA,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,HGB A1C WITH EAG ESTIMATION,HEMOGLOBIN A1C,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,SMN1 COPY NUMBER ANALYSIS,SPECIMEN TYPE,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.25,0.33999999999999997,0.85,0.0,0.148,0.37,0.01305909802814298,0.6981845870116105,0.9069761000074495,0.0,0.06755685946200152,0.08775968141298807,1,473835,ANA ANTI NUCLEAR AB WITH REFLEX TITER,ANTI NUCLEAR ANTIBODIES,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA
0.047142857142857146,0.030000000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,LYMPHOCYTE SUBSET PANEL 2,COMMENT S,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,MICROALBUMIN RANDOM,MICROALBUMIN CR RATIO,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS A TOTAL AB,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,POL CMP WITH EGFR INV,GLUCOSE,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.22333333333333336,0.25,1.0,0.0,0.0,0.0,0.0,0.15505905338492743,1.0,0.0,0.0,0.0,0,384834,CREATININE,EGFR IF AFRICN AM,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,DRUG ABUSE SCREEN I,AMPHETAMINES,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,HIV 1 QUANT PCR,HIV 1 VIRAL LOG,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,MICROALBUMIN RANDOM,MICROALBUMIN RANDOM,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.2,0.16666666666666666,0.0,0.0,0.0,0.0,0.03401801828400064,0.0,0.0,0.0,0.0,0.0,0,7138,CBC WITH AUTO DIFF,RDW,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,DRUG ABUSE SCREEN II,OPIATES,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,DRUG ABUSE SCREEN III,METHADONE,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,HEPATIC FUNCTION PANEL,ALT,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,PROTHROMBIN TIME,INR,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,CBC INCLUDES DIFF PLT,ABSOLUTE BLASTS,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,IRON TOTAL BINDING CAPACITY,% SATURATION,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,T4 THYROXINE,T4 THYROXINE,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,ALPHA FETOPROTEIN TUMOR MARKER,ALPHA FETOPROTEIN TUMOR,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,CMP14 CBC D PLT,HEMATOLOGY COMMENTS,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,GLUCOSE,GLUCOSE FASTING,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,HEPATITIS BE AG,HBEAG INS,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,VAP CHOLESTEROL PROFILE,TRIGLYCERIDES,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,ACTIVATED PTT,ACTIVATED PTT PATIENT,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.185,0.0,0.0,0.185,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,PSA TOTAL REFLEX FREE,PSA TOTAL,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,HEPATITIS C AB,HEPATITIS C AB,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,RHEUMATOID FACTOR,RHEUMATOID FACTOR,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,AST CBC D PLT,EOS,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,CMP WITH ESTIMATED GFR CALCULATED,FASTING NON FASTING,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.5,0.41428571428571426,1.0,0.5,0.2857142857142857,1.0,0.08384227635677743,0.226779813772099,0.16381776425537642,0.10268539797375953,0.18516494256834526,0.10031748330730439,1,30247,FREE T4 THYROXINE,FREE T4,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.0,0.0,0.0,0.3333333333333333,0.4,1.0,0.0,0.0,0.0,0.06538932921065,0.4808823462371743,0.7071067811865476,1,191239,CMP14 HP5 LP 6AC CBC D PLT,MAGNESIUM SERUM,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,FOLATE SERUM,FOLATE SERUM,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.0,0.05714285714285715,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,CBC W AUTO DIFF,ABS BASOPHILS,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,DRUG ABUSE SCREEN III,METHADONE,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CPK,CPK,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,ALT,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,HEMOGLOBIN A1C,ESTIMATED AVG GLUCOSE,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,COMPREHENSIVE METABOLIC PANEL W EGF,AST,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,LYMPHOCYTE SUBSET PANEL 1,% CD3 MATURE T CELLS,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.0,0.09090909090909091,0.25,0.0,0.09090909090909091,0.25,0.0,0.014322515936154967,0.0398842747256396,0.0,0.01450558691410242,0.04039407713823895,0,112599,HEPATITIS B SURFACE AB QUANT,HEPATITIS B SURFACE AB,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,COMPREHENSIVE METABOLIC PANEL W EGF,AST,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.1,0.16666666666666666,0.3333333333333333,0.475,0.7916666666666666,0.0,0.06759723732583833,0.09418963513805056,0.017692205955941787,0.04394436217825082,0.8489103365948751,1,241133,HEPATITIS PANEL 4,HEP B CORE AB IGM,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.12285714285714286,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,RENAL PANEL 10,EGFR IF NONAFRICN AM,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,HEPATIC FUNCTION PANEL 6,ALT SGPT,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,FASTING,FASTING STATUS,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,NASH FIBROSURE,AST SGOT P5P,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,CBC WITH AUTO DIFF,EOSINOPHILS #,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,TSH FREE T4 PROFILE,TSH THIRD GENERATION,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.03666666666666667,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,CBC WITH PLT DIFF,RBC MORPHOLOGY,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,HEPATITIS C VIRAL RNA NS3 GENOTYPE,BOCEPREVIR RESISTANCE,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.013636363636363636,0.0375,0.0,0.02,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,CRYOGLOBULINS REFLEX IFE QUANT,IGM CRYOPRECIPITATE,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,DRUG ABUSE SCREEN II,COCAINE METABOLITE,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD8 CELLS,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,CMP14 CBC D PLT ESR WES ANA,LYMPHS ABSOLUTE,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.22333333333333336,0.4,1.0,0.22333333333333336,0.4,1.0,0.0,0.10223598408605306,0.1503314858492919,0.0,0.10223598408605306,0.1503314858492919,1,21600,CREATININE SERUM,CREATININE SERUM,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.0,0.0,0.3333333333333333,0.14285714285714285,0.3333333333333333,0.0,0.0,0.0,0.0834655896020069,0.0,0.0,1,544346,NMR LIPOPROFILE,LDL P,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,DRUG ABUSE SCREEN III,AMPHETAMINES,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,CMP14 LP 2AC CBC D PLT MG T,WBC,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,CPK,CPK,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,CBC W AUTO DIFF ABS WBC MPV PLT,MCHC,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,HIV 1 HIV 2 AB SCREEN,HIV 1 HIV 2 AB SCREEN,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD8 CELLS,Basophils,Basophils [#/volume] in Blood,Basophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,HIV 1 HIV 2 AB RFLX,HIV 1 WESTERN BLOT RESULT,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,URINALYSIS,PH,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.075,0.15,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,HEP C RNA GENOT 3 NS5A,VELPATASVIR RESISTANCE,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.14285714285714285,0.18333333333333332,0.6875,0.0,0.0,0.0,0.026381830512237858,0.04432042353220711,0.12591840875016092,0.0,0.0,0.0,0,381806,HEP C RNA GENOT 3 NS5A,VELPATASVIR RESISTANCE,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,IMMUNOGLOBULIN A,IMMUNOGLOBULIN A,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,DRUG ABUSE SCREEN II,METHAQUALONE,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,PTH INTACT MOLECULE,PTH,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.14285714285714285,0.3333333333333333,0.0,0.14285714285714285,0.3333333333333333,0.0,0.009999352504996728,0.010166296374239492,0.0,0.009999352504996728,0.010166296374239492,0,98301,HEPATITIS B CORE AB TOTAL,HEPATITIS B CORE AB TOTAL,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,CBC,HEMOGLOBIN,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,CMP14 LP TP TSH 4AC CBC D P,HEMATOCRIT,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,TRANSFERRIN SATURATION,TRANSFERRIN,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,DRUG ABUSE SCREEN 9 NO THC W CONF,OXYCODONE,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,COMP METAB PANEL,GLUCOSE FASTING,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE LYMPHOCYTES,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.10333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,CD4 CD8 ENUMERATION,ABSOLUTE LYMPHOCYTES,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.06713496212611103,0.05720402135206337,0.7071067811865476,1,7518,CMP14 CBC D PLT RPR UA TSH,NEUTROPHILS ABSOLUTE,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.10714285714285714,0.125,0.0,0.0,0.0,0.0,0.044495573563027246,0.0,0.0,0.0,0.0,0,110114,CBC WITH DIFFERENTIAL PLATELETS,POLYS,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,EGFR,EGFR,Erythrocytes,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,CBC WITH AUTO DIFF,NRBC,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.07142857142857142,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,HIV AB 1 HIV 2 EIA W REFL 1 WB,HIV EIA AB SCREEN,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,COMPLEMENT COMPONENT C4C,COMPLEMENT COMPONENT C4C,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.182,0.16285714285714287,0.22800000000000004,0.0,0.0,0.0,0.0,0.025720888368633732,0.03471021044566758,0.0,0.0,0.0,0,728626,COMPREHENSIVE METABOLIC PANEL W O ALT,BUN CREATININE RATIO,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,GGT,GGT,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,HEPATIC FUNCTION PROFILE,BILIRUBIN INDIRECT,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,NGI HCV QUANTASURE,HEPATITIS C QUANTITATION,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,IRON PANEL,IRON,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,HCV RNA NS5A GENOTYPE,DACLATASVIR RESISTANCE,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,HCV RNA PCR RFX NS5B,HCV NS5B RESISTANCE ASSAY PDF,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.0769832768017027,0.08055537486383768,0.09169555407390673,1,264853,CBC WITH DIFFERENTIAL,MONOCYTES,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.5,0.16666666666666666,0.2,0.5,0.16666666666666666,0.2,0.017636738173009037,0.009401764836141302,0.028423266187874163,0.11136168435129556,0.05936451274361987,0.17946985244079683,1,63016,PROTHROMBIN TIME WITH INR,INR,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.11490614097199336,0.10964330813284906,0.7071067811865476,1,264747,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE LYMPHOCYTES,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.020106460188663466,0.0,0.0,0.0,0.0,0,7492,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,EOSINOPHILS #,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,LEUKEMIA LYMPHOMA EVALUATION,SPECIMEN TYPE,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,PROTEIN ELECTRO S,GAMMA GLOBULIN,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.028571428571428574,0.1,0.0,0.03142857142857143,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,COMP METABOLIC PANEL,RATIO,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,HEPASCORE R,SEX,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,DRUG ABUSE SCREEN W ETOH NO GCMS,AMPHETAMINES,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,DRUG ABUSE SCREEN W ETOH NO GCMS,BARBITURATES,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,HEPATITIS C ANTIBODY,HEPATITIS C ANTIBODY,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,FREE T4 THYROXINE,FREE T4,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B DRUG RESISTANCE ASSAY,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,TESTOSTERONE FREE TOTAL LC MS,TESTOSTERONE TOTAL LC MS,Hemoglobin,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,FIBROSIS SCORE,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D3,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.049239293855151356,0.0,0.0,0.0,0.0,1,143149,DRUG ABUSE SCREEN III,COCAINE METABOLITE,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,CMP14 EGFR,POTASSIUM,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B RESIST ASSAY INTERP,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,COMPREHENSIVE METABOLIC PANEL,GLUCOSE,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,CBC WITH PLT DIFF,VARIANT LYMPHOCYTES ABSOLUTE,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,PSA FREE TOTAL,FREE PSA,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,CBC WITH PLT DIFF,MPV,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,LP LDLDIR,TRIGLYCERIDES,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,QUESTASSURED TM 25OHD D2 D3,VITAMIN D 25 OH TOTAL,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,CMP13 LP TP TSH 2AC CBC D P,HDL CHOLESTEROL,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,ALPHA FETOPROTEIN TUMOR MARKER,ALPHA FETOPROTEIN TUMOR,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,NGI HCV ULTRAQUAL RFX SUPER QT,COPIES ML,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,CD4 T4 ENUMERATION,ABSOLUTE LYMPHOCYTES,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,MICROALBUMIN CONC,ALB CREAT RATIO,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,MORPHOLOGICAL REVIEW,MORPHOLOGICAL REVIEW,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.16,0.06666666666666667,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,CBCI COMPLETE BLOOD COUNT W DIFF,ABS NEUTROPHILS,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.22333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,COMPREHENSIVE METABOLIC PANEL REFL,UREA NITROGEN BUN,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,UREA NITROGEN BUN,UREA NITROGEN BUN,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,T4 THYROXINE,T4 THYROXINE,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,HEP B CORE TOTAL AB,HEP B CORE TOTAL AB,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,HCV RNA GENOTPE 1 NS5A DRUG RE,OMBITASVIR RESISTANCE,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,HP5,HEP C VIRUS AB,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,NMR LIPOPROFILE,LDL P,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.0,0.2222222222222222,0.0,0.3333333333333333,0.0,0.0,0.0,0.3009933254549282,0.0,0.03908045947241279,0.02823933563163694,0.0,1,59014,PROTHROMBIN TIME,PT POP MEAN,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,LIVER FIBROSIS,NECROINFLAM ACT SCORE,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,AFP TUMOR MARKER SIEMENS IMMULITE,AFP TUMOR MARKER,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD8 CELLS,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,DRUG ABUSE PANEL 10 WITH OXYCODONE,PHENCYCLIDINE,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.0769832768017027,0.08055537486383768,0.09169555407390673,0,301804,CBC INC DIFF PLT,BASOPHILS,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,IRON TOTAL,HEMOLYSIS,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt
0.0,0.0,0.0,0.0,0.33399999999999996,0.835,0.0,0.0,0.0,0.0,0.06312481184311647,0.10133615137556884,0,50484,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS A TOTAL AB,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,HEPATITIS A IGM,HEPATITIS A IGM,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,UA MICROSCOPIC REFLEX CULTURE,WHITE BLOOD CELLS,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.16625,0.44333333333333336,0.0,0.16625,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,HCV RNA PCR QN GRAPH RFX NS5A,HCV NS5A RESIST ASSAY INTERP,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,HEMOGRAM W AUTOMATED DIFF,WBC,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,COMPLEMENT C4 SERUM,COMPLEMENT C4 SERUM,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,CMP13 LP TP TSH 2AC CBC D P,CHOLESTEROL TOTAL,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,HEPATITIS B SURFACE AG,HEPATITIS B SURFACE AG,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,HCV RNA GENOTYPE LIPA R,HCV RNA GENOTYPE LIPA,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,UA MICROSCOPIC REFLEX CULTURE,OCCULT BLOOD,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,FIBROACT COMPLETE,APOLIPOPROTEIN A1,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,LIPID PANEL AMA,NON HDL CHOLESTEROL,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0825,0.10600000000000001,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0525901062858295,0.0,0.0,0,143149,URINALYSIS REFLEX,GLUCOSE QL,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.3,0.2,1.0,0.0,0.0,0.0,0.0,0.34003516797720323,1.0,1,45427,LIVER FIBROSIS PANEL,HAPTOGLOBIN,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,LYMPHOCYTE SUBSET PANEL 1,% CD3 MATURE T CELLS,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,VITAMIN B 12 FOLIC ACID,VITAMIN B 12,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,NEG HIV 4TH GEN,NEG HIV 1 RNA QL TMA,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,CHEM PROFILE 29,ALK PHOS,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,T4 THYROXINE,T4 THYROXINE,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.26,0.2,1.0,0.0,0.0,0.0,0.0,0.03360791982348876,0.09883659982411563,0.0,0.0,0.0,0,20933,LIPID PROFILE WITH CALC NON HDL CHOLESTEROL,RISK RATIO LDL HDL,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,COMPREHENSIVE METABOLIC PANEL AMA,GLOBULIN,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,CMP,ALBUMIN,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,URINALYSIS WITH MICROSCOPIC,UROBILINOGEN,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,URINALYSIS W REFLEX MICRO,GLUCOSE,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,CBC INCLUDES DIFF PLT,INTERNAL WBC,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,LIVER FIBROSIS FIBROMETER,FIBROMETER PROTHROMBIN INDEX,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.0,0.0,0.0,0.24333333333333332,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,GORBYMI CMP 4AC CORONARY RISK CBC TSH PROFILE,CALCIUM,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,NEG HIV 4TH GEN,HIV 1 AB WESTERN BLOT,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,HEMOGLOBIN A1C WITH EAG,ESTIMATED AVERAGE GLUCOSE,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,FOLATE,FOLATE,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.05714285714285715,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,DRUG ABUSE SCREEN W ETOH NO GCMS,BARBITURATES,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,HEPATIC FUNCTION PANEL,TOTAL PROTEIN,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.146,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,ACUTE HEPATITIS PANEL,HEPATITIS A IGM,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,HIV 1 QUANT PCR,HIV 1 VIRAL COPY,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.06,0.05142857142857143,0.09,0.0,0.15714285714285717,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,COMP METABOLIC PROFILE FASTING CMP,BUN CREATININE RATIO CALC,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,HIV AG AB 4TH GEN RFL,HIV AG AB 4TH GEN,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.2,0.3333333333333333,0.5,0.4,0.6666666666666666,1.0,0.05093349536754144,0.1013425379002848,0.14187034543632637,0.3590143888836951,0.7143320726301394,1.0,1,495416,FASTING,FASTING STATUS,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,CBC WITH AUTO DIFF,MONOCYTES #,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,MANUAL DIFFERENTIAL,EOSINOPHILS ABSOLUTE,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE MONOS,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,CBC,MO%,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,CBC DIFF PLT,MCHC,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.09090909090909091,0.25,0.0,0.10454545454545454,0.2875,0.0,0.04088056399127271,0.059884316562937245,0.0,0.0,0.0,0,322867,HEPATITIS PANEL DIAGNOSTIC,HEP B CORE TOTAL AB,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,BASIC METABOLIC PANEL,UREA NITROGEN BLOOD BUN,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,CBC PLATELET HEM REVIEW,EOS ABSOLUTE VALUE,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,BILIRUBIN DIRECT,DIRECT BILIRUBIN,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Ceruloplasmin,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc
0.31,0.386,0.5514285714285714,0.31,0.386,0.5514285714285714,0.021966949517961187,0.0,0.0,0.021966949517961187,0.0,0.0,1,736553,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A DRUG RESISTANCE ASSAY,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,COMPREHENSIVE METABOLIC PANEL AMA,CHLORIDE,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,HIV ANTIBODY 1 WESTERN BLOT,HIV WB INTERP,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.22333333333333336,0.2,1.0,0.0,0.0,0.0,0.0,0.34003516797720323,1.0,1,21600,COMPREHENSIVE METABOLIC PANEL WITH GFR,CREATININE,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.12999999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.066,0.07571428571428572,0.0,0.176,0.14285714285714285,1.0,0.0,0.0,0.0,0.0,0.07582142074137055,1.0,1,505511,URINALYSIS COMPLETE,BILIRUBIN,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,HEMOGLOBIN A1C,MEAN GLUCOSE EST,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,COMPREHENSIVE METABOLIC PANEL,OSMOLALITY,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.015714285714285715,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,CREATINE KINASE TOTAL,LIPEMIA,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,HEMATOPATH CONSULTATION SMEAR,WBC,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.11166666666666668,0.15555555555555556,0.2333333333333333,0.11166666666666668,0.12777777777777777,0.19166666666666665,0.0,0.008711511094573243,0.014397868590624308,0.0,0.0,0.0,0,481598,HEPATITIS B CORE IGM ANTIBODY,HEP B CORE IGM ANTIBODY,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,LYMPHOCYTE SUBSET PANEL 2,% CD8 SUPPRESSOR T CELLS,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,COMP METABOLIC PANEL W GFR,CHLORIDE,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,URINALYSIS W REFLEX MICRO,UROBILINOGEN,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,CMP13 LP TP TSH 2AC CBC D P,HDL CHOLESTEROL,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.3833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,24588,IMMUNOGLOBULINS IGG A M SER,IMMUNOGLOBULIN A,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.08399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,HB S AG W REFLEX CONF,HB S AG NEUTRALIZATION,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.008571428571428572,0.02,0.0,0.03142857142857143,0.07333333333333333,0.0,0.0,0.0,0.0,0.9131129509166843,0.9888882125258499,1,19885,CMP14 HP4 DBILI CBC D PLT R,C REACTIVE PROTEIN QUANT,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,URINALYSIS,NITRITE,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.14285714285714285,0.2,0.35,0.2857142857142857,0.2,0.0,0.0,0.0,0.005220096210042047,0.022637957283906385,0.01142075347408178,0,51953,PSA TOTAL REFLEX FREE,PROSTATE SPECIFIC AG SERUM,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,CMP12 7AC MG,PHOSPHORUS SERUM,Hemoglobin,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,DRUG ABUSE SCREEN 11 W ETOH W CONF,METHADONE,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,DIFFERENTIAL MANUAL,ABSOLUTE NEUTROPHILS,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,HCV AB W RFL RNA RFL GENO,HEPATITIS C AB,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.125,0.0,0.0,0.0,0.0,0.0,0.0036766185783748684,0.003210662064808134,0.005299833985824454,0.0,0.0,0.0,0,486423,LP NON HDL CHOLESTEROL,VLDL CHOLESTEROL CAL,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,ARTHRITIS PROFILE,ANTI NUCLEAR ANTIBODIES,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.08399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,IFE PE SERUM,M SPIKE,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,FOLATE SERUM,FOLATE SERUM,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Bacteria identified,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult
0.055,0.0,0.0,0.2783333333333333,0.20875,0.4175,0.0,0.0,0.0,0.03824958511211374,0.06054478342412972,0.09382047123123194,0,312017,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS A TOTAL AB,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH TOTAL,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,MICROALBUMIN RANDOM URINE W CREATININE,MICROALBUMIN CREATININE RATIO RANDOM URINE,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,URINALYSIS ROUTINE W RFX,BILIRUBIN,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,CMP,ALBUMIN,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.06605502583691747,0.05720402135206337,0.7071067811865476,1,7427,CBC,MONOCYTES ABSOLUTE,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.0,0.0,0.0,0.23249999999999998,0.9299999999999999,0.0,0.0,0.0,0.0,0.05834370368217123,0.09061940958216264,0,182626,CMP14 LP CBC D PLT UA MG TS,VLDL CHOLESTEROL CAL,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,MANUAL DIFFERENTIAL,EOSINOPHILS %,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,TSH ULTRASENSITIVE,TSH ULTRASENSITIVE,pH,pH of Urine by Test strip,pH Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,CMP12 LP TP TSH 6AC CBC D PLT,POTASSIUM,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,HEPATITIS B SURFACE AB,HEPATITIS B SURFACE AB,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,CBC PLT DIFF,MONOS,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,HNK1 CD57 PANEL,LYMPHS ABSOLUTE,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,DRUG ABUSE SCREEN II,COCAINE METABOLITE,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,PROTIME INR F,PT,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,ASH FIBROSURE,AST SGOT P5P,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,CBC WITH MANUAL DIFFERENTIAL,EOSINOPHILS,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,COMPREHENSIVE METABOLIC PANEL E GFR,CHLORIDE,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.178,0.3671428571428571,0.514,0.134,0.14285714285714285,0.2,0.0,0.021001017411413248,0.02834076815216946,0.0,0.036374829167206246,0.04908765036508733,0,728626,HEPATITIS C VIRAL RNA NS3 DRUG RESI,BOCEPREVIR RESISTANCE,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.057999999999999996,0.0,0.0,0.08,0.08857142857142856,0.155,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,DIFFERENTIAL MANUAL,NEUTROPHILS ABSOLUTE,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,HIV AG AB 4TH GEN RFL,RACE NR,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,DRUG PANEL 8 SCREEN,OPIATES,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,URINALYSIS WITH MICROSCOPIC,PH,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,CEA,CEA SIEMENS IMMULITE 2000,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.09166666666666667,0.03928571428571429,0.1375,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,PSA FREE TOTAL,INTERNAL %,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,BASIC METABOLIC PANEL,EGFR NON AFR AMERICAN,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,30916,BASIC METABOLIC PANEL,BUN,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.0,0.0,0.15,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.053099168504833205,0.0,0,142513,VITAMIN B12 FOLATE,FOLATE SERUM,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,PE INTERP RFX IFE S,ALBUMIN,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,URINALYSIS CULTURE IF INDICATED,NITRITE,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,HEPATIC FUNCTION PANEL A,TOTAL PROTEIN,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,HCV RNA NS5A GENOTYPE,VELPATASVIR RESISTANCE,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.02591934325789702,0.0,0.0,0.0,0.0,0,59055,CBC WITH ABSOLUTE NEUTROPHIL COUNT,NEUTROPHILS,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,AFP TUMOR MARKER SIEMENS IMMULITE,AFP TUMOR MARKER,Microalbumin/Creatinine ratio panel,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,VITAMIN D 25 OH LCMSMS W REFLEX,VITAMIN D 25 OH D3,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD8 CELLS,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,HEPATITIS A DIAGNOSTIC PANEL,HAV AB TOTAL,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.11166666666666668,0.1111111111111111,0.16666666666666666,0.26,0.1111111111111111,0.16666666666666666,0.0,0.025425559932405584,0.04202185668774028,0.032532779297970715,0.032824256728735124,0.05424998370944434,0,481598,AUTOIMMUNE HEPATITIS DIAG PNL,MITOCHONDRIAL AB SCREEN,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,HCV FIBROSURE RESULTS,FIBROSIS SCORE,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,CBC DIFF PLT,RDW,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.02823933563163694,0.0,0,59014,LIVER FIBROSIS FIBROMETER,FIBROMETER PROTHROMBIN INDEX,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,URINALYSIS,LEUKOCYTE ESTERASE,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,HBC AB TOTAL,HBC AB TOTAL,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.22,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.04802629258177493,0.5773502691896257,0,57703,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD8 CELLS,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,HEMOGLOBIN A1C,HEMOGLOBIN A1C,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.3333333333333333,0.3333333333333333,0.5,0.3333333333333333,0.3333333333333333,0.5,0.05339016372965322,0.5576035828430085,0.8164965809277261,0.05339016372965322,0.5576035828430085,0.8164965809277261,1,44982,COMPLEMENT C4 SERUM,COMPLEMENT C4 SERUM,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.26666666666666666,0.12,0.0,0.0,0.0,0.0,0.0,0.06462795662709708,0.0,0.0,0.0,0.0,0,17434,CBC W O DIFF WITH PLATELETS,RBC,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,PROTEIN ELECTRO S,GAMMA GLOBULIN,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.07333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,PROTHROMBIN TIME PT,PT CONTROL,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt
0.056999999999999995,0.05181818181818181,0.08142857142857142,0.033,0.030000000000000002,0.047142857142857146,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,DRUG ABUSE SCREEN III,COCAINE METABOLITE,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CBC WITH AUTO DIFF,BASOPHILS ABSOLUTE,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CBC W AUTO DIFF,HGB,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.009,0.045,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,GENERAL HEALTH PANEL,CALC GLOBULIN,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.3333333333333333,0.25,0.0,0.0,0.0,0.0,0.1503314858492919,0.0,0.0,1,264531,CBC W AUTO DIFF WITH PLATELETS,RBC,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.14285714285714285,0.25,0.0,0.14285714285714285,0.25,0.0,0.012044844185289949,0.012148037445748217,0.0,0.012044844185289949,0.012148037445748217,0,142513,HIV 1 HIV 2 AB SCREEN,HIV 1 HIV 2 AB SCREEN,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.066,0.047142857142857146,0.11,0.534,0.32857142857142857,0.5533333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,ACUTE HEPATITIS PANEL,HEPATITIS A AB IGM,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.2,0.14285714285714285,0.3333333333333333,0.2,0.14285714285714285,0.3333333333333333,0.028630174033719702,0.03839167061241977,0.04806998066173307,0.04526827987678228,0.06070256115709882,0.07600531298566238,1,81232,CD4 CD8 LYMPHOCYTE ENUMERATION,PERCENT CD4,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,CBC W AUTO DIFF,MCHC,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,HEPATITIS PANEL 4,HEP B CORE AB IGM,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,URINALYSIS REFLEX,GLUCOSE,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,PROTHROMBIN TIME,PT POP MEAN,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,CMP14 LP 1AC CBC D PLT TSH,LYMPHS,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,ANA SCREEN QUAL,ANA ANTIBODY SCREEN EIA,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,CMP14 5AC,EGFR IF NONAFRICN AM,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,CMP14 LP 6AC,PHOSPHORUS,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.1925,0.08833333333333333,0.0,0.0725,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,URINALYSIS CULTURE IF INDICATED,UROBILINOGEN,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,FERRITIN SERUM,FERRITIN SERUM,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,HCV AB W RFL RNA RFL GENO,HEPATITIS C AB,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.5,0.16666666666666666,0.0,0.0,0.0,0.0,0.11136168435129556,0.05936451274361987,0.0,0.0,0.0,0.0,1,149799,APTT,PARTIAL THROMBOPLASTIN,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,COMPREHENSIVE METABOLIC PANEL E GFR,CALC GLOBULIN,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,NASH FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,PSA FREE TOTAL,INTERNAL %,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,PSA TOTAL % FREE,% FREE PSA,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,PROTEIN ELECTRO S,ALPHA 1 GLOBULIN,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,CBC W DIFF PLATELET,HCT,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.0,0.0,0.025714285714285714,0.036,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,URINE DRUG SCREEN 1,CREATININE,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,CMP12 LP TP TSH 6AC CBC D PLT,EOS ABSOLUTE,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,VIT B 12 FOLATE PANEL,VITAMIN B 12,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.16666666666666666,0.25,0.0,0.2783333333333333,0.4175,0.0,0.06222027266620478,0.0627076954386303,0.0,0.08799275345909874,0.08868207335447242,0,161281,ACUTE HEPATITIS PANEL,HEPATITIS A IGM,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.0,0.03125,0.041666666666666664,0.0,0.03125,0.041666666666666664,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,ALBUMIN CREATININE RATIO URINE RANDOM,CALC ALBUMIN CREAT RND,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.134,0.11142857142857143,0.39,0.0,0.11142857142857143,0.39,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,LP WITHOUT VLDL CHOL HDL,LDL CHOLESTEROL CALC,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,HEPATITIS BE AG,HBEAG INS,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.266,0.19,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,OMBITASVIR RESISTANCE,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,LYMPHOCYTE SUBSET PANEL 4,% CD4 HELPER CELLS,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,LYMPHOCYTE SUBSET PANEL 3,% CD8 SUPPRESSOR T CELLS,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.19444444444444445,0.35,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,HEP B SURFACE AG W REFLEX CONFIRM,NEUTRALIZATION,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,CBC DIFF PLT,RDW,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,MANUAL DIFFERENTIAL,TOTAL NEUTROPHILS %,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,HEPATITIS BS AB QL,HEPATITIS B SURF AB QL,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,TESTOSTERONE FREE TOTAL,FREE TESTOSTERONE DIRECT,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,CBC W AUTO DIFF,HCT,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,CMP14 EGFR,POTASSIUM,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,LIVER FIBROSIS FIBROMETER,FIBROMETER PROTHROMBIN INDEX,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.016666666666666666,0.024999999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,CMP14 LP 6AC,PHOSPHORUS,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,CMP14 HP4 DBILI CBC D PLT R,LYMPHS,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,MANUAL DIFFERENTIAL,TOTAL NEUTROPHILS %,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,URINALYSIS W REFLEX MICRO,EPITHELIAL CELLS,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,CUSTOM HEPATITIS PANEL,HEPATITIS C ANTIBODY,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,CMP14 4AC,EGFR IF AFRICN AM,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,COMPREHENSIVE METABOLIC PANEL E GFR,CALCULATED A G RATIO,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,LIPID PROFILE,FASTING NON FASTING,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,CBC W O DIFF WITH PLATELETS,PLATELET COUNT,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,LIVER FIBROSIS FIBROTEST,FIBROSIS STAGE,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,CBC WITH DIFFERENTIAL,MONOCYTES,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0467853579525741,0.0,0.0,0,192708,MITOCHONDRIAL AB W RFX TITER,MITOCHONDRIAL AB SCN,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CBC PLT DIFF,MONOS,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,FIBROACT COMPLETE,APOLIPOPROTEIN A1,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,ARTHRITIS PROFILE,SEDIMENTATION RATE,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,CMP14 LP CBC D PLT,NEUTROPHILS,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.2857142857142857,0.26666666666666666,1.0,0.0,0.13333333333333333,0.5,0.017359878550121,0.014581951950834782,0.04142866966932579,0.0,0.0626785440493669,0.17807552140691663,0,381806,HCV AB W RFL RNA RFL GENO,HEPATITIS C AB,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA TITER,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.26666666666666666,0.16666666666666666,0.5,0.26666666666666666,0.16666666666666666,0.5,0.0,0.13142842488073536,0.288675134594813,0.0,0.13142842488073536,0.288675134594813,1,44859,COMPLEMENT COMPONENT C3C,COMPLEMENT COMPONENT C3C,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.10714285714285714,0.15,0.0,0.03571428571428571,0.05,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,HEPATIC FUNCTION PANEL,ALBUMIN,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,CBC DIFF PLT,LYMPHOCYTES #,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.39666666666666667,0.1,0.2,0.09499999999999999,0.056999999999999995,0.11399999999999999,0.025474992674050623,0.03132695058051882,0.06720098415971731,0.0,0.0,0.0,1,79053,HB S AG W REFLEX CONF,HFLAG NR,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.06605502583691747,0.05720402135206337,0.7071067811865476,1,7427,CBC INC DIFF PLT,ABSOLUTE MONOCYTES,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,CMP14 LP 2AC CBC D PLT MG T,WBC,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,HIV ANTIGEN ANTIBODY FOURTH GENERATION W RFL,HIV AG AB 4TH GEN,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,FERRITIN SERUM,FERRITIN SERUM,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,NEG HIV 4TH GEN,NEG HIV 1 RNA QL TMA,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,NEG HIV 4TH GEN,NEG HIV 1 RNA QL TMA,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,HDL CHOL DIRECT,HDL AS % CHOLESTEROL,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,BMP,C02 BICARBONATE,pH,pH of Urine by Test strip,pH Ur Strip
0.0,0.0,0.0,0.14333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,CHEM SCREEN PANEL,EGFR NON AFR AMERICAN,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.22999999999999998,0.1142857142857143,0.6,0.0,0.0,0.0,0.0,0.24044117311858715,0.7071067811865476,1,18697,FIBROACT COMPLETE,APOLIPOPROTEIN A1,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.15,0.3,0.0,0.25,0.5,0.0,0.05345799931322692,0.07240860968350848,0.0,0.06547241049372987,0.08868207335447242,1,139550,CUSTOM HEPATITIS PANEL,HEPATITIS C ANTIBODY,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.05747002207333629,0.0,0,539627,COMPLETE BLOOD COUNT,MEAN PLATELET VOLUME,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,LIPID PANEL STANDARD,CHOLESTEROL HDL RATIO,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.14333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,CMP14 4AC,EGFR IF AFRICN AM,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.3333333333333333,0.14285714285714285,0.3333333333333333,0.3333333333333333,0.14285714285714285,0.3333333333333333,0.03495206666531736,0.0,0.0,0.03495206666531736,0.0,0.0,1,18341,AFP TUMOR MARKER SIEMENS CLIA,AFP TUMOR MARKER SIEMENS CLIA,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,CMP14 5AC,BILIRUBIN TOTAL,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.125,0.125,0.0,0.0,0.0,0.0,0.0,0.057752863325096104,0.0,0.0,0.0,0.0,0,109009,PROTEIN ELEC INTERP SERUM,M SPIKE,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.22333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.28867513459481287,0.5,0,21618,BASIC METABOLIC PANEL,BUN CREATININE RATIO,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,CEA CARCINOEMBRYONIC ANTIGEN,CEA CENTAUR,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,CBC WITH AUTO DIFF,MCV,Basophils,Basophils [#/volume] in Blood,Basophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,LYMPHOCYTE SUBSET PANEL 2,COMMENT S,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.0,0.14285714285714285,0.0,0.324,0.2857142857142857,1.0,0.0,0.0953620011163746,0.0,0.04215892569416535,0.0953620011163746,0.5,1,28746,PROTEIN ELECTROPHORESIS,GAMMA GLOBULINS,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.047139540293659965,0.0,0.0,0.0,0.0,0,295410,CBC WITH PLT DIFF,PROMYELOCYTES,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,HEPATIC FUNCTION PANEL,ALBUMIN,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.05,0.03142857142857143,0.07333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,CEA CARCINOEMBRYONIC ANTIGEN,CEA CENTAUR,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.07142857142857142,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,CBC WITH AUTO DIFF,BASOPHILS ABSOLUTE,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.3333333333333333,0.3333333333333333,0.5,0.3333333333333333,0.3333333333333333,0.5,0.05339016372965322,0.5576035828430085,0.8164965809277261,0.05339016372965322,0.5576035828430085,0.8164965809277261,1,44859,COMPLEMENT C3 SERUM,COMPLEMENT C3 SERUM,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,RPR REFLEX T PALLIDUM PA,RPR,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,ALPHA 1 ANTITRYPSIN QN,ALPHA 1 ANTITRYPSIN QN,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,CBC,MO%,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,BASIC METABOLIC PANEL AMA,GLUCOSE,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,ACUTE HEPATITIS PANEL,HEPATITIS A IGM,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,CMP14 LP 5AC CBC D PLT RPR,HEMOGLOBIN A1C,pH,pH of Urine by Test strip,pH Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,UA MICROSCOPIC REFLEX CULTURE,WHITE BLOOD CELLS,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.0825,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,URINALYSIS WITH MICROSCOPIC,APPEARANCE,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,URINALYSIS WITH MICROSCOPIC,GLUCOSE,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.21668861764565872,0.0,0.0,0.21668861764565872,0.0,0,30940,C4 SERUM,C4 SERUM,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,CBC,HCT,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,CMP WITH ESTIMATED GFR CALCULATED,CARBON DIOXIDE,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,GGT,GGT,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,CBC WITH PLT DIFF,BANDS ABSOLUTE,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.32,0.16666666666666666,0.3333333333333333,0.32,0.16666666666666666,0.3333333333333333,0.0309504251567585,0.03920811077406172,0.053158992087206314,0.03790637447812928,0.04801993258748538,0.06510620292715197,1,130682,ANA TITER PATTERN,ANA PATTERN,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.1,0.12142857142857143,0.2833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,POL CMP WITH EGFR INV,GLUCOSE,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,MCCARJUH MCCARTHY PROFILE 1,MITOCHONDRIAL M2 AB,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,RPR REFLEX TITRE TPPA,RPR,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.11399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,RENAL PANEL 10,EGFR IF AFRICN AM,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.26,0.195,0.39,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,URINALYSIS WITH MICROSCOPIC,GLUCOSE,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,HCV RNA PCR QN GRAPH RFX NS5A,HCV NS5A RESIST ASSAY INTERP,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,DRUG SCREEN AUSTIN 20,PHENCYCLIDINE,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,FOLATE,FOLATE,Bacteria identified,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,MANUAL DIFFERENTIAL,SEGMENTED NEUTROPHILS %,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0.0,0.24044117311858715,0.0,0,19638,C4 SERUM,C4 SERUM,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,CMP14 HP4 DBILI CBC D PLT R,C REACTIVE PROTEIN QUANT,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.2,0.16666666666666666,0.0,0.0,0.0,0.0,0.03401801828400064,0.0,0.0,0.0,0.0,0.0,0,7369,CBC WITH AUTO DIFF,NRBC,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.07142857142857142,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,CBC WITH PLT DIFF,VARIANT LYMPHOCYTES ABSOLUTE,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,HEPATIC FUNCTION PANEL 6,ALT SGPT,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,30916,CMP,BUN,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,LDL CHOLESTEROL DIRECT,LDL CHOL DIRECT,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,URINALYSIS W MICROSCOPIC,BACTERIA,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,HEPATITIS C RNA PCR QUANTITATIVE,HCV VIRAL LOG,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,COMP METABOLIC PANEL W GFR,PROTEIN TOTAL,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,COMP METABOLIC PANEL,CREATININE,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.06666666666666667,0.1,0.0,0.0,0.0,0.0,0.0,0.05741909150255753,0.0,0.0,0.0,0.0,0,302398,CMP WITH EGFR,EGFR NON AFRICAN AM,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,URINALYSIS C,BILIRUBIN,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.375,0.20000000000000004,0.0,0.0,0.0,0.0,0.03960996495528413,0.0,0.0,0.0,0.0,0.0,1,204552,URINALYSIS W REFLEX MICRO,WHITE BLOOD CELLS,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,ANTI SMOOTH MUSCLE MITOCHOND,MITOCHONDRIAL M2 ANTIBODY,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,LYMPHOCYTE SUBSET PANEL 2,% CD8 SUPPRESSOR T CELLS,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.3333333333333333,0.14285714285714285,0.0,0.0,0.2857142857142857,0.6666666666666666,0.04737353280140688,0.0,0.0,0.0,0.12793313413942875,0.15892726613090935,1,326231,CBC W AUTO DIFF,MEAN PLATELET VOLUME,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,URINALYSIS WITH MICROSCOPIC,EPITHELIAL CELLS,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,LYMPHOCYTE SUBSET PANEL 3,% CD3 MATURE T CELLS,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.13909830811578938,0.0,0,93187,COMP METABOLIC PANEL,RATIO,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,QUESTASSURED 25 OH VIT D,VITAMIN D 25 OH D2,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,T3 FREE,T3 FREE,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,CBC DIFF PLT,MCH,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,PROTEIN ELECTRO S,PLEASE NOTE,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,TRIIODOTHYRONINE T3 FREE,TRIIODOTHYRONINE T3 FREE,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.09090909090909091,0.0,0.0,0.0,0.0,0.0,0.02619755394479084,0.0,0,602797,UA MICROSCOPIC REFLEX CULTURE,WHITE BLOOD CELLS,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,HEPATITIS B CORE AB TOTAL,HEPATITIS B CORE AB TOTAL,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,HELPER T LYMPH CD4,HEMATOLOGY COMMENTS,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,PROTEIN ELECTRO S,ALPHA 2 GLOBULIN,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.03272727272727272,0.05142857142857143,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,COMPREHENSIVE METABOLIC PANEL,CARBON DIOXIDE,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,LIPOPROT LDL DIRECT,LIPOPROT LDL DIRECT,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.0,0.0,0.34199999999999997,0.2857142857142857,1.0,0.0,0.0,0.0,0.039794905532140934,0.08429511355131847,0.8164965809277261,1,7344,CBC WITH PLT DIFF,VARIANT LYMPHOCYTES ABSOLUTE,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,RPR HBSAG HCVAB HSV1 HSV2 I,HEP C VIRUS AB,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.31,0.25,0.0,0.3333333333333333,0.25,1.0,0.0,0.0840117798597445,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,728592,HEPATITIS C VIRAL RNA NS3 GENOTYPE,BOCEPREVIR RESISTANCE,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,NASH FIBROSURE,AST SGOT P5P,Erythrocytes,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,CMP14 CBC D PLT RPR UA TSH,NEUTROPHILS ABSOLUTE,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,DRGABU2,METHAQUALONE,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.6566666666666666,0.48250000000000004,0.93,0.4333333333333333,0.48250000000000004,0.93,0.0,0.08936836789798819,0.0773952768944115,0.0,0.18521145193076438,0.16039782244384237,1,28886,PROTEIN 24 HOUR URINE,PROTEIN URINE CONC,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,SEDIMENTATION RATE WESTERGREN,SEDIMENTATION RATE WESTERGREN,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,CMP14 EGFR,POTASSIUM,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.24333333333333332,0.186,0.0,0.24333333333333332,0.186,0.0,0.0,0.04357905440832277,0.0,0.0,0.04357905440832277,0.0,1,64634,CULTURE ROUTINE,CULTURE ROUTINE,Bacteria identified,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult
0.26666666666666666,0.3,0.9,0.26666666666666666,0.3,0.9,0.0,0.16096628932775536,0.35355339059327373,0.0,0.16096628932775536,0.35355339059327373,1,44982,COMPLEMENT COMPONENT C4C,COMPLEMENT COMPONENT C4C,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,URINALYSIS W MICRO W REFLEX CULTURE,NITRITES,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,TRANSFERRIN,TRANSFERRIN,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.14666666666666667,0.22,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,NGI HCV SUPERQUANT,INTERNATIONAL UNITS,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,LIPID PNL W REFL TRIG>400,CHOLESTEROL HDL RATIO,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,LIPOPROT LDL DIRECT,LIPOPROT LDL DIRECT,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.175,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,CMP14 LP 7AC CBC D PLT T B,AMYLASE SERUM,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.3333333333333333,0.4,0.6666666666666666,0.3333333333333333,0.375,0.625,0.3590775716115062,0.609238940219434,0.06123184324815101,0.3590775716115062,0.5945908194933505,0.04082122883210071,1,241133,HEPATITIS B CORE IGM ANTIBODY,HEP B CORE IGM ANTIBODY,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.015454545454545455,0.0425,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,LIPID PANEL AMA,CHOLESTEROL HDL RATIO,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,RPR REFLEX PER CDC,RPR,Hemoglobin,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc
0.0,0.1111111111111111,0.2,0.16666666666666666,0.3333333333333333,0.6,0.0,0.04801838305228456,0.06720098415971731,0.033947326516491017,0.11089370552514821,0.15519402517768222,1,51961,ACUTE HEPATITIS PANEL,HEPATITIS B SURFACE ANTIGEN,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,PSA TOTAL % FREE,PSA FREE,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,PROTEIN ELEC INTERP SERUM,M SPIKE,Erythrocyte morphology finding,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,OBSTETRIC PANEL INCLUDING HIV,HEMOGLOBIN,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.06090909090909091,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,IRON IBC W RFX FERRITIN,%TRANSFERRIN SATURATION,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,CMP WITH EGFR,EGFR NON AFRICAN AM,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.1875,0.0,0.0,0.0,0.047142857142857146,0.066,0.0,0.13697041783001718,0.0,0.0,0.0,0.0,0,223149,PROTEIN ELECTRO SERUM,ALPHA 2 GLOBULIN,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,TSH,TSH,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,HEPATITIS PANEL ACUTE,HEPATITIS A IGM,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,HEPATITIS C VIRAL RNA QUAL TMA,HEPATITIS C VIRAL RNA QUAL TMA,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,ALKALINE PHOSPHATASE,LIPEMIA,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.09090909090909091,0.0,0.0,0.0,0.0,0.0,0.050647203319289846,0.0,0,831008,FERRITIN,FERRITIN SERUM,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,URINALYSIS COMPLETE,BILIRUBIN,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,NASH FIBROSURE,ALT SGPT P5P,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,COMPREHENSIVE METABOLIC PANEL E GFR,CALC GLOBULIN,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,PROTEIN TOTAL URINE,PROTEIN CR RATIO,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,URINALYSIS CULTURE IF INDICATED,WHITE BLOOD CELLS,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,LYMPHOCYTES,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,RPR REFLEX TP PA,RPR TITER,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,DACLATASVIR RESISTANCE,Appearance,Appearance of Urine,Appearance Ur
0.14285714285714285,0.08333333333333333,1.0,0.14285714285714285,0.08333333333333333,1.0,0.02319962292068234,0.0,0.0,0.026788617076707433,0.0,0.0,1,115790,TSH FREE T4 PROFILE,TSH THIRD GENERATION,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,THYROXINE T4 FREE,T 4 FREE,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,HEMOGLOBIN A1C EAG,HEMOGLOBIN A1C,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,CHEM SCREEN PANEL HDL,URIC ACID,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,MAYNAC CMP 4AC LIPID CBC T4 TSH PSA PROFILE,MCH,Eosinophils,Eosinophils [#/volume] in Blood,Eosinophil # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,CMP13 LP TP TSH 2AC CBC D P,CHOLESTEROL TOTAL,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,HCV FIBROSURE RESULTS,NECROINFLAMMAT ACT GRADE,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,HCV FIBROSURE,LIMITATIONS,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,URINALYSIS W REFLEX MICRO,OCCULT BLOOD,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.16666666666666666,0.16666666666666666,0.0,0.0,0.0,0.0,0.007033950267709588,0.005784455196572225,0.0,0.0,0.0,0.0,0,7732,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,WBC,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,TRANSFERRIN,TRANSFERRIN,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,ACUTE HEPATITIS PANEL,HEPATITIS B SURFACE ANTIGEN,Ceruloplasmin,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,CD4 T4 ENUMERATION,ABSOLUTE LYMPHOCYTES,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,HIV ANTIGEN ANTIBODY FOURTH GENERATION W RFL,HIV AG AB 4TH GEN,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,CBC WITH DIFFERENTIAL,ABS NEUTROPHILS,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,URINE MICROALBUMIN CREAT RATIO,UR MICROALBUMI,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,CREATININE,ICTERUS,Basophils,Basophils [#/volume] in Blood,Basophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,CBC WITH DIFF PLATELET,WBC,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.2857142857142857,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,NGI HCV ULTRAQUAL RFX SUPER QT,COPIES ML,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,IRON TIBC,UIBC,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,DRUG ABUSE SCREEN 8 W CONFIRMATION,BARBITURATES,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,HEPATIC FUNCTION PANEL,ALT,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.25,0.0,0.0,0.0,0.0,0.0,0.0672790962344263,0.051758104169687846,0.0,0.0,0.0,0.0,0,7120,DIFFERENTIAL MANUAL,ABSOLUTE NEUTROPHILS,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,CBC WITH PLT DIFF,MYELOCYTES,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,DRUG ABUSE SCREEN I,AMPHETAMINES,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.0,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,204552,URINALYSIS CULTURE IF INDICATED,WHITE BLOOD CELLS,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH TOTAL,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,MCCARJUH MCCARTHY PROFILE 1,MITOCHONDRIAL M2 AB,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0825,0.10600000000000001,0.0,0.25,0.2,1.0,0.0,0.0,0.0,0.0763206923693498,0.09762443806815091,1.0,1,254284,URINALYSIS REFLEX,GLUCOSE,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,CMP14 LP 1AC CBC D PLT TSH,LYMPHS,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,HEMOGLOBINOPATHY EVAL,MCH,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.5,0.0,0.0,0.0,0.059630238727867435,0.059630238727867435,0.1063004130698838,1,31377,FIBROACT COMPLETE,HEIGHT INCHES,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,ANA SCR W RFL T P LUPUS 1,ANA PATTERN,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,URINALYSIS W MICROSCOPIC,BACTERIA,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,CBC WITH PLT DIFF,NUCLEATED RBCS,Microalbumin/Creatinine ratio panel,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,DRUG SCREEN AUSTIN 20,PHENCYCLIDINE,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.266,0.16625,0.44333333333333336,0.0,0.16625,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,HEPATITIS C RNA PCR QUANTITATIVE,HCV VIRAL LOG,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,DIRECT LDL,DIRECT LDL,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,PSA TOTAL REFLEX FREE,PROSTATE SPECIFIC AG SERUM,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,MANUAL DIFFERENTIAL,BLASTS %,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.13999999999999999,0.2333333333333333,0.0,0.0,0.0,0.0,0.04275224669691968,0.05957075580329363,0.0,0.0,0.0,0,241133,HEPATITIS C VIRAL RNA NS3 GENOTYPE,TELAPREVIR RESISTANCE,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.3333333333333333,0.03,0.0,0.0,0.06666666666666667,0.2,0.03744933465634659,0.04503319834629371,0.0,0.0,0.0,0.0,0,205088,CMP14 CBC D PLT RPR UA TSH,NEUTROPHILS ABSOLUTE,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.09514701035893025,0.0731970128794921,1.0,0,7534,CBC DIFF AMBIGUOUS DEFAULT,NEUTROPHILS,Neutrophils,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,HEPATITIS C VIRAL RNA NS3 GENOTYPE,BOCEPREVIR RESISTANCE,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,LIVER FIBROSIS FIBROTEST ACTITEST,NECROINFLAMMAT ACT GRADE,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,LYMPHOCYTE SUBSET PANEL 4,ABS CD4 COUNT,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,LIPID PANEL WITH LDL HDL RATIO,LDL HDL RATIO,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,URINALYSIS W REFLEX MICRO,OCCULT BLOOD,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,BUN CREAT RATIO W EGFR,NON AFRICAN AMERICAN EGFR,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,PHOSPHATE AS PHOSPHORUS,ICTERUS,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,COMPREHENSIVE METABOLIC PANEL E GFR,CHLORIDE,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,BMP,C02 BICARBONATE,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.2375,0.2375,0.31666666666666665,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,LYMPHOCYTE SUBSET PANEL 3,% CD8 SUPPRESSOR T CELLS,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,CBC WITH ABSOLUTE NEUTROPHIL COUNT,PLATELET COUNT,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,CBC PLATELET HEM REVIEW,LYMPHS ABSOLUTE,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME NR,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,PROTEIN ELECTROPHORESIS SERUM,BETA,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.14285714285714285,0.08333333333333333,1.0,0.14285714285714285,0.08333333333333333,1.0,0.026788617076707433,0.0,0.0,0.026788617076707433,0.0,0.0,0,115790,TSH RFLX FT4,TSH RFLX FT4,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,HEP B CORE AB QUAL,HEPATITIS B CORE AB QL,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,HCV ANTIBODY REFLEX NAA,HCV RNA NAA QUALITATIVE,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,HEPATIC FUNCTION PANEL,ALBUMIN,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.19444444444444445,0.35,0.16666666666666666,0.2222222222222222,0.4,0.0,0.0,0.0,0.009009572220431195,0.014715515936648327,0.02059413688053624,0,51961,HEP B CORE AB QUAL,HEPATITIS B CORE AB QL,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.088,0.0,0.0,0.088,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,HEPATITIS B SURFACE AB,HEPATITIS B SURFACE AB,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,FE TIBC FER B12 HCT FOLRBC,IRON,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,CREATININE,LIPEMIA,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.16096628932775536,0.0,0.0,0.0,0.0,0,44859,PROTEIN ELEC INTERP SERUM,M SPIKE,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,PTH INTACT WITHOUT CALCIUM,PTH INTACT,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,HCV RNA QN REAL TIME PCR W RFX QL T,HCV RNA PCR QN,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,CBC INC DIFF PLT,BASOPHILS,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.0,0.0,0.0,0.2,0.05,0.13333333333333333,0.0,0.0,0.0,0.052601290786171706,0.07834499240220905,0.07600531298566238,1,244673,LYMPHOCYTE SUBSET PANEL 2,CD4 ABSOLUTE,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,PSA FREE TOTAL,PSA FREE,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.25,0.21428571428571427,0.75,0.25,0.21428571428571427,0.75,0.02882725037163869,0.0,0.0,0.02882725037163869,0.0,0.0,0,110114,HCV GENOSURE R NSA,HCV GENOSURE R NSA,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.1,0.125,0.0,0.0,0.0,0.0,0.03210415570861036,0.0,0.0,0.0,0.0,0,426171,CBC WITH DIFF PLATELET,WBC,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,GGT,GGT,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.2857142857142857,0.0,0.0,0.0,0.0,0.0,0.02082089594569836,0.0,0.0,0.0,0.0,0,716951,CBCI COMPLETE BLOOD COUNT W DIFF,ABS NEUTROPHILS,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,CMP,ALBUMIN,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,LEDIPASVIR RESISTANCE,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,COMP METABOLIC PROFILE FASTING CMP,BUN CREATININE RATIO CALC,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.1111111111111111,0.2,0.0,0.0,0.0,0.0,0.04766949495848305,0.03564741051749121,0,339358,HEPATITIS PANEL DIAGNOSTIC,HEP B CORE TOTAL AB,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,CBC W AUTO DIFF ABS WBC MPV PLT,MCHC,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.011196493383248574,0.0,0.0,0.0,0.0,0,349993,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,EOSINOPHILS #,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,CBC W AUTO DIFF,MONOCYTES %,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,ANA TITER PATTERN,ANA PATTERN,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,CBCM COMPLETE BLOOD CNT W MAN DIFF,EOSINOPHILS,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.44333333333333336,0.25,0.5,0.31,0.25,0.5,0.010363119229323314,0.621189378727853,0.9625978811059088,0.010765782298852833,0.6453259361159007,1.0,1,312017,HIV AB EIA WITH REFLEXES,HIV AB,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,MAYNAC CMP 4AC LIPID CBC T4 TSH PSA PROFILE,MCH,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,LYMPHOCYTE SUBSET PANEL 4,LYMPHOCYTES ABSOLUTE,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,ANA TITER PATTERN,ANA TITER,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,PROTEIN ELECTROPHORESIS SERUM,INTERPRETATION,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,URINALYSIS WITH MICROSCOPIC,EPITHELIAL CELLS,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,CBC W DIFF PLT,MPV,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,CBC PLATELET HEM REVIEW,NEUTROPHILS,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,CMP WITH EGFR,ALKALINE PHOSPHATASE,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,CBC DIFF AMBIGUOUS DEFAULT,NEUTROPHILS,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,PHENCYCLIDINE,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,CBC WITH AUTO DIFF,RDW,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,HELPER T LYMPH CD4,HEMATOLOGY COMMENTS,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0,0.04888888888888889,0.088,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,DRGABU2,METHAQUALONE,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,CREATININE,ICTERUS,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,C4 SERUM,C4 SERUM,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,TESTOSTERONE,TESTOSTERONE,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,MORPHOLOGICAL REVIEW,MORPHOLOGICAL REVIEW,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,CUSTOM HEPATITIS PANEL,HEPATITIS C ANTIBODY,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,CMP14 LP 5AC CBC D PLT RPR,WBC,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,HEMOGLOBINOPATHY INDICES,HEMATOCRIT,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,CBC W AUTO DIFF WITH PLATELETS,COMMENTS,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,IRON TIBC,UIBC,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.09499999999999999,0.10714285714285714,0.1875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,DRUG ABUSE SCREEN 9 NO THC W CONF,OXYCODONE,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.154,0.08833333333333333,0.0,0.4,0.3333333333333333,1.0,0.0,0.0,0.0,0.11277316640103974,0.16750164273558021,1.0,1,57992,URINALYSIS CULTURE IF INDICATED,LEUKOCYTE ESTERASE,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,EP LP 11AC CBC D PLT TSH FER,CALCIUM,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,LYMPHOCYTE SUBSET PANEL 2,% CD4 HELPER CELLS,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,ANEMIA PROFILE B,UIBC,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,CBC W DIFF PLT,PLATELET SUFFICIENCY,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.0,0.14285714285714285,0.2,0.0,0.14285714285714285,0.2,0.0,0.10609682943574561,0.05565150370408234,0.0,0.10609682943574561,0.05565150370408234,0,223149,HEPATITIS C VIRAL RNA QUAL TMA,HEPATITIS C VIRAL RNA QUAL TMA,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,TSH ULTRASENSITIVE,TSH ULTRASENSITIVE,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.010509233073549007,0.0,0,544346,B12,VIT B12 SERUM,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,RHEUMATOID FACTOR RF,RHEUMATOID FACTOR RF,Reference lab test method,Reference lab test method,Ref lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,LYMPHOCYTE SUBSET PANEL 3,CD4 CD8 RATIO,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,HCV RNA NS5A GENOTYPE,VELPATASVIR RESISTANCE,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,HEPASCORE R,AGE,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,CBC W AUTO DIFF ABS WBC MPV PLT,EOSINOPHILS,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,CMP14 CBC D PLT ESR WES ANA,NEUTROPHILS,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.09090909090909091,0.0,0.0,0.0,0.0,0.0,0.013298028875636914,0.0,0.0,0.0,0.0,0,112599,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0725,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,QUESTASSURED 25 OH VIT D,VITAMIN D 25 OH D2,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,CBC W O DIFF WITH PLATELETS,PLATELET COUNT,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,BUN CREAT RATIO W EGFR,NON AFRICAN AMERICAN EGFR,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,AUTOMATED BLD CNT,HEMOGLOBIN,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA TITER,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0825,0.08833333333333333,0.0,0.0,0.15833333333333333,0.95,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,URINALYSIS,LEUKOCYTE ESTERASE,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,LIPID PROFILE,NON HDL CHOLESTEROL,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,HCV FIBROSURE,LIMITATIONS,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.16,0.0,0.0,0.16,0.0,0.0,0.05685663912395744,0.0,0.0,0.05685663912395744,0.0,0,143149,ANA SCREEN IFA,ANA SCREEN IFA,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.146,0.10428571428571429,0.365,0.146,0.10428571428571429,0.365,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,IMMUNOGLOBULIN A,IMMUNOGLOBULIN A,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,PROTIME INR F,PT,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,PROTEIN ELECTROPHORESIS SERUM,INTERPRETATION,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.01,0.023333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,CMP14 LP CBC D PLT TSH UA M,AST SGOT,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,CMP14 4AC,EGFR IF NONAFRICN AM,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,URINALYSIS W REFLEX MICRO,GLUCOSE,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.027500000000000004,0.1375,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,COMPLETE BLOOD COUNT,NEUTROPHILS ABSOLUTE,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,FOLATE,FOLATE,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,HEP B SURFACE AB IMMUNITY QN,HEP B SURFACE AB IMMUNITY QN,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,ASH FIBROSURE,HAPTOGLOBIN,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.1111111111111111,0.0,0.0,0.1111111111111111,0.0,0.0,0.018119821154972793,0.0,0.0,0.018119821154972793,0.0,0,139543,TESTOSTERONE SERUM,TESTOSTERONE SERUM,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,HEPATITIS B SURF AG,HEPATITIS B SURF AG,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.148,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,PSA TOTAL REFLEX FREE,PSA TOTAL,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,BASIC METABOLIC PANEL 7,EGFR IF AFRICN AM,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,CREATINE KINASE TOTAL,LIPEMIA,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,CBC WITH PLT DIFF,NO CELLS DIFF,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,CMP,ALBUMIN,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,HEMOGLOBIN A1C,MEAN GLUCOSE EST,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.5425,0.7233333333333333,0.0,0.33375,0.445,0.0,0.1524643612967882,0.11313616447240271,0.0,0.09336497228411789,0.06928146860324524,1,519132,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,URINALYSIS WITH MICROSCOPIC,APPEARANCE,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,MICROALBUMIN RANDOM,MICROALBUMIN RANDOM,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,URINALYSIS WITH MICROSCOPIC,RED BLOOD CELLS,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,HEPATIC FUNCTION PANEL,ALBUMIN,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,HEPATITIS ABC PANEL,HEPATITIS A ANTIBODY TOTAL,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,COMP METABOLIC PANEL 12,ALKALINE PHOSPHATASE,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,CBC,MO%,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.0834655896020069,0.34003516797720323,1.0,1,28233,BMP8 EGFR,POTASSIUM,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.16743054821491843,1.0,1,20289,CMP WITH ESTIMATED GFR CALCULATED,CARBON DIOXIDE,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,LYMPHOCYTE SUBSET PANEL 4,COMMENTS,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,A FETOPROTEIN TUMOR MARKER,A FETOPROTEIN TUMOR MARKER,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,CMP12 LP TP TSH 6AC CBC D PLT,BILIRUBIN TOTAL,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,CBC INCLUDES DIFF PLT,BASOPHILS %,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,PROTEIN ELEC INTERP SERUM,P E INTERPRETATION S,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,CMP14 LP CBC D PLT TSH UA M,AST SGOT,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,LIPID PANEL W CHOL HDL RATIO,VLDL CHOLESTEROL CAL,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,PTH INTACT WITHOUT CALCIUM,PTH INTACT,Service comment,Service comment,Service Cmnt XXX-Imp
0.5675,0.23857142857142857,0.0,0.6675,0.3242857142857143,0.0,0.018299290118234723,0.10497865490644265,0.0,0.061241138223508074,0.058554296133023875,0.0,1,22368,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D2,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.2,0.5,0.3333333333333333,0.2,0.5,0.0,0.017111820417164192,0.017329306516888465,0.015025194405361209,0.017111820417164192,0.017329306516888465,0,205070,HEP B CORE AB QUAL,HEPATITIS B CORE AB QL,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.1063004130698838,0.10964330813284906,0.7071067811865476,1,264846,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE MONOCYTES,Monocytes,Monocytes [#/volume] in Blood,Monocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,LIPID PROFILE,CHOLESTEROL,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,MANUAL DIFFERENTIAL,SEGMENTED NEUTROPHILS %,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,CMP,BUN,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,PROTEIN ELECTRO S,ALPHA 2 GLOBULIN,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,CBC WITH PLT DIFF,WBC MORPHOLOGY,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.11833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,CBC RBC H H INDICES WBC PLT,RED BLOOD CELL COUNT,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.0,0.0,0.0,0.0,0.08287539106540942,0.7071067811865476,0.0,1,285403,CBC WITH MANUAL DIFFERENTIAL,MCHC,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.10714285714285714,0.125,0.0,0.0,0.0,0.0,0.03979805087390864,0.0,0.0,0.0,0.0,0,110114,CMP WITH ESTIMATED GFR CALCULATED,ALBUMIN,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.14285714285714285,0.5,0.0,0.0,0.0,0.0,0.16743054821491843,1.0,1,20289,BMP WITH ESTIMATED GFR CALCULATED,CARBON DIOXIDE,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,URINALYSIS,LEUKOCYTE ESTERASE,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,FIBROACT COMPLETE,HEIGHT INCHES,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,CBC PLATELET HEM REVIEW,NEUTROPHILS,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,CMP WITH EGFR,ANION GAP,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,ALKALINE PHOSPHATASE,LIPEMIA,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.028571428571428574,0.05,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,CBC W AUTO DIFF,MCV,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,CREATINE KINASE TOTAL,CREATINE KINASE TOTAL,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,POL CMP WITH EGFR INV,GLUCOSE,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,URINALYSIS REFLEX,GLUCOSE,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,PSA TOTAL REFLEX FREE,PSA TOTAL,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.19,0.266,0.25,0.5242857142857142,0.734,0.0,0.11861986140776393,0.06222027266620478,0.05489961348405459,0.3355076335393532,0.17598550691819748,1,223149,ACUTE HEPATITIS PANEL,HEPATITIS A IGM,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,PROTHROMBIN PTT,CONTROL,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,CBC W AUTO DIFF ABS WBC MPV PLT,NEUTROPHILS,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,HCV RNA PCR QN RFX GENO,PLEASE NOTE,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,UA W RFLX MICROSCOPIC,COLOR,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,LYMPHOCYTE SUBSET PANEL 4,RACE NR,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,PROTEIN ELECTRO S,BETA GLOBULIN,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,DRUG PANEL 8 SCREEN,OPIATES,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,LYMPHOCYTE SUBSET PANEL 1,% CD3 MATURE T CELLS,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,PROTEIN ELECTRO S,PLEASE NOTE,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,STOOL CULTURE,RESULT 1,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,LIVER FIBROTEST ACTITEST,FIBROSIS STAGE,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.125,0.0,0.0,0.125,0.0,0.0,0.05504399149282735,0.0,0.0,0.05504399149282735,0.0,0,25015,COMPLEMENT C4 SERUM,COMPLEMENT C4 SERUM,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,FERRITIN,FERRITIN,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,URINALYSIS RX ALB CREA,KETONES,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,LITHOLINK CMP14 P,ALBUMIN,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.2,0.2857142857142857,0.0,0.2,0.2857142857142857,0.0,0.03329989259909827,0.03615212504206189,0.0,0.03329989259909827,0.03615212504206189,0,736553,HEPATITIS C VIRAL RNA QUALITATIVE TMA,HEPATITIS C VIRAL RNA QUALITATIVE TMA,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,BMP WITH ESTIMATED GFR CALCULATED,CARBON DIOXIDE,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,UA MICROSCOPIC REFLEX CULTURE,KETONES,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.4333333333333333,0.48250000000000004,0.93,0.24333333333333332,0.14,0.56,0.0,0.1319329443888393,0.11425728143681435,0.0,0.08489650403181737,0.14704505836808368,0,28886,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN CREATININE RATIO,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.5,0.4,1.0,0.0,0.0,0.0,0.5980553435796393,0.7141611687807009,0.042181184586030485,1,81224,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD3 CELLS,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,URINALYSIS,BILIRUBIN,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.051234639146578664,0.0,0.0,0,139519,URINALYSIS REFLEX,GLUCOSE QL,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,MICROALBUMIN CREATININE RATIO,MICROALBUMIN RAN 24HR,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,UROGRAM,KETONES,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,COMPREHENSIVE METABOLIC PANEL E GFR,CARBON DIOXIDE,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,LD,LD,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D3,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,COMP METABOLIC PANEL W GFR,PROTEIN TOTAL,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.07692307692307693,0.0,0.0,0.0,0.0,0.0,0.047350448302201587,0.0,0.0,0.0,0.0,0,204479,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE MONOS,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,PT PROTIME,INR,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.045454545454545456,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,CBC PLT DIFF,MONOS,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,TSH FT4,FREE T4,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,LITHOLINK CMP14 P,ALBUMIN,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,LIPID CASCADE W RFLX APOLIB,LDL HDL RATIO,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.04,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,COMPREHENSIVE METABOLIC PANEL E GFR,SODIUM,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0225,0.045,0.088,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,CREATININE,LIPEMIA,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,VITAMIN B12 FOLATE,FOLATE SERUM,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.2866666666666667,0.0,0.0,0.0,0.2857142857142857,0.3333333333333333,0.0,0.0,0.0,0.0,0.1229667561500386,0.17375497797569384,1,18259,FE ANA TIBC FER A1A AMA ASM,ALPHA 1 ANTITRYPSIN SERUM,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,AMYLASE SERUM,AMYLASE SERUM,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,HCV FIBROSURE RESULTS,FIBROSIS SCORE,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,CBCI COMPLETE BLOOD COUNT W DIFF,MCHC,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,RPR,RPR RESULT,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,CBCI COMPLETE BLOOD COUNT W DIFF,LYMPHOCYTES,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,CMP14 2AC MG,EGFR IF NONAFRICN AM,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.08363636363636363,0.0,0.0,0.08363636363636363,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,HEPATITIS B CORE IGM,HEPATITIS B CORE IGM,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,COMP METABOLIC PANEL 14,EGFR IF AFRICN AM,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,SEDIMENTATION RATE WESTERGREN,SEDIMENTATION RATE WESTERGREN,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.25,0.16666666666666666,0.0,0.0,0.0,0.0,0.09341591340147393,0.0,0.0,1,7898,CBC W DIFF PLT,RBC,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,BASIC METABOLIC PANEL 7,EGFR IF AFRICN AM,Reference lab test method,Reference lab test method,Ref lab test method
0.0825,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,URINALYSIS WITH MICROSCOPIC,PROTEIN,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,LYMPHOCYTE SUBSET PANEL 2,% CD3 MATURE T CELL,Hemoglobin,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,BASIC METABOLIC PANEL,UREA NITROGEN BLOOD BUN,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,FASTING,FASTING STATUS,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.558,0.6666666666666666,0.6666666666666666,0.0,0.0,0.0,0.3757978134029263,0.022046838418816495,0.022046838418816495,1,487934,LIVER FIBROSIS,NECROINFLAM ACT GRADE,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.27999999999999997,0.09090909090909091,0.2,0.27999999999999997,0.09090909090909091,0.2,0.03501471280402846,0.02619755394479084,0.0413729178490605,0.03501471280402846,0.02619755394479084,0.0413729178490605,1,602797,ACCUTYPE R IL28B,ACCUTYPE R IL28B,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,LYMPHOCYTE SUBSET PANEL 2,CD4 ABSOLUTE,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.01044647483344363,0.0,0.0,0.0,0.0,0,178566,CBC COMPLETE BLOOD COUNT W O DIFF,MCHC,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,NASH FIBROSURE,ALT SGPT P5P,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,LYMPHOCYTE SUBSET PANEL 4,COMMENTS,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD8 CELLS,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,CBC W AUTO DIFF ABS WBC MPV PLT,LYMPHOCYTES,Body weight,Body weight Measured,Weight Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,ANTI SMOOTH MUSCLE MITOCHOND,MITOCHONDRIAL M2 ANTIBODY,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE EOSINOPHILS,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,LD,LD,Reference lab test method,Reference lab test method,Ref lab test method
0.134,0.09571428571428572,0.22333333333333336,0.134,0.09571428571428572,0.22333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,HEPATITIS BE AG,HB E AG,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.04776263735197994,0.0,0,24729,B12,VIT B12 SERUM,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.142,0.14285714285714285,0.5,0.0,0.0,0.0,0.0,0.07300170975033571,0.7071067811865476,0,7344,CBC W AUTO DIFF ABS WBC MPV PLT,LYMPHOCYTES,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,PTH INTACT WITHOUT CALCIUM,PTH INTACT,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.3333333333333333,0.2,1.0,0.0,0.2,0.0,0.06696411491014109,0.24044117311858715,0.7071067811865476,0.0,0.1963193957655779,0.0,1,24653,IGG SUBCLASSES,IMMUNOGLOBULIN G QN SERUM,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,ARTHRITIS PROFILE,ANTI NUCLEAR ANTIBODIES,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,MICROALBUMIN CREATININE RANDOM RATIO,CALC MICROALB CREAT RND,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,MAGNESIUM,MAGNESIUM,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,LYMPHOCYTE SUBSET PANEL 2,% CD3 MATURE T CELL,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,HCV RNA NS5A GENOTYPE,VELPATASVIR RESISTANCE,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,CBC WITH DIFFERENTIAL PLATELETS,MCH,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,CD4 CD8 LYMPHOCYTE ENUMERATION,PERCENT CD4,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,ANA ANTI NUCLEAR AB WITH REFLEX TITER,ANTI NUCLEAR ANTIBODIES,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,A FETOPROTEIN TUMOR MARKER,A FETOPROTEIN TUMOR MARKER,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.015714285714285715,0.055,0.0,0.015714285714285715,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,AFP TUMOR MARKER SIEMENS CLIA,AFP TUMOR MARKER SIEMENS CLIA,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,MANUAL DIFFERENTIAL,TOTAL NEUTROPHILS %,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,NMR LIPOPROFILE,LDL P,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.08399999999999999,0.0875,0.2333333333333333,0.168,0.185,0.24333333333333332,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,IMMUNOGLOBULINS,IMMUNOGLOBULIN M,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,CMP14 LP 2AC CBC D PLT MG T,WBC,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.16666666666666666,0.20428571428571426,0.715,0.16666666666666666,0.21428571428571427,0.75,0.02882725037163869,0.08899114712605449,0.25183681750032183,0.033286841524124755,0.0,0.0,1,110114,HEPATITIS C RNA PCR QUANT,HCV PCR QUANT,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.015477449545647781,0.0,0,265157,BASIC METABOLIC PANEL,UREA NITROGEN BLOOD BUN,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.11098565713428754,0.10964330813284906,0.7071067811865476,1,264994,CBC W AUTO DIFF,ABS NEUTROPHILS,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,DRUG ABUSE SCREEN II,OPIATES,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,CEA,CEA CENTAUR,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,CREATINE KINASE TOTAL,LIPEMIA,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,HCV RNA PCR QN RFX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,CPK,CPK,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.02948276095739455,0.0,0.0,0.0,0.0,0,264994,CBC COMPLETE BLOOD COUNT W O DIFF,MCHC,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,HCV RNA NS5A GENOTYPE,VELPATASVIR RESISTANCE,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.166,0.0,0.0,0.166,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,HEPATITIS B CORE AB TOTAL,HEPATITIS B CORE AB TOTAL,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,PTT,PTT,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,URINALYSIS REFLEX,GLUCOSE,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,HCV AB W RFL RNA RFL GENO,HEPATITIS C AB,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,TRICHOMONAS MALE,SOURCE,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06803603656800117,0.06673966886790239,0.10240603634159506,1,7708,CBC DIFF AMBIGUOUS DEFAULT,NEUTROPHILS,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,CBC WITH DIFFERENTIAL,IMMATURE GRANS,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.14666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,UROGRAM,KETONES,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,ACUTE HEPATITIS PANEL,HEPATITIS C ANTIBODY,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.25,0.16666666666666666,0.5,0.215,0.0,0.0,0.008779197456866394,0.04839660289257697,0.1063004130698838,0.0,0.0,0.0,1,25023,IRON TIBC,TRANSFERRIN SAT %,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,HCV RNA GENOTPE 1 NS5A DRUG RE,OMBITASVIR RESISTANCE,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,HEPATITIS B SURFACE AB IMMUN,HEPATITIS B SURFACE AB IMMUNITY QN,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,CBC WITH DIFFERENTIAL,EOSINOPHILS,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,HCV ANTIBODY REFLEX NAA,HCV RNA NAA QUALITATIVE,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.04289041814409744,0.0,0.0,0.0,0.0,0,203927,IFE PE SERUM,M SPIKE,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.06285714285714286,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,HBSAB AG,HEP B SURFACE AB QUAL,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.16625,0.44333333333333336,0.266,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,CRP,C REACTIVE PROTEIN ULTRA,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,PROTHROMBIN TIME,PT POP MEAN,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,MAYNAC CMP 4AC LIPID CBC T4 TSH PSA PROFILE,MCH,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,VIT B 12 FOLATE PANEL,VITAMIN B 12,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,MAGNESIUM SERUM,MAGNESIUM SERUM,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,BUN CREATININE RATIO,ICTERUS,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,HEPATIC FUNCTION PANEL A,TOTAL PROTEIN,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,URINALYSIS W REFLEX MICRO,GLUCOSE,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,CBC PLATELET HEM REVIEW,NEUTROPHILS,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,CMP12 2AC,ALBUMIN SERUM,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,CULTURE ROUTINE,CULTURE ROUTINE,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,DRUG ABUSE SCREEN 11 W ETOH W CONF,METHADONE,Erythrocyte distribution width,Erythrocyte distribution width [Entitic volume],RDW RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,NGI HCV ULTRAQUAL RFX SUPER QT,COPIES ML,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,RDW,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.10714285714285714,0.06363636363636363,0.0,0.07142857142857142,0.045454545454545456,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,PROTIME PTT,PTT,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.015714285714285715,0.055,0.0,0.012142857142857144,0.0425,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,HDL CHOL DIRECT,HDL AS % CHOLESTEROL,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0,22764,VITAMIN B12 FOLATE,FOLATE SERUM,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,DRUG ABUSE PANEL 10 WITH OXYCODONE,BENZODIAZEPINES,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.0,0.0,0.09666666666666666,0.0725,0.29,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,DRUG ABUSE SCREEN W ETOH NO GCMS,AMPHETAMINES,pH,pH of Urine by Test strip,pH Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,CMP WITH ESTIMATED GFR CALCULATED,FASTING NON FASTING,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,ASH FIBROSURE,WEIGHT,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,BASIC METABOLIC PANEL 8,EGFR IF AFRICN AM,Globulin,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,ARTHRITIS PROFILE,ANTI NUCLEAR ANTIBODIES,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,PROTEIN ELECTROPHORESIS SERUM,INTERPRETATION,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,COMP METABOLIC PANEL W GFR,SODIUM,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,CMP12 LP 6AC,CHOLESTEROL TOTAL,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,THYROID II PROFILE T3U T4 T7 TSH,T4 THYROXINE,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.61,0.59375,1.0,0.44333333333333336,0.25,0.5,0.010363119229323314,0.621189378727853,0.9625978811059088,0.033125112391305556,0.10486664102384657,0.1625018229625479,1,312017,HIV AB 1 HIV 2 EIA W REFL 1 WB,HIV EIA AB SCREEN,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,HCV QUANT GT1A NS5A PROFILE,HCV LOG10,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.42857142857142855,0.6666666666666666,0.3333333333333333,0.0,0.0,0.0,0.6630243943799374,1.0,0.09629383728860574,0.0,0.0,1,25007,IRON BINDING CAPACITY,TIBC,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.15,0.14285714285714285,0.0,0.15,0.14285714285714285,0.0,0.0,0.043355289534301455,0.0,0.0,0.043355289534301455,0.0,0,142513,COMPLEMENT C4 SERUM,COMPLEMENT C4 SERUM,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,COMPLETE BLOOD COUNT,BASOPHILS %,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,CBC WITH PLT DIFF,BANDS ABSOLUTE,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.165,0.265,0.0,0.5,0.5,1.0,0.0,0.0,0.0,0.14187034543632637,0.7071067811865476,1.0,1,57679,URINALYSIS COMPLETE,APPEARANCE,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,HEPATITIS C VIRAL RNA NS3 DRUG RESI,BOCEPREVIR RESISTANCE,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,MANUAL DIFFERENTIAL,BLASTS %,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,CBC W DIFF PLT,BLAST CELLS ABSOLUTE,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,COMP METABOLIC PANEL,ANION GAP,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.21,0.1111111111111111,0.25,0.0,0.0,0.0,0.0,0.006076686051585067,0.009744924678454114,1,32896,PROTIME PTT,PROTHROMBIN TIME PT,Prothrombin.activity actual/Normal,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,MITOCHONDRIAL M2 AB,MITOCHONDRIAL M2 AB,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,CBC PLATELET HEM REVIEW,NEUTROPHILS,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,PROTHROMBIN TIME WITH INR,INR,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,CEA,CEA SIEMENS IMMULITE 2000,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,URINALYSIS,LEUKOCYTE ESTERASE,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,LP LDL DIRECT,HDL CHOLESTEROL,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,LEUKEMIA LYMPHOMA EVALUATION,SPECIMEN TYPE,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,CMP14 HP4 DBILI CBC D PLT R,EOS ABSOLUTE,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,CBC INC DIFF PLT,ABSOLUTE MONOCYTES,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.009671476801487056,0.0,0.0,0.0,0.0,0,110544,MICROALBUMIN CREATININE RATIO,MICROALBUMIN RAN 24HR,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.2,0.0,0.0,0.19,0.16666666666666666,0.3333333333333333,0.048918155723576384,0.03837506794957857,0.0,0.0,0.05427054155128297,0.0946521642027649,1,7146,DIFFERENTIAL MANUAL,EOSINOPHILS,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,TSH FT4,TSH,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,HEP B SURFACE AB IMMUNITY QN,HEP B SURFACE AB IMMUNITY QN,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,IFE PE SERUM,ALPHA 1 GLOBULIN,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,LIPID PANEL WITH LDL HDL RATIO,HDL CHOLESTEROL,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.22,0.265,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,UA MICROSCOPIC REFLEX CULTURE,WHITE BLOOD CELLS,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,Hemoglobin,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,COMP METABOLIC PANEL,GLUCOSE NON FASTING,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,CBC INC DIFF PLT,ABSOLUTE MONOCYTES,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,PSA FREE TOTAL,FREE PSA,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,CBC PLATELET HEM REVIEW,NEUTROPHILS ABSOLUTE,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,CBC WITH PLT DIFF,BLASTS,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,COMP METABOLIC PANEL 12,ALKALINE PHOSPHATASE,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,ASH FIBROSURE,HEIGHT,Ceruloplasmin,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc
0.0,0.0,0.0,0.0,0.021052631578947368,0.044444444444444446,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,PROTHROMBIN TIME,PT POP MEAN,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,HIV 1 HIV 2 AB RFLX,HIV 1 WESTERN BLOT RESULT,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.2375,0.1357142857142857,0.95,0.25,0.14285714285714285,1.0,0.0,0.0,0.0,0.052570301148225806,0.05162000400267441,0.7071067811865476,1,303644,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE LYMPHOCYTES,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,HCV RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,LEUKEMIA LYMPHOMA EVALUATION,SPECIMEN TYPE,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,CMP14 HP4 1AC PT AFP,HEP A AB IGM,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,CBC,MO%,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.25,1.0,0.0,0.0,0.0,0.0,0.15505905338492743,1.0,1,7187,OBSTETRIC PANEL INCLUDING HIV,HEMOGLOBIN,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,HIV 1 QUANT PCR,HIV 1 VIRAL LOG,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,CMP WITH EGFR,EGFR NON AFRICAN AM,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,COMPLETE BLOOD COUNT,NEUTROPHILS ABSOLUTE,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.0,0.0,0.16666666666666666,0.1,0.5,0.0,0.0,0.0,0.0872369085792638,0.0,0.0,1,17434,FIBROACT,ALT,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,COMPREHENSIVE METABOLIC PANEL WITH GFR,CREATININE,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.2375,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.05720402135206337,0.7071067811865476,1,7112,CLR CBC W DIFF PLT,ABSOLUTE EOSINOPHILS,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06635350960296393,0.05287307875068503,0.08777198612321668,1,7096,CBC INCLUDES DIFF PLT,BLASTS,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.015035236243116534,0.0,0,30163,FE ANA TIBC FER A1A AMA ASM,ALPHA 1 ANTITRYPSIN SERUM,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,CBC WITH PLT DIFF,BANDS ABSOLUTE,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,T3 FREE,T3 FREE,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,HCV RNA NS5A GENOTYPE,VELPATASVIR RESISTANCE,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,CBCI COMPLETE BLOOD COUNT W DIFF,PLT MORPHOLOGY,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.028999999999999998,0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,CBC INCLUDES DIFF PLT,ABSOLUTE BLASTS,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,COMPREHENSIVE METABOLIC PANEL REFL,UREA NITROGEN BUN,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,HCV QUANT GT1A NS5A PROFILE,HCV LOG10,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,THYROXINE T4 FREE,T 4 FREE,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,CMP CBC TSH,ABSOLUTE BLASTS,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,URINALYSIS SCREEN,PH,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,BUN CREATININE,EGFR AFRICAN AMERICAN,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,URIC A ESR WES ANA RA QN CC,URIC ACID,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,ACTIVATED PTT,ACTIVATED PTT PATIENT,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,24653,IMMUNOGLOBULINS,IMMUNOGLOBULIN G,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,COMPREHENSIVE METABOLIC PANEL E GFR,CARBON DIOXIDE,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.2,0.14285714285714285,0.5,0.0,0.0,0.0,0.023231033798790213,0.02897748515715537,0.06407759902266841,0.0,0.0,0.0,0,204537,CBC WITH ABSOLUTE WHITE BLOOD CELLS,WBC,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,URINALYSIS CULTURE IF INDICATED,LEUKOCYTE ESTERASE,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,DIFFERENTIAL MANUAL,ABSOLUTE BAND NEUTROPHILS,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,FASTING,FASTING STATUS,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.19,0.266,0.25,0.42857142857142855,0.6,0.0,0.11861986140776393,0.06222027266620478,0.04482534670398419,0.41091125349005164,0.21553734703731142,1,223149,ACUTE HEPATITIS PANEL,HEPATITIS A AB IGM,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.0769832768017027,0.08055537486383768,0.09169555407390673,0,264853,CBC INC DIFF PLT,MONOCYTES,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.12285714285714286,0.0,0.0,0.0,0.023692166672912185,0.0,0.0,0.0,0.0,1,486431,BUN CREATININE,EGFR AFRICAN AMERICAN,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,1,460980,HEPASCORE R,SEX,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,CBC INC DIFF PLT,ABSOLUTE MONOCYTES,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,URINALYSIS COMP W RFL CULTURE,PROTEIN,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.05339016372965322,0.1963193957655779,0.5773502691896257,0,23457,HEMOGLOBIN A1C,MEAN GLUCOSE EST,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.175,0.08833333333333333,0.0,0.175,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,HEPATITIS B SURFACE ANTIBODY,HEPATITIS B SURFACE ANTIBODY,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.125,0.01,0.02,0.0,0.0,0.0,0.018324914347742194,0.0,0.0,0.0,0.0,0.0,0,486423,COMP METABOLIC PANEL W GFR,GLOBULIN,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.16666666666666666,0.94,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,CBC WITH PLT DIFF,BLASTS,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,DIFFERENTIAL MANUAL,EOSINOPHILS,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,MANUAL DIFFERENTIAL,SEGMENTED NEUTROPHILS %,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,ALPHA 1 ANTITRYPSIN PHENOTYPE,ALPHA 1 ANTITRYPSIN,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.06666666666666667,0.05,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,CBC WITH PLT MAN DIFF,BANDS ABSOLUTE,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,CREATININE,LIPEMIA,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,CREATININE,EGFR IF NONAFRICN AM,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,ANION GAP,ANION GAP,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,CBC W AUTO DIFF ABS WBC MPV PLT,MCHC,Monocytes,Monocytes [#/volume] in Blood,Monocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,FE ANA TIBC FER PTT PT A1A,MITOCHONDRIAL M2 ANTIBODY,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,URINE DRUG SCREEN 1,CREATININE,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,URINE PROTEIN TOTAL RANDOM W O CREATININE,PROTEIN TOTAL RANDOM UR,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.10714285714285714,0.125,0.0,0.0,0.0,0.0,0.033635492025985814,0.0,0.0,0.0,0.0,0,110114,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,MPV,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,CBCI COMPLETE BLOOD COUNT W DIFF,DIFFERENTIAL NEUTROPHILS,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,IRON TOTAL,HEMOLYSIS,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,ANA AMA ASMA LKM AB,MITOCHONDRIAL M2 ANTIBODY,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.10428571428571429,0.030000000000000002,0.0,0.14285714285714285,0.09090909090909091,0.5,0.0,0.0,0.0,0.0872369085792638,0.0,0.0,1,17442,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,ALT,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.142,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,HEMOGLOBINOPATHY INDICES,HEMATOCRIT,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,CBC WITH PLT DIFF,BANDS,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,CMP12 2AC,ALBUMIN SERUM,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.16,0.0,0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,LD,LD,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.19,0.15833333333333333,0.31666666666666665,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,LYMPHOCYTE SUBSET PANEL 1,% CD3 MATURE T CELLS,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.025,0.04,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,CBC WITH AUTO DIFF,BASOPHILS %,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,PROTHROMBIN TIME,INR,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,HEPATITIS C VIRAL RNA NS3 GENOTYPE,TELAPREVIR RESISTANCE,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,COMP METAB PANEL,ALBUMIN GLOBULIN RATIO,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,NEG HIV 4TH GEN,NEG HIV 2 ANTIBODY,Reference lab test method,Reference lab test method,Ref lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,CBC WITH DIFFERENTIAL,MYELOCYTES,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,COMP METAB PANEL,EGFR NON AFR AMERICAN,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.25,0.5,0.6666666666666666,0.25,0.5,0.6666666666666666,0.009742953581810432,0.39509527370447484,0.4582002501529394,0.009960706634886463,0.40392557361123926,0.46844093359181893,1,45484,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,CBC INCLUDES DIFF PLT,ABSOLUTE BLASTS,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,HIV 1 RNA QN RT PCR,HIV 1 RNA QN PCR,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,PROTEIN ELECTRO S,BETA GLOBULIN,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,LIVER FIBRO HEPSCORE R,AGE,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,BMP WITH ESTIMATED GFR CALCULATED,CARBON DIOXIDE,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,CBC WITH PLT DIFF,PROMYELOCYTES,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,EP LP 11AC CBC D PLT TSH FER,CALCIUM,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.4175,0.0,0.0,0.4175,0.0,0.0,0.030620569111754037,0.0,0.0,0.030620569111754037,0.0,0.0,0,22368,VITAMIN D 25 OH TOTAL,VITAMIN D 25 OH TOTAL,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,CMP14,EGFR IF AFRICN AM,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,URINALYSIS W REFLEX MICRO,EPITHELIAL CELLS,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,203935,MAGNESIUM,HEMOLYSIS,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.0,0.03666666666666667,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,CBCI COMPLETE BLOOD COUNT W DIFF,ABS NEUTROPHILS,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.25,0.0,0.0,0.0,0.0,0.0,0.05393370274893572,0.0,0.0,0.0,0.0,0.0,0,7047,CBC W AUTO DIFF,MONOCYTES %,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.06666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,HB S AG W REFLEX CONF,HB S AG NEUTRALIZATION,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,MAGNESIUM,MAGNESIUM,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE NEUTROPHILS,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.02414352270933806,0.0,0.0,0.0,0.0,0,59055,CBC COMPLETE BLOOD COUNT W O DIFF,MCV,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,MORPHOLOGICAL REVIEW,PATH REVIEW PERIPHERAL SMEAR,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,HEMOGLOBIN A1C,MEAN GLUCOSE EST,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,TRANSFERRIN SATURATION,TRANSFERRIN,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,RENAL PANEL 10,EGFR IF AFRICN AM,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,IRON BINDING CAPACITY,TIBC,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,DIFFERENTIAL MANUAL,PLATELET ESTIMATION,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.029479735120954365,0.0,0.0,0.0,0.0,0,7328,COMPLETE BLOOD COUNT,RED CELL DIST WIDTH,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.041666666666666664,0.025,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,LIPID PROFILE,NON HDL CHOLESTEROL,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.07571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,URINALYSIS CULTURE IF INDICATED,UROBILINOGEN,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,URINE DRUG SCREEN,OPIATES,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,IRON TOTAL,HEMOLYSIS,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,RHEUMATOID FACTOR RF,RHEUMATOID FACTOR RF,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,HCV RNA QN REAL TIME PCR W RFX QL T,HCV RNA PCR QN,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,CBC,HEMOGLOBIN,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,QUESTASSURED 25 OH VIT D,VITAMIN D 25 OH D2,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,IFE PE SERUM,GAMMA GLOBULIN,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,TSH W REFLEX FT4,TSH 3RD GENERATION W REFLEX FT4,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.146,0.16666666666666666,0.5,0.0,0.0,0.0,0.0,0.12820999839172398,0.40824829046386313,0.0,0.07402207708426334,0.0,1,128512,PROTEIN ELECTROPHORESIS SERUM,INTERPRETATION,Protein pattern,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,HEPATITIS C GENO TYPE 1 NS5A RESIST,OMBITASVIR RESISTANCE,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,ASH FIBROSURE,HAPTOGLOBIN,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,HEPATITIS B SURFACE ANTIBODY,HEPATITIS B SURFACE AB QUAL,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.07142857142857142,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,RPR RFX QN RPR CONFIRM TP,TREPONEMA PALLIDUM ANTIBODIES,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,RPR SCREEN W TITER,RPR SCREEN,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,MAGNESIUM,MAGNESIUM,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,CREATINE KINASE CK,CREATINE KINASE CK,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,CBC WITH PLT DIFF,WBC MORPHOLOGY,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,COMPREHENSIVE METABOLIC PANEL E GFR,CALCULATED A G RATIO,Neutrophils,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B RESIST ASSAY INTERP,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,HCV RNA NS5A GENOTYPE,DACLATASVIR RESISTANCE,Hemoglobin,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc
0.0,0.0,0.0,0.2375,0.25,0.3333333333333333,0.0,0.0,0.0,0.0,0.08253790759907542,0.0946521642027649,1,264507,CBC WITH DIFFERENTIAL,EOSINOPHILS,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,CBC WITH AUTO DIFF,EOSINOPHILS ABSOLUTE,Microalbumin/Creatinine ratio panel,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,LIVER FIBROSIS FIBROMETER,ALPHA 2 MACROGLOBULIN FM,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,TSH RFLX FT4,TSH RFLX FT4,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,CMP12 LP 6AC,CHOLESTEROL TOTAL,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,COMP METABOLIC PANEL W GFR,SODIUM,Erythrocyte distribution width,Erythrocyte distribution width [Entitic volume],RDW RBC
0.1425,0.36,0.0,0.0,0.0,0.0,0.0,0.14265122201011204,0.0,0.0,0.0,0.0,0,192708,URINE DRUG SCREEN 1,CREATININE,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,CBC WITH PLT DIFF,MPV,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,CBC WITH AUTO DIFF,BASOPHILS %,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD IU ML,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.3333333333333333,0.16666666666666666,0.5,0.3333333333333333,0.16666666666666666,0.5,0.06538932921065,0.45528141890436646,0.5,0.06538932921065,0.45528141890436646,0.5,1,44982,C4 SERUM,C4 SERUM,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,CBC WITH PLT DIFF,BANDS,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,CBC WITH DIFFERENTIAL,ABS NEUTROPHILS,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,URINALYSIS C,BILIRUBIN,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,NASH FIBROSURE,APOLIPOPROTEIN A 1,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.392,0.09571428571428572,0.1675,0.0,0.0,0.0,0.03321870600293453,0.043355289534301455,0.043726732586310324,1,142513,FE ANA TIBC FER PTT PT A1A,MITOCHONDRIAL M2 ANTIBODY,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.072,0.05142857142857143,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,COMPREHENSIVE METABOLIC PANEL WITH GFR,CREATININE,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.3333333333333333,0.235,0.94,0.0,0.0,0.0,0.11098565713428754,0.0,0.0,1,265157,CBC WITH ABSOLUTE NEUTROPHIL COUNT,PLATELET COUNT,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,DRUG ABUSE SCREEN CLINICAL 9,COCAINE,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,CBC DIFF PLT,LYMPHOCYTES #,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,CBC DIFF PLT,MCH,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.1,0.2,0.17833333333333334,0.16699999999999998,0.33399999999999996,0.0,0.04817920714100843,0.06891707028091865,0.0,0.06813568816319682,0.09746345547029489,0,51938,ACUTE HEPATITIS PANEL,HEPATITIS A IGM,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,HEP B SURFACE AG W REFLEX CONFIRM,NEUTRALIZATION,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,LIPOPROTEIN ANALYSIS NMR,LDL P,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,MAGNESIUM,HEMOLYSIS,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,URINALYSIS COMP W RFL CULTURE,PROTEIN,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,COMP METAB PANEL,ALT,Monocytes,Monocytes [#/volume] in Blood,Monocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,CBC W AUTO DIFF,MCV,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BENZODIAZEPINES,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,PROTEIN ELECTROPHORESIS,ALPHA 1 GLOBULINS,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,HEP B SURFACE AG W REFLEX,HEP B SURFACE AG W REFLEX,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,CBC W AUTO DIFF,HGB,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.1825,0.2,1.0,0.0,0.0,0.0,0.0,0.06903090216751562,0.7071067811865476,0.0,0.0,0.0,0,204545,PROTEIN ELECTROPHORESIS,GAMMA GLOBULINS,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,BUN CREATININE RATIO,ICTERUS,Age,Age,Age
0.14285714285714285,0.08333333333333333,1.0,0.14285714285714285,0.08333333333333333,1.0,0.04639924584136457,0.0,0.0,0.04639924584136457,0.0,0.0,1,115790,TSH,TSH,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,HELPER T LYMPH CD4,HEMATOLOGY COMMENTS,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,CBC W DIFF PLT,BLAST CELLS ABSOLUTE,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,ASH FIBROSURE,APOLIPOPROTEIN A 1,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,HEPATIC FUNCTION PANEL AMA,BILIRUBIN DIRECT,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.06666666666666667,0.25,0.0,0.06666666666666667,0.25,0.0,0.04432042353220711,0.12591840875016092,0.0,0.04432042353220711,0.12591840875016092,0,381806,HEPATITIS BS AB QL,HEPATITIS B SURF AB QL,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.5733333333333334,0.14285714285714285,0.0,0.5733333333333334,0.14285714285714285,0.0,0.0,0.08055416307669028,0.05461391574666674,0.0,0.11392078992866939,0.07723574034323777,1,110544,LIPID PANEL WITH LDL HDL RATIO,LDL HDL RATIO,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS A TOTAL AB,Body weight,Body weight Measured,Weight Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,CREATINE KINASE CK,CREATINE KINASE CK,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Alpha-2-Macroglobulin,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,IRON TIBC,TRANSFERRIN SAT %,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,ANA SCREEN QUAL,ANA ANTIBODY SCREEN EIA,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN CREATININE RATIO,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,FASTING,FASTING STATUS,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,URINALYSIS W MICROSCOPIC,BACTERIA,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.06517988722537793,0.0,0,304519,CBC W AUTO DIFF,MEAN PLATELET VOLUME,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,LIVER FIBROSIS PANEL,ALT,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,CREATININE SERUM,CREATININE SERUM,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,CMP14 5AC,EGFR IF NONAFRICN AM,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,LIVER FIBROSIS FIBROMETER,ALPHA 2 MACROGLOBULIN FM,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,COMP METABOLIC PANEL,GLOBULIN,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,LIPID PANEL AMA,CHOLESTEROL HDL RATIO,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,CMP WITH EGFR,EGFR NON AFRICAN AM,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,PROTEIN ELECTRO S,M SPIKE,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,CBC INCLUDES DIFF PLT,INTERNAL WBC,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,PSA FREE TOTAL,INTERNAL %,Monocytes,Monocytes [#/volume] in Blood,Monocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,DRUG ABUSE SCREEN 11 W ETOH NO CONF,OXYCODONE,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,URINALYSIS,LEUKOCYTE ESTERASE,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,BMP,C02 BICARBONATE,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,URINALYSIS,BACTERIA,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,CBC W DIFF PLT,RBC,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,HEPATITIS A TOTAL AB REFLEX IGM,HEPATITIS A TOTAL AB,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,URINALYSIS COMP W RFL CULTURE,PROTEIN,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.2,0.3055555555555556,0.55,0.2,0.3333333333333333,0.9339999999999999,0.03796471617953978,0.13817876011426722,0.14369156469154098,0.03796471617953978,0.20726814017140072,0.21553734703731142,1,139501,HEP A AB IGM,HEPATITIS A AB IGM,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,URINALYSIS WITH MICROSCOPIC,RED BLOOD CELLS,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,LP WITHOUT VLDL CHOL HDL,LDL CHOLESTEROL CALC,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,RHEUMATOID FACTOR,RHEUMATOID FACTOR,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.40824829046386313,0.030826194861158673,0,285403,CBC INCLUDES DIFF PLATELETS,MEAN PLATELET VOLUME,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,ACUTE HEPATITIS PANEL,HEPATITIS C ANTIBODY,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0130693498781973,0.0,0.0,0.0,0.0,0,192526,CBCI COMPLETE BLOOD COUNT W DIFF,DIFFERENTIAL NEUTROPHILS,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.056999999999999995,0.05181818181818181,0.08142857142857142,0.044,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,DRUG ABUSE SCREEN II,OPIATES,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,LIVER FIBROSIS PANEL,ALT,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,CREATININE,LIPEMIA,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.2,0.16666666666666666,0.0,0.2,0.16666666666666666,0.3333333333333333,0.03863209902397613,0.0,0.0,0.06691275831255872,0.06348916544989514,0.09169555407390673,1,59055,CBC W AUTO DIFF,MONOCYTES %,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,HEPATITIS C AB REFLEX HCV RNA QUANT,HEPATITIS C ANTIBODY,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.22333333333333336,0.2,0.5,0.0,0.0,0.0,0.0,0.13909830811578938,0.14187034543632637,0.0,0.0,0.0,0,93187,CREATININE,EGFR IF NONAFRICN AM,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,HCV FIBROSURE,COMMENT,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,CBC,MO#,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.25,0.2,0.5,0.0,0.0,0.0,0.01537831991578209,0.01836385050788525,0.023996969115470557,0,81224,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD8 CELLS,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.22333333333333336,0.25,0.5,0.22333333333333336,0.25,0.5,0.0,0.05054166547762551,0.40824829046386313,0.0,0.05054166547762551,0.40824829046386313,1,148692,MORPHOLOGICAL REVIEW,MORPHOLOGICAL REVIEW,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,MANUAL DIFFERENTIAL,TOTAL NEUTROPHILS %,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.2,0.5,0.0,0.2,0.5,0.0,0.06350553280338445,0.10133615137556884,0.0,0.06350553280338445,0.10133615137556884,0,422543,HBC AB TOTAL,HBC AB TOTAL,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,AUTOIMMUNE HEPATITIS DIAG PNL,MITOCHONDRIAL AB SCREEN,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.06666666666666667,0.05,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,CBC WITH PLT DIFF,EOSINOPHILS ABSOLUTE,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,NASH FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.124,0.15833333333333333,0.31666666666666665,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,URINALYSIS CULTURE IF INDICATED,LEUKOCYTE ESTERASE,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,DRUG ABUSE SCREEN II,OPIATES,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.03571428571428571,0.05,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,PTH INTACT WITHOUT CALCIUM,PTH INTACT,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.05,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE NEUTROPHILS,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,ANA SCREEN IFA,ANA SCREEN IFA,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,CBC WITH AUTO DIFF,MONOCYTES #,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,CREATINE KINASE TOTAL,CREATINE KINASE TOTAL,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,REFLEX ANA PATTERN,PATTERN 1,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,BASIC METABOLIC PANEL,EGFR NON AFR AMERICAN,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A DRUG RESISTANCE ASSAY,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,HEP A AB IGM,HEPATITIS A AB IGM,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.15166666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,7302,CBC WITH PLT DIFF,OTHERS,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,LYMPHOCYTE SUBSET PANEL 2,% CD4 HELPER CELLS,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,PROTEIN ELECTRO S,ALPHA 1 GLOBULIN,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.20750000000000002,0.20750000000000002,0.5,0.20750000000000002,0.20750000000000002,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,HEPATITIS C ANTIBODY,HEPATITIS C ANTIBODY,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,HP5,HEP C VIRUS AB,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,ANA AMA ASMA LKM AB,MITOCHONDRIAL M2 ANTIBODY,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,HEPATITIS C VIRAL RNA NS3 GENOTYPE,TELAPREVIR RESISTANCE,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,MCCARJUH MCCARTHY PROFILE 1,MITOCHONDRIAL M2 AB,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,CBC,% BASOPHILS,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,CBC INC DIFF PLT,MONOCYTES,Reference lab test method,Reference lab test method,Ref lab test method
0.0,0.0,0.0,0.27999999999999997,0.2857142857142857,1.0,0.0,0.0,0.0,0.011862808335706188,0.6345756122357417,1.0,1,28712,PE INTERP RFX IFE S,BETA GLOBULIN,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.1858678609476695,0.0,0.0,0.0,0.0,0,19711,PROTEIN ELECTROPHORESIS SERUM,INTERPRETATION,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,HEPATIC FUNCTION PANEL W O TP,BILIRUBIN DIRECT,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,UA MICROSCOPIC REFLEX CULTURE,SPECIFIC GRAVITY,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,ANEMIA PROFILE B,UIBC,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.176,0.14285714285714285,1.0,0.0,0.0,0.0,0.0,0.07582142074137055,1.0,0,505511,FSRC NEW PATIENT PANEL,D BILIRUBIN,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,HEMOGLOBIN A1C WITH EAG,ESTIMATED AVERAGE GLUCOSE,Ceruloplasmin,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,CBC WITH AUTO DIFF,MCV,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,LIPID PROFILE WITH CALC NON HDL CHOLESTEROL,RISK RATIO LDL HDL,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,LYMPHOCYTE SUBSET PANEL 3,% CD8 SUPPRESSOR T CELLS,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.2,0.2727272727272727,0.75,0.2,0.2727272727272727,0.75,0.009667106742768716,0.0,0.0,0.025640212011781238,0.0,0.0,1,322867,HCV RNA PCR QN RFX NSA,HCV GENOSURE R NSA PDF,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,IFE PE SERUM,ALPHA 2 GLOBULIN,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,URINALYSIS COMP W RFL CULTURE,PROTEIN,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,CMP14 LP 2AC CBC D PLT MG T,WBC,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.215,0.16666666666666666,0.5,0.0,0.0,0.0,0.0,0.0,0.0,1,203943,CREATININE,LIPEMIA,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,PROTHROMBIN TIME INR,PROTHROMBIN TIME,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,LIPID PANEL,HDL AS % CHOLESTEROL,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,CBC,MO%,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,LIVER FIBROSIS PNL HEPASCORE TM,METAVIR SCORE,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.1111111111111111,0.0,0.4166666666666667,0.2222222222222222,1.0,0.0,0.0075494158994710014,0.0,0.290759678007509,0.014423058883279771,1.0,1,273532,HEMOGLOBIN A1C WITH EAG,ESTIMATED AVERAGE GLUCOSE,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.03302675712634284,0.0,0.0,0.0,0.0,0,7112,CBC WITH ABSOLUTE WHITE BLOOD CELLS,RDW,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,495499,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESIST ASSAY INTERP,Reference lab test method,Reference lab test method,Ref lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,OBSTETRIC PANEL INCLUDING HIV,HEMOGLOBIN,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,ANTI SMOOTH MUSCLE MITOCHOND,MITOCHONDRIAL M2 ANTIBODY,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,HEPATITIS PANEL ACUTE,HEPATITIS C ANTIBODY,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,HCV RNA PCR QN GRAPH RFX NS5A,HCV NS5A RESIST ASSAY INTERP,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,DRUG ABUSE SCREEN 8 W CONFIRMATION,BARBITURATES,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,COMPREHENSIVE METABOLIC PANEL E GFR,CALCULATED A G RATIO,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.30428571428571427,0.0,0.0,0.17142857142857143,0.0,0.0,0.033908370185663395,0.0,0.0,0.043775517675370135,0.0,0,505511,HEPATITIS A TOTAL AB REFLEX IGM,HEPATITIS A TOTAL AB,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,CBC W AUTO DIFF ABS WBC MPV PLT,LYMPHOCYTES,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.03142857142857143,0.044,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,BUN CREAT RATIO W EGFR,NON AFRICAN AMERICAN EGFR,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,HEPATITIS C VIRAL RNA QUAL TMA,HEPATITIS C VIRAL RNA QUAL TMA,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,LIPID PANEL,CALC LDL CHOL,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,NASH FIBROSURE,ALT SGPT P5P,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,NEG HIV 4TH GEN,NEG HIV 1 ANTIBODY,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.0,0.0,0.1775,0.25,0.2,0.0,0.0,0.0,0.0,0.06650223739152306,0.21717918485032472,0.0,1,7856,HEMOGLOBINOPATHY EVAL,MCH,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,IFE PE SERUM,GAMMA GLOBULIN,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,HEPATITIS B SURFACE AB QUANT,HEPATITIS B SURFACE AB,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,UROGRAM,SPECIFIC GRAVITY,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,ALPHA FETOPROTEIN TUMOR MARKER,ALPHA FETOPROTEIN TUMOR,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,CD4 CD8 ENUMERATION,ABSOLUTE LYMPHOCYTES,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,AFP TUMOR MARKER SIEMENS IMMULITE,AFP TUMOR MARKER,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.0,0.235,0.94,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,CBC WITH PLT DIFF,PROMYELOCYTES,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,PROFILE 104 LIVER,AST SGOT,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,ACUTE HEPATITIS PANEL,HEPATITIS B SURF AG,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,CARDIO CRP R,CARDIO CRP R,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,COMPREHENSIVE METABOLIC PANEL AMA,GLOBULIN,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,ACUTE HEPATITIS PANEL,HEPATITIS C ANTIBODY,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.0,0.0,0.0,0.148,0.37,0.0,0.0,0.0,0.0,0.06755685946200152,0.08775968141298807,1,473835,ARTHRITIS PROFILE,ANTI NUCLEAR ANTIBODIES,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,PSA FREE TOTAL,INTERNAL %,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.11,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,UA MICROSCOPIC REFLEX CULTURE,OCCULT BLOOD,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.014000000000000002,0.02,0.0,0.018,0.025714285714285714,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,COMPREHENSIVE METABOLIC PANEL WITH GFR,CREATININE,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,IMMUNOGLOBULINS,IMMUNOGLOBULIN A,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,DIFFERENTIAL MANUAL,EOSINOPHILS,Erythrocyte morphology finding,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld
0.0,0.0,0.0,0.06285714285714286,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,URINE DRUG SCREEN,OPIATES,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,HCV FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,ANTI SMOOTH MUSCLE MITOCHOND,MITOCHONDRIAL M2 ANTIBODY,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,PSA FREE TOTAL,FREE PSA,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.25,0.2857142857142857,0.4,0.0,0.0,0.0,0.028826104685325094,0.04305039215257289,0.10921478730455103,0.0,0.0,0.0,0,487967,AUTOIMMUNE HEPATITIS DIAG PNL,MITOCHONDRIAL AB SCREEN,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,HIV 1 HIV 2 AG AB COMBO W REFLEXES,HIV INTERPRETATION,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,CBC PLT DIFF,POLYS,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,HCV RNA QN REAL TIME PCR W RFX QL T,HCV RNA PCR QN,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,HCV FIBROSURE RESULTS,NECROINFLAMMAT ACT GRADE,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,HEPATITIS B CORE AB,HEPATITIS B CORE AB,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,CBC W AUTO DIFF ABS WBC MPV PLT,EOSINOPHILS,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.02948276095739455,0.0,0.0,0.0,0.0,0,264747,CBCI COMPLETE BLOOD COUNT W DIFF,MCV,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,ANA SCREEN QUAL,ANA ANTIBODY SCREEN EIA,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,BASIC METABOLIC PANEL,EGFR NON AFR AMERICAN,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,IRON BINDING CAPACITY,TIBC,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,MAGNESIUM,MAGNESIUM,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,CMP13 LP TP TSH 2AC CBC D P,HDL CHOLESTEROL,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,CMP14 LP TP TSH 4AC CBC D P,HEMATOCRIT,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,BASIC METABOLIC PANEL,BUN,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,URINALYSIS RX ALB CREA,KETONES,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.25666666666666665,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,URINALYSIS CULTURE IF INDICATED,NITRITE,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,BASIC METABOLIC PANEL 7,EGFR IF AFRICN AM,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,URINALYSIS CULTURE IF INDICATED,NITRITE,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.0,0.07142857142857142,0.125,0.0,0.07142857142857142,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,IMMUNOGLOBULIN A,IMMUNOGLOBULIN A,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.066,0.07571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,URINALYSIS W REFLEX MICRO,GLUCOSE,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,TRANSFERRIN CARBOHYDRATE DEFICIENT ALCOHOL USE,TRANSFERRIN,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,URINALYSIS ROUTINE W RFX,BILIRUBIN,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0,24984,CMP12 7AC MG,PHOSPHORUS SERUM,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,CRYOGLOBULINS REFLEX IFE QUANT,IGM CRYOPRECIPITATE,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,IRON TOTAL IRON BIND CAPACITY,TIBC,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.154,0.07571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,URINALYSIS CULTURE IF INDICATED,NITRITE,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,PHENCYCLIDINE,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,PE INTERP RFX IFE S,ALBUMIN,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.0,0.14285714285714285,0.5,0.4375,0.2857142857142857,1.0,0.0,0.008985785328775364,0.015080876322248637,0.0,0.10343053687972403,0.17358784764553015,1,134585,LP NON HDL CHOLESTEROL,VLDL CHOLESTEROL CAL,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,URINALYSIS WITH MICROSCOPIC,GLUCOSE,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.17692551543363566,0.0,0.0,0.0,0.0,0,19687,IFE PE SERUM,M SPIKE,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,CMP14 LP CBC D PLT UA MG TS,VLDL CHOLESTEROL CAL,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,BILIRUBIN DIRECT,DIRECT BILIRUBIN,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,FOLATE SERUM,FOLATE SERUM,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,DACLATASVIR RESISTANCE,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,LITHOLINK CMP14 P,ALBUMIN,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,CMP WITH ESTIMATED GFR CALCULATED,CARBON DIOXIDE,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,HEPATITIS PANEL ACUTE,HEPATITIS C ANTIBODY,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,RENAL PANEL 10,EGFR IF AFRICN AM,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,AFP TUMOR MARKER SIEMENS IMMULITE,AFP TUMOR MARKER,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.2,0.1757142857142857,0.3075,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,LYMPHOCYTE SUBSET PANEL 4,ABS CD4 COUNT,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.12,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,HCV FIBROSURE RESULTS,FIBROSIS STAGE,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,URINALYSIS W MICROSCOPIC,URINALYSIS URINE COLOR,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.03666666666666667,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,RDW,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,COMPREHENSIVE METABOLIC PANEL,CALCIUM,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.05142857142857143,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,COMP METABOLIC PANEL W GFR,CHLORIDE,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,NEG HIV 4TH GEN,NEG HIV 1 ANTIBODY,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,COMPLETE BLOOD COUNT,NEUTROPHILS ABSOLUTE,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,LEDIPASVIR RESISTANCE,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,HCV FIBROSURE RESULTS,FIBROSIS SCORE,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,LIPID PROFILE,FASTING NON FASTING,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,HCV RNA PCR QN RFX GENO,PLEASE NOTE,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.5,0.3671428571428571,1.0,0.4175,0.2857142857142857,1.0,0.5067280016598822,0.9321360477537183,0.03985530026429307,0.07260954123608476,0.13093138652809455,0.14187034543632637,1,30247,THYROXINE T4 FREE,T 4 FREE,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,ANA TITER PATTERN,ANA TITER,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,LYMPHOCYTE SUBSET PANEL 2,HELPER SUPPRESSOR RATIO,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,RHEUMATOID FACTOR,RHEUMATOID FACTOR,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.057549248626998395,0.1125015497193188,1,303925,CBC WITH DIFFERENTIAL,NUCLEATED RBCS,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,QUESTASSURED TM 25OHD D2 D3,VITAMIN D 25 OH TOTAL,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,NGI HCV SUPERQUANT,INTERNATIONAL UNITS,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,CBC W DIFF PLT,MPV,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,CBC WITH DIFFERENTIAL,NUCLEATED RBCS,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,ALPHA 1 ANTITRYPSIN PHENOTYPE,ALPHA 1 ANTITRYPSIN,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,FERRITIN,FERRITIN,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,HEPATIC FUNCTION PANEL W O TP,BILIRUBIN DIRECT,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,PROTEIN ELECTROPHORESIS,ALPHA 1 GLOBULINS,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,DRUG ABUSE SCREEN III,AMPHETAMINES,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,CBC W AUTO DIFF WITH PLATELETS,RBC,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,HEPATIC FUNCTION PROFILE,BILIRUBIN INDIRECT,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,NASH FIBROSURE,ALT SGPT P5P,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,PROTHROMBIN TIME WITH INR,INR,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,CARDIO CRP R,CARDIO CRP R,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD IU ML,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,CREATININE,EGFR IF AFRICN AM,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,HIV AG AB 4TH GEN RFL,RACE NR,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,UA W RFLX MICROSCOPIC,COLOR,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.07166666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,LP LDL DIRECT,HDL CHOLESTEROL,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,CMP14 5AC,EGFR IF NONAFRICN AM,Protein pattern,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,URINALYSIS COMPLETE,APPEARANCE,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,PROTHROMBIN TIME,PT POP MEAN,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.029479735120954365,0.0,0.0,0.0,0.0,0,7120,COMPLETE BLOOD COUNT,RED CELL DIST WIDTH,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,HIV 4TH GEN RFLX CONF,HIV 4TH GEN RFLX CONF,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,CBC WITH DIFFERENTIAL,BASOPHILS,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,HGB A1C WITH EAG ESTIMATION,HEMOGLOBIN A1C,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,VAP CHOLESTEROL PROFILE,TRIGLYCERIDES,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,URINALYSIS,BILIRUBIN,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,CMP WITH ESTIMATED GFR CALCULATED,ALBUMIN,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,TRANSFERRIN,TRANSFERRIN,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,HEPATITIS B SURFACE AB IMMUN,HEPATITIS B SURFACE AB IMMUNITY QN,Hemoglobin,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,ANA SCR W RFL T P LUPUS 1,ANA PATTERN,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,URINALYSIS W MICRO,GLUCOSE,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,CLR CBC W DIFF PLT,ABSOLUTE EOSINOPHILS,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,WBC,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,CBC WITH PLT DIFF,PLATELET MORPHOLOGY,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.022000000000000002,0.0825,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,CMP14,EGFR IF AFRICN AM,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,HEPATITIS C VIRAL RNA NS3 GENOTYPE,BOCEPREVIR RESISTANCE,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,COMPLETE BLOOD COUNT,MEAN PLATELET VOLUME,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,GLU RFX HA1C IF ABN,GLU RFX HA1C IF ABN,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.297,0.49499999999999994,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,HCV FIBROSURE LABCORP,RESULT,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,COMPREHENSIVE METABOLIC PANEL AMA,CHLORIDE,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,MORPHOLOGICAL REVIEW,PATH REVIEW PERIPHERAL SMEAR,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,RPR SCREEN W TITER,RPR SCREEN,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,IMMUNOGLOBULINS,IMMUNOGLOBULIN A,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,FE ANA TIBC FER PTT PT A1A,MITOCHONDRIAL M2 ANTIBODY,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,URINALYSIS COMPLETE,APPEARANCE,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.0,0.0,0.06666666666666667,0.07666666666666666,0.13799999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,CBC INCLUDES DIFF PLT,ABSOLUTE BLASTS,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,COMPREHENSIVE METABOLIC PANEL REFL,UREA NITROGEN BUN,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc
0.225,0.12166666666666666,0.0,0.225,0.12166666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,HEPATITIS B SURFACE ANTIBODY,HEPATITIS B SURFACE ANTIBODY,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,COMP METABOLIC PANEL,ANION GAP,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,LIPID PANEL W CHOL HDL RATIO,VLDL CHOLESTEROL CAL,Sex,Sex,Sex
0.3175,0.18142857142857144,0.0,0.6675,0.3242857142857143,0.0,0.0,0.058554296133023875,0.0,0.061241138223508074,0.058554296133023875,0.0,1,22368,QUESTASSURED 25 OH VIT D,VITAMIN D 25 OH D2,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,CMP,ALT SGPT,Eosinophils,Eosinophils [#/volume] in Blood,Eosinophil # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,STOOL CULTURE,RESULT 2,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.028010578012092946,0.0,0.0,0.0,0.0,0,303503,COMPLETE BLOOD COUNT,NEUTROPHILS ABSOLUTE,Hemoglobin,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,MANUAL DIFFERENTIAL,SEGMENTED NEUTROPHILS %,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,UA MICROSCOPIC REFLEX CULTURE,BILIRUBIN,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,C4 SERUM,C4 SERUM,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.2857142857142857,0.0,0.0,0.0,0.0,0.0,0.028088169076683545,0.0,0.0,0.0,0.0,0,326231,CBCI COMPLETE BLOOD COUNT W DIFF,DIFFERENTIAL NEUTROPHILS,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,PROTHROMBIN TIME INR,PROTHROMBIN TIME,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,SMN1 COPY NUMBER ANALYSIS,SPECIMEN TYPE,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,HEPATITIS B CORE AB,HEPATITIS B CORE AB,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,ALPHA FETOPROTEIN TUMOR MARKER,ALPHA FETOPROTEIN TUMOR,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,IRON TOTAL IRON BIND CAPACITY,TIBC,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,CBC DIFF PLT,MCH,Bacteria identified,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,HEPATITIS C AB,HEPATITIS C AB,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,URINALYSIS CULTURE IF INDICATED,NITRITE,Sex,Sex,Sex
0.25,0.2,0.0,0.0,0.0,0.0,0.03325111869576147,0.0,0.0,0.0,0.0,0.0,0,7856,CBC WITH AUTO DIFF,MONOCYTES #,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,URINALYSIS,NITRITE,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,LP LDL DIRECT,HDL CHOLESTEROL,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.14666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D2,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.2,0.5,0.0,0.2,0.5,0.0,0.017102667899308477,0.02745542509461585,0.0,0.01776719878051214,0.028522216424445967,0,50484,HIV AB EIA WITH REFLEXES,HIV AB,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,ANACHOICE SCR W REFL TITER IFA,ANA SCREEN IFA,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,LIPOPROT LDL DIRECT,LIPOPROT LDL DIRECT,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA TITER,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.11399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,HEMOGLOBIN A1C,ESTIMATED AVG GLUCOSE,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,BASIC METABOLIC PANEL AMA,GLUCOSE,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,LP LDL DIRECT,HDL CHOLESTEROL,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.0,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,MITOCHONDRIAL AB W RFX TITER,MITOCHONDRIAL AB SCN,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,AFP WITH AFP L3%,AFP SERUM,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,X HEPATITIS COMPLEX PROFILE,ANTI HBC TOTAL,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,ANEMIA PROFILE B,UIBC,Body weight,Body weight Measured,Weight Measured
0.0,0.018181818181818184,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,URINALYSIS CULTURE IF INDICATED,COLOR,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,COMPREHENSIVE METABOLIC PANEL,GLUCOSE,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,URINALYSIS WITH MICROSCOPIC,PH,Reference lab test method,Reference lab test method,Ref lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,COMPREHENSIVE METABOLIC PANEL,CALCIUM,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,ANEMIA PROFILE B,UIBC,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,UA MICROSCOPIC REFLEX CULTURE,RED BLOOD CELLS,Race,Race,Race
0.0,0.0,0.0,0.2375,0.25,0.3333333333333333,0.0,0.0,0.0,0.0,0.058363114168254904,0.06692918716175766,0,264507,DIFFERENTIAL MANUAL,ABSOLUTE EOSINOPHILS,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.244,0.445,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,HEPATITIS ABC PANEL,HEPATITIS A ANTIBODY TOTAL,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,CMP14 CBC D PLT,HEMATOLOGY COMMENTS,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,PROTIME PTT,PTT,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,CBC PLATELET HEM REVIEW,EOS ABSOLUTE VALUE,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,DRGABU2,METHAQUALONE,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,CBC WITH AUTO DIFF,BASOPHILS %,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.0,0.0,0.0,0.03636363636363637,0.05714285714285715,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,CBC INCLUDES DIFF PLT,BAND NEUTROPHILS,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,CBC W AUTO DIFF WITH PLATELETS,COMMENTS,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,ARTHRITIS PROFILE,SEDIMENTATION RATE,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.4,0.25,0.6666666666666666,0.0,0.0,0.0,0.43159805011496677,0.036870751523516376,0.02890669461985995,1,141358,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD8 CELLS,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,HEPATITIS PANEL ACUTE,HEPATITIS C ANTIBODY,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,HIV AG AB 4TH GEN RFL,RACE NR,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,CBC W AUTO DIFF ABS WBC MPV PLT,LYMPHOCYTES,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,AFP TUMOR MARKER,AFP TUMOR MARKER,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,LP LDL DIRECT,HDL CHOLESTEROL,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,BAND NEUTROPHILS,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,LIVER FIBROSIS PANEL,HAPTOGLOBIN,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,183145,HELPER T LYMPH CD4,HEMATOLOGY COMMENTS,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.04198853313366668,0.0,0,45484,URINALYSIS CULTURE IF INDICATED,OCCULT BLOOD,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,CBC W AUTO DIFF ABS WBC MPV PLT,EOSINOPHILS,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0875,0.05,0.0,0.0,0.0,0.0,0.022679367039845966,0.0,0,339143,CBC W AUTO DIFF,MEAN PLATELET VOLUME,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,HIV 1 RNA QN RT PCR,HIV 1 RNA QN PCR,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.11499999999999999,0.05,0.1,0.06666666666666667,0.05,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE EOSINOPHILS,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,C REACTIVE PROTEIN,C REACTIVE PROTEIN,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.03571428571428571,0.125,0.0,0.0,0.0,0.0,0.03217053905643563,0.0,0.0,0.0,0.0,0,296095,CBC WITH PLT DIFF,OTHERS,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,BMP8 CBC D PLT,CREATININE,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,C REACTIVE PROTEIN,C REACTIVE PROTEIN,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,CMP CBC TSH,ABSOLUTE BLASTS,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,ANA TITER PATTERN,ANTI NUCLEAR AB TITER,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,HCV FIBROSURE RESULTS,NECROINFLAMMAT ACT GRADE,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,PLATELET ESTIMATION,PLATELET ESTIMATION,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.072,0.072,0.18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,COMPREHENSIVE METABOLIC PANEL,GLUCOSE,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,CBC W AUTO DIFF ABS WBC MPV PLT,EOSINOPHILS,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,CRYOGLOBULINS REFLEX IFE QUANT,IGM CRYOPRECIPITATE,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.04,0.072,0.0,0.027777777777777776,0.05,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,COMP METAB PANEL,ALT,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,X HEPATITIS COMPLEX PROFILE,ANTI HBC TOTAL,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.2866666666666667,0.125,0.25,0.3333333333333333,0.0,0.0,0.0,0.05504399149282735,0.05706333751424053,0.09247447620418048,0.0,0.0,1,25015,IRON IBC W O REFLEX,UIBC,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.03738691252681969,0.0,0,7096,CBC WITH AUTO DIFF,PLATELET COUNT,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,ASH FIBROSURE,HEIGHT,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,MICROALBUMIN RANDOM,MICROALBUMIN RANDOM,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,LP LDL DIRECT,HDL CHOLESTEROL,Leukocyte morphology finding,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,CBC WITH AUTO DIFF,RDW,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.06,0.05142857142857143,0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,COMP METABOLIC PANEL,GLOBULIN,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,CBC WITH AUTO DIFF,RDW,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,CBC,% BASOPHILS,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.5,0.3333333333333333,0.0,0.0,0.0,0.0,0.1503314858492919,0.7071067811865476,0.0,1,304287,CBC WITH AUTO DIFF,MCV,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.05102520497901342,0.0,0.0,0.05102520497901342,0.0,0.0,1,30163,TSH RFLX FT4,TSH RFLX FT4,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.45,0.3333333333333333,0.5,0.45,0.16666666666666666,0.5,0.008601747733996912,0.9228946763004718,1.0,0.008601747733996912,0.9228946763004718,1.0,1,115725,RHEUMATOID FACTOR,RHEUMATOID FACTOR,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD8 CELLS,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,CBC PLT DIFF,MONOS,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,IRON TOTAL IRON BIND CAPACITY,TIBC,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,FE TIBC FER B12 HCT FOLRBC,IRON,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.07571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,LEUKEMIA LYMPHOMA EVALUATION,SPECIMEN TYPE,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,TRIGLYCERIDES REFL,TRIGLYCERIDES,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,24588,IMMUNOGLOBULINS,IMMUNOGLOBULIN A,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,REFERRED CBC,MCH,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,TESTOSTERONE FREE TOTAL LC MS,FREE TESTOSTERONE DIRECT,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,CMP14 HP4 1AC PT AFP,HEP A AB IGM,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,LIVER FIBROSIS,NECROINFLAM ACT GRADE,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.09494317394815022,0.0,0.0,1,66902,CBC WITH DIFF PLATELET,WBC,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,HB S AG W REFLEX CONF,HB S AG NEUTRALIZATION,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,HCV FIBROSURE RESULTS,FIBROSIS SCORE,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,IRON BINDING CAPACITY,TIBC,Reference lab test method,Reference lab test method,Ref lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,MICROALBUMIN RANDOM URINE W CREATININE,MICROALBUMIN CREATININE RATIO RANDOM URINE,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,HEPATITIS BE AG,HB E AG,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE EOSINOPHILS,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,FIBROMETER VIRUS,GAMMA GLUTAMYL TRANSFERASE FM,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,203935,IRON TOTAL,HEMOLYSIS,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0,24588,C4 C3,COMPLEMENT C3 SERUM,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,OBSTETRIC PANEL,RPR RESULT,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,TSH RFLX FT4,TSH RFLX FT4,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,DIFFERENTIAL MANUAL,ABSOLUTE NEUTROPHILS,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.06,0.045,0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,COMP METABOLIC PANEL,RATIO,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,HEPATITIS BE AG,HBEAG INS,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,HEPATITIS BE AG,HB E AG,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,CMP WITH ESTIMATED GFR CALCULATED,FASTING NON FASTING,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,CMP12 LP TP TSH 6AC CBC D PLT,EOS ABSOLUTE,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,CMP WITH EGFR,ALKALINE PHOSPHATASE,Protein pattern,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,LYMPHOCYTE SUBSET PANEL 5,ANALYZED DATE TIME NR,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,UA W MICRO HOLD SPEC 24 HR,APPEARANCE,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,COMP METABOLIC PANEL,ANION GAP,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.14285714285714285,0.5,0.0,0.0,0.0,0.0,0.5074828171487041,1.0,0,67686,COMP METABOLIC PANEL,ALKALINE PHOSPHATASE,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.2,0.0,0.124,0.2,0.25,0.0,0.013131984011779396,0.0,0.0,0.048836476728888134,0.11878532636198913,1,265058,CBCI COMPLETE BLOOD COUNT W DIFF,DIFFERENTIAL NEUTROPHILS,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.014000000000000002,0.04666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,COMPREHENSIVE METABOLIC PANEL,OSMOLALITY,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,CBC WITH PLT DIFF,NUCLEATED RBCS,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,URINALYSIS WITH MICROSCOPIC,RED BLOOD CELLS,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.0778704158893051,0.14740142971618808,1.0,1,382507,COMPREHENSIVE METABOLIC PANEL,CALCIUM,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.24666666666666667,0.10888888888888888,0.16333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,HGB A1C WITH EAG ESTIMATION,HEMOGLOBIN A1C,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,HEPATITIS C VIRAL RNA NS3 GENOTYPE,BOCEPREVIR RESISTANCE,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,CBC WITH MANUAL DIFFERENTIAL,EOSINOPHILS,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.14285714285714285,0.25,0.0,0.2857142857142857,0.5,0.0,0.07075841156459017,0.07240860968350848,0.0,0.08666100167154711,0.08868207335447242,1,223271,HEPATITIS PANEL AMA,HEPATITIS C ANTIBODY,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,SPECIAL PROFILE 3619,LEUKOCYTE ESTERASE,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,CREATININE,EGFR IF AFRICN AM,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,LP WITHOUT VLDL CHOL HDL,LDL CHOLESTEROL CALC,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,CMP14 CBC D PLT ESR WES ANA,NEUTROPHILS,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.24333333333333332,0.0,0.0,0.0,0.0,0.0,0.0,0.04357905440832277,0.0,0.0,0.0,0.0,1,64634,STOOL CULTURE,RESULT 1,Bacteria identified,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,HB S AG W REFLEX CONF,HFLAG NR,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,CBC W AUTO DIFF WITH PLATELETS,COMMENTS,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,CBC WITH AUTO DIFF,EOSINOPHILS ABSOLUTE,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,HCV FIBROSURE RESULTS,FIBROSIS SCORE,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,ALKALINE PHOSPHATASE,LIPEMIA,Microalbumin/Creatinine ratio panel,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur
0.0,0.0,0.0,0.3333333333333333,0.1325,0.265,0.0,0.0,0.0,0.010713541722103481,0.014232105164471598,0.01954574209274329,1,453530,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME NR,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,CBC INC DIFF PLT,MONOCYTES,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,FE TIBC FER B12 HCT FOLRBC,IRON,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,CBC WITH PLT DIFF,MYELOCYTES,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,CBC WITH ABSOLUTE WHITE BLOOD CELLS,WBC,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,DRUG ABUSE SCREEN I,AMPHETAMINES,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,CLR CBC W DIFF PLT,ABSOLUTE EOSINOPHILS,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,EP LP 11AC CBC D PLT TSH FER,CALCIUM,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,FE CBC D PLT TIBC FER B12 F,FERRITIN SERUM,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.2,0.16666666666666666,0.0,0.2,0.16666666666666666,0.3333333333333333,0.009413595328285118,0.0075011219466417645,0.0,0.06635350960296393,0.05287307875068503,0.08777198612321668,1,7096,MANUAL DIFFERENTIAL,BLASTS %,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,ESR WES CRP,C REACTIVE PROTEIN QUANT,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,URINALYSIS COMP W RFL CULTURE,PROTEIN,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,URINALYSIS,PH,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,CBC WITH ABSOLUTE NEUTROPHIL COUNT,PLATELET COUNT,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,CREATININE,ICTERUS,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.1775,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,7310,HNK1 CD57 PANEL,LYMPHS ABSOLUTE,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.06666666666666667,0.1,0.0,0.03666666666666667,0.022,0.0,0.0,0.04060142897102936,0.0,0.0,0.0,0.0,0,302398,CBC WITH ABSOLUTE NEUTROPHIL COUNT,PLATELET COUNT,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,T3 FREE,T3 FREE,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,CMP WITH ESTIMATED GFR CALCULATED,FASTING NON FASTING,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.011111111111111112,0.025,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,COMPREHENSIVE METABOLIC PANEL W EGF,AST,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,CMP14 LP TP TSH 4AC CBC D P,HEMATOCRIT,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.0725,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D2,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.3333333333333333,0.31666666666666665,1.0,0.3333333333333333,0.31666666666666665,1.0,0.06538932921065,0.45528141890436646,0.7071067811865476,0.06538932921065,0.45528141890436646,0.7071067811865476,1,30262,T4 THYROXINE,T4 THYROXINE,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.26666666666666666,0.39999999999999997,0.0,0.26666666666666666,0.39999999999999997,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,HCV RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,CMP12 LP TP TSH 6AC CBC D PLT,EOS ABSOLUTE,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.155,0.16666666666666666,0.0,0.25,0.0,0.0,0.0,0.03367354734702066,0.0,0.0618006251322335,0.0,0.0,1,7880,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,RDW,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,DIFFERENTIAL MANUAL,EOSINOPHILS,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.028000000000000004,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,LIVER FIBROSIS FIBROMETER,ALPHA 2 MACROGLOBULIN FM,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,ACCUTYPE R IL28B,ACCUTYPE R IL28B,Microalbumin/Creatinine ratio panel,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,CMP14 LP 5AC CBC D PLT RPR,HEMOGLOBIN A1C,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,CMP13 LP 2AC CBC D PLT,ALT SGPT,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,RPR RFX QN RPR CONFIRM TP,TREPONEMA PALLIDUM ANTIBODIES,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,BMP8 CBC D PLT,CREATININE,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,CREATININE SERUM,CREATININE SERUM,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,HEP B CORE TOTAL AB,HEP B CORE TOTAL AB,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.045454545454545456,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,CBC W AUTO DIFF,ABS BASOPHILS,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,ACUTE HEPATITIS PANEL,HEPATITIS A AB IGM,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,PROTHROMBIN TIME WITH INR,INR,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,QUESTASSURED TM 25OHD D2 D3,VITAMIN D 25 OH TOTAL,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.055446852762574106,0.0,0,51961,AFP WITH AFP L3%,AFP SERUM,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,LIVER FIBROTEST ACTITEST,FIBROSIS STAGE,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.16666666666666666,0.125,0.0,0.0,0.0,0.0,0.022735876306813285,0.0,0.0,0.0,0.0,0.0,0,7641,AUTOMATED BLD CNT,HEMOGLOBIN,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,CMP CBC TSH,ABSOLUTE BLASTS,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.11399999999999999,0.0,0.0,0.4,0.5357142857142857,0.75,0.0,0.0,0.0,0.4305038496827379,0.8189098321511491,0.826652159481457,1,223222,HBSAB AG,HEP B SURFACE AB QUAL,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.2222222222222222,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,HCV FIBROSURE,GGT,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,PSA TOTAL % FREE,% FREE PSA,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,COMPLEMENT COMPONENT C4C,COMPLEMENT COMPONENT C4C,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,OBSTETRIC PANEL INCLUDING HIV,HEMOGLOBIN,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,URINALYSIS W REFLEX MICRO,OCCULT BLOOD,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,URINE DRUG SCREEN 1,CREATININE,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,TSH W REFLEX FT4,TSH 3RD GENERATION W REFLEX FT4,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.04,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,COMP METABOLIC PANEL W GFR,SODIUM,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,CMP12 LP TP TSH 6AC CBC D PLT,LDH,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,HEMATOPATH CONSULTATION SMEAR,WBC,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.07545454545454545,0.20750000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,LYMPHOCYTE SUBSET PANEL 1,% CD3 MATURE T CELLS,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.08333333333333333,0.15,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,HEPATIC FUNCTION PANEL,TOTAL PROTEIN,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCV,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.185,0.12333333333333334,0.74,0.185,0.16333333333333333,0.74,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,MICROALBUMIN CREATININE RATIO,MICROALBUMIN RAN 24HR,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,CBC WITH ABSOLUTE NEUTROPHIL COUNT,NEUTROPHILS,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,REFLEX ANA PATTERN,PATTERN 1,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,STOOL CULTURE,RESULT 1,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,HEPATITIS PANEL DIAGNOSTIC,HEP B CORE TOTAL AB,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.324,0.16666666666666666,0.0,0.0,0.0,0.0,0.027775595618823368,0.026612742019519464,0.0,0.0,0.0,0.0,0,7369,AUTOMATED BLD CNT,HEMOGLOBIN,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.075,0.05,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,CBC W O DIFF WITH PLATELETS,RBC,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,CBC WITH PLT DIFF,RBC MORPHOLOGY,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,HEP B CORE TOTAL AB,HEP B CORE TOTAL AB,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.5566666666666666,0.14285714285714285,0.0,0.0,0.0,0.0,0.037226205516931565,0.08646076331770092,0.04486334240136658,1,30973,COMP METABOLIC PROFILE FASTING CMP,BUN CREATININE RATIO CALC,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,URINE DRUG SCREEN 1,CREATININE,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,DRUG ABUSE PANEL 10 WITH OXYCODONE,BENZODIAZEPINES,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,TSH FREE T4 PROFILE,TSH THIRD GENERATION,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,CBC W AUTO DIFF ABS WBC MPV PLT,EOSINOPHILS,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,CMP14 5AC,EGFR IF NONAFRICN AM,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,CBC WITH PLT DIFF,MPV,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,URINALYSIS W REFLEX MICRO,UROBILINOGEN,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,HCV RNA GENOTYPE LIPA R,HCV RNA GENOTYPE LIPA,Erythrocyte morphology finding,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld
0.0,0.26999999999999996,0.42428571428571427,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,HCV FIBROSURE LABCORP,RESULT,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.2375,0.325,0.95,0.0,0.16666666666666666,0.0,0.0,0.03302675712634284,0.0,0.0,0.05720402135206337,0.0,0,7518,CBC WITH ABSOLUTE NEUTROPHIL COUNT,PLATELET COUNT,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,ALPHA 1 ANTITRYPSIN PHENOTYPE,A 1 ANTITRYPSIN PHENOTYPE,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,PROFILE 104 LIVER,AST SGOT,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,CBC INC DIFF PLT,ABSOLUTE MONOCYTES,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,URINALYSIS,BACTERIA,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.1,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BARBITURATES,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,HEP C RNA GENOT 3 NS5A,VELPATASVIR RESISTANCE,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,ACCUTYPE R IL28B NY,IL28B GENOTYPE,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.06333800979436033,0.0,0,134585,VITAMIN B12 FOLATE,FOLATE SERUM,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,CBC,MCH,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.03258155267402285,0.0,0.0,0.0,0.0,0,7310,COMPLETE BLOOD COUNT,BASOPHILS %,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,HP4 RPR,HEP C VIRUS AB,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.14777777777777779,0.266,0.0,0.1388888888888889,0.25,0.0,0.05983315826119562,0.06222027266620478,0.0,0.06908938005713361,0.07184578234577044,0,139501,ACUTE HEPATITIS PANEL,HEPATITIS B SURFACE ANTIGEN,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,PROTHROMBIN PTT,CONTROL,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,PROTHROMBIN PTT,CONTROL,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.3333333333333333,0.33375,0.534,0.455,0.5,0.8,0.06352960771703664,0.11550572665019232,0.1378341405618373,0.06352960771703664,0.11550572665019232,0.1378341405618373,1,109009,HEPATITIS BS AB QL,HEPATITIS B SURF AB QL,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,ASH FIBROSURE,AST SGOT P5P,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,LD,LD,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,CMP14 CBC D PLT,HEMATOLOGY COMMENTS,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,CBC INC DIFF PLT,PLATELET COUNT,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,PROTHROMBIN TIME PT,PROTHROMBIN TIME PT,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.05171526843986196,0.0,0,134585,CBC INCLUDES DIFF PLATELETS,MEAN PLATELET VOLUME,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,BASIC METABOLIC PANEL,ANION GAP,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,DRUG ABUSE SCREEN I,AMPHETAMINES,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.3333333333333333,0.3333333333333333,0.42857142857142855,0.3333333333333333,0.0,0.0,0.0,0.04737353280140688,0.0852887560929525,0.05297575537696986,0,326231,CBC H H RBC INDICES WBC PLT,PLATELET COUNT AUTO,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,TRANSFERRIN,TRANSFERRIN,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.172,0.0,0.0,0.392,0.09571428571428572,0.1675,0.0,0.0,0.0,0.03321870600293453,0.043355289534301455,0.043726732586310324,1,142513,ANTI SMOOTH MUSCLE MITOCHOND,MITOCHONDRIAL M2 ANTIBODY,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,IRON IBC W O REFLEX,UIBC,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,ANA ANTI NUCLEAR AB WITH REFLEX TITER,ANTI NUCLEAR ANTIBODIES,Hemoglobin,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc
0.0,0.045,0.06,0.0,0.04125,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,COMP METABOLIC PANEL,ANION GAP,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,LIPID PROFILE,NON HDL CHOLESTEROL,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D3,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,LIPID PANEL,LDL CALC,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,URINALYSIS WITH REFLEX MICROSCOP,PROTEIN TOTAL QUAL,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,URINALYSIS W REFLEX MICRO,RED BLOOD CELLS,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,CBCM COMPLETE BLOOD CNT W MAN DIFF,EOSINOPHILS,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,ANA SCREEN IFA,ANA SCREEN IFA,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.5,0.3333333333333333,1.0,0.0,0.0,0.0,0.09634172963278365,0.0731970128794921,1.0,0,7328,CBC DIFF PLT,LYMPHOCYTES #,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,COMP METABOLIC PANEL W GFR,CHLORIDE,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.014214327746301048,0.0,0.0,0.0,0.0,0,67421,COMPLETE BLOOD COUNT,BASOPHILS ABSOLUTE,Erythrocyte morphology finding,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,LIVER FIBROSIS FIBROMETER,FIBROMETER PROTHROMBIN INDEX,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.10357142857142858,0.2625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,CBCI COMPLETE BLOOD COUNT W DIFF,DIFFERENTIAL NEUTROPHILS,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,IRON TOTAL BINDING CAPACITY,% SATURATION,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,COMPREHENSIVE METABOLIC PANEL AMA,GLOBULIN,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,HEMOGLOBIN A1C EAG,HEMOGLOBIN A1C,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.0825,0.10600000000000001,0.0,0.1825,0.0,0.0,0.0,0.0,0.0,0.0,0.09762443806815091,1.0,1,204545,URINALYSIS WITH MICROSCOPIC,PROTEIN,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.14333333333333334,0.041875,0.08375,0.14333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,339143,BUN CREAT RATIO W EGFR,NON AFRICAN AMERICAN EGFR,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,RPR RFX QN RPR CONFIRM TP,TREPONEMA PALLIDUM ANTIBODIES,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,HCV GT3 NS5A DRUG RESIST ASSAY,HCV NS5A DRUG RESIST ASSAY,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,GLU RFX HA1C IF ABN,GLU RFX HA1C IF ABN,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,CBC COMPLETE BLOOD COUNT W O DIFF,MCV,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.0,0.0,0.0,0.25,0.2,0.0,0.0,0.0,0.0,0.0,0.06407759902266841,0.0,0,311472,IGG SUBCLASSES,IMMUNOGLOBULIN G QN SERUM,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.16666666666666666,0.21428571428571427,0.75,0.0,0.014285714285714287,0.05,0.028539992607010012,0.0,0.0,0.0,0.0,0.0,1,204164,NGI HCV ULTRAQUAL RFX SUPER QT,COPIES ML,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,TSH FT4,TSH,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,PROTEIN ELEC INTERP SERUM,M SPIKE,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,HB S AG W REFLEX CONF,HFLAG NR,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.16666666666666666,0.267,0.534,0.3,0.1,0.2,0.029415987755933792,0.07234649340221055,0.15519402517768222,0.03602708014099765,0.04430299837876139,0.09503654320349175,0,79053,HEPATITIS BE AG,HB E AG,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,URIC ACID,URIC ACID,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,PROTIME PTT,PTT,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,HEPATITIS B SURFACE AB,HEPATITIS B SURFACE AB,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,GORBYMI CMP 4AC CORONARY RISK CBC TSH PROFILE,CALCIUM,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,GLUCOSE,GLUCOSE FASTING,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,COMP METABOLIC PANEL W GFR,CHLORIDE,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.057999999999999996,0.0,0.0,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,MANUAL DIFFERENTIAL,LYMPHOCYTES ABSOLUTE,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,LYMPHOCYTE SUBSET PANEL 3,% CD3 MATURE T CELLS,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,CBC DIFF PLT,MCHC,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.31,0.31,0.0,0.0,0.0,0.0,0.14187034543632637,0.14187034543632637,0,82644,LYMPHOCYTE SUBSET PANEL 2,COMMENT S,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,IRON IBC W O REFLEX,UIBC,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,APTT,PARTIAL THROMBOPLASTIN,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,EGFR,EGFR,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.17692551543363566,0.0,0.0,0.0,0.0,0,30510,IFE PE SERUM,GAMMA GLOBULIN,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,DRUG ABUSE SCREEN III,COCAINE METABOLITE,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,PROTHROMBIN TIME PT,PROTHROMBIN TIME PT,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,URINALYSIS C,BILIRUBIN,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,IMMUNOGLOBULINS,IMMUNOGLOBULIN A,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,ACUTE HEPATITIS PANEL,HEPATITIS A IGM,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,CBC WITH PLT DIFF,NRBC,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,BUN CREATININE RATIO,ICTERUS,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,PSA TOTAL % FREE SERIAL,% FREE PSA,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,MANUAL DIFFERENTIAL,LYMPHOCYTES ABSOLUTE,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,FIBROMETER VIRUS,GAMMA GLUTAMYL TRANSFERASE FM,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.33399999999999996,0.0,0.0,0.06447593079677061,0.0652954005184736,0.0,0.06447593079677061,0.0652954005184736,0,205070,HEP A AB IGM,HEPATITIS A AB IGM,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,URINALYSIS,BILIRUBIN,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.2,0.25,0.2,0.0,0.25,0.0,0.031621853677024414,0.08399329824424573,0.027385328599057512,0.0,0.07274033002715963,0,345355,IMMUNE COMPETENCE PANEL,CD4 CD8 RATIO,Microalbumin/Creatinine ratio panel,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur
0.266,0.19,0.44333333333333336,0.266,0.19,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,HEPATITIS C AB REFLEX HCV RNA QUANT,HEPATITIS C ANTIBODY,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,CBC W AUTO DIFF WITH PLATELETS,RBC,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.0,0.11166666666666668,0.335,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,ALBUMIN CREATININE RATIO URINE RANDOM,CALC ALBUMIN CREAT RND,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,URINALYSIS ROUTINE W RFX,BILIRUBIN,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,LYMPHOCYTE SUBSET PANEL 3,% CD8 SUPPRESSOR T CELLS,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,HEPATITIS PANEL ACUTE,HEPATITIS C ANTIBODY,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.31,0.25,0.0,0.3333333333333333,0.25,1.0,0.0,0.032615729323927534,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,825208,HCV RNA NS5A GENOTYPE,VELPATASVIR RESISTANCE,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,CMP13 LP 2AC CBC D PLT,EGFR IF AFRICN AM,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.22333333333333336,0.25,1.0,0.0,0.0,0.0,0.0,0.5773502691896257,1.0,1,21618,PAIN MANAGEMENT 8,CREATININE,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,CBC WITH PLT DIFF,OTHERS,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.16666666666666666,0.14285714285714285,0.25,0.0,0.0,0.0,0.019980550553586607,0.022591121470101005,0.046910235615615914,0.0,0.0,0.0,0,427682,ANA AMA ASMA LKM AB,MITOCHONDRIAL M2 ANTIBODY,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,RENAL PANEL 10,EGFR IF AFRICN AM,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,CMP14,EGFR IF AFRICN AM,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,LYMPHOCYTE SUBSET PANEL 2,% CD8 SUPPRESSOR T CELLS,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,NASH FIBROSURE,HEIGHT,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,HEPATITIS B SURFACE AB,HEPATITIS B SURFACE AB,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.2,0.3814285714285714,0.6675,0.4,0.3814285714285714,0.6675,0.0,0.06229568196836488,0.07240860968350848,0.47662402489215927,0.01604041949885182,0.018644381728446624,1,139519,HEPATITIS A DIAGNOSTIC PANEL,HAV AB TOTAL,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,CREATININE,ICTERUS,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,DIFFERENTIAL MANUAL,ABSOLUTE NEUTROPHILS,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.0,0.0,0.0,0.0,0.08779161868611507,1.0,0.0,1,285395,CBC DIFF PLT,MCH,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,CMP12 LP TP TSH 6AC CBC D PLT,POTASSIUM,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,A FETOPROTEIN TUMOR MARKER,A FETOPROTEIN TUMOR MARKER,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,CMP13 LP TP TSH 2AC CBC D P,HDL CHOLESTEROL,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.04833333333333333,0.0,0.0,0.0,0.022222222222222223,0.03333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,CBC WITH DIFFERENTIAL,BASOPHILS,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,PROTHROMBIN TIME PT,PT CONTROL,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.0,0.051666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,CBC WITH PLT DIFF,NO CELLS DIFF,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,CBCI COMPLETE BLOOD COUNT W DIFF,PLT MORPHOLOGY,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,IMMUNOGLOBULIN A,IMMUNOGLOBULIN A,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,DIFFERENTIAL MANUAL,EOSINOPHILS,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,CMP,ALT SGPT,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,MICROALBUMIN CONC,ALB CREAT RATIO,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,CBC W AUTO DIFF,MEAN PLATELET VOLUME,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.1675,0.134,0.0,0.25,0.2,0.5,0.0,0.0,0.0,0.06428788335820634,0.07676866432248541,0.10031748330730439,1,81224,IMMUNODEF PROFILE #1,ABSOLUTE CD3,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,DRUG ABUSE SCREEN W ETOH NO GCMS,BARBITURATES,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.2,0.3333333333333333,0.0,0.2,0.3333333333333333,0.0,0.03172036032923009,0.03975928454250166,0.0,0.03172036032923009,0.03975928454250166,0,178566,HBC AB TOTAL,HBC AB TOTAL,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,LIPID PANEL,NON HDL CHOLESTEROL,pH,pH of Urine by Test strip,pH Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.041324889785846586,0.06634008347343534,0.0,0.04463598251539247,0.07165547981701126,0,50484,HIV AG AB 4TH GEN RFL,HIV AG AB 4TH GEN,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.18999999999999997,0.25,0.0,0.0,0.0,0.0,0.0,0.05636349559813292,0.0,0.0,0.0,0.0,0,58032,URINE DRUG SCREEN 1,CREATININE,pH,pH of Urine by Test strip,pH Ur Strip
0.0,0.08388888888888889,0.18875,0.0,0.08388888888888889,0.18875,0.0,0.0346899741763077,0.025416384909489387,0.0,0.0346899741763077,0.025416384909489387,0,622381,SED RATE MODIFIED WESTERGREN MANUAL,SED RATE MODIFIED WESTERGREN MANUAL,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,CHEM PROFILE 29,ALK PHOS,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.015714285714285715,0.055,0.0,0.017857142857142856,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,DRUG ABUSE SCREEN CLINICAL 9,COCAINE,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,ARTHRITIS PROFILE,SEDIMENTATION RATE,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2276407094521833,0.0,0,19711,CMP14 LP 7AC CBC D PLT T B,AMYLASE SERUM,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,ANACHOICE SCR W REFL TITER IFA,ANA SCREEN IFA,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.055192913156707046,0.0,0.0,0.0,0.0,0,241133,IFE PE SERUM,GAMMA GLOBULIN,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.25,0.25,0.0,0.0,0.0,0.0,0.0,0.057918325991897945,0.0,0,23366,FE ANA TIBC FER A1A AMA ASM,ALPHA 1 ANTITRYPSIN SERUM,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,LIPID PANEL,NON HDL CHOLESTEROL,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.125,0.125,0.0,0.125,0.125,0.0,0.0,0.0816748825802307,0.0,0.0,0.0816748825802307,0.0,0,109009,MAGNESIUM SERUM,MAGNESIUM SERUM,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.25,0.3244444444444444,0.584,0.25,0.2222222222222222,0.6,0.027952627376922723,0.12191232696899001,0.12681234287431364,0.034234837021806186,0.14931149721468506,0.15531276656446735,0,539627,AFP TUMOR MARKER SIEMENS IMMULITE,AFP TUMOR MARKER,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,ANTIPHOSPHOLIPID SYNDROME,PT,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.0,0.0,0.46499999999999997,0.10857142857142857,0.0,0.0,0.0,0.0,0.036633164844283916,0.05249109809053998,0.09061940958216264,1,134577,LIPID PANEL,CALC LDL CHOL,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,COMP METABOLIC PANEL,GLOBULIN,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.10714285714285714,0.125,0.0,0.0,0.0,0.0,0.05137906274872117,0.0,0.0,0.0,0.0,0,110114,CBC WITH DIFFERENTIAL,EOSINOPHILS,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,NGI HCV SUPERQUANT,HEPATITIS C QUANTITATION,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.00996262543708748,0.0,0.0,0.0,0,285395,HEMOGLOBIN A1C,ESTIMATED AVG GLUCOSE,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,HEPATITIS B SURFACE ANTIBODY,HEPATITIS B SURFACE AB QUAL,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.24333333333333332,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,PROTEIN ELECTRO S,ALPHA 1 GLOBULIN,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.22333333333333336,0.2857142857142857,0.3333333333333333,0.22333333333333336,0.2857142857142857,0.3333333333333333,0.0,0.029063908494738833,0.015080876322248637,0.0,0.029063908494738833,0.015080876322248637,0,30973,CREATININE SERUM,CREATININE SERUM,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,VITAMIN D 25 OH TOTAL,VITAMIN D 25 OH TOTAL,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,UROGRAM,SPECIFIC GRAVITY,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,ARTHRITIS PROFILE,ANTI NUCLEAR ANTIBODIES,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,IMMUNOFIXATION SERUM,IGG SERUM NR,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.47,0.3333333333333333,0.25,0.0,0.0,0.0,0.03694153252517385,0.530776546300907,0.08679392382276507,1,19687,HEPATIC FUNCTION PANEL W O TP,BILIRUBIN DIRECT,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,PROTHROMBIN PTT,CONTROL,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,AMY LIPASE,AMYLASE,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,TSH FT4,FREE T4,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,URINALYSIS REFLEX,GLUCOSE,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,CBC WITH DIFFERENTIAL,BASOPHILS,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,ANA SCREEN QUAL,ANA ANTIBODY SCREEN EIA,pH,pH of Urine by Test strip,pH Ur Strip
0.1925,0.10600000000000001,0.0,0.2325,0.2,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,58024,URINALYSIS W MICRO W REFLEX CULTURE,NITRITES,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,CMP14 5AC,EGFR IF NONAFRICN AM,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,MITOCHONDRIAL M2 AB,MITOCHONDRIAL M2 AB,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,LDL CHOLESTEROL DIRECT,LDL CHOL DIRECT,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,TESTOSTERONE FREE TOTAL LC MS,FREE TESTOSTERONE DIRECT,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,CBC W O DIFF WITH PLATELETS,PLATELET COUNT,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A DRUG RESISTANCE ASSAY,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,CBC,MCH,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.08,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,CBC WITH ABSOLUTE WHITE BLOOD CELLS,WBC,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.03142857142857143,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,CBC WITH PLT DIFF,NO CELLS DIFF,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,LIPID PANEL,CALC LDL CHOL,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,URINALYSIS,NITRITE,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,CBC WITH DIFFERENTIAL,NUCLEATED RBCS,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.125,0.2,0.75,0.0,0.0,0.0,0.0059890119329250036,0.0,0.0,0.0,0.0,0.0,0,426171,HCV FIBROSURE,LIMITATIONS,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE NEUTROPHILS,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.5519999999999999,0.5866666666666667,0.0,0.5519999999999999,0.5866666666666667,0.0,0.04688477512742151,0.03417919692361049,0.0,0.04688477512742151,0.03417919692361049,1,45377,SED RATE MODIFIED WESTERGREN MANUAL,SED RATE MODIFIED WESTERGREN MANUAL,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,IGG SUBCLASSES,IMMUNOGLOBULIN G QN SERUM,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,CBC DIFF PLT,MCH,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,CBC WITH PLT DIFF,EOSINOPHILS ABSOLUTE,Erythrocyte morphology finding,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,MAGNESIUM,MAGNESIUM,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,LIPID PANEL W CHOL HDL RATIO,VLDL CHOLESTEROL CAL,Erythrocytes,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,BASIC METABOLIC PANEL 8,EGFR IF AFRICN AM,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,TSH W REFLEX FT4,TSH 3RD GENERATION W REFLEX FT4,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,LIVER FIBROSIS FIBROMETER,ALPHA 2 MACROGLOBULIN FM,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,HCV FIBROSURE RESULTS,NECROINFLAMMAT ACT GRADE,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,HIV 1 HIV 2 AG AB COMBO W REFLEXES,HIV INTERPRETATION,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,UA W MICRO HOLD SPEC 24 HR,APPEARANCE,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,UA MICROSCOPIC REFLEX CULTURE,KETONES,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,CCP ANTIBODY IGG,ANTI CCP IGG,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD3 CELLS,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.16666666666666666,0.2727272727272727,0.75,0.16666666666666666,0.2727272727272727,0.75,0.026355222038017434,0.0,0.0,0.026355222038017434,0.0,0.0,0,112599,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A DRUG RESISTANCE ASSAY,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,CYCLIC CITRULLINATED PEPTIDE CCP AB IGG,CYCLIC CITRULLINATED PEPTIDE CCP AB IGG,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,HP5,HEP C VIRUS AB,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,PROTEIN ELECTRO S,GAMMA GLOBULIN,Leukocyte morphology finding,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,CBC WITH PLT DIFF,BANDS,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,IGG SUBCLASSES,IMMUNOGLOBULIN G QN SERUM,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.155,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.0,0.01152446298194254,0.018154913715053067,0,265074,MANUAL DIFFERENTIAL,SEGMENTED NEUTROPHILS %,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,LIVER FIBRO HEPSCORE R,AGE,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,COMPREHENSIVE METABOLIC PANEL E GFR,CARBON DIOXIDE,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.11166666666666668,0.0,0.0,0.11166666666666668,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,FREE T3,FREE T3,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,CREATINE KINASE CK,CREATINE KINASE CK,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,MANUAL DIFFERENTIAL,TOTAL NEUTROPHILS %,Basophils,Basophils [#/volume] in Blood,Basophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,COMP METABOLIC PANEL,RATIO,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,CEA,CEA CENTAUR,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.07142857142857142,0.01636363636363636,0.0,0.02428571428571429,0.015454545454545455,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,PTH INTACT,PARATHYROID HORMONE INTACT,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,IMMUNOGLOBULINS IGG A M SER,IMMUNOGLOBULIN A,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.3333333333333333,0.2,0.5,0.3333333333333333,0.2,0.5,0.04902889871464522,0.055837794002650876,0.0,0.09805779742929044,0.11167558800530164,0.0,1,205070,RPR REFLEX T PALLIDUM PA,RPR,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.2,0.0,0.0,0.2,0.0,0.0,0.026600414177338716,0.050346477724547034,0.050799169127257904,0.02873173112559746,0.05438041120182613,0.054869373801387455,0,169334,HIV AG AB 4TH GEN RFL,HIV AG AB 4TH GEN,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,BUN CREAT RATIO W EGFR,NON AFRICAN AMERICAN EGFR,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,CBC WITH AUTO DIFF,NRBC,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,VITAMIN D 25 OH LCMSMS W REFLEX,VITAMIN D 25 OH D3,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,HEMOGLOBIN A1C,HEMOGLOBIN A1C,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,COMP METAB PANEL,GLUCOSE FASTING,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,COMP METABOLIC PANEL,RATIO,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.4,0.5,0.0,0.0,0.0,0.0,0.023079813212858902,0.011759223742856317,0.0,0.0,0.0,0,311472,SMOOTH MUSCLE AB F ACTIN REFLEX IFA TITER,F ACTIN IGG,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,CBC,MCH,Ceruloplasmin,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,MPV,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.285,0.5,0.0,0.0,0.0,0.0,0.0,0.40824829046386313,0.0,0.0,0.0,0.0,0,57679,URINE DRUG SCREEN,OPIATES,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,COMPREHENSIVE METABOLIC PANEL W EGF,AST,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,AMYLASE SERUM,AMYLASE SERUM,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,CBC W AUTO DIFF ABS WBC MPV PLT,MCHC,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,PTH INTACT,PARATHYROID HORMONE INTACT,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,BUN CREATININE,EGFR AFRICAN AMERICAN,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,CMP WITH ESTIMATED GFR CALCULATED,ALBUMIN,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.0,0.06,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.05312922608795245,0.0,0,7898,UA MICROSCOPIC REFLEX CULTURE,OCCULT BLOOD,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,HEPASCORE R,SEX,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,HEMOGLOBIN A1C,HEMOGLOBIN A1C,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,PSA TOTAL REFLEX FREE,PSA TOTAL,pH,pH of Urine by Test strip,pH Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,COMPLETE BLOOD COUNT,BASOPHILS ABSOLUTE,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,DRUG ABUSE SCREEN 9 NO THC W CONF,OXYCODONE,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,URINALYSIS W REFLEX MICRO,UROBILINOGEN,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,CBC WITH PLT MAN DIFF,BANDS ABSOLUTE,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,TSH FT4,TSH,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.11,0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,IRON TOTAL BINDING CAPACITY,% SATURATION,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.29400000000000004,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CBC W AUTO DIFF ABS WBC MPV PLT,EOSINOPHILS,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,CBC PLATELET HEM REVIEW,LYMPHS ABSOLUTE,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,DRUG ABUSE SCREEN III,AMPHETAMINES,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.27,0.0,0.0,0.0,0.0,0.0,0.006570998517002713,0.0,0.0,0.0,0.0,0.0,0,487959,HCV FIBROSURE,LIMITATIONS,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0035000000000000005,0.0175,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,CMP12 LP TP TSH 6AC CBC D PLT,HEMOGLOBIN,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0825,0.08833333333333333,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.07065997001469593,0.09716253076254433,1.0,1,57927,URINALYSIS W REFLEX MICRO,GLUCOSE,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.0,0.0,0.0,0.115,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,7112,CMP12 LP TP TSH 6AC CBC D PLT,EOS ABSOLUTE,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,HEPATITIS PANEL ACUTE,HEPATITIS C ANTIBODY,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,ALT,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,CPK,CPK,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,DIFFERENTIAL MANUAL,PLATELET ESTIMATION,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.31399999999999995,0.0,0.0,0.534,0.0,0.0,0.03743378786862894,0.0,0.0,0.08201332011404516,0.0,0.0,1,19893,QUESTASSURED TM 25OHD D2 D3,VITAMIN D 25 OH TOTAL,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,GGT,GGT,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.04,0.05714285714285715,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,COMP METAB PANEL,ALT,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.08714285714285715,0.0,0.0,0.08714285714285715,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,HEPATITIS C VIRAL RNA QUAL TMA,HEPATITIS C VIRAL RNA QUAL TMA,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.24666666666666667,0.2,1.0,0.24666666666666667,0.2,1.0,0.0,0.34003516797720323,1.0,0.0,0.34003516797720323,1.0,1,29868,TESTOSTERONE,TESTOSTERONE,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,NEG HIV 4TH GEN,NEG HIV 2 ANTIBODY,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.435,0.16666666666666666,0.5,0.435,0.3333333333333333,1.0,0.010952274481359159,0.9131129509166843,0.9888882125258499,0.010348362482358597,0.03899614814102015,0.04223226840869254,1,29918,TESTOSTERONE FREE TOTAL,FREE TESTOSTERONE DIRECT,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,IMMUNOGLOBULINS,IMMUNOGLOBULIN M,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,HEPATIC FUNCTION PANEL AMA,BILIRUBIN DIRECT,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,LIPID PROFILE WITH CALCULATIONS NON HDL CHOLESTEROL,RISK RATIO CHOL HDL,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,CYCLIC CITRULLINATED PEPTIDE CCP AB IGG,CYCLIC CITRULLINATED PEPTIDE CCP AB IGG,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE LYMPHOCYTES,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,ANA AMA ASMA LKM AB,MITOCHONDRIAL M2 ANTIBODY,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.047142857142857146,0.0275,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,LIPID PNL W REFL TRIG>400,CHOLESTEROL HDL RATIO,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,TRICHOMONAS MALE,SOURCE,Monocytes,Monocytes [#/volume] in Blood,Monocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,VELPATASVIR RESISTANCE,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.04304429116142661,0.0,0,19687,B12,VIT B12 SERUM,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.1,0.14285714285714285,0.0,0.1,0.14285714285714285,0.0,0.03329989259909827,0.03615212504206189,0.0,0.04298997648893432,0.04667219273930456,0,736553,HEPATITIS A TOTAL AB REFLEX IGM,HEPATITIS A TOTAL AB,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.0,0.0,0.115,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,7120,CBC PLATELET HEM REVIEW,EOS ABSOLUTE VALUE,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,DIFFERENTIAL MANUAL,NEUTROPHILS,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,HEPATITIS C VIRAL RNA QUALITATIVE TMA,HEPATITIS C VIRAL RNA QUALITATIVE TMA,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,PROTEIN CREATININE RATIO URINE,PROTEIN UR MG DL,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.044,0.03142857142857143,0.07333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,CBC WITH PLT MAN DIFF,BANDS ABSOLUTE,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,CBC INCLUDES DIFF PLT,ABSOLUTE BLASTS,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,CMP14 CBC D PLT ESR WES ANA,LYMPHS ABSOLUTE,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,BASIC METABOLIC PANEL 7,EGFR IF AFRICN AM,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,CMP14 LP TP TSH 4AC CBC D P,HEMATOCRIT,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,CBC WITH DIFFERENTIAL,MYELOCYTES,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,FIBROACT COMPLETE,APOLIPOPROTEIN A1,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,CHEM SCREEN PANEL HDL,URIC ACID,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,CBC WITH DIFFERENTIAL,EOSINOPHILS,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCV,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,HEPATITIS B SURFACE AB QUANT,HEPATITIS B SURFACE AB,Erythrocyte distribution width,Erythrocyte distribution width [Entitic volume],RDW RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,URINALYSIS WITH MICROSCOPIC,PROTEIN,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.2857142857142857,0.0,0.0,0.42857142857142855,0.6666666666666666,0.0,0.029747647799953647,0.0,0.0,0.12793313413942875,0.15892726613090935,1,326231,COMPLETE BLOOD COUNT,MEAN PLATELET VOLUME,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,COMPREHENSIVE METABOLIC PANEL,CALCIUM SERUM,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.155,0.2316666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,204552,UA MICROSCOPIC REFLEX CULTURE,WHITE BLOOD CELLS,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.02428571428571429,0.015454545454545455,0.0,0.02428571428571429,0.015454545454545455,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,PROTHROMBIN TIME INR,PROTHROMBIN TIME,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,IRON IBC W O REFLEX,UIBC,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,CBC W DIFF PLT,RBC,Protein pattern,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp
0.0,0.12200000000000001,0.20750000000000002,0.0,0.022000000000000002,0.0825,0.0,0.026212933369651692,0.0,0.0,0.0,0.0,0,426171,CBC WITH ABSOLUTE NEUTROPHIL COUNT,PLATELET COUNT,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,HEP B SURFACE AG W REFLEX CONFIRM,NEUTRALIZATION,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,HEPATITIS B CORE IGM ANTIBODY,HEP B CORE IGM ANTIBODY,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.21818181818181817,0.34285714285714286,0.0,0.09090909090909091,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,HCV RNA PCR QN RFX GENO,PLEASE NOTE,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,APTT,PARTIAL THROMBOPLASTIN,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,MPV,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,COMP METABOLIC PANEL,ANION GAP,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,HEPATITIS BE AG,HB E AG,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.012,0.04,0.0,0.022,0.07333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,CMP14 CBC D PLT,HEMATOLOGY COMMENTS,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.2,0.42857142857142855,0.75,0.0,0.11857142857142856,0.2075,0.007080782168622735,0.6067712898584496,0.6842022182492856,0.0,0.04612090043126471,0.0520064526950299,1,632117,SMOOTH MUSCLE AB RFX TITER,F ACTIN IGG,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.04857142857142858,0.0,0.0,0.04857142857142858,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,HCV RNA QN GRAPH RFX NSA,HEPATITIS C QUANTITATION,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,COMP METAB PANEL,GLUCOSE FASTING,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,EGFR,EGFR,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,HEP B CORE AB QUAL,HEPATITIS B CORE AB QL,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,TSH FT4,FREE T4,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.24044117311858715,0.0,0.0,0.1963193957655779,0.0,0,23457,IMMUNOFIXATION SERUM,IGG SERUM NR,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,IRON TOTAL BINDING CAPACITY,% SATURATION,pH,pH of Urine by Test strip,pH Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,LYMPHOCYTE SUBSET PANEL 2,% CD3 MATURE T CELL,Body height,Body height Measured,Body height Measured
0.0,0.03571428571428571,0.05,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,UA MICROSCOPIC REFLEX CULTURE,KETONES,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.33399999999999996,0.0,0.0,0.534,0.0,0.0,0.026469685247406227,0.0,0.0,0.08201332011404516,0.0,0.0,0,19893,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D2,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,HCV FIBROSURE,LIMITATIONS,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.03548391705249854,0.0,0.0,0.0,0.0,0,196444,DRUG SCREEN AUSTIN 20,PHENCYCLIDINE,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.3333333333333333,0.14285714285714285,0.5,0.0,0.0,0.0,0.084905879372146,0.0,0.0,1,25320,CMP14 LP 3AC,LDH,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,URINALYSIS WITH MICROSCOPIC,PROTEIN,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.11399999999999999,0.0,0.0,0.2,0.39285714285714285,0.55,0.0,0.0,0.0,0.014454772493448287,0.05499209972276087,0.055512018790671136,0,223222,RPR HBSAG HCVAB HSV1 HSV2 I,HEP C VIRUS AB,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,RPR REFLEX T PALLIDUM PA,RPR,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,HGB A1C WITH EAG ESTIMATION,HEMOGLOBIN A1C,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,LYMPHOCYTE SUBSET PANEL 5,ANALYZED DATE TIME NR,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.25,0.27,0.0,0.0,0.0,0.0,0.0,0.05549282856714377,0.0,0.0,0.0,0.0,0,311472,PROTEIN ELEC INTERP SERUM,M SPIKE,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0725,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,DRUG ABUSE SCREEN 8 W CONFIRMATION,BARBITURATES,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,TSH FT4,FREE T4,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,CBC WITH ABSOLUTE WHITE BLOOD CELLS,WBC,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,NEG HIV 4TH GEN,HIV 1 AB WESTERN BLOT,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,LYMPHOCYTE SUBSET PANEL 3,% CD3 MATURE T CELLS,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,HEPATITIS BS AB QL,HEPATITIS B SURF AB QL,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,MICROALBUMIN RANDOM URINE W CREATININE,MICROALBUMIN CREATININE RATIO RANDOM URINE,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,MORPHOLOGICAL REVIEW,MORPHOLOGICAL REVIEW,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.1375,0.0,0.0,0.4225,0.3333333333333333,0.3333333333333333,0.0,0.0,0.0,0.04280810441337335,0.11098565713428754,0.11098565713428754,1,487926,FIBROACT,NECROINFL SCORE,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,AMYLASE SERUM,AMYLASE SERUM,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,TESTOSTERONE FREE TOTAL LC MS,FREE TESTOSTERONE DIRECT,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,COMP METABOLIC PANEL,CREATININE,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.16666666666666666,0.3,0.42857142857142855,0.0,0.0,0.0,0.006968613538708479,0.0,0.0,0.0,0.0,0.0,0,736553,HCV FIBROSURE,LIMITATIONS,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,HIV 1 HIV 2 AB SCREEN,HIV 1 HIV 2 AB SCREEN,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,CEA,CEA SIEMENS IMMULITE 2000,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,UA W MICRO HOLD SPEC 24 HR,SPECIFIC GRAVITY,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,CEA,CEA CENTAUR,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,MICROALBUMIN CONC,ALB CREAT RATIO,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,HEPATITIS B CORE IGM ANTIBODY,HEP B CORE IGM ANTIBODY,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.3333333333333333,0.16666666666666666,0.5,0.3333333333333333,0.16666666666666666,0.5,0.09247447620418048,0.0,0.0,0.04623723810209024,0.0,0.0,1,20396,CEA,CEA SIEMENS IMMULITE 2000,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,HEP B CORE TOTAL AB,HEP B CORE TOTAL AB,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0,0.0,0.0,0.04857142857142858,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,HP4 RPR,HEP C VIRUS AB,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,CBC PLT DIFF,POLYS,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.0,0.16,0.0,0.25,0.2,1.0,0.0,0.061769791070825475,0.0,0.07962607175736813,0.12353958214165095,1.0,1,195586,DRUG ABUSE SCREEN II,METHAQUALONE,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.182,0.19999999999999998,0.27999999999999997,0.0,0.0,0.0,0.0,0.029699923646854032,0.04007989868886952,0.0,0.0,0.0,0,728626,COMP METAB PANEL,ALBUMIN GLOBULIN RATIO,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,IRON TIBC,TRANSFERRIN SAT %,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.0,0.0642857142857143,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,CBC W DIFF PLT,PLATELET SUFFICIENCY,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,LYMPHOCYTE SUBSET PANEL 2,COMMENT S,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,AFP TUMOR MARKER SIEMENS IMMULITE,AFP TUMOR MARKER,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,FREE T3,FREE T3,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,PROTHROMBIN TIME WITH INR,INR,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,HCV RNA PCR RFX NS5B,HCV NS5B RESISTANCE ASSAY PDF,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.3,0.0,0.0,0.32,0.16666666666666666,0.3333333333333333,0.023974096238033038,0.0,0.0,0.03790637447812928,0.04801993258748538,0.06510620292715197,1,130682,ANA SCR W RFL T P LUPUS 1,ANA PATTERN,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,CBC WITH AUTO DIFF,BASOPHILS ABSOLUTE,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.09629383728860574,0.34003516797720323,1.0,1,17517,CMP WITH ESTIMATED GFR CALCULATED,ALBUMIN,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,RPR REFLEX TP PA,RPR TITER,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD IU ML,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.05875,0.07833333333333332,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,CMP13 LP 2AC CBC D PLT,EGFR IF AFRICN AM,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,HIV 1 QUANT PCR,HIV 1 VIRAL COPY,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,HEP B CORE AB QUAL,HEPATITIS B CORE AB QL,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME NR,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,CREATININE,LIPEMIA,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.24333333333333332,0.0,0.0,0.0,0.0,0.0,0.0,0.04357905440832277,0.0,0.0,0.0,0.0,1,64634,STOOL CULTURE,RESULT 2,Bacteria identified,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,ANA SCR IFA RFL TITR PATT,ANA SCREEN IFA,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.22333333333333336,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.022665574408004208,0.02434780138308501,0,17590,PROTEIN ELECTRO S,ALPHA 1 GLOBULIN,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,772020,HCV RNA PCR QN RFX GENO,PLEASE NOTE,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,LIVER FIBROTEST ACTITEST,FIBROSIS STAGE,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,PE INTERP RFX IFE S,BETA GLOBULIN,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,FERRITIN,FERRITIN,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,LYMPHOCYTE SUBSET PANEL 2,% CD8 SUPPRESSOR T CELLS,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.0,0.0,0.0,0.030000000000000002,0.047142857142857146,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,CBC WITH PLT DIFF,RBC MORPHOLOGY,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,LYMPHOCYTE SUBSET PANEL 3,% CD8 SUPPRESSOR T CELLS,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,CD4 CD8 LYMPHOCYTE ENUMERATION,PERCENT CD4,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.0,0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.06803609835483304,0.0,0,23242,FERRITIN,FERRITIN SERUM,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,URINALYSIS COMPLETE,BILIRUBIN,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,DIFFERENTIAL MANUAL,ABSOLUTE BAND NEUTROPHILS,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,MANUAL DIFFERENTIAL,EOSINOPHILS ABSOLUTE,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,CMP14 LP 5AC CBC D PLT RPR,HEMOGLOBIN A1C,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.047350448302201587,0.0,0.0,0.0,0.0,0,204479,CBC WITH PLT DIFF,BLASTS,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,CBC WITH ABSOLUTE WHITE BLOOD CELLS,RDW,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,RPR RFX QN RPR CONFIRM TP,TREPONEMA PALLIDUM ANTIBODIES,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.14285714285714285,0.2,0.75,0.25,0.2,0.75,0.023596626558496703,0.0,0.0,0.03730954251063512,0.0,0.0,1,381806,HCV QUANT GT1A NS5A PROFILE,HCV LOG10,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,CMP14 4AC,EGFR IF AFRICN AM,Neutrophils,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,CBC DIFF PLT,MONOCYTES %,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,HIV AB 1 HIV 2 EIA W REFL 1 WB,HIV EIA AB SCREEN,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,VITAMIN D 25 OH LCMSMS W REFLEX,VITAMIN D 25 OH D3,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,CBC WITH DIFFERENTIAL,IMMATURE GRANS,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,URINALYSIS REFLEX,GLUCOSE,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,CMP14 LP CBC D PLT UA MG TS,VLDL CHOLESTEROL CAL,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,HEP B SURFACE AG W REFLEX CONFIRM,NEUTRALIZATION,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,FIBROACT COMPLETE,WEIGHT LBS,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,CMP14 LP 1AC CBC D PLT TSH,LYMPHS,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,CBC W AUTO DIFF ABS WBC MPV PLT,MCHC,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,HEPATITIS B CORE IGM ANTIBODY,HEP B CORE IGM ANTIBODY,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,COMPLEMENT COMPONENT C3C,COMPLEMENT COMPONENT C3C,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.1675,0.10600000000000001,0.0,0.21000000000000002,0.2,0.5,0.0,0.0,0.0,0.0,0.38075107277079945,1.0,1,58115,UA W MICRO HOLD SPEC 24 HR,SPECIFIC GRAVITY,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,COMPLETE BLOOD COUNT,NEUTROPHILS ABSOLUTE,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,DRUG ABUSE PANEL 10 WITH OXYCODONE,BENZODIAZEPINES,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,HDL CHOL DIRECT,HDL AS % CHOLESTEROL,Globulin,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,RPR,TREPONEMA PALLIDUM ANTIBODIES,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,RENAL PANEL 10,EGFR IF AFRICN AM,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,CBCI COMPLETE BLOOD COUNT W DIFF,PLT MORPHOLOGY,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,NGI HCV SUPERQUANT,INTERNATIONAL UNITS,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.08,0.08857142857142856,0.155,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,CBC WITH ABSOLUTE WHITE BLOOD CELLS,RDW,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.1675,0.0,0.0,0.0,0.08,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,CBC INCLUDES DIFF PLT,ABSOLUTE BAND NEUTROPHILS,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.013421378514845816,0.0,0.0,0.0,0.0,0,67421,CBC COMPLETE BLOOD COUNT W O DIFF,MCHC,Erythrocyte morphology finding,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,URINALYSIS REFLEX,GLUCOSE QL,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.09247447620418048,0.34003516797720323,1.0,1,23457,POL CMP WITH EGFR INV,GLUCOSE,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,CBC COMPLETE BLOOD COUNT W O DIFF,MCHC,Erythrocyte distribution width,Erythrocyte distribution width [Entitic volume],RDW RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,SPECIAL PROFILE 3619,LEUKOCYTE ESTERASE,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,PROFILE 104 LIVER,AST SGOT,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0825,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,URINALYSIS W REFLEX MICRO,WHITE BLOOD CELLS,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,CMP12 LP TP TSH 6AC CBC D PLT,LDH,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,UA MICROSCOPIC REFLEX CULTURE,RED BLOOD CELLS,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,UA W MICRO HOLD SPEC 24 HR,APPEARANCE,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.072,0.36,0.0,0.072,0.36,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,PSA TOTAL % FREE,PSA FREE,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.26666666666666666,0.2,0.0,0.24333333333333332,0.1111111111111111,0.0,0.0,0.03458598148635306,0.0,0.0,0.048911964085985304,0.0,1,59014,PROTHROMBIN PTT,CONTROL,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD IU ML,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,HEMOGLOBIN A1C EAG,HEMOGLOBIN A1C,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,HEPATITIS B SURF AG,HEPATITIS B SURF AG,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,DRUG PANEL 8 SCREEN,OPIATES,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,CEA CARCINOEMBRYONIC ANTIGEN,CEA CENTAUR,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME NR,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,CEA,CEA CENTAUR,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,CREATINE KINASE TOTAL,LIPEMIA,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,LIPOPROT LDL DIRECT,LIPOPROT LDL DIRECT,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,CEA,CEA CENTAUR,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,ASH FIBROSURE,AST SGOT P5P,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,PTT,PTT,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,CMP14 4AC,EGFR IF AFRICN AM,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,ALPHA 1 ANTITRYPSIN QN,ALPHA 1 ANTITRYPSIN QN,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.1875,0.2,0.0,0.0,0.0,0.0,0.0,0.06755685946200152,0.0,0.0,0.0,0.0,0,473835,IFE PE FLC SERUM,ALBUMIN,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA
0.0,0.0,0.0,0.25,0.2,1.0,0.0,0.0,0.0,0.07962607175736813,0.12353958214165095,1.0,1,195586,DRGABU2,METHAQUALONE,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.09999999999999999,0.18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,DRUG ABUSE PANEL 10 WITH OXYCODONE,PHENCYCLIDINE,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,ANA TITER PATTERN,ANA TITER,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,PHENCYCLIDINE,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.5,0.3333333333333333,1.0,0.25,0.16666666666666666,0.5,0.11620501087019508,0.04902508028875774,0.05093349536754144,0.07747000724679676,0.0,0.0,1,27318,PTH INTACT MOLECULE,PTH,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.19999999999999998,0.14285714285714285,0.3333333333333333,0.0,0.0,0.0,0.0,0.040330345754134966,0.0413729178490605,0,433961,COMP METAB PANEL,EGFR NON AFR AMERICAN,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,IFE PE SERUM,GAMMA GLOBULIN,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BENZODIAZEPINES,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,CBC DIFF PLT,MCH,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,RPR REFLEX TITRE TPPA,RPR,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,RHEUMATOID FACTOR,RHEUMATOID FACTOR,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,HCV FIBROSURE RESULTS,FIBROSIS SCORE,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,HEPATITIS C VIRAL RNA QUAL TMA,HEPATITIS C VIRAL RNA QUAL TMA,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BENZODIAZEPINES,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,HEMOGLOBINOPATHY INDICES,HEMATOCRIT,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,CBC W DIFF PLT,BLAST CELLS ABSOLUTE,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,CBC W AUTO DIFF,ABS BASOPHILS,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,CBC INCLUDES DIFF PLT,BAND NEUTROPHILS,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,DRUG ABUSE SCREEN 11 W ETOH NO CONF,OXYCODONE,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,HCV RNA PCR QN RFX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.072,0.18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,COMP METABOLIC PANEL W GFR,GLOBULIN,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,DRUG ABUSE PANEL 10 WITH OXYCODONE,METHAQUALONE,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,PROTEIN ELEC INTERP SERUM,M SPIKE,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.01933333333333333,0.0725,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,LIPID CASCADE W RFLX APOLIB,LDL HDL RATIO,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,HIV AB EIA WITH REFLEXES,HIV AB,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.055,0.125,0.2,0.3333333333333333,0.5,0.8,0.0,0.0666872623744319,0.0795785781568974,0.3858852398421331,0.7201202914748582,0.8593267568211221,1,109009,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS B SURFACE AB,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,CHEM SCREEN PANEL,EGFR NON AFR AMERICAN,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,PROTEIN ELECTRO SERUM,ALPHA 2 GLOBULIN,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,ANTIPHOSPHOLIPID SYNDROME,PT,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,HEPATIC FUNCTION PANEL,TOTAL PROTEIN,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,CBC PLATELET HEM REVIEW,EOS ABSOLUTE VALUE,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.16666666666666666,0.3,0.6,0.16666666666666666,0.3,0.6,0.008069126798302184,0.019845433494145026,0.04257141653334451,0.007969795946009106,0.019601136450317025,0.04204736291598543,0,79053,HEPATITIS B SURFACE AB IMMUN,HEPATITIS B SURFACE AB IMMUNITY QN,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt
0.0,0.16,0.0,0.1875,0.2,1.0,0.0,0.05043482321394899,0.0,0.0,0.12353958214165095,1.0,1,143164,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BENZODIAZEPINES,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.1111111111111111,0.0,0.3333333333333333,0.1111111111111111,0.3333333333333333,0.0,0.007718143826505375,0.0,0.07216283646372013,0.059283288403659595,0.08109682212111924,1,273532,HEMOGLOBIN A1C,MEAN GLUCOSE EST,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,UA W MICRO HOLD SPEC 24 HR,APPEARANCE,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.16666666666666666,0.15,0.75,0.0,0.0125,0.0625,0.006656743412584709,0.0,0.0,0.0,0.0,0.0,0,347047,HCV FIBROSURE,COMMENT,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,CBC DIFF PLT,LYMPHOCYTES #,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,HCV GENOSURE R NSA,HCV GENOSURE R NSA,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,HEPATITIS A TOTAL AB REFLEX IGM,HEPATITIS A TOTAL AB,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,HEPATITIS BE ANTIGEN,HEP BE ANTIGEN,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.09258247128417263,0.0,0.0,0.09258247128417263,0.0,0,115725,C4 SERUM,C4 SERUM,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,FIBROACT COMPLETE,HEIGHT INCHES,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,LIPID PROFILE,CHOLESTEROL,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,COMPLEMENT C3 SERUM,COMPLEMENT C3 SERUM,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,UROGRAM,SPECIFIC GRAVITY,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,CBC WITH PLT DIFF,EOSINOPHILS ABSOLUTE,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,CBC W O DIFF WITH PLATELETS,PLATELET COUNT,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,AUTOIMMUNE HEPATITIS DIAG PNL,MITOCHONDRIAL AB SCREEN,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,CMP14 3AC CBC D PLT RPR MG,EOS,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,HCV RNA PCR RFX NS5B,HCV NS5B RESISTANCE ASSAY PDF,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,MAGNESIUM,HEMOLYSIS,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,CPK,CPK,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,CMP12 LP TP TSH 6AC CBC D PLT,POTASSIUM,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,BASIC METABOLIC PANEL,OSMOLALITY,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,CBC WITH DIFFERENTIAL PLATELETS,MCH,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,CBC WITH PLT DIFF,PLATELET MORPHOLOGY,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,HEPATITIS BE ANTIGEN,HEP BE ANTIGEN,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.023571428571428573,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,SPECIAL A 2 PANEL #9633,POLYS,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,URIC A ESR WES ANA RA QN CC,URIC ACID,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,PLATELET ESTIMATION,PLATELET ESTIMATION,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,CBC WITH DIFFERENTIAL,ABS NEUTROPHILS,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,CBC W O DIFF WITH PLATELETS,MCV,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BENZODIAZEPINES,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,HCV FIBROSURE,FIBROSIS SCORE,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,CBCI COMPLETE BLOOD COUNT W DIFF,DIFFERENTIAL NEUTROPHILS,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,URINE MICROALBUMIN CREAT RATIO,UR MICROALBUMI,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,SMN1 COPY NUMBER ANALYSIS,SPECIMEN TYPE,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.3333333333333333,0.2,0.5,0.3333333333333333,0.2,0.5,0.05661369574194264,0.06447593079677061,0.0,0.06933733351046811,0.07896656557154391,0.0,1,205070,RPR SCREEN W TITER,RPR SCREEN,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,HEPATITIS C AB REFLEX HCV RNA QUANT,HEPATITIS C ANTIBODY,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,ANA TITER PATTERN,ANA TITER,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,ASH FIBROSURE,HEIGHT,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.03301366825316199,0.0,0,128413,CMP12 2AC,ALBUMIN SERUM,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,RPR,TREPONEMA PALLIDUM ANTIBODIES,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.025251900757293,0.0,0,7641,URINALYSIS W REFLEX MICRO,WHITE BLOOD CELLS,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0335,0.07444444444444445,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,LIPID PROFILE WITH CALC NON HDL CHOLESTEROL,RISK RATIO LDL HDL,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,HCV GT3 NS5A DRUG RESIST ASSAY,HCV NS5A DRUG RESIST ASSAY,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,LYMPHOCYTE SUBSET PANEL 4,RACE NR,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,HEPATITIS BE AG,HBEAG INS,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,ANA SCR W RFL T P LUPUS 1,ANA PATTERN,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.13833333333333334,0.41500000000000004,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,UA MICROSCOPIC REFLEX CULTURE,BILIRUBIN,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,COMPREHENSIVE METABOLIC PANEL,CARBON DIOXIDE,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.435,0.3333333333333333,1.0,0.435,0.3333333333333333,1.0,0.010717967407183449,0.8935783031788724,0.9677324695650544,0.010717967407183449,0.8935783031788724,0.9677324695650544,1,29918,TESTOSTERONE FREE LC MS MS,TESTOSTERONE FREE LC MS MS,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.10999999999999999,0.21999999999999997,0.0,0.10999999999999999,0.21999999999999997,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,COMPLEMENT COMPONENT C4C,COMPLEMENT COMPONENT C4C,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,LYMPHOCYTE SUBSET PANEL 4,LYMPHOCYTES ABSOLUTE,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,GLUCOSE,GLUCOSE FASTING,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,X HEPATITIS COMPLEX PROFILE,ANTI HBC TOTAL,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,FIBROACT,ALT,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,TSH,TSH,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.4,0.41714285714285715,0.6666666666666666,0.0,0.0,0.0,0.07392279148774428,0.19825373455330964,0.12411615637026996,1,81232,LYMPHOCYTE SUBSET PANEL 4,% CD4 HELPER CELLS,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.09714285714285713,0.09,0.0,0.09714285714285713,0.09,0.0,0.037147338768416915,0.0,0.0,0.037147338768416915,0.0,0,296095,COMPLEMENT C4 SERUM,COMPLEMENT C4 SERUM,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,HEPATITIS PANEL DIAGNOSTIC,HEP B CORE TOTAL AB,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,CCP ANTIBODY IGG,ANTI CCP IGG,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.2375,0.15833333333333333,0.95,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,LYMPHOCYTE SUBSET PANEL 2,CD4 ABSOLUTE,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,CMP14 LP 2AC CBC D PLT MG T,WBC,Age,Age,Age
0.0,0.0,0.0,0.0,0.025,0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,ASH FIBROSURE,COMMENT,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.0,0.0,0.0,0.07142857142857142,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,IMMUNODEF PROFILE #1,ABSOLUTE CD3,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,PROTEIN CREATININE RATIO URINE,PROTEIN UR MG DL,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,COMP METAB PANEL,ALT,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.047619047619047616,0.0,0.1075,0.0,0.0,0.0,0.031972276975399616,0.0,0.0,0.0,0.0,1,882944,CREATININE,EGFR IF NONAFRICN AM,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,C REACTIVE PROTEIN,C REACTIVE PROTEIN,Leukocyte morphology finding,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,LYMPHOCYTE SUBSET PANEL 4,RACE NR,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,HEP B SURFACE AB IMMUNITY QN,HEP B SURFACE AB IMMUNITY QN,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.31,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.05153731836902975,0.0,0.0,1,7732,CBC WITH AUTO DIFF,NRBC,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.125,0.25,0.3333333333333333,0.0,0.0,0.0,0.014332452013588126,0.014858252907851144,0.09247447620418048,0.0,0.0,1,25015,IRON TIBC,UIBC,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,URINALYSIS,NITRITE,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,HIV 4TH GEN RFLX CONF,HIV 4TH GEN RFLX CONF,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,WBC,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,URINALYSIS W REFLEX MICRO,EPITHELIAL CELLS,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,HEMOGLOBIN A1C,ESTIMATED AVG GLUCOSE,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,LIVER FIBROSIS FIBROMETER,FIBROMETER PROTHROMBIN INDEX,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,DRUG ABUSE SCREEN W ETOH NO GCMS,AMPHETAMINES,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,ASH FIBROSURE,APOLIPOPROTEIN A 1,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,HAV AB TOTAL,HAV AB TOTAL,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,CMP12 LP TP TSH 6AC CBC D PLT,EOS ABSOLUTE,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,CBC WITH AUTO DIFF,MCV,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.06666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,CYSTIC FIBROSIS SCREEN,ETHNICITY,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.2,0.16666666666666666,0.0,0.0,0.0,0.0,0.009622921004768359,0.007736500585135864,0.0,0.0,0.0,0.0,0,237610,CBC WITH MANUAL DIFFERENTIAL,MCHC,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.04833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,DIFFERENTIAL MANUAL,NEUTROPHILS,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,HCV QUANT GT1A NS5A PROFILE,HCV NS5A RESISTANCE ASSAY PDF,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,HB S AG W REFLEX CONF,HFLAG NR,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,LDL CHOLESTEROL DIRECT,LDL CHOL DIRECT,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,UREA NITROGEN BUN,HEMOLYSIS,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,MAGNESIUM SERUM,MAGNESIUM SERUM,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.125,0.16666666666666666,0.0,0.5425,0.7233333333333333,0.0,0.0762321806483941,0.056568082236201356,0.0,0.1524643612967882,0.11313616447240271,1,519132,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS A TOTAL AB,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,CBC WITH MANUAL DIFFERENTIAL,EOSINOPHILS,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.06666666666666667,0.0,0.0,0.06666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,PROTHROMBIN TIME PT,PROTHROMBIN TIME PT,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,CBC INCLUDES DIFF PLT,BLASTS,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,DRUG ABUSE SCREEN 11 W ETOH W CONF,METHADONE,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,CBC W AUTO DIFF,MCHC,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,CMP12 LP TP TSH 6AC CBC D PLT,LDH,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,CMP14 CBC D PLT ESR WES ANA,NEUTROPHILS,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,PROTIME INR F,PT,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0825,0.08833333333333333,0.0,0.3225,0.16666666666666666,1.0,0.0,0.0,0.0,0.07097576385288318,0.09716253076254433,1.0,1,204057,URINALYSIS WITH MICROSCOPIC,UROBILINOGEN,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,IRON TIBC,UIBC,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,PROTIME PTT,PROTHROMBIN TIME PT,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,CBC WITH PLT DIFF,MYELOCYTES,Microalbumin/Creatinine ratio panel,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur
0.0,0.0,0.0,0.25,0.2,1.0,0.0,0.0,0.0,0.04406377228418268,0.05636349559813292,0.5773502691896257,0,254284,COMP METABOLIC PANEL,GLUCOSE NON FASTING,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,PROTEIN ELECTROPHORESIS,GAMMA GLOBULINS,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,BILIRUBIN DIRECT,DIRECT BILIRUBIN,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,OBSTETRIC PANEL,RPR RESULT,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,ANA AMA ASMA LKM AB,MITOCHONDRIAL M2 ANTIBODY,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.04833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,DIFFERENTIAL MANUAL,NEUTROPHILS ABSOLUTE,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.25,0.16666666666666666,0.5,0.0,0.16666666666666666,0.5,0.02919946346325475,0.16096628932775536,0.35355339059327373,0.0,0.2276407094521833,0.5,1,25023,IRON IBC W RFX FERRITIN,%TRANSFERRIN SATURATION,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.16666666666666666,0.014000000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,PE INTERP RFX IFE S,ALBUMIN,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,CMP,ALBUMIN,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.01,0.035,0.0,0.015714285714285715,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,COMPREHENSIVE METABOLIC PANEL E GFR,CHLORIDE,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.5,1.0,1.0,0.0,0.0,0.0,0.4792205357001811,1.0,1.0,1,487942,HCV FIBROSURE RESULTS,FIBROSIS STAGE,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,POL CMP WITH EGFR INV,GLUCOSE,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,URINALYSIS W REFLEX MICRO,OCCULT BLOOD,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,CMP14 5AC,BILIRUBIN TOTAL,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.028999999999999998,0.0,0.0,0.04,0.03636363636363637,0.05714285714285715,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,DIFFERENTIAL MANUAL,ABSOLUTE NEUTROPHILS,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.02142857142857143,0.049999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,CMP14 2AC MG,EGFR IF NONAFRICN AM,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,GORBYMI CMP 4AC CORONARY RISK CBC TSH PROFILE,CALCIUM,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,MITOCHONDRIAL ANTIBODY W REFL TITER,MITOCHONDRIAL AB SCREEN,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,RHEUMATOID FACTOR,RHEUMATOID FACTOR,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,LIPID PROFILE,NON HDL CHOLESTEROL,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.08222222222222222,0.148,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN CREATININE RATIO,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,HIV 1 HIV 2 AB RFLX,HIV 1 WESTERN BLOT RESULT,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,MCCARJUH MCCARTHY PROFILE 1,MITOCHONDRIAL M2 AB,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,HCV RNA QN GRAPH RFX NSA,HEPATITIS C QUANTITATION,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.142,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,CBC RBC H H INDICES WBC PLT,RED BLOOD CELL COUNT,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0825,0.10600000000000001,0.0,0.1825,0.11200000000000002,0.56,0.0,0.0,0.0,0.0,0.01881692037829108,0.19274805315811505,1,204545,URINALYSIS WITH REFLEX MICROSCOP,PROTEIN TOTAL QUAL,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,CMP14 2AC MG,EGFR IF NONAFRICN AM,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.04857142857142858,0.0,0.0,0.04857142857142858,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B RESIST ASSAY INTERP,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.07142857142857142,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,CBC DIFF PLT,MONOCYTES %,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.155,0.2316666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,327767,UA MICROSCOPIC REFLEX CULTURE,RED BLOOD CELLS,Erythrocytes,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,TSH FT4,FREE T4,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.16666666666666666,0.0775,0.31,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,CMP14 LP 3AC CBC D PLT,LYMPHS,pH,pH of Urine by Test strip,pH Ur Strip
0.0,0.0,0.0,0.21166666666666667,0.1111111111111111,0.2,0.0,0.0,0.0,0.00830243303583833,0.01348969066698702,0.018878613381142495,0,139527,MCCARJUH MCCARTHY PROFILE 1,MITOCHONDRIAL M2 AB,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,DRUG ABUSE SCREEN W ETOH NO GCMS,BARBITURATES,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,CMP13 LP TP TSH 2AC CBC D P,CHOLESTEROL TOTAL,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,BUN CREATININE RATIO,ICTERUS,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.061769791070825475,0.0,0.0,0.0,0.0,0,192708,DRUG ABUSE SCREEN II,METHAQUALONE,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,HEPATITIS B SURF AG,HEPATITIS B SURF AG,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.055,0.033,0.0,0.16666666666666666,0.1,0.5,0.0,0.0,0.0,0.0872369085792638,0.0,0.0,1,17434,LIVER FIBROSIS PANEL,ALT,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.061769791070825475,0.0,0.0,0.0,0.0,0,193433,DRUG ABUSE SCREEN II,OPIATES,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,HCV RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,ACUTE HEPATITIS PANEL,HEPATITIS C ANTIBODY,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,PROTEIN CREATININE RATIO URINE,PROTEIN UR MG DL,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.05555555555555555,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,LIPID PROFILE WITH CALCULATIONS NON HDL CHOLESTEROL,RISK RATIO CHOL HDL,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,URIC A ESR WES ANA RA QN CC,URIC ACID,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,PROTIME INR F,PT,Erythrocytes,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,PROTEIN ELECTRO S,ALPHA 1 GLOBULIN,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,HCV QUANT GT1A NS5A PROFILE,HCV LOG10,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,IRON IBC W O REFLEX,UIBC,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,CHEM SCREEN PANEL HDL,URIC ACID,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,LP NON HDL CHOLESTEROL,VLDL CHOLESTEROL CAL,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,PROTEIN ELECTROPHORESIS,ALPHA 1 GLOBULINS,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,HEPATITIS BE ANTIGEN,HEP BE ANTIGEN,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.2,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,CBC WITH PLT DIFF,BANDS ABSOLUTE,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.356,0.39,0.25,0.2,0.0,0.0,0.0488962690001733,0.0,0.051702018527091775,0.07731178956241591,0.0,1,50484,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA TITER,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,CBC WITH MANUAL DIFFERENTIAL,EOSINOPHILS,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,CBC WITH PLT DIFF,VARIANT LYMPHOCYTES ABSOLUTE,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,FIBROACT,ALT,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,MANUAL DIFFERENTIAL,TOTAL NEUTROPHILS %,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,COMP METABOLIC PANEL W GFR,CHLORIDE,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,CBC WITH DIFFERENTIAL,EOSINOPHILS,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,BUN CREATININE,EGFR AFRICAN AMERICAN,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,A FETOPROTEIN TUMOR MARKER,A FETOPROTEIN TUMOR MARKER,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.24333333333333332,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,ALT,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,UA W RFLX MICROSCOPIC,COLOR,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,DRUG ABUSE PANEL 10 WITH OXYCODONE,METHAQUALONE,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,MANUAL DIFFERENTIAL,BLASTS %,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,IRON TIBC,TRANSFERRIN SAT %,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,HCV RNA QN REAL TIME PCR W RFX QL T,HCV RNA PCR QN,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,LYMPHOCYTE SUBSET PANEL 4,RACE NR,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,HEPATITIS ABC PANEL,HEPATITIS A ANTIBODY TOTAL,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,URINE MICROALBUMIN CREAT RATIO,UR MICROALBUMI,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,PROTIME PTT,PTT,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,LIPID PNL W REFL TRIG>400,CHOLESTEROL HDL RATIO,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.033,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,URINALYSIS W MICROSCOPIC,URINALYSIS URINE COLOR,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.05157894736842105,0.016666666666666666,0.0,0.04315789473684211,0.09111111111111111,0.0,0.004660597787323417,0.0,0.0,0.003385758345142875,0.0,0,486431,MICROALBUMIN RANDOM URINE W CREATININE,MICROALBUMIN CREATININE RATIO RANDOM URINE,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE EOSINOPHILS,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,HEP B CORE AB QUAL,HEPATITIS B CORE AB QL,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,CREATININE SERUM,CREATININE SERUM,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,LP WITHOUT VLDL CHOL HDL,LDL CHOLESTEROL CALC,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.07647311194538908,0.0,0.0,1,205708,CBC W AUTO DIFF,HCT,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.02591934325789702,0.0,0.0,0.0,0.0,0,59055,CBC WITH ABSOLUTE WHITE BLOOD CELLS,WBC,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.15,0.14285714285714285,0.0,0.15,0.14285714285714285,0.0,0.0,0.07629631700059647,0.0,0.0,0.07629631700059647,0.0,0,139519,FERRITIN SERUM,FERRITIN SERUM,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.03571428571428571,0.05,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,DRUG ABUSE SCREEN II,COCAINE METABOLITE,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,GENERAL HEALTH PANEL,CALC GLOBULIN,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,ASH FIBROSURE,COMMENT,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,HEP B CORE TOTAL AB,HEP B CORE TOTAL AB,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.04857142857142858,0.0,0.0,0.04857142857142858,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,HEPATITIS C VIRAL RNA QUAL TMA,HEPATITIS C VIRAL RNA QUAL TMA,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,HEPASCORE R,SEX,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,IMMUNOGLOBULINS,IMMUNOGLOBULIN A,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,UREA NITROGEN BUN,HEMOLYSIS,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,AST CBC D PLT,EOS,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.33399999999999996,0.0,0.0,0.534,0.0,0.0,0.026469685247406227,0.0,0.0,0.08201332011404516,0.0,0.0,1,19893,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH TOTAL,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.25,0.0,0.0,0.25,0.125,0.25,0.010952274481359159,0.011337917407329035,0.011598869223880981,0.010348362482358597,0.010712740931190123,0.01095930377918175,0,108860,TESTOSTERONE FREE TOTAL,FREE TESTOSTERONE DIRECT,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,LYMPHOCYTE SUBSET PANEL 3,% CD3 MATURE T CELLS,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.003,0.015,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,CMP14 LP TP TSH 4AC CBC D P,HEMATOCRIT,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.4,0.3333333333333333,1.0,0.0,0.0,0.0,0.11277316640103974,0.16750164273558021,1.0,1,57992,SPECIAL PROFILE 3619,LEUKOCYTE ESTERASE,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,CBC WITH DIFFERENTIAL,IMMATURE GRANS,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,ASH FIBROSURE,HEIGHT,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,LIVER FIBROTEST ACTITEST,NECROINFLAMMAT ACT SCORE,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,ANA SCREEN QUAL,ANA ANTIBODY SCREEN EIA,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,COMPREHENSIVE METABOLIC PANEL AMA,CHLORIDE,Body weight,Body weight Measured,Weight Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,CBC WITH PLT DIFF,BLASTS,Eosinophils,Eosinophils [#/volume] in Blood,Eosinophil # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,CMP14 LP CBC D PLT,NEUTROPHILS,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.2222222222222222,0.4,0.0,0.2222222222222222,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,HCV RNA PCR QN GRAPH RFX NS5A,HCV NS5A RESIST ASSAY INTERP,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.011764705882352941,0.025,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,COMP METABOLIC PANEL,SODIUM,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,CBCI COMPLETE BLOOD COUNT W DIFF,MCHC,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,HCV FIBROSURE RESULTS,FIBROSIS SCORE,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,BASIC METABOLIC PANEL 7,EGFR IF AFRICN AM,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.09499999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,UA MICROSCOPIC REFLEX CULTURE,WHITE BLOOD CELLS,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.16666666666666666,0.0,0.0,0.16666666666666666,0.0,0.0,0.05391665993580863,0.0,0.0,0.0762496717190787,0.0,0,17590,LIPID PANEL WITH LDL HDL RATIO,LDL HDL RATIO,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,MICROALBUMIN RANDOM,MICROALBUMIN CR RATIO,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,HB CORE AB W IGM RFX,HB CORE AB TOTAL,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,NASH FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Erythrocyte morphology finding,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,UREA NITROGEN BUN,UREA NITROGEN BUN,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,COMP METABOLIC PANEL 12,ALKALINE PHOSPHATASE,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.0,0.05181818181818181,0.08142857142857142,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,DRUG ABUSE SCREEN 11 W ETOH NO CONF,OXYCODONE,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.08,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,WBC,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.25,0.2,1.0,0.0,0.0,0.0,0.06591673023183264,0.13909830811578938,1.0,1,108340,COMP METABOLIC PANEL W GFR,GLOBULIN,Globulin,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc
0.0,0.04,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,COMPREHENSIVE METABOLIC PANEL,OSMOLALITY,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,IMMUNOFIXATION SERUM,IGG SERUM NR,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.1,0.07142857142857142,0.16666666666666666,0.396,0.1142857142857143,0.26666666666666666,0.0,0.0,0.0,0.0,0.34003516797720323,1.0,1,18697,ASH FIBROSURE,APOLIPOPROTEIN A 1,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,CMP14 CBC D PLT ESR WES ANA,NEUTROPHILS,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,MANUAL DIFFERENTIAL,EOSINOPHILS %,Age,Age,Age
0.0,0.0,0.0,0.155,0.19,0.2375,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,URINALYSIS CULTURE IF INDICATED,LEUKOCYTE ESTERASE,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,FIBROACT COMPLETE,HEIGHT INCHES,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,CBC W O DIFF WITH PLATELETS,MCV,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,URINALYSIS CULTURE IF INDICATED,WHITE BLOOD CELLS,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,COMPREHENSIVE METABOLIC PANEL W O ALT,BUN CREATININE RATIO,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,THYROID PROFILE T4 T3UP FTI TSH,T 4,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,HEP B CORE AB QUAL,HEPATITIS B CORE AB QL,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,CBC W AUTO DIFF WITH PLATELETS,RBC,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,HB S AG W REFLEX CONF,HB S AG,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,DRUG ABUSE SCREEN 9 NO THC W CONF,OXYCODONE,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,LYMPHOCYTE SUBSET PANEL 2,CD4 ABSOLUTE,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.007000000000000001,0.014000000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,AUTOIMMUNE HEPATITIS DIAG PNL,MITOCHONDRIAL AB SCREEN,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,CMP14 LP 5AC CBC D PLT RPR,WBC,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,HEPATITIS C VIRAL RNA NS3 DRUG RESI,BOCEPREVIR RESISTANCE,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.05142857142857143,0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,COMPREHENSIVE METABOLIC PANEL REFL,UREA NITROGEN BUN,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,CBC WITH PLT DIFF,OTHERS,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,CBC W AUTO DIFF ABS WBC MPV PLT,NEUTROPHILS,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,UA MICROSCOPIC REFLEX CULTURE,SPECIFIC GRAVITY,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.21668861764565872,0.0,0,30940,CMP12 2AC,ALBUMIN SERUM,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,HEPATITIS BE ANTIGEN,HEP BE ANTIGEN,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,CBC WITH PLT DIFF,RDW,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.134,0.2783333333333333,0.0,0.19,0.16666666666666666,0.3333333333333333,0.0,0.022155855810859326,0.0,0.0,0.05427054155128297,0.0946521642027649,1,7146,CBCM COMPLETE BLOOD CNT W MAN DIFF,EOSINOPHILS,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,UREA NITROGEN BUN,HEMOLYSIS,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.5566666666666666,0.2,0.3333333333333333,0.0,0.0,0.0,0.05352091133427317,0.05336825693147673,0.05352091133427317,1,111567,CBC WITH PLT DIFF,WBC MORPHOLOGY,Leukocyte morphology finding,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld
0.0,0.8,0.8,0.8,0.8,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,PSA TOTAL REFLEX FREE,PROSTATE SPECIFIC AG SERUM,Age,Age,Age
0.0,0.0,0.0,0.12285714285714286,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,486431,CMP14,EGFR IF AFRICN AM,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.2,0.0,0.0,0.0,0.0,0.0,0.025715204707061123,0.0,0.0,0.0,0.0,0.0,0,7138,CBC W AUTO DIFF ABS WBC MPV PLT,MCHC,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0335,0.07444444444444445,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,IMMUNE COMPETENCE PANEL,CD4 CD8 RATIO,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.072,0.18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,COMP METABOLIC PANEL,RATIO,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,203927,BUN CREATININE RATIO,ICTERUS,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.0,0.16666666666666666,0.0,0.25,0.16666666666666666,1.0,0.0,0.06805282384001021,0.0,0.07257572557143144,0.13610564768002043,1.0,1,28621,IFE PE FLC SERUM,ALBUMIN,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BARBITURATES,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.02823933563163694,0.0,0,59014,COMPLETE BLOOD COUNT,MEAN PLATELET VOLUME,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.028571428571428574,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,COMP METABOLIC PANEL,ANION GAP,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,NASH FIBROSURE,AST SGOT P5P,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,TRANSFERRIN CARBOHYDRATE DEFICIENT ALCOHOL USE,TRANSFERRIN,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,RENAL PANEL 10,EGFR IF NONAFRICN AM,Bacteria identified,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0.0,0.0,0.0,0,23457,IFE PE SERUM,ALPHA 2 GLOBULIN,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,PROTEIN ELECTRO S,PLEASE NOTE,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,URINALYSIS COMPLETE,GLUCOSE QL,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,T B LYMPHOCYTE NK NYSDOH,PLATELETS,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.155,0.0,0.0,0.0,0.0,0.0,0.0,0.043379831448149275,0.0,0.0,0.0,0.0,0,7898,HEMOGRAM W AUTOMATED DIFF,WBC,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.0,0.0,0.0,0.0,0.11399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,COMPREHENSIVE METABOLIC PANEL W O ALT,BUN CREATININE RATIO,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,CBC WITH PLT DIFF,NRBC,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.2,0.17333333333333334,0.26,0.0,0.0,0.0,0.0360154199639221,0.07165999577194615,0.10031748330730439,1,495416,CMP WITH ESTIMATED GFR CALCULATED,FASTING NON FASTING,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,URINALYSIS W REFLEX MICRO,UROBILINOGEN,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.154,0.08833333333333333,0.0,0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,URINALYSIS CULTURE IF INDICATED,UROBILINOGEN,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,CBC PLT DIFF,POLYS,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,COMPLETE BLOOD COUNT,RED CELL DIST WIDTH,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.146497670544957,0.0,0.0,0.0,0.0,0,25320,IFE PE FLC SERUM,ALBUMIN,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,STOOL CULTURE,RESULT 1,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,ACUTE HEPATITIS PANEL,HEPATITIS A AB IGM,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.08,0.05714285714285715,0.08,0.08,0.05714285714285715,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE NEUTROPHILS,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,BILIRUBIN PANEL,BILIRUBIN INDIRECT,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,HEPATITIS C GENO TYPE 1 NS5A RESIST,OMBITASVIR RESISTANCE,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.022222222222222223,0.03333333333333333,0.0,0.022222222222222223,0.03333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,BILIRUBIN DIRECT,DIRECT BILIRUBIN,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,PROTEIN ELECTRO S,PLEASE NOTE,Alpha-2-Macroglobulin,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,LEDIPASVIR RESISTANCE,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,LIVER FIBROTEST ACTITEST,HAPTOGLOBIN,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,HEPATIC FUNCTION PANEL,TOTAL PROTEIN,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,PROFILE 104 LIVER,AST SGOT,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,LIPID PROFILE,CHOLESTEROL,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.011111111111111112,0.025,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,DRUG ABUSE SCREEN 11 W ETOH W CONF,METHADONE,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.26666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,PROTEIN CREATININE RATIO URINE,PROTEIN UR MG DL,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,FSRC NEW PATIENT PANEL,D BILIRUBIN,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,FREE T3,FREE T3,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,ACUTE HEPATITIS PANEL,HEPATITIS B SURFACE ANTIGEN,Leukocyte morphology finding,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,CBC WITH DIFFERENTIAL,BASOPHILS,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,HEMOGLOBIN A1C EAG,HEMOGLOBIN A1C,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,CBC INCLUDES DIFF PLT,ABSOLUTE BAND NEUTROPHILS,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,HEPATIC FUNCTION PANEL W O TP,BILIRUBIN DIRECT,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,COMP METABOLIC PANEL 12,ALKALINE PHOSPHATASE,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,BMP8 EGFR,POTASSIUM,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,BAND NEUTROPHILS,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,ALBUMIN CREATININE RATIO URINE RANDOM,CALC ALBUMIN CREAT RND,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,OMBITASVIR RESISTANCE,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,RPR,TREPONEMA PALLIDUM ANTIBODIES,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,MCCARJUH MCCARTHY PROFILE 1,MITOCHONDRIAL M2 AB,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,CEA CARCINOEMBRYONIC ANTIGEN,CEA CENTAUR,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,T B LYMPHOCYTE NK NYSDOH,PLATELETS,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,CBCI COMPLETE BLOOD COUNT W DIFF,ABS NEUTROPHILS,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,BUN CREATININE RATIO,ICTERUS,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,URINALYSIS CULTURE IF INDICATED,COLOR,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,COMPREHENSIVE METABOLIC PANEL,CALCIUM,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.0,0.0,0.08,0.05714285714285715,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE MONOS,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,ACCUTYPE R IL28B,ACCUTYPE R IL28B,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,HCV ANTIBODY REFLEX NAA,HCV RNA NAA QUALITATIVE,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,CBC WITH DIFFERENTIAL,MYELOCYTES,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,STOOL CULTURE,RESULT 2,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.155,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.0,0.05014728927652112,0.07899888361701268,0,265074,CBC WITH DIFFERENTIAL,ABS NEUTROPHILS,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,PHOSPHATE AS PHOSPHORUS,ICTERUS,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,RPR,TREPONEMA PALLIDUM ANTIBODIES,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,HEPATITIS B CORE AB TOTAL,HEPATITIS B CORE AB TOTAL,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,CBC WITH DIFFERENTIAL,BASOPHILS,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,SED RATE MODIFIED WESTERGREN MANUAL,SED RATE MODIFIED WESTERGREN MANUAL,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,ESR WES CRP,C REACTIVE PROTEIN QUANT,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B RESIST ASSAY INTERP,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,LEDIPASVIR RESISTANCE,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,CMP WITH EGFR,EGFR NON AFRICAN AM,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.1875,0.2,0.0,0.0,0.0,0.0,0.0,0.07800794199198469,0.0,0,473835,AFP WITH AFP L3%,AFP SERUM,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,ARTHRITIS PROFILE,SEDIMENTATION RATE,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,CBC WITH AUTO DIFF,EOSINOPHILS #,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,COMPREHENSIVE METABOLIC PANEL,CALCIUM SERUM,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,HCV FIBROSURE,LIMITATIONS,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.051250000000000004,0.10250000000000001,0.0,0.01125,0.0225,0.0,0.005776196926012056,0.0,0.0,0.0,0.0,0,339143,MICROALBUMIN CREATININE RANDOM RATIO,CALC MICROALB CREAT RND,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,PROTEIN CREATININE RATIO URINE,PROTEIN UR MG DL,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,TSH FT4,TSH,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,SPECIAL A 2 PANEL #9633,POLYS,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,URINALYSIS WITH MICROSCOPIC,UROBILINOGEN,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESIST ASSAY INTERP,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,HEPATITIS C AB,HEPATITIS C AB,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,FIBROACT,NECROINFL SCORE,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.3333333333333333,0.235,0.94,0.0,0.0,0.0,0.11098565713428754,0.0,0.0,1,265157,CBC WITH AUTO DIFF,PLATELET COUNT,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,COMP METABOLIC PANEL,RATIO,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,LIPID PANEL,NON HDL CHOLESTEROL,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.017142857142857144,0.04,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,CBC PLATELET HEM REVIEW,NEUTROPHILS,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.01,0.035,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,COMPREHENSIVE METABOLIC PANEL AMA,GLOBULIN,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,NASH FIBROSURE,HEIGHT,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D3,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,HIV 1 HIV 2 AG AB COMBO W REFLEXES,HIV INTERPRETATION,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.2857142857142857,1.0,0.0,0.2857142857142857,1.0,0.0,0.439493011634871,0.8660254037844386,0.0,0.439493011634871,0.8660254037844386,1,21576,CREATINE KINASE TOTAL,CREATINE KINASE TOTAL,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,COMPREHENSIVE METABOLIC PANEL E GFR,SODIUM,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,CMP13 LP TP TSH 2AC CBC D P,HDL CHOLESTEROL,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,CBC WITH AUTO DIFF,BASOPHILS ABSOLUTE,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME,Age,Age,Age
0.0,0.16999999999999998,0.238,0.0,0.16999999999999998,0.238,0.0,0.037109965159155545,0.019465476720620156,0.0,0.037109965159155545,0.019465476720620156,0,223149,HEP B SURFACE AB IMMUNITY QN,HEP B SURFACE AB IMMUNITY QN,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.05263157894736842,0.0,0.0,0.04894736842105263,0.02,0.0,0.023692166672912185,0.0,0.0,0.0,0.0,0,486431,IMMUNOFIXATION SERUM,IMMUNOGLOBULIN M,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,TSH ULTRASENSITIVE,TSH ULTRASENSITIVE,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,HP5,HEP C VIRUS AB,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,PROTHROMBIN TIME WITH INR,INR,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,DRUG ABUSE SCREEN II,BENZODIAZEPINES,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,CBC WITH DIFF PLATELET,WBC,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,IMMUNOGLOBULIN A,IMMUNOGLOBULIN A,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,LYMPHOCYTE SUBSET PANEL 4,ABS CD4 COUNT,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,BASIC METABOLIC PANEL 7,EGFR IF AFRICN AM,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.2,0.125,0.3333333333333333,0.0,0.0,0.0,0.042948774079294316,0.06396841842921241,0.06205807818513498,1,244673,LYMPHOCYTE SUBSET PANEL 4,ABS CD4 COUNT,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,HBSAB AG,HEP B SURFACE AB QUAL,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.05609681329090033,0.0,0,57976,CBC W AUTO DIFF,MEAN PLATELET VOLUME,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,CMP,BUN BLOOD UREA NITROGEN,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,LIPID PANEL,HDL AS % CHOLESTEROL,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.04857142857142858,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,HCV RNA NS5A GENOTYPE,LEDIPASVIR RESISTANCE,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,HCV RNA PCR QN GRAPH RFX NS5A,HCV NS5A RESIST ASSAY INTERP,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0725,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D3,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,CBC,MO#,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.055,0.033,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,HEPATITIS PANEL 4,HEP B CORE AB IGM,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CEA,CEA SIEMENS IMMULITE 2000,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.2,0.0,0.155,0.2,0.5,0.0,0.02146570986203966,0.0,0.0,0.07982873259716383,0.5,1,304519,CBCI COMPLETE BLOOD COUNT W DIFF,ABS NEUTROPHILS,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,COMPREHENSIVE METABOLIC PANEL,CALCIUM SERUM,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,HEP C RNA GENOT 3 NS5A,VELPATASVIR RESISTANCE,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.16,0.0,0.1875,0.2,1.0,0.0,0.061769791070825475,0.0,0.0,0.12353958214165095,1.0,1,143164,DRUG ABUSE SCREEN II,BENZODIAZEPINES,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,LIPID PANEL WITH LDL HDL RATIO,HDL CHOLESTEROL,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.3333333333333333,0.306,1.0,0.3333333333333333,0.306,1.0,0.09247447620418048,0.34003516797720323,1.0,0.09247447620418048,0.34003516797720323,1.0,1,20644,CERULOPLASMIN,CERULOPLASMIN,Ceruloplasmin,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,LP NON HDL CHOLESTEROL,VLDL CHOLESTEROL CAL,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,IRON TIBC,TRANSFERRIN SAT %,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,TESTOSTERONE FREE LC MS MS,TESTOSTERONE FREE LC MS MS,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,HELPER T LYMPH CD4,HEMATOLOGY COMMENTS,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CREATINE KINASE TOTAL,LIPEMIA,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.2,0.5,0.0,0.0,0.0,0.0,0.01685427816859486,0.0268944705826899,0,422543,HEPATITIS PANEL 4,HEP B CORE AB IGM,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.0165,0.0825,0.0,0.022,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,MICROALBUMIN CONC,ALB CREAT RATIO,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,HEMOGLOBIN A1C,HEMOGLOBIN A1C,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,MAGNESIUM SERUM,MAGNESIUM SERUM,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,URINALYSIS C,BILIRUBIN,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE NEUTROPHILS,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,BASIC METABOLIC PANEL,EGFR NON AFR AMERICAN,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.18555555555555556,0.2783333333333333,0.0,0.15777777777777777,0.23666666666666666,0.0,0.06958943805011741,0.14539805437566944,0.0,0.0,0.0,1,139543,HEPATITIS BE ANTIGEN,HEP BE ANTIGEN,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,PROTEIN ELECTROPHORESIS,GAMMA GLOBULINS,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,URINALYSIS SCREEN,PH,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,HEPATITIS B SURFACE AB QUANT,HEPATITIS B SURFACE AB,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,HEPATIC FUNCTION PANEL W O TP,BILIRUBIN DIRECT,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,UA W RFLX MICROSCOPIC,COLOR,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,ASH FIBROSURE,HEIGHT,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,SPECIAL A 2 PANEL #9633,POLYS,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,CMP13 LP 2AC CBC D PLT,EGFR IF AFRICN AM,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,CBC WITH AUTO DIFF,RDW,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,COMPREHENSIVE METABOLIC PANEL E GFR,ALBUMIN,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,CBC DIFF AMBIGUOUS DEFAULT,NEUTROPHILS,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,CBC WITH PLT DIFF,VARIANT LYMPHOCYTES ABSOLUTE,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,HCV RNA PCR QN RFX GENO,PLEASE NOTE,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.1425,0.08399999999999999,0.0,0.0,0.0,0.0,0.0,0.012943710088917482,0.0,0.0,0.0,0.0,0,143164,PROTEIN TOTAL URINE,PROTEIN CR RATIO,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD3 CELLS,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,PSA FREE TOTAL,FREE PSA,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,URINALYSIS,BILIRUBIN,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0075,0.0375,0.0,0.047,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,IMMUNE COMPETENCE PANEL,CD4 CD8 RATIO,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.047142857142857146,0.030000000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,HEPATITIS PANEL ACUTE,HEPATITIS C ANTIBODY,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,CREATININE,EGFR IF AFRICN AM,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,CMP14 HP4 DBILI CBC D PLT R,LYMPHS,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.125,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.06972447331798648,0.0,0,241109,C4 C3,COMPLEMENT C3 SERUM,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,URINALYSIS CULTURE IF INDICATED,UROBILINOGEN,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,REFLEX ANA PATTERN,PATTERN 1,Race,Race,Race
0.16,0.17142857142857143,0.3,0.0,0.41285714285714287,0.7225,0.0,0.06229568196836488,0.07240860968350848,0.0,0.06229568196836488,0.07240860968350848,1,139519,HEPATITIS ABC PANEL,HEPATITIS A ANTIBODY TOTAL,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,APTT,PARTIAL THROMBOPLASTIN,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.46499999999999997,0.0,0.0,0.0,0.0,0.0,0.044866280765879285,0.06428820318010176,0.11098565713428754,1,134577,LIPID PANEL,LDL CALC,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,LYMPHOCYTE SUBSET PANEL 4,RACE NR,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,COMPREHENSIVE METABOLIC PANEL E GFR,ALBUMIN,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.03571428571428571,0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BARBITURATES,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,CBC PLATELET HEM REVIEW,EOS ABSOLUTE VALUE,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,CYSTIC FIBROSIS SCREEN,ETHNICITY,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.18999999999999997,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,URINALYSIS SCREEN,PH,Erythrocyte morphology finding,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,CBC,MONOCYTES ABSOLUTE,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.25,0.2,0.5,0.0,0.0,0.0,0.05249083695705592,0.06268135194169755,0.08190888212768821,0,81224,LYMPHOCYTE SUBSET PANEL 3,% CD8 SUPPRESSOR T CELLS,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,VAP CHOLESTEROL PROFILE,TRIGLYCERIDES,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.14285714285714285,0.0,0.0,0.14285714285714285,0.0,0.0,0.02164436086704391,0.0,0.0,0.02164436086704391,0.0,0,18341,TESTOSTERONE SERUM,TESTOSTERONE SERUM,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,PT PROTIME,INR,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,CBC WITH DIFFERENTIAL,MONOCYTES,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,SMOOTH MUSCLE AB RFX TITER,F ACTIN IGG,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,PROTEIN ELECTRO S,ALPHA 1 GLOBULIN,Erythrocyte morphology finding,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,TESTOSTERONE FREE TOTAL LC MS,FREE TESTOSTERONE DIRECT,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,BASIC METABOLIC PANEL,BUN,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,LIPID PROFILE WITH CALCULATIONS NON HDL CHOLESTEROL,RISK RATIO CHOL HDL,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,PATHOLOGIST SMEAR REVIEW,RBC,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,HEPATIC FUNCTION PANEL,ALT,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,A FETOPROTEIN TUMOR MARKER,A FETOPROTEIN TUMOR MARKER,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,CBC,HEMOGLOBIN,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,ASH FIBROSURE,APOLIPOPROTEIN A 1,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.23666666666666666,0.25,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,264846,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE MONOS,Monocytes,Monocytes [#/volume] in Blood,Monocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,COMP METABOLIC PANEL,GLOBULIN,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.6975,0.93,0.6666666666666666,0.0,0.0,0.0,0.4224956153898245,0.022046838418816495,0.022046838418816495,1,487926,LIVER FIBROSIS,NECROINFLAM ACT SCORE,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,PLATELET ESTIMATION,PLATELET ESTIMATION,Alpha-2-Macroglobulin,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc
0.11499999999999999,0.05,0.08,0.06666666666666667,0.05,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE MONOCYTES,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.125,0.0475,0.0,0.125,0.0475,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,HEPATITIS B CORE AB TOTAL,HEPATITIS B CORE AB TOTAL,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,CEA CARCINOEMBRYONIC ANTIGEN,CEA CENTAUR,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,RENAL PANEL 10,EGFR IF AFRICN AM,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,CMP14 LP 3AC,LDH,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,HB CORE AB W IGM RFX,HB CORE AB TOTAL,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,MORPHOLOGICAL REVIEW,MORPHOLOGICAL REVIEW,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME NR,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,CBC,HEMOGLOBIN,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.054435397064445,0.056961251827243986,0.0648385480903172,0,264853,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE MONOCYTES,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,LIVER FIBROSIS FIBROTEST,FIBROSIS STAGE,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,CMP14 LP 5AC CBC D PLT RPR,HEMOGLOBIN A1C,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,ANA SCR W RFL T P LUPUS 1,ANA PATTERN,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,HIV 1 HIV 2 AB SCREEN,HIV 1 HIV 2 AB SCREEN,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,HCV FIBROSURE RESULTS,NECROINFLAMMAT ACT GRADE,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,MANUAL DIFFERENTIAL,SEGMENTED NEUTROPHILS %,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,PTT,PTT,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,URINALYSIS CULTURE IF INDICATED,COLOR,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,CBC WITH DIFFERENTIAL PLATELETS,POLYS,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.053626058777151875,0.0,0.0,0.0,0.0,0,28654,PROTEIN ELEC INTERP SERUM,M SPIKE,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.09,0.07142857142857142,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,COMPREHENSIVE METABOLIC PANEL WITH GFR,ANION GAP,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,BASIC METABOLIC PANEL 8,EGFR IF AFRICN AM,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,LIPID CASCADE W RFLX APOLIB,LDL HDL RATIO,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,LIPOPROTEIN ANALYSIS NMR,LDL P,Sex,Sex,Sex
0.3333333333333333,0.2,1.0,0.3333333333333333,0.4,1.0,0.03082482540139353,0.11334505599240108,0.33333333333333326,0.06538932921065,0.4808823462371743,0.7071067811865476,1,24984,IRON BINDING CAPACITY % SATURATION,IRON SERUM,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.020723268342491052,0.0,0.0,0.0,0.0,0,141358,CBCI COMPLETE BLOOD COUNT W DIFF,PLT MORPHOLOGY,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.25,0.25,0.0,0.0,0.0,0.0,0.0,0.40824829046386313,0.0,0,23366,CMP12 LP 6AC,PHOSPHORUS SERUM,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,HEPATITIS C RNA PCR QUANTITATIVE,HCV VIRAL LOG,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,CD4 CD8 LYMPHOCYTE ENUMERATION,PERCENT CD4,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,IRON PANEL,IRON,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,HCV FIBROSURE,GGT,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,ANTIPHOSPHOLIPID SYNDROME,PT,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,CBCM COMPLETE BLOOD CNT W MAN DIFF,EOSINOPHILS,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.25,0.5,0.75,0.25,0.5,0.75,0.015842090547775523,0.0,0.0,0.010024059465046142,0.0,0.0,0,161281,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD IU ML,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,LIPID CASCADE W RFLX APOLIB,LDL HDL RATIO,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,HIV 1 HIV 2 AG AB COMBO W REFLEXES,HIV INTERPRETATION,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,PROTIME PTT,PROTHROMBIN TIME PT,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.28,0.0,0.0,0.25,0.0,0.0,0.0,0.046706887849276346,0.0,0.09494317394815022,0.0,0.0,1,66902,HEMOGRAM W AUTOMATED DIFF,WBC,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,CBC WITH DIFFERENTIAL PLATELETS,POLYS,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.03238095238095238,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,HCV FIBROSURE,FIBROSIS SCORE,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,PROSTATE SPECIFIC ANTIGEN PSA,PSA,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,DRUG ABUSE SCREEN 11 W ETOH W CONF,METHADONE,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,URINALYSIS WITH MICROSCOPIC,GLUCOSE,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,1,27771,CMP12 LP 6AC,PHOSPHORUS SERUM,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.25,0.16666666666666666,0.0,0.25,0.3233333333333333,0.94,0.047471586974075164,0.0,0.0,0.06713496212611103,0.05720402135206337,0.0,0,7773,CBC WITH AUTO DIFF,PLATELET COUNT,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CMP14 EGFR,POTASSIUM,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,HEP B SURFACE AG W REFLEX,HEP B SURFACE AG W REFLEX,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,HELPER T LYMPH CD4,HEMATOLOGY COMMENTS,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.3333333333333333,0.2857142857142857,1.0,0.3333333333333333,0.2757142857142857,0.965,0.3783747610938436,0.015512265816446047,0.04372412516808821,0.3783747610938436,0.015512265816446047,0.04372412516808821,0,204164,HCV RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,CYSTIC FIBROSIS SCREEN,ETHNICITY,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.18999999999999997,0.25,0.0,0.3333333333333333,0.25,0.0,0.0,0.10736577230861277,0.0,0.016574515286607583,0.0,0.0,0,149575,URINE PROTEIN TOTAL RANDOM W O CREATININE,PROTEIN TOTAL RANDOM UR,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,ALPHA 1 ANTITRYPSIN QN,ALPHA 1 ANTITRYPSIN QN,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.2857142857142857,0.4,0.0,0.2857142857142857,0.4,0.0,0.06806864668278456,0.17268374102661144,0.0,0.06806864668278456,0.17268374102661144,0,487967,HEPATITIS C ANTIBODY,HEPATITIS C ANTIBODY,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,IMMUNE COMPETENCE PANEL,CD4 CD8 RATIO,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.014499999999999999,0.028999999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,MANUAL DIFFERENTIAL,LYMPHOCYTES ABSOLUTE,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,TSH FT4,FREE T4,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,RPR,RPR QUANT,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.31714285714285717,0.44400000000000006,0.0,0.2857142857142857,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,HCV ANTIBODY REFLEX NAA,HCV RNA NAA QUALITATIVE,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,COMP METABOLIC PANEL,CREATININE,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,HIV 1 QUANT PCR,HIV 1 VIRAL COPY,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,URINALYSIS,NITRITE,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.15,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.09418963513805056,0.0,0,51953,FE CBC D PLT TIBC FER B12 F,FERRITIN SERUM,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.182,0.14285714285714285,0.2,0.0,0.11857142857142858,0.166,0.0,0.029699923646854032,0.04007989868886952,0.0,0.0,0.0,0,728626,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD8 CELLS,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,CD4 CD8 LYMPHOCYTE ENUMERATION,PERCENT CD4,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,CBC W AUTO DIFF ABS WBC MPV PLT,EOSINOPHILS,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,DRUG ABUSE PANEL 10 WITH OXYCODONE,PHENCYCLIDINE,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,SMN1 COPY NUMBER ANALYSIS,SPECIMEN TYPE,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,METHADONE,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,ANA SCR W RFL T P LUPUS 1,ANA PATTERN,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,CBC WITH DIFFERENTIAL,NUCLEATED RBCS,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,HIV AG AB 4TH GEN RFL,RACE NR,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,PTT,PTT,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,HIV AB 1 HIV 2 EIA W REFL 1 WB,HIV EIA AB SCREEN,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.155,0.2,0.5,0.0,0.0,0.0,0.0,0.07982873259716383,0.5,1,304519,CBC WITH DIFFERENTIAL,ABS NEUTROPHILS,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,RPR,RPR QUANT,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,HEPASCORE R,SEX,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,CBC INCLUDES DIFF PLT,BASOPHILS ABSOLUTE,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,PE INTERP RFX IFE S,BETA GLOBULIN,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,COMP METABOLIC PANEL W GFR,SODIUM,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH TOTAL,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,HEMOGLOBIN A1C,HEMOGLOBIN A1C,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.182,0.125,0.3333333333333333,0.0,0.0,0.0,0.0,0.053626058777151875,0.08581004475672016,0.0,0.0,0.0,0,28688,ALPHA 1 ANTITRYPSIN PHENOTYPE,A 1 ANTITRYPSIN PHENOTYPE,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.172,0.14285714285714285,0.3333333333333333,0.372,0.2714285714285714,0.44333333333333336,0.0,0.037677447047597123,0.07267302452237867,0.009349256989389043,0.499060427605139,0.9625978811059088,1,52217,NEG HIV 4TH GEN,HIV 1 AB WESTERN BLOT,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.03875,0.0,0.0,0.0,0.02,0.04,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,PROTHROMBIN TIME,PT POP MEAN,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CREATINE KINASE CK,CREATINE KINASE CK,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,CBC WITH PLT DIFF,PLATELET MORPHOLOGY,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,URINALYSIS,BACTERIA,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.2,0.14285714285714285,0.5,0.0,0.0,0.0,0.04873860645800243,0.0,0.0,0,7344,CBC PLATELET HEM REVIEW,LYMPHS ABSOLUTE,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,HCV RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,LYMPHOCYTE SUBSET PANEL 4,% CD8 SUPPRESSOR T CELLS,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.0125,0.025,0.14333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,COMP METABOLIC PANEL 14,EGFR IF AFRICN AM,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,MICROALBUMIN RANDOM,MICROALBUMIN CR RATIO,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,PROTEIN ELECTROPHORESIS SR W RFX,INTERPRETATION,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,FREE T4 THYROXINE,FREE T4,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.05747002207333629,0.0,0.0,0.0,0.0,0,539627,IFE PE SERUM,GAMMA GLOBULIN,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,CRP,C REACTIVE PROTEIN ULTRA,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,IMMUNOGLOBULINS,IMMUNOGLOBULIN G,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,SED RATE MODIFIED WESTERGREN MANUAL,SED RATE MODIFIED WESTERGREN MANUAL,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,GGT,GGT,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.04097329812432471,0.0,0,196444,AUTOIMMUNE HEPATITIS DIAG PNL,MITOCHONDRIAL AB SCREEN,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,APTT,PARTIAL THROMBOPLASTIN,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,BASIC METABOLIC PANEL,OSMOLALITY,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,UA W RFLX MICROSCOPIC,COLOR,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,BAND NEUTROPHILS,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.061769791070825475,0.0,0.0,0.0,0.0,0,195586,DRUG ABUSE SCREEN II,COCAINE METABOLITE,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,CBC WITH MANUAL DIFFERENTIAL,NEUTROPHILS,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,CMP12 LP TP TSH 6AC CBC D PLT,POTASSIUM,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.31,0.386,0.5514285714285714,0.31,0.386,0.5514285714285714,0.018565460848511406,0.0,0.0,0.020052989617607597,0.0,0.0,1,736553,HCV GT3 NS5A DRUG RESIST ASSAY,HCV NS5A DRUG RESIST ASSAY,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,TSH FREE T4 PROFILE,TSH THIRD GENERATION,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,HCV QUANT GT1A NS5A PROFILE,HCV LOG10,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,IMMUNOGLOBULIN A,IMMUNOGLOBULIN A,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,COMP METABOLIC PANEL,ALKALINE PHOSPHATASE,Globulin,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,RHEUMATOID FACTOR,RHEUMATOID FACTOR,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,ASH FIBROSURE,APOLIPOPROTEIN A 1,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,HEP B SURFACE AG W REFLEX CONFIRM,NEUTRALIZATION,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,COMPREHENSIVE METABOLIC PANEL WITH GFR,ANION GAP,Protein pattern,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,NGI HCV QUANTASURE,HEPATITIS C QUANTITATION,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,LYMPHOCYTE SUBSET PANEL 2,HELPER SUPPRESSOR RATIO,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,IMMUNODEF PROFILE #1,ABSOLUTE CD3,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,TRANSFERRIN SATURATION,TRANSFERRIN,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,HB CORE AB W IGM RFX,HB CORE AB TOTAL,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,CBC WITH AUTO DIFF,WBC,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,PROTHROMBIN TIME PT,PROTHROMBIN TIME PT,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.3333333333333333,0.2857142857142857,0.3333333333333333,0.0,0.42857142857142855,1.0,0.01431514145072288,0.08047871402076756,0.06069061312293911,0.0,0.6630243943799374,1.0,1,25007,IRON TIBC SERUM,IRON BINDING CAPACITY,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.0,0.0,0.43,0.2857142857142857,0.6666666666666666,0.0,0.0,0.0,0.0,0.11303021146914194,0.11491730374182318,1,20958,LIPID PANEL,HDL AS % CHOLESTEROL,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,URINALYSIS COMPLETE,GLUCOSE QL,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,HIV ANTIGEN ANTIBODY FOURTH GENERATION W RFL,HIV AG AB 4TH GEN,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,NASH FIBROSURE,APOLIPOPROTEIN A 1,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.10714285714285714,0.1875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,HEPATIC FUNCTION PANEL AMA,BILIRUBIN DIRECT,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.03571428571428571,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,CBC PLT DIFF,POLYS,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,PROTHROMBIN TIME PT,PT CONTROL,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,PROTIME PTT,PROTHROMBIN TIME PT,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,COMP METABOLIC PANEL 14,EGFR IF AFRICN AM,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,CBC WITH PLT DIFF,EOSINOPHILS ABSOLUTE,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.07142857142857142,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,CBC INCLUDES DIFF PLT,BAND NEUTROPHILS,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,CMP CBC TSH,ABSOLUTE BLASTS,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,ANA TITER PATTERN,ANA PATTERN,Body weight,Body weight Measured,Weight Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,LIPOPROTEIN ANALYSIS NMR,LDL P,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,CMP14 CBC D PLT ESR WES ANA,LYMPHS ABSOLUTE,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.15,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0769055150490483,0.0,0,169334,AFP WITH AFP L3%,AFP SERUM,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,CHEM SCREEN PANEL,EGFR NON AFR AMERICAN,Eosinophils,Eosinophils [#/volume] in Blood,Eosinophil # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,HEPATIC FUNCTION PANEL,ALT,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,PTT,PTT,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.11,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,SPECIAL A 2 PANEL #9633,POLYS,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,LEUKEMIA LYMPHOMA EVALUATION,SPECIMEN TYPE,Body weight,Body weight Measured,Weight Measured
0.24333333333333332,0.0,0.0,0.0,0.0,0.0,0.0,0.10397655791204363,0.1063004130698838,0.0,0.0,0.0,0,28902,PROTEIN ELECTRO S,ALPHA 1 GLOBULIN,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,HEP B SURFACE AG W REFLEX CONFIRM,NEUTRALIZATION,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.2,0.6675,0.89,0.0,0.5425,0.7233333333333333,0.028106640914180137,0.17714757965778338,0.13145234425661956,0.0,0.1524643612967882,0.11313616447240271,1,519132,HEPATITIS A TOTAL AB REFLEX IGM,HEPATITIS A TOTAL AB,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,BILIRUBIN PANEL,BILIRUBIN INDIRECT,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.1425,0.2,0.0,0.25,0.2,0.0,0.0,0.008275315747042211,0.0,0.0525901062858295,0.0,0.0,0,143149,URINE MICROALBUMIN CREAT RATIO,UR MICROALBUMI,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,CBC W DIFF PLT,PLATELET SUFFICIENCY,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,HIV ANTIGEN ANTIBODY FOURTH GENERATION W RFL,HIV AG AB 4TH GEN,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,URINALYSIS WITH MICROSCOPIC,EPITHELIAL CELLS,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,MANUAL DIFFERENTIAL,EOSINOPHILS ABSOLUTE,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,MANUAL DIFFERENTIAL,TOTAL NEUTROPHILS %,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,HCV RNA QN REAL TIME PCR W RFX QL T,HCV RNA PCR QN,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.3244444444444444,0.584,0.0,0.3244444444444444,0.584,0.0,0.24382465393798014,0.2536246857486273,0.0,0.24382465393798014,0.2536246857486273,1,539627,A FETOPROTEIN TUMOR MARKER,A FETOPROTEIN TUMOR MARKER,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,CBC WITH ABSOLUTE NEUTROPHIL COUNT,PLATELET COUNT,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.0,0.0,0.26,0.2,1.0,0.0,0.0,0.0,0.0,0.05111799204302647,0.1503314858492919,1,20933,CMP13 LP TP TSH 2AC CBC D P,CHOLESTEROL TOTAL,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.16666666666666666,0.5,0.0,0.16666666666666666,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,CARDIO CRP R,CARDIO CRP R,Protein pattern,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp
0.0,0.0,0.0,0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,BASIC METABOLIC PANEL,UREA NITROGEN BLOOD BUN,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,HGB A1C WITH EAG ESTIMATION,HEMOGLOBIN A1C,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,IRON PANEL,IRON,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0625,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,CBC INC DIFF PLT,MONOCYTES,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,CBC WITH PLT DIFF,VARIANT LYMPHOCYTES ABSOLUTE,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,ALBUMIN CREATININE RATIO RANDOM URINE,CALC ALBUMIN CREAT RND,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,DRUG ABUSE SCREEN CLINICAL 9,COCAINE,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,PROTHROMBIN TIME,INR,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.08,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,PROTHROMBIN TIME,PT POP MEAN,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.125,0.3333333333333333,0.0,0.25,0.3333333333333333,0.0,0.0,0.0,0.0,0.06192203894113468,0.0,0,28688,AFP WITH AFP L3%,AFP SERUM,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,ALPHA 1 ANTITRYPSIN PHENOTYPE,ALPHA 1 ANTITRYPSIN,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,CBC WITH DIFFERENTIAL,NO CELLS DIFF,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,CMP14 LP 3AC CBC D PLT,LYMPHS,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,URINALYSIS W REFLEX MICRO,BACTERIA,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.29333333333333333,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.14397756228354264,1.0,1,19752,LIVER FIBROSIS FIBROTEST ACTITEST,BILIRUBIN,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,CBC DIFF PLT,MCH,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,PROTIME PTT,PROTHROMBIN TIME PT,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,MITOCHONDRIAL M2 AB,MITOCHONDRIAL M2 AB,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,UA W RFLX MICROSCOPIC,COLOR,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.07142857142857142,0.0,0.4375,0.2857142857142857,1.0,0.0,0.0,0.0,0.0,0.10343053687972403,0.17358784764553015,1,134585,LIPID PANEL W CHOL HDL RATIO,VLDL CHOLESTEROL CAL,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.4,0.18181818181818182,0.25,0.0,0.0,0.0,0.04802835732051414,0.11003603894321656,0.12851200387967032,1,542183,LYMPHOCYTE SUBSET PANEL 3,CD4 CD8 RATIO,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,COMPREHENSIVE METABOLIC PANEL E GFR,CALCULATED A G RATIO,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,B12,VIT B12 SERUM,Prothrombin.activity actual/Normal,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP
0.0,0.0,0.0,0.4,0.41714285714285715,0.6666666666666666,0.0,0.0,0.0,0.07392279148774428,0.19825373455330964,0.12411615637026996,1,81232,LYMPHOCYTE SUBSET PANEL 2,% CD4 HELPER CELLS,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,PSA FREE TOTAL,INTERNAL %,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,ACTIVATED PTT,ACTIVATED PTT PATIENT,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,AFP TUMOR MARKER SIEMENS CLIA,AFP TUMOR MARKER SIEMENS CLIA,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,ALBUMIN CREATININE RATIO RANDOM URINE,CALC ALBUMIN CREAT RND,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,ACCUTYPE R IL28B,ACCUTYPE R IL28B,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,HCV GT3 NS5A DRUG RESIST ASSAY,HCV NS5A DRUG RESIST ASSAY,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,FIBROACT,NECROINFL SCORE,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.25,0.2,0.25,0.0,0.0,0.0,0.0746172002260781,0.0,0.0,1,349993,CBC WITH DIFFERENTIAL PLATELETS,POLYS,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,CBC WITH MANUAL DIFFERENTIAL,MCHC,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.2,0.4,0.6666666666666666,0.2,0.4,0.3333333333333333,0.007635905779136087,0.36555680528551404,0.4582002501529394,0.007806566737586396,0.37372692636381444,0.46844093359181893,1,178566,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.06666666666666667,0.044444444444444446,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,CLR CBC W DIFF PLT,ABSOLUTE EOSINOPHILS,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,TSH RFLX FT4,TSH RFLX FT4,Erythrocytes,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,CARDIO CRP R,CARDIO CRP R,Age,Age,Age
0.0725,0.08,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCV,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,MICROALBUMIN CREATININE RATIO,MICROALBUMIN RAN 24HR,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,ANA SCR IFA RFL TITR PATT,ANA SCREEN IFA,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,PSA FREE TOTAL,PSA FREE,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,PSA TOTAL % FREE SERIAL,% FREE PSA,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,COMP METABOLIC PANEL W GFR,CHLORIDE,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,PE FLC SERUM,ALBUMIN,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B RESIST ASSAY INTERP,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,ACUTE HEPATITIS PANEL,HEPATITIS A AB IGM,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,PSA FREE TOTAL,PSA FREE,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,URINALYSIS,BACTERIA,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,COMP METABOLIC PANEL,GLUCOSE NON FASTING,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.050279195957160794,0.0,0.0,0.0,0.0,0,264531,CBC WITH ABSOLUTE WHITE BLOOD CELLS,WBC,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,HCV FIBROSURE,LIMITATIONS,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,HCV GENOSURE R NSA,HCV GENOSURE R NSA,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,ANA SCR IFA RFL TITR PATT,ANA SCREEN IFA,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,CBC W AUTO DIFF,HGB,Reference lab test method,Reference lab test method,Ref lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,COMP METABOLIC PROFILE FASTING CMP,BUN CREATININE RATIO CALC,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,CBC W DIFF PLT,PLATELET SUFFICIENCY,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,TSH FT4,FREE T4,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.15,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.04801993258748538,0.0,0,130682,IRON BINDING CAPACITY % SATURATION,IRON SERUM,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,CBC DIFF AMBIGUOUS DEFAULT,NEUTROPHILS,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.16,0.0,0.1675,0.192,0.96,0.0,0.07132561100505608,0.0,0.0,0.0,0.0,1,193433,DRUG ABUSE SCREEN I,AMPHETAMINES,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,HEMOGLOBIN A1C,ESTIMATED AVG GLUCOSE,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,HEMATOPATH CONSULTATION SMEAR,WBC,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,CBC WITH DIFFERENTIAL PLATELETS,MCH,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,HEPATITIS B SURFACE ANTIBODY,HEPATITIS B SURFACE AB QUAL,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.2866666666666667,0.172,0.0,0.2866666666666667,0.172,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,121855,PROTIME PTT,PTT,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,URINALYSIS WITH MICROSCOPIC,GLUCOSE,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,HEPATITIS C GENO TYPE 1 NS5A RESIST,OMBITASVIR RESISTANCE,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,PROSTATE SPECIFIC ANTIGEN PSA,PSA,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,CMP WITH ESTIMATED GFR CALCULATED,CARBON DIOXIDE,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,CBC,MO%,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.124,0.3333333333333333,0.0,0.19,0.16666666666666666,0.3333333333333333,0.0,0.036761239048585526,0.0,0.0,0.06444628140908037,0.0946521642027649,1,7138,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,EOSINOPHILS #,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,CBCI COMPLETE BLOOD COUNT W DIFF,LYMPHOCYTES,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,GLU RFX HA1C IF ABN,GLU RFX HA1C IF ABN,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.14285714285714285,0.0,0.27999999999999997,0.0,0.0,0.0,0.0633130619441763,0.0,0.0,0.0,0.0,1,333583,IFE PE SERUM,M SPIKE,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,IMMUNOFIXATION SERUM,IMMUNOGLOBULIN M,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,COMPLEMENT COMPONENT C4C,COMPLEMENT COMPONENT C4C,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,CBCI COMPLETE BLOOD COUNT W DIFF,MCV,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.235,0.2571428571428572,0.45,0.33499999999999996,0.1142857142857143,0.2,0.0,0.12507382086168062,0.15945061960482576,0.0,0.05896036458680387,0.07516574292464595,1,327692,ALPHA 1 ANTITRYPSIN PHENOTYPE,A 1 ANTITRYPSIN PHENOTYPE,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,LIVER FIBROSIS FIBROTEST ACTITEST,BILIRUBIN,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,PTH INTACT MOLECULE,PTH,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,NASH FIBROSURE,ALT SGPT P5P,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,PROTEIN ELECTROPHORESIS SERUM,BETA,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,DRUG ABUSE SCREEN II,OPIATES,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,CBC W O DIFF WITH PLATELETS,MCV,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,HEPASCORE R,SEX,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,CMP14 HP4 DBILI CBC D PLT R,C REACTIVE PROTEIN QUANT,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.14285714285714285,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,326231,CBC WITH PLT DIFF,MPV,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,COMPREHENSIVE METABOLIC PANEL,OSMOLALITY,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,CBC WITH AUTO DIFF,EOSINOPHILS ABSOLUTE,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.22999999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,IMMUNOGLOBULINS IGG A M SER,IMMUNOGLOBULIN A,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,LIPID PROFILE WITH CALC NON HDL CHOLESTEROL,RISK RATIO LDL HDL,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,PROTEIN ELECTRO S,GAMMA GLOBULIN,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,TSH FT4,TSH,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,CBC RBC H H INDICES WBC PLT,RED BLOOD CELL COUNT,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.04833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,LYMPHOCYTES,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,HEMOGLOBIN A1C EAG,HEMOGLOBIN A1C,Color,Color of Urine,Color Ur
0.0,0.0375,0.15,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,IFE PE SERUM,GLOBULIN TOTAL,pH,pH of Urine by Test strip,pH Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,LIPID PNL W REFL TRIG>400,CHOLESTEROL HDL RATIO,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,TRICHOMONAS MALE,SOURCE,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,URINALYSIS REFLEX,GLUCOSE QL,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.0,0.2,0.0,0.0,0.2,0.0,0.0,0.05111799204302647,0.0,0.0,0.05111799204302647,0.0,0,24984,TESTOSTERONE SERUM,TESTOSTERONE SERUM,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.07142857142857142,0.0,0.0,0.07142857142857142,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,HEMOGLOBIN A1C,HEMOGLOBIN A1C,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.2,0.16666666666666666,0.0,0.0,0.0,0.0,0.009413595328285118,0.0075011219466417645,0.0,0.0,0.0,0.0,0,7492,MANUAL DIFFERENTIAL,SEGMENTED NEUTROPHILS %,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,ALBUMIN CREATININE RATIO URINE RANDOM,CALC ALBUMIN CREAT RND,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.04833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,MANUAL DIFFERENTIAL,EOSINOPHILS %,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.182,0.2857142857142857,0.4,0.0,0.16428571428571428,0.22999999999999998,0.0,0.07274965833441249,0.09817530073017477,0.0,0.0,0.0,0,728626,HEPATITIS PANEL 4,HEP B CORE AB IGM,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.04125,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,URINALYSIS W REFLEX MICRO,RED BLOOD CELLS,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,CYCLIC CITRULLINATED PEPTIDE CCP AB IGG,CYCLIC CITRULLINATED PEPTIDE CCP AB IGG,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,BASIC METABOLIC PANEL,UREA NITROGEN BLOOD BUN,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.25,0.2,0.3333333333333333,0.0,0.0,0.0,0.033955663578360995,0.04983141571783456,0.05851014153708933,1,112821,CBC WITH DIFFERENTIAL,NO CELLS DIFF,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,ALBUMIN CREATININE RATIO RANDOM URINE,CALC ALBUMIN CREAT RND,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN RT PCR LOG COPIES ML,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,URINALYSIS,BILIRUBIN,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,BMP8 EGFR,POTASSIUM,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,MICROALBUMIN RANDOM,MICROALBUMIN CR RATIO,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,BMP,C02 BICARBONATE,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,TRANSFERRIN,TRANSFERRIN,Ceruloplasmin,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,CMP13 LP 2AC CBC D PLT,EGFR IF AFRICN AM,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,URINALYSIS COMPLETE,APPEARANCE,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,ANTI SMOOTH MUSCLE MITOCHOND,MITOCHONDRIAL M2 ANTIBODY,Monocytes,Monocytes [#/volume] in Blood,Monocytes # Bld
0.0,0.14285714285714285,0.0,0.33399999999999996,0.2857142857142857,1.0,0.0,0.0778627478619458,0.0,0.04215892569416535,0.1907240022327492,1.0,1,28746,IFE PE SERUM,GAMMA GLOBULIN,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,CBC WITH PLT DIFF,BLASTS,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.2857142857142857,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,HCV FIBROSURE,LIMITATIONS,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,FIBROACT,NECROINFL SCORE,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,DIRECT LDL,DIRECT LDL,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,CBC INC DIFF PLT,PLATELET COUNT,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,PTT,PTT,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,HEMOGLOBIN A1C,MEAN GLUCOSE EST,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.158,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,CMP14 LP CBC D PLT TSH UA M,AST SGOT,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,CULTURE ROUTINE,CULTURE ROUTINE,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,MITOCHONDRIAL ANTIBODY W REFL TITER,MITOCHONDRIAL AB SCREEN,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,MPV,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,TSH FREE T4 PROFILE,TSH THIRD GENERATION,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,DRUG ABUSE SCREEN III,COCAINE METABOLITE,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.01,0.035,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,COMPREHENSIVE METABOLIC PANEL,GLUCOSE,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,HEPATITIS B SURFACE ANTIBODY,HEPATITIS B SURFACE ANTIBODY,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,ASH FIBROSURE,COMMENT,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,CBC W AUTO DIFF,BASOPHILS ABSOLUTE,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,HIV AG AB 4TH GEN RFL,RACE NR,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,CBC WITH AUTO DIFF,HEMATOCRIT,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.25,0.2,0.0,0.25,0.2,0.0,0.0,0.07847871077409985,0.0,0.0,0.07847871077409985,0.0,0,311472,AMYLASE SERUM,AMYLASE SERUM,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,CBC WITH AUTO DIFF,BASOPHILS %,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,CREATINE KINASE TOTAL,CREATINE KINASE TOTAL,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.072,0.05142857142857143,0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,COMPREHENSIVE METABOLIC PANEL REFL,UREA NITROGEN BUN,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,ASH FIBROSURE,AST SGOT P5P,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,VITAMIN D 25 OH LCMSMS W REFLEX,VITAMIN D 25 OH D3,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,HB S AG W REFLEX CONF,HB S AG,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,RPR HBSAG HCVAB HSV1 HSV2 I,HEP C VIRUS AB,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,CMP,BUN,Color,Color of Urine,Color Ur
0.0,0.34285714285714286,0.48,0.0,0.34285714285714286,0.48,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,HCV GENOSURE R NSA,HCV GENOSURE R NSA,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,CBC WITH PLT DIFF,RBC MORPHOLOGY,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.08833333333333333,0.0,0.0,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,PLATELET ESTIMATION,PLATELET ESTIMATION,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,CBC WITH DIFFERENTIAL,NO CELLS DIFF,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,AMY LIPASE,AMYLASE,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,HCV FIBROSURE,LIMITATIONS,Hemoglobin,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,DRUG ABUSE SCREEN W ETOH NO GCMS,BARBITURATES,Erythrocyte morphology finding,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,COMP METAB PANEL,ALBUMIN GLOBULIN RATIO,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.09247447620418048,0.34003516797720323,1.0,1,23457,BASIC METABOLIC PANEL AMA,GLUCOSE,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.5,0.352,1.0,0.0,0.0,0.0,0.09322033388114626,0.0983573569202505,0.7071067811865476,1,108340,COMPREHENSIVE METABOLIC PANEL E GFR,CALC GLOBULIN,Globulin,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,BILIRUBIN DIRECT,DIRECT BILIRUBIN,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,CBCM COMPLETE BLOOD CNT W MAN DIFF,EOSINOPHILS,Globulin,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,LD,LD,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,CBC WITH ABSOLUTE WHITE BLOOD CELLS,RDW,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.3333333333333333,0.4,0.8,0.3333333333333333,0.4,0.8,0.3222721996715985,0.5931645460412418,0.8484814328311875,0.326391495961589,0.6007463992583407,0.8593267568211221,1,51938,HEPATITIS B SURFACE AB QUANT,HEPATITIS B SURFACE AB,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,PROTHROMBIN TIME PT,PROTHROMBIN TIME PT,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,CBC PLATELET HEM REVIEW,EOS ABSOLUTE VALUE,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,VELPATASVIR RESISTANCE,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,PROTHROMBIN TIME,INR,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,CMP12 LP TP TSH 6AC CBC D PLT,POTASSIUM,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,CBC DIFF AMBIGUOUS DEFAULT,NEUTROPHILS,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,TESTOSTERONE FREE LC MS MS,TESTOSTERONE FREE LC MS MS,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,PROTIME INR F,PT,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B DRUG RESISTANCE ASSAY,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE CD4,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,CCP ANTIBODY IGG,ANTI CCP IGG,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,URINALYSIS CULTURE IF INDICATED,WHITE BLOOD CELLS,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.0,0.0,0.0,0.39999999999999997,0.42857142857142855,0.5333333333333333,0.0,0.0,0.0,0.0,0.41219810878268626,0.4228537636689047,1,433961,LIPID PANEL AMA,NON HDL CHOLESTEROL,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,URIC ACID,URIC ACID,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,MANUAL DIFFERENTIAL,EOSINOPHILS %,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,HNK1 CD57 PANEL,LYMPHS ABSOLUTE,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.1416666666666667,0.42500000000000004,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,HP4 RPR,HEP C VIRUS AB,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,LIPID PANEL WITH LDL HDL RATIO,HDL CHOLESTEROL,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0825,0.08833333333333333,0.0,0.3225,0.16666666666666666,1.0,0.0,0.0,0.0,0.07097576385288318,0.09716253076254433,1.0,1,204057,URINALYSIS W REFLEX MICRO,UROBILINOGEN,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,CBC WITH PLT DIFF,NO CELLS DIFF,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,CMP12 LP TP TSH 6AC CBC D PLT,BILIRUBIN TOTAL,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.047142857142857146,0.066,0.08,0.05714285714285715,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,COMPLETE BLOOD COUNT,NEUTROPHILS ABSOLUTE,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,ANA TITER PATTERN,ANA PATTERN,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,CBC W AUTO DIFF,ABS NEUTROPHILS,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,UA W RFLX MICROSCOPIC,COLOR,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,CBC WITH ABSOLUTE WHITE BLOOD CELLS,RDW,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,NMR LIPOPROFILE,LDL P,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,LIPID PANEL,CALC LDL CHOL,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,LIVER FIBROSIS PNL HEPASCORE TM,METAVIR SCORE,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,MICROALBUMIN RANDOM,MICROALBUMIN RANDOM,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.02,0.028571428571428574,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,CMP14 5AC,BILIRUBIN TOTAL,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,CMP14 2AC MG,EGFR IF NONAFRICN AM,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.05747002207333629,0.0,0.0,0.0,0.0,0,539627,PE FLC SERUM,ALBUMIN,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,CBC W AUTO DIFF,ABS BASOPHILS,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,TSH,TSH,Hemoglobin,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,VITAMIN D 25 OH TOTAL,VITAMIN D 25 OH TOTAL,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,CBC DIFF PLT,MONOCYTES %,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.12,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,HCV FIBROSURE LABCORP,RESULT,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.4,0.5171428571428571,0.6666666666666666,0.0,0.0,0.0,0.07351377561058281,0.18661673850657123,0.09866725380717944,1,81018,LYMPHOCYTE SUBSET PANEL 2,% CD8 SUPPRESSOR T CELLS,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,CREATINE KINASE TOTAL,CREATINE KINASE TOTAL,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,HIV ANTIBODY 1 WESTERN BLOT,HIV WB INTERP,Globulin,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc
0.0,0.0165,0.03666666666666667,0.0,0.05,0.0,0.0,0.0,0.0,0.0,0.023665613663347074,0.0,0,882936,URINALYSIS W REFLEX MICRO,OCCULT BLOOD,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,TRANSFERRIN SATURATION,TRANSFERRIN,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.22,0.16666666666666666,0.5,0.0,0.0,0.0,0.0,0.05660928660351461,0.5773502691896257,1,151522,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,UA MICROSCOPIC REFLEX CULTURE,RED BLOOD CELLS,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,BASIC METABOLIC PANEL 8,EGFR IF AFRICN AM,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,RPR SCREEN W TITER,RPR SCREEN,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE CD4,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,IMMUNOGLOBULINS,IMMUNOGLOBULIN M,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,HEMOGLOBIN A1C,ESTIMATED AVG GLUCOSE,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,HEPATITIS ABC PANEL,HEPATITIS A ANTIBODY TOTAL,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.032629011509134775,0.03317376812494377,0.0,0.0,0.0,0,98301,IRON TOTAL IRON BIND CAPACITY,TIBC,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.1111111111111111,0.2,0.0,0.1111111111111111,0.2,0.0,0.014173192852829697,0.010598761837280257,0.0,0.014173192852829697,0.010598761837280257,0,339358,HAV AB TOTAL,HAV AB TOTAL,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,CMP WITH ESTIMATED GFR CALCULATED,FASTING NON FASTING,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,CBC INCLUDES DIFF PLT,ABSOLUTE BLASTS,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.0,0.0,0.5466666666666667,0.2857142857142857,0.3333333333333333,0.0,0.0,0.0,0.0,0.41731829815125243,0.41364362208294236,1,98301,LIPID PANEL STANDARD,CHOLESTEROL HDL RATIO,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,IMMUNODEF PROFILE #1,ABSOLUTE CD3,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,BASIC METABOLIC PANEL AMA,GLUCOSE,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,ANA SCREEN IFA,ANA SCREEN IFA,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,HEPATITIS C ANTIBODY,HEPATITIS C ANTIBODY,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.19999999999999998,0.27999999999999997,0.0,0.0,0.0,0.0,0.05557781728487099,0.14099568413003705,0.0,0.0,0.0,0,487967,COMP METABOLIC PANEL,ALKALINE PHOSPHATASE,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,PROFILE 104 LIVER,AST SGOT,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,FIBROSIS SCORE,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.0672790962344263,0.051758104169687846,0.7071067811865476,1,7534,CBC PLATELET HEM REVIEW,NEUTROPHILS ABSOLUTE,Neutrophils,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,PROTEIN ELECTRO SERUM,ALPHA 2 GLOBULIN,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.06666666666666667,0.0,0.0,0.125,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.08539469110668363,0.0,0,241109,FE CBC D PLT TIBC FER B12 F,FERRITIN SERUM,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.06713496212611103,0.0,0.0,1,66902,CBC INCLUDES DIFF PLT,INTERNAL WBC,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.047,0.15666666666666665,0.0,0.047,0.15666666666666665,0.0,0.35622065033847605,0.9888882125258499,0.0,0.35622065033847605,0.9888882125258499,1,305227,C REACTIVE PROTEIN CARDIAC,C REACTIVE PROTEIN CARDIAC,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,1,305250,LIVER FIBRO HEPSCORE R,AGE,Age,Age,Age
0.0,0.0,0.0,0.0,0.044444444444444446,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,CBC WITH PLT DIFF,BANDS ABSOLUTE,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,LIVER FIBROSIS PANEL,ALT,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,HEPATITIS A IGM,HEPATITIS A IGM,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.0,0.48857142857142855,0.6839999999999999,0.0,0.0,0.0,0.0,0.09554712567689871,0.5929029680469197,0,223149,HP4 RPR,HEP C VIRUS AB,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,HB S AG W REFLEX CONF,HFLAG NR,Appearance,Appearance of Urine,Appearance Ur
0.2,0.0,0.0,0.33399999999999996,0.0,0.0,0.03255480898950336,0.0,0.0,0.03255480898950336,0.0,0.0,0,57992,HEPATITIS BS AB QL,HEPATITIS B SURF AB QL,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD8 CELLS,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,LIPID CASCADE W RFLX APOLIB,LDL HDL RATIO,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,COMP METABOLIC PANEL,GLUCOSE NON FASTING,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,PROTIME INR F,PT,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0,20933,IGG SUBCLASSES,IMMUNOGLOBULIN G QN SERUM,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B RESIST ASSAY INTERP,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,HBSAB AG,HEP B SURFACE AB QUAL,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,CBC WITH AUTO DIFF,BASOPHILS ABSOLUTE,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,HEPATITIS B CORE IGM ANTIBODY,HEP B CORE IGM ANTIBODY,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,LYMPHOCYTE SUBSET PANEL 4,RACE NR,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,HCV FIBROSURE RESULTS,FIBROSIS STAGE,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0,0.0,0.2783333333333333,0.4488888888888889,0.6733333333333333,0.0,0.0,0.0,0.01134702515129804,0.27088019091696647,0.4476947053485614,1,481598,HP4 RPR,HEP C VIRUS AB,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.0,0.0,0.0,0.0,0.022222222222222223,0.04,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,CBC,% BASOPHILS,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,DRUG ABUSE SCREEN III,AMPHETAMINES,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,HCV GENOSURE R NSA,HCV GENOSURE R NSA,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,CBC WITH PLT DIFF,LYMPHOCYTES ABSOLUTE,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.43,0.14333333333333334,0.0,0.43,0.14333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,149799,PTT,PTT,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,ALKALINE PHOSPHATASE,LIPEMIA,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,URINALYSIS W REFLEX MICRO,EPITHELIAL CELLS,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.4175,0.18142857142857144,0.0,0.6675,0.3242857142857143,0.0,0.019765492370202753,0.0,0.0,0.061241138223508074,0.059062741744354885,0.0,1,19901,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D3,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,CREATINE KINASE TOTAL,CREATINE KINASE TOTAL,Age,Age,Age
0.0825,0.10600000000000001,0.0,0.5,0.2,1.0,0.0,0.0,0.0,0.1079337582384392,0.06903090216751562,0.7071067811865476,1,254284,URINALYSIS COMPLETE,GLUCOSE QL,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,CMP14 LP 3AC CBC D PLT,LYMPHS,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD8 CELLS,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,CMP14 HP4 DBILI CBC D PLT R,EOS ABSOLUTE,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,CMP14 LP 1AC CBC D PLT TSH,LYMPHS,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,RHEUMATOID FACTOR RF,RHEUMATOID FACTOR RF,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.009471207323415887,0.03344496038217104,0.09835735692025038,0.043063913198325254,0.1520683500675173,0.447213595499958,0,17517,ALBUMIN CREATININE RATIO RANDOM URINE,CALC ALBUMIN CREAT RND,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,TESTOSTERONE,TESTOSTERONE,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0775,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,ACUTE HEPATITIS PANEL,HEPATITIS B SURF AG,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.25,0.3333333333333333,0.6,0.25,0.3333333333333333,0.6,0.034234837021806186,0.14931149721468506,0.15531276656446735,0.034234837021806186,0.14931149721468506,0.15531276656446735,1,539627,AFP TUMOR MARKER,AFP TUMOR MARKER,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.075,0.05555555555555555,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,CBC WITH PLT DIFF,NUCLEATED RBCS,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,ANA SCREEN IFA,ANA SCREEN IFA,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,CMP12 LP TP TSH 6AC CBC D PLT,BILIRUBIN TOTAL,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.16666666666666666,0.1111111111111111,0.2,0.16666666666666666,0.1111111111111111,0.2,0.0341255995762636,0.055446852762574106,0.07759701258884111,0.0341255995762636,0.055446852762574106,0.07759701258884111,1,139527,HBC AB TOTAL,HBC AB TOTAL,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.15,0.125,0.0,0.15,0.125,0.0,0.0,0.09336497228411789,0.0,0.0,0.09336497228411789,0.0,0,519132,MAGNESIUM SERUM,MAGNESIUM SERUM,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.025569947555028505,0.0,0.0,0.0,0.0,0,59055,COMPLETE BLOOD COUNT,MEAN PLATELET VOLUME,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,HEPATITIS B CORE IGM ANTIBODY,HEP B CORE IGM ANTIBODY,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,BUN CREATININE,EGFR AFRICAN AMERICAN,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,LIVER FIBROSIS PNL HEPASCORE TM,METAVIR SCORE,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,CMP14 HP4 DBILI CBC D PLT R,EOS ABSOLUTE,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.2,0.25,0.3333333333333333,0.0,0.0,0.0,0.042948774079294316,0.12793683685842472,0.06205807818513498,0,244673,URINALYSIS W REFLEX MICRO,WHITE BLOOD CELLS,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.06222222222222223,0.11200000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,DRUG SCREEN AUSTIN 20,PHENCYCLIDINE,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,CBC W AUTO DIFF,MCHC,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.1416666666666667,0.42500000000000004,0.0,0.1416666666666667,0.42500000000000004,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,HCV RNA PCR QN RFX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,PTH INTACT,PARATHYROID HORMONE INTACT,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,HEPATIC FUNCTION PANEL,INDIRECT BILI,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,IRON BINDING CAPACITY % SATURATION,IRON SERUM,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,CBC WITH AUTO DIFF,MCV,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,UREA NITROGEN BUN,HEMOLYSIS,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.02,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,FIBROACT COMPLETE,HEIGHT INCHES,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,IRON TIBC,UIBC,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE NEUTROPHILS,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.22333333333333336,0.2,1.0,0.0,0.0,0.0,0.0,0.34003516797720323,1.0,1,21600,BMP8 CBC D PLT,CREATININE,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.2,0.2857142857142857,0.5,0.0,0.0,0.0,0.05340417440283707,0.1550846958164558,0.12872694659872408,0.0,0.0,0.0,0,333583,PROTEIN ELECTROPHORESIS,GAMMA GLOBULINS,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.06290250689706056,0.0,0.0,1,58214,CMP14 LP 5AC CBC D PLT RPR,WBC,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,LYMPHOCYTE SUBSET PANEL 2,% CD3 MATURE T CELL,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,DIFFERENTIAL MANUAL,ABSOLUTE BAND NEUTROPHILS,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.124,0.1357142857142857,0.475,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,LYMPHOCYTE SUBSET PANEL 2,% CD3 MATURE T CELL,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,HEPATITIS B SURFACE AB,HEPATITIS B SURFACE AB,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,PROTHROMBIN TIME,PT POP MEAN,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.07142857142857142,0.16666666666666666,0.0,0.07142857142857142,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,RPR REFLEX TITRE TPPA,RPR,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.03333333333333333,0.125,0.0,0.022000000000000002,0.0825,0.0,0.03210415570861036,0.0,0.0,0.0,0.0,0,426171,CBC WITH PLT DIFF,NO CELLS DIFF,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,ANEMIA PROFILE B,UIBC,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,IRON TOTAL IRON BIND CAPACITY,TIBC,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.03720807791980296,0.0,0,7138,URINALYSIS CULTURE IF INDICATED,WHITE BLOOD CELLS,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.08,0.08571428571428573,0.12000000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,CBC W AUTO DIFF,BASOPHILS ABSOLUTE,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,HEPATITIS B SURFACE ANTIBODY,HEPATITIS B SURFACE AB QUAL,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,COMPREHENSIVE METABOLIC PANEL E GFR,ALBUMIN,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.08333333333333333,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,ACUTE HEPATITIS PANEL,HEPATITIS B SURF AG,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,CMP WITH EGFR,ANION GAP,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.22,0.265,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,UA M W RFLX CULTURE COMP,WBC,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,LIPID CASCADE W RFLX APOLIB,LDL HDL RATIO,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.11,0.16166666666666665,0.44,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,UA MICROSCOPIC REFLEX CULTURE,SPECIFIC GRAVITY,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,CBC W AUTO DIFF WITH PLATELETS,RBC,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCV,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,HP4 RPR,HEP C VIRUS AB,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.1,0.0,0.2,0.125,0.5,0.0,0.023655944701665654,0.0,0.05623518965539054,0.07096783410499707,0.7071067811865476,1,196444,DRUG ABUSE SCREEN 11 W ETOH W CONF,OXYCODONE,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.15,0.14285714285714285,0.0,0.15,0.14285714285714285,0.0,0.0,0.04612090043126471,0.0,0.0,0.04612090043126471,0.0,0,632117,AMYLASE SERUM,AMYLASE SERUM,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.18666666666666668,0.2,1.0,0.18666666666666668,0.2,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,25718,TRIGLYCERIDES REFL,TRIGLYCERIDES,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BARBITURATES,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,CBC WITH DIFFERENTIAL,NEUTROPHILS,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,BASIC METABOLIC PANEL,OSMOLALITY,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,MICROALBUMIN CREATININE RATIO,MICROALBUMIN RAN 24HR,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.2,0.0,0.22333333333333336,0.4,0.6666666666666666,0.0,0.014350566291898903,0.0,0.0,0.05336825693147673,0.05352091133427317,1,111252,CBCI COMPLETE BLOOD COUNT W DIFF,PLT MORPHOLOGY,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.072,0.05142857142857143,0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,COMPREHENSIVE METABOLIC PANEL,GLUCOSE,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,PTH INTACT MOLECULE,PTH,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D3,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.0,0.028571428571428574,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,SMN1 COPY NUMBER ANALYSIS,SPECIMEN TYPE,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,LIPID CASCADE W RFLX APOLIB,LDL HDL RATIO,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,CMP14 CBC D PLT RPR UA TSH,NEUTROPHILS ABSOLUTE,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,428102,CBC WITH DIFFERENTIAL PLATELETS,MCH,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,CBC H H RBC INDICES WBC PLT,PLATELET COUNT AUTO,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,ANA SCR W RFL T P LUPUS 1,ANA PATTERN,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.0,0.0,0.5,0.5,1.0,0.0,0.0,0.0,0.12460215794786256,0.16901735079974012,1.0,1,330373,COMP METABOLIC PANEL W GFR,ANION GAP,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,NASH FIBROSURE,WEIGHT,Leukocyte morphology finding,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,DRUG ABUSE PANEL 10 WITH OXYCODONE,BENZODIAZEPINES,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.38166666666666665,0.47,0.6466666666666666,0.2783333333333333,0.5,0.3333333333333333,0.006381169499897754,0.09741942006693138,0.961483307801868,0.03275101358391164,1.0,0.1986458339579933,1,487959,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,FIBROSIS SCORE,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,ACCUTYPE R IL28B NY,IL28B GENOTYPE,Body weight,Body weight Measured,Weight Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,HEPATITIS BS AB QL,HEPATITIS B SURF AB QL,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,ASH FIBROSURE,AST SGOT P5P,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,CMP,BUN,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,URIC A ESR WES ANA RA QN CC,URIC ACID,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,FE ANA TIBC FER PTT PT A1A,MITOCHONDRIAL M2 ANTIBODY,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,IRON PANEL,IRON,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.2375,0.25,0.3333333333333333,0.0,0.0,0.0,0.0,0.08253790759907542,0.0946521642027649,1,264507,CBC WITH MANUAL DIFFERENTIAL,EOSINOPHILS,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.06,0.18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,BASIC METABOLIC PANEL,ANION GAP,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,URINALYSIS,PH,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.5,0.16666666666666666,0.2,0.0,0.0,0.0,0.11136168435129556,0.05936451274361987,0.17946985244079683,1,63016,PT PROTIME,INR,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,CBC WITH PLT DIFF,NRBC,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.06538932921065,0.24044117311858715,0.7071067811865476,0.09247447620418048,0.34003516797720323,1.0,1,24984,IRON PANEL,IRON,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,HEPATIC FUNCTION PANEL,ALBUMIN,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.24,0.39999999999999997,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,HCV FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,RPR,RPR QUANT,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,CBC WITH DIFFERENTIAL,NO CELLS DIFF,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,CREATININE,EGFR IF AFRICN AM,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,CBC WITH PLT DIFF,BLASTS,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.0691807192705608,0.0556189409485538,0.10240603634159506,0,237610,CBC W AUTO DIFF ABS WBC MPV PLT,NEUTROPHILS,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,HEMOGLOBIN A1C WITH EAG,ESTIMATED AVERAGE GLUCOSE,Body weight,Body weight Measured,Weight Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,METHADONE,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,APTT,PARTIAL THROMBOPLASTIN,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,CBC W AUTO DIFF,MCV,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,HCV RNA PCR QN GRAPH RFX NS5A,HCV NS5A RESIST ASSAY INTERP,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.08333333333333333,0.0,0.0,0.08333333333333333,0.0,0.0,0.031811089746947796,0.0,0.0,0.031811089746947796,0.0,0,115790,COMPLEMENT C3 SERUM,COMPLEMENT C3 SERUM,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.25,0.25,0.0,0.3333333333333333,0.25,1.0,0.0,0.33333333333333337,0.0,0.062049918084883915,0.40824829046386313,0.7071067811865476,1,23366,IFE PE SERUM,GLOBULIN TOTAL,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,COMPLEMENT COMPONENT C3C,COMPLEMENT COMPONENT C3C,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.0,0.0,0.0,0.2,0.3333333333333333,0.0,0.0,0.0,0.0,0.3694836435770804,0.5387102392856749,1,45377,ARTHRITIS PROFILE,SEDIMENTATION RATE,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.1,0.03142857142857143,0.07333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,URINALYSIS RX ALB CREA,KETONES,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.27,0.0,0.0,0.2783333333333333,1.0,0.3333333333333333,0.0065058524063457135,0.0,0.0,0.03275101358391164,1.0,0.1986458339579933,1,487959,HCV FIBROSURE RESULTS,FIBROSIS SCORE,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,CHEM SCREEN PANEL,EGFR NON AFR AMERICAN,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,CBC WITH MANUAL DIFFERENTIAL,EOSINOPHILS,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,CBC DIFF PLT,MCHC,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,CBC WITH DIFFERENTIAL,NO CELLS DIFF,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,HEPATITIS B SURF AG,HEPATITIS B SURF AG,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,183145,CBC W AUTO DIFF WITH PLATELETS,COMMENTS,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,CBC W O DIFF WITH PLATELETS,PLATELET COUNT,Alpha-2-Macroglobulin,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,HEPATITIS BS AB QL,HEPATITIS B SURF AB QL,Erythrocyte distribution width,Erythrocyte distribution width [Entitic volume],RDW RBC
0.3333333333333333,0.0,0.0,0.3333333333333333,0.2,0.0,0.05034268654663743,0.0,0.0,0.08719609088829028,0.21223170681007852,0.0,1,7872,CBC W AUTO DIFF,MCV,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,PROTEIN ELECTRO S,M SPIKE,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.06900104452272493,0.0,0,104661,VITAMIN B12 FOLATE,FOLATE SERUM,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,HCV FIBROSURE LABCORP,RESULT,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,CULTURE ROUTINE,CULTURE ROUTINE,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,HEPATITIS B SURFACE AB QUANT,HEPATITIS B SURFACE AB,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.25,0.2,0.0,0.0,0.0,0.0,0.0,0.06447593079677061,0.0,0,205070,C4 C3,COMPLEMENT C3 SERUM,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESIST ASSAY INTERP,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,URINALYSIS WITH MICROSCOPIC,PROTEIN,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,MICROALBUMIN RANDOM,MICROALBUMIN CR RATIO,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.09090909090909091,0.0,0.0,0.0,0.0,0.0,0.007185336230291495,0.0,0,831008,FE ANA TIBC FER A1A AMA ASM,ALPHA 1 ANTITRYPSIN SERUM,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,PROTHROMBIN TIME WITH INR,INR,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,HEPATITIS PANEL ACUTE,HEPATITIS A IGM,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.2,0.5,0.0,0.2,0.5,0.0,0.018257807468693765,0.018604799016202156,0.0,0.07847871077409985,0.0799702069104602,0,311472,HCV AB W RFL RNA RFL GENO,HEPATITIS C AB,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,MAGNESIUM,HEMOLYSIS,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESIST ASSAY INTERP,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.3333333333333333,0.2857142857142857,1.0,0.0,0.14285714285714285,0.5,0.30304972032715427,0.015005024364675101,0.04246284832312519,0.0,0.06292624359840293,0.17807552140691663,1,110114,HCV RNA QN GRAPH RFX NSA,HEPATITIS C QUANTITATION,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,PE FLC SERUM,ALBUMIN,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.04785883012676384,0.0,0.0,0.0,0.0,0,44982,IRON TIBC SERUM,IRON BINDING CAPACITY,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.16666666666666666,0.375,0.6,0.16666666666666666,0.375,0.6,0.03667883611694245,0.1333745247488638,0.1591571563137949,0.03667883611694245,0.1333745247488638,0.1591571563137949,1,109009,HEPATITIS B SURFACE ANTIBODY,HEPATITIS B SURFACE ANTIBODY,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.03571428571428571,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,CBC INC DIFF PLT,BASOPHILS,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.5,0.3333333333333333,0.5,0.0,0.0,0.0,0.14187034543632637,0.140463816246154,0.7071067811865476,1,31419,ASH FIBROSURE,WEIGHT,Body weight,Body weight Measured,Weight Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,DRUG ABUSE SCREEN 11 W ETOH W CONF,METHADONE,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,MITOCHONDRIAL ANTIBODY W REFL TITER,MITOCHONDRIAL AB SCREEN,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,NEG HIV 4TH GEN,NEG HIV 2 ANTIBODY,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,T4 THYROXINE,T4 THYROXINE,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,CBC INCLUDES DIFF PLT,ABSOLUTE BAND NEUTROPHILS,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,CBC,MONOCYTES ABSOLUTE,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,HB CORE AB W IGM RFX,HB CORE AB TOTAL,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,HCV RNA NS5A GENOTYPE,DACLATASVIR RESISTANCE,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.372,0.125,0.0,0.372,0.125,0.0,0.036291544283745814,0.1429123037254596,0.11098565713428754,0.036291544283745814,0.1429123037254596,0.11098565713428754,1,182626,DIRECT LDL,DIRECT LDL,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,PTT,PTT,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,GLU RFX HA1C IF ABN,GLU RFX HA1C IF ABN,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0775,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,CBC INCLUDES DIFF PLT,BASOPHILS ABSOLUTE,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,REFERRED CBC,MCH,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,LIVER FIBROSIS FIBROTEST ACTITEST,NECROINFLAMMAT ACT GRADE,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,LIVER FIBROSIS,NECROINFLAM ACT SCORE,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,FIBROACT COMPLETE,WEIGHT LBS,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,LYMPHOCYTE SUBSET PANEL 4,% CD8 SUPPRESSOR T CELLS,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME,Erythrocyte distribution width,Erythrocyte distribution width [Entitic volume],RDW RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,LYMPHOCYTES,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.0,0.06666666666666667,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,LYMPHOCYTE SUBSET PANEL 2,CD4 ABSOLUTE,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.014371228500239197,0.0,0.0,0.014371228500239197,0.0,0,241133,TESTOSTERONE SERUM,TESTOSTERONE SERUM,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,HEPATITIS C GENO TYPE 1 NS5A RESIST,OMBITASVIR RESISTANCE,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.048918155723576384,0.039328530307136456,0.07241200273157788,0,237610,CBC INCLUDES DIFF PLT,BAND NEUTROPHILS,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.055,0.033,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,HEPATIC FUNCTION PANEL 6,ALT SGPT,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,CBC W AUTO DIFF,HCT,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,UA W MICRO HOLD SPEC 24 HR,APPEARANCE,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.0,0.07142857142857142,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,CBC WITH AUTO DIFF,WBC,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,CEA,CEA SIEMENS IMMULITE 2000,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,PATHOLOGIST SMEAR REVIEW,RBC,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.01,0.022222222222222223,0.1075,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,882936,BASIC METABOLIC PANEL 7,EGFR IF AFRICN AM,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,CERULOPLASMIN,CERULOPLASMIN,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,LIPID PANEL W CHOL HDL RATIO,VLDL CHOLESTEROL CAL,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,URINALYSIS W REFLEX MICRO,BACTERIA,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.12714285714285714,0.2966666666666667,0.0,0.12714285714285714,0.2966666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,C REACTIVE PROTEIN CARDIAC,C REACTIVE PROTEIN CARDIAC,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,HAV AB TOTAL,HAV AB TOTAL,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,RPR REFLEX TITRE TPPA,RPR,Reference lab test method,Reference lab test method,Ref lab test method
0.0,0.0,0.0,0.5,0.5,1.0,0.0,0.0,0.0,0.4792205357001811,1.0,1.0,1,487942,LIVER FIBROTEST ACTITEST,FIBROSIS STAGE,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.16666666666666666,0.1111111111111111,0.2,0.0,0.0,0.0,0.009925923040149942,0.016127517176947825,0.022570210770395227,0,139527,ANA TITER PATTERN,ANTI NUCLEAR AB TITER,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,ALT,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD IU ML,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,LYMPHOCYTE SUBSET PANEL 2,CD4 ABSOLUTE,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,HIV AB 1 HIV 2 EIA W REFL 1 WB,HIV EIA AB SCREEN,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,CMP14 4AC,EGFR IF NONAFRICN AM,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.2866666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,MITOCHONDRIAL AB W RFX TITER,MITOCHONDRIAL AB SCN,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,A FETOPROTEIN TUMOR MARKER,A FETOPROTEIN TUMOR MARKER,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.146,0.3333333333333333,0.0,0.276,0.18666666666666668,0.0,0.0,0.07402207708426334,0.35355339059327373,0.0,0.07402207708426334,0.0,1,128512,PROTEIN ELEC INTERP SERUM,P E INTERPRETATION S,Protein pattern,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp
0.0,0.1111111111111111,0.0,0.0,0.0,0.0,0.0,0.02823933563163694,0.0,0.0,0.0,0.0,0,59014,CBC W DIFF PLATELET,HCT,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.066,0.047142857142857146,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,DRUG ABUSE PANEL 10 WITH OXYCODONE,METHAQUALONE,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,PATHOLOGIST SMEAR REVIEW,RBC,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.2222222222222222,0.4,0.0,0.1111111111111111,0.2,0.0,0.9613601026977308,1.0,0.0,0.9457737658261642,0.9837872022899338,1,539627,ALPHA FETOPROTEIN TUMOR MARKER,ALPHA FETOPROTEIN TUMOR,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.19999999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,NEG HIV 4TH GEN,HIV 1 AB WESTERN BLOT,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,HEPASCORE R,AGE,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,CBC,MONOCYTES ABSOLUTE,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,TRICHOMONAS MALE,SOURCE,Body height,Body height Measured,Body height Measured
0.0,0.039473684210526314,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,NGI HCV SUPERQUANT,INTERNATIONAL UNITS,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,TSH RFLX FT4,TSH RFLX FT4,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,PSA TOTAL REFLEX FREE,PSA TOTAL,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,NGI HCV ULTRAQUAL RFX SUPER QT,COPIES ML,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.066,0.06625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,URINALYSIS W REFLEX MICRO,BACTERIA,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,82511,HCV FIBROSURE,LIMITATIONS,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,CBC H H RBC INDICES WBC PLT,PLATELET COUNT AUTO,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,MICROALBUMIN RANDOM,MICROALBUMIN RANDOM,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,LIVER FIBROSIS FIBROTEST ACTITEST,NECROINFLAMMAT ACT GRADE,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,UA W MICRO HOLD SPEC 24 HR,SPECIFIC GRAVITY,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,GLU RFX HA1C IF ABN,GLU RFX HA1C IF ABN,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,SPECIAL A 2 PANEL #9633,POLYS,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE MONOCYTES,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,HCV FIBROSURE,INTERPRETATION,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B DRUG RESISTANCE ASSAY,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD3 CELLS,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,COMP METABOLIC PANEL W GFR,PROTEIN TOTAL,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,SMOOTH MUSCLE AB F ACTIN REFLEX IFA TITER,F ACTIN IGG,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.5,0.42857142857142855,0.8,0.0,0.0,0.0,0.4543382861631333,0.013656950654702071,0.034646396615759856,0.0,0.0,0.0,1,487967,HCV FIBROSURE,INTERPRETATION,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,FE TIBC FER B12 HCT FOLRBC,IRON,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,DRUG ABUSE SCREEN 8 W CONFIRMATION,BARBITURATES,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.062,0.10333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,PROSTATE SPECIFIC ANTIGEN PSA,PSA,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,203935,UREA NITROGEN BUN,HEMOLYSIS,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,UROGRAM,SPECIFIC GRAVITY,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.182,0.16285714285714287,0.22800000000000004,0.0,0.0,0.0,0.0,0.025720888368633732,0.03471021044566758,0.0,0.0,0.0,0,728626,COMPREHENSIVE METABOLIC PANEL E GFR,SODIUM,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE LYMPHOCYTES,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,ANION GAP,ANION GAP,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.0,0.04454545454545455,0.0725,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D2,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,UROGRAM,SPECIFIC GRAVITY,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,ALPHA 1 ANTITRYPSIN PHENOTYPE,A 1 ANTITRYPSIN PHENOTYPE,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.4,0.5714285714285714,0.8,0.4,0.5714285714285714,0.8,0.3866542573725118,0.8590550279997561,0.8667792391701724,0.3866542573725118,0.8590550279997561,0.8667792391701724,1,51953,HEPATITIS B SURFACE AG,HEPATITIS B SURFACE AG,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,CBC,MO#,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.021818181818181816,0.0,0.0,0.022727272727272728,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,IMMUNOGLOBULINS,IMMUNOGLOBULIN G,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE NEUTROPHILS,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,PROTHROMBIN PTT,CONTROL,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,ACUTE HEPATITIS PANEL,HEPATITIS A AB IGM,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,HEMOGLOBINOPATHY INDICES,HEMATOCRIT,Microalbumin/Creatinine ratio panel,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur
0.0,0.023333333333333334,0.035,0.0,0.023333333333333334,0.035,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,CERULOPLASMIN,CERULOPLASMIN,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BENZODIAZEPINES,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.07125,0.1425,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,LIVER FIBROSIS FIBROTEST,FIBROSIS STAGE,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,ANACHOICE SCR W REFL TITER IFA,ANA SCREEN IFA,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,COMPREHENSIVE METABOLIC PANEL REFL,UREA NITROGEN BUN,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,URINALYSIS CULTURE IF INDICATED,LEUKOCYTE ESTERASE,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,CUSTOM HEPATITIS PANEL,HEPATITIS C ANTIBODY,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,LIPID PROFILE,CHOLESTEROL,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.0,0.030000000000000002,0.047142857142857146,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,CBCI COMPLETE BLOOD COUNT W DIFF,MCV,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,HB S AG W REFLEX CONF,HB S AG,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.08653125463386624,0.0,0.0,0.0,0.0,0,30163,IFE PE SERUM,M SPIKE,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,HEPATIC FUNCTION PANEL,ALBUMIN,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,TESTOSTERONE,TESTOSTERONE,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.07142857142857142,0.0,0.0,0.015714285714285715,0.055,0.0,0.013229515977782214,0.0,0.0,0.0,0.0,0,110114,IRON TIBC SERUM,IRON BINDING CAPACITY,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,CMP14 4AC,EGFR IF NONAFRICN AM,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,MANUAL DIFFERENTIAL,LYMPHOCYTES ABSOLUTE,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,NEG HIV 4TH GEN,HIV 1 AB WESTERN BLOT,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,IRON TOTAL,HEMOLYSIS,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.031000977305273292,0.0,0,7831,LYMPHOCYTE SUBSET PANEL 4,ABS CD4 COUNT,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,LIVER FIBROTEST ACTITEST,FIBROSIS STAGE,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,MICROALBUMIN RANDOM URINE W CREATININE,MICROALBUMIN CREATININE RATIO RANDOM URINE,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,CBC WITH ABSOLUTE NEUTROPHIL COUNT,PLATELET COUNT,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,IFE PE FLC SERUM,ALBUMIN,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.035733545935331845,0.0,0.0,0.0,0.0,0,265116,CBCM COMPLETE BLOOD CNT W MAN DIFF,EOSINOPHILS,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,RPR REFLEX T PALLIDUM PA,RPR,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD8 CELLS,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,LP NON HDL CHOLESTEROL,VLDL CHOLESTEROL CAL,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,CMP14 3AC CBC D PLT RPR MG,EOS,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.2,0.3814285714285714,0.6675,0.2,0.3814285714285714,0.6675,0.011621900357138837,0.03461362111913402,0.0402327111953118,0.011621900357138837,0.03461362111913402,0.0402327111953118,0,139519,HEPATITIS B SURFACE AB,HEPATITIS B SURFACE AB,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,CBC INCLUDES DIFFERENTIAL PLATELETS,RBC,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,CBC INC DIFF PLT,BASOPHILS,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,HCV RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,ASH FIBROSURE,HEIGHT,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.1509090909090909,0.146,0.3,0.0,0.0,0.0,0.0,0.0,0.027122279912447533,0.0,0.0,0,602797,NEG HIV 4TH GEN,NEG HIV 1 RNA QL TMA,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,COMP METAB PANEL,EGFR NON AFR AMERICAN,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,PAIN MANAGEMENT 8,CREATININE,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,UROGRAM,SPECIFIC GRAVITY,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,DRG TOX CRT REFL SPEC GR,CREATININE,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,LEUKEMIA LYMPHOMA EVALUATION,SPECIMEN TYPE,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,HIV 1 HIV 2 AB SCREEN,HIV 1 HIV 2 AB SCREEN,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.09499999999999999,0.033,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,CBC COMPLETE BLOOD COUNT W O DIFF,MCV,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,DIFFERENTIAL MANUAL,ABSOLUTE EOSINOPHILS,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,HIV 1 HIV 2 AG AB COMBO W REFLEXES,HIV INTERPRETATION,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,RPR REFLEX TITRE TPPA,RPR,Monocytes,Monocytes [#/volume] in Blood,Monocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,CBC W DIFF PLT,MPV,Neutrophils,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,CBC WITH DIFFERENTIAL,NUCLEATED RBCS,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.372,0.21875,0.375,0.372,0.21875,0.375,0.02963192182426555,0.11668740736434247,0.09061940958216264,0.02963192182426555,0.11668740736434247,0.09061940958216264,1,182626,LIPOPROT LDL DIRECT,LIPOPROT LDL DIRECT,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,CBCM COMPLETE BLOOD CNT W MAN DIFF,EOSINOPHILS,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,IRON IBC W RFX FERRITIN,%TRANSFERRIN SATURATION,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.25,0.2,0.3333333333333333,0.0,0.0,0.0,0.033955663578360995,0.04983141571783456,0.05851014153708933,1,112821,CBC WITH PLT DIFF,NO CELLS DIFF,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,COMP METABOLIC PANEL,GLOBULIN,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,HIV 1 RNA QN RT PCR,HIV 1 RNA QN PCR,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.06666666666666667,0.07500000000000001,0.12000000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,CBC INCLUDES DIFF PLT,BASOPHILS ABSOLUTE,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,CBC DIFF AMBIGUOUS DEFAULT,NEUTROPHILS,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,URINALYSIS,LEUKOCYTE ESTERASE,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,ANA ANTI NUCLEAR AB WITH REFLEX TITER,ANTI NUCLEAR ANTIBODIES,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,URIC ACID,URIC ACID,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.124,0.1985714285714286,0.0,0.292,0.2571428571428572,0.9,0.0,0.0,0.0,0.008931533211845588,0.45222488980749964,1.0,1,204537,URINALYSIS WITH MICROSCOPIC,EPITHELIAL CELLS,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,CMP14 LP 5AC CBC D PLT RPR,WBC,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,RPR REFLEX T PALLIDUM PA,RPR,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,VITAMIN D 25 OH TOTAL,VITAMIN D 25 OH TOTAL,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,COMPREHENSIVE METABOLIC PANEL WITH GFR,ANION GAP,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,CBC WITH PLT DIFF,NRBC,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.16666666666666666,0.14285714285714285,0.25,0.3333333333333333,0.14285714285714285,0.25,0.03095373581683858,0.034998014890340046,0.07267302452237867,0.03095373581683858,0.034998014890340046,0.07267302452237867,1,427682,NEG HIV 4TH GEN,NEG HIV 1 RNA QL TMA,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.05357142857142857,0.1875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,HEPATIC FUNCTION PANEL AMA,BILIRUBIN DIRECT,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.1075,0.2866666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,TESTOSTERONE FREE TOTAL LC MS,TESTOSTERONE TOTAL LC MS,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,PROSTATE SPECIFIC ANTIGEN PSA,PSA,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,HEMOGRAM W AUTOMATED DIFF,WBC,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,URINALYSIS C,BILIRUBIN,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,pH,pH of Urine by Test strip,pH Ur Strip
0.22333333333333336,0.14285714285714285,0.0,0.3333333333333333,0.0,0.0,0.0,0.019015638707784333,0.009866962510997834,0.037226205516931565,0.0,0.0,0,30973,ALBUMIN CREATININE RATIO RANDOM URINE,CALC ALBUMIN CREAT RND,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.2,0.4,0.6666666666666666,0.2,0.2,0.6666666666666666,0.007635905779136087,0.36555680528551404,0.4582002501529394,0.007806566737586396,0.37372692636381444,0.46844093359181893,0,178566,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,IMMUNODEF PROFILE #1,ABSOLUTE CD3,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.01494774522171427,0.0,0,17830,BASIC METABOLIC PANEL,UREA NITROGEN BLOOD BUN,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,CMP14 CBC D PLT ESR WES ANA,LYMPHS ABSOLUTE,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.18,0.09125,0.0,0.08399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,HEP B SURFACE AG W REFLEX CONFIRM,NEUTRALIZATION,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,HB S AG W REFLEX CONF,HB S AG NEUTRALIZATION,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,CREATININE SERUM,CREATININE SERUM,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,B12,VIT B12 SERUM,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,T3 FREE,T3 FREE,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,NASH FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,PT PROTIME,INR,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.08,0.05714285714285715,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,APTT,PARTIAL THROMBOPLASTIN,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,HIV AB 1 HIV 2 EIA W REFL 1 WB,HIV EIA AB SCREEN,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,OBSTETRIC PANEL,RPR RESULT,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,CBC WITH DIFFERENTIAL,ABS NEUTROPHILS,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,PE INTERP RFX IFE S,ALBUMIN,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,LIPID PANEL AMA,CHOLESTEROL HDL RATIO,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,CARDIO CRP R,CARDIO CRP R,Erythrocyte morphology finding,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,CMP14 CBC D PLT,HEMATOLOGY COMMENTS,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,CBC INC DIFF PLT,BASOPHILS,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,CBC W O DIFF WITH PLATELETS,MCV,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,CBC WITH PLT DIFF,EOSINOPHILS ABSOLUTE,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CYSTIC FIBROSIS SCREEN,ETHNICITY,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,DRUG ABUSE SCREEN II,BENZODIAZEPINES,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,URINALYSIS WITH MICROSCOPIC,EPITHELIAL CELLS,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,CHEM SCREEN PANEL,EGFR NON AFR AMERICAN,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,PATHOLOGIST SMEAR REVIEW,RBC,Ceruloplasmin,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,BASIC METABOLIC PANEL,OSMOLALITY,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,X HEPATITIS COMPLEX PROFILE,ANTI HBC TOTAL,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,NGI HCV SUPERQUANT,HEPATITIS C QUANTITATION,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,HEPATITIS C AB,HEPATITIS C AB,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,ESR WES CRP,C REACTIVE PROTEIN QUANT,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.05947671273697719,0.0,0,264788,UA MICROSCOPIC REFLEX CULTURE,OCCULT BLOOD,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,LIPID PANEL,NON HDL CHOLESTEROL,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,MICROALBUMIN CONC,ALB CREAT RATIO,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06635350960296393,0.05287307875068503,0.08777198612321668,1,7096,CBC WITH PLT DIFF,BLASTS,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,CMP14 HP4 DBILI CBC D PLT R,LYMPHS,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,IMMUNOGLOBULINS,IMMUNOGLOBULIN G,pH,pH of Urine by Test strip,pH Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,PROTEIN ELECTROPHORESIS,GAMMA GLOBULINS,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CMP14 CBC D PLT ESR WES ANA,NEUTROPHILS,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,HCV RNA NS5A GENOTYPE,DACLATASVIR RESISTANCE,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,CBC DIFF PLT,MCHC,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,ANA SCR W RFL T P LUPUS 1,ANA PATTERN,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc
0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0618006251322335,0.0,0.0,0,7880,PATHOLOGIST SMEAR REVIEW,RBC,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,DRUG ABUSE SCREEN 8 W CONFIRMATION,BARBITURATES,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,CBC INCLUDES DIFF PLT,INTERNAL WBC,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.4,0.5357142857142857,0.75,0.6,0.5714285714285714,0.8,0.43773540378221376,0.8284997221788247,0.8359491946807684,0.4485192921815444,0.8489103365948751,0.8565433315613047,1,169334,HEP B CORE AB QUAL,HEPATITIS B CORE AB QL,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0825,0.08833333333333333,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.07065997001469593,0.09716253076254433,1.0,1,57927,URINALYSIS WITH MICROSCOPIC,GLUCOSE,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.022630959662032324,0.0,0,486423,CMP14 LP 7AC CBC D PLT T B,AMYLASE SERUM,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,ALPHA 1 ANTITRYPSIN QN,ALPHA 1 ANTITRYPSIN QN,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,BASIC METABOLIC PANEL 7,EGFR IF AFRICN AM,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.09338639438323382,0.0,0,18358,COMPREHENSIVE METABOLIC PANEL,CALCIUM SERUM,Alpha-2-Macroglobulin,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,COMP METABOLIC PANEL,GLUCOSE NON FASTING,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,CBC,% BASOPHILS,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,HEPATITIS B SURFACE AG,HEPATITIS B SURFACE AG,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,HB CORE AB W IGM RFX,HB CORE AB TOTAL,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,CMP14 LP CBC D PLT UA MG TS,VLDL CHOLESTEROL CAL,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,DRUG SCREEN AUSTIN 20,PHENCYCLIDINE,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.015714285714285715,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,CREATINE KINASE TOTAL,LIPEMIA,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,BASIC METABOLIC PANEL,EGFR NON AFR AMERICAN,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.1,0.25,0.0,0.1,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,HEPATITIS BE AG,HB E AG,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,TRANSFERRIN SATURATION,TRANSFERRIN,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,PTH INTACT WITHOUT CALCIUM,PTH INTACT,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,CREATININE,EGFR IF AFRICN AM,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,AST CBC D PLT,EOS,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.5,0.5,1.0,0.5,0.375,0.75,0.0850700205153394,0.04403271978274104,0.04504617029593683,0.4900689862175951,0.011465317579597123,0.011729201619518514,1,108860,PSA TOTAL % FREE,PSA FREE,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,ANACHOICE SCR W REFL TITER IFA,ANA SCREEN IFA,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.0,0.0,0.0,0.25,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,CBC W AUTO DIFF WITH PLATELETS,RBC,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.24333333333333332,0.1825,0.73,0.24333333333333332,0.1825,0.73,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,IMMUNOGLOBULIN A,IMMUNOGLOBULIN A,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,BUN CREATININE,EGFR AFRICAN AMERICAN,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,CMP14 LP 1AC CBC D PLT TSH,LYMPHS,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,RPR RFX QN RPR CONFIRM TP,TREPONEMA PALLIDUM ANTIBODIES,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.2539585678404015,0.005994763961878147,0.04372412516808821,0.0,0.0,0.0,0,347047,HCV RNA NS5A GENOTYPE,DACLATASVIR RESISTANCE,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,NASH FIBROSURE,HEIGHT,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,URINALYSIS W REFLEX MICRO,RED BLOOD CELLS,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,RPR HBSAG HCVAB HSV1 HSV2 I,HEP C VIRUS AB,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,CBC INC DIFF PLT,PLATELET COUNT,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,LYMPHOCYTE SUBSET PANEL 4,% CD8 SUPPRESSOR T CELLS,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.14666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,DRUG ABUSE SCREEN W ETOH NO GCMS,AMPHETAMINES,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,CREATINE KINASE TOTAL,CREATINE KINASE TOTAL,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,HEPATIC FUNCTION PANEL,TOTAL PROTEIN,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.10964330813284906,0.0,0,265157,URINALYSIS CULTURE IF INDICATED,OCCULT BLOOD,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,CBC W DIFF PLT,BLAST CELLS ABSOLUTE,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,BASIC METABOLIC PANEL,OSMOLALITY,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,GGT,GGT,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,UREA NITROGEN BUN,HEMOLYSIS,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.3,0.2,1.0,0.0,0.0,0.0,0.0,0.34003516797720323,1.0,1,45427,LIVER FIBROTEST ACTITEST,HAPTOGLOBIN,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,VITAMIN D 25 OH LCMSMS W REFLEX,VITAMIN D 25 OH D3,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,REFLEX ANA PATTERN,PATTERN 1,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.06714285714285714,0.094,0.0,0.06714285714285714,0.094,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,AFP TUMOR MARKER SIEMENS CLIA,AFP TUMOR MARKER SIEMENS CLIA,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,FE ANA TIBC FER PTT PT A1A,MITOCHONDRIAL M2 ANTIBODY,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,URINALYSIS WITH MICROSCOPIC,PROTEIN,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,DRUG ABUSE SCREEN II,METHAQUALONE,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,CBC WITH DIFF PLATELET,WBC,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,ACCUTYPE R IL28B,ACCUTYPE R IL28B,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,FIBROACT,ALT,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,CBC INC DIFF PLT,BASOPHILS,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,CBC W DIFF PLT,RBC,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,LYMPHOCYTE SUBSET PANEL 5,ANALYZED DATE TIME NR,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,ANA TITER PATTERN,ANA PATTERN,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,HEPATITIS B CORE AB,HEPATITIS B CORE AB,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,HEMOGLOBIN A1C,HEMOGLOBIN A1C,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,LIPID PANEL,NON HDL CHOLESTEROL,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B RESIST ASSAY INTERP,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.25,0.0,0.0,0.0,0.0,0.0,0.05481546703668205,0.0,0.0,0.0,0.0,0.0,0,7112,CBC W AUTO DIFF,ABS NEUTROPHILS,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,PE FLC SERUM,ALBUMIN,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.1375,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,LYMPHOCYTE SUBSET PANEL 5,ANALYZED DATE TIME NR,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,HIV 1 QUANT PCR,HIV 1 VIRAL COPY,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,PROTEIN 24 HOUR URINE,PROTEIN URINE CONC,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,CBC W AUTO DIFF ABS WBC MPV PLT,LYMPHOCYTES,Erythrocyte distribution width,Erythrocyte distribution width [Entitic volume],RDW RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,CBC WITH DIFFERENTIAL,MYELOCYTES,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,IMMUNOGLOBULINS IGG A M SER,IMMUNOGLOBULIN A,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,CBC W DIFF PLATELET,MCH,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.5,0.3333333333333333,0.5,0.0,0.0,0.0,0.08190888212768821,0.08109682212111924,0.40824829046386313,1,31419,FIBROACT COMPLETE,WEIGHT LBS,Body weight,Body weight Measured,Weight Measured
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.00911958532840973,0.0,0,121855,CBC RBC H H INDICES WBC PLT,RED BLOOD CELL COUNT,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.13799999999999998,0.0,0.0,0.13799999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,HEPATITIS B SURFACE AG,HEPATITIS B SURFACE AG,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,ANTIPHOSPHOLIPID SYNDROME,PT,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,T3 FREE,T3 FREE,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD8 CELLS,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.19000000000000003,0.14285714285714285,0.25,0.0,0.0,0.0,0.0,0.031610966010303554,0.0969878128389482,1,716951,CBC WITH DIFFERENTIAL,IMMATURE GRANS,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,HCV AB W RFL RNA RFL GENO,HEPATITIS C AB,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,203927,CREATININE,ICTERUS,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.31,0.25,0.0,0.3333333333333333,0.25,1.0,0.0,0.0840117798597445,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,825208,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,VELPATASVIR RESISTANCE,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,FREE T3,FREE T3,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,URIC ACID,URIC ACID,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,LDL CHOLESTEROL DIRECT,LDL CHOL DIRECT,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,MAGNESIUM,HEMOLYSIS,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,CMP,ALBUMIN,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,HBC AB TOTAL,HBC AB TOTAL,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.5466666666666667,0.2857142857142857,0.3333333333333333,0.0,0.0,0.0,0.0,0.41731829815125243,0.41364362208294236,1,98301,LIPID PNL W REFL TRIG>400,CHOLESTEROL HDL RATIO,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,CBC W AUTO DIFF,MCHC,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,RPR,RPR QUANT,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,LYMPHOCYTE SUBSET PANEL 5,ANALYZED DATE TIME NR,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,STOOL CULTURE,RESULT 2,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.11,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,204081,UA MICROSCOPIC REFLEX CULTURE,OCCULT BLOOD,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,ALPHA 1 ANTITRYPSIN QN,ALPHA 1 ANTITRYPSIN QN,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.10031748330730439,0.10964330813284906,0.7071067811865476,1,303768,CMP CBC TSH,ABSOLUTE BLASTS,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,DIFFERENTIAL MANUAL,EOSINOPHILS,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,URINALYSIS W REFLEX MICRO,UROBILINOGEN,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN CREATININE RATIO,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,COMP METABOLIC PANEL,CREATININE,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.16666666666666666,0.0,0.25,0.16666666666666666,1.0,0.0,0.07858063232628809,0.0,0.07257572557143144,0.13610564768002043,1.0,1,28621,PE FLC SERUM,ALBUMIN,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,HIV ANTIGEN ANTIBODY FOURTH GENERATION W RFL,HIV AG AB 4TH GEN,Neutrophils,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,RHEUMATOID FACTOR RF,RHEUMATOID FACTOR RF,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,LIPID PROFILE,FASTING NON FASTING,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.31,0.20428571428571426,0.9533333333333333,0.4533333333333333,0.2757142857142857,1.0,0.021033838986238895,0.07126828601996171,0.5345224838248488,0.03935070950753716,0.09999806581099036,0.5,1,295410,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN RT PCR LOG COPIES ML,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,BUN CREAT RATIO W EGFR,NON AFRICAN AMERICAN EGFR,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,CMP WITH ESTIMATED GFR CALCULATED,CARBON DIOXIDE,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,BILIRUBIN PANEL,BILIRUBIN INDIRECT,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,ACUTE HEPATITIS PANEL,HEPATITIS C ANTIBODY,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.07142857142857142,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,LYMPHOCYTES,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,A FETOPROTEIN TUMOR MARKER,A FETOPROTEIN TUMOR MARKER,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.14333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,CMP WITH EGFR,ANION GAP,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,HEPATIC FUNCTION PANEL,INDIRECT BILI,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.184,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,PT PROTIME,INR,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,URINE DRUG SCREEN,OPIATES,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.30333333333333334,0.25,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,303768,CBC W DIFF PLT,BLAST CELLS ABSOLUTE,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,UA MICROSCOPIC REFLEX CULTURE,OCCULT BLOOD,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.008571428571428572,0.03,0.0,0.008571428571428572,0.03,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,CEA,CEA CENTAUR,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,RPR,RPR QUANT,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,CBC WITH DIFFERENTIAL,MONOCYTES,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,X HEPATITIS COMPLEX PROFILE,ANTI HBC TOTAL,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,CBC W AUTO DIFF ABS WBC MPV PLT,LYMPHOCYTES,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,URINALYSIS WITH MICROSCOPIC,APPEARANCE,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,URINE PROTEIN TOTAL RANDOM W O CREATININE,PROTEIN TOTAL RANDOM UR,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.06192203894113468,0.0,0,28688,CBC INCLUDES DIFF PLATELETS,MEAN PLATELET VOLUME,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,CBC WITH MANUAL DIFFERENTIAL,MCHC,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,IRON BINDING CAPACITY,TIBC,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,LIVER FIBROSIS PANEL,ALT,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,CBC WITH PLT DIFF,EOSINOPHILS ABSOLUTE,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,BASIC METABOLIC PANEL AMA,GLUCOSE,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,ASH FIBROSURE,HAPTOGLOBIN,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,UROGRAM,KETONES,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,PHENCYCLIDINE,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,UA W MICRO HOLD SPEC 24 HR,SPECIFIC GRAVITY,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,PTT,PTT,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.372,0.125,0.5,0.372,0.0,0.0,0.007209164079868158,0.042583400634602975,0.04409367683763299,0.02963192182426555,0.11668740736434247,0.09061940958216264,1,182626,LDL CHOLESTEROL DIRECT,LDL CHOL DIRECT,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,AFP WITH AFP L3%,AFP SERUM,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,URINE MICROALBUMIN CREAT RATIO,UR MICROALBUMI,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,CMP14 LP CBC D PLT,NEUTROPHILS,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.06835323508016788,0.0,0,20289,CMP12 7AC MG,PHOSPHORUS SERUM,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.16666666666666666,0.21428571428571427,0.75,0.06333333333333334,0.0,0.0,0.033286841524124755,0.0,0.0,0.0,0.05137906274872117,0.0,1,110114,NGI HCV SUPERQUANT,INTERNATIONAL UNITS,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,COMP METABOLIC PANEL W GFR,ANION GAP,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,PE INTERP RFX IFE S,BETA GLOBULIN,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,CBCI COMPLETE BLOOD COUNT W DIFF,LYMPHOCYTES,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.31,0.25,0.0,0.3333333333333333,0.25,1.0,0.0,0.0840117798597445,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,823773,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,LEDIPASVIR RESISTANCE,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,LIPID PANEL WITH LDL HDL RATIO,LDL HDL RATIO,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,CBC W O DIFF WITH PLATELETS,RBC,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,SMOOTH MUSCLE AB F ACTIN REFLEX IFA TITER,F ACTIN IGG,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,FIBROACT,ALT,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,PROTEIN ELECTRO S,M SPIKE,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.030000000000000002,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,PROTEIN 24 HOUR URINE,PROTEIN URINE CONC,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,HB CORE AB W IGM RFX,HB CORE AB TOTAL,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,CBC WITH MANUAL DIFFERENTIAL,MCHC,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,HEPATITIS B SURFACE ANTIBODY,HEPATITIS B SURFACE ANTIBODY,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.43333333333333335,0.2857142857142857,1.0,0.43333333333333335,0.2857142857142857,1.0,0.0,0.43337723529131744,0.10031748330730439,0.0,0.43337723529131744,0.10031748330730439,1,30510,FREE T3,FREE T3,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,URINALYSIS CULTURE IF INDICATED,LEUKOCYTE ESTERASE,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,COMPREHENSIVE METABOLIC PANEL E GFR,CARBON DIOXIDE,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,LIVER FIBROTEST ACTITEST,NECROINFLAMMAT ACT SCORE,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0415,0.20750000000000002,0.0,0.0165,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,CBC WITH ABSOLUTE NEUTROPHIL COUNT,PLATELET COUNT,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,IRON TOTAL IRON BIND CAPACITY,TIBC,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,ASH FIBROSURE,AST SGOT P5P,Leukocyte morphology finding,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,CREATININE,EGFR IF NONAFRICN AM,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,NEG HIV 4TH GEN,NEG HIV 1 ANTIBODY,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,CBC,HCT,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,24588,IMMUNOGLOBULIN A,IMMUNOGLOBULIN A,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.06666666666666667,0.044444444444444446,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE LYMPHOCYTES,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0,23457,C4 C3,COMPLEMENT C3 SERUM,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.26666666666666666,0.0,0.0,0.26666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,25320,LD,LD,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.22166666666666668,0.033,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,HEPATIC FUNCTION PANEL W O TP,BILIRUBIN DIRECT,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,POL CMP WITH EGFR INV,GLUCOSE,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.22333333333333336,0.2,0.3333333333333333,0.22333333333333336,0.2,0.3333333333333333,0.0,0.05336825693147673,0.05352091133427317,0.0,0.05336825693147673,0.05352091133427317,0,111252,PLATELET ESTIMATION,PLATELET ESTIMATION,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,TESTOSTERONE SERUM,TESTOSTERONE SERUM,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,URINALYSIS WITH MICROSCOPIC,PH,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,CBC W O DIFF WITH PLATELETS,PLATELET COUNT,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCV,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Erythrocyte morphology finding,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,HCV RNA PCR QN RFX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,CBC W AUTO DIFF,MCHC,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.13428571428571429,0.3133333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,T B LYMPHOCYTE NK NYSDOH,PLATELETS,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,NGI HCV SUPERQUANT,INTERNATIONAL UNITS,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,THYROXINE T4 FREE,T 4 FREE,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.25,0.0,0.0,0.5,1.0,0.5,0.00954973917157309,0.01992765013214659,0.01992765013214659,0.4792205357001811,1.0,1.0,1,487942,LIVER FIBROSIS FIBROTEST,FIBROSIS STAGE,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.25,0.09090909090909091,1.0,0.0,0.0,0.0,0.058854483963441506,0.04322678270641078,1.0,1,611517,CMP,ALBUMIN,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,PROTEIN ELECTRO S,M SPIKE,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.03777777777777777,0.0,0.0,0.03777777777777777,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,HCV RNA QN GRAPH RFX NSA,HEPATITIS C QUANTITATION,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,LP LDLDIR,TRIGLYCERIDES,Prothrombin.activity actual/Normal,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,CYCLIC CITRULLINATED PEPTIDE CCP AB IGG,CYCLIC CITRULLINATED PEPTIDE CCP AB IGG,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,CBC W AUTO DIFF ABS WBC MPV PLT,LYMPHOCYTES,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,UA MICROSCOPIC REFLEX CULTURE,KETONES,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,URINALYSIS W REFLEX MICRO,EPITHELIAL CELLS,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.5,0.5,0.6666666666666666,0.25,0.5,0.6666666666666666,0.4265260514383984,0.008638751144131596,0.010018540333668557,0.009960706634886463,0.40392557361123926,0.46844093359181893,1,45484,HGB A1C WITH EAG ESTIMATION,HEMOGLOBIN A1C,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.0,0.02,0.04,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,CBC INCLUDES DIFF PLT,BASOPHILS %,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,HEPATIC FUNCTION PANEL,ALT,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,DRUG ABUSE PANEL 10 WITH OXYCODONE,METHAQUALONE,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,GORBYMI CMP 4AC CORONARY RISK CBC TSH PROFILE,CALCIUM,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,CBC WITH PLT DIFF,OTHERS,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,LEUKEMIA LYMPHOMA EVALUATION,SPECIMEN TYPE,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,LYMPHOCYTE SUBSET PANEL 4,LYMPHOCYTES ABSOLUTE,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,TESTOSTERONE FREE TOTAL LC MS,TESTOSTERONE TOTAL LC MS,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,CBC W AUTO DIFF,BASOPHILS ABSOLUTE,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.06625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,LIPID PANEL WITH LDL HDL RATIO,HDL CHOLESTEROL,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,BMP WITH ESTIMATED GFR CALCULATED,CARBON DIOXIDE,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.25,0.14285714285714285,1.0,0.0,0.0,0.0,0.052570301148225806,0.05162000400267441,0.7071067811865476,1,303644,CD4 CD8 ENUMERATION,ABSOLUTE LYMPHOCYTES,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.21,0.1111111111111111,0.25,0.21,0.1111111111111111,0.25,0.0,0.006076686051585067,0.009744924678454114,0.0,0.006076686051585067,0.009744924678454114,1,32896,PROTHROMBIN TIME PT,PROTHROMBIN TIME PT,Prothrombin.activity actual/Normal,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,RHEUMATOID FACTOR QUANT,RHEUMATOID FACTOR QUANT,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,CMP WITH EGFR,ANION GAP,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,HCV FIBROSURE,COMMENT,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.47,0.3333333333333333,0.3333333333333333,0.0,0.0,0.0,0.04524395250155222,0.45528141890436646,0.5,1,19711,HEPATIC FUNCTION PROFILE,BILIRUBIN INDIRECT,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,WBC,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS A TOTAL AB,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,DRUG ABUSE PANEL 10 WITH OXYCODONE,BENZODIAZEPINES,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,PROTIME PTT,PROTHROMBIN TIME PT,Basophils,Basophils [#/volume] in Blood,Basophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,IMMUNOGLOBULINS IGG A M SER,IMMUNOGLOBULIN A,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,CBC WITH PLT MAN DIFF,BANDS ABSOLUTE,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,CBC WITH DIFFERENTIAL,BASOPHILS,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,ACUTE HEPATITIS PANEL,HEPATITIS B SURFACE ANTIGEN,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,EOSINOPHILS #,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,UA MICROSCOPIC REFLEX CULTURE,BILIRUBIN,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,IMMUNOFIXATION SERUM,IGG SERUM NR,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,METHADONE,Alpha-2-Macroglobulin,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.07870803013413097,0.08752895424186691,0.10240603634159506,1,265116,CBC W AUTO DIFF ABS WBC MPV PLT,NEUTROPHILS,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,AFP TUMOR MARKER SIEMENS CLIA,AFP TUMOR MARKER SIEMENS CLIA,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,COMPREHENSIVE METABOLIC PANEL E GFR,CHLORIDE,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,HCV RNA GENOTPE 1 NS5A DRUG RE,OMBITASVIR RESISTANCE,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,RPR REFLEX T PALLIDUM PA,RPR,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.2,0.5,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.005257611612411561,0.013808527377614066,0,58115,PSA TOTAL REFLEX FREE,PROSTATE SPECIFIC AG SERUM,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,LIVER FIBROSIS FIBROTEST,FIBROSIS STAGE,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,CMP12 LP TP TSH 6AC CBC D PLT,POTASSIUM,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.005,0.0175,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,CMP14 LP 1AC CBC D PLT TSH,LYMPHS,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,LIVER FIBROSIS FIBROTEST,FIBROSIS STAGE,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,ASH FIBROSURE,HAPTOGLOBIN,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.013421378514845816,0.0,0.0,0.0,0.0,0,67421,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,RDW,Erythrocyte morphology finding,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld
0.0,0.018,0.025714285714285714,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,CREATININE,EGFR IF NONAFRICN AM,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,PROTHROMBIN TIME WITH INR,INR,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,IMMUNOGLOBULINS,IMMUNOGLOBULIN M,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.25,0.2,0.0,0.0,0.0,0.0,0.038616531850708125,0.0,0.0,0,422543,RENAL PANEL 10,EGFR IF NONAFRICN AM,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.02,0.028000000000000004,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,CMP CBC TSH,ABSOLUTE BLASTS,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,ANA SCR IFA RFL TITR PATT,ANA SCREEN IFA,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.11166666666666668,0.335,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,BASIC METABOLIC PANEL,BUN CREATININE RATIO,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,MORPHOLOGICAL REVIEW,PATH REVIEW PERIPHERAL SMEAR,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,CBCI COMPLETE BLOOD COUNT W DIFF,MCHC,Erythrocytes,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,TRICHOMONAS MALE,SOURCE,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.094,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.3333333333333333,0.0,0.25,0.16666666666666666,1.0,0.0,0.03258155267402285,0.0,0.06713496212611103,0.05720402135206337,0.7071067811865476,1,7518,COMPLETE BLOOD COUNT,NEUTROPHILS ABSOLUTE,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.2,0.0,0.3333333333333333,0.2,0.0,0.0,0.04035350753708156,0.0,0.08719609088829028,0.21223170681007852,0.0,1,7872,CBCI COMPLETE BLOOD COUNT W DIFF,MCV,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,LIVER FIBROSIS FIBROMETER,FIBROMETER PROTHROMBIN INDEX,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD3 CELLS,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,HCV FIBROSURE,LIMITATIONS,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,CMP14 LP 2AC CBC D PLT MG T,WBC,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,LEUKEMIA LYMPHOMA EVALUATION,SPECIMEN TYPE,Monocytes,Monocytes [#/volume] in Blood,Monocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,LIPID PANEL,NON HDL CHOLESTEROL,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,LIVER FIBROSIS FIBROMETER,FIBROMETER PROTHROMBIN INDEX,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,CBC,MO#,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,HCV RNA PCR RFX NS5B,HCV NS5B RESISTANCE ASSAY PDF,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,CBC W AUTO DIFF ABS WBC MPV PLT,NEUTROPHILS,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,LYMPHOCYTE SUBSET PANEL 2,% CD8 SUPPRESSOR T CELLS,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.22333333333333336,0.25,1.0,0.0,0.0,0.0,0.0,0.5773502691896257,1.0,0.0,0.0,0.0,0,21618,CREATININE,ICTERUS,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.0,0.0,0.1775,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,7328,CBC PLATELET HEM REVIEW,LYMPHS ABSOLUTE,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,CMP13 LP 2AC CBC D PLT,ALT SGPT,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.07142857142857142,0.125,0.0,0.047142857142857146,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,CBC WITH AUTO DIFF,PLATELET COUNT,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,HEPATITIS C VIRAL RNA NS3 GENOTYPE,TELAPREVIR RESISTANCE,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,LYMPHOCYTE SUBSET PANEL 4,% CD8 SUPPRESSOR T CELLS,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,CBC WITH AUTO DIFF,NRBC,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.11,0.066,0.165,0.11,0.066,0.165,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,CYCLIC CITRULLINATED PEPTIDE CCP AB IGG,CYCLIC CITRULLINATED PEPTIDE CCP AB IGG,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.045,0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,COMPREHENSIVE METABOLIC PANEL,OSMOLALITY,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,LIVER FIBROTEST ACTITEST,NECROINFLAMMAT ACT SCORE,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,HCV RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual
0.0,0.01,0.015,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,CMP14 CBC D PLT ESR WES ANA,LYMPHS ABSOLUTE,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,CBC WITH PLT DIFF,RDW,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,HEPATITIS B CORE IGM,HEPATITIS B CORE IGM,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.1825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,EP LP 11AC CBC D PLT TSH FER,CALCIUM,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,BASIC METABOLIC PANEL 8,EGFR IF AFRICN AM,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,DRUG ABUSE SCREEN 11 W ETOH NO CONF,OXYCODONE,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,CERULOPLASMIN,CERULOPLASMIN,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,ACCUTYPE R IL28B,ACCUTYPE R IL28B,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.03333333333333333,0.125,0.0,0.0,0.0,0.0,0.04432042353220711,0.0,0.0,0.0,0.0,0,381806,CBC WITH AUTO DIFF,HEMATOCRIT,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.0,0.0,0.0825,0.0775,0.10333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,CBC WITH PLT DIFF,NO CELLS DIFF,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.04125,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,RPR REFLEX PER CDC,RPR,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,UA W MICRO HOLD SPEC 24 HR,APPEARANCE,Age,Age,Age
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.030812177505569194,0.0,0.0,0.0,0.0,0,111252,CBC WITH ABSOLUTE WHITE BLOOD CELLS,WBC,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,PROTEIN 24 HOUR URINE,PROTEIN URINE CONC,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,LIPID PROFILE,CHOLESTEROL,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,DRUG ABUSE SCREEN CLINICAL 9,COCAINE,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,DRUG ABUSE SCREEN II,METHAQUALONE,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,HEPATITIS B SURFACE AB QUANT,HEPATITIS B SURFACE AB,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,URINALYSIS COMP W RFL CULTURE,PROTEIN,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,NASH FIBROSURE,AST SGOT P5P,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,MORPHOLOGICAL REVIEW,MORPHOLOGICAL REVIEW,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD8 CELLS,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.04,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,COMPREHENSIVE METABOLIC PANEL,CALCIUM,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,CMP14 LP 3AC CBC D PLT,LYMPHS,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,CBC W DIFF PLT,BLAST CELLS ABSOLUTE,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,CMP14 4AC,EGFR IF NONAFRICN AM,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.033999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,HCV FIBROSURE,COMMENT,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.27999999999999997,0.2857142857142857,1.0,0.0,0.0,0.0,0.011862808335706188,0.6345756122357417,1.0,1,28712,PROTEIN ELECTRO S,BETA GLOBULIN,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,IMMUNODEF PROFILE #1,ABSOLUTE CD3,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.06666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,ANA SCREEN QUAL,ANA ANTIBODY SCREEN EIA,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,HIV 1 HIV 2 AG AB COMBO W REFLEXES,HIV INTERPRETATION,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,NASH FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,CREATINE KINASE CK,CREATINE KINASE CK,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,AUTOIMMUNE HEPATITIS DIAG PNL,MITOCHONDRIAL AB SCREEN,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,COMP METABOLIC PANEL,RATIO,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,CMP14 HP4 DBILI CBC D PLT R,EOS ABSOLUTE,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,LYMPHOCYTE SUBSET PANEL 4,LYMPHOCYTES ABSOLUTE,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,LIVER FIBROSIS PANEL,HAPTOGLOBIN,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,CMP WITH ESTIMATED GFR CALCULATED,FASTING NON FASTING,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,HEPATITIS A IGM,HEPATITIS A IGM,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,DRUG ABUSE SCREEN II,COCAINE METABOLITE,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,ACCUTYPE R IL28B,IL28B GENOTYPE,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,HEMOGLOBIN A1C,MEAN GLUCOSE EST,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,FSRC NEW PATIENT PANEL,D BILIRUBIN,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.1475,0.0,0.0,0.1475,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,TESTOSTERONE,TESTOSTERONE,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.1285714285714286,0.045454545454545456,0.0,0.07142857142857142,0.045454545454545456,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,HEPATITIS C RNA PCR QUANT,HCV PCR QUANT,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,HEPASCORE R,SEX,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,NASH FIBROSURE,APOLIPOPROTEIN A 1,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.25,0.0,0.3333333333333333,0.0,0.0,0.0,0.0633025934653415,0.0,0.1569574215481997,0.0,0.0,1,264648,CBC WITH ABSOLUTE WHITE BLOOD CELLS,WBC,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,PTH INTACT MOLECULE,PTH,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,TSH W REFLEX FT4,TSH 3RD GENERATION W REFLEX FT4,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,URINALYSIS COMPLETE,APPEARANCE,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,CBC COMPLETE BLOOD COUNT W O DIFF,MCHC,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,CCP ANTIBODY IGG,ANTI CCP IGG,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,RPR,TREPONEMA PALLIDUM ANTIBODIES,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,TSH,TSH,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,59055,CBC,MO#,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,AST CBC D PLT,EOS,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,CBC WITH PLT DIFF,NUCLEATED RBCS,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.14666666666666667,0.0,0.0,0.14666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,TESTOSTERONE FREE TOTAL LC MS,TESTOSTERONE TOTAL LC MS,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,DIFFERENTIAL MANUAL,PLATELET ESTIMATION,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,CBCI COMPLETE BLOOD COUNT W DIFF,MCHC,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,FREE T3,FREE T3,Alpha-2-Macroglobulin,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.032694664605325,0.12022058655929357,0.35355339059327373,0.09247447620418048,0.34003516797720323,1.0,1,30346,TRANSFERRIN CARBOHYDRATE DEFICIENT ALCOHOL USE,TRANSFERRIN,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,HEP B SURFACE AB IMMUNITY QN,HEP B SURFACE AB IMMUNITY QN,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.14666666666666667,0.0,0.0,0.14666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,HEPATITIS B SURFACE AG,HEPATITIS B SURFACE AG,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,COMPREHENSIVE METABOLIC PANEL E GFR,CALCULATED A G RATIO,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,LP LDLDIR,TRIGLYCERIDES,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,LYMPHOCYTE SUBSET PANEL 2,% CD8 SUPPRESSOR T CELLS,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D3,Reference lab test method,Reference lab test method,Ref lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,HB S AG W REFLEX CONF,HB S AG,Ceruloplasmin,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,VAP CHOLESTEROL PROFILE,TRIGLYCERIDES,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,WBC,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,LIVER FIBROTEST ACTITEST,HAPTOGLOBIN,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,CMP,ALT SGPT,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.2375,0.1357142857142857,0.95,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,LYMPHOCYTE SUBSET PANEL 2,COMMENT S,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN CREATININE RATIO,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA
0.0,0.0,0.0,0.08,0.08857142857142856,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,HNK1 CD57 PANEL,LYMPHS ABSOLUTE,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0825,0.266,0.0,0.0,0.0,0.0,0.0,0.0696348771716293,0.0,0.0,0.0,0.0,0,143149,URINALYSIS SCREEN,PH,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,REFERRED CBC,MCH,Erythrocytes,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,HEMOGLOBIN A1C,MEAN GLUCOSE EST,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,IMMUNE COMPETENCE PANEL,CD4 CD8 RATIO,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,CMP,ALT SGPT,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,HEPATITIS C RNA PCR QUANT,HCV PCR QUANT,Globulin,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,RPR,RPR RESULT,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,CBC W AUTO DIFF,HCT,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,LIPID CASCADE W RFLX APOLIB,LDL HDL RATIO,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.3333333333333333,0.3333333333333333,0.5,0.3333333333333333,0.16666666666666666,0.5,0.007790750387184131,0.02597977891948333,0.013953992202479948,0.03542317119318572,0.059062741744354885,0.0634463472774005,0,17590,ALBUMIN CREATININE RATIO RANDOM URINE,CALC ALBUMIN CREAT RND,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,LIVER FIBROSIS FIBROTEST ACTITEST,BILIRUBIN,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,HCV FIBROSURE,INTERPRETATION,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,IMMUNOGLOBULINS,IMMUNOGLOBULIN M,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,CMP14 LP 3AC CBC D PLT,LYMPHS,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,NEG HIV 4TH GEN,HIV 1 AB WESTERN BLOT,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,VIT B 12 FOLATE PANEL,VITAMIN B 12,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,LIVER FIBROSIS FIBROTEST ACTITEST,BILIRUBIN,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.01933333333333333,0.0725,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D3,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,PTT,PTT,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,ANA ANTI NUCLEAR AB WITH REFLEX TITER,ANTI NUCLEAR ANTIBODIES,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.24333333333333332,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,HCV RNA PCR QN RFX GENO,PLEASE NOTE,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,CBC W AUTO DIFF,HCT,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,COMP METAB PANEL,ALT,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.07833333333333332,0.1175,0.0,0.07833333333333332,0.1175,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,C REACTIVE PROTEIN CARDIAC,C REACTIVE PROTEIN CARDIAC,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,CBC RBC H H INDICES WBC PLT,RED BLOOD CELL COUNT,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,LIPOPROT LDL DIRECT,LIPOPROT LDL DIRECT,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.0,0.0,0.0,0.25,0.09090909090909091,1.0,0.0,0.0,0.0,0.058854483963441506,0.04322678270641078,1.0,1,611517,HEPATIC FUNCTION PANEL,ALBUMIN,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.11,0.0,0.0,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,HEP B SURFACE AB IMMUNITY QN,HEP B SURFACE AB IMMUNITY QN,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,HEPATITIS C VIRAL RNA NS3 GENOTYPE,TELAPREVIR RESISTANCE,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.043574999314623164,0.0,0,111567,UA MICROSCOPIC REFLEX CULTURE,WHITE BLOOD CELLS,Leukocyte morphology finding,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld
0.0,0.07571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,UA W MICRO HOLD SPEC 24 HR,APPEARANCE,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,BASIC METABOLIC PANEL,BUN,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.27666666666666667,0.1925,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,825208,HEP C RNA GENOT 3 NS5A,VELPATASVIR RESISTANCE,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.01,0.023333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,CMP12 LP TP TSH 6AC CBC D PLT,LDH,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,LP WITHOUT VLDL CHOL HDL,LDL CHOLESTEROL CALC,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,CMP13 LP 2AC CBC D PLT,EGFR IF AFRICN AM,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,LDL CHOLESTEROL DIRECT,LDL CHOL DIRECT,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,CBC PLATELET HEM REVIEW,LYMPHS ABSOLUTE,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,COMP METABOLIC PANEL,ALKALINE PHOSPHATASE,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,LP NON HDL CHOLESTEROL,VLDL CHOLESTEROL CAL,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,HEPATITIS C VIRAL RNA NS3 DRUG RESI,BOCEPREVIR RESISTANCE,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.22333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,RPR REFLEX T PALLIDUM PA,RPR,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,TESTOSTERONE,TESTOSTERONE,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.26666666666666666,0.12,0.0,0.0,0.0,0.0,0.0,0.05780500170603886,0.0,0.0,0.0,0.0,0,17434,CBC W AUTO DIFF WITH PLATELETS,COMMENTS,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.0,0.05181818181818181,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,DRUG ABUSE SCREEN 11 W ETOH W CONF,OXYCODONE,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,CMP14 EGFR,POTASSIUM,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.028571428571428574,0.1,0.0,0.012857142857142857,0.045,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,COMP METABOLIC PANEL,CREATININE,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,URINALYSIS,BILIRUBIN,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.007000000000000001,0.023333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,CMP14 3AC CBC D PLT RPR MG,EOS,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,CBC INCLUDES DIFF PLT,BASOPHILS %,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,LIPID PANEL AMA,CHOLESTEROL HDL RATIO,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,HEPATITIS C VIRAL RNA QUALITATIVE TMA,HEPATITIS C VIRAL RNA QUALITATIVE TMA,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,CBC INCLUDES DIFF PLT,BASOPHILS %,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,LIPID PANEL,HDL AS % CHOLESTEROL,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,CMP14 2AC MG,EGFR IF NONAFRICN AM,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,HEPATITIS ABC PANEL,HEPATITIS A ANTIBODY TOTAL,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.25,0.20000000000000004,0.0,0.0,0.0,0.0,0.03960996495528413,0.0,0.0,0.0,0.0,0.0,1,327767,URINALYSIS W REFLEX MICRO,RED BLOOD CELLS,Erythrocytes,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,RHEUMATOID FACTOR QUANT,RHEUMATOID FACTOR QUANT,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.0,0.0,0.06200000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,HCV FIBROSURE,GGT,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,RPR REFLEX TITRE TPPA,RPR,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.1,0.0,0.0,0.0,0.04523809523809524,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,HEPATITIS BS AB QL,HEPATITIS B SURF AB QL,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.01112253319366252,0.0,0.0,0.0,0.0,0,544346,IRON TIBC SERUM,IRON BINDING CAPACITY,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,COMPLETE BLOOD COUNT,BASOPHILS %,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,HEPATITIS B SURFACE AG,HEPATITIS B SURFACE AG,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,FERRITIN,FERRITIN,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,CMP14 HP4 DBILI CBC D PLT R,C REACTIVE PROTEIN QUANT,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,URINALYSIS WITH MICROSCOPIC,PH,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,RPR,RPR RESULT,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.134,0.0,0.0,0.08,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CBC WITH AUTO DIFF,EOSINOPHILS ABSOLUTE,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,HEPATIC FUNCTION PANEL A,TOTAL PROTEIN,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,CMP14 LP TP TSH 4AC CBC D P,HEMATOCRIT,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,THYROXINE T4 FREE,T 4 FREE,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,CMP,BUN,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,URINALYSIS,NITRITE,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,CBC WITH ABSOLUTE NEUTROPHIL COUNT,NEUTROPHILS,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,CBC WITH PLT DIFF,NUCLEATED RBCS,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,COMPLEMENT COMPONENT C4C,COMPLEMENT COMPONENT C4C,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,PAIN MANAGEMENT 8,CREATININE,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,TSH,TSH,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,PROFILE 104 LIVER,AST SGOT,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,HCV RNA NS5A GENOTYPE,LEDIPASVIR RESISTANCE,Ceruloplasmin,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc
0.0,0.0625,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,CBC WITH PLT DIFF,MPV,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,DIFFERENTIAL MANUAL,PLATELET ESTIMATION,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,LIPID PANEL AMA,CHOLESTEROL HDL RATIO,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,HGB A1C WITH EAG ESTIMATION,HEMOGLOBIN A1C,Monocytes,Monocytes [#/volume] in Blood,Monocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.00936038251246707,0.0,0.0,0.0,0.0,0,296095,HGB A1C WITH EAG ESTIMATION,HEMOGLOBIN A1C,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,IRON BINDING CAPACITY,TIBC,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,LIVER FIBROSIS FIBROTEST,FIBROSIS STAGE,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0825,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,URINALYSIS WITH MICROSCOPIC,EPITHELIAL CELLS,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,CBC W DIFF PLT,RBC,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.14333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,339143,CHEM SCREEN PANEL,EGFR NON AFR AMERICAN,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.0769832768017027,0.08055537486383768,0.09169555407390673,1,301804,CBC WITH AUTO DIFF,BASOPHILS %,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,LIVER FIBROSIS PNL HEPASCORE TM,METAVIR SCORE,Body weight,Body weight Measured,Weight Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,MORPHOLOGICAL REVIEW,MORPHOLOGICAL REVIEW,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,HEPATITIS B CORE IGM ANTIBODY,HEP B CORE IGM ANTIBODY,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.025714285714285714,0.01636363636363636,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,CMP14 LP 6AC,PHOSPHORUS,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,URINALYSIS CULTURE IF INDICATED,LEUKOCYTE ESTERASE,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,REFLEX ANA PATTERN,PATTERN 1,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,DACLATASVIR RESISTANCE,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.0,0.0,0.0,0.465,0.465,0.0,0.0,0.0,0.0,0.0,0.0,1,82511,LYMPHOCYTE SUBSET PANEL 4,COMMENTS,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,SPECIAL A 2 PANEL #9633,POLYS,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,ASH FIBROSURE,HEIGHT,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,VITAMIN B 12 FOLIC ACID,VITAMIN B 12,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,CBC W DIFF PLT,MPV,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.2857142857142857,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,HCV FIBROSURE,COMMENT,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,COMP METABOLIC PANEL,ANION GAP,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,CBC PLATELET HEM REVIEW,NEUTROPHILS ABSOLUTE,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,ALBUMIN CREATININE RATIO URINE RANDOM,CALC ALBUMIN CREAT RND,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,HIV ANTIBODY 1 WESTERN BLOT,HIV WB INTERP,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,VITAMIN D 25 OH LCMSMS W REFLEX,VITAMIN D 25 OH D3,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,HEPATITIS C AB,HEPATITIS C AB,Bacteria identified,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,HELPER T LYMPH CD4,HEMATOLOGY COMMENTS,Body weight,Body weight Measured,Weight Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,HIV 1 QUANT PCR,HIV 1 VIRAL COPY,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,CD4 CD8 LYMPHOCYTE ENUMERATION,PERCENT CD4,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,CBC WITH AUTO DIFF,HEMATOCRIT,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.08581504994646605,0.11153417675642818,1.0,1,181826,COMPREHENSIVE METABOLIC PANEL,OSMOLALITY,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,COMP METABOLIC PANEL 14,EGFR IF AFRICN AM,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BENZODIAZEPINES,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,URINE PROTEIN TOTAL RANDOM W O CREATININE,PROTEIN TOTAL RANDOM UR,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,HCV RNA NS5A GENOTYPE,VELPATASVIR RESISTANCE,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,COMPREHENSIVE METABOLIC PANEL WITH GFR,ANION GAP,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,URINALYSIS W MICRO W REFLEX CULTURE,NITRITES,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.11,0.16166666666666665,0.44,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.07163871665340582,0.09716253076254433,1.0,1,57976,UA MICROSCOPIC REFLEX CULTURE,KETONES,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.08333333333333333,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.07032373783772172,0.0,0,302398,CMP14 HP5 LP 6AC CBC D PLT,MAGNESIUM SERUM,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,ACCUTYPE R IL28B,ACCUTYPE R IL28B,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,EP LP 11AC CBC D PLT TSH FER,CALCIUM,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,ANA TITER PATTERN,ANA PATTERN,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,NMR LIPOPROFILE,LDL P,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,BMP,C02 BICARBONATE,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,TSH W REFLEX FT4,TSH 3RD GENERATION W REFLEX FT4,Erythrocyte morphology finding,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CMP14 HP4 DBILI CBC D PLT R,C REACTIVE PROTEIN QUANT,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,PSA FREE TOTAL,FREE PSA,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.25,0.31799999999999995,1.0,0.25,0.31799999999999995,1.0,0.04511383330738772,0.0,0.0,0.04511383330738772,0.0,0.0,1,305227,CARDIO CRP R,CARDIO CRP R,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,FIBROACT COMPLETE,WEIGHT LBS,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,CBC W AUTO DIFF,ABS NEUTROPHILS,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,PROTEIN ELECTRO S,GAMMA GLOBULIN,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,ALPHA FETOPROTEIN TUMOR MARKER,ALPHA FETOPROTEIN TUMOR,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.3333333333333333,0.1325,0.265,0.0,0.0,0.0,0.010713541722103481,0.014232105164471598,0.01954574209274329,1,453530,LYMPHOCYTE SUBSET PANEL 5,ANALYZED DATE TIME NR,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,LIPID PROFILE,NON HDL CHOLESTEROL,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,CBC W DIFF PLT,MPV,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,CCP ANTIBODY IGG,ANTI CCP IGG,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD8 CELLS,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,LYMPHOCYTE SUBSET PANEL 5,ANALYZED DATE TIME NR,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.16,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,UA M W RFLX CULTURE COMP,WBC,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.25,0.16666666666666666,0.0,0.0,0.0,0.0,0.09341591340147393,0.0,0.0,1,7898,CBC INCLUDES DIFFERENTIAL PLATELETS,RBC,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,FERRITIN,FERRITIN SERUM,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,URINALYSIS W REFLEX MICRO,UROBILINOGEN,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,PE INTERP RFX IFE S,ALBUMIN,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,BAND NEUTROPHILS,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06691275831255872,0.06348916544989514,0.09169555407390673,1,7062,CBC INCLUDES DIFF PLT,BASOPHILS %,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,CBC W AUTO DIFF WITH PLATELETS,RBC,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,RPR HBSAG HCVAB HSV1 HSV2 I,HEP C VIRUS AB,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,HEPATITIS BE ANTIGEN,HEP BE ANTIGEN,Prothrombin.activity actual/Normal,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,BMP,C02 BICARBONATE,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,HCV QUANT GT1A NS5A PROFILE,HCV LOG10,pH,pH of Urine by Test strip,pH Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,URINALYSIS ROUTINE W RFX,BILIRUBIN,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,NEG HIV 4TH GEN,HIV 1 AB WESTERN BLOT,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,LIPID PANEL STANDARD,CHOLESTEROL HDL RATIO,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,SPECIAL PROFILE 3619,LEUKOCYTE ESTERASE,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,PSA TOTAL % FREE,% FREE PSA,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,TESTOSTERONE FREE TOTAL LC MS,TESTOSTERONE TOTAL LC MS,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,NEG HIV 4TH GEN,NEG HIV 1 ANTIBODY,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.3333333333333333,0.25,0.0,0.0,0.0,0.0,0.1503314858492919,0.0,0.0,1,264531,CBC W O DIFF WITH PLATELETS,RBC,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,DRUG ABUSE SCREEN III,COCAINE METABOLITE,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,HCV FIBROSURE,LIMITATIONS,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.03571428571428571,0.022727272727272728,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,ARTHRITIS PROFILE,ANTI NUCLEAR ANTIBODIES,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,MICROALBUMIN RANDOM URINE W CREATININE,MICROALBUMIN CREATININE RATIO RANDOM URINE,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,CBC WITH MANUAL DIFFERENTIAL,EOSINOPHILS,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,DACLATASVIR RESISTANCE,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,URINALYSIS W REFLEX MICRO,BACTERIA,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,CBC WITH DIFFERENTIAL,ABS NEUTROPHILS,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,CYCLIC CITRULLINATED PEPTIDE CCP AB IGG,CYCLIC CITRULLINATED PEPTIDE CCP AB IGG,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,CMP WITH ESTIMATED GFR CALCULATED,CARBON DIOXIDE,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,HNK1 CD57 PANEL,LYMPHS ABSOLUTE,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS B SURFACE AB,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,PATHOLOGIST SMEAR REVIEW,RBC,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.75,0.75,0.75,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,LIVER FIBROTEST ACTITEST,FIBROSIS STAGE,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,HEPATITIS C GENO TYPE 1 NS5A RESIST,OMBITASVIR RESISTANCE,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.16666666666666666,0.275,0.55,0.0,0.0,0.0,0.010820742557004048,0.03880787504793004,0.055512018790671136,0,51938,HP4 RPR,HEP C VIRUS AB,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,BMP8 CBC D PLT,CREATININE,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.025,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,CBC WITH DIFFERENTIAL PLATELETS,MCH,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D2,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,HEMOGLOBINOPATHY INDICES,HEMATOCRIT,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.03666666666666667,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,PATHOLOGIST SMEAR REVIEW,RBC,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.06899999999999999,0.11499999999999999,0.0,0.022,0.03666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,BASIC METABOLIC PANEL,BUN CREATININE RATIO,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,CHEM PROFILE 29,ALK PHOS,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,FIBROMETER VIRUS,GAMMA GLUTAMYL TRANSFERASE FM,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.0,0.0,0.0,0.14333333333333334,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.02446945846686055,0.08969841024226421,1,7732,CBC WITH PLT DIFF,NUCLEATED RBCS,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,HIV 1 HIV 2 AB RFLX,HIV 1 WESTERN BLOT RESULT,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,PSA FREE TOTAL,PSA FREE,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.2544444444444445,0.38166666666666665,0.0,0.0,0.0,0.0,0.025425559932405584,0.04202185668774028,0.0,0.0,0.0,0,481598,HEPATITIS C VIRAL RNA NS3 GENOTYPE,BOCEPREVIR RESISTANCE,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,HEPATITIS A TOTAL AB REFLEX IGM,HEPATITIS A TOTAL AB,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,CBC WITH PLT DIFF,NRBC,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,CBC W AUTO DIFF ABS WBC MPV PLT,MCHC,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,PROSTATE SPECIFIC ANTIGEN PSA,PSA,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0825,0.08833333333333333,0.0,0.22,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.08318397885080242,1.0,1,57703,URINALYSIS ROUTINE W RFX,BILIRUBIN,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,CMP WITH ESTIMATED GFR CALCULATED,CARBON DIOXIDE,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,VIT B 12 FOLATE PANEL,VITAMIN B 12,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,PSA FREE TOTAL,PSA FREE,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,MICROALBUMIN CONC,ALB CREAT RATIO,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,COMPREHENSIVE METABOLIC PANEL AMA,CHLORIDE,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,URINALYSIS W MICROSCOPIC,URINALYSIS URINE COLOR,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,ANACHOICE SCR W REFL TITER IFA,ANA SCREEN IFA,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.27999999999999997,0.09090909090909091,0.2,0.2,0.09090909090909091,0.2,0.03501471280402846,0.02619755394479084,0.0413729178490605,0.04288408992998327,0.032085319836887005,0.0506712689501424,1,602797,ACCUTYPE R IL28B,IL28B GENOTYPE,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.125,0.2,0.75,0.0,0.0,0.0,0.0059890119329250036,0.0,0.0,0.0,0.0,0.0,0,426171,HCV FIBROSURE,FIBROSIS SCORE,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,CBC WITH PLT DIFF,LYMPHOCYTES ABSOLUTE,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.048791106490973624,0.0,0.0,0.0,0.0,0,330373,IFE PE FLC SERUM,ALBUMIN,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,HCV GT3 NS5A DRUG RESIST ASSAY,HCV NS5A DRUG RESIST ASSAY,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.010714285714285714,0.0375,0.0,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.06317690320497038,0.0,0,204164,CMP12 LP 6AC,PHOSPHORUS SERUM,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.22,0.0,0.0,0.22,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,HEPATITIS B SURFACE ANTIBODY,HEPATITIS B SURFACE AB QUAL,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,PE INTERP RFX IFE S,BETA GLOBULIN,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,RDW,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,DRUG ABUSE SCREEN II,METHAQUALONE,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,CMP14 4AC,EGFR IF NONAFRICN AM,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,HCV RNA PCR QN RFX NSA,HCV GENOSURE R NSA PDF,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,LIVER FIBROTEST ACTITEST,NECROINFLAMMAT ACT SCORE,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.3316666666666666,0.0,0.0,0.2783333333333333,0.4488888888888889,0.6733333333333333,0.0,0.0,0.0,0.01134702515129804,0.27088019091696647,0.4476947053485614,1,481598,RPR HBSAG HCVAB HSV1 HSV2 I,HEP C VIRUS AB,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,IMMUNOGLOBULINS,IMMUNOGLOBULIN M,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,RHEUMATOID FACTOR,RHEUMATOID FACTOR,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,CBC WITH PLT DIFF,WBC MORPHOLOGY,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE NEUTROPHILS,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,LIPID PANEL AMA,NON HDL CHOLESTEROL,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.13125,0.2625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,CBCI COMPLETE BLOOD COUNT W DIFF,MCV,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.5,0.16666666666666666,0.2,0.0,0.0,0.0,0.11136168435129556,0.05936451274361987,0.17946985244079683,1,63016,PROTHROMBIN TIME,INR,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,CBC,% BASOPHILS,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,MORPHOLOGICAL REVIEW,MORPHOLOGICAL REVIEW,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,CUSTOM HEPATITIS PANEL,HEPATITIS C ANTIBODY,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,HEPATITIS A TOTAL AB REFLEX IGM,HEPATITIS A TOTAL AB,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,PTH INTACT,PARATHYROID HORMONE INTACT,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,CBC WITH PLT DIFF,WBC MORPHOLOGY,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,NGI HCV QUANTASURE,HEPATITIS C QUANTITATION,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,CD4 T4 ENUMERATION,ABSOLUTE LYMPHOCYTES,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.0,0.0,0.1075,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,882944,CMP14 4AC,EGFR IF NONAFRICN AM,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,SPECIAL PROFILE 3619,LEUKOCYTE ESTERASE,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,HCV RNA GENOTPE 1 NS5A DRUG RE,OMBITASVIR RESISTANCE,Prothrombin.activity actual/Normal,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,HEMOGRAM W AUTOMATED DIFF,WBC,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,HCV RNA PCR QN RFX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,ANA SCR IFA RFL TITR PATT,ANA SCREEN IFA,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,DRUG ABUSE PANEL 10 WITH OXYCODONE,BENZODIAZEPINES,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,COMPREHENSIVE METABOLIC PANEL WITH GFR,CREATININE,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.14285714285714285,0.0,0.24333333333333332,0.14285714285714285,0.0,0.0,0.0374090401158268,0.0,0.0,0.0,0.0,0,544346,PROTEIN ELEC INTERP SERUM,P E INTERPRETATION S,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,TESTOSTERONE FREE TOTAL,FREE TESTOSTERONE DIRECT,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.2866666666666667,0.2866666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,CBCI COMPLETE BLOOD COUNT W DIFF,MCHC,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,MITOCHONDRIAL M2 AB,MITOCHONDRIAL M2 AB,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,EP LP 11AC CBC D PLT TSH FER,CALCIUM,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,FE ANA TIBC FER PTT PT A1A,MITOCHONDRIAL M2 ANTIBODY,Leukocyte morphology finding,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,CBC W AUTO DIFF,ABS NEUTROPHILS,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,FE ANA TIBC FER A1A AMA ASM,ALPHA 1 ANTITRYPSIN SERUM,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS B SURFACE AB,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.4333333333333333,0.48250000000000004,0.93,0.5766666666666667,0.48250000000000004,0.93,0.0,0.21473154461722554,0.18596297263238892,0.017380646215893303,0.10927182779409028,0.18926435757528148,1,28886,URINE PROTEIN TOTAL RANDOM W O CREATININE,PROTEIN TOTAL RANDOM UR,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,ALKALINE PHOSPHATASE,LIPEMIA,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,CBC INC DIFF PLT,PLATELET COUNT,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,CMP,ALT SGPT,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,CLR CBC W DIFF PLT,ABSOLUTE EOSINOPHILS,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,ANA SCREEN QUAL,ANA ANTIBODY SCREEN EIA,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.034,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,UA MICROSCOPIC REFLEX CULTURE,SPECIFIC GRAVITY,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,COMPREHENSIVE METABOLIC PANEL,GLUCOSE,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,FIBROACT COMPLETE,HEIGHT INCHES,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,TSH FREE T4 PROFILE,TSH THIRD GENERATION,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,HEPATIC FUNCTION PANEL,ALT,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.15,0.2,0.0,0.0,0.0,0.0,0.0,0.0449917128842755,0.0,0.0,0.0,0.0,0,172841,PROTEIN ELEC INTERP SERUM,P E INTERPRETATION S,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,CMP14 LP 2AC CBC D PLT MG T,WBC,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,COMP METABOLIC PANEL,SODIUM,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.05555555555555555,0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,CBC DIFF PLT,RDW,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.0,0.0,0.0,0.31666666666666665,0.25,1.0,0.0,0.0,0.0,0.0,0.10964330813284906,0.7071067811865476,1,264499,CBC WITH PLT DIFF,EOSINOPHILS ABSOLUTE,Eosinophils,Eosinophils [#/volume] in Blood,Eosinophil # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,CBC WITH PLT MAN DIFF,BANDS ABSOLUTE,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,URINALYSIS W MICROSCOPIC,URINALYSIS URINE COLOR,Body weight,Body weight Measured,Weight Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,NASH FIBROSURE,AST SGOT P5P,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,URINALYSIS CULTURE IF INDICATED,OCCULT BLOOD,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,326249,CYSTIC FIBROSIS SCREEN,ETHNICITY,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,TSH ULTRASENSITIVE,TSH ULTRASENSITIVE,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN RT PCR LOG COPIES ML,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,LIPID CASCADE W RFLX APOLIB,LDL HDL RATIO,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,PROTEIN 24 HOUR URINE,PROTEIN URINE CONC,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.04857142857142858,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,HEPATITIS PANEL AMA,HEPATITIS C ANTIBODY,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,COMPREHENSIVE METABOLIC PANEL W EGF,AST,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,PROTHROMBIN TIME,INR,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,PROTHROMBIN TIME PT,PT CONTROL,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.1775,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,CBC RBC H H INDICES WBC PLT,RED BLOOD CELL COUNT,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,CBC WITH PLT DIFF,MEGAKARYOCYTE FRAGS,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,PTT,PTT,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,UA MICROSCOPIC REFLEX CULTURE,BILIRUBIN,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.16699999999999998,0.33399999999999996,0.0,0.16699999999999998,0.33399999999999996,0.0,0.03617324670110522,0.07759701258884111,0.0,0.04430299837876139,0.09503654320349175,0,79053,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,LYMPHOCYTE SUBSET PANEL 4,RACE NR,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,COMPREHENSIVE METABOLIC PANEL,GLUCOSE,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.08823529411764706,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,CBC W AUTO DIFF WITH PLATELETS,RBC,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.08571428571428572,0.3,0.0,0.14285714285714285,0.5,0.0,0.051583725460460195,0.14539805437566944,0.0,0.06317690320497038,0.17807552140691663,0,204164,CUSTOM HEPATITIS PANEL,HEPATITIS C ANTIBODY,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,EP LP 11AC CBC D PLT TSH FER,CALCIUM,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,CMP14 LP 1AC CBC D PLT TSH,LYMPHS,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,ANION GAP,ANION GAP,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,COMPREHENSIVE METABOLIC PANEL E GFR,ALBUMIN,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,PE INTERP RFX IFE S,ALBUMIN,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,DIFFERENTIAL MANUAL,EOSINOPHILS,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,LYMPHOCYTE SUBSET PANEL 3,CD4 CD8 RATIO,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,HDL CHOL DIRECT,HDL AS % CHOLESTEROL,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,VAP CHOLESTEROL PROFILE,TRIGLYCERIDES,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,CBC WITH AUTO DIFF,WBC,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0,0.0,0.0,0.0,0.029333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,PROTEIN TOTAL W CREAT RANDOM URINE,PROTEIN CREATININE RATIO,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,URINALYSIS WITH REFLEX MICROSCOP,PROTEIN TOTAL QUAL,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,FIBROACT COMPLETE,APOLIPOPROTEIN A1,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,CMP14 CBC D PLT ESR WES ANA,NEUTROPHILS,Prothrombin.activity actual/Normal,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE LYMPHOCYTES,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,CBC W O DIFF WITH PLATELETS,MCV,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.02948276095739455,0.0,0.0,0.0,0.0,0,303768,CBCI COMPLETE BLOOD COUNT W DIFF,DIFFERENTIAL NEUTROPHILS,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE MONOS,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,HCV RNA QN GRAPH RFX NSA,HEPATITIS C QUANTITATION,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,URINE DRUG SCREEN 1,CREATININE,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.26,0.195,0.39,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,URINALYSIS W MICRO,GLUCOSE,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,TESTOSTERONE FREE LC MS MS,TESTOSTERONE FREE LC MS MS,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,PE FLC SERUM,ALBUMIN,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,ANTI SMOOTH MUSCLE MITOCHOND,MITOCHONDRIAL M2 ANTIBODY,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.25,0.25,0.9,0.0,0.0,0.0,0.04253195834778967,0.09791498600859527,0.5773502691896257,0,81240,LYMPHOCYTE SUBSET PANEL 2,% CD4 HELPER CELLS,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,ANACHOICE SCR W REFL TITER IFA,ANA SCREEN IFA,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,CRYOGLOBULINS REFLEX IFE QUANT,IGM CRYOPRECIPITATE,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,CBC W AUTO DIFF,MONOCYTES %,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,HIV 1 QUANT PCR,HIV 1 VIRAL LOG,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,HCV FIBROSURE,LIMITATIONS,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.3457142857142857,0.484,0.0,0.0,0.0,0.0,0.03757248195290985,0.019708082981313435,0,223149,HBSAB AG,HEP B SURFACE AB QUAL,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.25,0.16666666666666666,0.94,0.0,0.0,0.0,0.041038896172230555,0.0464934312836901,0.0,0.0,0.0,0.0,0,93179,CBC W DIFF PLATELET,MCH,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,203927,PHOSPHATE AS PHOSPHORUS,ICTERUS,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,COMPLEMENT C4 SERUM,COMPLEMENT C4 SERUM,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,LIVER FIBROSIS FIBROTEST ACTITEST,NECROINFLAMMAT ACT GRADE,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,HEPASCORE R,AGE,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,FREE T4 THYROXINE,FREE T4,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,DRUG ABUSE SCREEN CLINICAL 9,COCAINE,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,VITAMIN D 25 OH TOTAL,VITAMIN D 25 OH TOTAL,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,CBC DIFF PLT,MCH,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,DRUG PANEL 8 SCREEN,OPIATES,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,ANA TITER PATTERN,ANA TITER,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.0,0.0,0.46499999999999997,0.4,0.6666666666666666,0.0,0.0,0.0,0.034103916281504665,0.16901735079974012,1.0,1,104661,COMP METABOLIC PANEL,ANION GAP,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.14285714285714285,0.3333333333333333,0.0,0.0,0.0,0.0,0.06603415273894597,0.07093517271816319,0.0,0.0,0.0,0,18358,ALPHA 1 ANTITRYPSIN PHENOTYPE,A 1 ANTITRYPSIN PHENOTYPE,Alpha-2-Macroglobulin,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.10031748330730439,0.10964330813284906,0.7071067811865476,1,303768,CBC INCLUDES DIFF PLT,ABSOLUTE BLASTS,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,ASH FIBROSURE,HAPTOGLOBIN,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,EOSINOPHILS #,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,CBC WITH PLT DIFF,MEGAKARYOCYTE FRAGS,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,AMY LIPASE,AMYLASE,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,URINALYSIS COMPLETE,BILIRUBIN,Ceruloplasmin,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,PROTHROMBIN TIME INR,PROTHROMBIN TIME,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,CMP WITH ESTIMATED GFR CALCULATED,ALBUMIN,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,PROTHROMBIN TIME PT,PROTHROMBIN TIME PT,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A DRUG RESISTANCE ASSAY,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,MORPHOLOGICAL REVIEW,MORPHOLOGICAL REVIEW,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,DIRECT LDL,DIRECT LDL,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,HCV FIBROSURE LABCORP,RESULT,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,FREE T4 THYROXINE,FREE T4,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,ACUTE HEPATITIS PANEL,HEPATITIS B SURFACE ANTIGEN,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,CBC W AUTO DIFF,MCHC,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,RPR,RPR RESULT,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,LIPID PANEL AMA,NON HDL CHOLESTEROL,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,DRUG ABUSE SCREEN 9 NO THC W CONF,OXYCODONE,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,HCV RNA GENOTPE 1 NS5A DRUG RE,OMBITASVIR RESISTANCE,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,BMP8 EGFR,POTASSIUM,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,HCV RNA PCR QN GRAPH RFX NS5A,HCV NS5A RESIST ASSAY INTERP,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,MICROALBUMIN RANDOM,MICROALBUMIN RANDOM,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,COMPREHENSIVE METABOLIC PANEL,OSMOLALITY,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,IRON TOTAL BINDING CAPACITY,% SATURATION,Erythrocytes,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,CBC WITH DIFFERENTIAL,NEUTROPHILS,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.0,0.0,0.06666666666666667,0.05,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE LYMPHOCYTES,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,HEP B SURFACE AG W REFLEX,HEP B SURFACE AG W REFLEX,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,LIVER FIBROTEST ACTITEST,HAPTOGLOBIN,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,CBC WITH PLT DIFF,BLASTS,Body weight,Body weight Measured,Weight Measured
0.1075,0.0,0.0,0.23249999999999998,0.0,0.0,0.0,0.0,0.0,0.018324914347742194,0.016002505041782356,0.026415305742815254,1,486423,CMP WITH EGFR,EGFR NON AFRICAN AM,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,RPR,TREPONEMA PALLIDUM ANTIBODIES,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,IRON BINDING CAPACITY,TIBC,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,IRON PANEL,IRON,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.22333333333333336,0.2,0.0,0.3333333333333333,0.0,0.0,0.0,0.04324449838094624,0.022105502111269937,0.04442890992893567,0.0,0.0,0,28902,MICROALBUMIN CREATININE RANDOM RATIO,CALC MICROALB CREAT RND,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,HIV 4TH GEN RFLX CONF,HIV 4TH GEN RFLX CONF,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,HEPATITIS PANEL ACUTE,HEPATITIS A IGM,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,COMPREHENSIVE METABOLIC PANEL AMA,GLOBULIN,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,MANUAL DIFFERENTIAL,EOSINOPHILS ABSOLUTE,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.09,0.08333333333333333,0.125,0.0,0.03,0.045,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,COMPREHENSIVE METABOLIC PANEL E GFR,CALC GLOBULIN,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN RT PCR LOG COPIES ML,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.07026134084271496,0.0,0,45443,LYMPHOCYTE SUBSET PANEL 4,ABS CD4 COUNT,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,CBCI COMPLETE BLOOD COUNT W DIFF,ABS NEUTROPHILS,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,COMP METABOLIC PANEL 14,EGFR IF AFRICN AM,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0085,0.017,0.0,0.075,0.05,0.0,0.0,0.0,0.0,0.018478101187162754,0.0,0,486423,URINALYSIS WITH MICROSCOPIC,RED BLOOD CELLS,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,IRON TIBC,TRANSFERRIN SAT %,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.03142857142857143,0.044,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,BMP8 EGFR,POTASSIUM,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.052529819653824195,0.0,0,203943,IRON BINDING CAPACITY % SATURATION,IRON SERUM,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,DRGABU2,METHAQUALONE,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,MITOCHONDRIAL ANTIBODY W REFL TITER,MITOCHONDRIAL AB SCREEN,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,HEPATITIS C VIRAL RNA NS3 GENOTYPE,BOCEPREVIR RESISTANCE,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,CBC WITH PLT DIFF,LYMPHOCYTES ABSOLUTE,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,BUN CREATININE RATIO,ICTERUS,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.25,0.16666666666666666,0.5,0.0,0.0,0.0,0.05209453566766953,0.09815496092726139,0.1063004130698838,0,29918,TSH FT4,FREE T4,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,CBC WITH AUTO DIFF,EOSINOPHILS #,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.11000000000000001,0.0,0.0,0.58,0.6666666666666666,0.9666666666666667,0.0,0.0,0.0,0.3757978134029263,0.022046838418816495,0.022046838418816495,1,487934,LIVER FIBROSIS FIBROTEST ACTITEST,NECROINFLAMMAT ACT GRADE,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,IMMUNOGLOBULIN A,IMMUNOGLOBULIN A,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.054432052556039556,0.0,0.0,0.0,0.0,0,295410,URINALYSIS WITH MICROSCOPIC,UROBILINOGEN,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,CARDIO CRP R,CARDIO CRP R,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.066,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06846967404361237,0.3219325786555107,1.0,1,15586,COMPREHENSIVE METABOLIC PANEL,GLUCOSE,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1059787103279074,0.0,0,30163,CMP14 HP5 LP 6AC CBC D PLT,MAGNESIUM SERUM,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,HEP B CORE TOTAL AB,HEP B CORE TOTAL AB,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,PTT,PTT,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.05054997977933906,0.0,0.0,0.0,0.0,0,29868,IRON TIBC SERUM,IRON BINDING CAPACITY,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,ACCUTYPE R IL28B,IL28B GENOTYPE,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,IMMUNODEF PROFILE #1,ABSOLUTE CD3,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,HEP B SURFACE AG W REFLEX,HEP B SURFACE AG W REFLEX,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,HEPATITIS B SURFACE AG,HEPATITIS B SURFACE AG,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.16666666666666666,0.14285714285714285,0.25,0.0,0.0,0.0,0.010289522566276799,0.011633906360121626,0.024157689081775402,0,427682,HEPATITIS A DIAGNOSTIC PANEL,HAV AB TOTAL,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,URINALYSIS W REFLEX MICRO,WHITE BLOOD CELLS,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,C REACTIVE PROTEIN CARDIAC,C REACTIVE PROTEIN CARDIAC,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,IRON TOTAL IRON BIND CAPACITY,TIBC,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,PSA TOTAL % FREE SERIAL,% FREE PSA,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,COMP METAB PANEL,ALT,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,BMP8 EGFR,POTASSIUM,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.006,0.008571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,CMP14 LP 5AC CBC D PLT RPR,HEMOGLOBIN A1C,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.05171526843986196,0.0,0,134585,C4 C3,COMPLEMENT C3 SERUM,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.045219878571918226,0.0,0,15586,B12,VIT B12 SERUM,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,OBSTETRIC PANEL INCLUDING HIV,HEMOGLOBIN,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.1,0.125,0.0,0.0,0.0,0.0,0.04432042353220711,0.0,0.0,0.0,0.0,0,381806,CBC WITH DIFFERENTIAL PLATELETS,POLYS,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,LIVER FIBROSIS FIBROTEST ACTITEST,BILIRUBIN,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,BASIC METABOLIC PANEL 8,EGFR IF AFRICN AM,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.06625,0.1325,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,VELPATASVIR RESISTANCE,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.43,0.14285714285714285,0.3333333333333333,0.43,0.2857142857142857,0.6666666666666666,0.0,0.037676737156380646,0.038305767913941025,0.0,0.11303021146914194,0.11491730374182318,1,20958,HDL CHOL DIRECT,HDL AS % CHOLESTEROL,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,HEPATITIS C GENO TYPE 1 NS5A RESIST,OMBITASVIR RESISTANCE,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,CBC WITH ABSOLUTE WHITE BLOOD CELLS,RDW,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,CBC WITH PLT DIFF,WBC MORPHOLOGY,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,DRUG ABUSE SCREEN 11 W ETOH W CONF,OXYCODONE,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,CMP14,EGFR IF AFRICN AM,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.07333333333333333,0.04,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,DRUG ABUSE SCREEN 9 NO THC W CONF,OXYCODONE,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,CMP14 LP CBC D PLT,NEUTROPHILS,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,PE INTERP RFX IFE S,BETA GLOBULIN,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.134,0.0,0.0,0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,CBCI COMPLETE BLOOD COUNT W DIFF,DIFFERENTIAL NEUTROPHILS,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,LYMPHOCYTE SUBSET PANEL 1,% CD3 MATURE T CELLS,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,CBC WITH PLT DIFF,LYMPHOCYTES ABSOLUTE,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,LYMPHOCYTE SUBSET PANEL 2,HELPER SUPPRESSOR RATIO,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,ALPHA 1 ANTITRYPSIN QN,ALPHA 1 ANTITRYPSIN QN,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,CBC WITH AUTO DIFF,MCV,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,IMMUNOGLOBULINS,IMMUNOGLOBULIN G,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.22333333333333336,0.335,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,CCP ANTIBODY IGG,ANTI CCP IGG,Body weight,Body weight Measured,Weight Measured
0.0,0.0,0.0,0.316,0.125,0.3333333333333333,0.0,0.06192203894113468,0.0,0.0,0.624939177332759,1.0,1,28688,PROTEIN ELECTRO SERUM,ALPHA 2 GLOBULIN,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.11600000000000002,0.19333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,HCV FIBROSURE,LIMITATIONS,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.3333333333333333,0.375,1.0,0.3333333333333333,0.375,1.0,0.08176255116563813,0.0,0.0,0.08176255116563813,0.0,0.0,1,23242,GGT,GGT,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,URINALYSIS REFLEX,GLUCOSE,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,LIPID PANEL AMA,CHOLESTEROL HDL RATIO,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,CMP13 LP TP TSH 2AC CBC D P,CHOLESTEROL TOTAL,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,COMPLETE BLOOD COUNT,MEAN PLATELET VOLUME,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,URINALYSIS COMPLETE,APPEARANCE,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,URINALYSIS CULTURE IF INDICATED,NITRITE,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,PT PROTIME,INR,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS B SURFACE AB,Erythrocyte distribution width,Erythrocyte distribution width [Entitic volume],RDW RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,TESTOSTERONE SERUM,TESTOSTERONE SERUM,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,CD4 CD8 ENUMERATION,ABSOLUTE LYMPHOCYTES,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,LYMPHOCYTE SUBSET PANEL 2,% CD3 MATURE T CELL,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.3333333333333333,0.14285714285714285,0.5,0.0,0.0,0.0,0.061685809626148336,0.0,0.0,1,17426,CMP13 LP 2AC CBC D PLT,ALT SGPT,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,RHEUMATOID FACTOR,RHEUMATOID FACTOR,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.3333333333333333,0.3,0.6,0.3333333333333333,0.462,0.8,0.3222721996715985,0.5931645460412418,0.8484814328311875,0.31830503283138056,0.5858626977271595,0.8380366367603552,1,51938,HEPATITIS B SURFACE AB IMMUN,HEPATITIS B SURFACE AB IMMUNITY QN,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE MONOCYTES,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,DRUG ABUSE SCREEN W ETOH NO GCMS,AMPHETAMINES,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.14285714285714285,0.2,0.346,0.5714285714285714,0.8,0.0,0.06660212972360224,0.06720098415971731,0.035467350927838925,0.1538110300980966,0.15519402517768222,1,51953,ACUTE HEPATITIS PANEL,HEPATITIS B SURF AG,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0825,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,URINALYSIS W REFLEX MICRO,WHITE BLOOD CELLS,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,HEPATIC FUNCTION PANEL A,TOTAL PROTEIN,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.16599999999999998,0.0,0.0,0.0,0.0,0.0,0.05633911693324667,0.0,0.0,0.0,0.0,0,104661,PROTEIN ELECTROPHORESIS SERUM,INTERPRETATION,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,LIVER FIBROSIS PANEL,ALT,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.03302675712634284,0.0,0.0,0.0,0.0,0,7518,CBCM COMPLETE BLOOD CNT W MAN DIFF,EOSINOPHILS,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.055,0.033,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,COMP METAB PANEL,ALBUMIN GLOBULIN RATIO,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.3333333333333333,0.29666666666666663,0.0,0.5766666666666667,0.1111111111111111,0.0,0.010857222961510482,0.30494157177919345,0.0,0.04786359231046444,0.06917196297270611,0.0,1,59014,PROTHROMBIN TIME PT,PT CONTROL,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.05181818181818181,0.0,0.0,0.05181818181818181,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,RPR SCREEN W TITER,RPR SCREEN,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,CBCI COMPLETE BLOOD COUNT W DIFF,ABS NEUTROPHILS,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.05720402135206337,0.0,0,7310,CBC INC DIFF PLT,PLATELET COUNT,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.06809002533324715,0.4808823462371743,0.7071067811865476,1,17517,CMP12 2AC,ALBUMIN SERUM,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,CBC INCLUDES DIFFERENTIAL PLATELETS,RBC,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,CBC WITH DIFFERENTIAL PLATELETS,POLYS,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,PAIN MANAGEMENT 8,CREATININE,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,HIV AB EIA WITH REFLEXES,HIV AB,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,C4 SERUM,C4 SERUM,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,NEG HIV 4TH GEN,NEG HIV 1 RNA QL TMA,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,CMP14 LP CBC D PLT TSH UA M,AST SGOT,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,HEP C RNA GENOT 3 NS5A,VELPATASVIR RESISTANCE,Monocytes,Monocytes [#/volume] in Blood,Monocytes # Bld
0.0,0.09999999999999999,0.18,0.0,0.03666666666666667,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,DRUG ABUSE SCREEN III,COCAINE METABOLITE,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.0,0.0,0.25,0.2,0.25,0.0,0.0,0.0,0.0746172002260781,0.0,0.0,1,349993,CBC PLT DIFF,POLYS,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,LYMPHOCYTE SUBSET PANEL 2,CD4 ABSOLUTE,Erythrocytes,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,CMP12 LP 6AC,PHOSPHORUS SERUM,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD8 CELLS,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.0,0.0,0.2375,0.25,0.3333333333333333,0.0,0.0,0.0,0.0,0.08253790759907542,0.0946521642027649,1,264507,CBC W AUTO DIFF ABS WBC MPV PLT,EOSINOPHILS,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,COMPREHENSIVE METABOLIC PANEL E GFR,CARBON DIOXIDE,Bacteria identified,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,HEMATOPATH CONSULTATION SMEAR,WBC,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,CBC WITH AUTO DIFF,NRBC,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.03571428571428571,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,CBC DIFF AMBIGUOUS DEFAULT,NEUTROPHILS,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.094701559498232,0.34003516797720323,1.0,1,178616,EP LP 11AC CBC D PLT TSH FER,CALCIUM,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.11098565713428754,0.0,0.0,0,264648,CBC INCLUDES DIFF PLT,INTERNAL WBC,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,URINALYSIS W REFLEX MICRO,BACTERIA,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,HCV FIBROSURE,FIBROSIS SCORE,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,BASIC METABOLIC PANEL,ANION GAP,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.04857142857142858,0.0,0.0,0.04857142857142858,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESIST ASSAY INTERP,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.14285714285714285,0.0,0.188,0.14285714285714285,0.5,0.0,0.07507973713479688,0.0,0.0,0.0,0.0,0,28712,PROTEIN ELECTROPHORESIS,GAMMA GLOBULINS,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,REFERRED CBC,MCH,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,DRUG ABUSE PANEL 10 WITH OXYCODONE,PHENCYCLIDINE,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.11490614097199336,0.10964330813284906,0.7071067811865476,1,264747,CBC WITH PLT DIFF,LYMPHOCYTES ABSOLUTE,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,EGFR,EGFR,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,VAP CHOLESTEROL PROFILE,TRIGLYCERIDES,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.21,0.1111111111111111,0.25,0.0,0.0,0.0,0.0,0.021872967314701564,0.03507675354076545,1,32896,LIVER FIBROSIS FIBROMETER,FIBROMETER PROTHROMBIN INDEX,Prothrombin.activity actual/Normal,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,TRIGLYCERIDES REFL,TRIGLYCERIDES,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,MITOCHONDRIAL ANTIBODY W REFL TITER,MITOCHONDRIAL AB SCREEN,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,MANUAL DIFFERENTIAL,TOTAL NEUTROPHILS %,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,CMP14 LP 3AC,LDH,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0825,0.33,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,URINALYSIS WITH REFLEX MICROSCOP,PROTEIN TOTAL QUAL,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0825,0.10600000000000001,0.0,0.0725,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,URINALYSIS WITH MICROSCOPIC,UROBILINOGEN,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,BASIC METABOLIC PANEL,BUN CREATININE RATIO,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,HCV FIBROSURE,INTERPRETATION,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,COMP METAB PANEL,ALBUMIN GLOBULIN RATIO,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,COMPREHENSIVE METABOLIC PANEL E GFR,SODIUM,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,HIV 1 HIV 2 AB RFLX,HIV 1 WESTERN BLOT RESULT,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.009701325200087374,0.009863293364013592,0.0,0.009701325200087374,0.009863293364013592,0,98301,HAV AB TOTAL,HAV AB TOTAL,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,CBC W DIFF PLT,BLAST CELLS ABSOLUTE,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,VIT B 12 FOLATE PANEL,VITAMIN B 12,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,MANUAL DIFFERENTIAL,SEGMENTED NEUTROPHILS %,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,DIFFERENTIAL MANUAL,ABSOLUTE BAND NEUTROPHILS,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,LYMPHOCYTE SUBSET PANEL 3,CD4 CD8 RATIO,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,CMP WITH ESTIMATED GFR CALCULATED,CARBON DIOXIDE,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.165,0.265,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,URINALYSIS,BILIRUBIN,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,NASH FIBROSURE,HEIGHT,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.125,0.0,0.0,0.0,0.05,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,PROTEIN ELECTRO S,BETA GLOBULIN,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,ANA TITER PATTERN,ANA PATTERN,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,DRUG ABUSE SCREEN 9 NO THC W CONF,OXYCODONE,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,BMP8 EGFR,POTASSIUM,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,HB CORE AB W IGM RFX,HB CORE AB TOTAL,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,TSH FT4,TSH,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.06272727272727273,0.09857142857142856,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,CBC INCLUDES DIFF PLT,ABSOLUTE BLASTS,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,HCV RNA PCR QN GRAPH RFX NS5A,HCV NS5A RESIST ASSAY INTERP,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,TRANSFERRIN CARBOHYDRATE DEFICIENT ALCOHOL USE,TRANSFERRIN,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.24,0.25,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,1,192526,CBC WITH PLT DIFF,MEGAKARYOCYTE FRAGS,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.0,0.0,0.0,0.39999999999999997,0.2285714285714286,1.0,0.0,0.0,0.0,0.0,0.41219810878268626,0.4228537636689047,1,433961,LIPID PANEL,NON HDL CHOLESTEROL,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,ARTHRITIS PROFILE,ANTI NUCLEAR ANTIBODIES,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,ALPHA FETOPROTEIN TUMOR MARKER,ALPHA FETOPROTEIN TUMOR,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,CMP WITH EGFR,ALKALINE PHOSPHATASE,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0,22764,CBC W AUTO DIFF,MEAN PLATELET VOLUME,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,IMMUNOFIXATION SERUM,IMMUNOGLOBULIN M,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.3333333333333333,0.42857142857142855,1.0,0.0,0.42857142857142855,0.6666666666666666,0.050078247894864814,0.0,0.0,0.0,0.6736085929872226,0.7002224033044667,1,28571,PSA TOTAL REFLEX FREE,PROSTATE SPECIFIC AG SERUM,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,FSRC NEW PATIENT PANEL,D BILIRUBIN,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.146,0.16666666666666666,0.5,0.0,0.0,0.0,0.0,0.07402207708426334,0.35355339059327373,0.0,0.07402207708426334,0.0,1,128512,PROTEIN ELECTROPHORESIS SR W RFX,INTERPRETATION,Protein pattern,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,ASH FIBROSURE,COMMENT,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,CMP14 LP 5AC CBC D PLT RPR,WBC,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,COMPREHENSIVE METABOLIC PANEL E GFR,CALC GLOBULIN,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,MANUAL DIFFERENTIAL,EOSINOPHILS ABSOLUTE,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.03125,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,DRUG ABUSE SCREEN W ETOH NO GCMS,BARBITURATES,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,FIBROACT,ALT,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,HEMOGLOBIN A1C WITH EAG,ESTIMATED AVERAGE GLUCOSE,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,TESTOSTERONE,TESTOSTERONE,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,CMP14 CBC D PLT RPR UA TSH,NEUTROPHILS ABSOLUTE,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.08,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,CBC INCLUDES DIFF PLT,ABSOLUTE BAND NEUTROPHILS,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,CBC WITH AUTO DIFF,WBC,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,URINALYSIS RX ALB CREA,KETONES,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.2,0.25,0.0,0.0,0.0,0.0,0.031621853677024414,0.08399329824424573,0.0,0.0,0.0,0,345355,HEPATITIS PANEL DIAGNOSTIC,HEP B CORE TOTAL AB,Microalbumin/Creatinine ratio panel,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,IMMUNOGLOBULINS,IMMUNOGLOBULIN M,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,CEA CARCINOEMBRYONIC ANTIGEN,CEA CENTAUR,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.04833333333333333,0.0,0.0,0.028333333333333335,0.01888888888888889,0.028333333333333335,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,MANUAL DIFFERENTIAL,EOSINOPHILS %,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,CBC WITH DIFFERENTIAL,MYELOCYTES,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,URINALYSIS WITH MICROSCOPIC,UROBILINOGEN,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.08,0.06666666666666667,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,DIFFERENTIAL MANUAL,ABSOLUTE NEUTROPHILS,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,CBC DIFF PLT,MONOCYTES %,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.20666666666666667,0.2,0.0,0.0,0.0,0.0,0.0,0.080707015074163,0.0,0.0,0.0,0.0,0,7872,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,RDW,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.08952338621207645,0.0,0,264499,CBC W AUTO DIFF,MEAN PLATELET VOLUME,Eosinophils,Eosinophils [#/volume] in Blood,Eosinophil # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,CMP14 CBC D PLT RPR UA TSH,NEUTROPHILS ABSOLUTE,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,CBC W AUTO DIFF,ABS BASOPHILS,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.0,0.044444444444444446,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,VITAMIN B 12 FOLIC ACID,VITAMIN B 12,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,HEMOGLOBINOPATHY EVAL,MCH,Neutrophils,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual
0.0,0.0,0.0,0.088,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,CEA,CEA CENTAUR,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,UROGRAM,KETONES,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.346,0.5714285714285714,0.8,0.346,0.5714285714285714,0.8,0.035467350927838925,0.1538110300980966,0.15519402517768222,0.035467350927838925,0.1538110300980966,0.15519402517768222,1,51953,HEPATITIS B SURF AG,HEPATITIS B SURF AG,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.2783333333333333,0.0,0.0,0.0,0.0,0.0,0.0131564119407096,0.0,0.0,0.0,0.0,0.0,0,109009,IMMUNOGLOBULINS IGG A M SER,IMMUNOGLOBULIN A,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,LYMPHOCYTE SUBSET PANEL 3,CD4 CD8 RATIO,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,CBC WITH PLT DIFF,BANDS,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.0,0.14285714285714285,0.2,0.0,0.02428571428571429,0.034,0.0,0.05557781728487099,0.14099568413003705,0.0,0.0,0.0,0,487967,LIPID PANEL AMA,NON HDL CHOLESTEROL,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,CBC WITH PLT DIFF,LYMPHOCYTES ABSOLUTE,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.142,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,1,7369,CMP14 HP4 DBILI CBC D PLT R,LYMPHS,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,UREA NITROGEN BUN,UREA NITROGEN BUN,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,HCV RNA NS5A GENOTYPE,LEDIPASVIR RESISTANCE,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,UROGRAM,KETONES,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30247,URINALYSIS,PH,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,FE ANA TIBC FER A1A AMA ASM,ALPHA 1 ANTITRYPSIN SERUM,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,LIPID PANEL,CALC LDL CHOL,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,URINALYSIS WITH MICROSCOPIC,APPEARANCE,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,URINE MICROALBUMIN CREAT RATIO,UR MICROALBUMI,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A DRUG RESISTANCE ASSAY,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,SPECIAL A 2 PANEL #9633,POLYS,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,APTT,PARTIAL THROMBOPLASTIN,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,DRUG ABUSE PANEL 10 WITH OXYCODONE,PHENCYCLIDINE,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,SMOOTH MUSCLE AB F ACTIN REFLEX IFA TITER,F ACTIN IGG,Eosinophils,Eosinophils [#/volume] in Blood,Eosinophil # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,COMPREHENSIVE METABOLIC PANEL,CARBON DIOXIDE,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.2,0.16666666666666666,0.0,0.2,0.16666666666666666,0.3333333333333333,0.009814692540447978,0.007890678365173986,0.0,0.048918155723576384,0.039328530307136456,0.07241200273157788,1,237610,MANUAL DIFFERENTIAL,TOTAL NEUTROPHILS %,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,AMYLASE SERUM,AMYLASE SERUM,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,MAGNESIUM,MAGNESIUM,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,CHEM SCREEN PANEL,EGFR NON AFR AMERICAN,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,LP LDL DIRECT,HDL CHOLESTEROL,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.2,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,HBC AB TOTAL,HBC AB TOTAL,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE MONOS,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7732,HNK1 CD57 PANEL,LYMPHS ABSOLUTE,Erythrocytes.nucleated/100 erythrocytes,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,HEMOGLOBINOPATHY INDICES,HEMATOCRIT,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.0,0.16,0.0,0.25,0.2,1.0,0.0,0.07132561100505608,0.0,0.08356777192520215,0.12353958214165095,1.0,1,192955,DRUG PANEL 8 SCREEN,OPIATES,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,CBC WITH DIFFERENTIAL,ABS NEUTROPHILS,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,CBC WITH PLT DIFF,BANDS ABSOLUTE,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,HEPATITIS B SURFACE AG,HEPATITIS B SURFACE AG,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,CMP14 4AC,EGFR IF AFRICN AM,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE LYMPHOCYTES,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.43,0.2857142857142857,0.3333333333333333,0.0,0.0,0.0,0.0,0.41731829815125243,0.41364362208294236,1,20958,LIPID PANEL AMA,CHOLESTEROL HDL RATIO,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,HEPATITIS C RNA PCR QUANTITATIVE,HCV VIRAL LOG,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,FE ANA TIBC FER PTT PT A1A,MITOCHONDRIAL M2 ANTIBODY,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,CBC DIFF PLT,MCHC,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.125,0.009523809523809525,0.02,0.0,0.0,0.0,0.019520405357162707,0.0,0.0,0.0,0.0,0.0,0,882944,COMP METABOLIC PANEL W GFR,ANION GAP,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,LIPOPROTEIN ANALYSIS NMR,LDL P,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,NASH FIBROSURE,APOLIPOPROTEIN A 1,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS A TOTAL AB,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,IRON IBC W RFX FERRITIN,%TRANSFERRIN SATURATION,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.1925,0.10600000000000001,0.0,0.25,0.2,1.0,0.0,0.0,0.0,0.0763206923693498,0.09762443806815091,1.0,1,58024,URINALYSIS CULTURE IF INDICATED,NITRITE,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,DIFFERENTIAL MANUAL,EOSINOPHILS,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,DIFFERENTIAL MANUAL,ABSOLUTE LYMPHOCYTES,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,RPR REFLEX TP PA,RPR TITER,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,CMP14 CBC D PLT ESR WES ANA,NEUTROPHILS,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,LIPID PANEL,LDL CALC,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,CMP,BUN BLOOD UREA NITROGEN,Service comment,Service comment,Service Cmnt XXX-Imp
0.5,0.5,1.0,0.5,0.5,1.0,0.12460215794786256,0.16901735079974012,1.0,0.12460215794786256,0.16901735079974012,1.0,1,330373,ANION GAP,ANION GAP,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,ESR WES CRP,C REACTIVE PROTEIN QUANT,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.21400000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,URIC A ESR WES ANA RA QN CC,URIC ACID,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,REFERRED CBC,MCH,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,PSA TOTAL % FREE,% FREE PSA,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,DRUG ABUSE SCREEN III,COCAINE METABOLITE,Eosinophils,Eosinophils [#/volume] in Blood,Eosinophil # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,CBC W AUTO DIFF,MONOCYTES %,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,IRON PANEL,IRON,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,CBC W O DIFF WITH PLATELETS,PLATELET COUNT,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,LIPID PANEL W CHOL HDL RATIO,VLDL CHOLESTEROL CAL,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,FIBROACT COMPLETE,WEIGHT LBS,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,CBC INCLUDES DIFF PLT,BASOPHILS ABSOLUTE,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,CHEM SCREEN PANEL HDL,URIC ACID,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,BUN CREAT RATIO W EGFR,NON AFRICAN AMERICAN EGFR,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.041666666666666664,0.025,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,ANA TITER PATTERN,ANTI NUCLEAR AB TITER,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,PROTEIN ELECTRO S,PLEASE NOTE,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,CBC,% BASOPHILS,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,LYMPHOCYTE SUBSET PANEL 3,% CD3 MATURE T CELLS,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,COMPREHENSIVE METABOLIC PANEL E GFR,CHLORIDE,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE MONOCYTES,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,URINALYSIS CULTURE IF INDICATED,LEUKOCYTE ESTERASE,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,URINALYSIS CULTURE IF INDICATED,OCCULT BLOOD,Body weight,Body weight Measured,Weight Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,BAND NEUTROPHILS,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,LIPOPROTEIN ANALYSIS NMR,LDL P,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,URINALYSIS,PH,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,HCV FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.16636363636363638,0.4575,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,HCV FIBROSURE RESULTS,FIBROSIS STAGE,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,HCV RNA QN GRAPH RFX NSA,HEPATITIS C QUANTITATION,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,BASIC METABOLIC PANEL AMA,GLUCOSE,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.25,0.5242857142857142,0.734,0.25,0.5242857142857142,0.734,0.05489961348405459,0.3355076335393532,0.17598550691819748,0.05489961348405459,0.3355076335393532,0.17598550691819748,1,223149,HEPATITIS A IGM,HEPATITIS A IGM,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.142,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,1,7369,CMP14 LP 3AC CBC D PLT,LYMPHS,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.047142857142857146,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,URINALYSIS CULTURE IF INDICATED,COLOR,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.2,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,LD,LD,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,RPR REFLEX PER CDC,RPR,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,CMP14 3AC CBC D PLT RPR MG,EOS,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,HEPATIC FUNCTION PANEL AMA,BILIRUBIN DIRECT,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,IMMUNE COMPETENCE PANEL,CD4 CD8 RATIO,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,LIVER FIBROTEST ACTITEST,NECROINFLAMMAT ACT SCORE,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,DACLATASVIR RESISTANCE,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.0,0.0,0.0,0.125,0.12166666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,LYMPHOCYTE SUBSET PANEL 3,% CD3 MATURE T CELLS,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,TRICHOMONAS MALE,SOURCE,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,IFE PE FLC SERUM,ALBUMIN,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,HEPATITIS BE AG,HBEAG INS,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,HIV ANTIGEN ANTIBODY FOURTH GENERATION W RFL,HIV AG AB 4TH GEN,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,CBC INCLUDES DIFF PLATELETS,MEAN PLATELET VOLUME,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.06,0.06,0.12,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,COMP METABOLIC PROFILE FASTING CMP,BUN CREATININE RATIO CALC,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.0,0.0,0.0,0.31666666666666665,0.25,1.0,0.0,0.0,0.0,0.0,0.10964330813284906,0.7071067811865476,1,264499,CBC WITH AUTO DIFF,EOSINOPHILS ABSOLUTE,Eosinophils,Eosinophils [#/volume] in Blood,Eosinophil # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,NEG HIV 4TH GEN,NEG HIV 1 ANTIBODY,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,COMP METABOLIC PANEL 14,EGFR IF AFRICN AM,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.009523809523809525,0.02,0.0,0.03190476190476191,0.067,0.0,0.0,0.0,0.0,0.015986138487699808,0.0,0,882944,COMPREHENSIVE METABOLIC PANEL W O ALT,BUN CREATININE RATIO,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,ALPHA 1 ANTITRYPSIN PHENOTYPE,ALPHA 1 ANTITRYPSIN,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,CBC W DIFF PLT,PLATELET SUFFICIENCY,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,RHEUMATOID FACTOR,RHEUMATOID FACTOR,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.0,0.4,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,CBC WITH PLT DIFF,NUCLEATED RBCS,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,URINALYSIS COMPLETE,GLUCOSE QL,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,VELPATASVIR RESISTANCE,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.22,0.16666666666666666,0.5,0.22,0.16666666666666666,0.5,0.0,0.05660928660351461,0.5773502691896257,0.0,0.06933193344079114,0.7071067811865476,1,151522,BILIRUBIN DIRECT,DIRECT BILIRUBIN,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.0,0.0,0.06666666666666667,0.04,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,IMMUNODEF PROFILE #1,ABSOLUTE CD3,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,CBC PLATELET HEM REVIEW,NEUTROPHILS ABSOLUTE,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,COMP METABOLIC PANEL,CREATININE,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS B SURFACE AB,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,264440,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE EOSINOPHILS,Basophils,Basophils [#/volume] in Blood,Basophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,CMP WITH EGFR,ANION GAP,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.3333333333333333,0.2857142857142857,1.0,0.3333333333333333,0.2857142857142857,1.0,0.040881275582819065,0.439493011634871,0.8660254037844386,0.040881275582819065,0.439493011634871,0.8660254037844386,1,21576,CREATINE KINASE CK,CREATINE KINASE CK,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0825,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,URINALYSIS COMPLETE,APPEARANCE,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,CBCI COMPLETE BLOOD COUNT W DIFF,MCHC,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,CMP14 HP4 DBILI CBC D PLT R,C REACTIVE PROTEIN QUANT,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,CMP12 LP 6AC,CHOLESTEROL TOTAL,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.09090909090909091,0.0,0.0,0.050647203319289846,0.0,0.0,0.050647203319289846,0.0,0,831008,FOLATE SERUM,FOLATE SERUM,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.030000000000000002,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,URINALYSIS W MICROSCOPIC,URINALYSIS URINE COLOR,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.015714285714285715,0.055,0.0,0.015714285714285715,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,C REACTIVE PROTEIN,C REACTIVE PROTEIN,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,URINALYSIS W MICROSCOPIC,BACTERIA,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,UREA NITROGEN BUN,HEMOLYSIS,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.16666666666666666,0.3,0.42857142857142855,0.16666666666666666,0.3,0.42857142857142855,0.02455979619023374,0.0,0.0,0.02455979619023374,0.0,0.0,0,736553,HCV GENOSURE R NSA,HCV GENOSURE R NSA,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,LYMPHOCYTE SUBSET PANEL 4,LYMPHOCYTES ABSOLUTE,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,UA MICROSCOPIC REFLEX CULTURE,RED BLOOD CELLS,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,HIV 1 QUANT PCR,HIV 1 VIRAL LOG,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.05834370368217123,0.0,0.0,0.0,0.0,0,182626,IFE PE SERUM,M SPIKE,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.2,0.2857142857142857,0.4,0.0,0.2857142857142857,0.4,0.009942744126395953,0.0,0.0,0.0,0.0,0.0,0,51953,HCV RNA QN REAL TIME PCR W RFX QL T,HCV RNA PCR QN,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,MORPHOLOGICAL REVIEW,PATH REVIEW PERIPHERAL SMEAR,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0825,0.08833333333333333,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.07065997001469593,0.09716253076254433,1.0,1,57927,URINALYSIS W MICRO,GLUCOSE,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.124,0.1357142857142857,0.475,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,LYMPHOCYTE SUBSET PANEL 2,CD4 ABSOLUTE,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.08333333333333333,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,HEPATIC FUNCTION PANEL,TOTAL PROTEIN,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,T3 FREE,T3 FREE,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,HIV 1 RNA QN RT PCR,HIV 1 RNA QN PCR,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,PROTIME PTT,PTT,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,TSH RFLX FT4,TSH RFLX FT4,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,COMPREHENSIVE METABOLIC PANEL E GFR,CARBON DIOXIDE,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,LIVER FIBROSIS FIBROTEST,FIBROSIS STAGE,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,COMPREHENSIVE METABOLIC PANEL E GFR,CALCULATED A G RATIO,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.16,0.0,0.25,0.2,1.0,0.0,0.04117986071388369,0.0,0.07962607175736813,0.12353958214165095,1.0,1,195503,DRUG ABUSE SCREEN 11 W ETOH W CONF,METHADONE,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.195,0.14285714285714285,0.3333333333333333,0.0,0.0,0.0,0.0,0.0762496717190787,0.08190888212768821,1,18358,NASH FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Alpha-2-Macroglobulin,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,CBC PLT DIFF,MONOS,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,DIRECT LDL,DIRECT LDL,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,HBSAB AG,HEP B SURFACE AB QUAL,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0825,0.10600000000000001,0.0,0.5,0.2,1.0,0.0,0.0,0.0,0.1079337582384392,0.06903090216751562,0.7071067811865476,1,254284,URINALYSIS REFLEX,GLUCOSE QL,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,CMP14 4AC,EGFR IF NONAFRICN AM,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,URINALYSIS,NITRITE,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,BMP8 CBC D PLT,CREATININE,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,CBC PLATELET HEM REVIEW,NEUTROPHILS ABSOLUTE,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,CMP14 2AC MG,EGFR IF NONAFRICN AM,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,URINALYSIS ROUTINE W RFX,BILIRUBIN,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0.0,0.0,0.0,0,22848,IFE PE SERUM,GLOBULIN TOTAL,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,LIVER FIBROSIS FIBROTEST ACTITEST,NECROINFLAMMAT ACT GRADE,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,CBC WITH DIFFERENTIAL,NUCLEATED RBCS,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,HEPATITIS C VIRAL RNA QUAL TMA,HEPATITIS C VIRAL RNA QUAL TMA,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,URINALYSIS CULTURE IF INDICATED,NITRITE,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,ALKALINE PHOSPHATASE,LIPEMIA,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,COMPREHENSIVE METABOLIC PANEL E GFR,ALBUMIN,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH TOTAL,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,CMP12 LP TP TSH 6AC CBC D PLT,BILIRUBIN TOTAL,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,CMP14 LP 1AC CBC D PLT TSH,LYMPHS,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.022727272727272728,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,URINALYSIS COMP W RFL CULTURE,PROTEIN,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.2544444444444445,0.38166666666666665,0.0,0.0,0.0,0.0,0.025425559932405584,0.04202185668774028,0.0,0.0,0.0,0,481598,HEPATITIS C GENO TYPE 1 NS5A RESIST,OMBITASVIR RESISTANCE,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,VITAMIN B 12 FOLIC ACID,VITAMIN B 12,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,ANA TITER PATTERN,ANA TITER,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,HEPATITIS B SURFACE ANTIBODY,HEPATITIS B SURFACE AB QUAL,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,PROTEIN ELECTROPHORESIS,GAMMA GLOBULINS,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,LP LDLDIR,TRIGLYCERIDES,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,LIPID PROFILE WITH CALCULATIONS NON HDL CHOLESTEROL,RISK RATIO CHOL HDL,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,CBC PLATELET HEM REVIEW,NEUTROPHILS,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,ANA TITER PATTERN,ANTI NUCLEAR AB TITER,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.3333333333333333,0.11166666666666668,0.0,0.0,0.0,0.0,0.05339016372965322,0.1858678609476695,0.0,0.0,0.0,0.0,0,30262,CD4 T4 ENUMERATION,ABSOLUTE LYMPHOCYTES,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.5,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,HCV GENOSURE R NSA,HCV GENOSURE R NSA,Erythrocyte distribution width,Erythrocyte distribution width [Entitic volume],RDW RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,HEPATITIS C ANTIBODY,HEPATITIS C ANTIBODY,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.0,0.0,0.0,0.07142857142857142,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,CMP,BUN BLOOD UREA NITROGEN,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,RPR REFLEX TP PA,RPR TITER,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.2,0.25,0.0,0.0,0.0,0.0,0.03399776577295499,0.03628200959254402,0,349993,LYMPHOCYTE SUBSET PANEL 4,% CD4 HELPER CELLS,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,ACCUTYPE R IL28B NY,IL28B GENOTYPE,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,TESTOSTERONE FREE TOTAL,FREE TESTOSTERONE DIRECT,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.4,0.5,1.0,0.2,0.375,0.75,0.3846649758459151,0.01523193555952651,0.020631585372129946,0.04869923401997367,0.13094482098745974,0.17736414670894485,1,139550,HCV AB W RFL RNA RFL GENO,HEPATITIS C AB,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,URINALYSIS W REFLEX MICRO,WHITE BLOOD CELLS,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,NASH FIBROSURE,WEIGHT,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.059,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,DACLATASVIR RESISTANCE,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,CBC H H RBC INDICES WBC PLT,PLATELET COUNT AUTO,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,LIPID PROFILE WITH CALC NON HDL CHOLESTEROL,RISK RATIO LDL HDL,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,HP5,HEP C VIRUS AB,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,CMP14 LP 6AC,PHOSPHORUS,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.63,0.2,0.5,0.3333333333333333,0.2,0.5,0.03821366308112262,0.04963429477595027,0.0,0.08544834831866432,0.11098565713428754,0.0,1,311472,RPR REFLEX TITRE TPPA,RPR,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.5,0.41111111111111115,0.74,0.5,0.41111111111111115,0.74,0.013012224336779066,0.9457662360035409,0.7072472090959524,0.013012224336779066,0.9457662360035409,0.7072472090959524,1,339358,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.24333333333333332,0.2,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.7071067811865476,1,28852,HEPATIC FUNCTION PANEL,TOTAL PROTEIN,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.0,0.16666666666666666,0.94,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.011201445595818926,0.0,0,93179,CBC RBC H H INDICES WBC PLT,RED BLOOD CELL COUNT,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,HEPASCORE R,SEX,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,CCP ANTIBODY IGG,ANTI CCP IGG,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,ANACHOICE SCR W REFL TITER IFA,ANA SCREEN IFA,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,CBC DIFF PLT,RDW,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.05102520497901342,0.0,0.0,0.03952395382410778,0.0,0.0,1,30163,TSH W REFLEX FT4,TSH 3RD GENERATION W REFLEX FT4,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,NEG HIV 4TH GEN,NEG HIV 1 ANTIBODY,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,CBC INCLUDES DIFF PLATELETS,MEAN PLATELET VOLUME,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.172,0.2866666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,IRON BINDING CAPACITY % SATURATION,IRON SERUM,Leukocyte morphology finding,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,CBC INC DIFF PLT,ABSOLUTE MONOCYTES,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.25,0.0,0.0,0.0,0.0,0.0,0.06812389033458222,0.051758104169687846,0.0,0.0,0.0,0.0,0,7328,DIFFERENTIAL MANUAL,PLATELET ESTIMATION,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,COMPREHENSIVE METABOLIC PANEL WITH GFR,ANION GAP,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.01611111111111111,0.03625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,LYMPHOCYTES,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD8 CELLS,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,HEPATITIS C VIRAL RNA QUALITATIVE TMA,HEPATITIS C VIRAL RNA QUALITATIVE TMA,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.0,0.041999999999999996,0.0525,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,URINALYSIS,PH,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,ALPHA 1 ANTITRYPSIN PHENOTYPE,A 1 ANTITRYPSIN PHENOTYPE,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,HEPATITIS C GENO TYPE 1 NS5A RESIST,OMBITASVIR RESISTANCE,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.2,0.5,0.0,0.2,0.5,0.0,0.01764292790422739,0.02815292359401722,0.0,0.01764292790422739,0.02815292359401722,0,422543,HIV 1 HIV 2 AB SCREEN,HIV 1 HIV 2 AB SCREEN,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,LITHOLINK CMP14 P,ALBUMIN,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,CBC DIFF PLT,RDW,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,CBC W DIFF PLATELET,HCT,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,CHEM SCREEN PANEL HDL,URIC ACID,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,CBC WITH AUTO DIFF,EOSINOPHILS #,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,FREE T4 THYROXINE,FREE T4,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.10333333333333333,0.0775,0.31,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,EOSINOPHILS #,pH,pH of Urine by Test strip,pH Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,HCV GENOSURE R NSA,HCV GENOSURE R NSA,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,PROTHROMBIN PTT,CONTROL,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,ANTIPHOSPHOLIPID SYNDROME,PT,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82644,ANACHOICE SCR W REFL TITER IFA,ANA SCREEN IFA,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,URINALYSIS W REFLEX MICRO,RED BLOOD CELLS,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,FSRC NEW PATIENT PANEL,D BILIRUBIN,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,HEPATITIS A IGM,HEPATITIS A IGM,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,DIFFERENTIAL MANUAL,ABSOLUTE LYMPHOCYTES,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,HEPATITIS PANEL AMA,HEPATITIS C ANTIBODY,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,HEPATITIS PANEL ACUTE,HEPATITIS C ANTIBODY,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,HIV 4TH GEN RFLX CONF,HIV 4TH GEN RFLX CONF,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.3333333333333333,0.034999999999999996,0.0,0.0,0.16666666666666666,1.0,0.03775254682189788,0.13142842488073536,0.0,0.0,0.0,0.0,1,30262,THYROID PROFILE T4 T3UP FTI TSH,T 4,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.25666666666666665,0.2225,0.89,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,CREATINE KINASE TOTAL,LIPEMIA,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,ANA SCREEN IFA,ANA SCREEN IFA,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.03882352941176471,0.0,0.0,0.03882352941176471,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,HEP B CORE AB QUAL,HEPATITIS B CORE AB QL,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,URINALYSIS CULTURE IF INDICATED,LEUKOCYTE ESTERASE,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,MITOCHONDRIAL M2 AB,MITOCHONDRIAL M2 AB,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,DRUG ABUSE PANEL 10 WITH OXYCODONE,METHAQUALONE,Ceruloplasmin,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,CMP14 HP5 LP 6AC CBC D PLT,MAGNESIUM SERUM,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,PROTEIN ELECTROPHORESIS SR W RFX,INTERPRETATION,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD8 CELLS,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.14666666666666667,0.1325,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,UA MICROSCOPIC REFLEX CULTURE,OCCULT BLOOD,pH,pH of Urine by Test strip,pH Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,URINE PROTEIN TOTAL RANDOM W O CREATININE,PROTEIN TOTAL RANDOM UR,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,C REACTIVE PROTEIN,C REACTIVE PROTEIN,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,RHEUMATOID FACTOR QUANT,RHEUMATOID FACTOR QUANT,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH TOTAL,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.06439428697416716,0.0,0.0,0.0,0.0,0,181826,IFE PE SERUM,GAMMA GLOBULIN,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,METHADONE,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.592,0.49333333333333335,0.9866666666666667,0.0,0.0,0.0,0.40795382993965124,0.5255474069833806,0.530075858529406,1,497818,MCCARJUH MCCARTHY PROFILE 1,MITOCHONDRIAL M2 AB,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN RT PCR LOG COPIES ML,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,CBCM COMPLETE BLOOD CNT W MAN DIFF,EOSINOPHILS,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.03132695058051882,0.0,0.0,0.0,0.0,0,79053,IFE PE FLC SERUM,ALBUMIN,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,DRUG ABUSE SCREEN 11 W ETOH W CONF,OXYCODONE,Globulin,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,MPV,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.3333333333333333,0.2,1.0,0.3333333333333333,0.4,1.0,0.094701559498232,0.34003516797720323,1.0,0.06696411491014109,0.4808823462371743,0.7071067811865476,1,22764,FERRITIN,FERRITIN SERUM,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,ASH FIBROSURE,WEIGHT,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,BASIC METABOLIC PANEL,ANION GAP,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,RPR,TREPONEMA PALLIDUM ANTIBODIES,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.09090909090909091,0.25,0.0,0.09090909090909091,0.25,0.0,0.03540360693747757,0.051861339431772846,0.0,0.05006826108790696,0.07334300958724782,0,322867,ACUTE HEPATITIS PANEL,HEPATITIS A IGM,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,LIPID PANEL,CALC LDL CHOL,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,HCV RNA QN REAL TIME PCR W RFX QL T,HCV RNA PCR QN,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,HIV 1 QUANT PCR,HIV 1 VIRAL LOG,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.0,0.0,0.266,0.16625,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,HEPATITIS PANEL AMA,HEPATITIS C ANTIBODY,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.08,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE LYMPHOCYTES,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,UREA NITROGEN BUN,UREA NITROGEN BUN,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.205,0.14285714285714285,0.3333333333333333,0.0,0.0,0.0,0.0,0.9216792638838566,0.9900858126069512,1,18358,LIVER FIBROSIS FIBROMETER,ALPHA 2 MACROGLOBULIN FM,Alpha-2-Macroglobulin,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,URINALYSIS CULTURE IF INDICATED,NITRITE,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,CBC W AUTO DIFF,MCV,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,LIVER FIBRO HEPSCORE R,AGE,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,HIV ANTIBODY 1 WESTERN BLOT,HIV WB INTERP,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.16,0.0,0.0,0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,IRON IBC W O REFLEX,UIBC,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,OBSTETRIC PANEL INCLUDING HIV,HEMOGLOBIN,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.06,0.04,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CARBON DIOXIDE,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,CREATININE,EGFR IF NONAFRICN AM,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,FIBROACT,NECROINFL SCORE,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,CMP14 HP4 1AC PT AFP,HEP A AB IGM,Erythrocyte morphology finding,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,HCV RNA PCR QN RFX NSA,HCV GENOSURE R NSA PDF,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,QUESTASSURED 25 OH VIT D,VITAMIN D 25 OH D2,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.0,0.010714285714285714,0.0375,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,CMP14 LP 6AC,PHOSPHORUS,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,TSH FREE T4 PROFILE,TSH THIRD GENERATION,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,CBC WITH ABSOLUTE WHITE BLOOD CELLS,WBC,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,HEP B SURFACE AB IMMUNITY QN,HEP B SURFACE AB IMMUNITY QN,Erythrocyte morphology finding,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,COMPREHENSIVE METABOLIC PANEL E GFR,CALC GLOBULIN,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,CBC WITH AUTO DIFF,NRBC,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A DRUG RESISTANCE ASSAY,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS A TOTAL AB,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,ASH FIBROSURE,COMMENT,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.25,0.0,0.0,0.25,0.0,0.0,0.03082964770587615,0.0,0.0,0.03082964770587615,0.0,0.0,0,203935,HEPATITIS BS AB QL,HEPATITIS B SURF AB QL,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,URINALYSIS CULTURE IF INDICATED,UROBILINOGEN,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.07692307692307693,0.0,0.0,0.0,0.0,0.0,0.013302049338986932,0.0,0,204479,B12,VIT B12 SERUM,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,CBC INCLUDES DIFF PLT,INTERNAL WBC,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.2,0.18181818181818182,0.25,0.0,0.0,0.0,0.05545837005546872,0.12705867340885235,0.04946429335601732,0,542183,URINALYSIS WITH MICROSCOPIC,RED BLOOD CELLS,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,PROTHROMBIN TIME INR,PROTHROMBIN TIME,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,COMPREHENSIVE METABOLIC PANEL,CALCIUM,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,PHENCYCLIDINE,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,CBC WITH DIFFERENTIAL PLATELETS,MCH,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.16,0.0,0.25,0.2,1.0,0.0,0.05043482321394899,0.0,0.07962607175736813,0.12353958214165095,1.0,1,195503,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,METHADONE,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,DIFFERENTIAL MANUAL,NEUTROPHILS,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,LIVER FIBRO HEPSCORE R,AGE,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,LIPID PANEL,LDL CALC,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,HIV 1 QUANT PCR,HIV 1 VIRAL LOG,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,CBC INCLUDES DIFF PLT,ABSOLUTE BLASTS,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,PROTIME PTT,PROTHROMBIN TIME PT,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.11,0.0,0.0,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,HEPATITIS B SURFACE AB,HEPATITIS B SURFACE AB,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,GENERAL HEALTH PANEL,CALC GLOBULIN,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.09571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,IRON IBC W RFX FERRITIN,%TRANSFERRIN SATURATION,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,AFP TUMOR MARKER,AFP TUMOR MARKER,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,DRUG ABUSE SCREEN W ETOH NO GCMS,AMPHETAMINES,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,FSRC NEW PATIENT PANEL,D BILIRUBIN,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,HCV FIBROSURE,GGT,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,HCV RNA NS5A GENOTYPE,LEDIPASVIR RESISTANCE,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,CBC WITH PLT DIFF,VARIANT LYMPHOCYTES ABSOLUTE,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,ANTI SMOOTH MUSCLE MITOCHOND,MITOCHONDRIAL M2 ANTIBODY,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,CBC W AUTO DIFF ABS WBC MPV PLT,LYMPHOCYTES,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.14285714285714285,0.16842105263157894,0.35555555555555557,0.0,0.0,0.0,0.017842702773463226,0.0,0.0,0.0,0.0,0.0,0,486431,COMPREHENSIVE METABOLIC PANEL WITH GFR,ANION GAP,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,MITOCHONDRIAL ANTIBODY W REFL TITER,MITOCHONDRIAL AB SCREEN,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,ACUTE HEPATITIS PANEL,HEPATITIS C ANTIBODY,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.4666666666666666,0.2222222222222222,0.4,0.4666666666666666,0.2222222222222222,0.4,0.3633923216427376,0.590435356546517,0.8263051464980926,0.36763357933547924,0.5973264996689122,0.8359491946807684,1,139527,HB CORE AB W IGM RFX,HB CORE AB TOTAL,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,ACUTE HEPATITIS PANEL,HEPATITIS B SURFACE ANTIGEN,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,X HEPATITIS COMPLEX PROFILE,ANTI HBC TOTAL,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,CBC W AUTO DIFF,MCV,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,BILIRUBIN PANEL,BILIRUBIN INDIRECT,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.1111111111111111,0.2,0.0,0.1111111111111111,0.2,0.0,0.015292166376676741,0.011435534045534657,0.0,0.015292166376676741,0.011435534045534657,0,339358,HEPATITIS B SURFACE AB,HEPATITIS B SURFACE AB,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.04125,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,CBC W DIFF PLT,RBC,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,TESTOSTERONE FREE TOTAL,FREE TESTOSTERONE DIRECT,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,LP LDL DIRECT,HDL CHOLESTEROL,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,SMOOTH MUSCLE AB RFX TITER,F ACTIN IGG,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.46499999999999997,0.4,0.6666666666666666,0.0,0.0,0.0,0.034103916281504665,0.16901735079974012,1.0,1,104661,BASIC METABOLIC PANEL,ANION GAP,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,HEMOGRAM W AUTOMATED DIFF,WBC,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,TSH FT4,TSH,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,HEPATITIS A DIAGNOSTIC PANEL,HAV AB TOTAL,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,ALPHA 1 ANTITRYPSIN QN,ALPHA 1 ANTITRYPSIN QN,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,NGI HCV SUPERQUANT,HEPATITIS C QUANTITATION,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,URINALYSIS,LEUKOCYTE ESTERASE,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,HCV GT3 NS5A DRUG RESIST ASSAY,HCV NS5A DRUG RESIST ASSAY,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.05555555555555555,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,LIPID PANEL WITH LDL HDL RATIO,HDL CHOLESTEROL,Prothrombin.activity actual/Normal,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP
0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.06054478342412972,0.0,0.0,0.0,0.0,0,312017,PROTEIN ELECTROPHORESIS SERUM,INTERPRETATION,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,HEPATITIS PANEL 4,HEP B CORE AB IGM,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,CMP14 CBC D PLT ESR WES ANA,NEUTROPHILS,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D2,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,CBC PLATELET HEM REVIEW,EOS ABSOLUTE VALUE,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,HEP B SURFACE AG W REFLEX CONFIRM,NEUTRALIZATION,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,COMPLEMENT COMPONENT C4C,COMPLEMENT COMPONENT C4C,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,ASH FIBROSURE,COMMENT,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,HIV 1 HIV 2 AB RFLX,HIV 1 WESTERN BLOT RESULT,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,CBC WITH AUTO DIFF,RDW,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.0,0.0,0.0,0.0,0.009523809523809525,0.02,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,CBC,MONOCYTES ABSOLUTE,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.0,0.0,0.0,0.58,0.6666666666666666,0.6666666666666666,0.0,0.0,0.0,0.3757978134029263,0.022046838418816495,0.022046838418816495,1,487934,HCV FIBROSURE RESULTS,NECROINFLAMMAT ACT GRADE,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,CBC WITH AUTO DIFF,HEMATOCRIT,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,ANA SCR IFA RFL TITR PATT,ANA SCREEN IFA,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,CBC PLT DIFF,POLYS,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.1111111111111111,0.0,0.25,0.2222222222222222,0.6666666666666666,0.0,0.007718143826505375,0.0,0.024054278821240005,0.059283288403659595,0.16219364424223837,1,273532,HEMOGLOBIN A1C,ESTIMATED AVG GLUCOSE,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.018155778848065962,0.0,0,17434,B12,VIT B12 SERUM,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,CMP14 LP 3AC,LDH,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,LIVER FIBROTEST ACTITEST,NECROINFLAMMAT ACT SCORE,Alpha-2-Macroglobulin,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,IRON PANEL,IRON,Erythrocytes,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro
0.066,0.08833333333333333,0.0,0.4,0.3333333333333333,1.0,0.0,0.0,0.0,0.11277316640103974,0.16750164273558021,1.0,1,57992,URINALYSIS,LEUKOCYTE ESTERASE,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.094701559498232,0.34003516797720323,1.0,1,178616,GORBYMI CMP 4AC CORONARY RISK CBC TSH PROFILE,CALCIUM,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,CBC WITH PLT DIFF,NO CELLS DIFF,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.3333333333333333,0.14285714285714285,0.3333333333333333,0.3333333333333333,0.42857142857142855,1.0,0.04479134659480144,0.15435187026024955,0.1628131125313349,0.10015649578972963,0.0,0.0,1,28571,PROSTATE SPECIFIC ANTIGEN PSA,PSA,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,CBC WITH PLT DIFF,PROMYELOCYTES,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.022727272727272728,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,AUTOMATED BLD CNT,HEMOGLOBIN,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,BUN CREATININE,EGFR AFRICAN AMERICAN,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,LIPID PANEL AMA,CHOLESTEROL HDL RATIO,Bacteria identified,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,DRG TOX CRT REFL SPEC GR,CREATININE,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,CBC W DIFF PLATELET,HCT,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,CUSTOM HEPATITIS PANEL,HEPATITIS C ANTIBODY,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.03882352941176471,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,HEP B SURFACE AG W REFLEX CONFIRM,NEUTRALIZATION,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,HIV 1 QUANT PCR,HIV 1 VIRAL LOG,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,CBC PLATELET HEM REVIEW,NEUTROPHILS,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.072,0.18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,COMP METABOLIC PANEL,GLUCOSE NON FASTING,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,BUN CREAT RATIO W EGFR,NON AFRICAN AMERICAN EGFR,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,CBC W DIFF PLT,PLATELET SUFFICIENCY,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,IRON TOTAL BINDING CAPACITY,% SATURATION,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.25,0.3333333333333333,0.0,0.25,0.3333333333333333,0.0,0.0,0.0,0.0,0.009098790524357914,0.01055205762210254,0,45484,HB CORE AB W IGM RFX,HB CORE AB TOTAL,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,HIV 4TH GEN RFLX CONF,HIV 4TH GEN RFLX CONF,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.2857142857142857,0.2857142857142857,1.0,0.0,0.14285714285714285,0.5,0.23877724716356408,0.021697426674713305,0.08492569664625027,0.0,0.04549601264246461,0.17807552140691663,0,296095,HEPATITIS C AB REFLEX HCV RNA QUANT,HEPATITIS C ANTIBODY,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.11,0.1325,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.08466774310592073,0.09762443806815091,1.0,1,58032,URINALYSIS SCREEN,PH,pH,pH of Urine by Test strip,pH Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,LYMPHOCYTE SUBSET PANEL 4,ABS CD4 COUNT,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,VITAMIN D 25 OH TOTAL,VITAMIN D 25 OH TOTAL,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,IRON TIBC,TRANSFERRIN SAT %,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.2,0.34375,0.4583333333333333,0.2,0.6675,0.89,0.03628551739281716,0.1524643612967882,0.11313616447240271,0.03628551739281716,0.2286965419451823,0.16970424670860396,0,519132,HEP A AB IGM,HEPATITIS A AB IGM,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,CMP14 LP 3AC CBC D PLT,LYMPHS,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.049012547892331004,0.0,0.0,0.0,0.0,0,45443,COMPLETE BLOOD COUNT,BASOPHILS %,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,LIVER FIBROSIS PANEL,HAPTOGLOBIN,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,TESTOSTERONE FREE TOTAL LC MS,FREE TESTOSTERONE DIRECT,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.2,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,MAYNAC CMP 4AC LIPID CBC T4 TSH PSA PROFILE,MCH,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,LIPID PANEL,HDL AS % CHOLESTEROL,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt
0.16666666666666666,0.2,0.4,0.0,0.0,0.0,0.020574984038708277,0.0,0.0,0.0,0.0,0.0,0,339143,COMPREHENSIVE METABOLIC PANEL WITH GFR,ANION GAP,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,COMP METABOLIC PANEL W GFR,CHLORIDE,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.10714285714285714,0.06363636363636363,0.0,0.12000000000000001,0.015454545454545455,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,PROTIME PTT,PROTHROMBIN TIME PT,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,CBC PLATELET HEM REVIEW,LYMPHS ABSOLUTE,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,CYSTIC FIBROSIS SCREEN,ETHNICITY,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,SEDIMENTATION RATE WESTERGREN,SEDIMENTATION RATE WESTERGREN,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,CBC WITH AUTO DIFF,WBC,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,1,305250,HEPASCORE R,AGE,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,HCV ANTIBODY REFLEX NAA,HCV RNA NAA QUALITATIVE,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,CBC WITH AUTO DIFF,MONOCYTES #,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.1111111111111111,0.2,0.0,0.1111111111111111,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,PSA TOTAL % FREE,PSA FREE,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0.0,0.0,0.0,0,20750,IFE PE SERUM,ALPHA 2 GLOBULIN,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108340,CBC INCLUDES DIFF PLT,BAND NEUTROPHILS,Globulin,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.02847373515410767,0.0,0.0,0.0,0.0,0,17830,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,EOSINOPHILS #,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,OBSTETRIC PANEL INCLUDING HIV,HEMOGLOBIN,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,CBC,MONOCYTES ABSOLUTE,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,21576,CPK,CPK,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,DRGABU2,METHAQUALONE,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,COMPREHENSIVE METABOLIC PANEL AMA,GLOBULIN,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,VITAMIN B12 FOLATE,FOLATE SERUM,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.028000000000000004,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,VAP CHOLESTEROL PROFILE,TRIGLYCERIDES,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,PROTEIN 24 HOUR URINE,PROTEIN URINE CONC,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,RPR REFLEX TP PA,RPR TITER,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30916,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,LEDIPASVIR RESISTANCE,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,BAND NEUTROPHILS,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.14333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESIST ASSAY INTERP,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,LIPID PANEL,LDL CALC,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,CBC WITH ABSOLUTE NEUTROPHIL COUNT,NEUTROPHILS,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.1875,0.2,0.0,0.0,0.0,0.0,0.0,0.07800794199198469,0.0,0.0,0.0,0.0,0,473835,IFE PE SERUM,ALPHA 2 GLOBULIN,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,LIPID PROFILE,FASTING NON FASTING,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,CMP12 LP 6AC,PHOSPHORUS SERUM,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.1425,0.2,0.0,0.3225,0.2,0.0,0.0,0.017972619952802193,0.0,0.011915739990152163,0.0,0.0,0,192708,PROTEIN CREATININE RATIO URINE,PROTEIN UR MG DL,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,FIBROSIS SCORE,Appearance,Appearance of Urine,Appearance Ur
0.25,0.16666666666666666,0.0,0.2375,0.16666666666666666,1.0,0.0672790962344263,0.051758104169687846,0.0,0.0,0.051758104169687846,0.7071067811865476,1,7120,DIFFERENTIAL MANUAL,ABSOLUTE EOSINOPHILS,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,PSA TOTAL REFLEX FREE,PSA TOTAL,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.43,0.14333333333333334,0.0,0.43,0.14333333333333334,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,149799,ACTIVATED PTT,ACTIVATED PTT PATIENT,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS A TOTAL AB,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,CMP14 CBC D PLT RPR UA TSH,NEUTROPHILS ABSOLUTE,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,CBC,MO#,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,URIC ACID,URIC ACID,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,QUESTASSURED 25 OH VIT D,VITAMIN D 25 OH D2,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0.0,0.0,0.0,0,25718,IFE PE SERUM,GLOBULIN TOTAL,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,UREA NITROGEN BUN,UREA NITROGEN BUN,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,HCV QUANT GT1A NS5A PROFILE,HCV NS5A RESISTANCE ASSAY PDF,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,CBC W AUTO DIFF ABS WBC MPV PLT,NEUTROPHILS,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,URINALYSIS W MICROSCOPIC,BACTERIA,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.0,0.07368421052631578,0.044444444444444446,0.0,0.0,0.0,0.0,0.0193445730832027,0.0,0,486431,CBC W AUTO DIFF,MEAN PLATELET VOLUME,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,PHOSPHATE AS PHOSPHORUS,ICTERUS,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.07142857142857142,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,CBC WITH PLT DIFF,BLASTS,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.028333333333333335,0.017,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,PROTHROMBIN TIME,INR,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.2866666666666667,0.3333333333333333,1.0,0.0,0.0,0.0,0.0,0.042056338045787456,0.046108379515458875,1,20859,CMP13 LP TP TSH 2AC CBC D P,HDL CHOLESTEROL,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.0,0.1,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,HIV AB 1 HIV 2 EIA W REFL 1 WB,HIV EIA AB SCREEN,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,LYMPHOCYTE SUBSET PANEL 2,COMMENT S,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,RHEUMATOID FACTOR RF,RHEUMATOID FACTOR RF,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,CBC WITH AUTO DIFF,PLATELET COUNT,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,CBC WITH AUTO DIFF,HEMATOCRIT,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,TRIGLYCERIDES REFL,TRIGLYCERIDES,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.178,0.11125,0.2966666666666667,0.0,0.0,0.0,0.0,0.0,0.0,1,7633,CBC WITH PLT DIFF,BANDS ABSOLUTE,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,PROTEIN ELECTRO SERUM,ALPHA 2 GLOBULIN,Basophils,Basophils [#/volume] in Blood,Basophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,URINALYSIS,LEUKOCYTE ESTERASE,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,LIPID PROFILE,FASTING NON FASTING,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,7427,CBC,MO%,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,CMP,ALT SGPT,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,HEMOGLOBIN A1C,MEAN GLUCOSE EST,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,CBC WITH DIFFERENTIAL,NEUTROPHILS,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,NASH FIBROSURE,APOLIPOPROTEIN A 1,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,IRON IBC W O REFLEX,UIBC,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,CMP14 5AC,BILIRUBIN TOTAL,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,CMP WITH EGFR,EGFR NON AFRICAN AM,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,LYMPHOCYTE SUBSET PANEL 1,% CD3 MATURE T CELLS,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.10964330813284906,0.0,0,7187,URINALYSIS W REFLEX MICRO,OCCULT BLOOD,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,CMP WITH ESTIMATED GFR CALCULATED,ALBUMIN,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.2875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,IMMUNOGLOBULINS IGG A M SER,IMMUNOGLOBULIN A,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,ANA TITER PATTERN,ANTI NUCLEAR AB TITER,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,LIPID PANEL,NON HDL CHOLESTEROL,Reference lab test method,Reference lab test method,Ref lab test method
0.1925,0.08833333333333333,0.0,0.3225,0.16666666666666666,1.0,0.0,0.0,0.0,0.07097576385288318,0.09716253076254433,1.0,1,204057,URINALYSIS CULTURE IF INDICATED,UROBILINOGEN,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,HEPATIC FUNCTION PANEL A,TOTAL PROTEIN,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,URINALYSIS RX ALB CREA,KETONES,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,BASIC METABOLIC PANEL 7,EGFR IF AFRICN AM,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,COMPREHENSIVE METABOLIC PANEL WITH GFR,ANION GAP,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,LIVER FIBROSIS,NECROINFLAM ACT SCORE,Reference lab test method,Reference lab test method,Ref lab test method
0.155,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.06941755906231628,0.0,0.0,0.0,0.0,0,45443,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,EOSINOPHILS #,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESIST ASSAY INTERP,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,URINALYSIS W REFLEX MICRO,OCCULT BLOOD,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,LD,LD,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.14285714285714285,0.2,0.0,0.3457142857142857,0.484,0.0,0.13697041783001718,0.07184578234577044,0.0,0.11861986140776393,0.06222027266620478,0,223149,HEPATITIS PANEL DIAGNOSTIC,HEP B CORE TOTAL AB,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,T4 THYROXINE,T4 THYROXINE,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,PSA TOTAL REFLEX FREE,PROSTATE SPECIFIC AG SERUM,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0,23457,COMPREHENSIVE METABOLIC PANEL,CALCIUM SERUM,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.03142857142857143,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,CBC PLATELET HEM REVIEW,LYMPHS ABSOLUTE,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.09338639438323382,0.0,0.0,0.0762496717190787,0.0,0,17590,IMMUNOFIXATION SERUM,IGG SERUM NR,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.036,0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,COMP METABOLIC PANEL W GFR,PROTEIN TOTAL,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,LIPID PROFILE WITH CALCULATIONS NON HDL CHOLESTEROL,RISK RATIO CHOL HDL,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,HEPATIC FUNCTION PANEL 6,ALT SGPT,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.2,0.42857142857142855,0.6,0.33399999999999996,0.6828571428571429,0.9560000000000001,0.021528614002227053,0.0,0.0,0.019652845868068813,0.021001017411413248,0.02834076815216946,1,728626,HCV QUANT GT1A NS5A PROFILE,HCV NS5A RESISTANCE ASSAY PDF,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,ALPHA FETOPROTEIN TUMOR MARKER,ALPHA FETOPROTEIN TUMOR,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.030526286249592305,0.0,0,7096,URINALYSIS CULTURE IF INDICATED,WHITE BLOOD CELLS,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,ANEMIA PROFILE B,UIBC,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,DRUG ABUSE SCREEN 11 W ETOH W CONF,OXYCODONE,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,HCV RNA NS5A GENOTYPE,LEDIPASVIR RESISTANCE,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,CBC W AUTO DIFF,ABS NEUTROPHILS,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,CBC WITH AUTO DIFF,EOSINOPHILS #,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,CMP14 EGFR,POTASSIUM,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,CBC WITH MANUAL DIFFERENTIAL,MCHC,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,COMP METABOLIC PANEL W GFR,CHLORIDE,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,CMP12 LP TP TSH 6AC CBC D PLT,POTASSIUM,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,PROTEIN ELECTRO SERUM,ALPHA 2 GLOBULIN,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128512,BASIC METABOLIC PANEL AMA,GLUCOSE,Protein pattern,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,LYMPHOCYTE SUBSET PANEL 3,CD4 CD8 RATIO,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.2,0.0,0.0,0.0,0.0,0.0,0.008585101422235897,0.0,0.0,0.0,0.0,0.0,0,58214,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,LYMPHOCYTES,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.045454545454545456,0.125,0.0,0.0,0.0,0.0,0.04521753067807699,0.0,0.0,0.0,0.0,0,112599,CBC WITH PLT DIFF,PLATELET MORPHOLOGY,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,URINALYSIS WITH MICROSCOPIC,GLUCOSE,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,IRON TOTAL BINDING CAPACITY,% SATURATION,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,MCCARJUH MCCARTHY PROFILE 1,MITOCHONDRIAL M2 AB,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,CBC WITH AUTO DIFF,BASOPHILS %,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,MANUAL DIFFERENTIAL,EOSINOPHILS %,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,PTH INTACT WITHOUT CALCIUM,PTH INTACT,Hemoglobin,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc
0.0,0.2222222222222222,0.4,0.0,0.2222222222222222,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,HCV RNA QUANTITATION PCR,HCV RNA VIRAL LOAD IU ML,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,PSA TOTAL REFLEX FREE,PROSTATE SPECIFIC AG SERUM,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,COMPREHENSIVE METABOLIC PANEL E GFR,CARBON DIOXIDE,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,CD4 CD8 ENUMERATION,ABSOLUTE LYMPHOCYTES,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.5,0.0,0.0,0.0,0.05498668394218953,0.07826082456743577,0.10031748330730439,1,312082,LEUKEMIA LYMPHOMA EVALUATION,SPECIMEN TYPE,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,CBC WITH MANUAL DIFFERENTIAL,NEUTROPHILS,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.26,0.2,1.0,0.0,0.0,0.0,0.0,0.34003516797720323,1.0,1,20933,LIPID PROFILE,CHOLESTEROL,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.05714285714285715,0.1,0.0,0.05714285714285715,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE NEUTROPHILS,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,495499,HCV RNA PCR QN GRAPH RFX NS5A,HCV NS5A RESIST ASSAY INTERP,Reference lab test method,Reference lab test method,Ref lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,CBC INCLUDES DIFF PLT,BLASTS,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,CUSTOM HEPATITIS PANEL,HEPATITIS C ANTIBODY,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,HCV FIBROSURE,INTERPRETATION,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,HCV RNA NS5A GENOTYPE,LEDIPASVIR RESISTANCE,Body weight,Body weight Measured,Weight Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,CBC INCLUDES DIFF PLT,BLASTS,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.3333333333333333,0.5,0.0,0.3333333333333333,0.5,0.0,0.08799275345909874,0.08868207335447242,0.0,0.08799275345909874,0.08868207335447242,1,161281,HEPATITIS C ANTIBODY,HEPATITIS C ANTIBODY,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,URINALYSIS WITH MICROSCOPIC,UROBILINOGEN,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,AFP TUMOR MARKER,AFP TUMOR MARKER,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,GENERAL HEALTH PANEL,CALC GLOBULIN,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.0,0.0,0.0,0.12285714285714286,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,622381,CMP14 4AC,EGFR IF AFRICN AM,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,SMOOTH MUSCLE AB RFX TITER,F ACTIN IGG,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.32142857142857145,0.02,0.0,0.03571428571428571,0.02,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17442,URINE PROTEIN TOTAL RANDOM W O CREATININE,PROTEIN TOTAL RANDOM UR,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,CRP,C REACTIVE PROTEIN ULTRA,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0,0.0,0.0,0.06999999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,HIV 1 HIV 2 AG AB COMBO W REFLEXES,HIV INTERPRETATION,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,BASIC METABOLIC PANEL,ANION GAP,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,CEA,CEA SIEMENS IMMULITE 2000,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,CMP13 LP TP TSH 2AC CBC D P,HDL CHOLESTEROL,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,CBC W AUTO DIFF ABS WBC MPV PLT,MCHC,Erythrocyte distribution width,Erythrocyte distribution width [Entitic volume],RDW RBC
0.0,0.0,0.0,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,IRON TOTAL BINDING CAPACITY,% SATURATION,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,C REACTIVE PROTEIN CARDIAC,C REACTIVE PROTEIN CARDIAC,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,HEPATITIS ABC PANEL,HEPATITIS A ANTIBODY TOTAL,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,CBC W DIFF PLATELET,MCH,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,BAND NEUTROPHILS,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,HEPATITIS B SURFACE AB,HEPATITIS B SURFACE AB,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,CBC INCLUDES DIFF PLT,INTERNAL WBC,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.2,0.0,0.0,0.2,0.0,0.0,0.24044117311858715,0.0,0.0,0.24044117311858715,0.0,0,191239,AMYLASE SERUM,AMYLASE SERUM,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,NMR LIPOPROFILE,LDL P,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.044,0.0,0.07333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,FIBROSIS SCORE,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,RHEUMATOID FACTOR QUANT,RHEUMATOID FACTOR QUANT,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.09499999999999999,0.08142857142857142,0.1425,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,DRUG ABUSE SCREEN II,BENZODIAZEPINES,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,DRUG PANEL 8 SCREEN,OPIATES,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,URINALYSIS W REFLEX MICRO,EPITHELIAL CELLS,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,CBC WITH DIFFERENTIAL,IMMATURE GRANS,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,RENAL PANEL 10,EGFR IF AFRICN AM,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,LYMPHOCYTE SUBSET PANEL 3,CD4 CD8 RATIO,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,GORBYMI CMP 4AC CORONARY RISK CBC TSH PROFILE,CALCIUM,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.2875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,IMMUNOGLOBULINS IGG A M SER,IMMUNOGLOBULIN A,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,CBC WITH MANUAL DIFFERENTIAL,EOSINOPHILS,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,LYMPHOCYTE SUBSET PANEL 4,LYMPHOCYTES ABSOLUTE,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.11166666666666668,0.335,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,LIPID PROFILE WITH CALCULATIONS NON HDL CHOLESTEROL,RISK RATIO CHOL HDL,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.1075,0.2866666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,PROTIME PTT,PTT,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.125,0.0,0.178,0.11125,0.2966666666666667,0.0,0.02194762094436742,0.0,0.0,0.0,0.0,0,141358,COMPLETE BLOOD COUNT,RED CELL DIST WIDTH,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,CMP14 LP 7AC CBC D PLT T B,AMYLASE SERUM,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.16,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D2,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,HEMOGLOBIN A1C EAG,HEMOGLOBIN A1C,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,HIV AG AB 4TH GEN RFL,HIV AG AB 4TH GEN,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,ASH FIBROSURE,COMMENT,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.6666666666666666,0.14285714285714285,0.25,0.16666666666666666,0.14285714285714285,0.25,0.06190747163367705,0.06999602978068009,0.14534604904475734,0.04894215363617116,0.1106734406379627,0.11490614097199336,1,427682,HIV 1 HIV 2 AG AB COMBO W REFLEXES,HIV INTERPRETATION,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.186,0.42857142857142855,0.4,0.134,0.14285714285714285,0.2,0.0,0.04601092386715899,0.031045756027934357,0.0,0.036374829167206246,0.04908765036508733,0,728626,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,OMBITASVIR RESISTANCE,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,LIVER FIBROSIS PANEL,HAPTOGLOBIN,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE NEUTROPHILS,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.2,0.14285714285714285,0.0,0.0,0.0,0.0,0.030148245705374777,0.0,0.0,0.0,0.0,0.0,0,505511,CBC WITH AUTO DIFF,WBC,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.165,0.265,0.0,0.5,0.5,1.0,0.0,0.0,0.0,0.14187034543632637,0.7071067811865476,1.0,1,57679,URINALYSIS WITH MICROSCOPIC,APPEARANCE,Appearance,Appearance of Urine,Appearance Ur
0.0,0.10714285714285714,0.125,0.0,0.0,0.0,0.0,0.008949735107846246,0.0,0.0,0.0,0.0,0,296095,CBC WITH MANUAL DIFFERENTIAL,NEUTROPHILS,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,CMP,ALT SGPT,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,CMP14 4AC,EGFR IF NONAFRICN AM,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,HCV FIBROSURE,FIBROSIS SCORE,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,FOLATE SERUM,FOLATE SERUM,Microalbumin/Creatinine ratio panel,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,PROTHROMBIN PTT,CONTROL,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.08653125463386624,0.0,0,30163,COMPLETE BLOOD COUNT,MEAN PLATELET VOLUME,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,TESTOSTERONE FREE LC MS MS,TESTOSTERONE FREE LC MS MS,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.5,0.48625,0.75,0.5,0.5,1.0,0.48462344379507305,0.011337917407329035,0.011598869223880981,0.10418907133533917,0.05392884772733497,0.055170066045780786,1,108860,PSA FREE TOTAL,FREE PSA,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.405,0.3333333333333333,0.6666666666666666,0.0,0.0,0.0,0.04707567369242904,0.0818901804741462,0.12900463674079643,1,265074,DIFFERENTIAL MANUAL,ABSOLUTE BAND NEUTROPHILS,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,ASH FIBROSURE,AST SGOT P5P,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,IRON TIBC,TRANSFERRIN SAT %,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,CBC INCLUDES DIFF PLT,BAND NEUTROPHILS,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,MAGNESIUM,HEMOLYSIS,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.19999999999999998,0.27999999999999997,0.0,0.19999999999999998,0.27999999999999997,0.0,0.007976513205319447,0.010764264748993724,0.0,0.007976513205319447,0.010764264748993724,0,728626,HEPATITIS B CORE AB,HEPATITIS B CORE AB,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.14285714285714285,1.0,0.0,0.0,0.0,0.0,0.5074828171487041,1.0,1,67686,CMP WITH EGFR,ALKALINE PHOSPHATASE,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,DRUG ABUSE SCREEN III,AMPHETAMINES,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESIST ASSAY INTERP,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.27999999999999997,0.34285714285714286,0.48,0.27999999999999997,0.34285714285714286,0.48,0.04976481809894295,0.18837927027610113,0.1900730864069835,0.04976481809894295,0.18837927027610113,0.1900730864069835,0,169334,HEPATITIS C AB,HEPATITIS C AB,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,HEP C RNA GENOT 3 NS5A,VELPATASVIR RESISTANCE,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,CMP14 LP 3AC CBC D PLT,LYMPHS,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,PROSTATE SPECIFIC ANTIGEN PSA,PSA,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,HCV FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,ACCUTYPE R IL28B,ACCUTYPE R IL28B,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,LIPID PNL W REFL TRIG>400,CHOLESTEROL HDL RATIO,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.0825,0.18333333333333335,0.0,0.0,0.07166666666666667,0.0,0.0,0.0,0.0,0.0,0.016033549977438,0.0,0,57703,URINALYSIS WITH REFLEX MICROSCOP,PROTEIN TOTAL QUAL,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.047619047619047616,0.0,0.0,0.0,0.0,0.0,0.01845920271835222,0.0,0.0,0.0,0.0,0,882944,PE FLC SERUM,ALBUMIN,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,NEG HIV 4TH GEN,HIV 1 AB WESTERN BLOT,Alpha-2-Macroglobulin,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,VITAMIN D 25 OH TOTAL,VITAMIN D 25 OH TOTAL,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.09666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,QUESTASSURED 25 OH VIT D,VITAMIN D 25 OH D2,pH,pH of Urine by Test strip,pH Ur Strip
0.16666666666666666,0.06142857142857143,0.2866666666666667,0.16666666666666666,0.06142857142857143,0.2866666666666667,0.009662054247360441,0.01636881517662514,0.12276848839929855,0.009662054247360441,0.01636881517662514,0.12276848839929855,0,295410,HCV RNA QUANT BDNA,HCV RNA QN BDNA,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH TOTAL,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,CBC W AUTO DIFF WITH PLATELETS,RBC,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,LIVER FIBROSIS PANEL,ALT,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.07545454545454545,0.20750000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,LYMPHOCYTE SUBSET PANEL 2,% CD4 HELPER CELLS,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,NASH FIBROSURE,APOLIPOPROTEIN A 1,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,CMP,BUN BLOOD UREA NITROGEN,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.14666666666666667,0.0,0.0,0.14666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,HEPATITIS B SURFACE AG,HEPATITIS B SURFACE AG,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,HIV ANTIBODY 1 WESTERN BLOT,HIV WB INTERP,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.0,0.2,0.25,0.2,0.0,0.25,0.0,0.031621853677024414,0.08399329824424573,0.027385328599057512,0.0,0.07274033002715963,0,345355,LYMPHOCYTE SUBSET PANEL 3,CD4 CD8 RATIO,Microalbumin/Creatinine ratio panel,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,RPR REFLEX TITRE TPPA,RPR,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.12166666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,ASH FIBROSURE,WEIGHT,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.235,0.16666666666666666,1.0,0.0,0.16666666666666666,0.0,0.0,0.04044935140918404,0.5,0.0,0.0,0.0,0,7773,CBC INCLUDES DIFFERENTIAL PLATELETS,RBC,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.25,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,823781,HCV RNA GENOTPE 1 NS5A DRUG RE,OMBITASVIR RESISTANCE,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,PROTHROMBIN TIME PT,PROTHROMBIN TIME PT,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,COMP METABOLIC PANEL W GFR,SODIUM,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,CBCI COMPLETE BLOOD COUNT W DIFF,LYMPHOCYTES,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.047142857142857146,0.09090909090909091,0.14285714285714285,0.14285714285714285,0.3409090909090909,0.5357142857142857,0.0,0.041353268343751526,0.05894070881685487,0.025344837556394273,0.07162596183040726,0.10208830230491539,1,831008,HEPATITIS PANEL DIAGNOSTIC,HEP B CORE TOTAL AB,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,CYSTIC FIBROSIS SCREEN,ETHNICITY,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,HEPASCORE R,SEX,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,CBC W O DIFF WITH PLATELETS,MCV,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.22333333333333336,0.0,0.0,0.22333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,UREA NITROGEN BUN,UREA NITROGEN BUN,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.31,0.25,0.0,0.3333333333333333,0.25,1.0,0.0,0.032615729323927534,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,823799,HCV RNA NS5A GENOTYPE,DACLATASVIR RESISTANCE,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,URINALYSIS,NITRITE,Neutrophils,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,URINALYSIS C,BILIRUBIN,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,CMP WITH EGFR,ANION GAP,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,CARDIO CRP R,CARDIO CRP R,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,UA W MICRO HOLD SPEC 24 HR,SPECIFIC GRAVITY,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,URINALYSIS W REFLEX MICRO,EPITHELIAL CELLS,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,PHENCYCLIDINE,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,HEMOGLOBIN A1C,ESTIMATED AVG GLUCOSE,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,HEPATITIS BE ANTIGEN,HEP BE ANTIGEN,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,ALT,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.08,0.05714285714285715,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,HNK1 CD57 PANEL,LYMPHS ABSOLUTE,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,IMMUNOFIXATION SERUM,IMMUNOGLOBULIN M,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,CMP14 HP4 DBILI CBC D PLT R,LYMPHS,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,HP5,HEP C VIRUS AB,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.10714285714285714,0.125,0.0,0.0,0.0,0.0,0.051583725460460195,0.0,0.0,0.0,0.0,0,204164,CMP WITH EGFR,ALKALINE PHOSPHATASE,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,HIV 4TH GEN RFLX CONF,HIV 4TH GEN RFLX CONF,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,DIRECT LDL,DIRECT LDL,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,BASIC METABOLIC PANEL 8,EGFR IF AFRICN AM,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,CBCI COMPLETE BLOOD COUNT W DIFF,MCHC,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,URINALYSIS CULTURE IF INDICATED,WHITE BLOOD CELLS,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,CMP14 4AC,EGFR IF AFRICN AM,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.05581018273830618,0.0,0,30973,C4 C3,COMPLEMENT C3 SERUM,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,NEG HIV 4TH GEN,HIV 1 AB WESTERN BLOT,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,HEPATITIS C VIRAL RNA NS3 GENOTYPE,BOCEPREVIR RESISTANCE,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,CULTURE ROUTINE,CULTURE ROUTINE,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.47,0.3333333333333333,0.25,0.0,0.0,0.0,0.03694153252517385,0.530776546300907,0.08679392382276507,1,19687,HEPATIC FUNCTION PANEL AMA,BILIRUBIN DIRECT,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD8 CELLS,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.0,0.06,0.18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,COMPREHENSIVE METABOLIC PANEL E GFR,CARBON DIOXIDE,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.14285714285714285,0.2,0.33399999999999996,0.3814285714285714,0.534,0.0,0.06660212972360224,0.06720098415971731,0.04063280382827705,0.1538110300980966,0.15519402517768222,0,169334,ACUTE HEPATITIS PANEL,HEPATITIS A AB IGM,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0,0.0,0.0,0.04,0.06666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0,241133,CD4 CD8 ENUMERATION,ABSOLUTE LYMPHOCYTES,Hepatitis B virus core Ab.IgM,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.3333333333333333,0.1325,0.265,0.0,0.0,0.0,0.010816689796725898,0.014369129342247433,0.019733925021995558,1,453530,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,IRON IBC W O REFLEX,UIBC,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,CBC WITH AUTO DIFF,MONOCYTES #,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,CCP ANTIBODY IGG,ANTI CCP IGG,Erythrocyte morphology finding,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld
0.18999999999999997,0.25,0.0,0.22333333333333336,0.25,1.0,0.0,0.33333333333333337,0.0,0.0,0.5773502691896257,1.0,1,21618,URINE DRUG SCREEN 1,CREATININE,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,IRON IBC W O REFLEX,UIBC,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,CBC WITH AUTO DIFF,RDW,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,CBC PLATELET HEM REVIEW,LYMPHS ABSOLUTE,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,LIPID PROFILE,NON HDL CHOLESTEROL,Race,Race,Race
0.0,0.0,0.0,0.0825,0.051666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,URINALYSIS WITH MICROSCOPIC,PH,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,HEPATITIS C RNA PCR QUANTITATIVE,HCV VIRAL LOG,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,GGT,GGT,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,DRUG ABUSE SCREEN I,AMPHETAMINES,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,LIVER FIBROTEST ACTITEST,FIBROSIS STAGE,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,DRUG ABUSE SCREEN III,METHADONE,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,HEPATITIS C AB REFLEX HCV RNA QUANT,HEPATITIS C ANTIBODY,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,CMP12 LP TP TSH 6AC CBC D PLT,HEMOGLOBIN,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,CMP14 LP CBC D PLT UA MG TS,VLDL CHOLESTEROL CAL,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESIST ASSAY INTERP,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,DIFFERENTIAL MANUAL,ABSOLUTE EOSINOPHILS,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,HIV 1 RNA QN RT PCR,HIV 1 RNA QN PCR,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.316,0.375,1.0,0.0,0.0,0.0,0.0,0.624939177332759,1.0,1,28654,PROTEIN ELECTRO S,ALPHA 1 GLOBULIN,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,CBC,MCH,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,CBC WITH PLT DIFF,RBC MORPHOLOGY,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.23857142857142857,0.33399999999999996,0.0,0.0,0.0,0.0,0.0769055150490483,0.07759701258884111,0.0,0.0,0.0,0,169334,HEPATITIS BE AG,HBEAG INS,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,DIFFERENTIAL MANUAL,PLATELET ESTIMATION,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,BMP WITH ESTIMATED GFR CALCULATED,CARBON DIOXIDE,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264846,CMP14,EGFR IF AFRICN AM,Monocytes,Monocytes [#/volume] in Blood,Monocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,TRANSFERRIN CARBOHYDRATE DEFICIENT ALCOHOL USE,TRANSFERRIN,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,CMP14 LP CBC D PLT TSH UA M,AST SGOT,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.5,0.3333333333333333,0.5,0.5,0.16666666666666666,1.0,0.10393692145274336,0.04384936485121893,0.045556303189397296,0.13418198861418107,0.05660928660351461,0.05881293452243719,1,27318,PTH INTACT WITHOUT CALCIUM,PTH INTACT,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,CMP14 5AC,EGFR IF NONAFRICN AM,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,FIBROACT COMPLETE,HEIGHT INCHES,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,IFE PE FLC SERUM,ALBUMIN,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,HB S AG W REFLEX CONF,HFLAG NR,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,MANUAL DIFFERENTIAL,LYMPHOCYTES ABSOLUTE,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,NEG HIV 4TH GEN,NEG HIV 1 RNA QL TMA,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,HEPATIC FUNCTION PANEL,ALBUMIN,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.155,0.2316666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,327767,URINALYSIS WITH MICROSCOPIC,RED BLOOD CELLS,Erythrocytes,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,ACUTE HEPATITIS PANEL,HEPATITIS A AB IGM,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.11249999999999999,0.15,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,DRUG ABUSE SCREEN 8 W CONFIRMATION,BARBITURATES,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0.0,0.0,0.0,0,24588,IFE PE SERUM,ALPHA 1 GLOBULIN,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,CBCI COMPLETE BLOOD COUNT W DIFF,LYMPHOCYTES,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,FREE T4 THYROXINE,FREE T4,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,ALKALINE PHOSPHATASE,LIPEMIA,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,UROGRAM,SPECIFIC GRAVITY,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.12571428571428572,0.29333333333333333,0.0,0.12571428571428572,0.29333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,LIPID PANEL WITH LDL HDL RATIO,LDL HDL RATIO,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,CMP13 LP 2AC CBC D PLT,EGFR IF AFRICN AM,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,RPR HBSAG HCVAB HSV1 HSV2 I,HEP C VIRUS AB,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.11399999999999999,0.08142857142857142,0.1425,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,DRUG ABUSE PANEL 10 WITH OXYCODONE,BENZODIAZEPINES,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,CMP14 LP 3AC,LDH,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,STOOL CULTURE,RESULT 1,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,DIFFERENTIAL MANUAL,EOSINOPHILS,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20958,HEPASCORE R,SEX,Cholesterol.in HDL/Cholesterol.total,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,HDLc SerPl
0.0,0.0,0.0,0.05142857142857143,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,BMP8 EGFR,POTASSIUM,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,PROTEIN CREATININE RATIO URINE,PROTEIN UR MG DL,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,CBC WITH PLT DIFF,MPV,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.018125,0.03625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,SMOOTH MUSCLE AB RFX TITER,F ACTIN IGG,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,HEMOGRAM W AUTOMATED DIFF,WBC,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,NEG HIV 4TH GEN,NEG HIV 1 ANTIBODY,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.192,0.192,0.48,0.392,0.392,0.98,0.0,0.0,0.0,0.03737810203089009,0.05195195509007766,0.06743073700930258,1,172841,MITOCHONDRIAL ANTIBODY W REFL TITER,MITOCHONDRIAL AB SCREEN,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,COMP METABOLIC PANEL W GFR,PROTEIN TOTAL,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,ACUTE HEPATITIS PANEL,HEPATITIS A IGM,Leukocyte morphology finding,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld
0.066,0.0,0.0,0.346,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.04841537082187086,0.45528141890436646,0.7071067811865476,1,15586,COMP METAB PANEL,GLUCOSE FASTING,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,DRG TOX CRT REFL SPEC GR,CREATININE,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,ANA SCREEN QUAL,ANA ANTIBODY SCREEN EIA,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,ANA SCR IFA RFL TITR PATT,ANA SCREEN IFA,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,COMPREHENSIVE METABOLIC PANEL,CARBON DIOXIDE,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,IGG SUBCLASSES,IMMUNOGLOBULIN G QN SERUM,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,CMP14 LP 6AC,PHOSPHORUS,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,SEDIMENTATION RATE WESTERGREN,SEDIMENTATION RATE WESTERGREN,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.0,0.09090909090909091,0.0,0.0,0.0,0.0,0.0,0.008627647515398906,0.0,0.0,0.0,0.0,0,602797,CBCI COMPLETE BLOOD COUNT W DIFF,ABS NEUTROPHILS,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,HEMATOPATH CONSULTATION SMEAR,WBC,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,PROTEIN ELECTROPHORESIS SR W RFX,INTERPRETATION,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,HEPASCORE R,AGE,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,LYMPHOCYTE SUBSET PANEL 3,CD4 CD8 RATIO,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,PROTHROMBIN TIME INR,PROTHROMBIN TIME,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,HEPATIC FUNCTION PANEL,TOTAL PROTEIN,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,FREE T3,FREE T3,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,QUESTASSURED 25 OH VIT D,VITAMIN D 25 OH D2,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,CBC INCLUDES DIFFERENTIAL PLATELETS,RBC,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,ALPHA 1 ANTITRYPSIN PHENOTYPE,A 1 ANTITRYPSIN PHENOTYPE,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.08333333333333333,0.018,0.0,0.08333333333333333,0.018,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,PTH INTACT MOLECULE,PTH,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.015714285714285715,0.055,0.0,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.06317690320497038,0.0,0,204164,IRON BINDING CAPACITY % SATURATION,IRON SERUM,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,VIT B 12 FOLATE PANEL,VITAMIN B 12,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.16666666666666666,0.26,0.715,0.16666666666666666,0.26,0.715,0.026355222038017434,0.08088757789668977,0.22524969726717137,0.026355222038017434,0.08088757789668977,0.22524969726717137,1,112599,HEPATITIS C VIRAL RNA QUALITATIVE TMA,HEPATITIS C VIRAL RNA QUALITATIVE TMA,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,DRUG ABUSE SCREEN 8 W CONFIRMATION,BARBITURATES,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,LYMPHOCYTE SUBSET PANEL 4,RACE NR,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D2,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,ANION GAP,ANION GAP,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,T3 FREE,T3 FREE,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,CMP14 LP CBC D PLT UA MG TS,VLDL CHOLESTEROL CAL,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,URINALYSIS RX ALB CREA,KETONES,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.0,0.058823529411764705,0.0,0.0,0.058823529411764705,0.0,0.0,0.027466179518855105,0.0,0.0,0.027466179518855105,0.0,0,771477,FOLATE SERUM,FOLATE SERUM,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,DRUG ABUSE SCREEN III,METHADONE,Body weight,Body weight Measured,Weight Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,CMP12 LP 6AC,CHOLESTEROL TOTAL,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,ARTHRITIS PROFILE,SEDIMENTATION RATE,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.06200000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,HEP C RNA GENOT 3 NS5A,VELPATASVIR RESISTANCE,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,ASH FIBROSURE,APOLIPOPROTEIN A 1,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,CBC W DIFF PLT,MPV,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,COMP METABOLIC PANEL 12,ALKALINE PHOSPHATASE,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,URINALYSIS WITH MICROSCOPIC,APPEARANCE,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,URINALYSIS RX ALB CREA,KETONES,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.088,0.22,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,DRGABU2,METHAQUALONE,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,HEP A AB IGM,HEPATITIS A AB IGM,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.0,0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.008101392516229877,0.0,0,25015,PSA TOTAL REFLEX FREE,PROSTATE SPECIFIC AG SERUM,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,ANA AMA ASMA LKM AB,MITOCHONDRIAL M2 ANTIBODY,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,IFE PE SERUM,M SPIKE,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,BILIRUBIN PANEL,BILIRUBIN INDIRECT,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.009671476801487056,0.0,0.0,0.0,0.0,0,110544,MICROALBUMIN CREATININE RANDOM RATIO,CALC MICROALB CREAT RND,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.05555555555555555,0.1,0.0,0.05555555555555555,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,ANA SCR IFA RFL TITR PATT,ANA SCREEN IFA,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,CMP14 4AC,EGFR IF AFRICN AM,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,FREE T3,FREE T3,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,DRUG ABUSE SCREEN W ETOH NO GCMS,BARBITURATES,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.04833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,CBC WITH DIFFERENTIAL,IMMATURE GRANS,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.08333333333333333,0.04,0.0,0.04833333333333333,0.129,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,HCV RNA PCR QN RFX GENO,PLEASE NOTE,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,HCV RNA GENOTYPE LIPA R,HCV RNA GENOTYPE LIPA,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD8 CELLS,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,NASH FIBROSURE,ALT SGPT P5P,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,DRUG ABUSE PANEL 10 WITH OXYCODONE,METHAQUALONE,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.2783333333333333,0.4488888888888889,0.6733333333333333,0.0,0.0,0.0,0.01134702515129804,0.27088019091696647,0.4476947053485614,1,481598,HP5,HEP C VIRUS AB,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,UA MICROSCOPIC REFLEX CULTURE,OCCULT BLOOD,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.04,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,CBC PLATELET HEM REVIEW,EOS ABSOLUTE VALUE,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.07142857142857142,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,CBC W AUTO DIFF,MONOCYTES %,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,RENAL PANEL 10,EGFR IF NONAFRICN AM,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.022727272727272728,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,STOOL CULTURE,RESULT 1,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,URINALYSIS W MICROSCOPIC,URINALYSIS URINE COLOR,Basophils,Basophils [#/volume] in Blood,Basophils # Bld
0.072,0.09857142857142856,0.13799999999999998,0.0,0.07142857142857142,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,BASIC METABOLIC PANEL,BUN,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.14285714285714285,0.0,0.0,0.14285714285714285,0.0,0.0,0.20717899254074368,0.0,0.0,0.20717899254074368,0.0,0,67686,FERRITIN SERUM,FERRITIN SERUM,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.06605502583691747,0.05720402135206337,0.7071067811865476,1,7047,CBC INCLUDES DIFF PLT,BASOPHILS ABSOLUTE,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,CREATININE,ICTERUS,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,CYSTIC FIBROSIS SCREEN,ETHNICITY,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,COMPREHENSIVE METABOLIC PANEL,CARBON DIOXIDE,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93187,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA TITER,Albumin/Creatinine,Albumin/Creatinine [Mass Ratio] in Urine,Albumin/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,PHENCYCLIDINE,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,DRUG ABUSE SCREEN III,METHADONE,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,CMP12 LP TP TSH 6AC CBC D PLT,POTASSIUM,Color,Color of Urine,Color Ur
0.2,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,LD,LD,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,HB CORE AB W IGM RFX,HB CORE AB TOTAL,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,PROFILE 104 LIVER,AST SGOT,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20750,URINALYSIS REFLEX,GLUCOSE QL,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.06,0.04,0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,MAGNESIUM,HEMOLYSIS,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,RENAL PANEL 10,EGFR IF NONAFRICN AM,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,HEPATIC FUNCTION PANEL AMA,BILIRUBIN DIRECT,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B RESIST ASSAY INTERP,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.125,0.0,0.0,0.09375,0.0,0.0,0.0714561518627298,0.0,0.0,0.0,0.0,0,182626,IMMUNOFIXATION SERUM,IMMUNOGLOBULIN M,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,CMP12 7AC MG,PHOSPHORUS SERUM,Body weight,Body weight Measured,Weight Measured
0.0,0.0,0.0,0.0,0.15,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,24729,IMMUNOGLOBULINS,IMMUNOGLOBULIN M,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,HEPATITIS B CORE AB,HEPATITIS B CORE AB,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,URINALYSIS,BILIRUBIN,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,VITAMIN B 12 FOLIC ACID,VITAMIN B 12,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.14285714285714285,0.08333333333333333,1.0,0.14285714285714285,0.08333333333333333,1.0,0.032809221376370656,0.0,0.0,0.032809221376370656,0.0,0.0,1,115790,TSH ULTRASENSITIVE,TSH ULTRASENSITIVE,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,CBC WITH AUTO DIFF,EOSINOPHILS #,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.2,0.5655555555555556,0.884,0.0,0.0,0.0,0.03796471617953978,0.13817876011426722,0.14369156469154098,1,139501,CMP14 HP4 1AC PT AFP,HEP A AB IGM,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,LYMPHOCYTE SUBSET PANEL 4,LYMPHOCYTES ABSOLUTE,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.044444444444444446,0.08,0.0,0.044444444444444446,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE EOSINOPHILS,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,CBC W DIFF PLT,MPV,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,HEP B CORE AB QUAL,HEPATITIS B CORE AB QL,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,HEMOGLOBIN A1C WITH EAG,ESTIMATED AVERAGE GLUCOSE,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,CCP ANTIBODY IGG,ANTI CCP IGG,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,LIPID PANEL,LDL CALC,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,HEMOGRAM W AUTOMATED DIFF,WBC,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,OMBITASVIR RESISTANCE,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,BILIRUBIN DIRECT,DIRECT BILIRUBIN,pH,pH of Urine by Test strip,pH Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,LIVER FIBROSIS,NECROINFLAM ACT GRADE,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,CBC WITH PLT DIFF,RDW,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,GENERAL HEALTH PANEL,CALC GLOBULIN,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.3166666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,CMP14 CBC D PLT ESR WES ANA,LYMPHS ABSOLUTE,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,AMYLASE SERUM,AMYLASE SERUM,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,CBC WITH PLT DIFF,VARIANT LYMPHOCYTES ABSOLUTE,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.14333333333333334,0.2866666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,PROTHROMBIN PTT,CONTROL,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,CBC COMPLETE BLOOD COUNT W O DIFF,MCV,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,CBC W AUTO DIFF,ABS BASOPHILS,Leukocyte morphology finding,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,PROTEIN ELECTROPHORESIS SERUM,BETA,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.03548391705249854,0.0,0.0,0.0,0.0,0,196444,DRUG ABUSE SCREEN III,METHADONE,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,LIPID PNL W REFL TRIG>400,CHOLESTEROL HDL RATIO,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,RPR,RPR RESULT,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,DIFFERENTIAL MANUAL,ABSOLUTE LYMPHOCYTES,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,STOOL CULTURE,RESULT 2,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,HCV AB W RFL RNA RFL GENO,HEPATITIS C AB,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,CBC,% BASOPHILS,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.16666666666666666,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,AFP TUMOR MARKER SIEMENS CLIA,AFP TUMOR MARKER SIEMENS CLIA,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,TRIIODOTHYRONINE T3 FREE,TRIIODOTHYRONINE T3 FREE,Bacteria identified,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,FE TIBC FER B12 HCT FOLRBC,IRON,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,CMP WITH ESTIMATED GFR CALCULATED,FASTING NON FASTING,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,PROTEIN ELECTRO S,ALPHA 2 GLOBULIN,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.05834370368217123,0.0,0.0,0.0,0.0,0,182626,IFE PE SERUM,GLOBULIN TOTAL,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,HEMOGLOBIN A1C WITH EAG,ESTIMATED AVERAGE GLUCOSE,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,TSH ULTRASENSITIVE,TSH ULTRASENSITIVE,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,PTH INTACT WITHOUT CALCIUM,PTH INTACT,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.165,0.265,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,URINALYSIS W MICRO,GLUCOSE,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0775,0.10333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE LYMPHOCYTES,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,COMP METAB PANEL,EGFR NON AFR AMERICAN,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.0,0.2857142857142857,0.6666666666666666,0.0,0.0,0.0,0.0,0.10683799300987995,0.15892726613090935,1,7765,CBC INCLUDES DIFF PLATELETS,MEAN PLATELET VOLUME,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,HCV RNA PCR RFX NS5B,HCV NS5B RESISTANCE ASSAY PDF,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,CBC W AUTO DIFF,MONOCYTES %,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,CBC W DIFF PLT,MPV,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,URINE DRUG SCREEN 1,CREATININE,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,CBC INC DIFF PLT,BASOPHILS,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,MANUAL DIFFERENTIAL,BLASTS %,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0625,0.125,0.08,0.05,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,CBC INCLUDES DIFF PLT,ABSOLUTE BAND NEUTROPHILS,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,HCV FIBROSURE RESULTS,NECROINFLAMMAT ACT GRADE,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,LIVER FIBROTEST ACTITEST,FIBROSIS STAGE,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.0,0.055625,0.0,0.0,0.0625,0.0,0.0,0.0,0.0,0.0,0.039281815996516256,0.0,0,339143,DRG TOX CRT REFL SPEC GR,CREATININE,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,URINALYSIS SCREEN,PH,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.285,0.285,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,PSA FREE TOTAL,INTERNAL %,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,COMPREHENSIVE METABOLIC PANEL,GLUCOSE,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
1.0,0.6666666666666666,0.0,1.0,0.6666666666666666,0.0,0.9870524497488843,0.9742725385552735,0.0,1.0,0.9870524497488843,0.0,1,59022,PROTHROMBIN TIME INR,PROTHROMBIN TIME,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.05181818181818181,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,611517,DRUG ABUSE SCREEN III,AMPHETAMINES,Albumin,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,Albumin SerPl BCG-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,HCV RNA NS5A GENOTYPE,VELPATASVIR RESISTANCE,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,CBC DIFF PLT,RDW,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,THYROXINE T4 FREE,T 4 FREE,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,COMPREHENSIVE METABOLIC PANEL E GFR,CALC GLOBULIN,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,PSA TOTAL % FREE,% FREE PSA,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,AMY LIPASE,AMYLASE,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,CBC WITH DIFF PLATELET,WBC,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,CBC W AUTO DIFF,MEAN PLATELET VOLUME,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.3333333333333333,0.14285714285714285,0.3333333333333333,0.3333333333333333,0.2857142857142857,0.3333333333333333,0.05339016372965322,0.0,0.0,0.05339016372965322,0.08312548434166944,0.0,1,18341,AFP WITH AFP L3%,AFP SERUM,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,CBC W DIFF PLATELET,HCT,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,PROTEIN ELECTROPHORESIS SERUM,BETA,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,DIFFERENTIAL MANUAL,NEUTROPHILS ABSOLUTE,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.02142857142857143,0.03,0.0,0.03142857142857143,0.044,0.0,0.0,0.0,0.0,0.0,0.0,0,728626,CRYOGLOBULINS REFLEX IFE QUANT,IGM CRYOPRECIPITATE,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,825208,CMP14 EGFR,POTASSIUM,Velpatasvir,Velpatasvir [Susceptibility] by Genotype method,Velpatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,FASTING,FASTING STATUS,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,COMPLEMENT COMPONENT C3C,COMPLEMENT COMPONENT C3C,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc
0.0,0.0,0.0,0.1375,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,LYMPHOCYTE SUBSET PANEL 5,ANALYZED DATE TIME NR,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,ACUTE HEPATITIS PANEL,HEPATITIS A IGM,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,CBC INCLUDES DIFF PLT,BLASTS,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,THYROID II PROFILE T3U T4 T7 TSH,T4 THYROXINE,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,LIVER FIBROTEST ACTITEST,HAPTOGLOBIN,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,MITOCHONDRIAL M2 AB,MITOCHONDRIAL M2 AB,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.046144390603046204,0.0,0,98301,CMP14 HP5 LP 6AC CBC D PLT,MAGNESIUM SERUM,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,BMP8 CBC D PLT,CREATININE,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,PE INTERP RFX IFE S,ALBUMIN,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,HCV RNA NS5A GENOTYPE,DACLATASVIR RESISTANCE,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,NGI HCV SUPERQUANT,HEPATITIS C QUANTITATION,Ceruloplasmin,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,MPV,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,LYMPHOCYTE SUBSET PANEL 4,% CD8 SUPPRESSOR T CELLS,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,LP LDLDIR,TRIGLYCERIDES,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,CBC DIFF PLT,MONOCYTES %,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,COMP METABOLIC PANEL,ALKALINE PHOSPHATASE,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,DIFFERENTIAL MANUAL,ABSOLUTE EOSINOPHILS,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,URINALYSIS CULTURE IF INDICATED,OCCULT BLOOD,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,QUESTASSURED 25 OH VIT D,VITAMIN D 25 OH D2,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,HIV 1 QUANT PCR,HIV 1 VIRAL COPY,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,CMP12 LP 6AC,CHOLESTEROL TOTAL,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,IMMUNOGLOBULINS,IMMUNOGLOBULIN A,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0365,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,HEPATITIS A DIAGNOSTIC PANEL,HAV AB TOTAL,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,426171,MITOCHONDRIAL M2 AB,MITOCHONDRIAL M2 AB,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.3333333333333333,0.4166666666666667,0.75,0.3333333333333333,0.4166666666666667,0.75,0.3657130515241863,0.5973264996689122,0.8359491946807684,0.3657130515241863,0.5973264996689122,0.8359491946807684,1,51961,HEP B SURFACE AG W REFLEX,HEP B SURFACE AG W REFLEX,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,LYMPHOCYTE SUBSET PANEL 4,ABS CD4 COUNT,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,CBC INCLUDES DIFF PLT,BLASTS,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CARBON DIOXIDE,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.1,0.07142857142857142,0.16666666666666666,0.1,0.07142857142857142,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,HGB A1C WITH EAG ESTIMATION,HEMOGLOBIN A1C,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,NGI HCV QUANTASURE,HEPATITIS C QUANTITATION,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,HCV FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,HB S AG W REFLEX CONF,HB S AG NEUTRALIZATION,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,RPR,TREPONEMA PALLIDUM ANTIBODIES,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,COMPLEMENT C3 SERUM,COMPLEMENT C3 SERUM,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,HEPATITIS C AB REFLEX HCV RNA QUANT,HEPATITIS C ANTIBODY,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,PROTHROMBIN TIME PT,PT CONTROL,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,RENAL PANEL 10,EGFR IF NONAFRICN AM,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,PROTHROMBIN TIME PT,PT CONTROL,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,PSA FREE TOTAL,INTERNAL %,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,CHEM PROFILE 29,ALK PHOS,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,ARTHRITIS PROFILE,ANTI NUCLEAR ANTIBODIES,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.25,0.16666666666666666,0.94,0.0,0.0,0.0,0.05026217761451124,0.056942591518096664,0.0,1,93179,DIFFERENTIAL MANUAL,PLATELET ESTIMATION,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.0691807192705608,0.0556189409485538,0.10240603634159506,1,237610,CBC PLATELET HEM REVIEW,NEUTROPHILS,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.03571428571428571,0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,URINALYSIS W MICRO W REFLEX CULTURE,NITRITES,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,NASH FIBROSURE,ALT SGPT P5P,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,TSH W REFLEX FT4,TSH 3RD GENERATION W REFLEX FT4,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,URINALYSIS RX ALB CREA,KETONES,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,CBC WITH PLT DIFF,MEGAKARYOCYTE FRAGS,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,MITOCHONDRIAL M2 AB,MITOCHONDRIAL M2 AB,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,HEMOGLOBIN A1C,HEMOGLOBIN A1C,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,HEPATIC FUNCTION PANEL A,TOTAL PROTEIN,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,IRON BINDING CAPACITY % SATURATION,IRON SERUM,Reference lab test method,Reference lab test method,Ref lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,UROGRAM,KETONES,Reference lab test method,Reference lab test method,Ref lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,HIV ANTIBODY 1 WESTERN BLOT,HIV WB INTERP,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.11399999999999999,0.05142857142857143,0.09,0.0,0.03571428571428571,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,COMP METAB PANEL,ALT,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,COMP METABOLIC PANEL 12,ALKALINE PHOSPHATASE,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.14285714285714285,0.0,0.0,0.10714285714285714,0.0,0.0,0.06835323508016788,0.0,0.0,0.0,0.0,0,20289,IMMUNOFIXATION SERUM,IMMUNOGLOBULIN M,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.3333333333333333,0.25,0.74,0.3333333333333333,0.25,0.74,0.012877229495112386,0.08489650403181737,0.0,0.05056050164439552,0.33333333333333337,0.0,1,149575,MICROALBUMIN CREATININE RATIO,MICROALBUMIN RAN 24HR,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,VITAMIN B 12 FOLIC ACID,VITAMIN B 12,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.09247447620418048,0.34003516797720323,1.0,0.09247447620418048,0.34003516797720323,1.0,1,22848,FOLATE,FOLATE,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,HEMATOPATH CONSULTATION SMEAR,WBC,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.47,0.3333333333333333,0.25,0.0,0.0,0.0,0.03694153252517385,0.530776546300907,0.08679392382276507,1,19687,HEPATIC FUNCTION PANEL,BILIRUBIN DIRECT,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.3333333333333333,0.5,0.0,0.3333333333333333,0.5,0.0,0.371735721895339,0.40824829046386313,0.0,0.371735721895339,0.40824829046386313,0,44859,COMPLEMENT C4 SERUM,COMPLEMENT C4 SERUM,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,FOLATE,FOLATE,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,CBC WITH DIFFERENTIAL,EOSINOPHILS,Erythrocytes,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,OMBITASVIR RESISTANCE,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,PROTEIN ELECTROPHORESIS,ALPHA 1 GLOBULINS,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,CBC WITH PLT DIFF,MYELOCYTES,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,CBC WITH MANUAL DIFFERENTIAL,NEUTROPHILS,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.15,0.21000000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,CBC COMPLETE BLOOD COUNT W O DIFF,MCHC,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE MONOCYTES,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178566,LIPID PROFILE WITH CALCULATIONS NON HDL CHOLESTEROL,RISK RATIO CHOL HDL,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.1475,0.0,0.0,0.1475,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,HEP B SURFACE AG W REFLEX,HEP B SURFACE AG W REFLEX,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,URINALYSIS ROUTINE W RFX,BILIRUBIN,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,ASH FIBROSURE,APOLIPOPROTEIN A 1,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.3833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,IMMUNOGLOBULINS IGG A M SER,IMMUNOGLOBULIN A,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,COMP METAB PANEL,GLUCOSE FASTING,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,LYMPHOCYTE SUBSET PANEL 2,CD4 ABSOLUTE,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,T4 THYROXINE,T4 THYROXINE,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,CBC WITH PLT DIFF,NRBC,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,UREA NITROGEN BUN,HEMOLYSIS,Microalbumin/Creatinine ratio panel,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,URINALYSIS W REFLEX MICRO,GLUCOSE,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.07870803013413097,0.08411277379800186,0.09704900074164846,1,264788,CBC W AUTO DIFF ABS WBC MPV PLT,LYMPHOCYTES,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,POL CMP WITH EGFR INV,GLUCOSE,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.5466666666666667,0.3,0.5333333333333333,0.5299999999999999,0.20857142857142857,0.15333333333333335,0.0,0.019349643319108933,0.019672694668938395,0.0,0.06525802301826944,0.03317376812494377,1,98301,LIPID PROFILE WITH CALCULATIONS NON HDL CHOLESTEROL,RISK RATIO CHOL HDL,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,CBC PLATELET HEM REVIEW,NEUTROPHILS,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7096,IRON IBC W RFX FERRITIN,%TRANSFERRIN SATURATION,Blasts/100 leukocytes,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,HDL CHOL DIRECT,HDL AS % CHOLESTEROL,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.0,0.075,0.15,0.0,0.02,0.04,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,HEPATIC FUNCTION PROFILE,BILIRUBIN INDIRECT,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,CBC WITH DIFFERENTIAL,MYELOCYTES,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.38999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,URIC A ESR WES ANA RA QN CC,URIC ACID,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.06666666666666667,0.05,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,CBC WITH ABSOLUTE NEUTROPHIL COUNT,PLATELET COUNT,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,CBC W AUTO DIFF WITH PLATELETS,RBC,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,IRON IBC W RFX FERRITIN,%TRANSFERRIN SATURATION,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,LIPID PANEL,CALC LDL CHOL,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CARBON DIOXIDE,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,LIPID PROFILE,CHOLESTEROL,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.022222222222222223,0.05,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,PROTHROMBIN TIME,PT POP MEAN,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,FERRITIN,FERRITIN,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,MANUAL DIFFERENTIAL,EOSINOPHILS %,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,PROTEIN ELECTRO S,PLEASE NOTE,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,PROTEIN ELECTRO S,BETA GLOBULIN,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204479,HCV FIBROSURE,FIBROSIS SCORE,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,CMP14 5AC,EGFR IF NONAFRICN AM,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,COMPREHENSIVE METABOLIC PANEL E GFR,SODIUM,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,URINALYSIS WITH MICROSCOPIC,PROTEIN,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,PSA FREE TOTAL,INTERNAL %,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,PTH INTACT MOLECULE,PTH,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,MICROALBUMIN CREATININE RATIO,MICROALBUMIN RAN 24HR,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.3814285714285714,0.534,0.0,0.3814285714285714,0.534,0.0,0.07270350853123586,0.03813553709233353,0.0,0.07270350853123586,0.03813553709233353,0,223149,HEPATITIS B CORE AB TOTAL,HEPATITIS B CORE AB TOTAL,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.09333333333333332,0.1275,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS A TOTAL AB,Prothrombin.activity actual/Normal,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264853,TESTOSTERONE FREE TOTAL LC MS,TESTOSTERONE TOTAL LC MS,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D3,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,WBC,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,VIT B 12 FOLATE PANEL,VITAMIN B 12,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.1375,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,URINALYSIS W MICROSCOPIC,BACTERIA,Prothrombin.activity actual/Normal,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP
0.134,0.2,0.25,0.0,0.0,0.0,0.0,0.054770657198115025,0.14548066005431926,0.0,0.0,0.0,0,345355,CREATININE,ICTERUS,Microalbumin/Creatinine ratio panel,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,CBC INCLUDES DIFF PLT,BASOPHILS %,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.21,0.32125,0.4,0.14333333333333334,0.25,0.2,0.0,0.034880496193767985,0.04779467294787276,0.0,0.04503052695530496,0.061702657454847154,1,134999,HIV ANTIBODY 1 WESTERN BLOT,HIV WB INTERP,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,CBC W DIFF PLATELET,HCT,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,PTH INTACT MOLECULE,PTH,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,ANACHOICE SCR W REFL TITER IFA,ANA SCREEN IFA,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.1569574215481997,0.0,0.0,1,303842,CBC WITH AUTO DIFF,RDW,Erythrocyte distribution width,Erythrocyte distribution width [Entitic volume],RDW RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,FERRITIN,FERRITIN,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.0475,0.095,0.0,0.0475,0.095,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,COMPLEMENT COMPONENT C3C,COMPLEMENT COMPONENT C3C,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17517,COMPREHENSIVE METABOLIC PANEL WITH GFR,ANION GAP,Albumin,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,QUESTASSURED 25 OH VIT D,VITAMIN D 25 OH D2,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D3,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.2,0.16666666666666666,0.0,0.0,0.0,0.0,0.048918155723576384,0.03837506794957857,0.0,0.0,0.0,0.0,0,7146,DIFFERENTIAL MANUAL,ABSOLUTE BAND NEUTROPHILS,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,HEPATITIS C RNA PCR QUANTITATIVE,HCV VIRAL LOG,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,IRON IBC W O REFLEX,UIBC,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.17166666666666666,0.08444444444444445,0.12666666666666668,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,COMP METABOLIC PANEL W GFR,ANION GAP,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,STOOL CULTURE,RESULT 1,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.125,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.08539469110668363,0.0,0,241109,CMP12 LP 6AC,PHOSPHORUS SERUM,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,ASH FIBROSURE,HAPTOGLOBIN,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.025,0.05555555555555555,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,HEMOGLOBINOPATHY EVAL,MCH,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,UA MICROSCOPIC REFLEX CULTURE,BILIRUBIN,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,CBC DIFF AMBIGUOUS DEFAULT,NEUTROPHILS,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.1075,0.2866666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,CBC W DIFF PLATELET,MCH,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,CBC PLATELET HEM REVIEW,LYMPHS ABSOLUTE,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,LYMPHOCYTE SUBSET PANEL 4,COMMENTS,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.07559327125736637,0.0,0,115725,NGI HCV SUPERQUANT,INTERNATIONAL UNITS,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.04666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,HEPATITIS C VIRAL RNA NS3 DRUG RESI,BOCEPREVIR RESISTANCE,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,X HEPATITIS COMPLEX PROFILE,ANTI HBC TOTAL,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,TESTOSTERONE FREE LC MS MS,TESTOSTERONE FREE LC MS MS,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,GENERAL HEALTH PANEL,CALC GLOBULIN,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,COMP METABOLIC PANEL W GFR,GLOBULIN,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,FIBROACT COMPLETE,WEIGHT LBS,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,CLR CBC W DIFF PLT,ABSOLUTE EOSINOPHILS,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,RHEUMATOID FACTOR QUANT,RHEUMATOID FACTOR QUANT,Hemoglobin,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,HIV ANTIBODY 1 WESTERN BLOT,HIV WB INTERP,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,HEPATITIS B SURFACE AG,HEPATITIS B SURFACE AG,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.22333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,HEPATITIS BS AB QL,HEPATITIS B SURF AB QL,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.011111111111111112,0.025,0.12285714285714286,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,622381,BASIC METABOLIC PANEL 8,EGFR IF AFRICN AM,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,HEPASCORE R,AGE,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D2,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,PTH INTACT,PARATHYROID HORMONE INTACT,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,ANION GAP,ANION GAP,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,URINALYSIS W MICRO W REFLEX CULTURE,NITRITES,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,TRICHOMONAS MALE,SOURCE,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,URINALYSIS W REFLEX MICRO,GLUCOSE,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.2,0.42857142857142855,0.6,0.4,0.5714285714285714,0.8,0.04144292597059562,0.15766650902399004,0.1591571563137949,0.4305038496827379,0.8405346550827468,0.8484814328311875,1,223222,HEPATITIS B SURFACE ANTIBODY,HEPATITIS B SURFACE AB QUAL,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.05339016372965322,0.1963193957655779,0.5773502691896257,0.06538932921065,0.4808823462371743,0.7071067811865476,1,22848,VITAMIN B12 FOLATE,FOLATE SERUM,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,TESTOSTERONE FREE TOTAL,FREE TESTOSTERONE DIRECT,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,CREATINE KINASE CK,CREATINE KINASE CK,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,PHOSPHATE AS PHOSPHORUS,ICTERUS,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.0,0.16666666666666666,0.0,0.0,0.16666666666666666,0.3333333333333333,0.0,0.017831508061623147,0.0,0.0,0.044274927162410105,0.04848838326247262,1,7880,COMPLETE BLOOD COUNT,RED CELL DIST WIDTH,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,LYMPHOCYTE SUBSET PANEL 4,COMMENTS,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0.0,0.0,0.0,0,24984,PROTEIN ELECTRO SERUM,ALPHA 2 GLOBULIN,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,CMP WITH ESTIMATED GFR CALCULATED,FASTING NON FASTING,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,MICROALBUMIN RANDOM,MICROALBUMIN RANDOM,Leukocyte morphology finding,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,C REACTIVE PROTEIN,C REACTIVE PROTEIN,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,HEPATITIS B CORE IGM ANTIBODY,HEP B CORE IGM ANTIBODY,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,ACCUTYPE R IL28B NY,IL28B GENOTYPE,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,URINALYSIS CULTURE IF INDICATED,NITRITE,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,LYMPHOCYTE SUBSET PANEL 1,% CD3 MATURE T CELLS,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,HB S AG W REFLEX CONF,HB S AG NEUTRALIZATION,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,CPK,CPK,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,0,24984,FE CBC D PLT TIBC FER B12 F,FERRITIN SERUM,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,30841,CHEM SCREEN PANEL HDL,URIC ACID,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,URINALYSIS COMPLETE,GLUCOSE QL,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,CBC PLATELET HEM REVIEW,NEUTROPHILS,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,HEPATIC FUNCTION PANEL,ALBUMIN,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.5,0.3333333333333333,0.5,0.0,0.0,0.0,0.14187034543632637,0.140463816246154,0.7071067811865476,1,31419,NASH FIBROSURE,WEIGHT,Body weight,Body weight Measured,Weight Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,CPK,CPK,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.14666666666666667,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,UA M W RFLX CULTURE COMP,WBC,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,CEA CARCINOEMBRYONIC ANTIGEN,CEA CENTAUR,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,AST CBC D PLT,EOS,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,URINALYSIS WITH REFLEX MICROSCOP,PROTEIN TOTAL QUAL,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,REFLEX ANA PATTERN,PATTERN 1,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,ANA SCREEN QUAL,ANA ANTIBODY SCREEN EIA,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.16636363636363638,0.4575,0.0,0.16636363636363638,0.4575,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,HCV RNA PCR QN RFX NSA,HCV GENOSURE R NSA PDF,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,PROTHROMBIN TIME,INR,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111567,ARTHRITIS PROFILE,SEDIMENTATION RATE,Leukocyte morphology finding,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,HCV ANTIBODY REFLEX NAA,HCV RNA NAA QUALITATIVE,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B DRUG RESISTANCE ASSAY,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,LP WITHOUT VLDL CHOL HDL,LDL CHOLESTEROL CALC,Age,Age,Age
0.055,0.033,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,ACUTE HEPATITIS PANEL,HEPATITIS C ANTIBODY,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,CBC INCLUDES DIFF PLATELETS,MEAN PLATELET VOLUME,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,HEPATIC FUNCTION PANEL A,TOTAL PROTEIN,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,MICROALBUMIN CREATININE RATIO,MICROALBUMIN RAN 24HR,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,CD4 CD8 LYMPHOCYTE ENUMERATION,PERCENT CD4,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.08333333333333333,0.05,0.0,0.125,0.075,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17434,ACTIVATED PTT,ACTIVATED PTT PATIENT,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,ALT SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,HEPATITIS B CORE AB TOTAL,HEPATITIS B CORE AB TOTAL,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,HIV AG AB 4TH GEN RFL,HIV AG AB 4TH GEN,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,COMPREHENSIVE METABOLIC PANEL E GFR,CHLORIDE,Bacteria identified,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult
0.0,0.0,0.0,0.0,0.25,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,CBC W AUTO DIFF WITH PLATELETS,RBC,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,ACCUTYPE R IL28B,IL28B GENOTYPE,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,TRICHOMONAS MALE,SOURCE,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,HEPATITIS B SURFACE AB QUANT,HEPATITIS B SURFACE AB,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,ARTHRITIS PROFILE,ANTI NUCLEAR ANTIBODIES,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,CMP14 LP 6AC,PHOSPHORUS,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.14285714285714285,0.0,0.0,0.14285714285714285,0.0,0.0,0.014531954247369416,0.0,0.0,0.014531954247369416,0.0,0,20289,CREATININE SERUM,CREATININE SERUM,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,URINALYSIS,NITRITE,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.25,1.0,0.0,0.0,0.0,0.0,0.15505905338492743,1.0,1,7187,CMP12 LP TP TSH 6AC CBC D PLT,HEMOGLOBIN,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,CBC PLATELET HEM REVIEW,NEUTROPHILS ABSOLUTE,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,CBC WITH PLT DIFF,PLATELET MORPHOLOGY,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,CBC W AUTO DIFF,MONOCYTES %,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,345355,HEMOGLOBIN A1C,MEAN GLUCOSE EST,Microalbumin/Creatinine ratio panel,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur
0.1675,0.0,0.0,0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,UREA NITROGEN BUN,UREA NITROGEN BUN,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.07142857142857142,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,CBC WITH PLT DIFF,MEGAKARYOCYTE FRAGS,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,NASH FIBROSURE,AST SGOT P5P,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,CMP14 CBC D PLT RPR UA TSH,NEUTROPHILS ABSOLUTE,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.1111111111111111,0.2,0.0,0.0,0.0,0.0,0.05351640367221466,0.05565150370408234,0.0,0.0,0.0,0,139501,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,LEDIPASVIR RESISTANCE,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,PHOSPHATE AS PHOSPHORUS,ICTERUS,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,GENERAL HEALTH PANEL,CALC GLOBULIN,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D3,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.05263157894736842,0.0,0.0,0.0,0.0,0.0,0.023692166672912185,0.0,0,486431,CMP12 2AC,ALBUMIN SERUM,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE MONOCYTES,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.115,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,7112,CMP14 HP4 DBILI CBC D PLT R,EOS ABSOLUTE,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,COMPLEMENT COMPONENT C4C,COMPLEMENT COMPONENT C4C,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.26,0.2,1.0,0.0,0.0,0.0,0.0,0.05111799204302647,0.1503314858492919,1,20933,CMP12 LP 6AC,CHOLESTEROL TOTAL,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,COMP METABOLIC PANEL 12,ALKALINE PHOSPHATASE,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.03571428571428571,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,URINALYSIS W MICRO W REFLEX CULTURE,NITRITES,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,CBC,HCT,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,ACUTE HEPATITIS PANEL,HEPATITIS B SURFACE ANTIGEN,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,HB S AG W REFLEX CONF,HFLAG NR,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,82644,HCV FIBROSURE LABCORP,RESULT,Service comment 03,Service comment 03,Service Cmnt 03 XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,URINE DRUG SCREEN,OPIATES,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,HEPATITIS PANEL 4,HEP B CORE AB IGM,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.39,0.91,0.3333333333333333,0.0,0.0,0.0,0.2706785755414476,0.4082482904638629,0.09629383728860574,0.0,0.0,1,25007,IRON TOTAL IRON BIND CAPACITY,TIBC,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,DIFFERENTIAL MANUAL,NEUTROPHILS,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,CMP14 2AC MG,EGFR IF NONAFRICN AM,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.25,0.16666666666666666,0.0,0.25,0.16666666666666666,1.0,0.013668034462936185,0.010384485502120788,0.0,0.06812389033458222,0.051758104169687846,0.7071067811865476,1,7328,MANUAL DIFFERENTIAL,LYMPHOCYTES ABSOLUTE,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,109009,FIBROACT,NECROINFL SCORE,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.158,0.0,0.0,0.158,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,TRIIODOTHYRONINE T3 FREE,TRIIODOTHYRONINE T3 FREE,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,MICROALBUMIN CREATININE RANDOM RATIO,CALC MICROALB CREAT RND,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,HB S AG W REFLEX CONF,HB S AG NEUTRALIZATION,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.06249285810975125,0.0,0.0,0.08837824749026779,0.0,0.0,1,30163,TSH FT4,TSH,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,DIFFERENTIAL MANUAL,ABSOLUTE NEUTROPHILS,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.2,0.16666666666666666,0.0,0.0,0.0,0.0,0.009622921004768359,0.007548940510311075,0.0,0.0,0.0,0.0,0,7146,CBC WITH MANUAL DIFFERENTIAL,NEUTROPHILS,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,SPECIAL A 2 PANEL #9633,POLYS,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,QUESTASSURED 25 OH VIT D,VITAMIN D 25 OH D2,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,DRUG ABUSE SCREEN II,COCAINE METABOLITE,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,TSH FREE T4 PROFILE,TSH THIRD GENERATION,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,TESTOSTERONE FREE TOTAL,FREE TESTOSTERONE DIRECT,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,CBC W AUTO DIFF,MONOCYTES %,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.25,0.10857142857142857,0.0,0.0,0.0,0.0,0.022433140382939643,0.0,0.0,0.0,0.0,0.0,0,134577,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CARBON DIOXIDE,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.5566666666666666,0.2857142857142857,0.0,0.0,0.0,0.0,0.041620163040118285,0.0966660720824497,0.050158741653652195,1,30973,COMPREHENSIVE METABOLIC PANEL W O ALT,BUN CREATININE RATIO,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.32,0.16666666666666666,0.3333333333333333,0.12,0.16666666666666666,0.3333333333333333,0.0309504251567585,0.03920811077406172,0.053158992087206314,0.0,0.06791043992946355,0.09207407517419319,1,130682,REFLEX ANA PATTERN,PATTERN 1,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,HIV AG AB 4TH GEN RFL,RACE NR,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,UREA NITROGEN BUN,HEMOLYSIS,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.09247447620418048,0.34003516797720323,1.0,1,24984,FE TIBC FER B12 HCT FOLRBC,IRON,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,COMP METABOLIC PANEL,ALKALINE PHOSPHATASE,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,LYMPHOCYTE SUBSET PANEL 4,COMMENTS,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,NASH FIBROSURE,AST SGOT P5P,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.16666666666666666,0.0,0.0,0.03666666666666667,0.022,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,CBC H H RBC INDICES WBC PLT,PLATELET COUNT AUTO,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,CBCI COMPLETE BLOOD COUNT W DIFF,LYMPHOCYTES,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,DRUG PANEL 8 SCREEN,OPIATES,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.05555555555555555,0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,CBC WITH PLT DIFF,BANDS,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.0,0.0,0.0,0.0,0.010588235294117647,0.0225,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,DRUG ABUSE SCREEN II,COCAINE METABOLITE,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,LIPID PANEL AMA,NON HDL CHOLESTEROL,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,TRIGLYCERIDES REFL,TRIGLYCERIDES,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,DRGABU2,METHAQUALONE,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,CBC DIFF PLT,MCHC,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,CBC INCLUDES DIFFERENTIAL PLATELETS,RBC,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,COMP METABOLIC PANEL,ALKALINE PHOSPHATASE,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,PROTIME INR F,PT,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,ARTHRITIS PROFILE,SEDIMENTATION RATE,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.596,0.548,0.435,0.348,0.148,0.185,0.005387097078791703,0.27303974821821997,0.04292727961786891,0.024494182533464692,0.0,0.0,1,345355,ALBUMIN CREATININE RATIO RANDOM URINE,CALC ALBUMIN CREAT RND,Microalbumin/Creatinine ratio panel,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur
0.0,0.09090909090909091,0.0,0.0,0.0,0.0,0.0,0.010012007480873608,0.0,0.0,0.0,0.0,0,542183,ALBUMIN CREATININE RATIO URINE RANDOM,CALC ALBUMIN CREAT RND,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,HELPER T LYMPH CD4,HEMATOLOGY COMMENTS,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,HEMOGRAM W AUTOMATED DIFF,WBC,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,AUTOMATED BLD CNT,HEMOGLOBIN,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,CRYOGLOBULINS REFLEX IFE QUANT,IGM CRYOPRECIPITATE,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,MAGNESIUM,HEMOLYSIS,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.19,0.44333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,HCV FIBROSURE RESULTS,FIBROSIS STAGE,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,HB S AG W REFLEX CONF,HFLAG NR,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.14333333333333334,0.125,0.2,0.21,0.125,0.2,0.0,0.034880496193767985,0.04779467294787276,0.0,0.04503052695530496,0.061702657454847154,1,134999,NEG HIV 4TH GEN,NEG HIV 2 ANTIBODY,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,COMP METABOLIC PANEL W GFR,ANION GAP,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,DRG TOX CRT REFL SPEC GR,CREATININE,Eosinophils,Eosinophils [#/volume] in Blood,Eosinophil # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,COMP METABOLIC PANEL W GFR,ANION GAP,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,RPR,RPR RESULT,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.11666666666666665,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,PROTEIN ELECTROPHORESIS SR W RFX,INTERPRETATION,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,ANACHOICE SCR W REFL TITER IFA,ANA SCREEN IFA,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,THYROID II PROFILE T3U T4 T7 TSH,T4 THYROXINE,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,CBC W AUTO DIFF,MCV,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,LIVER FIBROSIS FIBROMETER,ALPHA 2 MACROGLOBULIN FM,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,HCV AB W RFL RNA RFL GENO,HEPATITIS C AB,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,BASIC METABOLIC PANEL AMA,GLUCOSE,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,LIPID PANEL W CHOL HDL RATIO,VLDL CHOLESTEROL CAL,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,CBC DIFF PLT,MONOCYTES %,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,PROTEIN ELECTROPHORESIS SERUM,BETA,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.08312548434166944,0.0,0.0,0.0,0.0,0,18341,IFE PE SERUM,GAMMA GLOBULIN,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,COMP METABOLIC PANEL W GFR,ANION GAP,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,PSA FREE TOTAL,INTERNAL %,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.21166666666666667,0.1,0.2,0.21166666666666667,0.1,0.2,0.026867474523124324,0.04817920714100843,0.06891707028091865,0.031023887296742547,0.05563255642440801,0.0795785781568974,0,51938,MITOCHONDRIAL AB W RFX TITER,MITOCHONDRIAL AB SCN,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,DIFFERENTIAL MANUAL,ABSOLUTE EOSINOPHILS,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,THYROID PROFILE T4 T3UP FTI TSH,T 4,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.43333333333333335,0.22428571428571425,0.5,0.43333333333333335,0.22428571428571425,0.5,0.0,0.530776546300907,0.16381776425537642,0.0,0.530776546300907,0.16381776425537642,1,30510,TRIIODOTHYRONINE T3 FREE,TRIIODOTHYRONINE T3 FREE,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,NEG HIV 4TH GEN,NEG HIV 1 ANTIBODY,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28746,CCP ANTIBODY IGG,ANTI CCP IGG,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,X HEPATITIS COMPLEX PROFILE,ANTI HBC TOTAL,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.3066666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,URIC A ESR WES ANA RA QN CC,URIC ACID,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,REFLEX ANA PATTERN,PATTERN 1,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,HIV 1 QUANT PCR,HIV 1 VIRAL COPY,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,HEPATITIS BE AG,HBEAG INS,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.2857142857142857,0.22866666666666666,0.8575,0.2857142857142857,0.26666666666666666,0.965,0.2662211635159746,0.014346659179958254,0.04076018121777358,0.2855798754616614,0.01538990021601927,0.04372412516808821,1,381806,HCV RNA QN REAL TIME PCR W RFX QL T,HCV RNA PCR QN,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.0769832768017027,0.08055537486383768,0.09169555407390673,1,264853,CBC DIFF PLT,MONOCYTES %,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,LIVER FIBRO HEPSCORE R,AGE,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,CBC,MO#,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,THYROXINE T4 FREE,T 4 FREE,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,COMPREHENSIVE METABOLIC PANEL,CALCIUM,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,HIV 1 HIV 2 AG AB COMBO W REFLEXES,HIV INTERPRETATION,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,COMPREHENSIVE METABOLIC PANEL,CARBON DIOXIDE,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.06200000000000001,0.0,0.0,0.06200000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,HCV RNA PCR RFX NS5B,HCV NS5B RESISTANCE ASSAY PDF,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.01125,0.0225,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,MORPHOLOGICAL REVIEW,PATH REVIEW PERIPHERAL SMEAR,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.05,0.0,0.0,0.0,0.0,0.0,0.022630959662032324,0.0,0,486423,CMP12 LP 6AC,PHOSPHORUS SERUM,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,CBC,HEMOGLOBIN,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,HB S AG W REFLEX CONF,HB S AG NEUTRALIZATION,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,HB CORE AB W IGM RFX,HB CORE AB TOTAL,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,T3 FREE,T3 FREE,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882936,FIBROMETER VIRUS,GAMMA GLUTAMYL TRANSFERASE FM,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0825,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,URINALYSIS COMPLETE,BILIRUBIN,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,CMP14 LP TP TSH 4AC CBC D P,HEMATOCRIT,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,CMP14 LP CBC D PLT,NEUTROPHILS,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,HEMOGLOBINOPATHY EVAL,MCH,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,IMMUNOFIXATION SERUM,IMMUNOGLOBULIN M,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,IRON TIBC,UIBC,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,COMPREHENSIVE METABOLIC PANEL W O ALT,BUN CREATININE RATIO,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,HEPATITIS C VIRAL RNA QUALITATIVE TMA,HEPATITIS C VIRAL RNA QUALITATIVE TMA,Erythrocyte morphology finding,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,COMP METABOLIC PANEL W GFR,GLOBULIN,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.12166666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,PTH INTACT WITHOUT CALCIUM,PTH INTACT,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,632117,HEPATIC FUNCTION PANEL,TOTAL PROTEIN,Actin.smooth muscle Ab,Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence,SMA Ab Ser Ql IF
0.8,0.8,0.8,0.8,0.8,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,HEPATITIS B SURF AG,HEPATITIS B SURF AG,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,CMP14 LP 3AC CBC D PLT,LYMPHS,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,108860,UA M W RFLX CULTURE COMP,WBC,Prostate specific Ag.free,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,CRP,C REACTIVE PROTEIN ULTRA,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,CBC WITH PLT DIFF,MPV,Neutrophils,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual
0.0,0.20750000000000002,0.5,0.0,0.20750000000000002,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,HCV RNA PCR QN RFX NS5A,HCV NS5A RESISTANCE ASSAY PDF,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.13333333333333333,0.05555555555555555,0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,CBC W AUTO DIFF ABS WBC MPV PLT,LYMPHOCYTES,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.0,0.14285714285714285,0.2,0.0,0.1742857142857143,0.244,0.0,0.13697041783001718,0.07184578234577044,0.0,0.1677538167696766,0.08799275345909874,0,223149,CUSTOM HEPATITIS PANEL,HEPATITIS C ANTIBODY,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A DRUG RESISTANCE ASSAY,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,HELPER T LYMPH CD4,HEMATOLOGY COMMENTS,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,C4 SERUM,C4 SERUM,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,URINALYSIS,PH,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,CBC WITH AUTO DIFF,MONOCYTES #,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,CMP WITH ESTIMATED GFR CALCULATED,CARBON DIOXIDE,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,CBC WITH AUTO DIFF,EOSINOPHILS #,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,COMPREHENSIVE METABOLIC PANEL E GFR,ALBUMIN,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.05187148620777027,0.0,0.0,0.05187148620777027,0.0,0,542183,T4 THYROXINE,T4 THYROXINE,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,URINE PROTEIN TOTAL RANDOM W O CREATININE,PROTEIN TOTAL RANDOM UR,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,CMP14 LP 2AC CBC D PLT MG T,WBC,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,FIBROMETER VIRUS,GAMMA GLUTAMYL TRANSFERASE FM,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,COMP METABOLIC PANEL,GLOBULIN,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,CBC WITH PLT DIFF,BANDS ABSOLUTE,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,DIFFERENTIAL MANUAL,NEUTROPHILS,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.029882555375113973,0.0,0.0,0.0,0.0,0,7534,CBC WITH ABSOLUTE WHITE BLOOD CELLS,WBC,Neutrophils,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,CBC W DIFF PLT,MPV,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,HCV RNA PCR QN RFX GENO,PLEASE NOTE,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.25,0.0,0.0,0.215,0.172,0.0,0.025135483109621548,0.0,0.0,0.0,0.0,0.0,0,7856,CBC W AUTO DIFF ABS WBC MPV PLT,MCHC,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,CBC W AUTO DIFF,BASOPHILS ABSOLUTE,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,CBC WITH PLT DIFF,EOSINOPHILS ABSOLUTE,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,NASH FIBROSURE,ALT SGPT P5P,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,COMPREHENSIVE METABOLIC PANEL W EGF,AST,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,LYMPHOCYTE SUBSET PANEL 4,LYMPHOCYTES ABSOLUTE,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51961,DRUG SCREEN AUSTIN 20,PHENCYCLIDINE,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,HBV surface Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,CBC W AUTO DIFF WITH PLATELETS,COMMENTS,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,LIPID PANEL STANDARD,CHOLESTEROL HDL RATIO,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06635350960296393,0.05287307875068503,0.08777198612321668,1,7492,CBC WITH DIFFERENTIAL,MYELOCYTES,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,HEPATITIS BE AG,HB E AG,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,TESTOSTERONE FREE TOTAL LC MS,TESTOSTERONE TOTAL LC MS,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,PSA TOTAL % FREE SERIAL,% FREE PSA,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.24333333333333332,0.186,0.0,0.0,0.0,0.0,0.0,0.06679361170328513,0.1964314811924487,1,28852,COMP METABOLIC PANEL W GFR,PROTEIN TOTAL,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.0,0.0,0.0,0.0,0.13333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,NGI HCV SUPERQUANT,HEPATITIS C QUANTITATION,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.11399999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,URINE MICROALBUMIN CREAT RATIO,UR MICROALBUMI,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,CMP WITH EGFR,ANION GAP,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.1675,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,OMBITASVIR RESISTANCE,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303768,REFERRED CBC,MCH,Blasts,Blasts [#/volume] in Blood,Blasts # Bld
0.3333333333333333,0.4,1.0,0.3333333333333333,0.4,1.0,0.06538932921065,0.4808823462371743,0.7071067811865476,0.06538932921065,0.4808823462371743,0.7071067811865476,1,191239,MAGNESIUM SERUM,MAGNESIUM SERUM,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,CBC WITH PLT DIFF,VARIANT LYMPHOCYTES ABSOLUTE,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,183145,URIC A ESR WES ANA RA QN CC,URIC ACID,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,URINALYSIS W REFLEX MICRO,BACTERIA,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,BMP8 CBC D PLT,CREATININE,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,CHEM PROFILE 29,ALK PHOS,Prothrombin.activity actual/Normal,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,CBC PLATELET HEM REVIEW,LYMPHS ABSOLUTE,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,CBC INC DIFF PLT,MONOCYTES,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D3,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.4333333333333333,0.39,0.56,0.5766666666666667,0.25,0.0,0.0,0.16798659648849135,0.14548066005431926,0.013503536376491154,0.08489650403181737,0.14704505836808368,1,28886,PROTEIN CREATININE RATIO URINE,PROTEIN UR MG DL,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,CBC,MO#,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.16666666666666666,0.14285714285714285,0.3333333333333333,0.0,0.0,0.0,0.02271914272697939,0.07697854695255624,0.288675134594813,0.0,0.0,0.0,0,295410,HEPATITIS C VIRAL RNA NS3 DRUG RESI,BOCEPREVIR RESISTANCE,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,CBC,% BASOPHILS,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,URINALYSIS RX ALB CREA,KETONES,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,CBC WITH PLT DIFF,RDW,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,CBC W O DIFF WITH PLATELETS,RBC,Reference lab test method,Reference lab test method,Ref lab test method
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,COMPREHENSIVE METABOLIC PANEL E GFR,CALC GLOBULIN,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192526,MANUAL DIFFERENTIAL,EOSINOPHILS %,Megakaryocytes/100 leukocytes,Megakaryocytes/100 leukocytes in Blood,Megakaryocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,FE TIBC FER B12 HCT FOLRBC,IRON,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,URINE DRUG SCREEN,OPIATES,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.2,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,ESR WES CRP,C REACTIVE PROTEIN QUANT,Erythrocyte morphology finding,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld
0.11,0.1325,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,URINALYSIS W MICROSCOPIC,BACTERIA,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,URINALYSIS W MICRO,GLUCOSE,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,PSA TOTAL REFLEX FREE,PSA TOTAL,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,SMOOTH MUSCLE AB F ACTIN REFLEX IFA TITER,F ACTIN IGG,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.2,0.17333333333333334,0.26,0.0,0.0,0.0,0.0360154199639221,0.07165999577194615,0.10031748330730439,1,495416,LIPID PROFILE,FASTING NON FASTING,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,CBC WITH PLT DIFF,WBC MORPHOLOGY,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD3 CELLS,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,URIC ACID,URIC ACID,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,CBC WITH PLT DIFF,RBC MORPHOLOGY,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,X HEPATITIS COMPLEX PROFILE,ANTI HBC TOTAL,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0825,0.08833333333333333,0.0,0.22,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.08318397885080242,1.0,1,57703,URINALYSIS,BILIRUBIN,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.07142857142857142,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCV,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,MAGNESIUM,HEMOLYSIS,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,CBC WITH PLT DIFF,NRBC,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,LIPID PANEL,HDL AS % CHOLESTEROL,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,CD4 T4 ENUMERATION,ABSOLUTE LYMPHOCYTES,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,CBC WITH PLT DIFF,MEGAKARYOCYTE FRAGS,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,IRON TIBC,UIBC,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,HEP A AB IGM,HEPATITIS A AB IGM,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0,22848,AFP WITH AFP L3%,AFP SERUM,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.25,0.0,0.25,0.25,0.3333333333333333,0.0,0.015993111973885865,0.0,0.07870803013413097,0.08411277379800186,0.09704900074164846,1,264788,CBCI COMPLETE BLOOD COUNT W DIFF,LYMPHOCYTES,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,HIV 1 HIV 2 AB SCREEN,HIV 1 HIV 2 AB SCREEN,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,LYMPHOCYTE SUBSET PANEL 3,% CD8 SUPPRESSOR T CELLS,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,HEPATITIS B CORE IGM,HEPATITIS B CORE IGM,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.3333333333333333,0.2,0.5,0.3333333333333333,0.2,0.5,0.043852780155159476,0.0499428412414229,0.0,0.09805779742929044,0.11167558800530164,0.0,1,205070,RPR REFLEX PER CDC,RPR,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.25,0.15666666666666665,0.94,0.25,0.15666666666666665,0.94,0.06713496212611103,0.0,0.0,0.06713496212611103,0.0,0.0,0,7773,PLATELET ESTIMATION,PLATELET ESTIMATION,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,HCV RNA PCR RFX NS5B,HCV NS5B RESISTANCE ASSAY PDF,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,IMMUNOGLOBULINS,IMMUNOGLOBULIN A,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,ACTIVATED PTT,ACTIVATED PTT PATIENT,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,PSA TOTAL REFLEX FREE,PROSTATE SPECIFIC AG SERUM,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.3333333333333333,0.16666666666666666,0.5,0.3333333333333333,0.16666666666666666,0.5,0.09247447620418048,0.0,0.0,0.06538932921065,0.0,0.0,1,20396,CEA,CEA CENTAUR,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,PROTEIN ELECTRO S,PLEASE NOTE,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.392,0.392,0.98,0.0,0.0,0.0,0.03737810203089009,0.05195195509007766,0.06743073700930258,1,172841,AUTOIMMUNE HEPATITIS DIAG PNL,MITOCHONDRIAL AB SCREEN,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.028999999999999998,0.0,0.0,0.04,0.03636363636363637,0.05714285714285715,0.0,0.0,0.0,0.0,0.0,0.0,0,568881,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE MONOS,HIV 1+2 Ab+HIV1 p24 Ag,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,ALBUMIN CREATININE RATIO RANDOM URINE,CALC ALBUMIN CREAT RND,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,PROTHROMBIN TIME,INR,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.013248760030202367,0.0,0,17590,FE ANA TIBC FER A1A AMA ASM,ALPHA 1 ANTITRYPSIN SERUM,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,CBC W DIFF PLT,RBC,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,HEPATIC FUNCTION PANEL,ALT,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,OBSTETRIC PANEL INCLUDING HIV,HEMOGLOBIN,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,RPR RFX QN RPR CONFIRM TP,TREPONEMA PALLIDUM ANTIBODIES,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.0,0.07142857142857142,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,CBC W AUTO DIFF ABS WBC MPV PLT,EOSINOPHILS,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.05,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,CMP,BUN,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,DIFFERENTIAL MANUAL,ABSOLUTE BAND NEUTROPHILS,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,HEPATITIS A IGM,HEPATITIS A IGM,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.14285714285714285,0.2,0.75,0.2857142857142857,0.3333333333333333,0.75,0.026381830512237858,0.08864084706441411,0.25183681750032183,0.06092622779182233,0.10235363382767193,0.0,1,381806,HEPATITIS C RNA PCR QUANTITATIVE,HCV VIRAL LOG,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.05263157894736842,0.0,0.0,0.05263157894736842,0.0,0.0,0.023692166672912185,0.0,0.0,0.023692166672912185,0.0,0,486431,FERRITIN SERUM,FERRITIN SERUM,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,HBC AB TOTAL,HBC AB TOTAL,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,CHEM PROFILE 29,ALK PHOS,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,COMP METABOLIC PANEL,SODIUM,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28712,HEPATITIS PANEL DIAGNOSTIC,HEP B CORE TOTAL AB,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.004285714285714286,0.015,0.0,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.06292624359840293,0.0,0,110114,CMP14 HP5 LP 6AC CBC D PLT,MAGNESIUM SERUM,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.14285714285714285,0.25,0.0,0.0,0.0,0.0,0.011892829556906959,0.011994720443926465,0,142513,HEPATITIS B SURFACE ANTIBODY,HEPATITIS B SURFACE AB QUAL,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,URINALYSIS CULTURE IF INDICATED,UROBILINOGEN,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,URINALYSIS,BILIRUBIN,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,CBC WITH MANUAL DIFFERENTIAL,EOSINOPHILS,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,TRANSFERRIN,TRANSFERRIN,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.05581018273830618,0.0,0,20289,IGG SUBCLASSES,IMMUNOGLOBULIN G QN SERUM,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115725,URINALYSIS COMPLETE,APPEARANCE,Rheumatoid factor,Rheumatoid factor [Units/volume] in Serum or Plasma,Rheumatoid fact SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,CBC COMPLETE BLOOD COUNT W O DIFF,MCHC,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,MITOCHONDRIAL ANTIBODY W REFL TITER,MITOCHONDRIAL AB SCREEN,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,ACCUTYPE R IL28B,IL28B GENOTYPE,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,UA W MICRO HOLD SPEC 24 HR,SPECIFIC GRAVITY,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,CMP14 HP4 DBILI CBC D PLT R,LYMPHS,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,CMP WITH ESTIMATED GFR CALCULATED,ALBUMIN,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.405,0.3333333333333333,0.6666666666666666,0.0,0.0,0.0,0.04707567369242904,0.0818901804741462,0.12900463674079643,1,265074,CBC INCLUDES DIFF PLT,ABSOLUTE BAND NEUTROPHILS,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.1425,0.10857142857142857,0.19,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223271,COMP METAB PANEL,ALT,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327767,DRUG ABUSE SCREEN II,OPIATES,Erythrocytes,Erythrocytes [Presence] in Urine sediment by Light microscopy,RBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,COMP METABOLIC PANEL W GFR,ANION GAP,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,COMPREHENSIVE METABOLIC PANEL AMA,CHLORIDE,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,COMP METABOLIC PANEL W GFR,SODIUM,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,COMPLETE BLOOD COUNT,NEUTROPHILS ABSOLUTE,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,IMMUNOGLOBULINS,IMMUNOGLOBULIN A,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.047139540293659965,0.0,0.0,0.0,0.0,0,295410,CBC WITH AUTO DIFF,EOSINOPHILS #,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,COMPREHENSIVE METABOLIC PANEL,CARBON DIOXIDE,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264507,FIBROACT COMPLETE,APOLIPOPROTEIN A1,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,CBC WITH PLT DIFF,LYMPHOCYTES ABSOLUTE,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,URINALYSIS W REFLEX MICRO,BACTERIA,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,PROTIME INR F,PT,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.31,0.25,0.0,0.0,0.0,0.0,0.0,0.0840117798597445,0.0,0.0,0.0,0.0,0,823799,HEPATITIS C VIRAL RNA NS3 GENOTYPE,TELAPREVIR RESISTANCE,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,COMPREHENSIVE METABOLIC PANEL,CALCIUM,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,CBC W DIFF PLT,RBC,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,IFE PE SERUM,ALPHA 1 GLOBULIN,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.22333333333333336,0.25,0.5,0.5566666666666666,0.45,0.9,0.0,0.05054166547762551,0.40824829046386313,0.0360154199639221,0.03573835439169104,0.28867513459481287,1,148692,MORPHOLOGICAL REVIEW,PATH REVIEW PERIPHERAL SMEAR,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,PTT,PTT,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.12,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,AST CBC D PLT,EOS,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.06818181818181818,0.1875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,HEPATIC FUNCTION PANEL,INDIRECT BILI,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.0,0.07571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,DIFFERENTIAL MANUAL,PLATELET ESTIMATION,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,PROTHROMBIN TIME PT,PROTHROMBIN TIME PT,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,TESTOSTERONE SERUM,TESTOSTERONE SERUM,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,PAIN MANAGEMENT 8,CREATININE,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.16,0.0,0.3225,0.2,1.0,0.0,0.061769791070825475,0.0,0.08103461702415493,0.12353958214165095,1.0,1,192708,DRUG ABUSE SCREEN 8 W CONFIRMATION,BARBITURATES,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD3 CELLS,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7864,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,WBC,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.11098565713428754,0.10964330813284906,0.7071067811865476,1,264994,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE NEUTROPHILS,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,PROTEIN ELECTROPHORESIS SR W RFX,INTERPRETATION,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,CBCI COMPLETE BLOOD COUNT W DIFF,PLT MORPHOLOGY,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,PROTIME INR F,PT,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.45,0.0,0.0,0.45,0.0,0.0,0.04459053011835212,0.0,0.0,0.04459053011835212,0.0,0.0,1,422543,ANA SCREEN IFA,ANA SCREEN IFA,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,RENAL PANEL 10,EGFR IF AFRICN AM,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.11098565713428754,0.10964330813284906,0.7071067811865476,1,264994,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE NEUTROPHILS,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,MAGNESIUM,MAGNESIUM,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.2,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.06635350960296393,0.05287307875068503,0.08777198612321668,1,7492,CBC WITH PLT DIFF,MYELOCYTES,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.3333333333333333,0.14285714285714285,0.5,0.0,0.0,0.0,0.0872369085792638,0.0,0.0,1,17426,COMP METAB PANEL,ALT,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,IRON BINDING CAPACITY,TIBC,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.5,0.49,0.94,0.0,0.0,0.0,0.109630934073364,0.046706887849276346,0.0,1,7773,CBC H H RBC INDICES WBC PLT,PLATELET COUNT AUTO,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.2,0.1142857142857143,0.0,0.5,0.2857142857142857,1.0,0.0,0.0,0.0,0.10268539797375953,0.18516494256834526,0.10031748330730439,1,30247,TSH FT4,FREE T4,Thyroxine.free,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.029411764705882353,0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,CBC DIFF PLT,MCH,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BENZODIAZEPINES,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,NASH FIBROSURE,HEIGHT,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,HCV RNA PCR QN RFX NSA,HCV GENOSURE R NSA PDF,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.31,0.25,0.0,0.0,0.0,0.0,0.0,0.09392802533856826,0.0,0.0,0.0,0.0,0,728592,HCV GENOTYPE REFLEX NS5A,HCV NS5A RESIST ASSAY INTERP,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,121855,IRON TIBC SERUM,IRON BINDING CAPACITY,Coagulation surface induced,aPTT in Control Blood by Coagulation assay,aPTT Cont Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,CBC W AUTO DIFF,ABS NEUTROPHILS,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,SEDIMENTATION RATE WESTERGREN,SEDIMENTATION RATE WESTERGREN,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,LITHOLINK CMP14 P,ALBUMIN,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,PROTHROMBIN TIME PT,PT CONTROL,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7898,CBC WITH PLT DIFF,PROMYELOCYTES,Erythrocytes,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto
0.0,0.08,0.28,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,TRANSFERRIN CARBOHYDRATE DEFICIENT ALCOHOL USE,TRANSFERRIN,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19638,LIPID PANEL WITH LDL HDL RATIO,HDL CHOLESTEROL,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,LIPID PROFILE,FASTING NON FASTING,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,CBC DIFF PLT,RDW,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.16,0.0,0.1675,0.192,0.96,0.0,0.061769791070825475,0.0,0.0,0.0,0.0,1,193433,DRUG ABUSE SCREEN III,AMPHETAMINES,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.011063663610396235,0.0,0.0,0.0,0.0,0,178566,COMPLETE BLOOD COUNT,BASOPHILS ABSOLUTE,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,CBC WITH DIFFERENTIAL,EOSINOPHILS,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.022222222222222223,0.04,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,CBC INCLUDES DIFF PLT,BASOPHILS %,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,CMP12 7AC MG,PHOSPHORUS SERUM,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,NASH FIBROSURE,HEIGHT,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,MCV,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,FERRITIN,FERRITIN,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58032,ANA ANTI NUCLEAR AB WITH REFLEX TITER,ANTI NUCLEAR ANTIBODIES,pH,pH of Urine by Test strip,pH Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,PTH INTACT,PARATHYROID HORMONE INTACT,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,MITOCHONDRIAL M2 AB,MITOCHONDRIAL M2 AB,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,COMPREHENSIVE METABOLIC PANEL E GFR,SODIUM,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,HCV GT3 NS5A DRUG RESIST ASSAY,HCV NS5A DRUG RESIST ASSAY,Basophils,Basophils [#/volume] in Blood,Basophils # Bld
0.1925,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,URINALYSIS W MICRO W REFLEX CULTURE,NITRITES,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.25,0.16666666666666666,1.0,0.0,0.0,0.0,0.07065997001469593,0.09716253076254433,1.0,0,57927,COMPREHENSIVE METABOLIC PANEL,GLUCOSE,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,CBC W AUTO DIFF,HCT,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD3 CELLS,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,IFE PE SERUM,GLOBULIN TOTAL,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.09090909090909091,0.0,0.0,0.09090909090909091,0.0,0.0,0.041353268343751526,0.0,0.0,0.041353268343751526,0.0,0,831008,COMPLEMENT C4 SERUM,COMPLEMENT C4 SERUM,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.1,0.0,0.2,0.125,0.5,0.0,0.028972496951288118,0.0,0.05623518965539054,0.07096783410499707,0.7071067811865476,1,196444,DRUG ABUSE SCREEN 9 NO THC W CONF,OXYCODONE,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,HBSAB AG,HEP B SURFACE AB QUAL,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,UREA NITROGEN BUN,HEMOLYSIS,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,COMPREHENSIVE METABOLIC PANEL E GFR,ALBUMIN,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0625,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,882944,DRUG ABUSE SCREEN 11 W ETOH NO CONF,OXYCODONE,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,LP WITHOUT VLDL CHOL HDL,LDL CHOLESTEROL CALC,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,RPR,TREPONEMA PALLIDUM ANTIBODIES,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7534,TSH,TSH,Neutrophils,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual
0.26666666666666666,0.16666666666666666,0.3333333333333333,0.21166666666666667,0.16666666666666666,0.3333333333333333,0.03622836077219149,0.06038316515886655,0.07352252918404178,0.04183290768824732,0.06972447331798648,0.08489650403181737,0,241109,MITOCHONDRIAL AB W RFX TITER,MITOCHONDRIAL AB SCN,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,CBC WITH PLT DIFF,PROMYELOCYTES,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264499,COMPREHENSIVE METABOLIC PANEL AMA,CHLORIDE,Eosinophils,Eosinophils [#/volume] in Blood,Eosinophil # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,CBC WITH PLT DIFF,LYMPHOCYTES ABSOLUTE,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.12353958214165095,1.0,1,196592,DRUG ABUSE PANEL 10 WITH OXYCODONE,PHENCYCLIDINE,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,CBC WITH DIFFERENTIAL,NUCLEATED RBCS,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,THYROID II PROFILE T3U T4 T7 TSH,T4 THYROXINE,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,UA MICROSCOPIC REFLEX CULTURE,SPECIFIC GRAVITY,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,CMP13 LP TP TSH 2AC CBC D P,CHOLESTEROL TOTAL,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA TITER,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.16666666666666666,0.29666666666666663,0.445,0.09499999999999999,0.0,0.0,0.038211926035394805,0.13917887610023483,0.290796108751339,0.0,0.0,0.0,1,139543,HEPATITIS BE AG,HBEAG INS,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CBC WITH AUTO DIFF,MCV,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.375,0.14285714285714285,0.0,0.275,0.0,0.0,0.034234837021806186,0.0,0.0,0.0,0.09338639438323382,0.0,1,21329,VIT B 12 FOLATE PANEL,VITAMIN B 12,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,PROTHROMBIN TIME PT,PT CONTROL,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,COMPLETE BLOOD COUNT,BASOPHILS %,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,DIFFERENTIAL MANUAL,EOSINOPHILS,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,PSA FREE TOTAL,INTERNAL %,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.5,0.0,0.0,0.0,0.05498668394218953,0.07826082456743577,0.10031748330730439,1,312082,SMN1 COPY NUMBER ANALYSIS,SPECIMEN TYPE,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,CRYOGLOBULINS REFLEX IFE QUANT,IGM CRYOPRECIPITATE,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,182626,TRIIODOTHYRONINE T3 FREE,TRIIODOTHYRONINE T3 FREE,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.03916666666666666,0.0,0.0,0.03916666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,HEP B SURFACE AB IMMUNITY QN,HEP B SURFACE AB IMMUNITY QN,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,LIPOPROTEIN ANALYSIS NMR,LDL P,Prothrombin.activity actual/Normal,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18697,UA MICROSCOPIC REFLEX CULTURE,SPECIFIC GRAVITY,Apolipoprotein A-I,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc
0.182,0.14285714285714285,0.2,0.0,0.0,0.0,0.0,0.029699923646854032,0.04007989868886952,0.0,0.0,0.0,0,728626,LYMPHOCYTE SUBSET PANEL 2,HELPER SUPPRESSOR RATIO,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203943,HEPATITIS B SURFACE AG,HEPATITIS B SURFACE AG,Sample lipemic,Sample lipemic [Presence] of Serum or Plasma Qualitative,Sample Lipemic SerPl Ql
0.2,0.2727272727272727,0.75,0.2,0.2727272727272727,0.75,0.028666628507924785,0.0,0.0,0.028666628507924785,0.0,0.0,1,322867,HCV GENOSURE R NSA,HCV GENOSURE R NSA,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0625,0.125,0.0,0.04125,0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,CBC WITH PLT DIFF,NUCLEATED RBCS,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.0877518356997824,0.5773502691896257,1.0,1,23366,COMP METABOLIC PANEL,GLOBULIN,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,178616,NASH FIBROSURE,WEIGHT,Calcium,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc
0.0,0.0,0.0,0.11666666666666665,0.0,0.0,0.0,0.04933139714173884,0.05057759975839826,0.0,0.0,0.0,0,205088,HIV 1 HIV 2 AG AB COMBO W REFLEXES,HIV INTERPRETATION,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728592,URINALYSIS W MICRO W REFLEX CULTURE,NITRITES,Boceprevir,Boceprevir [Susceptibility] by Genotype method,Boceprevir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,CMP14 5AC,EGFR IF NONAFRICN AM,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.05533333333333334,0.20750000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0,381806,LYMPHOCYTE SUBSET PANEL 3,% CD8 SUPPRESSOR T CELLS,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.534,0.0,0.0,0.534,0.0,0.0,0.08201332011404516,0.0,0.0,0.08201332011404516,0.0,0.0,1,19893,VITAMIN D 25 OH TOTAL,VITAMIN D 25 OH TOTAL,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,CBC INCLUDES DIFF PLT,ABSOLUTE BLASTS,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,LYMPHOCYTE SUBSET PANEL 2,HELPER SUPPRESSOR RATIO,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,UA MICROSCOPIC REFLEX CULTURE,SPECIFIC GRAVITY,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,LEDIPASVIR RESISTANCE,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,HEPATIC FUNCTION PANEL,TOTAL PROTEIN,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,NASH FIBROSURE,WEIGHT,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.09247447620418048,0.0,0.0,1,25015,ANEMIA PROFILE B,UIBC,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,FIBROACT COMPLETE,WEIGHT LBS,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,PTT,PTT,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,CMP14 HP4 1AC PT AFP,HEP A AB IGM,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,CMP12 LP TP TSH 6AC CBC D PLT,POTASSIUM,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,CBC INCLUDES DIFF PLT,BLASTS,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,CBC PLT DIFF,POLYS,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,CBC WITH DIFF PLATELET,WBC,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,PROTEIN ELEC INTERP SERUM,P E INTERPRETATION S,Color,Color of Urine,Color Ur
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.02948276095739455,0.0,0.0,0.0,0.0,0,264846,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,EOSINOPHILS #,Monocytes,Monocytes [#/volume] in Blood,Monocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81018,LIVER FIBROTEST ACTITEST,HAPTOGLOBIN,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,HIV ANTIBODY 1 WESTERN BLOT,HIV WB INTERP,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,RPR REFLEX PER CDC,RPR,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,AUTOIMMUNE HEPATITIS DIAG PNL,MITOCHONDRIAL AB SCREEN,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,PROTEIN TOTAL URINE,PROTEIN CR RATIO,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,CBC WITH DIFFERENTIAL PLATELETS,MCH,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57703,CBC W DIFF PLT,PLATELET SUFFICIENCY,Bilirubin,Bilirubin.total [Presence] in Urine by Test strip,Bilirub Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,CBC INC DIFF PLT,PLATELET COUNT,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,CBC WITH MANUAL DIFFERENTIAL,MCHC,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,URINALYSIS WITH MICROSCOPIC,PH,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,CBC WITH DIFFERENTIAL,BASOPHILS,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.22333333333333336,0.25,1.0,0.0,0.0,0.0,0.0,0.15505905338492743,1.0,1,384834,COMP METABOLIC PANEL,CREATININE,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,CBC WITH PLT DIFF,EOSINOPHILS ABSOLUTE,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D2,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,CLR CBC W DIFF PLT,ABSOLUTE EOSINOPHILS,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,CMP14 HP4 DBILI CBC D PLT R,EOS ABSOLUTE,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.006363636363636364,0.0175,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.05006826108790696,0.0,0,322867,CMP14 LP 7AC CBC D PLT T B,AMYLASE SERUM,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.2,0.0,0.0,0.0,0.0,0.0,0.008243665568212544,0.0,0.0,0.0,0.0,0.0,0,495416,HCV RNA QN REAL TIME PCR W RFX QL T,HCV RNA PCR QN,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,COMP METAB PANEL,EGFR NON AFR AMERICAN,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,CBC WITH DIFFERENTIAL PLATELETS,MCH,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,NASH FIBROSURE,WEIGHT,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.26142857142857145,0.0,0.08,0.14285714285714285,0.5,0.0,0.1226046973350281,0.0,0.0,0.10617878251543655,0.16732250730743758,1,28712,PROTEIN ELECTROPHORESIS SERUM,BETA,Beta globulin,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc
0.0,0.0,0.0,0.1775,0.16666666666666666,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1,7310,CMP14 CBC D PLT ESR WES ANA,LYMPHS ABSOLUTE,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,CMP12 LP TP TSH 6AC CBC D PLT,HEMOGLOBIN,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.02,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,COMP METABOLIC PANEL,ANION GAP,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,CBC WITH PLT DIFF,MYELOCYTES,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,HCV FIBROSURE RESULTS,NECROINFLAMMAT ACT GRADE,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7856,RHEUMATOID FACTOR RF,RHEUMATOID FACTOR RF,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass] by Automated count,MCH RBC Qn Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.05137906274872117,0.0,0.0,0.0,0.0,0,110114,PROTEIN ELECTROPHORESIS SERUM,BETA,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,A FETOPROTEIN TUMOR MARKER,A FETOPROTEIN TUMOR MARKER,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,CBC WITH PLT DIFF,MPV,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.07571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,TSH W REFLEX FT4,TSH 3RD GENERATION W REFLEX FT4,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,LIVER FIBROSIS,NECROINFLAM ACT SCORE,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,728600,PROSTATE SPECIFIC ANTIGEN PSA,PSA,Telaprevir,Telaprevir [Susceptibility] by Genotype method,Telaprevir Islt Genotyp
0.0,0.0,0.0,0.25,0.5,0.6666666666666666,0.0,0.0,0.0,0.009960706634886463,0.40392557361123926,0.46844093359181893,1,45484,CMP14 LP 5AC CBC D PLT RPR,HEMOGLOBIN A1C,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,LIPID PANEL AMA,CHOLESTEROL HDL RATIO,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.1075,0.172,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,PROTIME PTT,PROTHROMBIN TIME PT,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,HEPATITIS B SURFACE ANTIBODY,HEPATITIS B SURFACE ANTIBODY,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,CBC W O DIFF WITH PLATELETS,RBC,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0775,0.10333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD8 CELLS,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.19999999999999998,0.27999999999999997,0.0,0.19999999999999998,0.27999999999999997,0.0,0.014926543204853204,0.03786723325382768,0.0,0.014926543204853204,0.03786723325382768,0,487967,HEPATITIS B CORE IGM,HEPATITIS B CORE IGM,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,HEPATITIS B SURFACE AB QUANT,HEPATITIS B SURFACE AB,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,HCV FIBROSURE,LIMITATIONS,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,MANUAL DIFFERENTIAL,EOSINOPHILS ABSOLUTE,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.04623723810209024,0.17001758398860156,0.5,0.0,0.0,0.0,0,24984,IRON IBC W RFX FERRITIN,%TRANSFERRIN SATURATION,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,LYMPHOCYTE SUBSET PANEL 4,% CD4 HELPER CELLS,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,COMP METABOLIC PANEL W GFR,SODIUM,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264440,CMP13 LP 2AC CBC D PLT,ALT SGPT,Basophils,Basophils [#/volume] in Blood,Basophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,NEG HIV 4TH GEN,NEG HIV 2 ANTIBODY,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44859,BUN CREAT RATIO W EGFR,NON AFRICAN AMERICAN EGFR,Complement C3,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE LYMPHOCYTES,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD3 CELLS,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,CBC,MO%,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.14285714285714285,0.2,0.0,0.3814285714285714,0.534,0.0,0.13697041783001718,0.07184578234577044,0.0,0.0761054698735828,0.03991998499008553,0,223149,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS B SURFACE AB,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,CBC WITH DIFFERENTIAL,NEUTROPHILS,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,DRUG ABUSE SCREEN 11 W ETOH W CONF,OXYCODONE,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,OBSTETRIC PANEL,RPR RESULT,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,TRIIODOTHYRONINE T3 FREE,TRIIODOTHYRONINE T3 FREE,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,CMP14 LP 5AC CBC D PLT RPR,HEMOGLOBIN A1C,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,CMP12 7AC MG,PHOSPHORUS SERUM,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.06666666666666667,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,LYMPHOCYTE SUBSET PANEL 3,ABSOLUTE CD8 CELLS,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,CREATINE KINASE TOTAL,LIPEMIA,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265157,CULTURE ROUTINE,CULTURE ROUTINE,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A DRUG RESISTANCE ASSAY,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,CMP,BUN,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,URINALYSIS CULTURE IF INDICATED,WHITE BLOOD CELLS,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.125,0.5,0.0,0.0,0.0,0.0,0.010188907117803736,0.01582540512567787,0,182626,LIPID PANEL AMA,NON HDL CHOLESTEROL,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,DRUG ABUSE SCREEN II,OPIATES,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.0,0.0,0.31,0.25,0.0,0.0,0.0,0.0,0.0,0.13283428732072688,0.0,0,823799,ACCUTYPE R IL28B,IL28B GENOTYPE,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,SED RATE MODIFIED WESTERGREN MANUAL,SED RATE MODIFIED WESTERGREN MANUAL,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,CBC W AUTO DIFF ABS WBC MPV PLT,NEUTROPHILS,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,HEPATITIS PANEL ACUTE,HEPATITIS A IGM,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,CBC W AUTO DIFF,HGB,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.16666666666666666,0.0,0.3333333333333333,0.16666666666666666,0.5,0.0,0.0762496717190787,0.0,0.07920861876657559,0.13206830547789195,0.14187034543632637,0,17590,PE FLC SERUM,ALBUMIN,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.7071067811865476,0.7071067811865476,0.7071067811865476,1,326249,HIV AG AB 4TH GEN RFL,RACE NR,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,CMP14 LP CBC D PLT TSH UA M,AST SGOT,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,HEPATITIS PANEL ACUTE,HEPATITIS A IGM,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.0,0.0,0.1,0.06666666666666667,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,161281,DIFFERENTIAL MANUAL,ABSOLUTE BAND NEUTROPHILS,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,HNK1 CD57 PANEL,LYMPHS ABSOLUTE,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,COMP METABOLIC PANEL,ALKALINE PHOSPHATASE,Prothrombin.activity actual/Normal,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,FIBROACT COMPLETE,HEIGHT INCHES,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.5,0.5714285714285714,0.8,0.5,0.5714285714285714,0.8,0.06590544081750016,0.0466883773873078,0.05277740204670134,0.09320436823828604,0.03301366825316199,0.037319258880631256,1,128413,PSA TOTAL % FREE SERIAL,% FREE PSA,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,PSA TOTAL % FREE,% FREE PSA,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,IMMUNE COMPETENCE PANEL,CD4 CD8 RATIO,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,CMP14 LP TP TSH 4AC CBC D P,HEMATOCRIT,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.072,0.06,0.12,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,BASIC METABOLIC PANEL 8,EGFR IF AFRICN AM,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,HEPATITIS B CORE IGM,HEPATITIS B CORE IGM,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,TRIGLYCERIDES REFL,TRIGLYCERIDES,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,CMP WITH EGFR,ANION GAP,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312017,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH D3,HIV 1+2 Ab,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,HIV1+2 Ab SerPl Ql IA
0.0825,0.10600000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,URINALYSIS,PH,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.005454545454545454,0.015,0.0,0.02,0.055,0.0,0.0,0.0,0.0,0.0,0.0,0,322867,CMP14 HP4 DBILI CBC D PLT R,C REACTIVE PROTEIN QUANT,Hepatitis C virus genotype,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,HCV Gentyp SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,CBC WITH AUTO DIFF,WBC,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,460980,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE LYMPHOCYTES,Sex,Sex,Sex
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,LIVER FIBRO HEPSCORE R,AGE,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,CBCI COMPLETE BLOOD COUNT W DIFF,MCHC,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,CHEM SCREEN PANEL HDL,URIC ACID,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.045219878571918226,0.0,0,25023,B12,VIT B12 SERUM,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,LIVER FIBROSIS FIBROTEST ACTITEST PANEL,FIBROSIS SCORE,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303842,BILIRUBIN DIRECT,DIRECT BILIRUBIN,Erythrocyte distribution width,Erythrocyte distribution width [Entitic volume],RDW RBC
0.0,0.0,0.0,0.0,0.03571428571428571,0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,DRUG ABUSE SCREEN III,COCAINE METABOLITE,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.0834655896020069,0.34003516797720323,1.0,1,20750,COMPREHENSIVE METABOLIC PANEL AMA,CHLORIDE,Chloride,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc
0.066,0.07571428571428572,0.0,0.176,0.14285714285714285,1.0,0.0,0.0,0.0,0.0,0.07582142074137055,1.0,1,505511,URINALYSIS,BILIRUBIN,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,BASIC METABOLIC PANEL,BUN CREATININE RATIO,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,DACLATASVIR RESISTANCE,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,CEA,CEA CENTAUR,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28852,SMOOTH MUSCLE AB F ACTIN REFLEX IFA TITER,F ACTIN IGG,Protein,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,HEMOGLOBIN A1C WITH EAG,HEMOGLOBIN A1C,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.0,0.062,0.20666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,UA M W RFLX CULTURE COMP,WBC,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,CBC W AUTO DIFF WITH PLATELETS,COMMENTS,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,PROTEIN TOTAL URINE,PROTEIN CR RATIO,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.38999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,CMP13 LP TP TSH 2AC CBC D P,HDL CHOLESTEROL,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,DIFFERENTIAL MANUAL,PLATELET ESTIMATION,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.4,0.5171428571428571,0.6666666666666666,0.0,0.0,0.0,0.07351377561058281,0.18661673850657123,0.09866725380717944,1,81018,LYMPHOCYTE SUBSET PANEL 4,% CD8 SUPPRESSOR T CELLS,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,PSA FREE TOTAL,FREE PSA,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,433961,CBC,HCT,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,PROTEIN ELECTRO S,PLEASE NOTE,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.22400000000000003,0.376,0.47,0.0,0.0,0.0,0.0,0.42501189506304327,0.054596653825419894,1,265058,MANUAL DIFFERENTIAL,SEGMENTED NEUTROPHILS %,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.31,0.25,0.0,0.3333333333333333,0.25,1.0,0.0,0.0840117798597445,0.0,0.058638610139614133,0.13283428732072688,0.7071067811865476,1,823799,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,DACLATASVIR RESISTANCE,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,32896,CBC INCLUDES DIFF PLT,BLASTS,Prothrombin.activity actual/Normal,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,Prothrom Act/Nor PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,URINALYSIS WITH MICROSCOPIC,GLUCOSE,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.2222222222222222,0.3333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,HCV RNA NS5A GENOTYPE,LEDIPASVIR RESISTANCE,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.033,0.11,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,URINALYSIS WITH MICROSCOPIC,RED BLOOD CELLS,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.20750000000000002,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,HCV FIBROSURE,GGT,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,HIV ANTIGEN ANTIBODY FOURTH GENERATION W RFL,HIV AG AB 4TH GEN,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,ARTHRITIS PROFILE,SEDIMENTATION RATE,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,GORBYMI CMP 4AC CORONARY RISK CBC TSH PROFILE,CALCIUM,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,CD4 CD8 LYMPHOCYTE ENUMERATION,ABSOLUTE CD4,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,ALT,Color,Color of Urine,Color Ur
0.0,0.028571428571428574,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110114,COMP METABOLIC PANEL,SODIUM,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.5,0.49444444444444446,0.89,0.5,0.49444444444444446,0.89,0.013012224336779066,0.9551892175975994,0.7142937467921189,0.013012224336779066,0.9551892175975994,0.7142937467921189,1,339358,CYCLIC CITRULLINATED PEPTIDE CCP AB IGG,CYCLIC CITRULLINATED PEPTIDE CCP AB IGG,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,AFP TUMOR MARKER,AFP TUMOR MARKER,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.0,0.0,0.0,0.0,0.06888888888888889,0.124,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,CBC INC DIFF PLT,ABSOLUTE MONOCYTES,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,NASH FIBROSURE,ALPHA 2 MACROGLOBULINS QN,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17426,CBC W DIFF PLT,BLAST CELLS ABSOLUTE,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc
0.0,0.0,0.0,0.0,0.06888888888888889,0.124,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,LYMPHOCYTE SUBSET PANEL 4,ABSOLUTE CD8 CELLS,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,URINE MICROALBUMIN CREAT RATIO,UR MICROALBUMI,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1059787103279074,0.0,0,30163,CMP14 LP 7AC CBC D PLT T B,AMYLASE SERUM,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,COMPREHENSIVE METABOLIC PANEL W EGF,AST,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,PROTEIN CREATININE RATIO URINE,PROTEIN UR MG DL,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,FERRITIN,FERRITIN,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.04656947195532102,0.0,0.0,0.0,0.0,0,433961,IFE PE SERUM,GLOBULIN TOTAL,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.072,0.09857142857142856,0.13799999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,BASIC METABOLIC PANEL,UREA NITROGEN BLOOD BUN,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.25,0.16666666666666666,0.0,0.2375,0.16666666666666666,1.0,0.013498539226855177,0.010384485502120788,0.0,0.0,0.051758104169687846,0.7071067811865476,1,7120,MANUAL DIFFERENTIAL,EOSINOPHILS ABSOLUTE,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,RPR REFLEX TP PA,RPR TITER,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,CREATINE KINASE CK,CREATINE KINASE CK,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.25,0.6666666666666666,0.0,0.0,0.0,0.0,0.954340621668645,0.9950058640482824,1,23242,FIBROMETER VIRUS,GAMMA GLUTAMYL TRANSFERASE FM,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.057999999999999996,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,CBC WITH MANUAL DIFFERENTIAL,EOSINOPHILS,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,A FETOPROTEIN TUMOR MARKER,A FETOPROTEIN TUMOR MARKER,Alpha-2-Macroglobulin,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,COMP METABOLIC PANEL,ALKALINE PHOSPHATASE,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.07142857142857142,0.0,0.0,0.0,0.0,0.0,0.01493130666257958,0.0,0.0,0.0,0.0,0,295410,PROTHROMBIN TIME WITH INR,INR,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,CBCI COMPLETE BLOOD COUNT W DIFF,DIFFERENTIAL NEUTROPHILS,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,ANA AMA ASMA LKM AB,MITOCHONDRIAL M2 ANTIBODY,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN RT PCR LOG COPIES ML,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.14285714285714285,0.0,0.0,0.14285714285714285,0.0,0.0,0.02027404021968271,0.0,0.0,0.02027404021968271,0.0,0,28746,TESTOSTERONE SERUM,TESTOSTERONE SERUM,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,NASH FIBROSURE,HEIGHT,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,RPR RFX QN RPR CONFIRM TP,TREPONEMA PALLIDUM ANTIBODIES,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20859,FIBROACT COMPLETE,WEIGHT LBS,Cholesterol.in HDL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc
0.0,0.14285714285714285,0.0,0.0,0.14285714285714285,0.0,0.0,0.0762496717190786,0.0,0.0,0.0762496717190786,0.0,0,21329,COMPLEMENT C3 SERUM,COMPLEMENT C3 SERUM,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,312082,CULTURE ROUTINE,CULTURE ROUTINE,Specimen source,Specimen source identified,Specimen source XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,COMP METABOLIC PANEL W GFR,GLOBULIN,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,HCV FIBROSURE RESULTS,FIBROSIS STAGE,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.06696411491014109,0.24044117311858715,0.7071067811865476,0,24653,SMOOTH MUSCLE AB RFX TITER,F ACTIN IGG,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,REFLEX ANA PATTERN,PATTERN 1,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,GLU RFX HA1C IF ABN,GLU RFX HA1C IF ABN,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,STOOL CULTURE,RESULT 2,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,HEP B SURFACE AG W REFLEX,HEP B SURFACE AG W REFLEX,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23242,CBC WITH DIFFERENTIAL,NEUTROPHILS,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,IMMUNOGLOBULINS,IMMUNOGLOBULIN G,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.04,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,333583,CBC INC DIFF PLT,MONOCYTES,Protein.monoclonal,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,LYMPHOCYTES,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,CBC PLATELET HEM REVIEW,NEUTROPHILS ABSOLUTE,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.16,0.0,0.25,0.2,1.0,0.0,0.061769791070825475,0.0,0.07962607175736813,0.12353958214165095,1.0,1,195503,DRUG ABUSE SCREEN III,METHADONE,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,CBC INC DIFF PLT,BASOPHILS,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,CBC WITH PLT DIFF,EOSINOPHILS ABSOLUTE,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.05957327454539674,0.0,0,52217,CMP12 7AC MG,PHOSPHORUS SERUM,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,301804,PTH INTACT WITHOUT CALCIUM,PTH INTACT,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.5566666666666666,0.3333333333333333,0.5,0.0,0.0,0.0,0.01112594487153995,0.9402300820764442,0.9900858126069512,1,17590,COMP METAB PANEL,ALBUMIN GLOBULIN RATIO,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,C REACTIVE PROTEIN CARDIAC,C REACTIVE PROTEIN CARDIAC,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.16666666666666666,0.21428571428571427,0.75,0.0,0.14285714285714285,0.5,0.04036164461486136,0.0,0.0,0.0,0.06317690320497038,0.17807552140691663,1,204164,NGI HCV QUANTASURE,HEPATITIS C QUANTITATION,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,LIPID PROFILE WITH CALC NON HDL CHOLESTEROL,RISK RATIO LDL HDL,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.134,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58214,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,VELPATASVIR RESISTANCE,Leukocytes,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF
0.0,0.0,0.0,0.3333333333333333,0.14285714285714285,0.5,0.0,0.0,0.0,0.084905879372146,0.0,0.0,1,25320,CMP12 LP TP TSH 6AC CBC D PLT,LDH,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,ACUTE HEPATITIS PANEL,HEPATITIS B SURF AG,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,RPR SCREEN W TITER,RPR SCREEN,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.06625828633711617,0.0,0.0,0,45484,CBC W AUTO DIFF,HGB,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.25,0.35,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,HEP B SURFACE AG W REFLEX CONFIRM,NEUTRALIZATION,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,COMP METABOLIC PANEL,CREATININE,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,HEPATIC FUNCTION PROFILE,BILIRUBIN INDIRECT,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18358,LYMPHOCYTE SUBSET PANEL 4,% CD4 HELPER CELLS,Alpha-2-Macroglobulin,Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma,A2 Macroglob SerPl-mCnc
0.0,0.030000000000000002,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,SPECIAL A 2 PANEL #9633,POLYS,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203935,IMMUNOGLOBULINS,IMMUNOGLOBULIN M,Sample hemolyzed,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,Sample Hemolyzed SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326231,ACUTE HEPATITIS PANEL,HEPATITIS B SURFACE ANTIGEN,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,PTH INTACT MOLECULE,PTH,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,505511,HELPER T LYMPH CD4,HEMATOLOGY COMMENTS,Bilirubin,Bilirubin.total [Presence] in Urine by Automated test strip,Bilirub Ur Ql Strip.auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,URINALYSIS REFLEX,GLUCOSE,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,COMP METAB PANEL,ALBUMIN GLOBULIN RATIO,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,CMP12 2AC,ALBUMIN SERUM,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18341,COMPREHENSIVE METABOLIC PANEL W EGF,AST,Alpha-1-Fetoprotein,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc
0.0725,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,CBC WITH DIFFERENTIAL,MYELOCYTES,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.0,0.0,0.0,0.024444444444444446,0.03666666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0,139543,COMPREHENSIVE METABOLIC PANEL W O ALT,BUN CREATININE RATIO,Hepatitis B virus little e Ag,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,HBV e Ag SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,CMP13 LP TP TSH 2AC CBC D P,CHOLESTEROL TOTAL,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,RPR,RPR RESULT,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,FIBROMETER VIRUS,GAMMA GLUTAMYL TRANSFERASE FM,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,BUN CREATININE,EGFR AFRICAN AMERICAN,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.165,0.265,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,URINALYSIS COMPLETE,APPEARANCE,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.1063004130698838,0.10964330813284906,0.7071067811865476,1,264440,CBC WITH AUTO DIFF,BASOPHILS ABSOLUTE,Basophils,Basophils [#/volume] in Blood,Basophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,COMPLEMENT C3 SERUM,COMPLEMENT C3 SERUM,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0633025934653415,0.0,0.0,0.0,0.0,0,264648,CBCM COMPLETE BLOOD CNT W MAN DIFF,EOSINOPHILS,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28571,DRUG ABUSE PANEL 10 WITH OXYCODONE,BENZODIAZEPINES,Prostate specific Ag,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,LYMPHOCYTE SUBSET PANEL 3,% CD3 MATURE T CELLS,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.07571428571428572,0.0,0.0,0.07571428571428572,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,327692,CERULOPLASMIN,CERULOPLASMIN,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.25,0.0,0.0,0.25,0.2,0.0,0.038831829427041664,0.0,0.0,0.06725870151848445,0.21223170681007852,0.0,1,7864,CBC W AUTO DIFF,MCHC,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,HEPATIC FUNCTION PANEL,ALT,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,BMP,C02 BICARBONATE,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,CBC PLT DIFF,MONOS,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,GGT,GGT,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,CBC COMPLETE BLOOD COUNT W O DIFF,MCV,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME NR,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.15,0.0,0.0,0.24044117311858715,0.0,0.0,0.0,0.0,1,24729,IMMUNOFIXATION SERUM,IMMUNOGLOBULIN M,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,CMP12 LP TP TSH 6AC CBC D PLT,LDH,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.20750000000000002,0.08833333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,URINALYSIS W REFLEX MICRO,WHITE BLOOD CELLS,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28233,CBC WITH ABSOLUTE NEUTROPHIL COUNT,NEUTROPHILS,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,IRON TIBC,UIBC,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.16666666666666666,0.21428571428571427,0.75,0.0,0.0,0.0,0.008179463936407672,0.0,0.0,0.0,0.0,0.0,0,110114,HCV FIBROSURE,ALPHA 2 MACROGLOBULINS QN,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-aCnc
0.0,0.0,0.0,0.39999999999999997,0.31428571428571433,1.0,0.0,0.0,0.0,0.0,0.41219810878268626,0.4228537636689047,1,433961,LIPID PROFILE,NON HDL CHOLESTEROL,Cholesterol.non HDL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,FASTING,FASTING STATUS,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,HEPATITIS ABC PANEL,HEPATITIS A ANTIBODY TOTAL,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.16,0.0,0.0,0.0,0.0,0.0,0.07132561100505608,0.0,0.0,0.0,0.0,0,195503,DRUG PANEL 8 SCREEN,OPIATES,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,ASH FIBROSURE,HEIGHT,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,DRUG ABUSE SCREEN III,COCAINE METABOLITE,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.125,0.2573333333333333,0.715,0.25,0.2573333333333333,0.965,0.018878981028615627,0.08614448942962882,0.22524969726717137,0.22848423004998408,0.011147902332567239,0.04372412516808821,1,426171,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,HEP A AB IGM,HEPATITIS A AB IGM,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE LYMPHOCYTES,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN RT PCR LOG COPIES ML,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,CBC WITH DIFFERENTIAL,ABS NEUTROPHILS,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59014,CBC INCLUDES DIFF PLT,BASOPHILS ABSOLUTE,Coagulation tissue factor induced,Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay,PT Cont PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,CMP12 LP TP TSH 6AC CBC D PLT,EOS ABSOLUTE,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195503,CBC WITH DIFFERENTIAL,NUCLEATED RBCS,Methadone,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,PTH INTACT,PARATHYROID HORMONE INTACT,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,DRUG ABUSE SCREEN 11 W ETOH W CONF,METHADONE,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.11,0.1325,0.0,0.3333333333333333,0.25,1.0,0.0,0.0,0.0,0.08466774310592073,0.09762443806815091,1.0,1,58032,URINALYSIS WITH MICROSCOPIC,PH,pH,pH of Urine by Test strip,pH Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205708,LIVER FIBROSIS FIBROTEST ACTITEST,BILIRUBIN,Hematocrit,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,PROTHROMBIN PTT,CONTROL,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,TSH FT4,TSH,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17590,PTT,PTT,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21329,PSA FREE TOTAL,PSA FREE,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,CBC WITH AUTO DIFF,EOSINOPHILS ABSOLUTE,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.07333333333333333,0.0,0.0,0.07333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,HEPATITIS A TOTAL AB REFLEX IGM,HEPATITIS A TOTAL AB,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57976,BASIC METABOLIC PANEL AMA,GLUCOSE,Ketones,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,NMR LIPOPROFILE,LDL P,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,CBC WITH ABSOLUTE WHITE BLOOD CELLS,RDW,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.3566666666666667,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,VELPATASVIR RESISTANCE,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45443,CMP13 LP 2AC CBC D PLT,EGFR IF AFRICN AM,Hematocrit,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto
0.0,0.14285714285714285,0.0,0.0,0.14285714285714285,0.0,0.0,0.0953620011163746,0.0,0.0,0.0953620011163746,0.0,0,28746,FERRITIN SERUM,FERRITIN SERUM,Gamma globulin,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,DRUG ABUSE PANEL 10 WITH OXYCODONE,BENZODIAZEPINES,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.275,0.21428571428571427,0.0,0.275,0.14285714285714285,0.0,0.0,0.06603415273894597,0.0,0.0,0.09338639438323382,0.0,1,21329,VITAMIN B 12 FOLIC ACID,VITAMIN B 12,Cobalamins,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,Vit B12 SerPl-mCnc
0.0,0.005454545454545454,0.015,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,CMP14 CBC D PLT RPR UA TSH,NEUTROPHILS ABSOLUTE,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,66902,LP NON HDL CHOLESTEROL,VLDL CHOLESTEROL CAL,Leukocytes,Leukocytes [#/volume] in Blood by Automated count,WBC # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45484,DIRECT LDL,DIRECT LDL,Hemoglobin A1c/Hemoglobin.total,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,CMP14,EGFR IF AFRICN AM,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7427,DRUG ABUSE SCREEN III,AMPHETAMINES,Monocytes,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,NEG HIV 4TH GEN,NEG HIV 1 RNA QL TMA,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,DRUG ABUSE SCREEN II,BENZODIAZEPINES,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223222,CMP14 LP 5AC CBC D PLT RPR,HEMOGLOBIN A1C,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.16666666666666666,0.2,0.75,0.0,0.0,0.0,0.020983850759697886,0.046324040643815456,0.22524969726717137,0.0,0.0,0.0,0,347047,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,LEDIPASVIR RESISTANCE,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,COMPLEMENT C3 SERUM,COMPLEMENT C3 SERUM,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.0,0.0,0.0,0.0,0.04857142857142858,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,RPR HBSAG HCVAB HSV1 HSV2 I,HEP C VIRUS AB,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Appearance,Appearance of Urine,Appearance Ur
0.047142857142857146,0.030000000000000002,0.0,0.14285714285714285,0.09090909090909091,0.5,0.0,0.0,0.0,0.0872369085792638,0.0,0.0,1,17442,HEPATIC FUNCTION PANEL,ALT,Alanine aminotransferase,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,ALT SerPl w/o P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,PE INTERP RFX IFE S,ALBUMIN,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,PROTEIN 24 HOUR URINE,PROTEIN URINE CONC,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,DRUG ABUSE PANEL 10 WITH OXYCODONE,PHENCYCLIDINE,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,NMR LIPOPROFILE,LDL P,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.028333333333333335,0.017,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,ALKALINE PHOSPHATASE,LIPEMIA,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,382507,IRON TOTAL BINDING CAPACITY,% SATURATION,Calcium,Calcium [Mass/volume] in Unspecified specimen,Calcium XXX-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339358,CBC DIFF PLT,LYMPHOCYTES #,Cyclic citrullinated peptide Ab.IgG,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,cCP IgG SerPl-aCnc
0.0,0.14285714285714285,0.0,0.25,0.14285714285714285,1.0,0.0,0.013880466255054902,0.0,0.0743456328618588,0.07300170975033571,1.0,0,303644,CBCI COMPLETE BLOOD COUNT W DIFF,LYMPHOCYTES,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,DRUG ABUSE SCREEN 11 W ETOH W CONF,OXYCODONE,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24984,PROTHROMBIN TIME INR,PROTHROMBIN TIME,Iron,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc
0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7112,DRUG ABUSE SCREEN 11 W ETOH NO CONF,OXYCODONE,Eosinophils,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,PLATELET ESTIMATION,PLATELET ESTIMATION,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,495499,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B RESIST ASSAY INTERP,Reference lab test method,Reference lab test method,Ref lab test method
0.285,0.5,0.0,0.285,0.5,0.0,0.0,0.0983573569202505,0.0,0.0,0.07145311764613438,0.0,0,57679,MICROALBUMIN RANDOM URINE W CREATININE,MICROALBUMIN CREATININE RATIO RANDOM URINE,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.1475,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,HBSAB AG,HEP B SURFACE AB QUAL,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,CBC,MCH,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,CBC H H RBC INDICES WBC PLT,PLATELET COUNT AUTO,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,QUESTASSURED TM 25OHD D2 D3,VITAMIN D 25 OH TOTAL,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.22166666666666668,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,481598,PE INTERP RFX IFE S,BETA GLOBULIN,Hepatitis C virus Ab Signal/Cutoff,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,HB S AG W REFLEX CONF,HFLAG NR,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.11166666666666668,0.0,0.0,0.19999999999999998,0.16666666666666666,0.3333333333333333,0.0,0.0,0.0,0.03622836077219149,0.18114949547659975,0.22056758755212558,1,241109,RPR RFX QN RPR CONFIRM TP,TREPONEMA PALLIDUM ANTIBODIES,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,CMP14 5AC,BILIRUBIN TOTAL,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.11600000000000002,0.19333333333333336,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,HCV FIBROSURE,INTERPRETATION,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,URINALYSIS W MICRO,GLUCOSE,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.1425,0.2,0.0,0.0,0.0,0.0,0.0,0.013324042926865065,0.0,0.0,0.0,0.0,0,254284,ALBUMIN CREATININE RATIO URINE RANDOM,CALC ALBUMIN CREAT RND,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20289,CRP,C REACTIVE PROTEIN ULTRA,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,79053,PT PROTIME,INR,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,497818,LYMPHOCYTE SUBSET PANEL 3,% CD3 MATURE T CELLS,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264994,ANA SCREEN IFA,ANA SCREEN IFA,Neutrophils,Neutrophils [#/volume] in Blood,Neutrophils # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,CBC W AUTO DIFF,MCV,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.14285714285714285,0.2,0.2,0.42857142857142855,0.6,0.0,0.0769055150490483,0.07759701258884111,0.011288490889579728,0.042731346311152496,0.04311556610120715,0,169334,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS B SURFACE AB,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,64634,RHEUMATOID FACTOR QUANT,RHEUMATOID FACTOR QUANT,Bacteria identified,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,CBC INCLUDES DIFF PLT,BASOPHILS ABSOLUTE,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,RPR,TREPONEMA PALLIDUM ANTIBODIES,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112599,BASIC METABOLIC PANEL,UREA NITROGEN BLOOD BUN,Hepatitis C virus RNA,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,HCV RNA SerPl Ql NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,HEPATITIS B SURFACE ANTIBODY,HEPATITIS B SURFACE ANTIBODY,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.1425,0.36,0.0,0.25,0.2,1.0,0.0,0.14265122201011204,0.0,0.08356777192520215,0.12353958214165095,1.0,1,192955,URINE DRUG SCREEN,OPIATES,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,BILIRUBIN PANEL,BILIRUBIN INDIRECT,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,183145,CMP14 CBC D PLT,HEMATOLOGY COMMENTS,Morphology,Morphology [Interpretation] in Blood Narrative,Morphology Bld-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,VITAMIN B 12 FOLIC ACID,VITAMIN B 12,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,URINALYSIS W MICRO W REFLEX CULTURE,NITRITES,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,CMP14 CBC D PLT,HEMATOLOGY COMMENTS,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,HEPATITIS B SURFACE ANTIBODY,HEPATITIS B SURFACE ANTIBODY,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,237610,STOOL CULTURE,RESULT 2,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,MPV,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,AMYLASE SERUM,AMYLASE SERUM,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,ANA TITER PATTERN,ANA TITER,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,LYMPHOCYTE SUBSET PANEL 2,ABSOLUTE CD3 CELLS,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,CBC WITH DIFFERENTIAL,ABS NEUTROPHILS,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,193433,CMP13 LP 2AC CBC D PLT,ALT SGPT,Amphetamine,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,DIFFERENTIAL MANUAL,NEUTROPHILS,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7369,DRUG ABUSE SCREEN III,METHADONE,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,TESTOSTERONE FREE LC MS MS,TESTOSTERONE FREE LC MS MS,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.25,0.14285714285714285,1.0,0.0,0.0,0.0,0.052570301148225806,0.05162000400267441,0.7071067811865476,1,303644,CD4 T4 ENUMERATION,ABSOLUTE LYMPHOCYTES,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.02948276095739455,0.0,0.0,0.0,0.0,0,264846,CBCI COMPLETE BLOOD COUNT W DIFF,MCHC,Monocytes,Monocytes [#/volume] in Blood,Monocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7344,TRIGLYCERIDES REFL,TRIGLYCERIDES,Lymphocytes.variant,Variant lymphocytes [#/volume] in Blood by Manual count,Variant Lymphs # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,CHEM SCREEN PANEL HDL,URIC ACID,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,LIVER FIBROSIS,NECROINFLAM ACT SCORE,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,CMP14 CBC D PLT ESR WES ANA,LYMPHS ABSOLUTE,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487926,FE ANA TIBC FER A1A AMA ASM,ALPHA 1 ANTITRYPSIN SERUM,Necroinflammatory activity score,Necroinflammatory activity score,Necroinflammatory act score SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,CYCLIC CITRULLINATED PEPTIDE CCP AB IGG,CYCLIC CITRULLINATED PEPTIDE CCP AB IGG,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,PSA FREE TOTAL,PSA FREE,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,CMP,BUN BLOOD UREA NITROGEN,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,HIV 1 QUANT PCR,HIV 1 VIRAL COPY,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.0,0.0,0.0,0.026363636363636363,0.05714285714285715,0.0,0.0,0.0,0.0,0.0,0.0,0,831008,LYMPHOCYTE SUBSET PANEL 2,CD4 ABSOLUTE,Hepatitis B virus core Ab.IgG+IgM,Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,HBV core IgG+IgM SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,HEPATITIS B CORE IGM,HEPATITIS B CORE IGM,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.04421052631578947,0.024444444444444446,0.0,0.05263157894736842,0.0,0.0,0.0,0.0,0.0,0.03350578343083632,0.0,0,486431,BMP8 CBC D PLT,CREATININE,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,URINALYSIS CULTURE IF INDICATED,UROBILINOGEN,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,IFE PE SERUM,GLOBULIN TOTAL,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,COMP METAB PANEL,ALBUMIN GLOBULIN RATIO,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.04097329812432471,0.0,0.0,0.0,0.0,0,196444,DRUG PANEL 8 SCREEN,OPIATES,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27771,COMPLETE BLOOD COUNT,BASOPHILS %,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.2,0.0,0.25,0.2,0.0,0.0,0.04035350753708156,0.0,0.06725870151848445,0.21223170681007852,0.0,1,7864,CBCI COMPLETE BLOOD COUNT W DIFF,MCHC,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume] by Automated count,MCHC RBC Auto-mCnc
0.0,0.0,0.0,0.1075,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,882944,RENAL PANEL 10,EGFR IF NONAFRICN AM,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.012142857142857144,0.0425,0.0,0.0,0.0,0.0,0.0,0.0,0,204164,LIPID PANEL,HDL AS % CHOLESTEROL,Hepatitis C virus RNA,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24588,HEPASCORE R,SEX,IgA,IgA [Mass/volume] in Serum or Plasma,IgA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,CMP13 LP TP TSH 2AC CBC D P,CHOLESTEROL TOTAL,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,MANUAL DIFFERENTIAL,BLASTS %,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7773,HCV FIBROSURE RESULTS,FIBROSIS STAGE,Platelets,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto
0.0,0.2,0.0,0.3333333333333333,0.4,1.0,0.0,0.24044117311858715,0.0,0.05467597086898157,0.3926387915311558,0.5773502691896257,1,24653,IMMUNOFIXATION SERUM,IGG SERUM NR,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.06,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134999,NASH FIBROSURE,HEIGHT,HIV 1 Ab band pattern,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,HIV1 Ab Patrn Ser IB-Imp
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.13206830547789195,0.0,1,17590,COMP METABOLIC PANEL,RATIO,Albumin/Globulin,Albumin/Globulin [Mass Ratio] in Serum or Plasma,Albumin/Glob SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19752,PROTHROMBIN TIME PT,PT CONTROL,Bilirubin,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20933,ANEMIA PROFILE B,UIBC,Cholesterol,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7146,CBC W AUTO DIFF,BASOPHILS ABSOLUTE,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,CMP WITH ESTIMATED GFR CALCULATED,ALBUMIN,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,LIPID PROFILE,CHOLESTEROL,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,CMP14 5AC,BILIRUBIN TOTAL,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,HCV QUANT GT1A NS5A PROFILE,HCV NS5A RESISTANCE ASSAY PDF,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,URINALYSIS,LEUKOCYTE ESTERASE,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,LYMPHOCYTES,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,ACCUTYPE R IL28B,IL28B GENOTYPE,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,HEPATITIS PANEL ACUTE,HEPATITIS A IGM,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,FASTING,FASTING STATUS,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196444,LIPID PANEL,CALC LDL CHOL,oxyCODONE cutoff,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,oxyCODONE CtO Ur Scn-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,LIVER FIBROSIS,NECROINFLAM ACT SCORE,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.392,0.45,0.98,0.392,0.392,0.98,0.032370385903997545,0.0449917128842755,0.05839673124596356,0.03737810203089009,0.05195195509007766,0.06743073700930258,1,172841,MITOCHONDRIAL AB W RFX TITER,MITOCHONDRIAL AB SCN,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,181826,COMPREHENSIVE METABOLIC PANEL E GFR,ALBUMIN,Osmolality,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc
0.16666666666666666,0.23076923076923078,0.6666666666666666,0.0,0.0,0.0,0.028275241940297513,0.08470305693504976,0.3162277660168379,0.0,0.0,0.0,0,204479,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,LEDIPASVIR RESISTANCE,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30841,CBC WITH DIFFERENTIAL,NEUTROPHILS,Urate,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc
0.0,0.0,0.0,0.0,0.14285714285714285,0.0,0.0,0.0,0.0,0.0,0.21668861764565872,0.0,0,30510,COMPREHENSIVE METABOLIC PANEL,CALCIUM SERUM,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,427682,CBC WITH AUTO DIFF,PLATELET COUNT,HIV 1 & 2 Ab,HIV 1 and 2 Ab [Interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,CMP14 5AC,BILIRUBIN TOTAL,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.05,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305227,CBC WITH DIFFERENTIAL,IMMATURE GRANS,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,736553,PROTEIN ELEC INTERP SERUM,M SPIKE,Hepatitis C virus NS5 gene mutations detected,Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method,HCV NS5 Mut Det Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,111252,PROTEIN ELECTRO S,GAMMA GLOBULIN,Platelet morphology finding,Platelet morphology finding [Identifier] in Blood,Plat morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,110544,ALPHA 1 ANTITRYPSIN PHENOTYPE,A 1 ANTITRYPSIN PHENOTYPE,Cholesterol.in LDL/Cholesterol.in HDL,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,LDLc/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29512,PTH INTACT,PARATHYROID HORMONE INTACT,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30163,SMN1 COPY NUMBER ANALYSIS,SPECIMEN TYPE,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA TITER,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,OBSTETRIC PANEL INCLUDING HIV,HEMOGLOBIN,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME NR,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487934,CBC DIFF PLT,RDW,Necroinflammatory activity grade,Necroinflammatory activity grade,Necroinflammatory act grade SerPl Ql
0.0,0.0,0.0,0.22,0.16666666666666666,0.25,0.0,0.0,0.0,0.0,0.30644398188636846,0.1503314858492919,0,19687,URINALYSIS,BILIRUBIN,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67421,HEPATITIS C VIRAL RNA NS3 DRUG RESI,BOCEPREVIR RESISTANCE,Erythrocyte morphology finding,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,CMP14 CBC D PLT,HEMATOLOGY COMMENTS,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,PROTEIN ELEC INTERP SERUM,P E INTERPRETATION S,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,CMP14,EGFR IF AFRICN AM,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,CBC PLT DIFF,POLYS,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7831,C4 C3,COMPLEMENT C3 SERUM,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45377,C4 SERUM,C4 SERUM,Erythrocyte sedimentation rate,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,COMPREHENSIVE METABOLIC PANEL,OSMOLALITY,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,COMP METABOLIC PANEL,GLOBULIN,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,COMPLETE BLOOD COUNT,NEUTROPHILS ABSOLUTE,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264531,MICROALBUMIN RANDOM,MICROALBUMIN RANDOM,Erythrocytes,Erythrocytes [#/volume] in Blood,RBC # Bld
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.0834655896020069,0.34003516797720323,1.0,1,29512,COMP METABOLIC PANEL,SODIUM,Sodium,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc
0.0,0.072,0.18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,473835,BASIC METABOLIC PANEL AMA,GLUCOSE,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303644,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Lymphocytes,Lymphocytes [#/volume] in Blood by Flow cytometry (FC),Lymphocytes # Bld FC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,CBC WITH ABSOLUTE WHITE BLOOD CELLS,RDW,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.178,0.89,0.0,0.0,0.0,0.0,0.0,0.0,0,21600,ESR WES CRP,C REACTIVE PROTEIN QUANT,Creatinine,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304287,RENAL PANEL 10,EGFR IF NONAFRICN AM,Erythrocyte mean corpuscular volume,MCV [Entitic volume],MCV RBC
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,296095,URINALYSIS,BILIRUBIN,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,LITHOLINK CMP14 P,ALBUMIN,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,HEPATITIS C ANTIBODY,HEPATITIS C ANTIBODY,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57679,OBSTETRIC PANEL,RPR RESULT,Appearance,Appearance of Urine,Appearance Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,CBC WITH DIFFERENTIAL,MYELOCYTES,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,GORBYMI CMP 4AC CORONARY RISK CBC TSH PROFILE,CALCIUM,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,FERRITIN SERUM,FERRITIN SERUM,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,THYROXINE T4 FREE,T 4 FREE,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20396,ANA TITER PATTERN,ANA PATTERN,Carcinoembryonic Ag,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,304519,LIPID PANEL,CALC LDL CHOL,Neutrophils.segmented,Segmented neutrophils [#/volume] in Blood,Neuts Seg # Bld
0.0,0.07142857142857142,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,CMP,ALT SGPT,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,CMP WITH EGFR,ANION GAP,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31419,CBC WITH PLT DIFF,MEGAKARYOCYTE FRAGS,Body weight,Body weight Measured,Weight Measured
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,CMP12 LP 6AC,PHOSPHORUS SERUM,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0,0.0,0.0,0.09,0.315,0.0,0.0,0.0,0.0,0.0,0.0,1,20289,BMP,C02 BICARBONATE,Carbon dioxide,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,PE INTERP RFX IFE S,ALBUMIN,Ceruloplasmin,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58024,CMP12 LP TP TSH 6AC CBC D PLT,HEMOGLOBIN,Nitrite,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,ALPHA 1 ANTITRYPSIN PHENOTYPE,A 1 ANTITRYPSIN PHENOTYPE,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.5233333333333333,0.5,0.74,0.6533333333333333,0.5,0.74,0.0073589315492957885,0.09703136255850453,0.0,0.06192371508395944,0.0,0.0,1,149575,URINE MICROALBUMIN CREAT RATIO,UR MICROALBUMI,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,428102,HEPATITIS PANEL AMA,HEPATITIS C ANTIBODY,Hemoglobin,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CARBON DIOXIDE,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.40824829046386313,0.0,0,23366,CMP14 LP 7AC CBC D PLT T B,AMYLASE SERUM,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,CBC W AUTO DIFF,MCV,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.15,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.04801993258748538,0.0,0,130682,CMP14 LP 7AC CBC D PLT T B,AMYLASE SERUM,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.125,0.125,0.125,0.125,0.125,0.125,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,TESTOSTERONE FREE TOTAL,FREE TESTOSTERONE DIRECT,Reference lab test method,Reference lab test method,Ref lab test method
0.0,0.0625,0.08333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,519132,TESTOSTERONE FREE TOTAL LC MS,FREE TESTOSTERONE DIRECT,Hepatitis A virus Ab.IgG+IgM,Hepatitis A virus IgG+IgM Ab [Presence] in Serum,HAV IgG+IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7310,CEA,CEA SIEMENS IMMULITE 2000,Lymphocytes,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto
0.0,0.25,0.5,0.2,0.375,0.75,0.0,0.041408388212339164,0.05608746788525232,0.011957462693671705,0.0,0.0,0,139550,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,CBC INCLUDES DIFF PLT,BASOPHILS ABSOLUTE,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7187,PSA TOTAL REFLEX FREE,PROSTATE SPECIFIC AG SERUM,Hemoglobin,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,FE TIBC FER B12 HCT FOLRBC,IRON,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,326249,ANION GAP,ANION GAP,Race,Race,Race
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81240,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS B SURFACE AB,Cells.CD3/100 cells,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld
0.1825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204545,PROTIME PTT,PTT,Protein,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,MITOCHONDRIAL ANTIBODY W REFL TITER,MITOCHONDRIAL AB SCREEN,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,POL CMP WITH EGFR INV,GLUCOSE,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,COMPREHENSIVE METABOLIC PANEL WITH GFR,CREATININE,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,384834,CHEM SCREEN PANEL HDL,URIC ACID,Creatinine,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,CMP12 7AC MG,PHOSPHORUS SERUM,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.10714285714285714,0.125,0.0,0.0,0.0,0.0,0.03217053905643563,0.0,0.0,0.0,0.0,0,296095,CBC WITH AUTO DIFF,EOSINOPHILS ABSOLUTE,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,31377,HEPATITIS C RNA PCR QUANTITATIVE,HCV VIRAL LOG,Body height,Body height Measured,Body height Measured
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.04135584299524686,0.15206835006751718,0.44721359549995787,1,30916,CMP,BUN BLOOD UREA NITROGEN,Urea,Urea [Mass/volume] in Serum or Plasma,Urea SerPl-mCnc
0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.03602708014099765,0.0,0.0,0,79053,URINALYSIS COMPLETE,GLUCOSE QL,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,HBV surface Ag SerPl Ql Nt
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,347047,LIVER FIBROTEST ACTITEST,NECROINFLAMMAT ACT SCORE,Hepatitis C virus RNA,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL,HCV RNA SerPl NAA DL=50-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265116,LYMPHOCYTE SUBSET PANEL 4,LYMPHOCYTES ABSOLUTE,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,ALKALINE PHOSPHATASE,LIPEMIA,Service comment,Service comment,Service Cmnt XXX-Imp
0.18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,HCV FIBROSURE RESULTS,FIBROSIS STAGE,Color,Color of Urine,Color Ur
0.4,0.5714285714285714,0.8,0.4,0.5714285714285714,0.8,0.4360065673004285,0.8512784030381061,0.8593267568211221,0.4360065673004285,0.8512784030381061,0.8593267568211221,1,223222,HEPATITIS B SURFACE AB,HEPATITIS B SURFACE AB,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql
0.0725,0.0,0.0,0.0,0.08,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,DIFFERENTIAL MANUAL,ABSOLUTE EOSINOPHILS,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B DRUG RESISTANCE ASSAY,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.142,0.71,0.0,0.0,0.0,0.0,0.0,0.0,1,19638,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,CARBON DIOXIDE,Bicarbonate,Bicarbonate [Moles/volume] in Serum or Plasma,HCO3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,STOOL CULTURE,RESULT 2,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.24044117311858715,0.0,1,27771,CMP12 7AC MG,PHOSPHORUS SERUM,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29918,NGI HCV SUPERQUANT,HEPATITIS C QUANTITATION,Testosterone.free,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81232,HEPATITIS A TOTAL AB REFLEX IGM,HEPATITIS A TOTAL AB,Cells.CD3+CD4+/100 cells,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22848,LIPID PANEL AMA,NON HDL CHOLESTEROL,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,HCV NS5B DRUG RESISTANCE ASSAY,HCV NS5B RESIST ASSAY INTERP,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,CMP14 4AC,EGFR IF NONAFRICN AM,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,PE INTERP RFX IFE S,BETA GLOBULIN,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,HCV QUANT GT1A NS5A PROFILE,HCV LOG10,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,CBC WITH DIFFERENTIAL,NUCLEATED RBCS,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.125,0.125,0.0,0.0,0.0,0.0,0.0,0.0666872623744319,0.0,0.0,0.0,0.0,0,109009,PE FLC SERUM,ALBUMIN,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,DRUG SCREEN AUSTIN 20,PHENCYCLIDINE,Age,Age,Age
0.0,0.08333333333333333,0.125,0.1875,0.22666666666666666,0.09,0.0,0.0,0.0,0.0,0.07184578234577044,0.0,0,161281,C4 C3,COMPLEMENT C3 SERUM,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql
0.3133333333333333,0.0,0.0,0.3333333333333333,0.485,0.94,0.0,0.07752952669246371,0.5,0.09061940958216264,0.08952338621207645,0.0,0,265157,CBC INCLUDES DIFF PLATELETS,MEAN PLATELET VOLUME,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,CBC WITH PLT DIFF,WBC MORPHOLOGY,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7120,CBC W DIFF PLATELET,HCT,Eosinophils,Eosinophils [#/volume] in Blood by Manual count,Eosinophil # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,18259,CBC W DIFF PLT,PLATELET SUFFICIENCY,Alpha 1 antitrypsin,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143149,GLUCOSE,GLUCOSE FASTING,Benzoylecgonine,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn
0.0,0.015263157894736841,0.03222222222222222,0.0,0.021052631578947368,0.044444444444444446,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,CBC WITH MANUAL DIFFERENTIAL,MCHC,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.125,0.0,0.306,0.125,0.3333333333333333,0.0,0.07583869961926504,0.0,0.0,0.07583869961926504,0.12135372908279596,1,28654,PROTEIN ELECTROPHORESIS,ALPHA 1 GLOBULINS,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,ANTINUCLEAR ANTIBODIES TITER PATTERN,ANA TITER,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,LIPID PANEL,NON HDL CHOLESTEROL,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134585,AFP TUMOR MARKER SIEMENS CLIA,AFP TUMOR MARKER SIEMENS CLIA,Cholesterol.in VLDL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285395,BILIRUBIN PANEL,BILIRUBIN INDIRECT,Erythrocyte mean corpuscular hemoglobin,MCH [Entitic mass],MCH RBC Qn
0.25,0.27,0.0,0.2833333333333333,0.0,0.0,0.0,0.055837794002650876,0.0,0.0,0.0,0.0,0,205070,PROTEIN ELEC INTERP SERUM,P E INTERPRETATION S,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,CBC INC DIFF PLT,ABSOLUTE MONOCYTES,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.16,0.07272727272727274,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,542183,VITAMIN D 25 OH LCMSMS W REFLEX,VITAMIN D 25 OH D3,Cells.CD3+CD4+/Cells.CD3+CD8+,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,FIBROMETER VIRUS,GAMMA GLUTAMYL TRANSFERASE FM,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,DIFFERENTIAL MANUAL,NEUTROPHILS,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,295410,CBC,MCH,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,772020,LYMPHOCYTE SUBSET PANEL 4,LYMPHOCYTES ABSOLUTE,Laboratory comment,Laboratory comment [Text] in Report Narrative,Laboratory comment Report
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,MORPHOLOGICAL REVIEW,PATH REVIEW PERIPHERAL SMEAR,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.3333333333333333,0.2,1.0,0.3333333333333333,0.2,1.0,0.06538932921065,0.4808823462371743,0.7071067811865476,0.06538932921065,0.4808823462371743,0.7071067811865476,1,22848,FOLATE SERUM,FOLATE SERUM,Folate,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc
0.0,0.14285714285714285,0.2,0.0,0.14285714285714285,0.2,0.0,0.029699923646854032,0.04007989868886952,0.0,0.008147013515057533,0.010994354065787082,0,728626,HEPATITIS B SURFACE ANTIBODY,HEPATITIS B SURFACE AB QUAL,Hepatitis C virus resistance panel,Hepatitis C virus resistance panel by Genotype method,HCV resis panell Islt Genotyp
0.2,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,539627,HEPATITIS C VIRAL RNA QUALITATIVE TMA,HEPATITIS C VIRAL RNA QUALITATIVE TMA,Alpha-1-Fetoprotein.tumor marker,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,771477,FIBROACT,NECROINFL SCORE,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA.pred SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,339143,CBC WITH AUTO DIFF,PLATELET COUNT,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,CBCI COMPLETE BLOOD COUNT W DIFF,MCV,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,COMPREHENSIVE METABOLIC PANEL E GFR,SODIUM,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,602797,CREATININE,EGFR IF AFRICN AM,IL28B gene associated variant rs12979860,IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method,IL28B rs12979860 Bld/T Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265074,CBC WITH AUTO DIFF,RDW,Neutrophils.band form,Band form neutrophils [#/volume] in Blood,Neuts Band # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,67686,HEPATITIS BE AG,HB E AG,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc
0.0,0.03777777777777777,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,622381,HCV FIBROSURE,LIMITATIONS,Glomerular filtration rate/1.73 sq M.predicted,"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA.pred SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,PSA TOTAL % FREE,PSA FREE,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7641,URINALYSIS WITH MICROSCOPIC,APPEARANCE,Neutrophils.band form/100 leukocytes,Band form neutrophils/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204552,DRUG ABUSE SCREEN W ETOH NO GCMS,AMPHETAMINES,Leukocytes,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30510,PROTEIN ELECTRO S,M SPIKE,Triiodothyronine.free,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,HDL CHOL DIRECT,HDL AS % CHOLESTEROL,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149799,NASH FIBROSURE,APOLIPOPROTEIN A 1,Coagulation surface induced,aPTT in Platelet poor plasma by Coagulation assay,aPTT PPP
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59022,PROFILE 104 LIVER,AST SGOT,Coagulation tissue factor induced,Prothrombin time (PT),Prothrombin time
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7328,PE INTERP RFX IFE S,ALBUMIN,Lymphocytes,Lymphocytes [#/volume] in Blood by Manual count,Lymphocytes # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,CBC W DIFF PLT,PLATELET SUFFICIENCY,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.3333333333333333,0.375,1.0,0.0,0.0,0.0,0.08176255116563813,0.0,0.0,1,23242,HCV FIBROSURE,GGT,Gamma glutamyl transferase,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,195586,LIPID PANEL,HDL AS % CHOLESTEROL,Methaqualone,Methaqualone [Presence] in Urine by Screen method,Methaqualone Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,NGI HCV SUPERQUANT,INTERNATIONAL UNITS,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19687,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,CYCLIC CITRULLINATED PEPTIDE CCP ANTIBODIES IGG,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19893,AFP TUMOR MARKER SIEMENS CLIA,AFP TUMOR MARKER SIEMENS CLIA,Calcidiol,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc
0.0,0.14285714285714285,0.2,0.0,0.0,0.0,0.0,0.04813180165558817,0.12210584428057858,0.0,0.0,0.0,0,487967,BASIC METABOLIC PANEL,OSMOLALITY,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,254284,CMP14 HP4 1AC PT AFP,HEP A AB IGM,Glucose,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57992,CMP14,EGFR IF AFRICN AM,Leukocyte esterase,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip
0.0,0.04,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139501,COMPREHENSIVE METABOLIC PANEL AMA,GLOBULIN,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,HAV IgM SerPl Ql IA
0.0,0.0,0.0,0.08,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,172841,UROGRAM,SPECIFIC GRAVITY,Mitochondria Ab,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19901,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,OMBITASVIR RESISTANCE,Cholecalciferol,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc
0.0,0.07600000000000001,0.25,0.0,0.06666666666666667,0.25,0.0,0.037070685880943643,0.14539805437566944,0.0,0.0,0.0,0,426171,HEPATITIS A DIAGNOSTIC PANEL,HAV AB TOTAL,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,93179,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,Platelets,Platelet adequacy [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,142513,COMPLETE BLOOD COUNT,RED CELL DIST WIDTH,Mitochondria M2 Ab.IgG,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc
0.0,0.0,0.0,0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264648,CBC W DIFF PLT,RBC,Leukocytes,Leukocytes [#/volume] in Blood,WBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25320,HEPATITIS C VIRAL RNA QUALITATIVE TMA,HEPATITIS C VIRAL RNA QUALITATIVE TMA,Lactate dehydrogenase,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc
0.14333333333333334,0.07142857142857142,0.3333333333333333,0.2866666666666667,0.21428571428571427,0.3333333333333333,0.0,0.054432052556039556,0.40824829046386313,0.032129719769984244,0.16329615766811867,0.40824829046386313,1,295410,HIV 1 QUANT PCR,HIV 1 VIRAL LOG,HIV 1 RNA,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA SerPl NAA+probe-Log#
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,422543,NASH FIBROSURE,HEIGHT,Nuclear Ab,Nuclear Ab [Presence] in Serum by Immunofluorescence,ANA Ser Ql IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,CMP,ALT SGPT,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,44982,DRUG ABUSE SCREEN 8 W CONFIRMATION,BARBITURATES,Complement C4,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc
0.0,0.07333333333333333,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17830,HEPATITIS A DIAGNOSTIC PANEL,HAV AB TOTAL,Alkaline phosphatase,Alkaline phosphatase [Enzymatic activity/volume] in Blood,ALP Bld-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28688,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE NEUTROPHILS,Alpha 2 globulin,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7518,HEPATITIS C VIRAL RNA QUANTITATIVE BDNA,HCV RNA QN BDNA,Neutrophils,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,29868,DRUG ABUSE SCREEN III,METHADONE,Testosterone,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22764,IRON IBC W O REFLEX,UIBC,Ferritin,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25718,CBC INCLUDES DIFFERENTIAL PLATELETS,RBC,Triglyceride,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,HEMOGLOBINOPATHY EVAL,MCH,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823781,COMP METAB PANEL,ALT,Ombitasvir,Ombitasvir [Susceptibility] by Genotype method,Ombitasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1963193957655779,0.0,0,27771,AFP WITH AFP L3%,AFP SERUM,Phosphate,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28621,RPR REFLEX TITRE TPPA,RPR,Albumin,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,ACCUTYPE R IL28B,ACCUTYPE R IL28B,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7872,HEPATITIS A TOTAL AB,HEPATITIS A TOTAL,Erythrocyte mean corpuscular volume,MCV [Entitic volume] by Automated count,MCV RBC Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,CREATINE KINASE CK,CREATINE KINASE CK,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,128413,BASIC METABOLIC PANEL,OSMOLALITY,Prostate specific Ag.free/Prostate specific Ag.total,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl
0.0,0.06666666666666667,0.0,0.0,0.0,0.0,0.0,0.026212933369651692,0.0,0.0,0.0,0.0,0,426171,DRUG ABUSE PANEL 10 WITH OXYCODONE,BENZODIAZEPINES,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification,HCV RNA SerPl Probe+sig amp-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23457,URINALYSIS W REFLEX MICRO,UROBILINOGEN,Glucose,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,112821,PROTEIN ELECTROPHORESIS,GAMMA GLOBULINS,Cells counted.total,Cells Counted Total [#] in Blood,Total Cells Counted Bld
0.09,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,HCV FIBROSURE,LIMITATIONS,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28886,IMMUNE COMPETENCE PANEL,CD4 CD8 RATIO,Protein,Protein [Mass/volume] in Urine,Prot Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,CMP12 LP TP TSH 6AC CBC D PLT,BILIRUBIN TOTAL,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487967,TSH,TSH,Hepatitis C virus FibroSURE panel,Hepatitis C virus FibroSURE panel - Serum or Plasma,HCV FibroSURE Pnl SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,251454,ALPHA 1 ANTITRYPSIN QN,ALPHA 1 ANTITRYPSIN QN,Bacteria,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,ARTHRITIS PROFILE,SEDIMENTATION RATE,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,CBC WITH AUTO DIFF,EOSINOPHILS ABSOLUTE,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,COMP METABOLIC PROFILE FASTING CMP,BUN CREATININE RATIO CALC,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264747,CBC WITH PLT DIFF,RDW,Lymphocytes,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,453530,HEPATIC FUNCTION PROFILE,BILIRUBIN INDIRECT,Date of analysis,Date of analysis of unspecified specimen,Date Of Analysis XXX
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487959,CBC DIFF PLT,LYMPHOCYTES #,Liver fibrosis score,Fibrosis score,Liver fibr score SerPl Calc.FibroSure
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,223149,VITAMIN D 25 OH LCMSMS W REFLEX,VITAMIN D 25 OH D3,Hepatitis A virus Ab.IgM,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql
0.0,0.09375,0.1875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,HEPATIC FUNCTION PANEL,INDIRECT BILI,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,LYMPHOCYTE SUBSET PANEL 4,% CD8 SUPPRESSOR T CELLS,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,RPR HBSAG HCVAB HSV1 HSV2 I,HEP C VIRUS AB,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.1875,0.2,1.0,0.0,0.0,0.0,0.0,0.12353958214165095,1.0,1,143164,DRUG ABUSE PANEL 10 WITH OXYCODONE,BENZODIAZEPINES,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,15586,COMP METABOLIC PANEL,SODIUM,Glucose^post CFst,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,HEMOGLOBINOPATHY INDICES,HEMATOCRIT,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303503,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS B SURFACE AB,Hemoglobin,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.0,0.0,0.0,0.0,0.08287539106540942,0.7071067811865476,0.0,1,285403,CBC DIFF PLT,MCHC,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.0,0.14285714285714285,0.2,0.0,0.0,0.0,0.0,0.0769055150490483,0.07759701258884111,0.0,0.0,0.0,1,169334,X HEPATITIS COMPLEX PROFILE,ANTI HBC TOTAL,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,196592,IRON PANEL,IRON,Phencyclidine,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn
0.592,0.49333333333333335,0.9866666666666667,0.592,0.49333333333333335,0.9866666666666667,0.40795382993965124,0.5255474069833806,0.530075858529406,0.40795382993965124,0.5255474069833806,0.530075858529406,1,497818,MITOCHONDRIAL M2 AB,MITOCHONDRIAL M2 AB,Mitochondria M2 Ab,Mitochondria M2 Ab [Units/volume] in Serum,Mitochondria M2 Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,203927,CBC WITH AUTO DIFF,MCV,Sample icteric,Sample icteric [Presence] of Serum or Plasma Qualitative,Sample Icteric SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,HCV RNA QUANT BDNA,HCV RNA QN BDNA,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7880,QUESTASSURED TM 25OHD D2 D3,VITAMIN D 25 OH TOTAL,Erythrocyte distribution width,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto
0.0,0.0,0.0,0.4,0.5171428571428571,0.6666666666666666,0.0,0.0,0.0,0.07351377561058281,0.18661673850657123,0.09866725380717944,1,81018,LYMPHOCYTE SUBSET PANEL 3,% CD8 SUPPRESSOR T CELLS,Cells.CD3+CD8+/100 cells,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,273532,NGI HCV QUANTASURE,HEPATITIS C QUANTITATION,Estimated average glucose,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204081,RPR SCREEN W TITER,RPR SCREEN,Leukocytes,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24729,SPECIAL PROFILE 3619,LEUKOCYTE ESTERASE,IgM,IgM [Mass/volume] in Serum or Plasma,IgM SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,QUESTASSURED 25 OH VIT D D2 D3 LC MS MS,VITAMIN D 25 OH D2,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,CBC WITH DIFFERENTIAL,IMMATURE GRANS,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,GLU RFX HA1C IF ABN,GLU RFX HA1C IF ABN,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.2,0.16666666666666666,0.0,0.19,0.16666666666666666,0.3333333333333333,0.009814692540447978,0.007699380476897,0.0,0.0,0.05427054155128297,0.0946521642027649,1,7146,MANUAL DIFFERENTIAL,EOSINOPHILS %,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,58115,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE MONOS,Specific gravity,Specific gravity of Urine by Test strip,Sp Gr Ur Strip
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,DRG TOX CRT REFL SPEC GR,CREATININE,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.596,0.548,0.435,0.348,0.148,0.185,0.0074752449497415,0.0224257348492245,0.05956676211255352,0.024494182533464692,0.0,0.0,1,345355,ALBUMIN CREATININE RATIO URINE RANDOM,CALC ALBUMIN CREAT RND,Microalbumin/Creatinine ratio panel,Microalbumin/Creatinine panel in random Urine,Microalbumin/Creat ratio pnl Ur
0.0,0.0,0.0,0.0,0.1142857142857143,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,139519,FIBROACT COMPLETE,APOLIPOPROTEIN A1,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,241109,URINALYSIS WITH MICROSCOPIC,GLUCOSE,Treponema pallidum Ab,Treponema pallidum Ab [Presence] in Serum by Immunoassay,T pallidum Ab Ser Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,FIBROACT COMPLETE,WEIGHT LBS,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,98301,HEPATITIS C GENO TYPE 1 NS5A RESIST,OMBITASVIR RESISTANCE,Cholesterol.total/Cholesterol.in HDL,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,Cholest/HDLc SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25015,URINALYSIS COMPLETE,BILIRUBIN,Iron binding capacity.unsaturated,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.051666666666666666,0.062,0.0,0.0,0.0,0.0,0.0,0.0,0,63016,PROSTATE SPECIFIC ANTIGEN PSA,PSA,Coagulation tissue factor induced.INR,INR in Platelet poor plasma by Coagulation assay,INR PPP
0.0,0.16,0.0,0.3225,0.2,1.0,0.0,0.05043482321394899,0.0,0.08103461702415493,0.12353958214165095,1.0,1,192708,DRUG ABUSE SCREEN 10 REFLEX CONFIRM,BARBITURATES,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205070,HEPATITIS PANEL AMA,HEPATITIS C ANTIBODY,Reagin Ab,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql
0.0,0.0,0.0,0.22,0.16666666666666666,0.5,0.0,0.0,0.0,0.0,0.09805016057751559,1.0,1,151522,FSRC NEW PATIENT PANEL,D BILIRUBIN,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,RPR REFLEX PER CDC,RPR,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.31,0.22,0.9533333333333333,0.31,0.22,0.9533333333333333,0.023896941029320717,0.07158714895716911,0.5345224838248488,0.03161268152937924,0.09470089660440306,0.7071067811865476,1,204479,HIV 1 RNA QUANTITATIVE REAL TIME PCR,HIV 1 RNA QN PCR,HIV 1 RNA,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,HIV1 RNA # SerPl NAA+probe
0.0,0.0,0.0,0.0,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.042260315089851286,0.0,0,7534,CBC INCLUDES DIFF PLATELETS,MEAN PLATELET VOLUME,Neutrophils,Neutrophils [#/volume] in Blood by Manual count,Neutrophils # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,HCV AB W RFL RNA RFL GENO,HEPATITIS C AB,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,20644,ANA AMA ASMA LKM AB,MITOCHONDRIAL M2 ANTIBODY,Ceruloplasmin,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7492,CMP12 LP 6AC,CHOLESTEROL TOTAL,Myelocytes/100 leukocytes,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual
0.0,0.0,0.0,0.0,0.08,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0,311472,CLR CBC W DIFF PLT,ABSOLUTE EOSINOPHILS,Reagin Ab,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr
0.0,0.0,0.0,0.25,0.25,0.3333333333333333,0.0,0.0,0.0,0.0769832768017027,0.08055537486383768,0.09169555407390673,1,301804,CBC WITH DIFFERENTIAL,BASOPHILS,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205674,TRIGLYCERIDES REFL,TRIGLYCERIDES,Ferritin,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,Ferritin SerPl IA-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,CMP14 2AC MG,EGFR IF NONAFRICN AM,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30262,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE LYMPHOCYTES,Thyroxine,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30940,SMOOTH MUSCLE AB RFX TITER,F ACTIN IGG,Urea nitrogen,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495416,CBC WITH MANUAL DIFFERENTIAL ABSOLUTE WBC,ABSOLUTE MONOCYTES,Fasting status,Fasting status - Reported,Fasting status Patient Ql Reported
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,143164,HIV AB EIA WITH REFLEXES,HIV AB,Benzodiazepines,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,148692,DRUG ABUSE SCREEN CLINICAL 9,COCAINE,Pathologist review,Pathologist review of Blood tests,Path Rev Bld -Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21576,CBC W AUTO DIFF,BASOPHILS ABSOLUTE,Creatine kinase,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,487942,FIBROACT,ALT,Fibrosis stage,Fibrosis stage,Fibrosis stage SerPl Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7062,TSH FREE T4 PROFILE,TSH THIRD GENERATION,Basophils/100 leukocytes,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25023,CREATININE,LIPEMIA,Iron saturation,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57786,IMMUNOFIXATION SERUM,IGG SERUM NR,Color,Color of Urine,Color Ur
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28654,HEPATITIS B CORE IGM ANTIBODY,HEP B CORE IGM ANTIBODY,Alpha 1 globulin,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc
0.0,0.0,0.0,0.3333333333333333,0.2,1.0,0.0,0.0,0.0,0.0834655896020069,0.34003516797720323,1.0,1,28233,CMP12 LP TP TSH 6AC CBC D PLT,POTASSIUM,Potassium,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,115790,CBC WITH AUTO DIFF,BASOPHILS ABSOLUTE,Thyrotropin,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192955,CBC INC DIFF PLT,ABSOLUTE MONOCYTES,Opiates,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30973,NGI HCV SUPERQUANT,INTERNATIONAL UNITS,Urea nitrogen/Creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,BUN/Creat SerPl
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,747741,HCV QUANT GT1A NS5A PROFILE,HCV NS5A RESISTANCE ASSAY PDF,Glucose,"Glucose [Mass/volume] in Serum, Plasma or Blood",Glucose SerPlBld-mCnc
0.0,0.0,0.0,0.3333333333333333,0.3333333333333333,0.5,0.0,0.0,0.0,0.08432989233649546,0.08432989233649546,0.1503314858492919,1,31377,NASH FIBROSURE,HEIGHT,Body height,Body height Measured,Body height Measured
0.235,0.39999999999999997,0.7,0.235,0.39999999999999997,0.7,0.0,0.08338254724112037,0.1063004130698838,0.0,0.08338254724112037,0.1063004130698838,1,327692,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,ALPHA 1 ANTITRYPSIN AAT PHENOTYPE,Alpha 1 antitrypsin phenotyping,Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma,A1AT Phenotyp SerPl-Imp
0.2,0.375,0.75,0.2,0.375,0.75,0.03080009996173494,0.0,0.0,0.03080009996173494,0.0,0.0,0,139550,HCV NS5A DRUG RESISTANCE ASSAY,HCV NS5A DRUG RESISTANCE ASSAY,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,CARDIO CRP R,CARDIO CRP R,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,265058,CBC INCLUDES DIFF PLT WITH SMEAR REVIEW,MPV,Neutrophils.segmented/100 leukocytes,Segmented neutrophils/100 leukocytes in Blood,Neuts Seg/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823773,LYMPHOCYTE SUBSET PANEL 4,% CD8 SUPPRESSOR T CELLS,Ledipasvir,Ledipasvir [Susceptibility] by Genotype method,Ledipasvir Islt Genotyp
0.0825,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,57927,NGI HCV QUANTASURE,HEPATITIS C QUANTITATION,Glucose,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7708,HEPATITIS PANEL DIAGNOSTIC,HEPATITIS B SURFACE AB,Neutrophils/100 leukocytes,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,ACCUTYPE R IL28B,IL28B GENOTYPE,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,149575,HEPATITIS C VIRAL RNA NS3 GENOTYPE,TELAPREVIR RESISTANCE,Albumin,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,LIPID PROFILE,CHOLESTEROL,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,52217,URINALYSIS W REFLEX MICRO,OCCULT BLOOD,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7633,HEPATIC FUNCTION PANEL AMA,BILIRUBIN DIRECT,Neutrophils.band form,Band form neutrophils [#/volume] in Blood by Manual count,Neuts Band # Bld Manual
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19208,SEDIMENTATION RATE WESTERGREN,SEDIMENTATION RATE WESTERGREN,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,303925,CBC WITH DIFFERENTIAL PLATELETS,POLYS,Erythrocytes.nucleated,Nucleated erythrocytes [#/volume] in Blood,nRBC # Bld
0.06,0.04,0.072,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,139527,COMPREHENSIVE METABOLIC PANEL REFL,UREA NITROGEN BUN,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,HBV core Ab SerPl Ql IA
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,23366,CBC WITH PLT DIFF,MEGAKARYOCYTE FRAGS,Globulin,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7047,SPECIAL PROFILE 3619,LEUKOCYTE ESTERASE,Basophils,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto
0.0,0.01,0.02,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,PTH INTACT MOLECULE,PTH,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,24653,CBC WITH DIFFERENTIAL PLATELETS,ABSOLUTE NEUTROPHILS,IgG,IgG [Mass/volume] in Serum or Plasma,IgG SerPl-mCnc
0.0,0.0,0.0,0.0,0.465,0.465,0.0,0.0,0.0,0.0,0.7071067811865476,0.7071067811865476,1,82511,LYMPHOCYTE SUBSET PANEL 2,COMMENT S,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,330373,HEPATITIS C AB,HEPATITIS C AB,Anion gap,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,28902,ACUTE HEPATITIS PANEL,HEPATITIS C ANTIBODY,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.07142857142857142,0.16666666666666666,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19885,CBC INCLUDES DIFF PLT,BASOPHILS %,C reactive protein,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,823799,AMYLASE SERUM,AMYLASE SERUM,Daclatasvir,Daclatasvir [Susceptibility] by Genotype method,Daclatasvir Islt Genotyp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,244673,CBC INC DIFF PLT,PLATELET COUNT,Cells.CD3+CD4+,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld
0.0,0.0,0.0,0.1075,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,882936,RENAL PANEL 10,EGFR IF AFRICN AM,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,HEPATITIS A DIAGNOSTIC PANEL,HAV AB TOTAL,Service comment,Service comment,Service Cmnt XXX-Imp
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,285403,AFP TUMOR MARKER SIEMENS IMMULITE,AFP TUMOR MARKER,Erythrocyte mean corpuscular hemoglobin concentration,MCHC [Mass/volume],MCHC RBC-mCnc
0.10333333333333333,0.062,0.31,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,30346,HEPATITIS C VIRAL RNA GENOTYPE 1 NS,OMBITASVIR RESISTANCE,Transferrin,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,264788,PE INTERP RFX IFE S,BETA GLOBULIN,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,CBC WITH DIFFERENTIAL,NO CELLS DIFF,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,21618,CMP14 LP 7AC CBC D PLT T B,AMYLASE SERUM,Creatinine,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,CBC WITH PLT DIFF,OTHERS,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,141358,LIPID PANEL,LDL CALC,Cells.CD3+CD8+,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,22368,LIVER FIBROTEST ACTITEST,HAPTOGLOBIN,Calciferol,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc
0.4,0.3814285714285714,0.6675,0.4,0.3814285714285714,0.6675,0.47662402489215927,0.01604041949885182,0.018644381728446624,0.47662402489215927,0.01604041949885182,0.018644381728446624,1,139519,HAV AB TOTAL,HAV AB TOTAL,Hepatitis A virus Ab,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA
0.2,0.17142857142857146,0.0,0.292,0.2571428571428572,0.9,0.03285364306619687,0.0,0.0,0.008931533211845588,0.45222488980749964,1.0,1,204537,URINALYSIS W REFLEX MICRO,EPITHELIAL CELLS,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,19711,HEPATITIS ABC PANEL,HEPATITIS A ANTIBODY TOTAL,Bilirubin.non-glucuronidated,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,205088,LIPOPROTEIN ANALYSIS NMR,LDL P,Reagin Ab,Reagin Ab [Units/volume] in Serum by RPR,RPR Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7765,CHEM SCREEN PANEL,EGFR NON AFR AMERICAN,Platelet mean volume,Platelet mean volume [Entitic volume] in Blood by Rees-Ecker,PMV Bld Rees-Ecker
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,45427,CMP13 LP TP TSH 2AC CBC D P,CHOLESTEROL TOTAL,Haptoglobin,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc
0.0,0.0,0.0,0.09375,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486423,ASH FIBROSURE,APOLIPOPROTEIN A 1,Glomerular filtration rate/1.73 sq M.predicted.non black,"Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pr.non blk SerPlBld MDRD-ArV
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,59055,LIPID PROFILE WITH CALCULATIONS NON HDL CHOLESTEROL,RISK RATIO CHOL HDL,Monocytes/100 leukocytes,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,25007,HEPATIC FUNCTION PANEL,INDIRECT BILI,Iron binding capacity,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,495499,CBC WITH PLT DIFF,BLASTS,Reference lab test method,Reference lab test method,Ref lab test method
0.0,0.25,0.0,0.0,0.0,0.0,0.0,0.02948276095739455,0.0,0.0,0.0,0.0,0,265157,COMPLETE BLOOD COUNT CBC W AUTOMATED DIFF,RDW,Platelets,Platelets [#/volume] in Blood,Platelet # Bld
0.0,0.0,0.0,0.25,0.16699999999999998,0.5,0.0,0.0,0.0,0.049020432311290385,0.0,0.0,1,302398,NASH FIBROSURE,AST SGOT P5P,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,130682,PROTEIN ELECTRO S,ALPHA 2 GLOBULIN,Nuclear Ab pattern,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp
0.11,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204057,STOOL CULTURE,RESULT 1,Urobilinogen,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.05957327454539674,0.0,0.0,0.05957327454539674,0.0,0,52217,C4 SERUM,C4 SERUM,HIV 1 Ab,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,HIV1 Ab SerPl Ql IB
0.5,0.5714285714285714,1.0,0.0,0.2857142857142857,0.5,0.02835463752905909,0.041329352180867085,0.04229321806927422,0.0,0.08666100167154711,0.08868207335447242,1,223271,HEPATITIS C AB REFLEX HCV RNA QUANT,HEPATITIS C ANTIBODY,Hepatitis C virus Ab,Hepatitis C virus Ab [Units/volume] in Serum,HCV Ab Ser-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,17988,LIPID PANEL WITH LDL HDL RATIO,LDL HDL RATIO,Amylase,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,HEPATITIS PANEL ACUTE,HEPATITIS C ANTIBODY,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,COMPREHENSIVE METABOLIC PANEL AMA,CHLORIDE,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,305250,VITAMIN B12 FOLATE,FOLATE SERUM,Age,Age,Age
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,81224,DIFFERENTIAL MANUAL,NEUTROPHILS,Cells.CD3,CD3 cells [#/volume] in Blood,CD3 Cells # Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51953,ALPHA 1 ANTITRYPSIN PHENOTYPE,ALPHA 1 ANTITRYPSIN,Hepatitis B virus surface Ag,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,191239,COMP METABOLIC PANEL,SODIUM,Magnesium,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,349993,CMP14 HP4 DBILI CBC D PLT R,EOS ABSOLUTE,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes in Blood,Polys/leuk NFr Bld
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,NEG HIV 4TH GEN,NEG HIV 1 ANTIBODY,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,COMPREHENSIVE METABOLIC PANEL WITH CALC ANION GAP,ALT,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,134577,CBC WITH DIFFERENTIAL,EOSINOPHILS,Cholesterol.in LDL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7302,LYMPHOCYTE SUBSET PANEL 4,ANALYZED DATE TIME NR,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual
0.055,0.033,0.0,0.09999999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,302398,COMP METAB PANEL,GLUCOSE FASTING,Aspartate aminotransferase,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,AST SerPl w P-5'-P-cCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,82511,ASH FIBROSURE,WEIGHT,Service comment,Service comment,Service Cmnt XXX-Imp
0.4333333333333333,0.192,0.27,0.4333333333333333,0.364,0.41,0.0,0.030812935781862727,0.015750799349785072,0.0,0.16979300806363473,0.08679392382276507,1,28902,PROTEIN TOTAL URINE,PROTEIN CR RATIO,Protein/Creatinine,Protein/Creatinine [Mass Ratio] in Urine,Prot/Creat Ur
0.0,0.047142857142857146,0.066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,169334,CBCI COMPLETE BLOOD COUNT W DIFF,MCV,Hepatitis B virus core Ab,Hepatitis B virus core Ab [Presence] in Serum,HBV core Ab Ser Ql
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,27318,TSH,TSH,Parathyrin.intact,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc
0.0,0.0625,0.125,0.16,0.05,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0,139550,CBC W AUTO DIFF,ABS BASOPHILS,Hepatitis C virus Ab,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,HCV Ab SerPl Ql IA
0.0,0.053000000000000005,0.0,0.0,0.053000000000000005,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,51938,CERULOPLASMIN,CERULOPLASMIN,Hepatitis B virus surface Ab,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,HBV surface Ab SerPl IA-aCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,7138,CBC WITH PLT DIFF,PLATELET MORPHOLOGY,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto
0.0,0.06666666666666667,0.25,0.0,0.07666666666666666,0.2875,0.0,0.05117681691383591,0.14539805437566944,0.0,0.0,0.0,0,381806,HEPATITIS PANEL DIAGNOSTIC,HEP B CORE TOTAL AB,Hepatitis C virus RNA,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,HCV RNA SerPl NAA+probe-Log IU
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,192708,VITAMIN D 25 HYDROXY LC MS MS,VITAMIN D 25 OH TOTAL,Barbiturates,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn
0.0,0.0,0.0,0.0,0.05263157894736842,0.0,0.0,0.0,0.0,0.0,0.0193445730832027,0.0,0,486431,IGG SUBCLASSES,IMMUNOGLOBULIN G QN SERUM,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,151522,NEG HIV 4TH GEN,NEG HIV 2 ANTIBODY,Bilirubin.glucuronidated,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,Bilirub Conj SerPl-mCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,544346,CBC COMPLETE BLOOD COUNT W O DIFF,MCV,Lipoprotein.beta.subparticle,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,LDL SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,486431,FOLATE,FOLATE,Glomerular filtration rate/1.73 sq M.predicted.black,"Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",GFR/BSA pred.black SerPlBld MDRD-ArVRat
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,50484,CREATINE KINASE CK,CREATINE KINASE CK,Nuclear Ab,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,104661,CYCLIC CITRULLINATED PEPTIDE CCP AB IGG,CYCLIC CITRULLINATED PEPTIDE CCP AB IGG,Anion gap 3,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc
0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,204537,PAIN MANAGEMENT 8,CREATININE,Epithelial cells,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro
0.0,0.05142857142857143,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,716951,RPR REFLEX TP PA,RPR TITER,Granulocytes.immature/100 leukocytes,Immature granulocytes/100 leukocytes in Blood by Automated count,Imm Granulocytes/leuk NFr Bld Auto
